Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AATF	"BFR2, CHE-1, CHE1, DED"	ENSG00000275700	"Apoptosis antagonizing transcription factor"	Q9NY61	17	36948875-37056871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 137.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004940, HPA075963"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA004940: AB_1078075, HPA075963: "	"unprognostic (1.10e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.21e-3)"	8.2	6.8	5.7	11.4	9.8	14.4	7.1	7.5	6.9	7.5	8.8	9.2	7.5	6.2	9.7	6.3	7.6	8.2	7.5	9.8	5.9		7.6	8.7	6.8	11.0	10.1	4.5	11.1	8.8	8.5	5.2	11.1	8.3	7.1	8.6	4.6	6.7	9.2	13.0	8.3	8.5	8.5	7.9	11.2	7.0	8.7	10.2	18.5	9.5	7.2	13.1	10.4	13.5	19.4	18.8	32.1	27.3	20.5	27.2	19.0	20.8	33.7	7.3	14.7	9.9	11.5	13.5	13.4	9.8	15.3	13.6	23.1	14.6	37.7	17.1	11.6	24.6	18.4	27.7	15.4	20.7	19.1	20.7	17.5	13.3	16.1	12.1	28.1	14.9	10.1	27.7	19.7	17.6	13.6	11.0	18.4	24.2	11.3	13.2	15.2	30.9	21.3	9.3	12.0	12.9	20.0	22.1	20.2	12.7	18.4	15.9	6.9	19.7	8.1	18.0	16.8	14.1	14.5	12.3	11.8	20.0	25.0	42.0	12.8	18.2	28.4	14.7	21.0	20.8	14.2	20.2	32.1	23.9	27.3	23.5	18.0	21.5	25.0	18.8	19.4	19.6	19.6	26.1	20.5	25.9	17.4	27.2	19.0											20.8	28.8	32.8	36.7	38.8	12.4	16.1	28.1	36.1	40.9	24.4	21.6	62.0	8.3	31.9	21.4	24.3	32.8	23.3	41.6	49.6	22.2	22.9	46.2	13.9	41.7	17.5	15.4	8.6	24.5	50.0	21.9	36.5	27.0	64.9	22.6	26.9	40.2	25.9	21.9	36.9	22.5	32.3	37.3	47.2	30.2	38.3	137.1	42.4	29.3	33.1
ABCF3	EST201864	ENSG00000161204	"ATP binding cassette subfamily F member 3"	Q9NUQ8	3	184186023-184194012	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036332	Approved		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA036332: AB_10603571"	"unprognostic (1.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.53e-2)"	13.0	47.0	18.9	10.6	19.7	12.4	12.7	23.0	27.2	15.3	12.1	15.4	33.8	13.1	13.5	11.1	16.1	15.0	10.8	22.9	15.4	16.8	16.5	22.3	12.1	12.7	15.4	15.1	17.8	19.7	41.6	17.9	16.0	19.8	13.3	11.8	15.5	21.4	30.1	33.8	15.2	12.8	10.8	12.3	14.9	13.3	12.6	18.6	8.8	15.4	14.4	14.2	12.5	13.8	16.1	16.4	13.9	19.4	14.5	25.4	21.5	21.9	13.6	7.8	15.0	22.8	12.8	15.4	16.0	17.9	21.7	17.1	23.2	8.8	13.3	32.4	17.1	25.5	21.1	12.1	16.8	11.3	16.9	11.6	11.4	11.9	13.6	19.2	12.8	11.7	18.8	15.5	15.3	15.3	12.8	15.5	11.7	10.5	16.1	15.3	26.5	12.5	8.2	11.8	22.8	18.9	12.6	13.0	22.3	11.9	13.3	13.5	7.8	16.5	31.8	14.7	8.9	43.0	11.3	15.1	11.7	12.7	18.2	23.6	18.2	17.5	17.1	18.1	12.8	14.3	5.3	18.6	13.9	22.7	19.4	23.5	16.0	20.1	18.7	16.4	16.1	25.4	20.5	9.3	14.5	19.1	10.1	17.2	21.5	18.9	19.7	23.0	27.2	15.4	16.8	15.4	15.1	19.8	18.6	8.9	1.3	14.9	9.2	12.9	15.7	10.5	12.7	4.0	4.5	14.0	13.7	32.3	24.9	18.7	6.1	9.2	19.0	0.0	19.5	21.8	10.8	7.8	9.2	18.1	18.8	19.1	10.9	14.1	10.3	7.6	11.5	8.1	15.1	28.9	12.7	13.7	17.3	10.2	11.0	23.7	20.6	6.5	7.3	10.7	14.7	8.9	36.6	15.4	13.1	11.5
ABTB1	"BPOZ, Btb3, BTBD21, EF1ABP"	ENSG00000114626	"Ankyrin repeat and BTB domain containing 1"	Q969K4	3	127672935-127680920	"Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 107.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 107.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035022, HPA035023"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA035022: AB_10669998, HPA035023: AB_10602104"	"unprognostic (6.76e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.55e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.92e-3)"	20.4	13.7	11.7	17.7	20.1	42.3	14.2	43.4	27.2	15.4	14.3	13.8	12.9	12.3	15.6	10.9	9.6	13.1	17.6	20.4	10.9	8.2	11.4	8.3	15.5	22.1	9.7	15.8	15.8	11.2	7.8	15.3	12.0	11.4	13.5	4.9	12.4	15.2	14.5	25.1	11.6	13.0	13.3	7.5	41.4	11.7	5.9	12.5	17.8	10.2	9.1	10.4	14.6	17.4	2.9	3.8	107.3	8.6	3.2	5.8	5.1	3.1	7.6	0.7	1.5	7.2	6.9	5.8	5.0	8.7	3.5	4.8	0.2	6.7	1.4	9.0	3.8	4.3	1.4	0.0	3.8	0.8	14.7	2.1	2.3	13.5	1.8	5.8	0.3	7.1	8.6	4.1	3.5	0.9	11.3	3.6	5.9	0.1	10.3	3.7	5.0	3.5	9.9	0.6	3.6	8.4	2.2	4.2	9.8	5.2	2.0	7.0	4.7	3.6	4.4	18.2	1.9	1.1	2.6	6.6	3.6	3.1	6.5	1.6	8.4	2.7	0.4	8.5	2.9	5.7	4.5	8.6	20.5	2.4	6.2	2.3	2.5	2.6	2.3	3.8	2.9	2.2	1.9	107.3	3.2	5.4	2.4	5.8	5.1	11.7	20.1	43.4	27.2	10.9	8.2	9.7	15.8	11.4	12.5	17.9	18.3	15.2	14.1	10.4	9.9	6.2	10.2	4.0	2.3	7.0	17.7	6.5	13.3	12.2	0.4	13.5	12.4	0.0	15.1	20.9	14.5	11.3	14.9	8.5	19.9	3.2	23.0	23.4	52.6	1.9	31.4	20.7	10.1	45.9	16.6	16.2	19.1	23.0	21.2	17.0	30.1	64.7	31.9	0.7	6.8	8.2	13.3	46.5	11.2	8.4
AC008560.1		ENSG00000253251	"Uncharacterized protein FLJ26957 "	Q6ZNX1	5	65624765-65630891	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"Alveolar cells type 2: 1.4;Ciliated cells: 1.4;Club cells: 2.3;Cytotrophoblasts: 3.3;Extravillous trophoblasts: 3.7;Hofbauer cells: 3.1;Syncytiotrophoblasts: 4.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA066071, HPA068764"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA066071: AB_2685609, HPA068764: AB_2686028"	"unprognostic (7.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.09e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.17e-4)"	5.8	7.1	7.3	6.5	13.1	31.5	10.0	8.7	13.3	5.4	6.6	7.1	5.5	7.0	5.9	7.4	6.3	5.3	6.1	4.9	8.2	7.9	11.6	9.7	6.2	9.9	9.9	8.0	5.9	8.7	3.8	13.1	6.5	11.3	10.7	7.6	5.7	6.4	6.6	6.6	7.0	7.6	7.8	9.1	8.9	6.0	7.5	8.6	10.4	6.9	6.4	8.3	5.3	5.0	5.0	4.4	13.4	4.1	6.3	8.8	2.9	2.7	3.7	5.7	11.9	3.3	3.8	6.8	4.3	3.8	6.0	7.7	6.4	8.7	5.0	4.9	5.0	7.1	3.6	5.5	5.2	9.2	6.7	6.9	4.6	9.6	8.5	2.6	5.0	7.9	2.3	7.3	6.4	6.8	1.8	4.1	8.5	6.5	11.9	5.0	7.1	7.1	7.3	4.5	1.6	2.2	4.9	5.4	7.9	5.0	6.0	7.7	5.8	3.8	3.5	10.8	3.9	4.2	4.5	3.1	5.7	7.5	4.4	6.8	7.5	13.8	11.2	4.2	6.2	5.2	13.4	4.1	7.5	5.4	3.7	5.7	5.0	6.5	5.6	3.7	4.9	8.8	8.1	4.3	6.3	4.1	4.4	7.9	2.9	7.3	13.1	8.7	13.3	8.2	7.9	9.9	8.0	11.3	8.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979363	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.6"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 185.5;Hepatocytes: 244.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 22.9;neutrophil: 38.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 38.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 35.3;RT4: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes		NA	NA		160000	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	21.8	12.9	8.8	8.3	10.2	4.2	13.6	6.4	9.8	6.4	26.5	8.2	9.6	31.0	6.6	6.7	19.5	6.0	12.3	16.0	8.3	7.9	20.8	95.6	9.2	7.5	8.2	8.3	7.6	28.7	9.8	8.9	13.6	7.8	9.5	14.3	11.3	9.5	9.1	18.3	13.4	53.1	7.9	6.7	7.2	13.6	6.2	6.3	7.1	9.1	11.4	10.6	10.6	7.9	1.6	3.3	38.6	5.8	2.1	2.7	2.2	5.4	7.7	2.5	3.8	13.3	5.6	35.3	4.0	4.0	4.8	5.5	5.4	9.0	3.1	4.3	6.8	4.5	3.3	10.7	4.2	7.6	2.8	3.2	4.0	4.4	17.7	7.2	3.4	2.6	9.3	3.3	5.4	3.6	5.1	12.0	4.3	4.1	3.1	5.3	16.1	7.6	2.5	1.9	13.5	6.7	4.2	7.7	3.6	8.1	47.5	3.1	4.6	11.4	17.8	3.8	8.7	10.9	3.9	7.9	6.7	4.9	5.4	3.8	5.1	3.5	1.2	3.9	3.2	3.9	22.9	5.8	1.6	2.1	4.5	2.7	1.6	2.0	2.7	3.3	1.6	2.4	2.3	38.6	2.1	2.8	2.9	2.6	2.2	8.8	10.2	6.4	9.8	8.3	7.9	8.2	8.3	7.8	6.3	26.8	20.6	3.0	13.1	11.9	23.8	38.6	48.4	14.7	18.2	22.7	21.6	32.5	18.3	19.8	8.4	14.6	185.5	23.3	35.6	39.3	17.0	27.2	16.2	244.8	23.1	17.5	33.1	22.1	31.8	6.5	27.6	19.9	13.5	25.2	35.0	64.2	31.5	87.7	44.2	74.6	28.4	0.0	16.4	5.6	10.7	26.5	36.2	10.2	32.4	22.6
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732573-111118222	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 29.7;lung: 20.8;placenta: 23.8"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 27.4"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"A-431: 9.1;RPMI-8226: 16.5;RT4: 21.3;U-266/70: 14.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA035392: AB_2674604, HPA035393: AB_2674605"	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.48e-4)"	0.3	0.3	0.2	0.5	0.4	1.6	0.3	0.2	0.4	0.4	0.4	0.2	2.3	0.0	0.3	29.7	0.2	0.5	0.4	0.3	0.2	0.2	0.6	0.2	20.8	0.6	0.2	0.2	0.2	0.4	4.9	0.7	23.8	0.4	4.1	0.1	0.2	0.5	0.2	0.3	0.4	0.3	2.6	0.2	1.3	0.4	4.6	0.2	0.6	1.5	0.2	0.9	8.5	5.2	1.0	0.6	4.1	1.1	0.7	0.6	0.3	9.1	0.0	0.2	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.6	0.2	0.2	0.1	0.2	1.0	0.0	0.0	0.0	0.2	3.2	0.2	0.4	0.2	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.3	0.0	0.4	1.4	1.4	0.1	3.3	0.7	0.4	3.1	0.1	0.4	0.1	0.2	16.5	0.0	21.3	2.0	0.4	0.1	0.4	0.1	0.7	0.2	1.0	0.3	0.2	0.4	0.2	0.1	14.4	3.7	0.5	0.1	0.2	0.2	2.2	1.1	0.5	0.4	0.7	0.2	1.0	0.4	0.6	0.2	0.8	0.5	0.4	4.1	0.7	0.4	0.6	0.4	0.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	0.0	27.4	0.0	0.2	0.2	0.6	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.1	0.0	1.2	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.3	0.9	2.2	0.3	0.0	0.0	0.0	0.7
ACVR1	"ACVR1A, ACVRLK2, ALK2, SKR1"	ENSG00000115170	"Activin A receptor type 1"	Q04771	2	157736444-157875862	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007505, HPA046514"	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA007505: AB_1844752, HPA046514: AB_2732526"	"unprognostic (6.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.17e-4)"	18.9	9.2	18.0	10.0	12.7	1.6	38.7	15.3	12.2	25.2	14.4	7.4	8.4	8.9	24.8	26.8	11.0	16.6	20.5	18.8	18.7	8.6	21.7	18.9	22.5	15.1	10.4	7.9	18.5	12.3	11.3	17.0	14.2	12.3	16.8	10.5	14.3	18.1	13.6	15.6	12.8	11.5	29.2	12.3	9.2	11.8	8.8	10.9	7.5	34.0	14.6	6.9	16.1	32.5	1.4	2.4	3.8	2.6	1.9	10.0	1.6	2.1	4.3	5.0	6.5	25.4	26.5	7.0	15.4	25.6	12.4	13.2	3.4	4.8	0.0	7.1	16.6	12.0	6.0	3.6	8.3	13.3	14.7	3.1	8.7	2.5	4.9	20.1	0.6	10.4	33.2	15.8	25.3	32.3	16.2	13.4	2.4	3.2	2.4	15.5	3.8	0.1	0.2	7.5	3.0	7.8	1.4	6.7	1.8	16.0	8.1	4.4	5.5	5.9	3.4	21.1	8.2	1.8	2.3	19.3	18.8	6.2	9.2	5.8	1.6	1.2	0.1	19.3	0.5	20.2	3.8	2.6	0.2	1.1	1.7	1.2	1.4	7.8	2.5	1.8	0.8	3.1	1.5	0.8	1.9	2.3	2.4	10.0	1.6	18.0	12.7	15.3	12.2	18.7	8.6	10.4	7.9	12.3	10.9	8.9	7.0	0.8	6.8	8.8	7.5	9.2	12.7	6.7	9.1	7.0	0.0	7.0	5.0	8.4	0.5	13.5	3.1	0.0	15.5	4.4	11.6	8.9	4.7	12.1	6.5	3.2	4.1	17.2	11.6	1.1	18.7	7.7	3.3	3.6	5.2	6.1	14.7	3.5	14.9	15.3	1.5	12.9	15.5	0.5	2.5	6.6	8.8	1.0	3.5	7.6
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892192	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	16	"Ito cells: 17.8;Leydig cells: 20.4;Peritubular cells: 16.6;Sertoli cells: 51.8;Smooth muscle cells: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 20.2;hTERT-RPE1: 36.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"	NA	NA			Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: AB_2732278"	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (6.78e-4)"	13.7	5.4	0.2	2.5	0.8	0.0	17.6	0.3	1.0	6.0	3.0	2.3	2.6	0.6	13.0	4.4	1.4	3.1	5.9	1.4	0.3	0.6	2.0	2.1	9.4	4.2	1.2	0.2	4.9	8.7	1.2	0.9	5.5	2.1	6.7	1.4	2.7	4.4	4.2	4.1	2.0	1.6	9.4	6.5	0.6	1.8	5.0	0.3	0.1	2.6	4.1	1.6	4.3	7.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.4	0.3	10.4	0.0	15.4	7.3	0.0	5.4	13.9	7.1	8.8	0.0	0.0	0.0	0.0	3.7	12.6	0.3	0.2	7.0	10.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	5.8	0.0	20.2	5.3	36.2	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	12.2	15.6	0.1	3.2	1.8	1.3	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	1.0	0.3	0.6	1.2	0.2	2.1	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.2	3.3	0.4	0.0	0.0	0.2	0.2	12.8	0.1	0.0	0.0	0.5	0.0	0.0	17.8	0.3	2.5	20.4	0.0	6.8	0.0	0.0	6.7	0.2	0.0	16.6	2.2	0.2	51.8	14.2	0.2	1.7	0.6	0.7	0.0	0.0	0.1
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase, RNA specific"	P55265	1	154582062-154627999	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	36.1	33.1	30.3	36.6	44.4	43.1	29.7	41.4	50.8	30.7	28.2	33.3	19.9	31.4	38.0	26.5	27.7	32.9	28.9	24.0	25.7	38.1	31.5	36.0	34.7	41.3	27.3	32.6	39.2	29.5	46.2	38.4	33.9	39.8	28.8	31.1	32.2	36.7	30.2	14.0	27.0	40.6	36.3	24.4	47.7	29.1	21.9	26.9	57.6	32.8	16.7	41.9	29.7	27.6	7.8	6.1	25.1	8.6	6.4	9.7	5.6	26.6	30.9	26.5	32.6	26.8	27.8	31.5	18.4	36.9	61.6	53.5	26.6	26.2	48.0	29.7	29.3	34.2	25.9	33.8	34.9	31.4	46.6	16.9	25.0	21.9	15.0	29.2	35.3	27.8	27.0	25.5	31.5	32.3	25.2	31.5	34.7	23.6	37.0	21.5	32.5	42.6	18.2	43.7	35.7	23.3	40.8	21.8	38.6	21.1	29.7	26.4	31.5	31.7	51.3	37.6	41.3	34.5	43.5	28.7	22.1	21.8	18.2	21.2	43.8	48.0	51.6	21.5	23.3	24.9	6.9	6.6	12.0	9.4	8.3	8.8	7.8	9.4	9.7	6.1	6.2	8.8	8.6	25.1	6.4	8.6	5.5	7.1	5.6	30.3	44.4	41.4	50.8	25.7	38.1	27.3	32.6	39.8	26.9	77.4	46.4	72.2	33.2	29.7	90.3	15.5	33.1	41.5	43.3	45.4	90.3	33.7	8.3	43.8	3.6	83.1	68.1	23.3	58.0	42.0	39.5	47.9	61.1	78.8	46.9	158.9	60.6	78.0	80.2	9.5	68.1	57.4	18.6	68.5	54.5	46.8	58.0	53.7	55.5	36.0	81.7	51.8	36.9	11.7	23.2	35.3	26.3	58.3	48.2	41.3
AGTPBP1	"CCP1, KIAA1035, Nna1"	ENSG00000135049	"ATP/GTP binding protein 1"	Q9UPW5	9	85546539-85742029	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.2"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057208, HPA071094"	Approved		Approved	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA057208: AB_2683370, HPA071094: "	"unprognostic (2.15e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.26e-3)"	"unprognostic (5.69e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.25e-1)"	7.9	5.7	13.1	8.6	14.6	48.2	6.0	14.2	21.4	5.1	5.0	21.6	1.8	3.8	5.0	4.2	5.4	4.2	5.3	11.2	17.3	13.5	6.8	4.5	11.9	16.0	18.8	14.5	3.5	6.4	8.0	4.8	6.0	23.5	4.9	5.9	7.4	3.9	3.4	13.6	6.0	4.3	6.4	24.1	12.8	5.3	12.5	14.4	8.8	5.8	4.3	7.8	5.7	3.8	1.6	10.7	20.3	9.5	4.5	6.6	5.7	2.9	5.7	16.9	6.7	3.5	3.8	6.4	4.4	3.8	4.5	5.2	3.0	5.1	18.4	3.8	4.6	8.0	1.7	7.8	5.6	4.3	19.5	6.9	3.1	6.9	5.4	7.3	14.1	3.7	3.6	6.6	4.2	14.5	2.9	7.2	9.5	3.9	14.8	2.0	4.6	11.0	8.4	11.7	10.6	4.0	10.1	6.2	5.6	7.9	3.2	20.4	14.5	5.0	5.5	9.1	16.8	2.1	4.6	7.1	2.9	5.2	18.5	5.2	10.1	8.4	8.4	6.2	13.9	5.9	20.3	9.5	8.3	6.6	5.7	6.4	1.6	3.3	5.1	10.7	1.2	2.7	5.2	14.0	4.5	4.3	1.7	3.4	5.7	13.1	14.6	14.2	21.4	17.3	13.5	18.8	14.5	23.5	14.4	59.6	13.8	5.4	2.3	7.0	29.1	39.1	0.0	18.7	21.6	3.5	96.2	3.7	6.6	4.8	44.2	7.5	2.7	0.0	3.5	3.5	4.5	3.7	25.5	3.6	7.2	33.4	7.5	10.4	38.6	49.1	1.7	22.6	3.3	9.0	4.9	16.0	4.6	0.0	2.5	6.1	56.8	12.9	7.2	25.0	27.2	9.4	2.4	20.8	3.8	1.6
AL121900.2		ENSG00000284776			20	18567453-18744216	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 8.9;Ciliated cells: 5.3"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 22.9"									HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA040981: AB_10673268"																		4.0	5.7	4.0	4.4	5.8	5.8	6.0	4.5	14.1	3.6	6.2	2.0	6.0	5.2	7.4	5.9	4.5	5.4	5.4	7.8	4.4		15.4	6.3	4.7	6.9	4.5	5.4	7.7	16.1	8.3	5.3	4.4	7.6	4.6	6.4	3.1	8.8	8.2	12.2	1.1	5.5	5.9	4.3	5.8	0.9	6.8	5.4	3.6	5.1	9.9	6.8	5.7	6.4	4.9	6.9	2.9	4.8	3.9	5.9	1.7	3.7	1.8	7.9	3.9	2.6	9.1	0.5	2.4	6.5	6.2	0.7	0.9	5.6	0.5	1.9	7.8	3.5	3.5	4.9	15.1	22.9	0.9	0.3	5.1	2.0	2.0	3.1	10.0	6.0	0.0	14.4	4.5	7.4	3.6	8.0	1.5	0.9	7.9	5.3	2.8	1.7	0.8	2.1	3.2	0.0	0.3	4.1	5.5	4.9	4.7	7.8	2.0	0.2	6.4	3.1	6.6	5.0	6.5	0.0	8.5	0.4	7.1	5.3	1.7	8.5	1.5	5.1	1.6	5.6	2.9	3.2	2.7	4.8	4.8	5.9	4.9	5.4	3.6	6.9	2.9	1.7	3.4	1.9	3.9	2.8	1.2	4.5	1.7											8.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALG14	MGC19780	ENSG00000172339	"ALG14, UDP-N-acetylglucosaminyltransferase subunit"	Q96F25	1	94974407-95072945	"Disease related genes, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031829	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA031829: AB_2674062"	"unprognostic (7.79e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.93e-1)"	5.8	13.2	6.8	4.1	8.5	4.6	6.8	5.6	8.0	5.5	7.5	8.5	7.0	8.5	5.4	11.3	5.7	4.8	6.1	6.3	7.0	7.2	8.9	15.1	5.3	7.5	8.2	4.7	5.3	12.6	5.8	6.6	6.3	8.4	5.1	8.7	6.9	14.5	9.8	7.2	5.0	9.2	4.4	9.4	5.8	6.0	10.0	4.2	3.7	8.5	6.2	5.3	4.8	4.2	4.9	5.8	3.1	3.9	2.8	3.8	1.9	5.2	3.3	2.8	2.5	2.2	3.8	2.5	3.8	4.1	3.9	3.3	3.9	1.8	2.7	4.0	4.7	4.7	3.6	3.2	3.6	4.7	5.7	5.5	1.5	3.6	5.9	3.6	3.6	1.0	4.1	3.7	2.9	2.9	3.2	3.3	3.6	2.9	3.6	3.7	2.5	3.8	2.3	1.7	5.2	4.8	2.4	5.7	2.9	4.4	3.0	2.5	3.2	2.1	7.2	6.3	2.2	3.2	3.1	2.6	2.5	2.8	4.4	7.9	2.3	2.2	2.4	1.8	1.8	2.0	3.1	3.2	1.1	2.5	3.9	2.4	4.9	3.1	3.1	4.5	4.4	2.9	3.0	2.7	2.8	1.9	5.8	3.8	1.9	6.8	8.5	5.6	8.0	7.0	7.2	8.2	4.7	8.4	4.2	0.0	12.6	5.2	10.9	10.4	14.8	7.3	10.2	8.1	11.4	15.7	5.9	28.7	16.6	21.4	5.4	8.0	19.2	23.3	46.6	23.6	21.1	9.2	1.1	30.6	17.2	7.9	4.1	14.7	6.3	6.5	13.3	10.8	30.4	11.8	11.1	28.5	21.0	25.9	9.6	34.3	12.9	32.3	12.5	33.6	22.6	7.5	21.1	4.4	24.9	9.1
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 104.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol		No	No		69000	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	12.8	16.9	8.6	11.4	10.1	12.7	10.9	7.3	16.0	9.4	8.8	11.1	11.3	19.5	10.4	11.9	8.4	9.0	14.6	11.8	7.1	4.8	15.3	10.5	20.0	15.8	9.8	11.3	8.1	10.1	6.5	7.5	10.7	8.9	8.6	2.4	10.9	16.1	9.6	10.2	15.0	19.1	7.2	8.3	22.2	11.5	25.7	7.9	7.3	9.9	11.0	8.9	9.3	8.0	9.8	17.1	16.6	15.8	4.9	8.1	4.8	6.5	8.8	1.9	4.0	2.1	1.7	14.3	5.9	2.5	4.7	5.9	6.3	11.6	3.0	4.2	1.1	10.1	6.0	1.1	1.6	0.1	3.8	5.3	4.3	7.9	8.2	8.0	3.1	14.1	4.0	1.7	3.4	0.5	1.2	2.9	8.5	9.8	7.2	1.9	15.6	5.1	8.6	4.1	0.5	6.8	19.7	3.0	11.0	1.3	3.6	7.3	7.2	3.8	9.2	15.5	0.3	9.5	0.8	4.0	5.3	8.1	10.5	3.0	15.2	9.7	5.9	5.9	5.9	6.6	9.9	6.1	16.5	7.4	15.8	5.5	9.8	5.9	5.3	2.3	7.4	5.0	4.2	16.6	4.9	15.2	17.1	8.1	4.8	8.6	10.1	7.3	16.0	7.1	4.8	9.8	11.3	8.9	7.9	3.0	12.3	13.1	4.6	7.9	9.0	2.0	7.6	5.3	2.3	5.2	5.9	14.1	5.0	24.6	45.6	7.1	18.1	0.0	14.7	23.4	8.0	6.0	6.9	10.4	104.3	22.3	12.1	18.4	33.6	16.0	9.8	15.9	18.6	34.3	9.0	10.8	16.8	14.4	6.0	38.1	12.0	0.0	4.4	7.7	17.2	7.9	23.3	15.3	7.0	3.8
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 944.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	29.3	26.1	44.9	21.9	34.1	39.6	27.2	19.5	31.8	19.4	26.3	14.8	30.3	26.1	19.2	27.5	31.7	24.6	26.0	63.6	32.9	26.7	25.9	38.4	18.5	26.7	35.2	31.8	17.2	40.3	12.6	20.6	25.7	29.8	25.4	12.2	18.1	48.8	24.0	94.2	21.6	24.8	25.4	27.6	18.9	25.9	42.2	27.3	18.5	32.5	45.7	17.0	23.5	25.5	54.9	107.5	74.0	80.1	43.1	52.8	80.4	41.4	97.5	23.2	34.3	18.5	21.1	26.6	20.1	15.8	18.3	20.9	40.0	36.6	13.1	22.5	17.7	20.2	24.2	9.3	25.7	6.6	19.2	70.6	19.6	43.3	60.3	20.8	14.6	17.4	23.4	23.5	18.7	15.3	11.9	29.3	17.9	26.7	38.2	18.9	74.7	35.5	24.2	21.9	40.3	72.8	14.8	22.1	26.3	16.7	37.3	29.2	47.4	21.7	34.3	39.4	16.7	41.9	35.6	17.4	35.6	28.5	38.1	37.7	18.7	7.8	16.5	37.4	22.3	28.4	70.1	80.1	74.0	45.3	63.7	42.8	54.9	46.4	49.5	64.6	51.6	45.2	43.5	40.5	43.1	59.3	107.5	52.8	80.4	44.9	34.1	19.5	31.8	32.9	26.7	35.2	31.8	29.8	27.3	119.1	121.6	108.7	168.5	132.0	55.6	277.3	203.8	155.2	153.6	188.5	19.6	436.4	442.7	236.1	329.1	152.3	247.2	186.9	293.4	435.1	217.2	291.4	105.2	427.2	386.6	31.8	182.7	139.3	155.4	944.1	168.2	179.2	248.0	315.6	205.6	112.3	274.1	235.0	154.9	400.2	53.7	103.5	220.7	379.1	245.5	163.2	425.4	121.6	237.2	254.5
AP002495.1		ENSG00000254469	"Putative short transient receptor potential channel 2-like protein "	Q6ZNB5	11	71865509-71928654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 2.7;Cytotrophoblasts: 4.7;Extravillous trophoblasts: 2.1;Hofbauer cells: 1.8;Syncytiotrophoblasts: 2.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA051121, HPA051124"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		NA	NA			Nucleoli	"Mitotic chromosome"	"HPA051121: AB_2681349, HPA051124: "	"unprognostic (1.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.32e-3)"	"unprognostic (9.79e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.12e-3)"	5.8	6.9	8.2	7.7	7.3	9.1	7.3	7.4	8.7	7.5	6.3	11.6	21.7	6.1	9.2	13.2	6.2	7.2	5.0	4.8	6.4	4.9	7.6	5.1	5.4	8.9	6.8	5.4	12.1	7.2	7.4	12.7	4.8	6.6	7.2	8.5	10.4	7.9	15.7	5.9	8.8	7.5	6.4	6.5	7.9	6.9	9.7	11.9	11.6	8.7	3.6	12.2	7.1	6.8	6.0	7.5	3.4	4.5	1.8	8.5	3.2	2.8	6.4	5.1	4.8	1.9	2.0	3.2	3.3	2.5	3.5	3.3	7.6	7.3	6.2	3.0	2.1	4.2	9.2	5.4	3.4	3.9	9.0	4.7	10.0	7.2	4.5	1.4	4.8	3.4	2.6	1.6	5.7	4.6	2.8	5.2	8.8	6.7	9.2	3.5	5.8	4.8	3.5	5.6	9.8	4.7	4.0	18.7	4.3	3.7	3.6	7.6	7.8	4.8	4.5	10.1	3.9	6.5	2.4	4.9	2.7	4.8	5.2	2.0	5.7	9.1	7.7	4.7	5.1	4.4	3.4	3.0	2.5	4.6	4.5	2.9	4.2	8.5	6.3	3.5	6.0	8.2	6.8	2.6	1.8	2.7	7.5	7.1	3.2	8.2	7.3	7.4	8.7	6.4	4.9	6.8	5.4	6.6	11.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32972606-33025168	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	12.9	20.3	17.5	11.2	18.4	19.9	16.5	15.1	21.7	12.0	15.2	19.3	9.3	11.7	14.7	12.9	19.1	14.7	8.0	11.9	13.3	13.9	17.9	23.4	12.6	11.8	16.4	16.5	11.8	14.3	15.8	14.3	12.1	20.2	12.1	18.1	14.6	12.5	11.9	14.1	20.6	13.8	14.6	15.7	11.7	12.5	18.2	14.5	8.8	10.5	12.6	16.1	13.4	12.1	17.1	18.4	16.1	20.8	26.4	19.4	15.0	21.6	16.4	12.5	10.8	12.8	11.2	16.6	14.5	15.1	17.7	19.6	21.8	7.7	16.9	8.7	12.1	11.0	11.5	20.3	19.4	22.0	22.8	8.3	10.0	23.5	22.2	14.8	16.1	9.6	15.0	23.8	20.3	26.4	11.3	16.9	13.1	15.1	16.9	16.5	9.3	14.4	23.7	19.1	14.2	17.7	13.1	8.7	12.0	14.5	13.2	8.7	7.3	13.3	11.9	9.7	12.1	13.5	6.6	10.4	9.9	13.2	17.1	14.9	7.3	12.0	16.9	14.7	13.2	7.9	9.1	17.7	14.9	13.4	16.3	17.6	17.0	15.2	15.5	18.4	17.1	18.0	14.6	16.1	26.4	20.8	17.9	19.4	15.0	17.5	18.4	15.1	21.7	13.3	13.9	16.4	16.5	20.2	14.5	17.9	31.9	15.7	18.7	14.8	13.6	12.9	28.1	25.4	19.4	8.7	9.8	23.7	24.9	20.4	49.1	11.9	11.6	0.0	24.6	22.8	12.6	16.4	16.1	17.4	16.5	12.7	16.1	6.7	15.2	35.4	12.4	14.5	13.5	20.8	12.6	17.8	24.5	3.5	9.9	24.1	16.2	12.9	12.2	35.9	27.0	18.4	23.3	14.1	15.1	20.4
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639949	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4;lymphoid tissue: 35.0"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 20.0;Spermatocytes: 24.4;Spermatogonia: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040830, HPA066481"	Enhanced		Approved	Nucleoli,Cytosol		No	Yes			Cytosol	Nucleoli	"HPA040830: AB_10805830, HPA066481: "	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.05e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.9	1.5	2.0	17.2	2.9	16.4	3.3	1.1	3.9	1.6	5.4	1.6	0.5	4.3	2.3	0.5	7.5	0.5	4.1	1.4	2.2	1.9	0.8	1.2	2.0	9.4	4.4	0.8	0.8	3.1	0.9	1.0	4.7	2.0	1.2	6.7	0.8	2.0	0.5	1.7	3.2	9.6	3.3	8.9	5.0	2.6	6.4	1.9	35.0	1.0	5.3	10.3	2.6	2.7	0.9	1.7	2.6	1.8	0.5	3.8	1.1	23.5	25.4	20.3	13.4	1.4	3.8	12.2	23.9	13.8	22.8	17.6	17.5	12.0	13.7	7.6	14.0	26.1	17.5	14.3	12.5	30.8	26.9	8.3	43.4	22.9	8.9	0.5	32.3	17.4	1.2	1.5	18.3	14.5	4.3	16.8	27.0	30.0	32.6	26.4	9.6	16.9	10.8	12.7	19.7	14.9	20.1	45.5	10.7	8.1	12.5	19.6	13.5	25.1	13.0	5.4	11.0	18.5	31.0	12.9	30.8	22.8	12.9	25.4	11.9	18.8	37.8	13.2	38.4	26.9	0.1	1.1	2.6	2.3	1.8	0.9	0.9	3.8	3.3	1.7	0.7	1.5	2.0	0.0	0.5	0.3	0.6	2.8	1.1	2.0	2.9	1.1	3.9	2.2	1.9	4.4	0.8	2.0	1.9	0.0	2.9	1.5	0.9	4.2	0.0	0.8	5.1	1.4	2.3	1.8	0.0	2.5	0.0	0.8	2.9	1.1	0.5	0.0	0.7	20.0	1.1	1.0	0.0	1.0	8.0	0.0	0.0	2.5	4.1	3.4	0.6	3.2	0.0	3.6	3.7	0.0	0.5	1.1	0.4	0.2	0.9	6.5	0.9	24.4	18.6	1.9	2.6	3.2	5.1	1.4
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552638	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Smooth muscle cells: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 73.1;RPMI-8226: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favorable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	20.1	4.1	6.8	24.5	8.7	14.6	26.2	3.1	8.8	10.5	14.6	4.9	4.1	7.2	17.5	16.1	9.1	11.5	16.8	17.8	7.0	5.5	5.4	7.2	26.0	29.0	10.7	3.1	11.4	9.8	3.8	6.6	13.0	17.4	14.7	3.7	11.4	8.2	5.1	26.1	7.3	12.3	33.1	13.6	14.9	10.1	5.4	6.2	12.4	8.2	7.7	15.7	19.5	12.0	5.2	12.8	21.4	5.3	17.7	11.5	8.8	0.8	0.3	0.4	1.5	0.8	0.9	2.2	1.4	4.9	1.7	1.5	0.8	0.2	0.2	1.0	0.8	2.6	1.3	0.4	0.0	0.5	73.1	1.1	1.8	0.3	1.7	1.0	1.2	1.4	0.6	1.6	1.4	0.2	1.5	1.5	2.2	1.5	11.1	0.6	0.8	2.4	4.3	0.9	0.4	0.0	3.3	3.0	32.2	0.2	0.7	0.6	0.3	0.1	0.1	1.1	0.4	0.0	2.7	1.4	1.5	1.9	1.7	1.2	6.8	5.3	0.9	0.8	3.0	1.4	7.2	5.3	21.4	11.5	4.8	11.1	4.4	9.7	10.7	7.1	5.2	10.8	10.5	15.3	17.7	3.3	12.8	11.0	8.8	6.8	8.7	3.1	8.8	7.0	5.5	10.7	3.1	17.4	6.2	3.0	28.9	11.8	34.4	46.5	17.4	12.2	5.1	10.7	11.4	3.5	29.5	3.6	3.3	29.9	14.9	43.6	3.2	0.0	27.0	7.0	17.5	22.9	58.0	22.2	62.8	0.0	0.0	22.1	29.8	23.3	3.4	64.4	55.6	95.6	5.4	6.2	24.8	5.3	6.0	5.0	24.7	45.3	294.5	2.7	17.6	28.4	3.3	91.4	2.6	17.8
ARL9		ENSG00000196503	"ADP ribosylation factor like GTPase 9"	Q6T311	4	56505209-56525481	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;testis: 12.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 81.2;Late spermatids: 192.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 4.4;REH: 8.7;SCLC-21H: 9.2"					"Low region specificity"	"Detected in all"			HPA072942	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA072942: AB_2686561"	"unprognostic (9.91e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.24e-3)"	"unprognostic (6.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.79e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	1.3	1.1	4.4	0.8	4.9	3.4	2.0	1.5	7.1	1.3	1.3	0.6	2.4	1.0	2.0	1.1	1.1	1.2	2.4	0.8	3.9	3.2	0.5	0.5	0.6	1.0	1.3	2.9	3.0	0.4	0.4	1.6	0.3	8.7	2.2	1.0	1.9	0.9	3.8	0.4	4.1	1.0	3.7	2.5	0.8	1.0	12.6	0.6	0.1	1.1	1.2	0.7	1.5	2.5	2.1	2.2	1.6	0.4	1.4	1.4	0.1	0.0	0.5	0.6	0.5	1.2	2.9	0.1	0.9	0.5	2.1	2.1	0.5	0.7	0.7	0.0	1.5	0.1	0.2	0.4	0.2	1.2	0.1	0.1	0.3	0.0	0.1	2.8	0.3	0.7	4.4	0.7	1.9	0.4	0.4	2.1	0.2	0.2	0.9	2.0	0.0	0.3	0.1	2.2	0.1	1.3	8.7	0.0	0.1	0.1	0.3	9.2	0.1	0.3	0.4	0.2	0.2	0.2	0.1	0.4	0.3	0.4	0.0	0.1	0.4	0.4	0.4	0.1	0.0	0.3	0.8	0.4	0.4	0.7	0.4	0.4	1.0	1.2	1.0	0.3	2.1	1.4	0.6	1.6	1.4	0.4	2.2	1.0	0.1	4.4	4.9	1.5	7.1	3.9	3.2	1.3	2.9	8.7	0.6	0.0	1.4	0.0	0.8	5.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.4	81.2	0.2	0.0	0.0	0.2	0.1	1.2	0.7	0.0	0.0	0.1	0.0	0.0	0.6	0.3	192.4	1.4	0.0	5.0	0.0	0.3	1.0	0.6	0.0	1.1	0.3	0.0	0.0	0.2	12.2	0.9	1.4	0.0	0.0	0.4	0.3
ARNTL2	"bHLHe6, BMAL2, CLIF, MOP9, PASD9"	ENSG00000029153	"Aryl hydrocarbon receptor nuclear translocator like 2"	Q8WYA1	12	27332854-27425289	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.0"	"Cell type enhanced"	"Detected in many"	15	"Glandular cells: 33.6;Pancreatic endocrine cells: 57.8;Urothelial cells: 126.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.3;U-2197: 48.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059074	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA059074: AB_2683897"	"unprognostic (6.86e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (5.29e-6)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-1)"	3.5	1.3	5.7	9.8	5.9	2.2	3.3	3.6	10.6	6.8	3.1	1.1	0.0	2.9	1.5	0.5	30.0	1.5	3.9	1.9	9.1	2.8	1.6	10.3	2.7	5.0	2.1	6.8	0.9	2.3	2.4	1.5	14.7	2.6	1.9	3.5	0.0	9.2	0.9	1.0	7.7	2.8	4.7	2.0	1.2	10.9	2.8	1.3	3.8	1.2	15.4	21.1	5.9	12.5	0.6	1.4	4.5	0.5	0.5	1.5	0.2	21.9	5.6	1.2	0.4	1.1	3.4	17.7	7.8	10.3	5.1	8.0	5.3	17.1	0.2	4.4	3.7	15.8	9.1	3.6	27.4	13.1	35.3	4.7	4.2	3.7	4.4	1.5	8.5	1.8	1.2	2.4	17.8	14.0	8.8	23.9	5.3	2.1	9.0	5.8	2.6	4.6	4.6	9.7	7.5	19.7	8.6	20.7	1.3	4.3	12.6	4.1	0.7	4.0	0.6	0.1	3.1	0.8	2.8	16.2	16.6	9.6	48.3	32.2	1.3	2.4	0.0	14.3	6.9	3.2	4.5	0.5	0.5	0.2	0.3	0.2	0.5	0.2	0.2	1.4	0.6	0.2	0.3	2.4	0.5	0.2	0.3	1.5	0.2	5.7	5.9	3.6	10.6	9.1	2.8	2.1	6.8	2.6	1.3	3.0	2.2	0.0	32.7	0.7	1.1	0.8	17.8	0.0	7.9	8.7	0.0	1.3	0.0	22.0	3.3	4.2	0.7	0.0	23.8	3.5	2.3	33.6	0.0	4.2	1.3	0.0	1.2	3.1	2.8	3.0	0.0	5.0	1.7	26.2	2.7	0.0	57.8	0.0	0.0	0.6	0.0	0.0	2.1	3.4	4.9	1.9	3.5	0.0	0.6	126.8
ARPP21	"ARPP-21, R3HDM3, TARPP"	ENSG00000172995	"CAMP regulated phosphoprotein 21"	Q9UBL0	3	35638945-35794496	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 2.8;Cardiomyocytes: 3.4;Early spermatids: 1.6;Late spermatids: 2.2"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 146.9"	"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 12.1"	"Cell line enhanced"	"Detected in some"		"JURKAT: 46.2;MOLT-4: 27.1;REH: 15.0;RH-30: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017303	Enhanced	Supported	Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA017303: AB_1845049"	"unprognostic (1.72e-4)"				"unprognostic (2.35e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.61e-2)"		"unprognostic (6.30e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.42e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.52e-1)"		1.2	1.3	12.3	1.5	146.9	4.6	1.1	27.8	67.9	1.1	1.4	0.3	0.0	1.3	1.1	1.1	3.2	1.1	1.1	1.1	6.8	2.8	2.0	2.9	1.2	1.2	3.9	11.5	1.1	1.1	1.1	1.9	1.1	6.7	2.0	1.5	0.0	1.1	1.3	43.6	1.1	1.4	1.1	0.8	1.2	1.1	1.1	14.8	41.2	1.5	3.5	1.5	1.1	0.1	0.1	12.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.2	0.0	46.2	0.0	0.1	1.1	0.0	27.1	0.0	0.0	0.0	1.1	15.0	8.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	12.3	146.9	27.8	14.7	6.8	2.8	3.9	11.5	6.7	14.8	0.0	0.0	0.0	0.0	0.0	2.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ASNA1	"ARSA-I, GET3, TRC40"	ENSG00000198356	"ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		52000	Nucleoli	Nucleoplasm	"HPA045951: AB_2679511, HPA048087: AB_2680258"	"unprognostic (2.87e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavorable (8.47e-4)"	22.3	33.9	32.3	23.1	32.8	35.1	22.2	28.2	51.9	23.5	27.2	26.1	23.6	24.7	24.8	30.3	33.3	30.7	28.9	48.0	30.5	27.9	46.9	28.5	21.2	26.6	29.2	26.5	24.2	30.3	23.8	25.2	32.0	27.3	21.8	18.3	30.9	26.7	21.5	35.7	28.9	24.7	21.3	24.5	26.5	24.2	30.9	18.5	25.8	40.7	28.0	23.5	28.7	20.6	12.5	27.1	16.0	26.9	9.3	20.2	19.4	33.6	27.8	14.9	32.1	29.7	18.3	18.4	17.5	24.2	34.0	26.8	21.7	16.8	15.5	27.4	22.7	39.0	18.1	20.6	23.4	16.3	23.8	32.3	13.4	21.0	24.6	31.8	19.8	26.1	21.1	20.6	27.4	16.3	22.0	24.0	18.4	16.6	21.1	26.5	75.3	26.1	15.9	37.7	21.7	52.4	19.4	23.2	30.3	31.7	28.8	27.7	23.5	23.7	31.9	28.0	13.3	26.3	19.1	20.4	48.1	16.3	53.2	40.6	38.0	63.9	14.3	33.7	32.4	26.4	16.0	26.9	15.0	16.1	20.4	13.7	12.5	14.4	14.2	27.1	10.6	10.4	12.8	9.6	9.3	23.7	17.8	20.2	19.4	32.3	32.8	28.2	51.9	30.5	27.9	29.2	26.5	27.3	18.5	3.0	6.5	44.7	52.5	61.4	33.5	7.4	66.2	9.4	5.7	52.4	15.7	89.1	112.7	135.7	88.0	42.9	87.6	46.7	116.1	66.8	58.1	46.3	34.5	24.5	125.2	27.0	53.9	36.8	50.0	143.9	44.5	54.1	77.6	138.9	56.6	59.9	93.6	94.7	53.0	177.7	23.1	32.3	54.5	52.9	128.0	69.5	92.6	59.8	57.4	54.0
ASXL1	KIAA0978	ENSG00000171456	"Additional sex combs like 1, transcriptional regulator"	Q8IXJ9	20	32358330-32439319	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor"	"Cancer-related genes, Craniosynostosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064156			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA064156: AB_2685200"	"unprognostic (1.49e-1)"	"unprognostic (5.97e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (6.69e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (2.01e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.06e-1)"	24.3	19.6	19.0	35.0	18.2	39.0	24.7	28.3	23.8	32.4	22.7	17.7	16.9	15.6	32.4	22.2	14.3	20.5	21.6	17.9	19.7	10.7	21.2	25.2	27.3	26.7	20.3	14.7	28.1	27.1	21.2	16.3	19.8	18.2	20.6	16.4	16.6	17.4	23.3	25.5	18.2	21.8	21.8	12.2	28.2	19.7	32.1	23.0	47.4	26.8	15.8	29.0	23.2	35.3	9.8	3.1	1.3	0.8	1.7	14.6	1.9	22.9	13.3	20.9	11.6	9.6	12.0	18.2	15.4	13.2	26.9	19.9	39.6	14.8	21.7	9.9	19.0	25.6	16.0	17.6	14.8	22.0	32.5	9.6	34.6	21.1	21.6	8.6	14.4	14.4	13.3	9.9	18.7	14.1	13.3	14.8	17.9	16.7	11.8	12.5	7.0	19.7	11.6	5.0	10.7	15.4	11.5	25.1	9.4	11.0	11.1	9.6	15.1	27.9	9.3	12.2	11.6	13.3	10.2	15.3	28.6	25.0	13.2	17.1	13.8	14.7	16.0	14.5	38.4	10.9	0.0	0.8	1.3	4.4	0.7	3.5	9.8	5.2	5.6	0.7	5.8	5.8	5.9	0.9	1.7	0.7	3.1	14.6	1.9	19.0	18.2	28.3	23.8	19.7	10.7	20.3	14.7	18.2	23.0	47.6	38.1	41.7	41.8	35.5	18.7	18.5	15.3	21.4	25.0	26.2	49.1	16.2	21.6	12.4	73.4	61.8	21.2	0.0	10.8	12.8	37.0	40.7	17.4	29.3	18.3	17.5	6.9	34.4	16.8	61.5	23.6	23.6	74.2	10.0	12.1	12.6	14.1	11.5	13.8	22.1	30.4	6.5	44.0	25.6	13.5	26.7	4.9	41.5	15.5	32.6
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.4"	"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 644.1;Intestinal endocrine cells: 855.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 39.9;SuSa: 49.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA001562	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	41.5	21.5	9.5	41.0	7.1	9.4	30.2	3.0	8.0	30.0	16.2	15.3	36.4	5.0	34.9	28.6	31.4	38.1	33.4	31.8	6.5	6.9	19.4	36.1	42.8	4.6	13.5	6.5	23.1	16.0	15.1	12.4	65.1	9.4	30.4	15.0	8.1	12.1	138.4	13.2	39.5	11.4	76.1	13.0	5.4	31.6	10.7	12.4	1.5	45.5	37.3	7.4	38.3	33.8	0.3	2.2	6.1	8.1	0.0	0.4	0.8	6.1	0.3	12.3	2.6	1.2	3.2	39.9	4.4	3.5	3.8	9.1	8.1	4.6	0.1	2.0	0.2	20.8	3.4	7.3	1.1	6.3	29.1	7.1	0.4	3.6	2.9	22.6	2.6	6.9	5.5	19.8	10.6	24.7	0.7	0.7	7.1	2.8	23.2	0.5	0.8	7.9	1.6	8.8	3.3	2.6	2.3	8.2	5.2	0.5	0.9	5.5	5.6	5.7	10.3	17.3	49.4	6.0	1.9	0.7	1.1	5.9	3.7	2.0	18.3	7.7	2.1	3.6	1.4	3.2	6.1	0.9	0.0	0.4	5.5	0.4	0.1	0.1	0.0	2.2	0.3	0.0	0.0	0.3	0.0	8.1	1.1	0.0	0.8	9.5	7.1	3.0	8.0	6.5	6.9	13.5	6.5	9.4	12.4	393.1	144.2	7.7	234.8	180.1	3.7	604.8	73.9	128.5	135.4	52.4	0.0	136.7	1.7	158.3	2.8	136.2	500.9	0.0	108.1	256.8	236.1	644.1	77.3	21.2	99.6	1.6	855.0	28.8	13.4	2.5	16.1	211.8	165.4	55.1	427.3	12.1	155.6	312.1	1.1	1.2	2.5	97.0	421.2	0.3	2.1	177.2	351.7	6.9	216.0	169.1
ATF6B	"CREBL1, G13"	ENSG00000213676	"Activating transcription factor 6 beta"	Q99941	6	32115264-32128253	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046871	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA		31000000	Nucleoplasm	Nucleoli	"HPA046871: AB_10963542"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-2)"	11.7	19.4	23.1	13.7	29.4	24.9	14.3	20.2	19.1	17.8	20.2	15.4	9.8	11.2	19.2	32.7	20.0	27.7	15.4	11.0	19.4	11.4	13.5	14.0	15.6	17.0	20.6	16.5	22.6	18.4	38.1	16.1	21.1	16.9	16.8	18.8	14.1	16.2	14.0	7.1	17.8	15.9	9.4	12.8	22.8	20.2	19.5	17.0	21.7	21.2	11.8	21.0	18.0	16.4	4.4	5.7	6.6	4.1	5.6	4.9	4.4	0.7	2.9	8.1	3.0	6.0	6.8	2.9	3.3	3.1	7.3	9.1	9.4	15.7	14.3	11.5	29.1	10.5	4.6	10.9	21.8	5.3	2.9	12.0	1.0	15.1	10.0	19.9	1.1	17.4	11.4	9.7	1.3	20.2	18.4	19.7	26.9	18.9	19.0	18.5	7.4	10.0	7.0	2.4	14.0	0.5	0.7	3.5	6.4	6.5	1.4	0.5	0.8	14.2	7.7	19.2	3.7	24.2	1.8	8.5	4.0	4.4	6.4	9.8	19.1	8.2	6.7	9.2	6.6	9.8	6.6	2.2	1.9	4.9	4.1	4.7	4.4	2.8	2.3	5.7	3.4	1.8	3.5	2.5	5.6	3.7	3.8	4.5	4.4	23.1	29.4	20.2	19.1	19.4	11.4	20.6	16.5	16.9	17.0	11.9	14.6	95.8	29.3	22.0	84.7	1.7	45.9	28.1	10.3	52.4	90.3	71.4	5.0	39.2	2.4	30.3	49.8	0.0	37.3	41.1	28.7	30.1	16.1	18.3	46.0	41.3	51.5	37.4	39.0	3.2	65.6	45.4	30.4	53.3	48.7	43.1	31.4	49.1	48.8	11.3	83.5	58.2	28.4	71.1	55.1	22.1	74.6	74.8	52.7	35.4
ATG10	"APG10L, DKFZP586I0418, FLJ13954"	ENSG00000152348	"Autophagy related 10"	Q9H0Y0	5	81972025-82276857	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044163	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA044163: AB_2678842"	"unprognostic (1.20e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.43e-1)"	8.2	9.2	8.4	6.3	13.6	8.4	11.7	11.3	15.4	7.2	8.9	14.7	7.5	5.5	12.0	13.7	10.9	7.2	7.3	8.0	8.4	7.9	9.3	10.4	7.1	8.3	10.3	13.5	5.8	9.9	23.0	9.5	7.9	11.3	9.6	10.2	12.4	8.6	9.6	10.3	10.9	6.0	9.1	10.4	6.7	7.1	27.0	8.9	22.8	11.7	4.6	9.9	9.2	8.2	7.6	11.4	12.2	9.3	9.2	8.9	6.0	3.4	9.2	6.0	17.0	4.0	7.7	15.3	4.0	3.2	2.9	4.5	2.7	12.5	6.0	3.4	6.4	22.4	2.0	4.3	8.9	3.9	10.2	3.1	6.6	8.7	2.8	3.9	3.4	5.5	7.1	6.1	4.3	3.6	4.5	5.5	13.0	7.9	5.2	10.6	6.9	7.8	4.0	8.5	2.5	6.0	5.9	8.6	14.4	7.5	4.8	8.9	12.8	6.5	3.6	7.4	10.7	7.0	6.5	4.3	5.6	5.2	2.8	8.3	7.0	11.7	8.3	7.4	8.3	8.9	3.3	9.3	12.2	8.4	8.8	7.9	5.9	7.5	7.7	11.4	7.6	7.2	8.9	12.1	9.2	6.5	8.8	7.4	6.0	8.4	13.6	11.3	15.4	8.4	7.9	10.3	13.5	11.3	8.9	14.9	14.1	6.0	15.3	22.0	16.1	7.0	12.7	9.4	18.2	12.2	9.8	22.1	13.3	13.4	56.8	11.3	7.8	0.0	16.0	38.5	13.5	10.0	10.5	11.9	15.9	17.5	9.2	9.2	11.9	69.6	6.4	17.8	30.4	20.8	7.6	11.4	14.5	9.9	9.6	13.5	14.7	0.0	13.4	45.1	18.1	28.0	17.6	15.2	10.9	11.2
ATP6AP1L		ENSG00000205464	"ATPase H+ transporting accessory protein 1 like"	Q52LC2	5	82279462-82386977	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 27.5;Early spermatids: 20.6"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	8	"dendritic cells: 1.3;NK-cells: 1.5;T-cells: 1.2"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 15.7"									HPA053771	Approved		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA053771: AB_2682257"	"unprognostic (1.64e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	1.6	1.0	2.6	0.2	2.4	0.6	0.7	2.5	2.1	1.8	1.2			0.1	1.5	0.1	1.4	2.4	1.7	2.0	2.7	1.8	0.8	1.4	1.5	0.7	2.5		4.4	2.4	0.1	2.0	0.7		1.4	0.6		2.6	2.5	3.3	5.1	0.2	0.6	2.7	0.8	1.8	3.8			1.5		0.4	0.9	0.5	0.1	1.3	0.0	0.1	1.5	1.2	0.0	0.1	0.0	0.1	1.0	0.6	0.3	0.0	0.1	0.3	0.4	0.9	0.1	0.0	0.0	0.0	0.9	1.3	0.0	0.3	2.9	0.0	1.3	0.6	0.5	0.2	0.3	2.3	0.2	0.0	2.1	1.1	0.0	2.6	0.2	0.5	0.2	0.7	1.2	0.0	0.2	15.7	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.2	0.1	0.7	1.2	0.0	1.5	0.0	1.3	0.0	0.0											0.0	1.6	0.5	2.3	1.9	12.1	2.4	0.0	14.7	1.2	5.2	27.5	6.1	1.7	2.6	20.6	1.8	1.3	0.0	2.9	2.7	3.8	1.2	2.3	1.6	1.2	1.6	1.2	4.9	1.5	16.6	4.4	1.3	0.0	1.0	1.8	10.6	2.6	0.0	2.8	1.1	14.2	0.0	1.4	14.0	5.5	1.3	2.9	1.9	1.1	1.3
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587746-114598373	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		150000	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	34.8	66.4	41.5	36.7	38.0	56.6	56.6	37.5	49.4	45.2	34.2	23.4	42.3	26.7	43.7	91.0	57.5	32.3	39.2	45.4	40.8	52.5	84.9	65.9	45.3	50.0	52.2	39.5	49.2	55.9	39.5	79.4	77.8	44.7	65.3	33.2	49.2	63.2	45.1	54.9	40.8	33.2	31.7	35.6	66.5	52.7	58.3	25.6	51.7	65.2	53.5	53.4	45.8	40.1	99.9	81.6	96.6	67.9	50.0	85.1	121.6	18.2	17.6	36.2	8.8	30.1	21.8	33.6	28.5	22.6	23.6	17.0	23.6	22.0	17.7	24.9	20.3	44.1	41.4	27.0	21.5	19.9	14.0	18.6	17.0	22.3	34.2	42.1	37.8	31.5	27.9	57.9	18.9	23.6	24.8	22.3	28.7	32.5	37.6	32.2	39.6	36.4	23.9	42.8	52.2	33.2	35.4	23.2	28.3	48.4	31.4	27.3	34.9	38.4	67.2	101.2	36.5	54.4	44.9	29.7	19.3	15.3	30.0	31.9	50.7	99.4	30.9	24.8	22.7	26.4	78.3	67.9	96.6	46.7	63.9	57.9	99.9	65.6	56.0	50.9	94.2	85.1	67.1	87.3	50.0	65.8	81.6	76.5	121.6	41.5	38.0	37.5	49.4	40.8	52.5	52.2	39.5	44.7	25.6	148.9	142.4	298.6	409.4	461.0	169.7	124.8	155.4	207.5	149.0	314.0	39.3	304.8	822.3	322.2	78.2	218.7	155.2	93.5	229.3	273.5	294.0	644.3	261.0	292.4	487.8	155.7	346.4	198.9	353.7	42.3	283.3	376.1	469.0	820.6	271.3	242.1	355.1	164.9	235.8	828.3	125.3	232.8	269.9	334.2	301.9	504.0	633.4	276.3	162.4	656.9
AXIN1	PPP1R49	ENSG00000103126	"Axin 1"	O15169	16	287440-352673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012987	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"CAB012987: AB_2533178"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-1)"	10.8	8.3	13.7	18.9	17.1	28.1	21.0	26.4	13.6	10.4	15.8	12.7	9.4	17.3	12.6	8.5	14.1	10.7	12.7	11.0	11.5	7.7	9.8	9.6	13.6	13.4	15.6	10.6	13.3	17.7	11.1	11.9	8.4	13.9	11.4	10.2	9.6	13.9	9.5	17.7	16.9	17.6	18.9	9.6	15.1	15.2	9.6	14.6	17.5	12.7	7.5	14.5	11.9	22.9	1.8	1.4	5.5	1.1	3.6	10.4	2.4	9.6	14.0	7.5	13.2	5.6	5.2	15.8	6.5	6.0	9.1	7.8	20.6	11.3	15.0	10.1	6.7	10.9	13.9	11.7	10.2	4.1	14.7	19.2	9.7	11.8	14.9	9.6	11.1	10.8	5.1	17.8	9.3	11.5	8.0	6.0	11.0	24.1	8.3	4.1	25.8	12.0	7.7	17.1	11.7	8.6	22.7	6.8	20.8	6.8	5.7	17.1	10.5	12.4	13.9	20.5	5.9	9.2	14.2	6.7	9.0	9.7	10.3	9.4	9.6	9.3	18.3	4.3	7.4	8.8	1.4	1.1	5.5	10.4	0.9	9.5	1.8	3.0	7.0	0.8	1.6	3.2	4.3	3.2	3.6	0.7	1.4	3.0	2.4	13.7	17.1	26.4	13.6	11.5	7.7	15.6	10.6	13.9	14.6	3.0	11.3	5.2	5.3	16.4	4.9	5.0	5.1	6.7	6.8	3.5	0.0	3.1	0.0	6.1	1.0	6.7	18.6	0.0	6.1	20.3	5.9	9.4	10.4	4.7	6.5	4.8	10.4	4.3	7.5	1.3	4.9	5.9	10.1	3.6	14.5	3.7	8.8	11.9	4.6	2.1	5.4	12.9	5.3	4.4	7.6	13.2	3.1	7.7	11.8	8.7
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203543-122208952	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 16.3;skin 1: 8.5"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.6;Proximal tubular cells: 6.1;Spermatogonia: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;hTCEpi: 9.9;T-47d: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA055261: AB_2682765"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.7	3.2	7.3	0.8	6.8	4.6	0.8	16.3	9.1	0.5	0.7	0.5	0.0	1.0	0.6	0.7	1.8	1.1	1.1	0.8	4.9	4.0	6.1	0.6	1.1	0.9	1.5	7.3	0.8	0.8	0.8	1.9	0.8	4.0	0.7	0.6	1.0	1.7	0.7	1.1	8.5	1.0	0.6	0.6	1.0	0.7	2.0	0.3	0.0	0.8	0.3	0.8	0.6	0.5	0.8	1.0	0.8	1.7	0.4	1.9	0.4	5.5	1.0	0.4	2.2	0.2	0.1	1.0	0.1	0.0	0.3	0.7	3.5	0.5	0.5	1.0	0.0	0.4	2.0	2.7	2.2	0.2	8.2	2.8	0.2	1.5	0.3	0.6	0.7	1.1	0.7	9.9	0.1	0.5	0.8	0.0	2.0	1.6	0.7	0.2	4.9	0.0	0.7	0.6	0.2	2.0	0.4	0.6	1.0	1.4	0.6	1.4	1.8	1.6	1.0	0.5	0.9	7.6	0.1	0.1	0.5	2.8	0.5	0.3	0.6	5.0	1.2	0.5	0.8	0.3	0.8	0.4	0.2	0.8	0.1	0.4	0.8	1.3	0.2	0.2	0.5	1.9	0.2	0.5	0.4	1.7	1.0	0.6	0.4	7.3	6.8	16.3	8.1	4.9	4.0	1.5	7.3	4.0	0.3	0.0	2.6	0.0	0.7	1.1	0.1	0.4	0.0	1.4	1.2	0.0	0.0	0.4	1.7	1.0	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.4	0.6	0.0	6.1	0.1	0.0	0.2	0.5	2.6	1.3	0.5	0.5	0.3	0.4
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 56.4;Hepatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			Mitochondria	Nucleoli	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	13.9	12.0	9.9	9.0	12.2	5.8	18.1	9.5	14.3	10.2	17.3	22.7	9.4	9.1	11.6	7.7	10.2	10.9	7.4	14.7	11.9	7.6	24.7	58.6	6.4	8.1	11.3	11.2	13.9	12.1	13.7	15.5	5.5	14.1	13.1	16.5	11.7	30.5	10.3	8.2	8.6	11.8	11.5	16.7	5.3	15.0	10.0	12.4	11.2	12.5	7.9	7.7	14.0	8.2	9.1	10.3	2.6	4.3	13.4	15.7	5.2	7.0	2.6	10.0	13.4	10.2	8.9	8.0	5.0	10.4	8.3	11.4	4.3	9.7	20.0	5.4	12.0	9.7	7.1	5.5	6.6	11.6	24.8	8.2	9.9	6.9	5.8	11.3	14.0	4.5	8.5	6.8	5.7	7.1	7.4	9.8	15.6	8.3	17.9	18.5	3.9	5.1	8.2	7.4	15.4	3.4	13.0	31.1	17.1	22.9	10.8	6.7	9.5	8.5	7.1	5.0	11.5	9.1	10.8	4.2	5.0	3.4	4.5	6.7	12.8	12.5	6.6	6.1	10.5	7.4	2.6	3.4	0.8	8.5	4.0	11.1	9.1	7.2	7.2	6.6	9.1	9.6	10.0	0.7	13.4	4.3	10.3	15.7	5.2	9.9	12.2	9.5	14.3	11.9	7.6	11.3	11.2	14.1	12.4	8.9	15.2	6.7	10.1	7.6	7.0	26.0	10.2	16.0	14.8	5.2	2.0	15.7	23.2	6.8	56.4	9.0	12.4	0.0	9.0	6.6	13.0	8.6	16.1	55.0	10.2	3.2	11.5	11.1	9.8	4.1	8.1	6.1	15.1	10.0	28.8	14.6	4.5	11.5	8.1	25.2	8.2	6.5	8.9	7.7	4.8	10.8	8.7	8.9	15.3	9.8
BRIX1	"BRIX, BXDC2, FLJ11100"	ENSG00000113460	"BRX1, biogenesis of ribosomes"	Q8TDN6	5	34915376-34925996	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039614			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoli, Mitotic chromosome"		"HPA039614: AB_10963698"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (3.37e-2)"	"unprognostic (3.84e-3)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.07e-9)"	"unprognostic (1.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-2)"	18.9	18.4	20.4	15.6	24.0	30.6	23.7	24.9	24.1	16.4	14.4	10.7	18.9	11.9	18.1	18.2	23.4	17.6	11.9	16.4	15.8	15.2	17.0	18.6	14.0	22.2	21.1	15.6	19.4	13.4	15.6	19.1	24.5	20.9	15.9	16.5	7.7	15.7	14.5	19.7	15.9	13.3	22.9	18.6	17.0	14.7	13.4	21.9	17.0	16.6	14.2	23.1	21.6	21.7	22.9	14.0	4.1	10.4	15.0	22.1	16.2	14.8	14.7	15.0	20.7	6.5	9.3	29.6	18.4	13.0	24.9	15.9	20.0	19.7	32.8	9.5	10.9	27.7	12.4	26.2	18.9	28.3	17.6	25.9	21.9	35.2	17.8	17.9	34.8	15.2	11.2	12.3	22.9	20.7	7.6	11.4	17.2	38.3	10.0	16.2	16.1	24.1	38.1	24.2	17.6	21.6	21.6	27.2	14.1	14.3	17.3	18.2	16.3	38.0	26.7	17.1	12.4	16.7	21.5	6.8	19.1	20.9	13.7	35.1	9.1	19.4	41.6	16.5	40.1	23.7	4.1	8.5	4.0	14.4	7.9	20.4	22.9	17.7	18.1	10.7	18.0	22.1	19.6	0.5	15.0	10.4	14.0	16.4	16.2	20.4	24.0	24.9	24.1	15.8	15.2	21.1	15.6	20.9	21.9	26.8	30.7	36.9	76.5	96.6	20.2	18.6	15.3	46.8	48.9	22.7	11.8	108.4	41.4	38.0	10.5	32.1	8.4	23.3	37.3	80.2	49.4	31.2	18.6	11.5	37.1	20.6	20.2	16.5	12.9	6.8	36.5	20.6	30.4	33.3	17.8	15.1	37.9	10.5	27.3	26.6	34.1	6.5	35.4	54.6	70.7	83.7	105.5	31.6	29.0	66.5
BTBD16	"C10orf87, Em:AC061711.1, FLJ25359"	ENSG00000138152	"BTB domain containing 16"	Q32M84	10	122271306-122338162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 9.1;testis: 27.6;urinary bladder: 17.9"	"Group enriched"	"Detected in some"	19	"Early spermatids: 100.4;Late spermatids: 53.9"	"Cancer enriched"	"Detected in many"	14	"urothelial cancer: 18.4"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	29	"T-reg: 2.8"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.8"	"Cell line enriched"	"Detected in some"	8	"RT4: 27.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA040529, HPA057638"	Uncertain		Uncertain	Nucleoli,Cytosol		Yes	NA			Nucleoli	Cytosol	"HPA040529: AB_2677022, HPA057638: "	"unprognostic (1.41e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.12e-2)"	"unprognostic (9.44e-3)"	0.3	0.0	0.6	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.6	0.3	0.3	0.2	0.3	0.3	0.9	0.4	0.3	4.4	0.3	0.3	1.2	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	0.3	9.1	0.3	0.3	2.3	0.3	0.0	27.6	0.3	0.3	0.3	0.3	0.3	17.9	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	1.3	27.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.6	0.5	0.3	0.3	0.9	0.4	1.2	0.3	0.3	0.3	0.0	0.0	0.0	0.2	2.5	0.0	0.2	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.9	100.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	53.9	0.6	0.0	0.0	0.0	0.0	0.0	1.3	2.9	0.4	0.8	0.0	0.0	0.2	3.7	0.9	2.8	0.1	0.0	0.0	0.8
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23, rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 144.6;Exocrine glandular cells: 122.2;Pancreatic endocrine cells: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 113.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA052185: AB_2681753"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	16.6	23.4	16.3	15.0	18.8	19.6	18.3	12.3	20.6	17.5	19.3	17.9	19.5	18.3	19.1	30.6	17.5	24.1	23.1	34.2	16.0	17.5	28.1	36.3	16.1	18.3	25.3	17.5	19.3	27.9	14.3	21.8	22.1	16.4	16.5	19.8	20.3	25.1	25.6	52.2	19.3	21.6	21.2	18.7	18.7	18.9	97.0	16.5	22.1	25.8	22.6	22.7	18.7	14.8	43.9	49.0	14.4	18.3	30.1	37.6	31.4	22.2	24.6	9.0	71.4	12.4	11.1	15.0	15.4	13.9	19.9	16.3	34.0	30.1	26.0	8.1	16.5	34.3	16.0	20.7	14.9	18.4	18.2	24.0	11.3	28.7	13.7	15.7	31.7	16.6	10.0	17.2	17.5	15.9	10.1	12.8	21.5	44.7	48.2	17.2	35.1	19.9	43.6	21.5	51.7	28.3	17.8	17.6	113.3	22.0	16.1	27.3	20.5	20.6	55.0	22.8	9.3	34.6	25.4	13.7	17.2	21.9	21.7	32.9	16.7	29.2	43.7	39.4	24.2	35.9	11.5	17.1	14.4	30.7	18.3	34.3	43.9	35.5	33.6	31.5	38.0	37.6	34.4	3.2	30.1	16.2	49.0	37.3	31.4	16.3	18.8	12.3	20.6	16.0	17.5	25.3	17.5	16.4	16.5	41.7	53.9	0.0	0.0	0.0	0.0	0.0	0.0	144.6	78.5	43.6	0.0	64.0	82.9	81.2	0.0	0.0	0.0	0.0	122.2	66.3	0.0	0.0	43.0	0.0	62.2	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	36.9	0.0	0.0	97.5	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	0.0	89.2	0.0	0.0	0.0
C12orf43	FLJ12448	ENSG00000157895	"Chromosome 12 open reading frame 43"	Q96C57	12	121000486-121016502	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046148, HPA061739"	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			Nucleoli	"Golgi apparatus"	"HPA046148: AB_10965169, HPA061739: AB_2684597"	"unprognostic (1.51e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (3.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	10.0	8.6	12.1	7.5	12.9	7.5	8.7	15.2	19.6	7.4	10.2	8.5	3.1	5.7	11.4	5.3	7.2	11.2	5.8	8.7	8.4	8.5	7.2	12.0	7.8	9.2	8.3	11.1	14.3	8.8	9.3	6.8	8.3	13.1	7.3	6.4	8.0	10.0	8.0	7.2	6.4	5.8	10.0	7.1	7.3	7.2	7.1	6.7	7.5	7.6	4.0	8.4	9.6	6.9	16.2	10.7	5.8	13.7	11.0	19.9	13.4	9.8	22.3	11.7	9.1	10.4	8.2	12.9	12.2	12.6	20.6	13.0	16.0	9.3	18.3	12.6	11.8	10.9	11.2	13.7	18.7	12.4	21.9	15.3	14.6	9.5	11.8	12.3	19.3	11.8	9.6	9.9	18.9	12.0	13.1	11.8	19.3	17.3	4.9	10.8	16.2	21.1	15.2	20.8	7.7	16.7	19.0	13.8	13.8	12.6	14.8	16.0	10.2	16.4	7.2	13.2	10.2	19.4	9.1	11.2	11.4	13.7	9.2	12.8	8.9	12.8	14.3	15.0	11.6	16.8	3.7	10.3	5.8	16.9	13.7	15.4	16.2	16.7	16.4	10.7	13.0	19.9	16.9	1.6	11.0	11.4	8.6	15.1	13.4	12.1	12.9	15.2	19.6	8.4	8.5	8.3	11.1	13.1	6.7	23.8	17.8	18.3	14.4	7.8	17.3	5.9	7.6	22.7	7.9	17.4	19.6	19.3	19.9	13.9	4.8	14.4	4.9	0.0	15.9	18.1	10.8	10.6	13.9	10.2	14.6	15.9	2.4	11.1	11.0	8.2	12.7	8.1	13.5	25.2	7.7	15.4	13.1	8.6	12.0	12.9	13.6	19.4	14.4	12.6	12.8	6.8	11.4	16.6	9.5	10.6
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 70.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 4.7;JURKAT: 21.7;MOLT-4: 17.6;RH-30: 4.8;U-2 OS: 9.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	1.0	2.7	0.0	0.6	0.2	0.0	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4	1.7	0.0	0.6	16.9	0.0	0.2	1.6	0.0	1.6	6.7	0.1	3.8	0.0	0.3	0.1	0.5	0.0	0.6	14.9	0.0	0.0	0.4	1.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	4.7	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.6	0.0	0.1	0.0	21.7	0.0	0.0	1.6	0.0	17.6	0.2	2.3	0.0	1.1	0.0	4.8	0.0	0.3	1.2	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.6	0.0	1.4	5.7	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	3.2	0.0	0.0	0.0	5.1	0.3	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.7	0.0	1.0	0.0	0.0	70.5	6.1	0.0	0.0	0.0	0.0	0.1
C17orf97	"LIAT1, LOC400566"	ENSG00000187624	"Chromosome 17 open reading frame 97"	Q6ZQX7	17	410327-431062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.2"	"Group enriched"	"Detected in many"	11	"Early spermatids: 432.9;Late spermatids: 984.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 8.9;U-2197: 11.8"									HPA023583	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA023583: AB_1853122"	"unprognostic (6.62e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (7.73e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.98e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.19e-2)"	2.1	4.9	6.0	2.4	10.6	1.9	2.7	5.2	8.7	3.9	3.6	4.2	4.4	2.2	3.5	4.5	2.4	13.6	6.6	3.8	5.2	6.1	7.6	1.9	3.8	2.8	4.0	7.6	3.8	3.8	3.4	8.2	1.4	6.2	3.3	2.9	4.2	3.5	5.8	4.3	2.5	4.7	1.9	2.8	2.1	2.4	53.2	2.9	5.0	6.9	1.8	1.9	3.1	1.8	0.4	0.9	2.7	0.4	0.8	1.4	0.2	2.6	3.8	1.8	2.2	1.0	0.8	0.9	2.0	1.3	1.5	0.9	0.1	4.0	0.7	1.5	4.3	1.2	8.9	4.8	1.0	1.4	0.3	0.6	1.9	3.3	0.3	3.4	0.4	0.8	1.0	2.5	3.3	0.4	2.2	1.5	4.4	0.3	0.1	1.0	2.2	6.4	3.4	2.8	7.9	1.2	0.7	0.4	2.4	6.2	2.2	0.6	2.1	2.4	3.4	0.5	3.2	2.0	2.9	1.4	1.8	0.9	11.8	0.8	0.2	0.2	0.0	2.3	0.9	1.1	0.4	0.4	2.7	0.3	0.2	0.0	0.2	0.2	0.8	0.5	0.4	1.4	1.3	0.2	0.8	0.4	0.9	0.0	0.2	6.0	10.6	5.2	8.7	5.2	6.1	4.0	7.6	6.2	2.9	3.0	5.1	0.0	3.8	3.0	4.3	5.3	10.2	62.9	11.4	19.2	19.6	0.9	53.0	10.2	432.9	1.8	10.5	23.3	3.1	0.2	3.7	3.9	2.3	4.7	1.7	1.6	15.4	1.8	0.0	984.3	7.8	2.5	3.3	4.6	9.3	10.0	4.7	5.8	6.0	19.3	22.2	6.5	2.1	58.4	13.3	0.9	0.7	0.0	8.5	0.9
C17orf98	LOC388381	ENSG00000275489	"Chromosome 17 open reading frame 98"	A8MV24	17	38835088-38841455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 10.7"	"Cell type enriched"	"Detected in some"	14	"Early spermatids: 184.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 7.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051696	Uncertain		Approved	"Nucleoli,Intermediate filaments"		NA	NA			"Intermediate filaments"	Nucleoli	"HPA051696: AB_2681576"	"unprognostic (2.30e-1)"			"unprognostic (3.25e-4)"	"unprognostic (1.46e-1)"					"unprognostic (3.01e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.58e-2)"	"unprognostic (9.02e-2)"		0.1	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	10.7			0.0		0.0	0.0		1.3	0.5	0.4	0.4	0.2	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.2	0.3	0.0	0.0	7.9	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.0	1.2	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.1	0.0	1.0	0.5	0.0	1.3	0.3	0.5	0.0	0.2	0.2	0.5	0.7	0.0											0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	184.7	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.1	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.2	1.3	0.0	0.0	0.0	0.0	0.0
C18orf21	"HsT3108, PNAS-124, PNAS-131"	ENSG00000141428	"Chromosome 18 open reading frame 21"	Q32NC0	18	35972083-35979286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 94.7;Spermatocytes: 73.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA065505, HPA067322"	Uncertain		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Nucleoli, Plasma membrane"		"HPA065505: AB_2685498, HPA067322: AB_2685822"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (9.88e-2)"	"unprognostic (8.66e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.38e-6)"	"unprognostic (2.53e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.35e-3)"	"unprognostic (5.97e-2)"	14.1	16.1	13.4	16.7	12.5	53.0	18.4	23.1	25.8	13.0	12.8	7.9	17.6	15.2	15.0	17.7	15.0	12.9	11.7	15.2	12.4	12.5	14.0	14.5	11.3	17.1	11.7	14.7	16.4	22.0	12.9	16.9	14.8	13.0	13.4	12.3	8.1	16.5	17.8	28.7	13.6	14.1	15.8	10.6	17.2	16.7	28.7	11.7	22.9	14.8	21.4	15.7	17.8	14.8	18.5	15.1	40.6	16.5	16.5	21.7	10.6	13.3	9.1	19.8	13.6	12.7	19.4	13.3	18.4	17.5	22.1	22.5	7.7	9.1	10.7	19.7	13.5	15.3	13.7	13.8	14.1	24.6	16.2	14.1	11.2	10.8	17.3	18.4	34.0	14.0	18.7	23.0	19.5	19.8	20.6	18.0	17.2	18.1	17.4	14.5	14.9	22.4	23.6	16.6	6.2	10.0	15.2	16.9	20.8	14.9	14.7	12.7	19.0	12.3	9.9	29.4	18.9	14.4	15.3	12.8	21.8	10.4	8.0	16.2	24.4	21.7	23.5	11.1	17.7	11.4	40.6	16.5	18.3	14.6	16.5	14.6	18.5	15.9	13.7	15.1	16.1	12.3	16.0	14.9	16.5	15.3	14.6	21.7	10.6	13.4	12.5	23.1	25.8	12.4	12.5	11.7	14.7	13.0	11.7	17.9	6.7	15.9	8.2	10.5	9.1	10.8	5.1	2.7	11.4	1.8	5.9	15.8	10.0	17.5	94.7	8.7	9.3	0.0	24.9	24.6	8.9	7.3	13.9	9.4	18.9	7.9	6.9	8.6	16.8	46.0	20.8	13.1	11.8	10.8	13.0	8.4	18.6	11.5	15.9	17.0	11.1	0.0	8.6	73.2	36.1	10.8	11.0	12.8	16.6	7.1
C19orf53	"HSPC023, LYDG10"	ENSG00000104979	"Chromosome 19 open reading frame 53"	Q9UNZ5	19	13774168-13778462	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059928, HPA061291"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA059928: AB_2684165, HPA061291: AB_2684469"	"unprognostic (3.94e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.85e-2)"	37.3	41.5	55.6	31.1	53.7	42.1	33.1	22.0	41.7	40.4	35.7	27.0	34.2	28.0	33.9	55.6	43.1	44.0	39.3	67.0	46.2	44.8	42.8	68.4	35.5	42.4	47.2	34.7	49.9	46.9	27.4	41.8	27.2	37.3	39.2	26.4	30.1	45.9	35.7	90.7	31.5	29.2	39.6	37.0	34.8	31.3	34.1	30.0	59.6	53.5	47.7	41.6	43.1	43.1	67.9	63.0	57.3	49.6	36.3	75.8	92.4	35.4	50.6	25.2	21.0	35.8	40.5	16.7	33.4	29.7	41.6	41.5	46.9	17.3	18.9	41.7	40.4	30.6	19.0	23.3	50.5	21.5	22.6	73.5	17.7	54.7	50.9	37.1	27.7	23.5	49.4	36.5	38.5	21.8	26.5	35.6	28.2	27.4	32.6	32.4	79.9	39.1	28.7	32.1	27.2	89.7	21.5	19.2	32.7	36.9	44.0	23.0	27.7	23.4	27.8	33.9	19.5	25.3	28.5	23.7	47.3	18.9	50.6	45.7	36.5	46.4	28.2	28.7	31.5	25.6	48.1	48.8	57.3	49.0	49.6	55.5	67.9	63.4	57.0	44.2	63.3	75.8	68.0	23.7	36.3	43.1	63.0	69.4	92.4	55.6	53.7	22.0	41.7	46.2	44.8	47.2	34.7	37.3	30.0	107.2	86.2	241.2	221.7	258.6	46.5	224.1	198.7	117.8	97.8	254.7	21.6	202.0	532.2	215.9	134.2	206.4	254.0	163.5	291.0	335.7	214.9	274.6	125.8	284.8	320.6	33.4	218.2	154.1	231.7	499.2	202.5	228.8	219.4	359.7	182.1	129.2	247.0	245.4	171.5	582.8	48.4	90.5	205.0	94.7	135.7	304.6	178.2	221.8	197.3	276.6
C1D	"LRP1, Rrp47, SUN-CoR, SUNCOR"	ENSG00000197223	"C1D nuclear receptor corepressor"	Q13901	2	68041130-68110948	"Predicted intracellular proteins"	"Apoptosis, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037413, HPA037588"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037413: AB_2675463, HPA037588: AB_10672907"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.01e-1)"	17.1	20.1	15.9	13.3	17.9	31.5	17.2	13.9	26.5	15.4	16.3	12.4	15.4	14.7	14.9	14.6	13.8	13.9	12.4	15.8	14.9	15.6	28.4	29.8	14.4	21.0	14.8	16.8	14.9	27.3	12.5	25.3	18.6	17.0	14.8	13.9	8.6	13.5	14.0	29.4	11.7	19.2	12.2	17.2	16.4	15.1	13.8	18.6	17.4	18.0	16.4	14.7	13.2	20.0	20.0	16.1	32.1	19.6	22.6	19.7	9.4	21.9	12.3	15.4	12.9	15.6	19.8	20.5	28.5	19.7	20.0	16.5	21.5	24.7	27.7	17.4	19.0	21.2	10.8	18.1	13.3	31.2	29.5	21.8	32.5	10.5	24.6	15.8	40.3	34.5	16.3	22.4	15.0	14.3	24.4	15.3	26.2	25.8	24.2	18.3	11.1	26.8	34.9	16.5	20.4	15.3	16.9	18.3	21.8	18.1	15.9	13.5	15.5	10.4	18.2	28.2	18.6	13.3	27.4	17.0	17.3	19.9	21.1	25.0	23.2	25.8	35.0	22.0	25.1	19.6	28.1	14.3	32.1	15.9	18.5	18.7	20.0	18.0	13.2	16.1	17.2	19.6	19.7	29.0	22.6	19.6	15.0	19.0	9.4	15.9	17.9	13.9	26.5	14.9	15.6	14.8	16.8	17.0	18.6	71.5	36.3	61.4	75.3	75.6	34.8	30.5	61.1	75.0	45.5	61.1	21.6	86.5	198.9	74.3	40.6	40.9	39.1	23.3	52.1	69.0	56.7	67.4	42.8	75.7	76.6	33.4	49.7	40.5	54.7	18.1	51.5	56.0	54.0	76.7	38.4	39.8	54.5	63.3	55.5	180.4	29.5	97.0	44.0	91.4	84.7	75.4	90.2	57.5	31.5	88.7
C1orf210	"MGC52423, TEMP"	ENSG00000253313	"Chromosome 1 open reading frame 210"	Q8IVY1	1	43281883-43285617	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.0"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 105.5;Paneth cells: 49.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in some"		"A-431: 7.4;BEWO: 8.3;CACO-2: 7.8;CAPAN-2: 25.2;OE19: 20.3;SK-BR-3: 8.8;T-47d: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA013788	Uncertain		Uncertain	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA013788: AB_1845637"	"unprognostic (1.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.57e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.61e-2)"	0.3	0.1	0.3	6.5	0.3	0.0	7.4	0.3	0.3	3.9	28.6	0.4	7.4	20.6	1.0	10.9	11.2	2.6	20.7	0.3	0.3	0.1	25.2	3.3	13.5	0.3	0.3	0.3	1.0	29.8	3.0	9.6	6.1	0.4	4.4	14.4	0.4	25.8	7.2	0.3	10.6	64.0	0.5	0.3	0.3	14.6	1.1	0.3	1.0	32.1	7.8	7.7	3.4	5.2	0.1	0.3	5.4	0.3	0.4	0.2	0.0	7.4	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	7.8	25.2	0.0	0.1	0.0	0.0	5.7	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.1	0.0	20.3	0.0	0.0	0.0	0.2	0.6	4.8	3.0	0.2	0.0	8.8	0.0	1.4	9.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.3	0.4	0.3	0.2	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.4	0.3	20.8	10.7	0.8	5.9	1.0	0.0	0.0	22.9	4.0	4.5	21.0	0.0	11.1	24.9	17.9	0.1	0.0	105.5	0.0	29.5	2.9	0.2	10.4	0.0	0.9	0.6	0.0	32.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	34.2	0.0	16.3	49.1	0.0	39.3	0.0	0.0	0.2	0.1	0.0	2.3	3.9	0.0	31.2	7.8
C22orf46	"CTA-216E10.6, FLJ23584"	ENSG00000184208	"Chromosome 22 open reading frame 46"	C9J442	22	41688939-41698136	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 19.8"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 65.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			HPA052741	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted - unknown location"	NA	NA			Nucleoplasm	Nucleoli	"HPA052741: AB_2681933"	"unprognostic (3.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	3.9	2.0	8.1	3.1	6.8	1.0	3.9	2.2	5.7	2.7	2.4			2.3	3.1	4.5	1.7	2.4	2.7	4.8	8.7	7.5	2.7	2.3	2.2	3.1	12.8		5.2	1.4	8.3	3.5	2.1		3.3	2.8		2.8	3.0	3.3	3.3	2.6	2.9	19.8	2.8	2.4	6.2			3.5		3.1	2.2	1.5	1.1	0.4	0.1	2.6	3.5	1.2	0.7	8.8	4.5	11.1	6.8	8.2	8.7	10.1	7.5	8.1	6.4	8.6	4.5	5.8	5.5	5.5	6.2	6.3	4.1	5.7	5.8	7.7	19.7	5.4	6.1	9.4	3.8	4.8	4.5	12.0	6.9	7.8	10.7	7.6	4.9	1.6	8.6	9.9	8.2	5.6	14.6	3.5	5.5	4.5	13.4	3.5	5.1	9.2	6.1	5.4	6.1	2.7	4.2	8.7	7.9	11.3	8.5	9.0	5.5	4.3	8.4	14.4	4.4	3.9	17.5	17.8	5.1	5.0	5.5	11.4	0.1	0.5	0.0	0.7	0.4	0.9	1.1	1.1	1.1	0.2	0.5	0.9	1.2	0.1	3.5	2.6	0.4	0.7	0.7											11.9	16.5	7.1	3.9	1.9	9.4	18.9	5.1	8.1	11.4	7.0	13.7	8.3	1.7	4.2	65.6	7.1	8.4	0.0	4.2	5.8	4.9	2.0	7.0	4.0	4.2	3.2	2.9	9.2	7.3	8.2	4.9	8.3	1.7	9.0	7.2	9.7	3.7	3.7	6.0	1.3	6.2	0.0	3.5	12.0	11.5	2.3	7.1	15.8	4.0	1.4
C7orf50	"MGC11257, YCR016W"	ENSG00000146540	"Chromosome 7 open reading frame 50"	Q9BRJ6	7	996986-1138260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 250.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052281	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA052281: AB_2681784"	"unprognostic (1.64e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	22.5	14.2	37.7	14.9	29.4	9.7	14.9	16.4	32.8	17.0	17.5	15.5	19.4	12.8	20.1	18.8	14.8	21.0	20.3	28.7	28.1	21.4	21.7	14.2	16.1	21.2	22.4	23.0	21.6	79.5	12.3	39.3	13.9	17.3	21.7	7.9	25.9	25.1	28.8	68.4	8.2	13.8	34.5	19.1	19.5	25.1	19.5	9.8	6.0	20.8	18.0	16.6	17.2	10.9	32.3	41.5	76.3	27.0	8.1	20.6	22.7	41.6	26.7	8.9	27.2	4.8	6.9	18.9	18.7	9.3	16.7	14.2	18.8	17.9	12.5	12.4	12.0	21.2	26.5	10.7	22.6	3.3	11.9	21.6	11.4	18.9	25.5	19.7	14.5	7.9	9.8	18.1	15.5	14.3	7.3	11.4	10.6	20.3	12.0	7.4	60.2	6.7	38.9	21.9	18.8	39.7	19.8	3.3	20.7	7.8	11.6	20.6	29.5	15.4	18.3	25.2	6.2	43.9	26.8	13.1	9.7	43.2	28.9	24.5	10.3	13.8	11.4	19.5	24.2	30.6	3.2	27.0	76.3	20.6	26.2	14.6	23.6	16.9	17.4	41.5	32.3	13.2	15.3	3.0	8.1	25.0	12.0	19.7	22.7	37.7	29.4	16.4	32.8	28.1	21.4	22.4	23.0	17.3	9.8	32.8	64.7	92.5	33.2	20.6	74.8	64.4	40.8	56.2	30.7	62.8	17.7	65.3	250.4	73.5	7.0	40.5	17.6	23.3	74.9	70.2	42.1	41.1	54.3	32.5	140.0	54.0	87.1	33.7	63.1	3.4	34.2	61.3	67.4	120.8	45.0	82.9	55.6	17.3	41.8	101.0	58.5	25.8	67.4	18.1	41.5	21.3	38.9	48.4	57.1	30.7
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7"	"Cell type enhanced"	"Detected in many"	16	"Mucus-secreting cells: 113.3;Undifferentiated cells: 69.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	8	"OE19: 57.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA050769	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA050769: AB_2681230"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.4	0.0	0.4	1.7	0.4	0.0	6.1	0.4	0.4	5.3	16.1	0.5	10.5	9.1	1.0	0.4	2.4	1.5	7.1	0.4	0.4	0.0	0.4	0.5	3.6	0.4	0.4	0.4	0.4	3.9	0.0	0.8	0.4	0.4	11.6	20.9	0.4	34.3	17.0	0.4	3.8	7.0	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	1.6	5.2	1.3	0.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	57.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	3.7	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	8.9	12.3	0.0	2.5	0.2	0.0	0.2	22.9	5.3	10.3	0.0	0.0	0.0	0.0	4.3	0.0	0.0	7.7	0.0	9.9	0.0	0.2	16.2	0.0	0.9	0.1	0.0	24.9	0.0	0.0	0.0	0.0	0.2	10.1	0.0	113.3	0.0	5.3	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	69.7	4.7
CACHD1	"KIAA1573, VWCD1"	ENSG00000158966	"Cache domain containing 1"		1	64470792-64693058	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 37.5;Club cells: 18.2"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	11	"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"AF22: 21.4;NTERA-2: 29.3;SuSa: 19.1;U-2197: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017202	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA017202: AB_1852423"	"unprognostic (2.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.32e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.13e-1)"	5.4	7.6	6.5	0.5	8.4	0.0	4.7	1.2	4.3	7.3	0.8			0.2	6.1	5.2	1.6	8.5	2.1	1.2	3.5	4.2	3.3	0.4	4.7	0.4	2.3		14.2	3.7	5.5	4.5	5.5		4.0	1.0		4.4	4.3	0.8	3.0	0.9	5.3	0.6	1.7	3.3	0.5			2.4		0.2	2.1	4.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.8	21.4	3.1	8.5	3.0	0.0	3.0	3.9	5.1	4.9	12.4	0.1	0.0	8.8	4.8	3.7	1.5	11.9	2.5	5.2	2.3	6.4	4.4	1.3	0.0	0.0	1.9	0.0	2.6	1.7	0.6	3.2	2.9	2.7	3.0	0.0	0.0	0.0	0.3	0.3	0.0	29.3	0.1	2.2	2.3	2.1	0.0	0.0	0.6	0.5	11.2	6.5	0.0	2.6	19.1	0.8	0.2	1.9	0.5	3.8	15.0	2.6	0.0	0.0	0.0	0.4	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0											6.0	37.5	0.0	6.1	15.3	12.7	1.4	0.0	13.4	18.2	3.5	0.0	0.0	0.0	2.0	7.7	11.8	0.0	0.0	2.5	0.1	4.1	1.2	2.3	0.9	0.2	0.0	0.0	3.1	0.3	2.3	13.3	1.8	1.7	0.0	0.0	5.2	1.3	0.0	2.8	3.1	1.1	6.5	5.7	0.4	0.4	12.9	0.0	0.0	0.1	4.8
CASP8AP2	"CED-4, FLASH, FLJ11208, KIAA1315, RIP25"	ENSG00000118412	"Caspase 8 associated protein 2"		6	89829894-89874436	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatogonia: 89.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053573			Approved	"Nucleoli,Nuclear bodies"		NA	NA			"Nucleoli, Nuclear bodies"		"HPA053573: AB_2682194"	"unprognostic (7.80e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.75e-4)"	"unprognostic (4.58e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.53e-1)"	3.8	3.1	5.4	8.0	7.3	4.8	6.0	9.7	7.8	7.4	4.7	3.3	3.8	3.5	5.0	3.4	4.5	3.7	3.5	3.9	6.5		3.1	3.4	3.9	8.8	6.1	5.0	6.6	3.8	5.7	7.0	5.9	6.6	7.2	4.3	3.5	4.0	5.2	3.2	2.6	4.7	5.3	5.7	5.4	4.0	5.0	5.9	9.1	4.5	2.1	5.9	6.5	3.2	9.9	7.8	17.7	4.1	17.8	12.3	3.6	4.2	4.3	13.8	9.5	4.7	4.7	5.5	10.6	4.0	7.6	9.9	5.0	3.4	12.6	5.6	5.4	5.8	6.4	12.4	5.3	8.8	12.9	10.5	15.7	10.2	1.7	2.0	14.7	8.3	2.3	2.5	9.9	4.6	3.1	5.5	12.5	16.9	7.6	5.1	3.8	8.3	2.7	4.0	4.0	4.0	16.4	17.2	4.9	1.4	9.3	9.1	6.3	8.8	1.9	3.8	6.5	4.2	7.5	7.4	4.9	4.2	8.4	9.6	4.6	11.2	7.5	5.0	8.4	7.7	17.7	2.5	8.2	10.7	4.1	10.3	8.3	12.3	11.2	3.1	9.9	9.9	9.5	4.4	17.8	3.5	7.8	10.2	3.6											29.8	16.4	13.9	8.5	0.0	18.7	39.9	5.1	25.4	21.6	7.0	5.9	14.1	3.3	13.0	4.6	12.8	9.6	0.0	11.0	13.0	12.4	10.8	15.1	6.6	10.6	33.4	2.4	8.6	9.7	3.5	21.3	11.3	0.0	28.9	10.0	16.6	8.2	10.1	24.4	6.9	23.8	19.4	13.7	29.1	89.7	0.0	9.2	13.8	13.3	7.3
CBS	HIP4	ENSG00000160200	Cystathionine-beta-synthase	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 55.7;pancreas: 43.0"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 3.5;Hepatocytes: 2.6;Melanocytes: 5.0;Smooth muscle cells: 2.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	84	"neutrophil: 8.3"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 40.8;HAP1: 38.9;HHSteC: 52.7;MCF7: 45.1;RPMI-8226: 43.1"									HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	1.3	1.5	6.5	2.4	5.1	0.4	1.0	12.3	6.7	4.8	1.3	2.0	0.8	1.6	0.9	0.8	0.8	2.0	2.1	2.0	5.6	5.5	1.3	55.7	1.7	1.4	4.8	2.8	13.9	43.0	0.3	1.4	1.4	2.3	4.0	0.7	2.8	9.3	3.4	0.8	0.6	2.9	1.4	3.7	0.8	2.7	2.2	3.3	0.8	5.0	0.8	0.9	2.6	0.8	0.0	0.0	8.3	0.0	0.0	0.0	0.0	6.4	3.9	5.1	20.0	11.5	7.4	40.8	8.0	2.0	3.3	3.4	12.0	0.3	0.0	4.3	15.0	0.0	0.4	38.9	2.8	0.6	0.0	4.9	2.7	15.6	14.4	52.7	1.6	3.8	4.5	0.4	3.6	3.2	3.0	8.8	18.9	30.1	22.7	2.5	45.1	2.8	0.0	4.8	14.6	6.8	0.0	0.0	43.1	0.1	3.6	10.6	15.6	17.4	1.0	7.5	4.3	6.2	20.4	1.2	0.2	10.0	0.1	0.8	7.9	6.3	9.0	3.7	2.4	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	6.5	5.1	12.3	5.2	5.6	5.5	4.8	2.8	2.3	3.3	0.0	0.3	0.0	0.0	0.3	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.2	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.0	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.9	0.1	0.0	0.0	0.0
CBSL		ENSG00000274276	"Cystathionine-beta-synthase like"	P0DN79	21	6444869-6468040	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.5;liver: 21.2;pancreas: 18.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	47	"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 36.5;NTERA-2: 67.6;SH-SY5Y: 21.6;U-266/70: 21.3"									HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA		190000	Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (2.39e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.61e-1)"	0.0	0.0		0.0		0.0	0.0		11.5	1.8	0.0			0.4	0.0	0.0	0.0	0.3	0.0	1.0			0.0	21.2	0.0	0.0			1.6	18.5	0.0		0.0		1.8	0.0		0.0	3.5	0.0	0.0	0.8	0.0		0.0	0.0	0.0			5.0		0.0	0.3		0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	12.2	36.5	0.0	0.0	0.4	7.6	4.4	2.8	8.5	0.1	4.9	0.0	0.0	0.0	4.7	3.2	0.0	3.9	1.7	0.0	9.6	0.0	0.0	0.0	0.2	0.0	5.2	4.2	14.2	0.0	7.1	0.0	0.0	0.8	0.2	16.9	0.1	0.0	5.7	0.6	67.6	0.0	0.0	0.0	0.0	0.0	11.0	0.0	14.1	21.6	0.0	1.1	14.7	0.0	0.0	0.0	0.0	0.7	0.0	4.7	1.5	21.3	7.8	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CC2D2B	"bA248J23.4, bA690P14.3, C10orf130, C10orf131"	ENSG00000188649	"Coiled-coil and C2 domain containing 2B"	Q6DHV5	10	95907603-96032684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.6"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 8.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA044091, HPA072122"	Enhanced		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA044091: AB_2732514, HPA072122: AB_2686489"	"unprognostic (6.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.11e-3)"	"unprognostic (9.11e-4)"	"unprognostic (1.93e-2)"	"unprognostic (4.34e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-1)"	0.5	1.7	1.0	1.7	1.0	1.7	0.6	0.3	3.1	0.8	0.8			0.6	2.3	0.2	0.8	1.3	2.0	0.8	0.6	0.6	0.6	0.3	0.9	1.1	0.9		0.8	0.2	0.0	0.4	0.7		0.9	0.0		0.5	0.1	1.6	2.6	0.9	1.2	0.7	1.4	0.6	10.6			4.0		0.0	1.0	1.1	4.1	1.0	1.8	1.0	0.8	2.9	0.5	1.2	4.0	3.9	7.2	0.2	0.4	4.1	3.9	0.4	0.6	0.1	4.2	0.8	5.1	3.1	0.0	4.0	2.8	0.3	0.2	0.0	4.9	8.8	9.2	3.4	3.2	0.0	9.8	0.6	0.7	0.0	0.4	0.1	1.7	0.3	1.3	7.9	3.0	0.9	2.5	4.5	3.3	8.5	3.0	6.6	11.6	3.5	4.3	0.7	1.3	7.1	3.8	4.3	1.1	2.7	5.1	7.0	4.4	3.4	4.5	4.5	3.1	5.6	2.6	11.0	0.1	3.4	10.0	2.9	0.0	1.0	0.2	1.9	0.3	2.9	3.4	1.4	1.1	0.9	4.1	1.3	0.4	1.8	0.8	0.8	1.0	0.8	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CCDC137	MGC16597	ENSG00000185298	"Coiled-coil domain containing 137"	Q6PK04	17	81666364-81673904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052637, HPA053914"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoli, Mitotic chromosome"		"HPA052637: AB_2681894, HPA053914: AB_2682306"	"unprognostic (3.04e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (2.21e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (4.26e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.39e-1)"	11.3	10.9	10.9	16.0	14.1	20.2	10.2	11.3	17.0	10.3	11.5	8.0	8.9	16.2	9.1	6.4	25.2	9.2	9.1	9.1	12.1	9.0	10.6	12.1	8.7	18.8	12.4	11.9	8.4	12.0	9.4	8.4	11.2	11.8	13.1	6.4	5.7	13.0	9.9	12.7	29.8	11.8	10.3	9.1	17.7	11.4	13.4	12.4	9.8	9.2	13.1	16.6	10.6	14.7	12.8	12.6	10.2	9.2	11.9	11.2	5.9	12.4	24.7	6.7	12.0	4.9	4.9	13.5	14.3	6.8	20.6	11.4	21.8	7.5	12.9	7.6	8.5	11.6	16.4	13.9	16.1	7.7	6.6	21.4	20.0	11.0	17.3	7.5	15.3	13.1	7.2	8.7	18.9	8.5	4.5	14.5	14.0	19.0	6.9	9.6	13.6	15.2	16.6	16.1	9.5	25.0	18.2	12.7	8.3	6.5	11.4	16.5	21.3	13.1	27.0	11.7	7.9	19.5	12.7	9.9	29.8	17.4	11.9	19.7	18.2	10.5	13.0	10.7	15.0	16.9	1.9	7.8	10.2	11.2	8.4	7.0	10.3	9.7	9.6	7.4	12.8	10.7	9.6	3.5	11.9	9.2	12.6	9.5	5.9	10.9	14.1	11.3	17.0	12.1	9.0	12.4	11.9	11.8	12.4	20.8	13.4	25.0	19.6	28.2	5.7	6.2	10.2	26.8	25.0	12.2	2.0	19.0	16.6	24.5	1.0	19.6	12.7	23.3	18.6	32.2	11.4	18.3	18.5	10.9	21.5	17.5	6.9	14.1	11.0	0.9	12.7	18.2	15.1	33.3	13.4	12.9	26.4	13.6	12.7	10.2	7.1	6.5	15.6	31.2	46.5	30.1	17.4	29.9	17.0	18.6
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553086-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 152.4;Late spermatids: 134.7;Rod photoreceptor cells: 44.6;Spermatocytes: 149.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.5;HEL: 14.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	2.5	2.5	5.8	5.5	7.5	4.0	3.6	8.2	7.8	4.1	2.4	1.1	6.9	1.9	11.6	5.8	2.4	4.6	3.4	2.6	4.9	4.1	2.8	1.3	2.5	2.4	3.4	7.6	6.3	3.4	4.2	7.8	7.3	6.6	3.4	2.5	2.0	1.9	7.4	2.4	4.9	2.2	7.1	6.1	1.5	3.1	20.4	3.3	20.2	4.3	1.4	2.2	2.5	2.8	1.6	0.7	5.1	0.6	0.4	1.8	0.2	1.7	0.9	2.2	2.1	1.2	2.6	1.4	1.4	1.1	1.4	1.5	0.6	0.8	9.5	0.7	0.8	2.5	0.4	0.9	1.3	1.5	2.0	0.9	14.8	1.5	1.3	1.8	2.1	1.9	1.5	2.6	1.1	2.1	1.0	0.6	5.4	0.4	2.6	1.6	0.7	4.1	1.9	1.7	0.8	2.1	4.9	1.6	0.3	1.0	1.4	3.1	1.5	2.8	1.0	3.6	1.9	1.1	1.5	1.1	2.9	1.6	0.8	0.9	1.4	1.7	6.2	1.2	1.2	2.0	5.1	0.6	0.0	0.8	0.6	1.8	0.7	0.7	0.7	0.7	1.6	0.5	0.9	0.5	0.4	0.4	0.7	0.6	0.2	5.8	7.5	8.2	7.8	4.9	4.1	3.4	7.6	6.6	3.3	0.0	6.9	0.0	5.3	2.5	24.3	7.0	0.0	17.4	9.1	3.5	15.7	4.8	5.0	2.0	152.4	2.6	2.7	0.0	3.1	3.6	1.9	0.5	1.1	0.8	1.6	9.5	1.2	2.5	0.3	134.7	5.5	1.1	0.0	1.8	2.6	11.2	2.0	0.0	5.6	1.4	44.6	12.9	2.1	149.3	27.2	2.9	4.7	0.7	3.6	2.6
CCDC58	FLJ33273	ENSG00000160124	"Coiled-coil domain containing 58"	Q4VC31	3	122359591-122383231	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047777, HPA051965"	Approved		Approved	Nucleoli,Mitochondria		No	No			Mitochondria	Nucleoli	"HPA047777: AB_2680152, HPA051965: AB_2681676"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (5.64e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.84e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (7.29e-4)"	9.5	13.3	8.7	6.8	8.1	7.1	9.2	6.9	12.6	8.2	13.3	7.1	12.4	10.6	7.3	12.4	14.0	5.8	7.7	12.4	7.2	7.0	21.9	23.3	5.4	10.0	8.6	5.3	8.8	9.3	3.1	7.7	6.7	8.5	8.2	14.4	6.5	7.2	6.9	35.2	6.9	10.2	6.3	7.2	8.6	9.1	8.7	9.3	5.5	8.8	24.5	9.6	8.7	7.1	13.9	18.3	1.7	10.2	11.4	16.1	4.6	34.9	11.1	21.2	13.5	7.9	11.1	27.3	13.4	14.6	32.6	32.1	31.3	17.7	25.7	23.2	10.2	25.4	24.5	34.4	23.0	39.1	8.8	12.2	30.2	7.9	37.8	13.2	44.9	10.8	9.1	11.9	20.0	21.9	13.9	15.0	22.9	34.2	11.2	17.1	17.4	28.6	32.2	40.7	38.6	21.0	19.0	25.2	31.6	22.4	18.6	21.5	10.5	15.6	16.6	37.3	18.7	16.5	29.6	8.6	18.3	23.4	7.7	26.7	8.9	11.9	55.4	20.8	21.8	16.1	0.4	5.0	1.7	10.2	10.2	12.0	13.9	13.6	13.4	10.3	13.5	16.1	14.9	0.9	11.4	8.5	18.3	10.5	4.6	8.7	8.1	6.9	12.6	7.2	7.0	8.6	5.3	8.5	9.3	3.0	17.1	19.3	16.0	13.6	9.4	23.0	25.5	32.1	20.5	12.2	9.8	19.1	46.4	27.4	0.3	11.3	13.4	0.0	25.7	38.8	10.2	10.9	19.8	46.1	15.7	0.0	5.2	11.6	7.6	0.7	11.8	12.4	8.5	26.2	14.7	6.6	31.7	14.0	7.8	78.7	8.8	12.9	8.0	13.5	23.4	16.2	12.7	7.1	22.4	21.2
CDRT1	"FBXW10B, FBXW10P1, HREP, SM25H2"	ENSG00000241322	"CMT1A duplicated region transcript 1"	O95170	17	15565483-15619512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 9.8;testis: 12.8"	"Cell type enhanced"	"Detected in some"	24	"Ciliated cells: 4.0;Early spermatids: 18.5;Late spermatids: 8.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"T-reg: 2.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 15.6;HaCaT: 28.6;HeLa: 9.7;OE19: 7.1"									"HPA013332, HPA047457"			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA013332: AB_1848471, HPA047457: "	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (7.03e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.31e-8)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.86e-1)"	1.1	1.8	0.0	0.9	0.0	0.0	0.7	0.2	0.0	2.4	0.3			2.9	0.0	0.8	9.8	0.3	0.7	0.7	0.0	0.0	0.1	0.5	0.9	0.7	0.0		0.0	0.0	0.0	0.1	1.8		0.3	0.6		2.6	0.1	2.1	4.4	1.3	0.0	0.0	0.2	2.6	12.8			1.6		3.0	2.0	4.1	0.4	0.1	0.0	0.3	0.1	2.1	0.0	2.4	6.8	0.2	2.0	0.2	0.7	0.2	0.5	1.5	0.2	0.7	5.1	15.6	0.1	0.4	1.3	1.6	28.6	0.4	0.3	0.4	2.4	0.3	0.1	9.7	0.2	0.2	0.0	0.1	0.3	0.9	0.6	0.4	0.1	0.1	0.4	0.0	1.2	0.8	0.1	0.4	0.2	0.2	7.1	0.8	0.0	0.4	0.0	1.9	3.7	0.1	0.2	2.3	2.0	0.1	0.8	0.1	0.1	1.2	0.5	1.4	0.0	0.4	0.6	2.9	0.0	1.7	0.1	0.8	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.0	0.1	0.1	0.0	2.1	0.0											0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.2	18.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.5	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.4	0.0	0.0	0.0	0.0	0.3
CENPBD1	MGC16385	ENSG00000177946	"CENPB DNA-binding domain containing 1"	B2RD01	16	89969773-89972832	"Predicted intracellular proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEK 293: 7.8;K-562: 4.7"									"HPA052759, HPA060522"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA052759: AB_2681938, HPA060522: AB_2684304"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.48e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (5.27e-11)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	7.2	5.9	6.6	2.6	7.3	4.5	6.3	6.1	9.5	3.3	4.0	4.9	10.5	5.9	3.6	5.0	4.0	3.6	4.6	4.2	6.6	6.1	7.6	5.6	6.7	7.1	7.9	7.0	7.6	8.9	3.9	7.1	4.4	6.2	4.9	6.0	3.8	6.0	4.8	4.2	5.1	2.9	3.8	5.6	6.6	4.7	8.2	6.3	2.5	3.5	1.8	2.5	4.8	2.7	3.7	3.6	1.4	1.6	1.4	2.7	1.3	1.2	0.0	0.2	0.4	0.5	0.9	2.1	0.8	0.3	0.0	0.0	0.6	0.0	1.3	1.2	0.9	0.3	2.0	0.0	0.0	0.3	0.0	7.8	0.0	0.3	0.5	0.4	0.4	1.3	0.0	1.4	0.0	0.0	0.2	0.0	0.6	4.7	0.9	0.0	1.1	1.4	0.6	0.7	0.4	0.5	3.2	1.6	0.0	0.0	0.0	2.7	2.0	2.9	0.3	0.1	0.3	0.7	0.0	0.0	0.2	1.9	0.3	1.2	0.8	1.3	1.0	0.5	1.2	0.5	0.6	1.6	1.4	2.4	0.7	2.1	1.2	1.9	0.8	3.6	3.7	2.7	2.3	0.5	1.4	1.4	3.1	1.1	1.3	6.6	7.3	6.1	9.5	6.6	6.1	7.9	7.0	6.2	6.3	8.9	10.7	3.7	3.1	4.1	9.6	0.4	5.1	6.7	9.1	5.2	17.7	3.7	6.6	5.6	1.5	1.6	3.4	0.0	5.1	3.6	3.5	3.4	6.9	5.8	7.4	4.8	1.2	1.3	6.3	1.3	4.4	6.9	5.0	9.0	3.2	12.6	5.2	2.9	4.9	5.0	22.5	0.0	2.8	21.8	18.8	2.8	4.2	3.2	2.6	2.1
CENPP	"CENP-P, RP11-19J3.3"	ENSG00000188312	"Centromere protein P"	Q6IPU0	9	92325484-92620533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 30.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 56.2;Suprabasal keratinocytes: 88.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021787, HPA058945"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA021787: AB_1846524, HPA058945: AB_2683860"	"unprognostic (5.48e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (4.88e-5)"	"unprognostic (8.06e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.68e-3)"	"unprognostic (9.20e-8)"	"unprognostic (1.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.04e-1)"	5.0	5.1	6.8	8.9	8.8	15.5	4.9	14.9	7.4	6.0	3.8	3.5	1.4	4.5	6.4	4.1	8.4	3.6	4.6	4.3	5.4	4.6	3.5	3.2	3.5	7.8	6.1	4.5	4.6	7.5	7.8	9.4	5.3	6.8	4.8	4.5	5.5	5.0	2.8	11.8	30.0	3.2	4.8	4.4	5.4	3.0	8.7	6.5	14.8	3.0	7.4	9.1	4.4	8.0	6.7	4.8	4.1	10.3	5.1	8.2	4.0	7.9	5.0	7.1	5.1	2.9	3.2	6.7	8.4	4.7	10.5	8.4	2.3	4.6	10.1	3.9	2.7	9.7	9.6	6.8	4.6	9.8	14.4	8.0	10.3	4.5	3.3	1.5	21.1	10.0	3.4	2.6	10.2	6.6	1.4	5.3	10.0	11.1	14.7	8.0	5.0	29.6	6.4	5.7	15.0	9.5	10.0	11.6	11.3	1.6	8.0	15.8	5.5	9.5	6.1	3.0	5.3	3.2	6.5	2.5	10.3	5.1	15.5	12.0	9.8	11.4	13.3	11.5	10.5	9.3	3.0	3.2	4.1	4.9	10.3	8.2	6.7	5.3	4.1	3.6	5.7	5.0	4.8	0.8	5.1	5.1	4.8	5.7	4.0	6.8	8.8	14.9	7.4	5.4	4.6	6.1	4.5	6.8	6.5	0.0	0.3	1.5	3.6	56.2	6.4	2.0	2.5	0.0	1.2	0.0	7.9	2.7	1.7	0.9	15.3	3.1	0.7	0.0	2.0	8.2	5.6	2.1	0.0	0.8	13.9	1.6	1.2	1.3	1.3	3.6	4.0	3.0	13.5	0.0	0.6	2.5	1.2	0.0	4.6	1.1	7.5	6.5	6.7	11.1	5.7	88.2	3.2	4.3	1.7	2.4
CERS5	"FLJ25304, LASS5, MGC45411, Trh4"	ENSG00000139624	"Ceramide synthase 5"	Q8N5B7	12	50129306-50167533	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026589	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA026589: AB_1852727"	"unprognostic (1.59e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.49e-3)"	"prognostic unfavorable (4.63e-5)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (9.33e-11)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (3.26e-1)"	18.0	13.2	18.3	13.3	21.6	10.9	18.0	38.3	19.6	21.1	15.0	17.5	8.9	6.3	22.6	20.9	14.1	17.7	14.9	9.9	16.7	11.6	16.0	7.8	14.7	15.1	13.9	19.1	22.5	13.8	23.9	22.4	19.7	14.3	15.6	11.5	14.9	14.6	16.2	5.0	21.5	12.2	21.8	10.3	15.7	13.3	11.6	14.4	12.7	15.5	7.0	14.9	18.4	18.3	21.0	26.1	33.5	35.1	29.0	26.3	22.3	9.2	10.4	23.0	6.5	12.8	10.8	19.5	20.5	17.7	19.7	18.7	24.5	14.7	14.0	17.2	29.0	10.3	8.7	10.0	7.9	19.6	22.1	10.2	11.7	8.8	14.8	25.6	11.9	16.0	18.5	12.0	16.2	15.1	25.9	17.9	12.3	8.8	13.0	24.7	16.2	10.3	32.4	14.7	5.2	10.1	13.5	15.0	10.0	25.6	12.0	7.0	11.4	17.4	8.2	27.5	15.8	11.2	13.7	17.1	17.0	11.4	12.7	8.9	12.7	12.1	11.3	13.4	8.3	7.8	24.8	19.0	28.1	26.0	25.5	22.9	17.9	22.9	22.4	18.2	21.0	17.9	24.3	33.5	29.0	35.1	26.1	26.3	22.3	18.3	21.6	38.3	19.6	16.7	11.6	13.9	19.1	14.3	14.4	17.9	17.3	12.1	17.3	15.3	41.7	5.6	15.3	9.4	14.8	14.0	19.6	27.6	6.6	19.6	0.6	14.9	9.1	0.0	12.2	48.5	20.0	10.2	15.0	3.8	17.4	30.2	15.0	15.4	17.0	1.1	15.5	16.5	11.8	30.7	7.0	21.7	14.2	7.0	16.3	6.8	36.1	32.3	17.6	8.1	7.5	12.5	28.1	20.0	6.0	11.3
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678778-60868028	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.1"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 227.8;Muller glia cells: 155.9;Rod photoreceptor cells: 196.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"AF22: 26.3;SCLC-21H: 24.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 110.3"	HPA053075			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA053075: AB_2682035"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.9	2.2	7.0	7.9	11.2	25.1	4.1	47.1	9.0	2.3	5.7	13.4	3.1	5.9	2.6	3.2	5.1	3.2	3.1	4.1	8.1	4.3	3.6	3.6	4.7	7.0	8.1	3.3	1.4	6.4	12.4	9.9	5.6	9.9	2.9	5.5	6.4	5.7	2.8	10.3	5.7	6.6	2.4	7.5	6.1	4.5	4.3	12.2	1.6	5.4	2.2	7.3	2.9	5.9	12.2	0.6	12.6	0.6	0.0	5.5	0.4	3.9	2.0	26.3	4.6	0.1	0.0	8.3	0.2	0.0	0.9	0.8	4.9	3.7	7.6	0.5	0.0	1.2	2.4	13.5	3.9	0.8	2.9	7.2	17.9	3.3	6.4	1.1	5.4	3.3	0.5	3.0	0.0	4.4	1.6	3.9	6.2	1.3	6.8	0.6	4.0	8.4	6.2	18.0	3.9	0.9	17.6	6.2	2.4	2.0	4.5	24.0	11.9	0.7	3.0	7.3	9.7	5.3	5.1	4.5	0.3	4.3	0.3	2.1	7.3	4.2	11.9	1.5	0.6	6.7	10.4	0.3	12.6	2.6	0.1	3.3	8.0	2.9	0.9	0.1	12.2	5.5	2.0	7.1	0.0	0.6	0.6	0.2	0.4	7.0	11.2	47.1	6.5	8.1	4.3	8.1	3.3	9.9	12.2	29.8	17.4	46.9	22.3	27.0	32.3	30.7	30.6	20.1	23.9	15.7	227.8	7.1	1.7	15.6	11.9	29.6	17.6	0.0	9.7	5.5	7.1	31.3	38.3	9.5	11.9	66.7	83.8	27.0	12.9	7.6	0.9	10.3	20.3	19.8	30.6	155.9	13.9	22.6	0.4	4.2	196.3	0.0	4.4	4.9	3.4	28.2	5.1	13.8	21.7	25.1
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046174-22065674	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Syncytiotrophoblasts: 445.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	8.1	28.2	28.1	9.6	31.6	17.6	14.9	16.3	39.3	12.1	34.3	14.5	17.1	29.4	12.8	32.0	33.2	10.0	11.0	18.1	28.8	33.4	12.8	31.9	7.9	9.8	33.9	27.3	11.9	18.6	14.6	14.3	20.2	34.3	17.0	33.1	10.2	14.8	12.9	18.2	12.9	32.9	13.3	18.0	8.5	12.9	30.2	14.8	6.4	10.9	11.9	12.4	11.8	17.2	12.2	19.5	19.4	18.9	22.8	19.9	15.0	19.4	15.8	19.4	9.2	15.3	19.1	28.2	13.6	15.0	14.8	15.7	35.3	22.6	17.3	13.4	11.6	27.3	15.9	11.4	18.9	20.0	22.8	14.4	52.1	12.8	17.7	14.3	13.7	27.7	12.8	18.0	18.8	28.1	20.2	19.6	18.8	32.7	8.8	26.2	25.6	15.8	32.0	46.8	21.8	21.9	11.2	20.3	16.4	17.6	21.4	7.8	13.7	10.7	19.0	15.3	40.7	26.1	18.9	14.2	16.7	13.8	14.7	24.9	6.1	7.8	23.0	27.2	10.8	16.8	10.3	17.9	19.4	13.7	18.9	17.8	12.2	18.6	18.1	19.5	12.1	16.8	17.4	1.8	22.8	16.5	12.3	19.9	15.0	28.1	31.6	16.3	39.3	28.8	33.4	33.9	27.3	34.3	14.8	11.9	13.7	19.0	62.8	26.0	35.2	62.1	28.1	46.8	28.4	22.7	3.9	144.0	64.6	44.6	10.3	38.6	126.2	116.8	73.5	117.3	40.1	92.3	22.0	56.7	56.8	33.4	40.0	38.6	32.1	12.9	23.6	27.0	42.2	49.5	94.4	20.7	65.2	133.3	26.2	64.8	17.4	19.4	37.0	79.6	93.5	38.9	445.4	22.3	85.9	97.2
COQ5	MGC4767	ENSG00000110871	"Coenzyme Q5, methyltransferase"	Q5HYK3	12	120503274-120534434	"Enzymes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049487	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"HPA049487: AB_2680789"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.30e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.88e-2)"	14.6	21.7	15.8	16.1	16.7	7.0	29.5	15.6	21.3	12.5	16.4	13.5	21.8	15.7	12.6	16.4	14.0	15.5	13.5	31.9	14.8	13.1	26.0	39.8	17.6	19.1	17.5	15.4	15.1	28.6	14.2	13.4	18.6	19.4	12.7	17.1	11.6	17.9	17.8	58.4	11.1	13.2	14.0	18.5	14.6	12.4	16.9	15.0	17.2	17.7	30.4	15.2	10.1	17.0	21.3	27.4	9.7	19.6	25.1	28.2	22.4	15.9	25.6	23.1	6.6	30.5	23.5	15.9	19.5	12.8	20.0	12.7	10.2	13.5	16.1	23.1	20.4	14.2	17.3	20.5	21.7	20.6	20.1	12.1	21.4	15.7	16.9	24.9	23.3	13.5	22.5	23.5	18.6	22.0	31.3	17.5	31.1	21.0	11.8	23.1	20.9	13.4	26.8	20.3	11.5	19.9	25.0	23.4	23.3	25.7	12.2	17.5	14.1	14.1	7.2	26.5	25.2	36.3	19.3	17.5	13.9	15.9	10.2	12.9	25.5	21.5	18.3	15.8	22.2	16.6	9.4	19.6	9.7	18.8	19.2	18.2	21.1	20.4	19.9	27.4	21.3	28.2	22.3	2.1	25.1	17.9	18.0	24.4	22.4	15.8	16.7	15.6	21.3	14.8	13.1	17.5	15.4	19.4	15.0	11.9	10.9	16.3	10.7	6.9	11.5	26.2	15.3	16.0	7.9	14.0	13.7	60.9	39.7	25.5	42.0	11.7	17.2	23.3	17.3	38.3	14.1	8.4	17.3	37.2	40.3	4.8	14.5	16.0	15.6	14.5	15.3	13.1	21.9	36.1	14.6	11.8	12.3	23.2	17.7	52.6	14.4	6.5	10.3	13.7	15.4	7.9	48.7	17.5	29.2	7.5
COX7A2L	"COX7AR, COX7RP, EB1, SIG81"	ENSG00000115944	"Cytochrome c oxidase subunit 7A2 like"	O14548	2	42333546-42425088	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059124, CAB073545"			Enhanced	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB073545: , HPA059124: AB_2683912"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.02e-1)"	25.1	73.3	47.3	24.4	63.3	47.7	45.4	35.2	58.2	33.4	33.8	21.0	28.8	31.7	30.2	37.9	20.9	31.2	27.1	49.8	40.4	45.3	50.9	48.9	24.0	28.1	42.6	35.6	49.8	49.3	24.9	42.7	24.0	34.9	29.5	36.2	32.3	37.0	30.3	24.4	21.5	32.1	28.4	33.1	23.1	29.4	24.8	20.5	28.0	35.8	35.8	30.9	24.5	31.1	45.1	59.7	57.2	48.7	40.5	53.7	100.9	38.3	24.6	27.3	29.6	46.9	66.9	32.7	31.8	46.5	29.1	37.2	26.9	27.8	34.0	31.9	36.4	37.3	17.2	32.5	33.7	42.6	52.2	25.0	23.0	17.6	47.7	55.3	34.5	25.6	65.6	67.9	28.4	68.8	42.2	40.9	26.7	33.4	58.4	45.0	31.2	41.1	57.4	26.8	45.4	25.6	22.5	47.4	28.8	41.6	31.1	32.5	37.1	13.3	33.6	91.2	31.7	24.1	40.3	30.8	26.4	34.6	31.9	31.0	48.0	53.6	25.5	37.4	37.5	22.4	57.2	48.7	27.2	39.0	42.0	50.0	45.1	47.9	45.3	53.1	37.6	53.7	46.1	21.6	40.5	46.3	59.7	52.8	100.9	47.3	63.3	35.2	58.2	40.4	45.3	42.6	35.6	34.9	20.5	29.8	61.2	171.1	166.3	235.9	115.5	140.5	132.5	96.4	51.2	141.3	35.3	190.2	547.2	206.3	15.8	157.6	103.8	23.3	199.6	263.9	167.1	184.8	86.4	193.0	204.8	123.9	277.2	113.5	243.6	17.7	149.8	177.9	209.2	287.7	202.3	182.8	197.6	161.4	149.2	386.1	95.5	109.9	206.0	195.8	267.6	214.7	275.6	186.4	235.2	168.4
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 298.3"	"Cell type enriched"	"Detected in many"	72	"Hepatocytes: 1670.2"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 90.5;SK-BR-3: 27.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA		2100000	"Nucleoli, Nucleoli rim"		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	0.4	0.1	0.5	0.3	1.6	0.0	0.8	0.3	0.7	0.4	0.2	0.7	0.3	31.5	0.3	0.7	0.5	0.2	0.4	0.3	0.5	0.4	0.6	298.3	0.2	0.3	1.5	0.8	0.7	0.2	0.0	0.4	1.1	1.4	0.3	0.0	0.6	0.2	0.2	0.3	0.3	17.2	0.4	2.3	0.3	0.2	1.3	0.5	0.0	0.4	0.4	0.1	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.4	6.3	4.3	4.2	7.4	6.7	2.3	2.7	2.7	4.2	0.6	0.0	1.0	0.1	2.5	3.8	1.1	0.2	3.8	6.8	0.0	1.9	4.0	90.5	5.6	1.4	2.1	0.0	3.8	2.8	5.3	5.4	6.9	0.3	1.7	4.0	0.3	4.4	1.1	0.1	0.2	2.4	0.0	0.6	0.2	5.8	0.5	5.7	0.0	0.1	0.4	15.8	27.3	3.0	8.5	0.0	0.7	3.0	7.0	2.1	2.1	4.9	0.0	0.3	0.0	4.6	4.4	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.3	0.7	0.5	0.4	1.5	0.8	1.4	0.5	11.9	9.6	20.7	0.5	1.9	1.1	0.7	15.3	1.4	6.8	1.8	7.9	0.3	0.0	0.1	23.2	1.4	0.3	23.3	0.2	0.4	2.5	1.2	3.5	1670.2	0.2	0.0	0.0	16.5	22.7	3.6	2.3	1.8	1.7	0.0	0.1	1.4	0.0	0.0	1.1	0.7	2.2	0.0	2.5	0.3	1.1	1.6	17.4	5.0	0.1	0.4
CRELD1	AVSD2	ENSG00000163703	"Cysteine rich with EGF like domains 1"	Q96HD1	3	9933822-9945413	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026964	Uncertain		Approved	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA		16000000	Cytosol	Nucleoli	"HPA026964: AB_10602210"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.78e-2)"	21.8	22.9	31.6	15.3	32.4	7.3	27.3	52.2	45.1	9.9	22.4	12.0	17.1	12.5	15.1	17.8	13.1	20.1	15.8	50.2	25.6	24.9	16.6	23.5	15.8	11.0	17.2	30.7	19.7	15.2	21.9	32.4	15.1	27.2	25.4	11.4	10.0	19.4	32.2	24.4	11.6	13.1	19.5	19.4	11.9	14.8	11.1	22.3	5.9	45.7	7.4	8.2	17.8	15.6	10.5	13.7	11.5	12.5	13.4	14.3	10.4	2.8	5.2	8.5	4.4	14.4	9.4	47.1	10.4	3.1	2.6	4.9	5.0	8.5	3.4	22.9	7.2	12.1	1.8	4.1	7.5	1.8	6.7	3.9	3.1	6.7	11.8	28.8	1.1	12.0	9.6	13.9	6.4	5.9	31.4	11.8	5.2	3.7	4.1	2.5	6.8	2.0	8.4	2.3	11.6	3.5	2.1	1.2	8.1	11.0	4.9	3.4	11.0	4.8	4.5	9.3	11.7	11.5	6.8	8.2	5.0	8.1	6.6	2.5	4.7	6.0	6.3	11.1	3.5	5.3	11.5	11.4	9.4	14.2	11.6	14.3	8.9	10.5	13.7	8.2	10.5	14.2	12.7	1.8	13.4	12.5	13.7	8.0	10.4	31.6	32.4	52.2	45.1	25.6	24.9	17.2	30.7	27.2	22.3	17.9	13.7	10.7	19.5	8.7	20.8	34.7	33.1	8.1	7.9	15.7	15.7	20.0	6.6	17.7	5.8	15.0	14.7	0.0	3.9	9.2	21.7	31.7	20.7	11.5	18.5	30.2	25.9	16.0	7.8	7.9	29.7	10.2	11.8	19.0	14.9	21.0	8.8	15.0	24.8	8.2	15.0	25.8	14.1	49.7	11.9	10.8	18.5	12.1	14.1	16.3
CRISPLD2	"DKFZP434B044, LCRISP2, LGL1"	ENSG00000103196	"Cysteine rich secretory protein LCCL domain containing 2"	Q9H0B8	16	84819984-84920768	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	19	"Leydig cells: 251.5;Peritubular cells: 250.0;Smooth muscle cells: 678.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 36.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 36.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.3;BEWO: 23.8;HHSteC: 56.8;HSkMC: 23.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA030054, HPA030055"	Approved		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	No	219000000000		"Nucleoplasm, Nucleoli"		"HPA030054: AB_2732452, HPA030055: AB_10611821"	"unprognostic (8.91e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (7.35e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.15e-3)"	29.2	11.6	2.2	41.1	5.0	3.0	57.2	2.1	3.6	44.1	26.0	2.5	10.6	4.2	38.5	58.7	21.1	43.6	107.4	19.1	2.1	2.0	10.1	6.7	31.0	21.4	5.5	1.6	37.1	9.1	1.0	6.4	50.2	7.1	31.6	7.3	21.9	6.8	23.6	15.9	12.0	17.5	48.0	8.6	10.0	22.5	16.8	3.1	0.4	15.9	11.4	3.3	40.3	32.7	0.0	0.5	36.0	7.9	0.0	0.1	1.3	0.3	0.7	0.2	2.0	15.3	5.7	23.8	11.6	10.3	9.3	6.6	1.5	0.9	0.0	1.0	10.1	2.7	0.3	0.0	0.0	9.4	0.0	0.0	0.1	0.2	0.0	56.8	0.0	0.1	23.8	0.0	2.7	0.0	3.1	0.0	0.0	0.1	0.1	1.0	0.4	0.1	0.5	0.6	1.5	0.6	0.0	0.1	0.1	0.1	1.8	2.3	0.1	2.7	1.2	0.2	3.4	4.7	0.3	1.3	0.1	0.6	9.7	0.3	0.1	0.0	1.9	0.0	0.2	1.4	4.4	7.9	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	1.3	2.2	5.0	2.1	3.6	2.1	2.0	5.5	1.6	7.1	3.1	3.0	2.9	0.8	7.9	41.0	0.6	7.6	0.0	1.4	2.3	0.0	0.0	6.0	0.0	1.1	10.8	12.0	0.4	0.0	0.4	24.6	126.1	19.2	6.9	0.0	4.4	1.6	2.9	60.2	40.4	10.7	251.5	12.2	45.5	0.0	4.2	5.0	0.8	0.0	250.0	0.0	0.5	90.5	678.7	0.9	0.9	37.4	7.6	4.8	1.3	5.2
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776445	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8"	"Cell type enhanced"	"Detected in all"	7	"Hofbauer cells: 2667.6;Urothelial cells: 2153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 68.7;RT4: 87.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA		6100000	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755"	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	21.1	7.5	5.6	6.1	5.9	3.2	13.6	3.0	5.3	57.8	8.8	4.4	3.9	5.6	6.1	6.4	365.3	6.0	7.2	6.5	4.6	5.0	9.6	17.3	17.2	11.2	5.3	4.9	7.8	5.0	3.2	7.6	5.2	5.8	7.1	7.2	7.8	65.2	6.2	4.8	9.4	7.5	6.3	5.1	7.4	10.4	4.1	4.1	8.6	11.6	138.8	130.6	14.0	81.5	11.4	43.2	25.4	69.1	7.7	22.3	21.3	55.9	16.9	5.6	7.1	29.8	24.5	13.9	12.1	14.1	7.7	7.6	13.0	31.4	4.5	9.4	18.8	68.7	10.0	12.9	13.5	4.8	18.8	15.3	12.6	13.0	15.0	26.7	3.1	10.6	26.0	14.1	21.0	10.5	14.4	10.6	4.3	9.3	25.0	11.2	14.1	3.9	9.7	13.5	37.6	29.2	6.5	3.1	51.3	22.0	87.3	5.3	4.8	15.9	8.5	34.0	2.8	7.9	7.8	16.3	12.7	6.6	11.9	7.6	6.1	10.8	8.4	55.4	14.7	8.9	16.8	28.2	16.9	14.5	45.9	13.3	11.4	18.6	15.0	43.2	9.7	13.2	13.0	25.4	7.7	69.1	5.3	22.3	21.3	5.6	5.9	3.0	5.3	4.6	5.0	5.3	4.9	5.8	4.1	163.8	245.7	187.7	333.5	342.3	67.2	88.0	305.8	447.0	218.4	394.3	33.4	255.6	455.9	484.2	8.1	312.8	471.8	23.3	431.0	773.3	255.1	459.8	223.9	313.1	2667.6	63.5	229.7	229.6	443.8	23.5	353.0	857.1	447.1	1223.7	177.1	98.3	684.5	378.7	310.4	313.1	54.5	116.4	179.2	37.0	105.4	520.9	336.5	191.8	261.7	2153.8
CT45A1	"CT45-1, CT45.1"	ENSG00000268940	"Cancer/testis antigen family 45 member A1"	Q5HYN5	X	135713453-135723539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	17	"testis: 12.5"	"Cell type enriched"	"Detected in some"	5	"Spermatogonia: 5.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HMC-1: 70.1;Karpas-707: 32.4"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"										"unprognostic (6.58e-3)"					"unprognostic (2.14e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	32.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.6	0.0	0.0	0.5	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	5.5	0.0	0.0	0.0	0.0	0.0
CT45A10		ENSG00000269586	"Cancer/testis antigen family 45 member A10"	P0DMU9	X	135881063-135889086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 14.1"	"Cell type enriched"	"Detected in some"	16	"Spermatogonia: 57.9"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 33.3;K-562: 9.9;Karpas-707: 36.9;U-266/84: 31.0"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"					"unprognostic (3.55e-1)"					"unprognostic (7.08e-3)"					"unprognostic (2.08e-1)"			0.0	0.0		0.0		0.0	0.0		0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	14.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	7.3	31.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	57.9	0.0	0.0	0.0	0.0	0.0
CT45A2	"CT45-2, CT45.2"	ENSG00000271449	"Cancer/testis antigen family 45 member A2"	Q5DJT8	X	135811668-135820012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	42	"testis: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 32.7"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A3	"CT45-3, CT45-4, CT45.3, CT45.4, CT45A4"	ENSG00000269096	"Cancer/testis antigen family 45 member A3"	Q8NHU0	X	135759846-135768191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"testis: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 29.9;T-47d: 17.5;U-266/84: 90.4"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	1.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	15.6			0.0		0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.1	0.0	0.0	0.6	0.0	0.0	0.1	90.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0
CT45A5	"CT45-5, CT45.5"	ENSG00000228836	"Cancer/testis antigen family 45 member A5"	P0DMU8	X	135777130-135785298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	14	"testis: 10.5"	"Group enriched"	"Detected in some"	18	"Alveolar cells type 2: 2.2;Spermatogonia: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 18.3;Karpas-707: 12.8;RPMI-8226: 6.8;U-266/84: 66.2"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5			0.0		0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	2.5	0.0	0.0	0.9	66.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0
CT45A6	"CT45-6, CT45.6"	ENSG00000278289	"Cancer/testis antigen family 45 member A6"	P0DMU7	X	135794706-135802656	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"testis: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"U-266/84: 47.3"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A7		ENSG00000273696	"Cancer/testis antigen family 45 member A7"	P0DMV0	X	135829247-135837268	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	5	"testis: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.1;Karpas-707: 3.4;PC-3: 1.0;THP-1: 1.6"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.4	0.0		0.0		0.0	0.0		0.8	0.0	0.0			0.1	0.0	0.0	0.5	0.0	0.0	0.0			0.0	0.0	0.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	4.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.4	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A8		ENSG00000278085	"Cancer/testis antigen family 45 member A8"	P0DMV1	X	135846499-135854538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	16	"testis: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AN3-CA: 14.2;HMC-1: 30.1"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A9		ENSG00000270946	"Cancer/testis antigen family 45 member A9"	P0DMV2	X	135863776-135871812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	17	"testis: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HMC-1: 55.7"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869448	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 297.0"	"Cell type enhanced"	"Detected in all"	11	"Hofbauer cells: 2617.6;Kupffer cells: 1392.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 239.8;fHDF/TERT166: 139.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		130000000	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	227.9	42.1	19.6	67.2	24.4	14.7	67.6	14.9	31.4	76.7	49.1	30.1	22.7	29.9	53.2	44.8	54.2	52.4	43.6	120.7	18.3	23.7	95.6	167.8	94.3	175.1	29.1	16.5	44.2	31.6	13.8	21.6	68.7	24.8	42.6	27.9	33.8	63.7	33.6	41.3	22.8	51.2	51.1	35.9	116.4	26.7	21.5	20.4	18.1	297.0	25.9	38.4	56.8	62.2	7.9	95.4	53.1	127.4	5.3	17.1	108.5	6.4	29.5	3.8	16.2	66.6	74.9	11.8	122.8	239.8	43.0	51.0	14.0	38.4	0.1	17.8	139.3	57.7	35.8	5.2	33.9	27.2	3.2	5.0	9.5	3.4	34.5	67.8	2.1	7.1	82.1	46.2	38.9	34.8	74.9	84.1	2.8	7.9	21.7	35.7	5.2	0.8	3.5	3.2	75.8	9.9	3.4	3.8	16.6	13.1	10.2	1.6	9.6	14.2	7.7	64.0	11.7	12.5	6.4	116.4	73.1	24.8	23.4	22.8	21.6	15.7	0.6	83.9	8.2	34.2	53.1	127.4	16.3	5.2	97.0	7.2	7.9	17.1	5.8	68.0	6.1	9.6	4.1	18.5	5.3	54.7	95.4	13.4	108.5	19.6	24.4	14.9	28.0	18.3	23.7	29.1	16.5	24.8	20.4	101.3	205.9	73.7	364.9	48.5	44.4	251.7	175.8	137.9	227.5	108.2	39.3	224.9	23.2	276.8	13.3	119.6	152.5	210.2	211.7	280.5	149.9	239.1	169.3	203.7	2617.6	55.6	148.7	214.9	1392.4	12.2	70.8	859.7	153.5	399.5	80.9	115.8	264.9	108.7	87.4	331.7	35.7	38.8	121.0	4.8	18.5	35.4	543.3	50.7	114.7	284.4
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 377.8;Late spermatids: 391.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		190000	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: AB_2685294"	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	26.0	20.9	21.2	20.4	22.4	22.3	27.5	27.5	26.2	23.9	25.8	19.5	22.5	16.7	30.2	23.7	22.7	21.2	18.7	25.7	21.1	21.8	16.9	35.2	20.5	26.5	21.7	16.7	25.0	17.9	24.9	30.7	32.0	21.0	23.9	18.8	22.7	19.6	25.0	58.9	20.5	21.2	37.7	26.3	21.9	22.4	65.6	23.7	16.9	24.5	24.6	24.5	26.1	28.8	16.8	24.1	13.4	17.1	22.1	20.8	16.1	30.8	24.0	23.6	36.5	18.6	20.9	30.0	25.5	30.2	25.8	24.7	25.5	21.6	42.4	20.5	25.2	41.8	20.9	33.7	23.8	30.5	27.7	28.6	25.0	17.0	24.8	21.8	28.4	23.8	17.1	23.4	18.9	19.2	23.4	28.1	21.4	38.6	32.7	28.1	29.5	24.6	32.5	44.2	26.3	23.0	29.9	20.8	40.8	21.2	22.6	34.0	24.9	29.8	35.5	20.1	29.0	11.6	22.6	21.6	18.5	6.4	37.4	29.3	30.7	21.3	42.0	37.6	31.7	27.2	13.4	15.2	12.0	16.1	17.1	18.6	16.8	16.7	18.6	24.1	14.4	20.8	16.7	2.1	22.1	14.5	5.5	15.9	16.1	21.2	22.4	27.5	26.2	21.1	21.8	21.7	16.7	21.0	23.7	32.8	29.7	24.2	26.3	24.7	29.4	23.2	10.2	42.8	42.1	8.7	27.5	57.0	14.9	24.9	377.8	21.8	9.5	23.3	22.9	69.2	23.6	16.6	22.0	37.5	26.1	20.6	15.0	19.0	15.2	391.5	20.1	22.4	27.0	64.1	19.5	32.1	23.7	14.4	28.7	9.3	42.8	32.3	27.8	53.2	33.0	22.2	61.2	20.8	16.5	17.9
CUZD1	"ERG-1, UO-44"	ENSG00000138161	"CUB and zona pellucida like domains 1"	Q86UP6	10	122832149-122850793	"Predicted membrane proteins"	"Cell adhesion, Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	200	"pancreas: 650.6"	"Group enriched"	"Detected in some"	23	"Exocrine glandular cells: 224.1;Pancreatic endocrine cells: 71.0"	"Cancer enriched"	"Detected in some"	54	"pancreatic cancer: 32.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Group enriched"	"Detected in many"	6	"B-cells: 1.1;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 7.2;LHCN-M2: 8.0"	"Low region specificity"	"Detected in single"							"HPA068479, HPA068660, HPA074117"	Enhanced		Approved	Nucleoli,Vesicles		No	No			Nucleoli	Vesicles	"HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663"	"unprognostic (4.68e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.52e-5)"	"unprognostic (8.08e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.15e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.75e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.83e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	650.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.2	0.0	3.2	0.2	1.6	1.7	1.7	0.0	0.5	0.8	1.0	2.5	0.7	0.3	1.7	1.8	3.7	0.9	0.7	1.1	0.0	1.7	0.0	1.5	2.6	2.3	2.2	3.6	4.7	0.8	0.3	0.0	3.8	1.2	0.3	1.5	7.2	0.2	1.8	1.5	1.3	1.5	8.0	0.4	2.0	2.7	1.7	0.9	1.3	0.0	4.0	0.6	1.4	1.3	1.9	0.7	0.9	0.4	1.1	2.0	1.3	1.9	3.6	0.0	2.4	0.9	0.0	1.9	1.4	3.2	1.3	5.9	0.0	0.0	0.1	0.3	0.8	0.1	1.3	0.6	0.9	1.1	0.1	1.1	1.4	0.7	0.0	0.0	0.2	0.2	3.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.1	0.0	0.0	0.0	224.1	0.0	0.1	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	4.5	0.3	0.0	0.0	6.4	0.0	0.0	71.0	0.0	0.4	0.0	0.5	0.0	0.0	0.5	0.2	0.1	0.0	0.5	0.0	0.0
CYB561A3	CYBASC3	ENSG00000162144	"Cytochrome b561 family member A3"	Q8NBI2	11	61348745-61362299	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 113.7;blood: 98.8"	"Cell type enhanced"	"Detected in many"	10	"Melanocytes: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8"	"Group enriched"	"Detected in all"	10	"B-cells: 50.1;dendritic cells: 98.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045674, HPA052548"	Approved		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA045674: , HPA052548: AB_2681866"	"unprognostic (2.61e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.41e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.80e-3)"	10.0	113.7	4.0	22.5	6.4	7.1	7.5	4.7	6.9	6.6	10.9	10.9	14.4	6.1	10.9	9.9	8.8	11.0	11.0	5.7	5.1	4.1	9.7	30.6	12.4	21.7	8.3	3.5	14.5	17.9	9.0	6.6	21.0	6.8	9.2	9.6	10.7	10.9	8.1	10.2	24.8	15.8	7.6	5.6	24.0	8.5	8.0	7.0	16.8	10.0	8.4	33.3	10.7	7.3	50.1	98.8	3.8	7.4	3.3	3.8	8.7	18.2	30.8	4.9	14.2	23.4	15.5	4.2	9.2	14.0	11.1	11.1	8.3	20.4	35.5	16.6	16.2	9.0	25.5	4.7	25.6	6.8	23.7	10.5	6.1	20.8	5.6	11.0	8.4	15.9	21.8	36.2	24.1	11.1	9.2	16.5	16.1	20.0	21.3	18.6	19.6	15.8	3.6	9.2	16.3	17.7	19.2	4.8	26.5	12.8	18.1	6.1	10.1	18.8	27.1	21.2	3.4	22.0	9.8	10.9	13.1	6.8	12.7	13.2	13.3	17.6	19.9	18.0	14.7	16.4	1.6	7.4	3.8	3.8	6.0	3.4	40.5	2.7	3.4	7.4	50.1	2.8	3.0	2.5	3.3	6.4	98.8	2.6	8.7	4.0	6.4	4.7	6.9	5.1	4.1	8.3	3.5	6.8	7.0	6.0	28.1	119.0	16.1	25.1	15.4	1.4	7.6	29.4	25.0	12.2	29.5	43.5	10.0	22.6	55.7	11.9	46.6	0.0	34.2	35.0	17.5	17.4	8.1	18.7	49.1	17.5	18.5	11.6	20.3	10.6	19.2	29.8	303.7	77.5	27.1	16.9	21.9	38.6	19.4	12.9	51.6	12.9	12.3	5.4	11.1	21.0	33.1	21.8	26.6	12.9
CYB5D1	FLJ32499	ENSG00000182224	"Cytochrome b5 domain containing 1"	Q6P9G0	17	7857746-7862282	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 56.2;Early spermatids: 65.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA021632	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Nucleoli, Golgi apparatus"		"HPA021632: AB_1847368"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-2)"	14.0	13.0	13.2	5.5	22.5	7.2	13.1	14.1	16.8	10.5	7.9	14.0	12.8	6.5	10.9	17.0	7.9	28.2	9.4	13.9	14.4	12.0	19.2	13.0	8.8	4.7	9.4	13.5	14.6	13.1	9.7	18.1	7.0	16.5	11.0	7.8	11.7	10.5	13.2	9.9	10.1	6.0	9.4	6.5	5.9	8.4	14.5	11.7	6.9	22.8	8.6	5.6	7.4	7.5	3.4	3.1	2.7	2.3	1.6	5.9	1.8	16.1	12.0	5.8	15.4	10.4	9.3	3.5	8.3	8.3	9.0	8.6	7.6	3.1	7.0	5.9	6.7	5.3	14.5	12.8	10.9	13.5	4.6	14.7	4.6	15.7	10.8	4.7	8.1	3.3	7.8	13.8	15.6	14.1	5.5	9.5	17.1	3.3	4.8	4.9	7.0	12.6	3.3	7.3	10.5	12.5	8.7	2.7	7.0	14.1	3.1	7.9	5.3	13.2	7.4	7.6	6.2	8.7	3.3	6.6	7.0	6.1	12.2	10.5	2.5	6.1	3.9	14.5	4.5	4.4	0.5	2.3	0.1	2.7	1.9	3.3	3.4	2.4	1.4	3.1	1.5	5.9	3.1	2.7	1.6	1.1	1.4	2.2	1.8	13.2	22.5	14.1	16.8	14.4	12.0	9.4	13.5	16.5	11.7	11.9	24.5	1.9	4.1	4.5	4.2	0.2	10.2	56.2	15.9	5.2	19.6	3.6	11.6	3.6	65.5	6.8	5.1	0.0	2.7	2.1	5.3	8.0	10.4	7.6	3.4	1.6	5.8	6.2	1.0	34.0	4.4	4.0	5.0	0.0	7.5	6.8	5.2	3.5	3.5	9.6	18.0	6.5	3.8	2.8	2.5	5.4	2.2	1.3	7.6	1.6
CYTH1	"B2-1, cytohesin-1, D17S811E, PSCD1"	ENSG00000108669	"Cytohesin 1"	Q15438	17	78674048-78782297	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 139.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047498			Uncertain	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA047498: "	"unprognostic (3.82e-3)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.48e-4)"	"unprognostic (6.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	17.4	12.4	20.7	28.5	36.0	34.4	12.0	17.7	27.5	10.1	17.4	64.1	5.0	13.2	7.7	6.5	25.9	10.2	15.5	10.3	21.5	16.0	11.5	16.0	25.7	42.3	44.4	27.4	5.9	16.0	7.5	8.4	15.8	32.1	15.2	19.9	10.1	17.3	5.3	17.5	15.9	21.4	10.0	31.2	31.8	24.8	7.9	45.2	19.3	15.2	9.2	50.1	14.4	12.1	24.7	19.1	45.9	20.0	21.8	39.4	31.3	9.1	6.4	6.4	5.5	4.4	5.7	6.2	4.3	3.8	5.3	6.3	4.0	10.3	6.8	4.4	5.7	9.1	8.1	3.1	11.3	4.3	14.3	8.7	2.7	8.1	7.4	3.2	5.6	27.6	2.7	9.3	6.0	6.3	3.6	17.1	23.0	4.5	26.4	6.3	4.7	36.3	5.0	1.6	14.9	5.7	9.6	7.1	23.9	5.8	6.4	3.7	13.6	7.6	14.8	6.0	6.8	7.2	6.7	8.1	4.2	6.2	6.7	4.4	30.7	14.1	25.0	3.1	5.7	4.4	45.9	16.2	31.4	39.4	20.0	28.6	24.7	32.8	31.8	13.7	23.0	36.5	30.7	33.8	21.8	17.6	19.1	24.5	31.3	20.7	36.0	17.7	27.5	21.5	16.0	44.4	27.4	32.1	45.2	56.6	46.2	41.5	26.5	36.6	62.3	16.6	17.8	33.5	31.8	5.2	104.1	2.4	6.6	10.4	23.5	51.6	24.0	0.0	16.1	7.5	15.4	34.8	33.7	24.6	41.7	41.3	26.6	30.7	66.6	33.2	4.0	73.5	35.4	139.7	45.7	16.5	31.3	24.9	4.9	5.8	74.3	6.5	11.7	14.1	15.3	30.1	6.1	71.7	15.2	45.7
DCTN3	DCTN-22	ENSG00000137100	"Dynactin subunit 3"	O75935	9	34613545-34620523	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044905	Approved		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA044905: AB_10960996"	"unprognostic (3.38e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.47e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.88e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.26e-3)"	"unprognostic (4.24e-3)"	"prognostic favorable (5.76e-11)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.43e-2)"	26.4	32.5	42.4	16.2	49.1	46.5	30.4	33.7	58.3	25.7	23.3	20.7	22.2	21.4	24.6	25.5	33.7	31.7	23.1	42.8	36.3	37.4	32.8	32.4	21.1	21.9	35.8	48.4	32.6	33.7	29.8	36.3	23.0	37.4	27.4	20.6	27.5	32.4	28.6	69.1	37.9	18.3	28.0	26.2	19.4	23.7	16.2	22.0	42.6	32.4	37.1	29.2	22.5	24.9	28.5	44.6	62.3	45.9	29.9	56.0	46.8	34.2	28.8	26.8	28.0	23.8	33.3	11.0	29.3	27.4	40.9	32.2	18.4	12.9	15.8	18.4	38.5	14.3	13.7	24.3	30.7	26.2	49.5	30.5	10.5	51.0	15.8	25.8	27.6	32.1	29.3	26.6	28.2	18.5	20.0	26.9	29.8	12.5	32.8	35.6	28.2	34.7	74.5	8.1	14.4	46.5	17.5	14.5	21.7	19.7	12.2	8.9	22.9	21.7	20.0	11.2	8.2	26.8	31.7	24.4	25.8	20.9	29.2	28.4	22.2	28.7	10.5	40.5	16.1	52.4	62.3	44.0	59.3	35.2	44.2	32.0	28.5	37.8	37.2	44.0	28.3	29.9	35.7	38.4	29.9	45.9	44.6	56.0	46.8	42.4	49.1	33.7	58.3	36.3	37.4	35.8	48.4	37.4	22.0	29.8	31.8	49.9	82.5	90.2	76.0	72.8	63.7	57.6	43.3	76.8	23.6	100.4	175.8	103.7	8.3	78.7	68.5	210.2	135.3	93.0	101.4	62.7	86.5	74.9	115.9	69.9	71.7	73.1	79.5	15.7	95.8	80.9	141.7	86.6	53.8	145.8	101.0	66.0	115.2	170.3	63.4	58.2	101.0	73.5	71.3	124.6	83.4	96.6	55.1	72.9
DCUN1D5	"FLJ32431, MGC2714"	ENSG00000137692	"Defective in cullin neddylation 1 domain containing 5"	Q9BTE7	11	103062076-103092215	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050863	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA050863: AB_2681259"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.62e-4)"	"prognostic unfavorable (2.01e-7)"	"unprognostic (1.92e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (9.52e-5)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (2.64e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.43e-3)"	20.9	18.3	18.9	17.2	24.5	13.4	19.1	22.5	28.8	12.9	13.5	15.9	11.5	11.4	15.9	13.7	26.5	12.9	10.6	24.2	20.3	16.6	14.4	19.0	13.9	21.5	15.6	21.0	12.2	17.7	14.5	17.0	17.3	23.6	15.4	13.9	9.9	15.6	13.5	38.7	14.0	11.3	18.4	17.5	15.7	16.0	24.0	21.0	19.4	13.2	24.2	21.3	14.4	14.7	14.4	17.3	11.8	13.1	20.5	17.0	13.4	22.3	12.4	13.7	21.0	11.2	14.2	15.2	22.2	12.1	18.3	18.9	47.5	26.2	10.8	39.3	15.8	19.0	21.3	28.8	28.1	18.9	19.0	19.4	28.9	10.7	18.4	19.0	41.4	15.0	12.4	25.0	24.5	25.4	9.6	22.7	26.4	47.2	0.0	17.3	20.2	27.3	32.4	26.7	19.5	31.7	11.6	21.9	27.4	13.9	23.0	18.6	19.7	20.7	21.2	18.4	14.7	24.8	17.4	18.4	14.9	18.1	26.4	19.8	9.1	14.4	36.0	10.6	40.7	15.4	11.8	11.1	10.2	13.8	13.1	16.3	14.4	16.3	14.2	13.7	14.1	14.0	16.3	4.0	20.5	10.0	17.3	17.0	13.4	18.9	24.5	22.5	28.8	20.3	16.6	15.6	21.0	23.6	21.0	14.9	8.3	25.2	44.6	70.6	11.0	26.6	15.3	14.7	14.8	8.7	7.9	51.2	41.4	60.4	3.0	19.7	6.9	23.3	48.3	76.2	37.5	35.6	15.1	21.3	40.1	6.4	13.8	20.9	29.7	5.9	13.3	22.6	28.7	25.2	16.1	14.8	51.7	14.0	18.4	31.1	12.3	25.8	31.1	118.2	114.7	73.1	36.6	24.5	23.4	57.0
DCXR	"DCR, KIDCR, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037732	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Xylose metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 293.8"	"Group enriched"	"Detected in all"	5	"Distal tubular cells: 688.1;Hepatocytes: 2593.4;Proximal tubular cells: 1817.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 305.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 65.1;MCF7: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules		NA	NA		2700000	"Nucleoli, Microtubules"		"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	12.7	6.1	12.8	4.3	12.1	5.7	12.2	9.0	15.1	9.9	9.5	8.4	18.1	7.8	4.4	62.7	11.7	6.1	4.8	11.8	9.8	9.7	50.8	293.8	10.5	5.3	14.4	7.3	8.1	13.0	6.7	7.2	9.0	13.4	22.3	5.4	7.8	19.3	14.0	22.5	8.6	6.8	3.6	8.4	4.4	14.9	8.7	9.7	8.3	15.6	12.6	9.1	7.5	6.4	32.8	52.7	25.3	33.1	35.2	43.7	35.8	8.9	12.4	5.7	10.3	23.1	5.8	15.2	4.6	6.0	12.7	8.7	21.8	3.9	18.6	9.0	6.4	1.6	10.6	10.4	9.3	4.4	3.9	26.8	17.8	9.3	65.1	24.7	13.7	21.9	8.4	11.5	4.0	14.6	2.7	7.1	11.1	20.2	13.6	6.7	80.0	11.4	32.8	6.6	40.3	13.1	10.5	7.7	24.2	9.4	12.8	16.0	9.4	6.5	55.1	8.0	3.6	41.3	13.5	3.6	6.7	8.4	9.1	8.6	13.9	10.2	8.8	5.8	15.0	4.9	13.9	33.1	25.3	24.7	30.6	23.6	28.6	30.8	23.6	52.7	32.8	43.7	31.9	16.5	35.2	28.0	42.5	33.1	35.8	12.8	12.1	9.0	15.1	9.8	9.7	14.4	7.3	13.4	9.7	47.6	155.8	118.2	185.0	52.0	15.8	102.4	124.9	20.1	28.4	169.3	17.7	343.4	688.1	41.9	5.1	35.2	135.9	23.3	37.0	376.5	68.0	203.5	64.5	2593.4	145.3	20.6	52.6	88.4	114.9	15.1	65.6	57.1	170.4	47.7	117.0	81.8	32.4	105.2	44.6	1817.7	18.5	19.4	66.5	6.6	48.3	64.0	286.5	126.9	129.4	155.9
DDA1	"C19orf58, MGC2594, PCIA1"	ENSG00000130311	"DET1 and DDB1 associated 1"	Q9BW61	19	17309518-17323301	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 364.2;Syncytiotrophoblasts: 212.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042134, HPA055272"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA042134: AB_10794169, HPA055272: AB_2682767"	"unprognostic (1.30e-1)"	"unprognostic (6.35e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	11.6	15.5	24.5	12.7	26.6	16.1	9.9	14.6	36.2	10.8	14.6	13.5	9.6	15.4	11.6	9.9	13.4	13.5	11.8	16.4	18.9	19.8	12.9	17.9	14.6	14.7	19.0	24.4	12.9	13.4	10.9	10.9	26.4	23.0	12.9	13.1	10.8	13.6	15.9	17.8	20.8	16.9	11.5	13.2	13.4	17.4	29.6	12.0	15.9	10.5	10.9	13.7	12.4	9.9	7.1	12.7	11.5	8.0	6.5	8.8	5.7	12.5	11.2	8.5	6.7	8.9	6.4	13.2	8.5	10.9	13.1	12.1	9.9	11.1	5.0	11.9	8.7	6.3	10.7	6.2	12.4	6.4	8.2	16.5	6.1	8.8	9.3	10.8	6.8	11.9	9.7	14.3	7.8	7.3	8.0	7.6	11.6	7.2	8.7	6.8	6.3	13.7	10.2	9.7	12.6	19.2	8.7	6.7	8.3	10.3	9.4	8.7	13.0	6.2	14.4	7.4	5.3	7.3	9.1	11.4	8.8	7.4	22.6	11.8	10.7	14.5	6.9	19.3	11.8	8.6	5.0	7.3	11.5	8.6	8.0	7.4	7.1	7.2	8.5	5.9	6.6	8.3	8.0	8.2	6.5	6.9	12.7	8.8	5.7	24.5	26.6	14.6	36.2	18.9	19.8	19.0	24.4	23.0	12.0	26.8	13.1	28.4	28.3	48.4	17.7	14.5	2.5	16.0	18.2	26.2	11.8	121.6	33.2	69.0	364.2	20.2	49.3	0.0	40.5	112.0	27.8	33.7	38.1	21.7	56.2	12.7	19.4	14.7	21.1	84.5	20.8	27.9	28.7	77.5	38.9	25.1	96.6	38.6	25.5	44.5	14.3	19.4	29.8	67.3	35.1	54.1	212.0	34.6	23.5	76.5
DDRGK1	"C20orf116, dJ1187M17.3, UFBP1"	ENSG00000198171	"DDRGK domain containing 1"	Q96HY6	20	3190350-3204685	"Predicted intracellular proteins"	"Ubl conjugation pathway"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013373, HPA013705"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"HPA013373: AB_2091955, HPA013705: AB_2668872"	"unprognostic (2.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.10e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.01e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.90e-2)"	29.5	47.3	28.5	18.6	45.7	17.8	20.5	33.4	38.2	22.1	23.9	29.8	23.7	35.3	21.5	17.8	21.1	21.0	24.3	17.7	27.0	21.8	28.5	54.0	27.0	17.5	47.9	22.9	23.9	43.6	37.5	17.7	31.3	30.9	27.3	16.6	20.6	48.5	29.3	29.5	22.2	31.9	17.1	36.8	20.2	31.5	14.7	39.3	12.6	34.0	14.2	16.2	20.8	29.4	15.1	32.0	24.4	20.2	12.3	21.0	12.9	29.9	37.8	9.4	17.4	21.3	8.1	13.5	19.1	9.2	11.8	13.0	29.7	21.9	18.0	15.7	10.6	22.8	33.7	9.6	28.6	4.4	12.2	18.0	15.2	12.6	51.5	29.2	17.1	16.5	12.7	28.1	22.6	16.2	13.1	10.8	13.0	21.1	21.7	7.5	16.4	11.7	32.0	11.6	20.6	17.5	15.5	8.3	27.3	19.2	28.3	20.8	12.8	19.6	55.7	17.8	5.9	23.6	10.5	16.2	19.1	8.5	13.4	29.1	16.2	18.2	7.6	5.3	14.5	11.1	11.7	20.2	24.4	19.6	13.3	19.5	15.1	20.9	21.0	20.5	15.1	18.7	18.2	5.4	12.3	12.1	32.0	18.6	12.9	28.5	45.7	33.4	38.2	27.0	21.8	47.9	22.9	30.9	39.3	41.7	48.8	26.8	54.1	23.4	43.2	27.9	104.4	44.2	40.9	66.3	60.9	110.7	16.6	129.1	42.5	50.1	133.4	0.0	154.4	53.3	42.9	64.4	27.6	109.1	106.6	49.3	51.3	39.3	55.8	12.9	51.8	50.8	37.1	61.3	57.4	61.1	136.8	122.8	64.7	61.9	91.7	64.7	41.2	35.6	20.7	33.9	122.1	30.5	77.9	57.1
DDX23	"prp28, PRPF28, SNRNP100, U5-100K"	ENSG00000174243	"DEAD-box helicase 23"	Q9BUQ8	12	48829764-48852842	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038680, HPA039037"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA038680: AB_10795401, HPA039037: AB_2676317"	"unprognostic (1.32e-3)"	"unprognostic (8.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (3.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-1)"	26.1	26.5	29.5	35.6	34.2	19.4	27.2	32.8	35.6	26.7	32.8	23.3	27.5	27.9	31.0	22.3	31.0	31.1	25.2	25.1	29.8	20.3	25.2	37.7	27.7	35.2	26.5	25.3	36.2	30.4	32.2	28.1	34.4	25.0	29.9	32.6	24.7	31.1	27.0	44.4	30.6	32.3	29.4	24.1	40.0	30.6	24.9	32.0	46.8	28.2	29.8	38.9	28.9	47.9	12.0	11.5	19.6	13.3	11.2	19.8	10.6	22.0	50.5	24.0	25.4	24.0	16.6	25.5	27.4	21.1	31.1	19.8	49.1	29.5	27.9	30.1	22.7	29.4	20.0	52.0	24.9	26.7	43.7	27.6	37.0	43.0	22.1	12.9	37.3	33.7	16.0	22.4	33.0	19.8	21.4	25.5	24.8	48.9	25.0	22.6	30.7	35.3	35.4	35.7	31.4	24.0	37.8	28.4	22.2	18.4	31.1	29.6	17.3	27.4	31.5	11.4	25.7	30.8	34.3	22.8	23.6	17.3	11.6	21.7	18.9	26.3	33.7	20.0	26.3	12.9	17.1	11.1	19.6	19.5	13.3	19.8	12.0	14.5	17.6	10.8	11.4	14.0	16.9	11.9	11.2	8.9	11.5	13.1	10.6	29.5	34.2	32.8	35.6	29.8	20.3	26.5	25.3	25.0	32.0	23.8	25.5	22.4	12.7	11.4	16.9	17.1	22.9	44.2	31.8	12.2	23.6	22.5	13.3	22.3	6.9	21.0	23.3	23.3	33.5	24.6	16.2	21.2	17.4	16.3	16.7	14.3	13.4	17.8	9.9	4.1	22.7	15.0	13.5	24.4	22.7	24.3	28.9	31.6	20.8	10.2	24.0	19.4	18.4	33.8	36.1	13.2	22.2	24.2	23.9	17.1
DDX24		ENSG00000089737	"DEAD-box helicase 24"	Q9GZR7	14	94048291-94081245	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 103.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002554	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA002554: AB_1078631"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (3.06e-9)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (6.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.66e-2)"	18.0	45.5	19.7	13.7	41.3	53.3	18.5	31.4	40.8	17.4	20.9	21.9	14.3	13.6	23.2	103.0	20.1	18.9	21.3	28.6	25.0	31.3	36.3	30.1	16.4	27.4	22.0	29.0	21.4	12.5	8.3	32.0	11.2	38.7	16.0	14.6	17.4	15.9	17.7	28.5	23.4	12.6	17.9	21.8	18.1	15.0	38.5	17.4	14.3	25.3	11.8	25.8	21.7	14.9	4.1	3.1	10.6	3.3	6.2	5.3	5.0	3.8	1.1	7.2	4.6	4.3	5.7	1.7	10.8	9.1	14.1	12.7	1.4	2.5	17.9	4.1	2.4	4.2	2.5	7.4	0.6	15.4	7.8	0.4	9.5	2.1	5.8	3.6	13.7	4.2	0.9	4.1	2.6	2.5	4.7	2.3	3.4	4.9	5.3	6.0	10.8	4.1	11.7	4.8	1.2	0.1	5.5	16.7	2.1	10.2	1.4	5.7	5.3	10.6	2.6	5.0	1.3	4.2	4.9	6.9	4.0	2.7	5.1	3.3	2.1	13.8	19.3	5.8	7.5	3.1	10.6	3.3	2.5	5.0	2.6	1.4	2.9	2.9	3.0	2.0	4.1	5.3	5.3	2.6	6.2	2.5	3.1	3.3	5.0	19.7	41.3	31.4	40.8	25.0	31.3	22.0	29.0	38.7	17.4	157.8	151.6	175.7	121.2	162.3	169.0	198.2	58.6	192.7	154.7	139.6	123.7	76.5	230.5	124.3	63.9	107.4	65.5	116.8	86.3	59.9	133.4	81.0	147.1	96.2	75.0	219.3	93.7	105.0	83.4	46.7	214.3	119.2	94.5	181.3	57.7	131.2	82.3	69.1	230.2	135.3	189.8	161.7	156.5	383.4	396.2	127.2	131.4	217.1	54.9	94.1
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177517469	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: AB_2680527"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	17.9	22.7	27.0	25.1	30.7	17.2	16.5	22.8	39.2	19.1	21.2	16.9	18.5	25.5	19.5	16.5	23.0	22.1	17.1	15.3	29.3	20.1	23.7	29.3	16.8	19.9	22.1	24.8	21.2	18.0	22.2	15.1	22.1	27.4	16.3	15.4	19.0	19.0	17.5	36.6	21.7	26.8	16.7	14.8	21.9	19.7	16.8	15.4	24.9	22.9	18.2	23.5	19.6	18.4	15.9	22.5	16.4	22.8	18.6	20.6	18.0	21.2	24.3	13.3	15.7	13.7	16.3	44.9	19.1	11.6	14.1	10.4	39.6	19.8	23.9	29.1	18.0	24.7	17.4	17.4	43.7	9.6	57.0	21.8	30.3	24.7	23.5	18.2	31.3	32.2	15.9	15.4	13.3	17.9	12.0	17.9	23.9	26.2	17.0	16.5	45.8	26.1	15.4	23.5	19.9	19.7	28.4	16.2	28.1	15.7	24.8	15.8	17.3	20.3	27.0	22.8	8.1	18.9	45.8	19.1	25.7	15.2	16.4	29.7	20.5	24.0	40.7	28.2	34.6	16.9	10.6	22.8	16.4	16.1	21.5	20.6	15.9	16.0	15.3	22.5	14.1	14.8	15.5	7.7	18.6	21.4	10.2	15.6	18.0	27.0	30.7	22.8	39.2	29.3	20.1	22.1	24.8	27.4	15.4	23.8	19.1	26.4	18.3	18.7	17.4	7.1	25.5	14.7	15.9	8.7	2.0	40.7	34.9	39.1	8.4	20.3	22.6	23.3	34.4	49.6	19.5	16.0	28.9	16.3	43.7	7.9	10.9	12.3	22.2	16.2	13.8	21.8	11.8	41.5	23.7	15.8	29.9	20.1	19.8	28.9	9.4	12.9	20.6	24.2	23.2	17.8	31.4	22.3	26.3	16.3
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64499616-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043, HPA071154"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		150000	"Nucleoplasm, Nucleoli"		"CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: "	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	91.6	61.4	46.9	80.0	68.0	108.3	94.7	61.6	58.9	81.6	81.1	53.3	104.2	27.4	106.7	94.5	64.5	96.9	101.4	53.9	48.5	30.6	53.1	68.0	84.8	70.9	62.8	44.1	74.0	49.3	88.9	110.5	56.6	73.1	59.5	55.4	50.9	62.2	103.6	77.6	59.7	54.7	113.1	71.0	67.6	69.0	39.7	57.8	82.1	81.1	77.7	69.3	91.0	63.9	46.9	59.6	66.4	66.2	40.3	60.8	109.8	55.1	20.8	63.0	39.9	58.4	55.0	40.1	54.7	70.6	67.1	67.2	22.5	33.8	80.9	31.4	71.8	47.8	32.9	67.8	62.9	75.9	28.7	48.7	52.6	15.9	17.2	42.8	66.9	56.1	61.9	54.3	61.3	47.8	37.4	71.6	69.9	41.7	69.1	51.7	32.8	139.9	19.5	36.7	50.9	64.3	87.6	66.6	56.9	41.1	26.5	44.3	74.3	53.1	51.5	66.6	56.7	48.2	37.7	50.3	40.8	45.6	43.9	56.6	38.6	76.1	142.8	43.2	32.9	48.1	66.4	62.5	66.4	53.7	56.9	60.8	46.9	42.9	51.7	59.6	46.8	44.5	43.1	37.8	40.3	66.2	37.0	50.2	109.8	46.9	68.0	61.6	58.9	48.5	30.6	62.8	44.1	73.1	57.8	497.3	661.1	481.3	1231.3	781.2	369.6	221.7	262.4	725.4	624.4	350.7	316.1	372.7	283.5	416.6	432.3	643.3	503.6	116.8	366.6	307.8	528.8	417.0	836.7	222.3	399.0	397.3	638.0	483.1	539.2	80.3	384.6	631.0	410.0	779.1	366.4	576.1	376.0	445.4	411.5	208.8	514.0	485.0	599.5	374.0	341.8	652.0	741.9	719.3	310.9	1106.4
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643464	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 210.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA056173: AB_2683056"	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	6.4	4.5	4.3	5.3	5.5	9.1	4.6	8.1	6.5	6.9	6.1	4.8	5.0	5.9	7.8	10.7	6.7	3.5	5.0	3.0	4.5		9.4	7.1	4.2	5.1	5.4	3.1	6.3	4.4	6.2	8.8	5.8	6.5	6.1	6.0	4.0	4.1	4.8	6.7	6.0	10.6	4.8	6.2	5.7	4.8	4.8	4.9	8.7	5.7	5.8	6.1	6.0	6.9	4.0	5.7	3.5	4.2	3.5	4.7	1.5	4.8	9.9	1.0	9.8	5.5	4.9	4.2	6.5	5.8	8.6	8.3	5.0	1.8	2.7	4.5	4.3	1.8	4.4	10.9	7.1	11.5	6.5	12.3	6.1	6.2	4.0	5.4	7.8	3.2	5.1	7.3	5.6	6.9	4.1	9.8	2.7	0.8	1.9	5.0	1.5	11.7	4.0	5.6	2.7	0.4	7.6	8.6	5.0	9.7	5.4	7.2	5.8	7.8	1.8	4.8	5.7	3.4	6.0	6.6	7.0	4.4	3.6	7.4	2.4	3.9	5.5	5.7	4.9	5.5	3.4	3.2	3.5	4.2	4.2	3.3	3.6	4.0	3.5	2.3	4.0	3.4	4.7	2.8	3.5	2.4	5.7	3.1	1.5											38.7	19.5	26.1	27.2	30.7	28.6	28.7	28.1	28.1	38.7	26.2	31.4	30.7	29.9	64.6	210.7	26.3	24.7	0.0	45.3	25.7	21.9	24.4	26.5	32.8	22.8	44.5	25.2	29.4	23.8	70.2	22.7	23.7	16.9	47.7	26.7	23.2	47.9	21.0	22.6	32.3	32.6	25.8	12.6	28.9	57.6	29.1	20.9	34.4	36.5	43.1
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620941	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA039962: AB_2676774, HPA044101: AB_2678810"	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	15.0	13.5	12.3	16.4	14.0	27.7	16.3	21.4	13.9	13.0	13.2	15.7	16.2	12.0	14.7	13.2	14.2	15.0	11.8	8.8	11.4	10.9	10.2	17.8	11.2	19.9	15.6	10.3	17.5	25.9	13.8	20.3	12.3	14.4	14.4	14.5	11.9	15.2	12.6	12.6	21.4	12.9	11.9	10.5	18.8	11.6	11.2	14.8	16.9	12.2	12.5	16.5	11.9	23.1	13.4	12.8	7.3	10.0	12.2	15.7	8.5	10.1	14.5	11.1	11.2	9.6	7.6	16.8	12.6	4.6	11.3	7.8	16.4	7.5	15.1	10.1	5.5	10.2	12.6	16.9	9.4	13.2	11.3	15.3	20.4	16.0	12.1	7.3	25.0	16.1	6.4	10.0	13.4	15.5	8.8	8.1	12.3	20.8	8.0	7.9	10.5	24.5	34.1	17.2	11.8	14.4	18.5	11.9	9.8	7.9	17.7	13.2	11.0	10.3	13.4	17.2	9.7	23.8	16.2	8.3	9.8	12.9	15.9	15.6	14.8	18.3	27.4	9.3	18.0	16.6	2.8	9.2	7.3	12.0	10.0	12.7	13.4	11.6	12.5	7.5	11.3	15.7	14.7	5.6	12.2	5.9	12.8	9.1	8.5	12.3	14.0	21.4	13.9	11.4	10.9	15.6	10.3	14.4	14.8	20.8	11.5	9.0	8.3	9.7	18.5	2.2	7.6	13.4	10.3	7.0	21.6	11.2	6.6	9.6	42.5	10.5	5.1	46.7	10.4	13.9	10.1	8.4	24.3	8.5	12.6	14.3	6.9	6.2	6.6	50.7	15.8	7.9	6.8	4.6	10.5	15.6	11.6	7.0	13.8	5.4	25.4	6.5	8.5	17.9	19.6	14.8	6.4	10.2	8.3	7.8
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565417-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		NA	NA			Nucleoli	"Mitotic chromosome"	"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.8	12.0	10.3	12.4	11.9	12.4	9.2	13.6	18.9	11.9	10.0	12.2	8.6	11.9	12.8	10.3	13.1	12.6	12.5	9.3	10.6	9.9	17.7	29.2	8.9	13.2	10.4	9.3	15.0	22.5	13.1	11.9	12.3	12.2	14.1	9.0	11.0	16.9	11.5	16.9	16.3	11.4	8.4	8.8	12.1	10.6	14.6	10.9	14.5	13.8	16.7	15.1	9.2	10.3	12.8	16.0	6.9	16.5	15.7	12.3	12.7	7.6	20.5	1.6	4.4	2.0	2.0	6.8	7.3	3.7	8.3	7.3	13.2	7.6	13.5	9.5	2.7	11.4	13.1	3.3	7.3	1.5	5.0	20.8	8.9	13.0	10.1	3.6	9.3	5.0	2.9	5.3	7.4	4.6	1.5	4.2	5.0	18.3	3.8	5.3	10.1	4.7	8.6	11.1	6.6	19.3	3.8	7.2	5.3	4.7	8.2	5.2	8.4	9.6	15.0	5.5	1.3	10.9	9.6	8.9	6.8	9.9	4.6	18.3	12.4	19.0	19.4	7.5	11.4	9.5	6.9	11.8	4.3	9.9	15.3	12.3	11.5	10.7	11.1	16.0	12.8	12.3	10.3	0.4	15.7	16.5	7.7	10.1	12.7	10.3	11.9	13.6	18.9	10.6	9.9	10.4	9.3	12.2	10.9	14.9	25.3	16.0	20.1	15.1	25.2	10.8	12.7	24.1	34.2	21.0	13.7	48.6	23.2	34.9	39.1	23.8	26.9	0.0	28.4	38.8	18.4	15.9	27.7	27.7	31.4	6.4	17.7	18.4	10.1	30.0	19.5	17.4	13.5	32.5	19.6	20.6	31.1	20.1	18.7	40.8	23.2	12.9	20.6	30.2	29.0	17.3	39.5	18.7	27.0	18.1
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100160163	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.5;skin 1: 30.6"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 77.6;Collecting duct cells: 78.5;Intestinal endocrine cells: 53.2;Undifferentiated cells: 46.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 22.9"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 11.9;granulocytes: 6.4"	"Group enriched"	"Detected in some"	16	"OE19: 29.1;T-47d: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046644			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA046644: AB_2797231"	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.66e-4)"	0.4	0.3	2.0	2.3	4.6	0.5	5.8	22.9	6.4	5.3	20.2	1.8	0.6	20.8	3.4	4.6	20.9	1.9	13.3	0.3	2.0	1.5	8.7	17.2	2.6	0.8	2.4	1.4	0.8	13.0	0.3	1.6	0.6	2.7	2.5	4.2	0.8	4.5	2.3	0.5	30.6	44.5	0.7	1.9	0.5	17.9	0.7	0.7	0.0	2.4	7.3	11.1	7.1	5.2	11.9	0.7	6.4	0.5	0.2	1.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.7	0.1	0.1	0.0	29.1	0.0	0.1	0.0	1.5	0.0	0.7	2.2	0.0	0.0	1.3	0.0	0.0	45.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.5	6.4	1.8	0.0	0.0	11.9	0.1	0.8	0.7	5.9	0.0	1.2	0.2	0.2	0.0	0.1	0.0	0.8	2.0	4.6	22.9	6.4	2.0	1.5	2.4	1.4	2.7	0.7	3.0	5.3	0.0	2.8	1.5	4.4	0.4	38.2	77.6	11.4	78.5	0.0	5.9	1.7	13.4	1.0	0.9	31.3	0.0	1.3	1.5	0.3	1.1	9.2	0.2	1.6	0.0	53.2	0.6	1.9	1.5	0.3	1.0	0.0	0.0	43.3	1.2	2.8	43.8	0.0	0.1	24.4	0.0	0.2	0.9	1.9	13.4	31.2	1.3	46.7	17.4
DENND5B	MGC24039	ENSG00000170456	"DENN domain containing 5B"	Q6ZUT9	12	31382223-31591097	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 41.3;Cardiomyocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.0;naive B-cell: 4.1;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	5	"B-cells: 4.1;dendritic cells: 2.2"	"Cell line enhanced"	"Detected in many"		"SuSa: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038865	Approved		Approved	Nucleoli,Microtubules		NA	NA			Microtubules	Nucleoli	"HPA038865: AB_2676245"	"unprognostic (5.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.60e-2)"	6.0	9.5	9.9	9.3	16.6	3.1	5.9	24.5	17.8	6.5	8.1	7.9	2.7	12.4	9.7	3.4	3.9	6.0	6.2	14.4	9.3	12.4	10.7	17.0	4.6	9.3	8.7	10.9	30.5	7.9	6.0	12.8	6.9	16.0	4.7	6.3	7.7	3.2	5.0	10.9	2.8	14.6	10.2	6.4	8.9	6.8	20.3	8.4	0.4	4.6	3.2	11.1	6.6	7.3	4.1	2.2	0.6	0.3	0.4	0.2	0.2	1.5	15.2	11.2	4.3	4.1	5.1	1.7	3.7	4.1	9.5	6.9	10.2	6.1	5.6	6.2	8.0	10.4	0.4	2.2	1.0	9.5	0.0	4.7	0.1	12.0	6.1	3.8	5.1	0.1	3.1	3.3	6.3	10.5	8.7	8.7	3.2	2.1	11.5	5.9	1.4	3.0	5.3	11.4	3.5	2.7	2.9	15.5	0.1	8.0	2.0	3.6	5.4	9.3	1.0	8.1	33.8	1.6	2.8	9.0	3.6	9.1	6.4	7.8	6.1	6.8	5.7	6.1	0.6	6.0	0.3	0.3	0.3	0.2	0.1	0.1	4.0	0.1	0.1	0.6	4.1	0.1	0.1	0.6	0.4	0.2	2.2	0.0	0.2	9.9	16.6	24.5	17.8	9.3	12.4	8.7	10.9	16.0	8.4	3.0	0.3	20.1	2.6	2.6	41.3	39.9	20.4	2.7	3.4	7.0	29.5	0.5	3.3	1.4	15.1	5.8	9.9	0.0	8.0	2.5	8.9	2.1	0.0	29.2	3.6	27.0	8.1	23.4	4.3	6.4	7.8	2.5	21.9	3.6	2.3	12.5	6.9	3.4	9.9	11.1	23.4	6.5	8.0	29.0	14.3	1.3	0.6	0.5	2.3	0.9
DFFB	"CAD, CPAN, DFF-40, DFF40"	ENSG00000169598	"DNA fragmentation factor subunit beta"	O76075	1	3857267-3885429	"Predicted intracellular proteins"	Apoptosis	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 43.2;Extravillous trophoblasts: 23.7;Horizontal cells: 14.3;Rod photoreceptor cells: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004328, HPA052904"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"CAB004328: AB_626776, HPA052904: AB_2681985"	"unprognostic (2.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.86e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.29e-5)"	4.7	4.1	6.0	5.0	7.8	3.8	4.0	13.2	7.8	3.8	4.3	4.2	2.0	12.5	5.9	1.5	3.1	4.9	4.2	4.1	4.1	1.8	2.9	2.0	3.5	2.9	5.4	4.1	6.7	9.3	1.3	8.7	4.8	2.9	3.0	1.6	4.3	3.3	3.3	1.9	2.3	5.6	2.6	3.0	5.6	4.1	1.7	6.3	2.8	3.2	1.0	5.6	4.7	3.4	3.1	6.3	6.9	8.2	2.7	6.4	3.7	3.1	2.9	1.4	4.0	0.9	1.0	0.9	2.7	0.9	3.0	2.9	1.7	1.3	1.2	1.8	0.6	0.3	0.9	0.4	1.7	0.2	7.3	7.5	11.0	1.2	1.6	2.6	6.0	8.6	0.5	0.3	2.7	0.1	0.8	3.3	4.9	6.1	1.3	0.7	0.9	6.6	3.6	2.2	1.1	6.3	5.5	2.3	2.4	0.6	0.4	2.9	5.0	2.0	3.0	8.3	0.0	0.7	3.6	5.0	1.2	1.0	5.8	2.4	2.4	3.6	3.4	1.4	9.4	1.7	5.3	5.5	6.9	4.7	5.1	2.9	3.1	3.0	3.8	6.3	1.2	2.8	4.5	1.7	2.7	8.2	0.1	6.4	3.7	6.0	7.8	13.2	7.8	4.1	1.8	5.4	4.1	2.9	6.3	3.0	5.8	0.0	1.0	0.6	4.4	0.8	2.5	1.4	2.3	1.8	43.2	3.0	1.7	1.9	0.8	2.1	2.0	0.0	1.4	23.7	2.1	0.7	0.0	1.6	2.5	14.3	2.4	3.1	5.3	1.1	1.1	1.9	0.0	0.0	4.1	3.5	1.6	0.0	4.6	2.2	19.3	0.0	0.5	1.8	3.2	0.3	1.1	3.2	3.7	0.7
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 291.1;Paneth cells: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.2	2.0	3.6	3.2	1.3	2.3	2.8	2.7	2.6	1.8	9.7	2.6	1.5	10.7	1.7	1.3	3.3	1.6	3.8	0.6	2.8	4.0	2.8	3.4	15.8	2.3	0.7	2.9	1.8	2.9	1.7	1.9	1.8	2.0	4.9	2.2	3.6	1.7	3.2	4.8	3.1	0.9	9.2	17.6	6.3	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	0.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.1	0.4	0.6	1.5	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2	14.9	21.3	6.5	9.8	7.1	24.2	17.9	15.3	4.0	7.9	17.4	27.5	10.2	1.7	6.8	13.4	13.5	291.1	0.0	10.4	8.3	7.1	8.8	6.9	49.5	16.5	17.5	22.4	10.4	25.4	16.4	6.4	15.0	5.0	1.0	70.1	18.1	11.4	112.2	6.3	6.8	21.9	0.0	10.5	25.1	15.9	8.2	13.7	8.5	84.8	18.4
DHRS3	"RDH17, retSDR1, Rsdr1, SDR1, SDR16C1"	ENSG00000162496	"Dehydrogenase/reductase 3"	O75911	1	12567910-12617731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5"	"Cell line enhanced"	"Detected in many"		"A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010844	Supported		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA010844: AB_1847653"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.65e-4)"	"unprognostic (5.48e-2)"	22.7	4.4	6.3	6.2	8.6	2.5	30.6	4.0	7.9	16.7	16.3	3.4	9.2	13.6	7.6	15.5	19.0	12.2	11.2	16.1	6.8	8.6	12.3	45.6	11.6	8.3	9.0	4.5	11.8	20.3	0.5	8.9	11.5	9.8	16.3	5.6	20.3	11.8	14.3	10.2	5.6	18.9	11.1	9.8	4.2	12.3	5.2	4.2	3.1	40.5	5.4	5.2	21.0	9.4	0.2	8.6	2.1	0.3	13.8	33.5	15.6	4.8	27.6	0.0	12.2	16.0	1.3	3.2	1.6	0.0	0.0	0.1	3.3	56.6	0.0	1.3	16.2	4.9	22.3	6.0	3.1	0.0	0.0	9.9	4.3	2.8	15.4	2.4	0.0	0.0	8.1	3.7	0.0	0.1	55.9	5.2	0.1	6.5	0.0	0.1	0.8	1.1	0.2	1.8	5.2	11.2	0.1	0.0	5.6	0.0	9.5	0.3	0.5	9.3	30.4	1.7	3.9	2.9	1.2	3.8	0.1	0.6	8.5	0.1	0.8	0.0	0.0	6.4	0.3	52.5	2.1	0.2	0.0	33.5	0.1	24.2	0.2	18.3	15.7	8.6	0.2	31.6	19.7	1.7	13.8	0.3	1.0	0.5	15.6	6.3	8.6	4.0	7.9	6.8	8.6	9.0	4.5	9.8	4.2	89.3	49.3	3.7	141.7	22.8	0.8	31.9	38.2	58.9	55.7	19.2	17.7	22.8	19.9	81.6	86.2	36.5	70.9	23.3	142.3	39.4	26.7	66.3	15.1	157.8	60.3	0.0	24.1	62.0	40.2	235.9	21.0	19.3	6.8	17.2	30.8	13.7	112.0	49.1	9.2	39.4	2.0	0.0	30.1	1.4	1.4	23.6	22.0	22.3	29.9	124.6
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839369-182887751	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		97000	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	30.2	25.9	25.7	28.5	28.6	68.9	32.9	42.5	33.1	31.9	24.5	23.3	25.2	19.8	38.2	24.2	27.7	30.6	19.7	22.9	24.4	22.6	36.2	31.4	27.8	32.0	34.2	23.1	37.5	24.9	51.8	35.8	28.5	28.0	25.7	30.1	21.1	28.2	29.4	27.6	26.6	27.0	31.6	25.3	32.8	26.5	29.4	37.4	68.3	30.1	31.6	41.2	32.4	31.9	16.8	22.9	12.0	17.4	14.7	21.9	15.0	35.7	35.0	50.3	27.6	26.3	20.4	49.7	31.7	29.1	46.1	31.3	39.1	27.6	57.4	31.0	28.4	27.6	31.0	76.3	34.3	51.7	23.3	37.9	38.2	28.7	26.4	14.8	55.3	26.2	18.1	17.3	45.2	12.3	20.9	36.0	29.5	60.0	20.6	36.9	31.4	55.9	13.6	63.7	38.5	21.6	51.0	46.9	32.8	29.8	41.6	36.3	41.6	44.9	28.4	18.5	44.2	33.3	31.3	28.1	28.6	32.0	29.0	42.9	21.7	35.4	68.1	18.0	30.4	38.8	5.6	16.0	12.0	19.2	17.4	21.9	16.8	16.8	17.6	22.9	14.6	18.4	19.9	6.5	14.7	14.3	11.1	15.4	15.0	25.7	28.6	42.5	33.1	24.4	22.6	34.2	23.1	28.0	37.4	38.7	64.9	41.5	53.0	47.7	55.9	37.2	35.7	72.3	69.4	48.8	49.1	40.4	16.6	39.6	17.1	44.9	31.7	0.0	43.7	37.7	35.9	40.6	42.8	24.3	35.2	27.0	51.6	38.1	37.7	32.0	55.8	34.4	28.7	27.1	33.8	42.7	42.4	25.9	44.2	33.5	72.8	38.8	45.7	63.0	65.2	41.3	41.4	32.4	45.7	48.7
DLG3	"KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102"	ENSG00000082458	"Discs large MAGUK scaffold protein 3"	Q92796	X	70444861-70505490	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.1;MAIT T-cell: 1.8;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.8;NK-cell: 1.7;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"OE19: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001733, HPA078130"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA001733: AB_1078675, HPA078130: AB_2686879"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.98e-2)"	"prognostic favorable (1.72e-10)"	"unprognostic (3.36e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-3)"	2.7	3.3	12.5	6.5	17.6	0.7	10.8	16.4	25.2	9.2	16.0	4.3	14.7	11.7	7.6	23.7	14.5	17.4	16.3	6.0	15.2	10.0	10.8	1.4	7.8	3.1	6.5	10.2	11.2	27.1	21.2	8.9	5.5	8.0	9.6	17.1	10.2	21.0	10.4	1.1	8.4	20.8	11.3	3.4	14.6	13.8	1.9	3.5	3.2	13.8	2.6	8.0	11.2	9.9	0.4	0.0	0.0	0.0	1.7	2.4	0.3	3.4	1.6	9.9	4.2	2.6	3.1	6.9	2.0	2.3	1.1	1.1	9.8	8.1	0.0	4.8	2.0	0.8	7.5	19.2	4.5	0.7	4.0	5.8	0.0	8.8	5.3	5.0	0.1	1.3	3.2	3.0	1.4	3.2	10.2	0.4	6.6	1.8	13.8	1.1	12.1	7.8	0.0	16.7	28.0	11.6	7.3	4.9	1.4	6.7	10.6	4.7	0.3	1.6	19.2	3.7	8.6	10.1	0.0	0.7	1.3	1.3	1.2	1.5	9.1	6.8	4.3	1.9	0.0	1.9	0.0	0.0	0.0	2.1	0.0	1.8	0.4	1.7	2.4	0.0	0.0	1.1	1.8	0.0	1.7	0.0	0.0	2.4	0.3	12.5	17.6	16.4	25.2	15.2	10.0	6.5	10.2	8.0	3.5	17.9	16.1	3.2	4.8	0.7	15.6	16.7	25.5	32.1	12.5	8.7	0.0	5.5	10.0	11.9	0.0	0.3	27.4	0.0	21.3	2.0	5.0	15.9	1.1	0.0	0.6	4.8	24.6	1.8	0.3	0.0	1.4	1.3	1.7	2.8	22.3	10.3	21.5	17.3	6.0	3.7	5.8	6.5	5.1	0.4	1.7	1.8	1.4	3.8	17.2	9.0
DMXL1		ENSG00000172869	"Dmx like 1"	Q9Y485	5	119037772-119249138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036431, HPA036432"	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA036431: AB_10669791, HPA036432: AB_2675120"	"unprognostic (2.47e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.16e-5)"	"unprognostic (4.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.18e-2)"	17.8	10.4	9.3	14.0	14.1	29.3	16.1	14.2	15.4	12.0	11.6	15.4	9.6	8.3	15.7	8.5	13.0	12.0	10.3	10.2	8.9	5.6	18.8	9.6	13.9	12.5	11.5	11.4	17.4	20.1	21.3	14.1	9.5	18.9	35.9	9.8	13.3	13.6	10.9	10.9	21.4	13.1	13.0	10.9	11.5	12.4	9.2	13.1	18.1	17.9	6.8	13.8	14.3	12.4	11.2	9.5	4.6	9.0	1.5	3.8	2.6	9.5	7.4	8.5	8.6	9.1	12.1	9.0	7.9	7.9	8.0	9.4	8.9	5.9	18.6	8.2	10.1	12.4	5.8	9.3	9.4	10.4	14.3	9.3	13.1	12.9	3.1	7.6	8.5	11.4	9.6	5.3	9.2	7.7	8.2	10.4	11.7	11.0	12.6	6.4	6.0	11.4	4.9	4.6	3.3	4.5	9.0	15.6	7.2	6.2	11.1	7.9	8.0	13.6	5.0	12.2	9.4	8.2	9.9	10.0	9.5	8.0	9.5	8.3	11.9	8.4	16.2	11.8	8.4	7.6	4.6	5.5	3.9	2.9	4.9	3.6	9.7	2.3	2.4	3.8	11.2	3.8	2.1	4.5	1.5	9.0	9.5	2.8	2.6	9.3	14.1	14.2	15.4	8.9	5.6	11.5	11.4	18.9	13.1	26.8	15.3	22.9	15.7	12.0	36.2	22.4	2.5	12.0	14.8	15.7	23.6	9.9	14.9	9.5	6.0	13.4	14.6	0.0	17.5	7.5	11.6	51.6	13.9	13.4	14.8	20.6	5.8	9.2	20.5	7.4	14.1	17.3	32.1	27.1	11.4	17.3	12.1	11.9	14.5	27.0	22.4	12.9	15.0	15.6	19.2	16.4	13.6	14.9	10.1	10.7
DNAJC21	"DNAJA5, GS3, JJJ1"	ENSG00000168724	"DnaJ heat shock protein family (Hsp40) member C21"	Q5F1R6	5	34929593-34958964	"Disease related genes, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040789	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA040789: AB_10794147"	"unprognostic (1.37e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.77e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.68e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.02e-2)"	13.8	12.2	13.5	12.1	16.5	15.9	20.9	17.2	16.0	20.7	17.9	7.9	13.6	11.6	16.0	11.6	20.1	11.0	10.5	26.7	12.1	11.7	19.0	19.3	13.3	16.6	16.2	12.2	13.6	17.0	16.6	18.7	19.2	17.6	16.6	14.4	6.7	15.4	14.5	50.6	11.6	13.3	23.1	14.5	12.9	15.4	41.9	17.0	17.2	16.5	18.9	14.2	23.8	25.2	5.8	4.8	8.3	3.5	7.5	6.3	1.9	14.3	9.9	12.8	16.9	16.5	19.8	23.8	19.2	15.5	15.1	10.1	16.8	17.3	30.3	8.7	17.7	19.3	10.3	15.0	19.2	17.8	17.9	11.2	16.4	38.0	14.1	27.1	23.5	15.9	14.0	18.1	16.9	27.6	10.9	14.1	11.2	25.5	23.9	11.1	12.1	20.1	17.8	8.9	15.9	8.8	18.3	31.8	13.4	15.4	18.3	7.0	7.2	51.0	24.0	16.1	15.1	16.4	26.3	17.2	19.1	19.0	11.5	15.2	17.2	15.5	20.6	15.6	28.6	10.1	4.0	2.9	8.3	3.6	2.4	5.1	5.8	5.1	3.2	4.8	3.7	5.2	5.1	0.6	7.5	3.5	4.6	6.3	1.9	13.5	16.5	17.2	16.0	12.1	11.7	16.2	12.2	17.6	17.0	71.5	99.0	29.6	53.2	32.7	48.1	137.7	43.3	29.4	46.6	34.9	41.2	41.7	74.6	18.3	74.9	35.9	26.2	0.0	26.3	24.2	33.6	57.4	8.1	50.8	21.3	71.5	17.3	35.0	23.5	29.9	37.4	29.5	35.4	47.7	33.5	29.1	23.4	29.8	35.7	52.4	61.9	12.9	29.3	68.3	51.3	40.8	54.9	29.8	33.3	61.6
DOCK11	"ACG, FLJ32122, FLJ43653, ZIZ2"	ENSG00000147251	"Dedicator of cytokinesis 11"	Q5JSL3	X	118495898-118686163	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 43.8;Kupffer cells: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.8;HMC-1: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059695	Uncertain		Approved	"Nuclear membrane,Nucleoli"		NA	NA			Nucleoli	"Nuclear membrane"	"HPA059695: AB_2684104"	"unprognostic (4.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.16e-3)"	27.3	6.9	5.0	15.9	15.0	23.5	30.6	1.4	3.1	7.6	11.6	1.5	4.2	2.5	7.9	8.2	7.8	7.0	7.3	6.7	4.4	3.3	7.4	2.6	11.7	27.5	5.4	2.0	3.5	1.7	2.4	15.9	10.0	3.9	6.0	4.8	1.4	4.4	4.1	2.5	4.4	9.7	9.6	7.8	13.8	7.3	3.7	5.3	19.7	9.4	3.6	13.8	9.3	13.3	5.2	4.6	13.1	7.3	7.6	11.3	2.1	0.0	2.4	2.0	1.9	27.8	11.9	5.4	2.8	6.1	2.3	6.2	0.3	0.0	7.5	0.2	10.2	2.8	0.1	3.6	0.0	2.1	9.3	3.1	16.5	2.7	0.0	9.0	9.9	39.9	8.3	0.1	2.5	2.8	1.6	0.1	6.6	5.0	13.7	1.4	1.6	5.9	13.2	2.1	2.2	3.9	4.0	5.3	0.2	0.0	0.5	0.7	4.9	8.5	7.9	2.7	1.6	0.9	8.4	0.1	1.9	0.6	10.9	1.2	4.2	6.3	7.0	4.1	15.9	1.0	6.3	4.2	7.5	8.8	6.1	5.5	4.9	7.4	7.0	4.6	5.2	6.7	8.3	13.1	7.6	7.3	3.7	11.3	2.1	5.0	15.0	1.4	3.1	4.4	3.3	5.4	2.0	3.9	5.3	26.8	3.0	16.0	0.1	2.6	0.4	1.1	0.0	1.4	13.6	7.0	0.0	3.2	0.0	0.1	0.3	2.1	0.7	0.0	0.0	2.6	8.0	0.4	43.8	0.8	17.4	0.0	4.1	3.7	50.0	0.2	11.2	27.1	8.5	10.8	3.7	0.2	0.5	0.8	4.6	4.8	0.3	25.8	9.1	0.7	3.0	1.6	5.7	23.8	0.8	0.1
DPH5	CGI-30	ENSG00000117543	"Diphthamide biosynthesis 5"	Q9H2P9	1	100989623-101026088	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046439, HPA076234"	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA046439: AB_2679667, HPA076234: AB_2797274"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.00e-2)"	12.6	21.5	11.2	9.1	19.0	7.9	21.4	10.4	11.9	17.3	12.8	11.5	13.2	6.8	20.6	19.0	16.1	19.3	10.0	19.2	11.2	11.9	14.1	18.1	8.5	15.2	11.9	11.4	39.0	28.4	15.5	31.7	9.3	12.3	15.3	13.7	10.8	16.1	12.7	16.8	11.5	9.2	15.4	16.7	13.6	11.5	9.2	11.3	22.2	18.4	15.5	17.7	14.4	14.7	12.1	8.4	3.3	6.2	14.9	16.2	6.7	9.6	8.8	13.1	12.8	16.2	46.2	11.3	8.5	14.0	12.5	10.6	10.5	2.4	17.0	11.4	7.2	7.8	6.3	14.6	13.0	18.4	7.1	10.7	8.9	8.5	19.9	25.3	10.8	4.7	31.0	18.9	11.7	38.0	24.1	18.6	11.8	19.9	5.4	18.8	8.3	13.2	10.6	10.6	5.2	13.8	12.2	19.1	9.8	14.1	7.4	15.2	7.4	4.7	13.1	37.7	10.4	8.5	6.4	9.4	7.4	10.4	10.7	11.2	6.4	7.4	10.4	10.1	10.2	2.7	3.3	5.1	2.6	11.1	5.5	15.1	12.1	12.3	12.1	8.4	9.6	16.2	14.8	1.9	14.9	6.2	6.2	8.2	6.7	11.2	19.0	10.4	11.9	11.2	11.9	11.9	11.4	12.3	11.3	6.0	10.5	39.8	17.8	14.1	5.0	21.8	17.8	20.1	7.9	7.0	0.0	22.0	19.9	12.0	1.2	11.3	3.4	0.0	15.9	23.6	15.8	9.8	25.3	25.4	17.0	1.6	9.8	13.5	29.4	1.5	25.0	11.3	11.8	26.2	11.4	15.8	10.5	17.5	13.1	22.8	6.2	6.5	10.3	16.4	16.4	15.7	10.9	20.0	23.2	6.3
DRICH1	C22orf43	ENSG00000189269	"Aspartate rich 1"	Q6PGQ1	22	23608452-23632321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 68.5"	"Group enriched"	"Detected in some"	100	"Early spermatids: 369.6;Late spermatids: 442.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	5	"CACO-2: 15.6"									HPA020446			Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA020446: AB_1853151"	"unprognostic (7.48e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.22e-4)"	"unprognostic (6.46e-2)"	"unprognostic (8.35e-4)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.73e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.70e-4)"	"unprognostic (1.08e-3)"	0.5	0.5	0.5	0.5	0.5	1.3	0.8	1.0	0.5	0.5	0.5	0.5	0.5	0.1	1.3	9.7	0.5	0.6	0.5	0.5	0.5	0.3	1.2	0.5	0.5	0.7	0.5	0.5	1.3	0.9	8.3	0.8	0.5	0.5	0.7	0.2	0.5	0.5	0.6	0.5	1.3	0.6	0.5	0.5	0.8	0.4	68.5	0.5	0.5	1.0	0.5	0.5	0.5	0.5	0.0	0.0	0.4	0.6	0.0	1.0	0.0	0.7	0.9	2.2	0.6	2.7	0.6	2.0	0.0	0.0	0.1	0.1	15.6	0.6	1.0	0.1	0.6	0.5	1.5	3.0	0.1	0.4	0.2	1.5	0.5	1.2	0.7	1.0	0.4	2.4	1.2	1.3	0.5	0.0	0.9	0.4	0.4	1.2	0.3	0.2	0.8	0.3	0.7	0.2	0.7	0.8	1.6	0.1	0.0	0.4	1.7	1.0	0.7	0.0	1.3	1.1	0.5	0.3	0.1	0.4	0.0	2.8	2.5	0.2	1.0	1.4	0.1	2.6	0.6	0.2	0.0	0.3	0.0	1.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.5	1.0	0.5	0.5	0.3	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	369.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	442.6	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.4	0.3	0.0	0.0	0.0	4.1	1.5	0.0	0.1	0.0	0.0	0.0
DTD1	"bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68"	ENSG00000125821	"D-tyrosyl-tRNA deacylase 1"	Q8TEA8	20	18587893-18766644	"Enzymes, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 137.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA		180000	"Nucleoli, Cytosol"		"HPA040981: AB_10673268"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.53e-2)"	14.9	17.7	25.2	13.6	26.5	13.6	19.7	22.4	35.4	13.5	13.7	22.2	10.5	10.6	14.4	17.2	18.8	14.5	11.1	16.7	24.7	29.5	20.1	9.4	13.7	15.5	25.2	30.4	19.1	19.7	20.3	23.7	12.7	27.3	13.6	16.0	17.1	17.6	12.4	22.5	17.6	9.8	15.0	30.9	12.7	16.3	20.6	14.4	4.8	29.5	24.9	17.4	13.4	12.6	20.9	27.5	29.9	20.6	16.4	22.5	12.6	18.7	21.1	20.8	20.4	8.9	16.6	11.6	16.6	15.4	13.2	14.5	13.8	14.7	0.0	11.4	15.4	18.5	10.6	16.6	35.2	13.9	9.1	11.9	20.9	4.8	22.9	28.2	16.2	11.3	13.1	28.3	14.9	55.0	11.3	22.4	3.6	13.0	24.4	19.2	27.5	3.4	29.5	19.3	14.2	46.5	0.0	31.0	15.8	20.1	10.1	28.5	21.5	8.9	24.7	42.8	9.5	14.0	10.1	22.1	17.5	9.5	22.3	22.4	19.6	19.4	10.4	12.0	19.0	14.5	29.9	14.5	10.4	22.2	20.6	22.2	20.9	21.7	22.5	27.5	17.8	16.0	16.7	17.1	16.4	20.5	6.4	16.1	12.6	25.2	26.5	22.4	35.4	24.7	29.5	25.2	30.4	27.3	14.4	32.8	20.0	24.2	32.6	20.9	39.1	17.3	30.6	25.4	17.0	40.1	2.0	25.2	36.5	64.2	24.1	30.8	7.3	0.0	76.4	30.7	25.8	26.4	41.5	10.4	41.2	41.3	22.3	24.5	20.4	17.6	16.7	29.6	40.5	48.7	19.7	48.4	68.4	24.6	18.4	51.2	30.2	0.0	17.5	60.6	137.5	31.1	10.4	30.5	24.3	23.6
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768090-172771195	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 326.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 326.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 43.7;hTCEpi: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA069577: AB_2686156"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	158.4	78.0	12.4	68.5	14.0	89.7	91.8	17.4	14.9	81.4	37.1	32.4	48.5	9.4	55.4	71.6	82.7	94.8	138.8	49.2	12.5	11.4	29.8	115.4	135.0	43.5	30.6	9.7	69.4	34.4	26.6	40.8	93.7	29.3	67.1	34.2	61.0	38.1	192.8	54.8	116.1	27.6	65.0	29.5	36.1	53.6	45.9	18.7	10.8	90.4	104.1	46.9	69.0	109.7	2.4	11.5	326.0	31.8	4.5	9.8	14.0	2.1	5.5	1.7	2.4	38.1	22.3	2.9	35.4	10.3	23.8	9.6	6.0	2.6	0.7	10.3	24.8	27.4	0.9	1.7	8.7	11.2	19.4	4.7	0.4	12.0	2.5	43.7	0.2	0.8	21.3	76.4	10.8	17.6	12.4	7.4	1.5	1.8	13.9	15.3	2.5	1.1	1.0	1.5	1.6	1.6	41.1	3.2	6.4	16.9	1.1	7.5	3.1	9.6	16.3	1.2	7.6	1.4	0.4	19.5	16.9	8.4	16.4	2.7	2.9	1.6	0.6	15.1	0.3	0.6	33.3	24.6	69.8	3.9	25.0	9.8	2.4	3.5	4.0	11.5	2.1	1.7	1.9	326.0	4.5	31.8	0.6	2.8	14.0	12.4	14.0	17.4	14.9	12.5	11.4	30.6	9.7	29.3	18.7	381.2	398.8	474.0	769.9	1136.9	64.0	181.6	236.9	45.5	126.3	200.7	25.5	239.6	48.0	361.0	67.1	510.4	567.7	46.7	76.6	355.3	824.5	763.6	295.5	297.9	967.3	46.1	687.8	403.9	1172.3	21.1	356.4	1745.4	514.5	55.9	830.1	603.1	188.6	648.8	292.4	25.4	177.1	756.7	886.8	11.8	23.0	1710.3	486.7	546.6	309.1	534.2
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488012-63499322	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 298.6"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 100.4;Cardiomyocytes: 108.0;Horizontal cells: 254.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HAP1: 56.2;HBF TERT88: 28.3;MCF7: 46.5;SCLC-21H: 29.6;T-47d: 24.1;U-2 OS: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Approved	Nucleoli,Cytosol		NA	NA		55000000	Cytosol	Nucleoli	"CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	2.2	8.0	21.3	2.3	23.5	1.9	2.2	41.1	51.3	1.9	2.3	2.3	0.1	2.2	2.0	2.3	4.1	2.1	2.6	51.9	23.0	21.0	2.0	2.0	2.0	2.1	13.9	31.0	2.0	3.5	6.1	16.6	2.0	23.1	3.7	2.1	1.8	3.4	2.2	298.6	2.2	2.3	2.1	4.8	2.0	3.6	2.3	3.6	0.0	2.0	23.9	2.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.3	0.1	10.8	0.2	2.6	0.0	0.1	1.3	2.1	0.3	10.7	3.6	1.4	7.1	0.0	18.9	0.1	2.9	5.1	56.2	0.1	28.3	0.1	2.6	0.0	4.0	0.4	0.6	0.0	2.5	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	46.5	0.1	0.1	1.9	19.3	18.1	1.3	0.0	1.7	0.4	0.5	29.6	18.0	17.1	1.9	0.1	0.5	24.1	0.6	0.0	0.0	32.9	0.1	0.3	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	21.3	23.5	41.1	51.3	23.0	21.0	13.9	31.0	23.1	3.6	0.0	0.0	0.0	0.5	0.3	100.4	108.0	0.0	0.0	1.2	0.0	11.8	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.2	0.1	0.2	2.9	5.7	0.0	0.0	254.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.8	0.3	0.0	0.0	0.3	33.6	0.0	0.3	0.0	0.1	1.6	0.0	0.0	0.0	0.9
EID3	"FLJ25832, NSE4B, NSMCE4B"	ENSG00000255150	"EP300 interacting inhibitor of differentiation 3"	Q8N140	12	104303739-104305205	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 69.1"	"Cell type enriched"	"Detected in many"	6	"Spermatocytes: 291.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.9;NK-cells: 6.6;T-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"A549: 10.2;BJ: 9.5;BJ hTERT+: 7.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.8;HeLa: 8.6"	"Low region specificity"	"Detected in single"							HPA059367	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059367: AB_2683992"	"unprognostic (1.25e-1)"	"unprognostic (5.41e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (8.02e-2)"	"unprognostic (5.88e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (8.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.87e-2)"	1.7	1.7	2.0	2.9	2.7	3.0	1.7	4.0	2.6	1.6	1.8	1.5	0.2	0.6	2.1	1.9	1.3	1.8	1.8	1.2	1.9	1.9	1.2	0.9	1.8	3.7	1.2	2.3	3.4	1.7	0.9	5.3	1.1	2.2	2.7	0.6	1.7	1.3	4.1	1.5	1.6	1.6	1.6	1.2	1.9	1.4	69.1	1.6	2.3	1.0	0.4	2.5	1.5	1.3	2.9	0.5	0.7	1.5	6.6	9.5	2.6	0.3	10.2	0.3	1.0	2.3	2.4	2.0	9.5	7.8	4.6	7.8	0.2	0.5	0.1	0.1	2.1	2.1	0.2	0.3	0.8	6.8	0.6	0.1	1.9	8.6	1.5	3.4	0.2	0.5	3.2	0.0	2.9	0.6	0.4	0.7	0.4	0.1	0.6	2.8	0.1	3.4	1.4	0.5	0.2	2.0	0.3	0.0	0.1	2.5	0.3	0.1	0.0	6.3	0.4	0.2	0.2	0.0	0.0	1.4	0.1	0.3	2.3	0.4	0.5	0.2	0.1	0.2	0.0	1.0	0.0	0.3	0.5	5.2	1.5	5.5	2.7	6.6	6.2	0.3	2.9	9.5	5.7	0.7	6.6	0.9	0.5	7.6	2.6	2.0	2.7	4.0	2.6	1.9	1.9	1.2	2.3	2.2	1.6	0.0	5.9	2.9	50.8	11.8	3.4	1.1	0.0	4.0	1.2	1.8	25.5	2.0	0.0	2.4	44.2	5.2	1.3	0.0	1.2	1.1	8.0	25.2	1.1	1.7	1.7	11.1	0.0	6.2	4.0	12.9	8.1	6.1	1.7	5.4	0.0	7.6	5.0	0.2	4.2	1.0	17.5	6.5	8.2	291.8	33.6	6.8	2.1	10.2	0.7	39.4
EIF2S2	"EIF2, EIF2beta, PPP1R67"	ENSG00000125977	"Eukaryotic translation initiation factor 2 subunit beta"	P20042	20	34088298-34112332	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034415, HPA041262, HPA041332"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"CAB034415: AB_2095998, HPA041262: AB_2677381, HPA041332: AB_2677417"	"unprognostic (5.76e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (9.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (9.64e-10)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-2)"	25.9	30.1	32.8	23.3	40.7	21.4	38.1	20.2	37.7	21.1	24.3	10.9	27.1	21.2	21.2	22.4	36.3	17.0	18.3	36.3	30.1	20.4	22.0	40.1	27.2	37.7	40.0	26.2	19.9	45.4	18.7	22.4	29.9	35.8	20.4	24.7	7.4	26.3	25.5	101.8	21.2	20.4	37.0	50.2	23.0	28.1	19.6	35.6	18.2	24.1	32.7	30.1	25.0	30.7	38.8	48.5	28.1	39.3	32.4	42.4	27.3	39.3	26.5	20.1	24.2	19.7	30.0	38.4	36.1	34.6	36.0	36.4	93.1	27.8	35.4	26.6	32.6	40.1	37.3	32.6	59.3	43.8	11.3	17.8	70.1	21.8	47.5	51.0	44.8	22.9	30.6	50.7	35.6	53.3	24.7	37.6	52.5	41.1	33.9	29.6	25.3	41.5	37.5	19.5	45.8	48.5	23.9	34.3	32.7	28.4	33.0	20.5	14.0	40.0	24.3	74.0	24.4	36.7	53.1	25.3	41.2	25.4	25.8	33.8	31.8	28.0	36.9	38.7	34.9	29.8	21.2	37.0	28.1	26.9	39.3	32.9	38.8	38.2	37.6	34.7	31.8	36.4	36.5	21.9	32.4	35.6	48.5	42.4	27.3	32.8	40.7	20.2	37.7	30.1	20.4	40.0	26.2	35.8	35.6	157.8	148.8	160.1	252.4	160.3	53.2	134.4	252.3	164.6	154.7	132.6	29.5	312.1	260.2	306.9	265.0	180.9	122.1	397.1	456.4	341.9	160.2	180.5	139.9	436.7	212.4	39.7	121.7	263.9	224.1	127.6	117.1	190.4	113.1	327.4	153.0	65.4	448.4	141.1	121.6	191.6	90.0	109.9	93.7	435.4	188.7	152.4	536.6	139.5	166.4	296.5
EIF3L	"EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025"	ENSG00000100129	"Eukaryotic translation initiation factor 3 subunit L"	Q9Y262	22	37848868-37889407	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003028	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		22000000	Nucleoli	Nucleoplasm	"HPA003028: AB_1078726"	"unprognostic (2.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.74e-2)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.03e-3)"	30.9	18.4	17.4	17.5	19.8	26.4	55.1	34.4	19.3	40.7	29.1	16.1	16.7	20.8	36.1	18.9	33.4	24.2	14.0	15.5	15.0	15.6	23.7	36.1	18.4	31.3	14.0	13.4	63.4	78.8	20.2	26.8	27.9	17.7	38.7	23.8	21.5	39.6	31.0	40.3	30.6	25.2	35.8	15.6	24.7	22.7	19.6	11.4	44.0	54.8	32.3	31.0	38.6	22.0	33.6	58.1	9.8	35.9	25.0	42.5	55.2	16.8	9.6	27.1	19.6	26.3	58.8	19.5	16.2	39.0	26.2	35.8	16.0	12.5	58.2	4.5	18.9	9.1	10.9	29.8	22.4	30.9	7.6	49.8	20.5	14.0	7.5	16.4	54.4	17.7	31.6	25.7	19.3	29.2	45.4	32.5	19.3	17.0	15.9	30.2	6.6	14.5	25.2	15.4	20.6	25.3	16.6	37.2	17.0	19.9	10.2	19.8	30.6	16.0	18.8	21.9	31.8	14.3	22.0	15.7	16.3	19.9	9.9	12.9	9.5	15.5	23.7	15.3	24.1	13.3	9.8	35.9	9.6	20.7	35.4	34.6	33.6	30.0	25.0	58.1	27.5	42.5	31.8	4.8	25.0	29.1	28.4	29.1	55.2	17.4	19.8	34.4	19.3	15.0	15.6	14.0	13.4	17.7	11.4	110.2	191.5	294.7	357.3	352.7	56.1	1.4	165.6	77.6	174.0	62.8	27.5	578.0	353.1	204.0	111.9	215.8	81.1	116.8	400.6	517.3	230.5	236.6	216.1	101.7	227.0	23.8	189.5	125.8	250.1	286.2	206.0	267.8	215.9	373.3	211.0	74.0	242.7	189.4	199.4	249.7	32.9	161.7	287.4	90.7	87.1	375.5	588.1	261.5	327.6	377.5
ESF1	"bA526K24.1, C20orf6"	ENSG00000089048	"ESF1 nucleolar pre-rRNA processing protein homolog"	Q9H501	20	13714322-13784886	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047083, HPA050396"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047083: AB_2679924, HPA050396: AB_2681111"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (7.81e-9)"	"unprognostic (2.52e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.91e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.57e-1)"	12.4	10.5	13.5	9.7	19.7	7.1	11.9	17.0	17.4	10.8	8.8	6.9	9.2	7.7	11.2	11.5	11.9	9.2	9.1	9.7	17.2	11.6	10.8	14.6	7.0	10.3	16.8	17.5	14.1	8.7	12.9	20.0	11.9	17.2	12.2	10.7	4.2	8.9	8.6	29.9	11.3	7.5	12.9	28.9	10.7	8.1	14.3	17.9	9.2	11.5	12.1	10.1	11.2	9.2	13.8	14.6	2.0	10.6	11.5	12.4	3.7	13.4	12.8	11.9	6.0	9.1	11.0	6.6	14.4	8.8	10.5	9.0	13.6	12.7	17.7	7.3	6.8	19.6	20.7	17.7	14.4	18.7	4.7	8.4	23.3	5.2	31.9	12.7	28.0	6.4	8.8	10.3	17.2	14.0	7.8	7.9	9.2	32.3	8.1	11.9	11.9	21.2	16.8	11.4	12.5	7.7	13.8	29.5	12.9	7.4	11.9	11.7	7.2	11.6	18.3	17.9	11.6	9.2	12.3	10.7	16.2	11.2	11.8	26.6	8.2	19.7	21.7	6.8	12.3	14.7	1.8	6.9	2.0	8.7	8.6	10.0	13.6	10.0	9.3	6.9	13.8	12.4	11.3	0.4	11.5	10.6	14.6	7.5	3.7	13.5	19.7	17.0	17.4	17.2	11.6	16.8	17.5	17.2	17.9	20.8	32.3	50.2	39.5	55.0	83.6	53.4	40.8	40.2	51.2	31.4	43.2	41.7	28.2	45.6	67.2	39.8	42.3	0.0	36.5	34.4	44.1	25.1	25.4	49.7	38.2	90.6	46.6	38.1	29.7	20.6	60.4	41.3	25.3	49.5	47.3	45.9	48.7	42.1	69.3	31.9	67.2	32.3	50.5	168.4	174.8	46.9	34.7	29.9	52.5	31.5
ETV6	TEL	ENSG00000139083	"ETS variant 6"	P41212	12	11649854-11895402	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.7;NB-4: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA000264	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA000264: AB_611466"	"unprognostic (4.03e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (9.38e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (4.66e-8)"	"unprognostic (1.33e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.92e-2)"	"prognostic favorable (1.54e-5)"	17.2	8.9	5.1	20.0	7.6	32.8	20.4	1.6	9.1	10.5	14.5	6.0	9.8	7.2	10.8	14.2	11.3	8.9	15.3	6.7	5.6	3.8	9.2	9.6	16.0	13.4	6.0	3.1	10.5	10.4	8.4	8.7	7.7	7.4	14.9	11.0	8.0	41.9	12.4	6.9	23.9	14.6	25.0	9.4	17.8	9.7	4.7	5.7	30.6	10.0	10.0	19.9	19.0	15.8	2.9	6.2	11.4	7.1	2.4	2.2	1.3	2.6	3.5	3.2	5.6	2.5	2.3	3.9	1.9	3.3	2.5	3.0	0.2	12.4	2.2	1.9	3.3	3.0	3.4	1.4	5.9	3.1	39.7	0.7	14.0	1.9	1.3	3.1	14.7	15.3	4.6	3.7	2.5	5.2	4.9	7.6	10.2	1.0	7.4	2.3	1.7	8.3	21.1	5.3	2.7	0.9	2.3	3.1	5.7	5.8	16.5	0.6	3.3	3.8	3.7	3.6	5.4	1.2	9.3	8.6	5.7	4.9	1.9	4.1	3.3	2.5	1.2	3.7	0.1	6.5	5.6	5.7	6.6	1.5	6.6	2.0	2.9	2.2	1.4	4.1	2.3	1.3	0.8	11.4	2.4	7.1	6.2	1.4	1.3	5.1	7.6	1.6	9.1	5.6	3.8	6.0	3.1	7.4	5.7	6.0	8.1	21.4	28.1	13.3	1.9	7.5	17.8	28.1	22.7	14.0	5.9	11.8	1.7	15.2	4.5	23.5	22.5	0.0	30.8	3.6	10.8	33.7	10.4	9.3	17.1	0.0	31.2	38.6	48.1	3.6	7.2	48.8	27.0	40.5	26.8	4.8	31.2	24.9	10.3	7.9	4.0	19.4	28.8	0.6	7.0	19.6	7.2	14.6	20.4	60.6
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease mutation, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA021756: AB_2670809, HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	13.0	14.2	14.4	18.6	17.0	12.7	17.9	22.7	18.0	16.1	14.3	15.8	13.6	11.0	18.7	10.1	16.6	19.0	11.7	12.5	15.8	12.5	14.3	18.4	11.1	16.7	18.5	17.3	22.1	25.0	19.6	12.6	13.1	13.9	13.9	17.4	14.6	14.1	13.7	22.3	13.1	11.5	18.7	12.3	14.0	13.4	8.4	17.6	17.3	14.2	15.7	21.3	15.8	13.9	11.0	10.4	5.6	7.9	16.8	11.7	7.7	13.6	27.9	16.7	14.8	6.0	6.8	12.2	20.5	9.9	20.5	15.9	22.5	11.9	27.2	11.2	11.0	22.6	25.0	26.7	20.4	22.8	16.1	13.0	21.7	27.4	15.6	11.4	32.7	14.4	8.7	7.7	28.8	33.7	7.5	14.5	18.3	23.6	11.8	14.2	24.2	23.0	9.1	20.7	37.4	18.1	18.2	30.7	29.6	9.6	12.7	10.3	11.5	23.9	18.3	10.8	12.2	19.0	11.8	8.9	20.3	15.8	18.0	28.9	6.1	23.8	41.2	14.5	19.1	15.8	1.5	7.7	5.6	10.9	7.9	11.2	11.0	11.0	9.2	10.4	10.4	11.7	10.0	2.0	16.8	5.4	6.8	9.9	7.7	14.4	17.0	22.7	18.0	15.8	12.5	18.5	17.3	13.9	17.6	6.0	18.6	18.5	10.3	9.4	12.8	7.4	2.5	9.4	5.7	3.5	5.9	14.1	5.0	10.0	1.0	6.8	3.6	0.0	9.8	17.2	9.3	5.7	12.7	8.6	11.5	4.8	1.2	7.4	3.8	0.2	7.8	8.0	6.8	4.6	6.4	10.4	7.3	0.0	7.4	8.7	12.5	6.5	10.8	4.2	13.5	7.3	7.0	10.2	10.5	7.1
EXOSC5	"hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p"	ENSG00000077348	"Exosome component 5"	Q9NQT4	19	41386374-41397479	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Extravillous trophoblasts: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053150, HPA055677"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA053150: AB_2682058, HPA055677: AB_2682882"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.50e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.83e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (6.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.82e-2)"	9.1	14.3	12.6	12.3	16.6	13.1	11.1	7.6	21.3	8.8	12.1	10.8	9.0	10.0	8.1	6.0	14.6	13.6	6.4	11.6	12.0	10.3	7.9	25.1	5.7	17.0	13.4	9.9	13.2	46.9	3.2	4.9	6.5	10.3	9.5	6.6	6.3	14.0	8.1	30.9	18.5	9.5	6.6	14.0	12.7	9.8	7.5	11.8	16.8	15.1	15.7	12.2	11.3	8.6	22.9	36.8	3.3	23.7	17.1	21.1	13.5	17.9	33.5	4.7	13.8	3.0	3.8	11.0	7.6	3.6	12.5	10.3	19.5	13.3	28.0	19.8	3.7	6.4	6.8	9.3	8.5	3.9	17.8	32.1	12.5	12.7	14.9	9.6	22.4	12.4	4.7	19.1	10.0	9.6	3.4	5.8	16.0	16.6	20.1	4.1	23.4	19.3	15.8	16.6	25.4	16.6	18.3	12.9	25.2	5.0	12.8	18.2	13.6	11.0	18.3	18.6	3.2	8.5	27.7	4.6	13.1	11.0	8.3	23.3	31.7	40.5	30.4	10.2	32.4	11.1	3.3	21.7	0.6	13.2	23.7	15.8	21.1	14.4	13.3	34.1	22.9	21.1	18.5	1.5	17.1	14.0	36.8	11.1	13.5	12.6	16.6	7.6	21.3	12.0	10.3	13.4	9.9	10.3	11.8	3.0	3.7	19.5	26.4	27.1	5.6	8.1	17.8	18.7	11.4	17.4	3.9	24.0	31.5	14.5	7.3	9.0	5.1	23.3	18.3	115.4	11.0	15.5	4.7	17.9	26.6	6.4	8.2	4.3	13.8	5.6	15.5	19.8	13.5	14.4	16.8	4.8	20.0	5.8	11.7	19.5	2.1	6.5	18.4	11.9	27.2	29.1	17.7	11.7	30.9	22.0
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801317-121817021	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 108.4;Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	12.5	12.7	10.1	18.9	14.7	29.7	13.9	16.8	18.6	11.2	9.7	8.1	12.5	7.5	12.5	12.4	13.3	11.8	7.8	13.1	13.5	11.3	11.3	14.0	11.9	19.8	11.3	12.2	12.6	10.4	14.2	15.5	12.1	12.9	10.3	12.0	9.6	10.9	8.9	17.6	12.1	10.3	10.6	11.7	14.2	10.4	36.7	10.0	33.7	9.2	15.4	18.9	12.2	10.5	19.9	15.9	20.1	17.7	11.6	23.6	14.0	19.5	9.2	24.9	14.8	3.9	8.0	12.1	25.4	14.7	36.4	28.2	9.9	16.4	34.3	6.3	15.8	11.0	7.0	26.9	11.8	32.5	15.2	12.3	17.2	14.2	12.8	8.2	29.1	16.0	6.0	6.1	25.4	7.3	7.5	17.9	22.1	29.4	13.6	34.0	11.4	44.6	22.5	13.1	7.6	10.8	24.9	41.7	15.4	12.4	6.4	15.9	16.7	9.3	13.9	15.4	13.2	11.8	18.8	10.8	16.3	24.1	13.7	24.4	19.8	15.0	41.2	16.9	20.3	10.7	12.0	13.3	20.1	18.7	17.7	18.4	19.9	20.5	23.6	15.9	19.9	23.3	20.7	3.3	11.6	17.0	15.7	21.6	14.0	10.1	14.7	16.8	18.6	13.5	11.3	11.3	12.2	12.9	10.0	41.7	15.5	16.4	12.6	11.3	10.7	11.1	7.6	18.7	26.1	3.5	9.8	24.1	1.7	17.1	108.4	14.2	4.5	0.0	26.6	25.0	13.6	7.6	30.1	4.9	21.1	15.9	5.8	12.3	10.3	9.2	12.0	18.0	8.5	20.8	7.9	13.8	16.5	8.7	10.3	7.1	16.3	6.5	11.3	107.2	58.5	12.9	9.2	19.2	10.5	12.9
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	11.6	5.2	11.8	10.4	11.4	19.0	11.3	23.3	20.0	8.5	13.8	3.8	6.6	11.4	7.5	8.2	6.5	6.7	15.7	9.2	15.6	14.3	4.6	5.1	8.1	8.8	12.6	19.0	10.5	5.8	12.1	7.3	6.0	11.4	8.5	15.7	5.5	13.5	9.6	2.3	4.2	11.5	11.4	10.2	8.6	7.9	8.8	5.0	9.4	6.7	4.3	8.4	16.4	18.0	0.9	2.7	5.7	2.3	0.7	1.4	0.5	3.6	2.6	5.4	2.8	9.7	5.9	3.5	2.2	2.9	3.4	5.8	0.9	3.7	4.0	2.0	5.6	3.5	7.2	18.2	0.7	4.4	2.6	2.6	5.7	20.5	0.4	2.5	7.3	11.0	3.1	0.8	5.0	0.3	6.9	2.2	6.8	13.8	22.8	7.9	15.1	4.7	5.3	4.2	8.7	13.4	10.8	13.6	0.8	0.9	4.3	17.5	5.1	8.7	15.2	4.5	4.0	3.2	12.1	0.4	5.5	10.4	4.7	8.2	4.1	1.0	3.8	8.1	5.8	2.9	5.7	1.1	1.0	1.0	2.3	0.6	0.9	1.0	1.4	2.7	0.9	0.7	0.5	1.0	0.7	0.9	0.5	0.8	0.5	11.8	11.4	23.3	20.0	15.6	14.3	12.6	19.0	11.4	5.0	0.0	2.1	0.0	2.1	5.5	4.6	1.2	10.2	2.7	2.3	1.8	0.0	2.1	1.7	1.7	9.2	5.8	7.1	0.0	5.3	2.1	7.3	2.6	7.0	0.8	8.9	0.0	6.9	6.7	22.2	4.5	13.3	16.8	5.0	10.0	10.0	1.2	4.3	10.5	19.4	0.4	0.9	0.0	3.9	1.7	6.0	3.1	2.9	5.0	13.0	4.6
FAM105A	"FLJ11127, NET20"	ENSG00000145569	"Family with sequence similarity 105 member A"	Q9NUU6	5	14581775-14615007	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 89.3;Hofbauer cells: 83.6;Intestinal endocrine cells: 59.1;Kupffer cells: 69.4;Spermatogonia: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.0;HMC-1: 44.0;OE19: 12.3;THP-1: 12.2;U-937: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA046638: AB_2679731"	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	5.1	3.5	4.0	7.9	4.9	35.4	5.2	3.1	5.1	6.3	15.4	9.0	4.5	8.3	3.0	5.6	2.9	3.1	4.1	3.0	3.9	4.3	5.2	1.9	28.8	16.7	6.1	3.8	4.0	13.3	1.9	8.7	6.7	7.9	12.6	17.3	10.3	3.1	13.5	1.3	2.6	13.7	3.3	10.8	13.2	5.4	4.4	4.1	3.5	27.2	3.0	6.2	7.1	5.8	0.1	26.7	6.9	26.2	14.1	9.6	16.2	0.0	0.6	1.2	0.0	0.2	0.0	5.3	1.5	1.4	0.4	0.7	1.9	1.4	0.0	0.8	0.7	2.2	0.1	2.6	1.2	0.6	0.8	3.6	3.4	14.0	0.3	1.3	0.0	44.0	0.1	0.3	0.2	0.0	0.0	0.0	2.2	0.0	5.5	0.1	1.1	0.0	1.2	1.9	12.3	9.4	0.4	0.5	1.6	0.0	10.5	4.6	5.1	0.7	0.5	0.0	1.3	0.5	12.2	0.0	0.6	3.4	0.2	1.1	0.0	0.0	0.0	0.8	20.8	0.2	0.0	26.2	0.1	4.5	12.4	6.0	0.1	5.7	6.1	26.7	0.1	7.8	7.5	6.9	14.1	9.4	19.7	9.6	16.2	4.0	4.9	3.1	5.1	3.9	4.3	6.1	3.8	7.9	4.1	89.3	8.2	0.9	4.4	7.4	0.7	0.0	2.5	0.0	3.4	0.0	0.0	0.7	0.0	0.0	1.1	6.3	22.2	0.0	0.0	1.5	5.9	7.8	49.6	0.2	83.6	0.0	59.1	4.3	69.4	2.0	4.0	37.7	11.8	0.0	39.6	2.5	0.0	37.1	3.2	0.0	0.9	0.0	3.8	20.5	57.7	5.9	1.1	30.5	41.5	2.7
FAM133A	"CT115, FLJ37659, RP1-32F7.2"	ENSG00000179083	"Family with sequence similarity 133 member A"	Q8N9E0	X	93674013-93712274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 14.8;pituitary gland: 8.2;testis: 16.1"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 12.3;Early spermatids: 14.0;Horizontal cells: 19.1;Late spermatids: 18.2;Spermatocytes: 21.3;Spermatogonia: 34.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.1;Karpas-707: 22.2;U-2197: 11.6;U-266/70: 17.4;U-266/84: 37.7"					"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Uncertain	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.67e-3)"	"unprognostic (4.45e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.22e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.39e-2)"	"unprognostic (7.12e-4)"	"unprognostic (1.67e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-3)"	0.5	3.0	4.7	0.4	14.8	0.3	0.8	2.3	7.7	1.7	0.5	0.5	0.0	0.4	1.0	0.8	0.4	1.1	0.7	2.2	2.5	4.5	0.4	0.4	0.5	0.4	2.3	4.4	1.4	0.4	0.4	8.2	0.4	3.7	0.4	0.5	0.2	0.4	0.5	0.3	0.6	0.5	0.8	4.5	0.5	0.4	16.1	2.6	0.0	0.9	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	22.2	0.0	0.0	0.0	0.0	0.5	0.0	5.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.4	0.5	11.6	0.5	17.4	37.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	14.8	2.3	7.3	2.5	4.5	2.3	4.4	3.7	2.6	0.0	0.0	0.0	0.0	0.6	12.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	19.1	0.0	1.3	0.0	18.2	1.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.7	0.0	1.1	0.0	0.2	21.3	34.9	0.1	0.0	0.0	0.0	0.0
FAM133B	MGC40405	ENSG00000234545	"Family with sequence similarity 133 member B"	Q5BKY9	7	92560793-92590394	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066175, HPA069513"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (5.54e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.87e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.73e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-2)"	10.5	11.7	18.5	11.1	23.6	32.1	15.1	25.7	23.3	13.6	10.4	8.2	12.0	11.9	13.0	22.5	11.4	10.4	9.2	9.2	13.8	9.1	11.2	14.3	11.2	14.1	15.3	13.2	15.1	13.6	13.4	21.3	12.9	18.0	12.0	11.7	7.5	11.4	10.5	17.1	12.8	10.8	15.7	18.5	12.1	10.6	7.3	17.3	15.9	12.5	7.5	12.8	10.6	12.0	22.5	23.2	9.8	11.7	10.7	17.0	5.9	13.1	6.8	19.2	29.4	11.3	12.0	11.5	14.9	16.1	14.6	17.8	10.9	14.6	21.5	14.5	10.1	12.7	10.6	15.1	9.4	22.4	12.1	19.7	17.4	10.0	21.8	11.8	19.1	15.1	8.0	9.9	11.2	14.0	11.5	8.6	16.8	22.9	27.3	15.6	16.0	30.0	29.9	26.2	12.0	8.8	21.8	19.3	17.8	14.5	14.1	18.6	18.0	12.8	16.3	17.3	18.8	15.1	14.1	9.9	16.8	26.7	19.5	16.7	7.1	7.5	38.5	10.1	25.2	21.6	9.5	11.7	9.8	10.7	10.5	13.9	22.5	13.6	13.2	9.6	18.8	17.0	14.4	4.9	10.7	7.8	23.2	14.3	5.9	18.5	23.6	25.7	23.3	13.8	9.1	15.3	13.2	18.0	17.3	53.6	65.5	102.1	185.5	101.5	81.2	25.7	180.9	38.8	62.6	83.7	70.7	55.8	84.6	78.1	31.4	87.5	92.6	163.5	75.9	52.0	92.4	103.6	86.4	97.3	62.9	52.4	131.6	108.1	107.2	13.2	95.0	114.5	72.6	69.5	83.4	83.5	72.6	112.3	83.4	48.4	75.1	51.8	103.0	97.0	117.4	91.7	59.0	97.2	97.8	127.1
FAM193B	"FLJ10404, IRIZIO, KIAA1931"	ENSG00000146067	"Family with sequence similarity 193 member B"	Q96PV7	5	177519788-177554541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035847, HPA035848"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035847: , HPA035848: AB_10601320"	"unprognostic (6.58e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (3.71e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.30e-5)"	13.5	9.5	18.5	16.5	17.2	35.6	15.8	37.9	20.4	18.1	13.5	13.6	17.2	15.4	19.8	11.6	13.8	13.3	12.3	9.1	18.4	8.0	16.3	18.5	17.0	20.5	17.3	18.3	22.1	22.1	10.3	15.2	15.2	17.0	19.0	11.6	17.1	14.3	14.6	11.6	34.9	18.7	12.7	10.9	27.8	14.9	14.0	16.2	11.7	16.9	9.5	15.3	13.7	23.1	1.3	1.6	2.9	1.8	2.0	2.8	0.9	5.3	7.1	15.8	13.8	7.8	7.6	34.3	4.9	5.2	8.1	7.7	19.1	10.4	10.2	7.5	4.7	10.2	9.3	7.2	10.2	6.0	22.4	7.5	7.2	11.2	9.1	4.6	7.0	14.8	7.5	11.4	6.8	7.5	14.5	8.1	16.2	6.9	10.1	5.7	17.9	12.7	20.4	11.0	4.7	5.7	20.8	3.5	8.6	7.7	15.3	14.7	9.4	5.6	16.3	4.8	12.5	15.9	9.7	10.0	9.0	7.4	5.8	5.7	11.1	4.6	8.2	7.2	11.4	7.4	0.0	1.8	0.7	2.8	0.2	1.8	0.7	1.4	2.0	1.1	1.3	0.7	1.0	2.9	2.0	1.1	1.6	0.9	0.9	18.5	17.2	37.9	20.4	18.4	8.0	17.3	18.3	17.0	16.2	17.9	29.0	6.0	5.1	7.7	10.9	6.4	22.9	8.1	13.6	10.4	17.7	4.3	0.0	5.4	5.1	9.2	9.1	0.0	7.6	6.8	7.8	7.9	4.7	10.4	4.2	11.1	8.1	14.1	7.6	7.4	9.2	7.8	8.5	3.6	13.9	9.1	5.5	5.8	4.9	2.2	12.4	6.5	9.9	10.6	12.9	11.3	3.8	7.9	10.3	5.4
FAM204A	"bA319I23.1, C10orf84, FLJ13188"	ENSG00000165669	"Family with sequence similarity 204 member A"	Q9H8W3	10	118297930-118342328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038182, HPA062025"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA038182: AB_10669519, HPA062025: AB_2684663"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (8.52e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (5.55e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.76e-3)"	31.2	17.5	30.0	18.5	31.6	40.3	28.1	18.9	37.8	24.9	26.8	20.0	19.6	17.9	27.4	29.5	26.1	19.2	19.2	29.5	25.4	21.7	25.0	24.8	21.4	22.4	23.4	25.9	26.2	21.4	19.1	31.3	19.1	30.4	21.1	21.6	19.4	21.9	20.7	36.3	17.1	18.5	34.0	31.2	24.1	20.8	39.9	20.9	19.8	26.0	21.9	23.0	32.8	18.4	27.4	32.4	36.6	35.1	17.5	27.2	28.7	21.6	9.8	16.1	22.4	16.1	17.6	9.2	17.1	32.3	24.9	22.6	11.5	20.3	15.4	10.7	18.4	11.2	18.7	13.4	17.9	22.7	24.1	16.7	12.7	10.0	10.1	24.1	33.1	18.2	12.1	22.0	18.2	38.4	20.9	21.1	19.9	13.3	18.2	20.5	12.0	20.3	30.8	11.4	9.5	8.7	17.4	31.2	11.2	22.5	11.0	10.4	16.4	11.7	11.0	25.2	8.3	17.5	24.0	14.7	13.1	12.2	11.5	26.0	13.1	11.6	22.1	25.5	35.9	13.2	29.8	31.7	36.6	21.7	34.4	22.7	27.4	24.6	19.8	32.4	20.2	21.3	24.7	17.6	17.5	35.1	23.5	27.2	28.7	30.0	31.6	18.9	37.8	25.4	21.7	23.4	25.9	30.4	20.9	56.6	51.4	57.2	54.8	49.3	36.8	71.2	50.9	53.5	47.8	41.8	68.7	32.9	114.4	58.3	206.7	61.6	25.0	46.7	98.7	40.6	62.0	51.0	65.9	40.6	54.1	31.8	40.3	59.5	64.6	82.8	70.8	79.5	57.3	48.7	48.6	54.4	77.4	58.3	65.7	92.5	54.8	25.8	71.2	217.2	170.6	44.3	25.6	57.4	45.3	52.2
FAM32A	"DKFZP586O0120, OTAG-12"	ENSG00000105058	"Family with sequence similarity 32 member A"	Q9Y421	19	16185380-16192046	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051712	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051712: AB_2681582"	"unprognostic (3.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.49e-3)"	37.2	42.9	56.2	34.0	37.6	53.1	43.9	33.4	56.2	29.0	39.9	18.7	33.1	50.5	37.2	35.1	41.2	30.9	35.4	32.5	51.6	35.7	39.8	54.9	31.7	35.5	34.9	45.9	30.3	32.5	25.1	24.8	51.1	41.5	30.4	38.8	18.6	34.6	33.4	52.0	42.7	56.7	35.2	45.8	43.2	40.4	24.1	34.3	32.8	33.5	29.8	37.5	40.3	38.9	27.9	41.5	94.9	65.7	27.6	32.2	51.5	29.3	22.6	35.5	22.9	42.0	32.4	33.7	28.6	32.5	35.4	39.0	31.0	35.6	19.5	50.0	36.8	25.5	22.7	36.3	31.2	31.3	25.7	39.9	36.2	20.4	27.4	34.0	45.5	42.6	37.3	32.9	28.3	26.1	31.5	38.1	40.6	28.3	28.9	34.9	39.1	35.1	47.6	51.0	48.9	55.9	37.1	24.6	32.2	38.7	29.5	30.7	46.6	24.1	23.1	30.6	26.7	19.6	52.1	35.3	27.6	16.4	50.3	35.8	34.5	57.0	30.8	40.1	55.5	23.8	41.0	47.8	94.9	24.7	60.1	26.1	27.9	23.7	26.7	41.5	27.8	28.8	31.4	41.0	27.6	65.7	28.5	32.2	51.5	56.2	37.6	33.4	56.2	51.6	35.7	34.9	45.9	41.5	34.3	41.7	44.0	67.1	29.7	41.4	26.9	32.3	50.9	45.5	35.2	34.9	19.6	83.5	77.9	90.3	13.7	55.9	94.4	0.0	90.4	92.4	53.1	40.3	61.2	86.3	76.1	39.7	65.1	40.5	62.3	28.5	35.9	54.8	55.6	104.6	53.1	39.3	101.4	119.3	49.1	57.2	18.8	25.8	42.9	23.5	40.4	46.5	88.4	65.0	48.0	48.7
FAM90A1	FLJ10408	ENSG00000171847	"Family with sequence similarity 90 member A1"	Q86YD7	12	8221260-8227618	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 9.8"	"Cell type enhanced"	"Detected in some"	15	"Cholangiocytes: 2.5;Early spermatids: 1.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"classical monocyte: 1.1;myeloid DC: 2.8;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.8;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.3;HDLM-2: 7.9;NTERA-2: 19.1"									HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA060078: "	"unprognostic (2.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (2.69e-3)"	"unprognostic (1.94e-4)"	"unprognostic (4.37e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.30e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.06e-2)"	0.2	2.5	2.1	1.2	4.1	0.1	0.3	4.1	9.8	0.3	0.2			0.6	1.9	1.4	1.0	1.6	2.9	2.0	2.3	2.7	0.5	0.0	1.4	0.8	2.2		5.8	2.5	0.0	3.3	0.4		1.7	0.0		2.8	0.6	0.4	2.3	0.3	0.2	1.8	0.7	0.4	2.1			3.1		0.1	0.6	0.5	0.1	2.8	0.0	1.1	0.1	0.2	0.2	0.0	0.0	0.7	1.3	0.2	0.0	5.3	0.4	0.4	0.1	0.0	0.0	2.2	0.3	0.9	0.1	0.3	0.0	3.4	0.0	0.0	7.9	0.4	0.5	0.0	0.1	0.0	0.1	0.0	0.5	1.3	0.3	0.2	2.5	0.2	0.8	2.9	0.4	0.0	1.1	0.1	2.9	19.1	0.0	0.0	0.2	0.1	0.0	1.3	0.4	0.2	0.4	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.8	0.0	0.2	0.1	0.4	2.9	0.0	2.0	2.5	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.1	0.2	2.0	0.0	0.2											0.0	0.0	0.0	0.0	0.1	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.3	0.5	0.7	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.0
FAM90A26	FAM90A26P	ENSG00000229924	"Family with sequence similarity 90 member A26"		4	9170409-9176730	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTERT-RPE1: 1.1"									HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA060078: "	"unprognostic (1.80e-2)"				"unprognostic (3.76e-1)"			"unprognostic (1.56e-1)"		"unprognostic (1.37e-2)"			"unprognostic (2.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.41e-1)"		0.0	0.6	0.1	0.0	0.3	0.1	0.1	0.2	1.6	0.0	0.0			0.0	0.1	0.1	0.0	0.3	0.4	0.3	0.1	0.1	0.0	0.1	0.2	0.0	0.0		0.7	0.3	0.0	0.2	0.0		0.2	0.0		0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.1			0.2		0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAR2	"FLJ10462, MLSTD1, SDR10E2"	ENSG00000064763	"Fatty acyl-CoA reductase 2"	Q96K12	12	29149103-29340980	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Syncytiotrophoblasts: 162.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 26.3;HUVEC TERT2: 30.8;NB-4: 26.4;SK-BR-3: 32.5;TIME: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015884	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA015884: AB_1853998"	"unprognostic (6.32e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.13e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-3)"	9.4	7.2	9.8	6.9	17.4	12.0	7.6	5.1	18.2	4.6	25.7	3.2	6.1	13.3	6.2	29.4	6.0	3.7	4.2	5.4	12.8	10.9	4.0	3.1	8.6	6.7	9.4	10.4	2.1	2.6	1.0	2.9	19.2	6.6	2.8	22.3	4.1	4.8	1.7	4.5	8.7	14.0	6.0	5.1	12.3	3.7	8.4	5.9	7.2	3.5	4.5	2.3	6.6	4.3	0.9	4.0	23.7	11.5	1.8	7.6	4.4	0.9	1.8	1.8	0.4	2.6	10.1	0.8	7.6	9.0	2.1	2.0	3.0	10.3	1.3	2.0	1.0	1.5	0.5	4.7	0.0	0.5	0.6	11.8	26.3	4.2	0.9	5.4	10.5	8.8	2.8	0.0	3.2	4.1	5.4	30.8	1.0	2.3	1.0	0.3	0.3	6.7	26.4	7.1	0.5	20.1	5.6	2.9	1.1	9.5	2.6	3.1	2.8	1.7	32.5	12.9	3.8	1.5	9.9	25.0	5.7	1.7	2.0	3.3	1.6	1.7	0.6	9.1	13.8	4.9	1.3	11.5	23.7	2.7	6.9	1.8	0.9	4.5	3.2	4.0	0.7	1.5	1.7	20.7	1.8	3.7	1.5	7.6	4.4	9.8	17.4	5.1	18.2	12.8	10.9	9.4	10.4	6.6	5.9	0.0	3.5	0.0	0.1	1.1	1.9	8.7	0.0	4.0	2.3	0.0	0.0	14.0	0.0	0.0	16.3	11.1	22.3	0.0	0.2	16.9	4.3	0.4	10.4	0.0	16.4	4.8	6.9	3.7	19.8	4.2	1.1	7.2	15.1	1.0	19.9	0.4	1.9	31.9	0.4	0.3	1.1	0.0	3.3	0.2	0.9	0.3	162.1	4.4	19.4	0.1
FBXL22	"Fbl22, FLJ39626"	ENSG00000197361	"F-box and leucine rich repeat protein 22"	Q6P050	15	63597353-63602428	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 65.9;smooth muscle: 68.0"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 10.5;Muller glia cells: 9.8;Peritubular cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 8.0;SCLC-21H: 9.1;U-937: 5.7"									"HPA047624, HPA054627"	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA047624: AB_2680107, HPA054627: AB_2682548"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	1.9	0.4	0.4	5.5	0.4	0.0	1.1	0.6	0.7	31.4	26.0	0.0	20.8	1.4	65.9	7.6	11.9	10.5	31.1	10.3	0.4	0.4	0.6	0.4	0.7	0.2	0.4	0.3	7.1	0.4	0.0	0.4	1.0	0.2	20.1	2.9	1.9	3.3	24.0	2.2	0.7	4.1	68.0	0.4	0.4	6.3	4.2	0.0	0.0	0.6	1.0	0.4	38.2	4.8	1.5	4.3	0.5	0.2	2.0	2.9	0.5	1.2	2.2	0.3	1.3	0.7	0.9	0.1	0.4	0.1	0.5	0.0	1.4	1.6	0.5	1.1	0.2	0.8	1.3	0.7	0.4	0.0	1.3	0.9	0.4	1.5	3.5	0.2	0.5	0.2	0.5	0.3	0.1	0.7	0.1	0.2	3.7	0.0	1.9	0.0	8.0	1.2	1.0	2.5	1.3	0.8	1.1	0.0	3.9	0.3	0.4	9.1	0.3	1.1	1.8	0.3	0.0	3.2	0.9	1.3	0.6	1.8	0.8	0.4	1.2	2.0	1.3	0.9	5.7	1.3	0.4	0.1	0.0	1.2	0.1	1.6	1.5	1.3	1.4	0.0	1.2	2.9	1.0	0.5	2.0	0.2	4.3	0.1	0.5	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.3	0.2	0.0	0.0	0.0	2.2	1.7	0.1	10.5	7.2	5.1	0.0	1.2	7.0	3.9	0.6	8.3	0.9	0.6	0.6	1.3	0.0	1.0	0.7	0.6	1.4	0.0	3.6	0.7	0.0	4.7	5.5	1.5	0.2	0.3	0.4	0.0	0.0	5.6	9.8	0.6	3.5	10.6	2.1	2.5	0.0	1.3	3.9	3.4	0.6	0.5	0.5	3.6	0.5
FBXO11	"FBX11, UBR6"	ENSG00000138081	"F-box protein 11"	Q86XK2	2	47789316-47905793	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002690			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA002690: AB_1848448"	"unprognostic (1.18e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	18.0	13.8	18.6	15.7	18.8	17.5	26.1	42.2	31.7	21.3	15.3	12.7	15.1	10.4	28.9	16.8	14.5	16.3	15.0	14.1	16.9	13.6	14.3	17.0	22.3	15.0	17.4	21.7	28.9	12.4	25.2	14.4	14.5	19.7	15.3	13.3	12.0	15.6	16.5	22.9	14.5	13.5	19.9	16.4	14.5	13.3	25.1	16.0	14.6	17.3	9.8	17.2	19.3	21.9	4.7	4.3	8.2	2.7	4.8	6.6	2.0	25.5	13.3	31.9	27.2	22.4	21.1	19.0	17.9	24.6	16.7	16.5	11.2	13.0	16.5	23.4	25.1	20.8	12.7	21.8	18.9	24.7	11.0	10.8	15.4	10.9	17.8	21.5	16.0	16.4	20.6	21.3	14.9	25.2	26.6	21.4	8.3	15.0	17.1	20.5	12.3	15.3	15.6	19.4	16.9	13.1	20.0	29.6	12.3	23.9	20.9	22.5	26.6	16.9	15.9	26.1	24.7	7.4	13.7	23.1	20.8	19.2	13.9	19.6	14.8	7.7	30.1	14.1	15.1	21.1	8.2	2.3	4.3	3.8	2.7	3.8	4.7	3.4	4.1	3.1	3.6	6.6	4.1	4.1	4.8	2.4	4.3	3.6	2.0	18.6	18.8	42.2	31.7	16.9	13.6	17.4	21.7	19.7	16.0	14.9	36.6	13.7	38.4	59.5	42.4	7.8	12.7	37.5	23.9	17.4	31.4	16.6	10.0	15.5	22.2	26.9	15.8	0.0	13.2	13.7	43.3	34.1	27.8	17.0	21.7	52.4	23.0	29.4	42.9	29.9	27.9	40.9	33.7	17.2	16.7	30.9	20.6	14.4	37.4	11.3	39.1	19.4	35.3	51.9	40.4	51.6	30.1	26.6	16.9	57.8
FBXO36	"Fbx36, FLJ37592"	ENSG00000153832	"F-box protein 36"	Q8NEA4	2	229922302-230013109	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 54.9;Cone photoreceptor cells: 33.4;Early spermatids: 33.5;Spermatocytes: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053865			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053865: AB_2682282"	"unprognostic (4.39e-3)"	"unprognostic (6.51e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.68e-1)"	4.0	7.8	8.9	1.9	12.6	1.9	7.3	4.1	12.2	6.7	2.8	11.9	4.7	3.2	5.4	8.9	3.8	21.7	3.9	2.9	8.3	9.1	10.3	3.7	4.9	2.1	8.1	6.9	6.8	3.7	11.7	11.7	3.6	10.1	6.4	3.0	9.3	5.0	5.8	2.0	6.1	3.2	3.9	8.9	2.1	3.7	14.0	5.2	2.7	14.8	2.8	2.7	2.9	3.3	2.8	3.6	0.8	1.7	2.7	4.5	1.2	1.3	2.6	3.1	1.2	1.5	9.4	6.1	1.6	4.3	2.3	4.0	0.8	4.1	0.1	0.9	2.8	2.8	1.0	1.4	0.8	4.0	0.3	0.9	0.5	0.9	1.6	6.0	1.0	0.4	9.9	7.0	4.4	3.4	3.0	2.4	4.5	1.8	0.8	2.7	5.2	2.2	2.4	8.1	2.8	2.9	2.6	0.9	0.6	4.1	1.0	2.9	3.7	2.6	2.1	1.1	3.6	4.5	1.8	1.8	3.8	1.4	6.1	0.6	2.8	2.3	0.9	4.7	0.5	2.8	0.1	1.7	0.1	2.5	1.3	2.1	2.8	1.9	1.7	3.6	2.0	4.5	2.5	0.8	2.7	0.9	1.7	3.5	1.2	8.9	12.6	4.1	12.2	8.3	9.1	8.1	6.9	10.1	5.2	8.9	1.4	0.0	2.9	3.4	7.0	3.1	0.0	54.9	10.3	10.4	33.4	1.6	13.3	4.9	33.5	2.4	1.8	0.0	5.8	1.5	3.1	2.8	0.0	2.4	0.9	9.5	0.0	1.8	1.0	5.4	3.1	1.2	3.3	4.6	1.4	6.6	4.5	0.0	3.9	7.5	27.5	6.5	2.7	34.9	10.3	4.0	1.8	0.5	1.5	1.1
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792637-61797244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.3"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 61.7;Spermatogonia: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		NA	Yes		38000	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavorable (5.73e-6)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	4.8	9.6	7.9	14.6	8.5	23.9	7.4	16.9	14.9	4.9	11.0	8.5	5.0	8.1	5.0	6.6	13.3	4.2	7.0	4.6	8.6	8.5	4.9	9.3	5.0	22.5	8.3	9.8	3.9	6.3	5.2	7.9	11.2	12.6	4.7	12.0	7.3	9.3	4.6	11.2	6.8	8.2	6.4	7.1	12.3	7.2	16.2	5.9	36.3	3.5	10.6	25.5	6.1	4.2	11.5	18.1	14.5	9.4	13.3	18.0	7.3	31.2	28.8	31.6	17.0	3.1	3.9	20.1	27.7	15.8	33.9	38.6	25.1	23.6	45.1	21.6	11.7	32.0	33.1	44.4	24.2	34.8	23.7	24.5	23.8	39.3	25.6	2.4	37.0	24.7	2.7	3.3	31.3	8.3	5.0	13.2	25.5	36.0	32.7	28.1	39.4	51.6	33.3	34.7	24.6	28.2	35.4	36.6	46.6	13.5	29.6	36.0	29.9	18.5	24.2	15.9	15.5	35.1	26.0	8.8	30.2	38.2	38.4	27.8	25.9	40.2	46.9	21.1	24.8	26.0	14.5	5.0	10.2	12.4	9.4	13.1	11.5	10.0	11.8	5.8	11.5	11.2	11.3	2.1	13.3	8.8	18.1	18.0	7.3	7.9	8.5	16.9	14.9	8.6	8.5	8.3	9.8	12.6	5.9	0.0	2.1	12.6	4.8	9.2	21.1	4.0	5.1	6.7	3.4	0.0	11.8	28.6	6.6	11.6	16.8	2.7	3.1	23.3	10.5	61.7	7.6	4.4	0.0	6.8	21.8	14.3	4.6	1.3	5.1	9.8	5.2	7.1	5.0	19.0	5.3	29.9	9.3	6.0	6.7	4.7	20.5	0.0	4.2	33.0	63.4	5.4	25.9	14.1	13.0	3.7
FGF7	KGF	ENSG00000140285	"Fibroblast growth factor 7"	P21781	15	49423096-49488775	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 101.2;Fibroblasts: 91.0;Leydig cells: 77.1;Smooth muscle cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 24.2;ASC TERT1: 22.3;fHDF/TERT166: 10.0;HSkMC: 22.6;RH-30: 18.0;U-138 MG: 12.2"	"Region enriched"	"Detected in single"	9	"cerebellum: 9.7"					HPA043605	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA043605: AB_10960215"	"unprognostic (4.65e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.63e-3)"	39.7	2.7	0.6	9.9	0.6	0.0	16.5	0.6	2.4	73.3	22.2	0.0	10.1	1.1	13.1	16.1	25.2	14.1	25.4	19.1	0.6	0.6	5.9	1.2	44.8	5.5	2.1	0.0	43.7	2.5	2.9	2.8	9.1	0.8	42.5	4.5	2.7	6.4	8.1	25.6	3.6	4.2	38.3	1.4	1.0	6.6	12.7	0.0	0.0	23.2	24.7	2.9	72.2	32.4	0.2	0.1	1.6	0.2	0.3	0.5	0.0	0.1	0.0	0.1	0.1	24.2	22.3	0.0	7.3	4.5	0.0	0.0	0.0	0.1	0.0	0.1	10.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.1	0.0	22.6	0.4	1.9	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	18.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.1	12.2	0.2	0.4	0.0	0.2	0.1	0.0	3.3	0.0	0.2	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.5	0.2	0.0	0.3	0.2	0.1	0.4	0.0	0.6	0.6	0.6	0.6	0.6	0.6	2.1	0.0	0.8	0.0	11.9	13.4	0.9	13.5	12.8	7.9	40.0	5.1	0.0	0.0	8.7	2.0	4.7	101.2	1.1	2.8	5.3	0.0	0.0	0.6	3.8	91.0	9.0	1.1	2.5	1.8	3.2	0.0	0.0	1.0	3.1	77.1	3.1	6.8	0.0	0.0	7.3	0.6	0.0	4.6	24.5	6.0	6.5	82.4	0.3	0.1	11.0	2.4	1.0	0.0	7.1
FKBP15	"FKBP133, KIAA0674, PPP1R76, WAFL"	ENSG00000119321	"FK506 binding protein 15"	Q5T1M5	9	113161006-113221361	"Predicted intracellular proteins"	"Endocytosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 53.0;Kupffer cells: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007979	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA007979: AB_1848615"	"unprognostic (2.81e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (3.44e-2)"	"unprognostic (5.62e-3)"	19.8	17.8	16.7	25.3	21.9	19.2	19.4	18.6	21.6	16.9	15.3	25.4	14.2	15.1	18.1	17.0	18.8	16.7	14.4	16.4	16.2	13.1	15.7	17.2	26.7	30.9	22.6	15.4	18.6	17.5	34.7	22.1	24.4	19.2	17.2	18.7	17.6	20.0	22.3	19.2	22.3	18.2	20.5	23.5	36.5	15.9	6.8	20.9	25.1	18.7	13.4	23.3	18.6	18.3	2.8	8.5	5.7	20.5	3.7	3.4	4.5	11.7	12.1	8.1	7.9	17.7	15.6	11.0	14.7	22.3	16.6	14.9	7.6	12.3	19.7	7.2	18.7	32.9	25.8	9.9	14.4	15.3	15.0	6.6	7.6	13.2	7.3	14.4	16.1	19.9	15.7	14.7	18.2	19.0	17.1	16.1	11.4	9.3	12.1	16.9	18.0	12.0	8.5	8.5	16.9	9.7	10.9	17.2	7.1	12.0	10.9	7.2	7.2	17.9	13.7	8.6	11.2	16.4	6.0	18.7	17.9	6.7	17.6	15.2	10.4	11.3	9.1	18.7	9.3	14.6	1.8	11.6	1.6	3.4	14.6	2.8	2.0	2.1	2.1	8.5	2.8	2.5	1.9	5.7	3.7	20.5	3.5	2.2	4.5	16.7	21.9	18.6	21.6	16.2	13.1	22.6	15.4	19.2	20.9	14.9	29.0	13.4	5.8	5.0	12.3	12.0	10.2	14.7	14.8	14.0	25.5	11.9	1.7	10.8	0.9	11.3	8.1	0.0	11.8	10.2	12.4	6.3	10.5	7.8	53.0	11.1	4.6	17.8	50.5	1.1	15.5	49.5	6.8	1.0	7.4	8.3	13.5	8.6	14.9	4.3	16.1	19.4	6.1	3.9	11.5	3.6	10.2	11.8	8.0	9.2
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109725	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 37.0;salivary gland: 12.4"	"Cell type enriched"	"Detected in some"	13	"Distal tubular cells: 23.2"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	48	"eosinophil: 4.7"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 4.7"	"Group enriched"	"Detected in some"	5	"MCF7: 4.0;SuSa: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Uncertain	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	37.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.3	0.0	0.0	12.4	3.7	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.9	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.0	0.0	0.0
FP565260.1		ENSG00000275464			21	5130871-5154734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 17.2"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 2: 10.8;Ductal cells: 8.0;Exocrine glandular cells: 6.9;Hofbauer cells: 5.1;monocytes: 5.4;Pancreatic endocrine cells: 7.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 38.1"									HPA024573	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.40e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	3.0	3.0	1.1	3.0	2.2	3.3	1.4	1.1	6.8	1.7	1.9	7.2	1.1	2.8	1.6	2.6	1.9	2.4	4.8	2.9	3.2		1.8	1.1	1.8	4.2	2.4	1.1	1.9	2.0	2.5	1.1	2.3	2.9	1.8	2.7	1.1	1.7	1.1	6.8	1.8	2.2	3.4	1.1	2.8	1.4	1.4	1.1	1.1	1.7	1.1	2.3	2.4	1.1	8.9	6.6	5.0	12.9	7.4	17.2	7.5	11.8	8.9	6.0	9.3	2.6	2.0	3.5	0.0	0.0	0.0	0.0	0.0	7.6	0.0	5.5	4.0	8.0	7.9	16.7	7.3	0.0	2.5	5.4	38.1	4.6	4.5	4.2	17.4	11.3	7.2	8.9	10.2	8.0	1.9	7.8	5.9	21.2	4.2	2.5	10.4	12.8	12.0	23.7	13.7	11.1	20.1	5.6	10.5	5.3	9.5	5.7	10.4	9.8	14.8	5.6	1.6	12.3	9.4	3.8	4.5	11.6	0.1	12.3	4.9	5.3	23.9	8.1	23.1	6.3	2.6	5.5	5.0	15.0	9.7	17.2	8.7	9.1	11.0	6.6	8.9	9.2	12.6	3.3	7.4	12.9	4.4	6.0	7.5											0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.5	0.0	0.0	2.3	0.0	8.0	0.0	0.0	0.0	0.0	6.9	1.6	0.0	0.0	4.7	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.4	0.0	0.0	7.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0
GIN1	"FLJ20125, GIN-1, TGIN1, ZH2C2"	ENSG00000145723	"Gypsy retrotransposon integrase 1"	Q9NXP7	5	103086000-103120151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037402, HPA061362"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037402: AB_10672790, HPA061362: AB_2684491"	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.89e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.08e-2)"	6.0	9.3	5.0	5.7	9.5	1.4	8.0	15.0	9.6	9.0	7.0	6.5	6.1	4.9	7.0	5.6	7.2	6.4	3.7	12.7	5.8	5.1	7.9	8.3	5.6	6.6	14.0	4.2	11.0	6.0	8.4	17.4	5.1	9.4	8.3	6.7	3.6	6.1	7.6	14.6	4.5	5.9	5.8	11.4	6.9	6.3	9.3	10.8	8.6	9.1	6.1	6.7	9.4	9.5	4.6	3.3	4.8	7.1	3.7	8.3	2.8	5.5	6.0	7.6	5.5	3.6	9.3	6.2	7.4	5.1	5.6	5.0	3.6	7.2	3.3	7.0	2.9	4.8	6.6	7.0	10.5	7.6	4.2	5.6	4.8	5.8	4.0	7.5	4.3	3.1	3.6	11.7	5.1	10.5	6.0	4.4	5.5	4.2	4.9	8.8	4.0	5.9	2.8	6.5	4.0	9.4	5.3	8.7	8.6	7.4	4.6	6.2	4.5	4.9	4.1	7.1	5.7	12.0	6.5	3.6	5.7	3.5	6.1	5.6	6.0	4.8	4.8	7.3	6.8	4.6	0.4	2.7	4.8	3.4	3.4	3.9	4.6	4.6	5.0	3.3	3.8	5.6	5.6	3.8	3.7	7.1	3.2	8.3	2.8	5.0	9.5	15.0	9.6	5.8	5.1	14.0	4.2	9.4	10.8	8.9	4.0	1.4	4.8	0.8	9.5	16.5	0.0	8.1	3.4	5.2	0.0	6.6	19.9	6.7	1.0	3.0	3.2	0.0	3.7	4.0	2.4	3.6	16.1	3.9	4.8	0.0	4.1	3.1	3.2	0.2	4.6	5.3	0.0	3.6	3.3	8.5	3.6	3.1	6.3	6.7	12.1	6.5	3.9	24.0	12.8	1.8	6.9	4.3	3.2	3.1
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1, RNA export mediator"	Q53GS7	9	128504700-128542288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 55.3;Late spermatids: 44.8;Spermatocytes: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	12.5	17.0	11.1	13.5	13.2	12.2	14.7	22.1	13.8	13.1	15.7	16.5	17.6	14.6	13.8	11.4	18.5	13.5	12.6	13.2	10.5	8.9	13.1	20.4	11.3	23.0	11.2	9.9	15.7	21.1	20.8	16.3	16.4	10.6	13.4	17.2	13.1	13.6	16.7	23.3	18.3	14.9	12.0	9.8	17.5	12.1	42.8	11.8	27.2	12.4	14.6	20.0	14.3	13.5	16.0	19.2	26.2	22.5	22.6	20.5	15.8	10.8	20.4	10.0	17.1	9.9	10.1	13.3	11.0	9.4	15.5	11.0	13.7	7.6	22.0	8.9	12.3	14.9	38.3	17.3	15.7	13.4	20.9	11.3	11.3	22.5	12.7	11.2	18.2	14.9	7.1	15.3	17.5	18.8	8.6	8.7	20.7	16.1	19.5	17.7	25.2	17.9	12.9	8.5	29.2	17.7	18.3	24.6	29.1	10.4	9.7	11.9	8.9	26.8	16.3	9.6	8.5	30.0	12.9	6.3	16.5	11.0	19.2	15.2	19.6	47.1	17.2	15.4	13.9	17.7	26.2	18.1	20.3	20.5	22.5	16.7	12.0	16.0	18.1	19.2	16.0	14.4	16.6	15.4	22.6	22.0	11.4	18.3	15.8	11.1	13.2	22.1	13.8	10.5	8.9	11.2	9.9	10.6	11.8	8.9	7.0	10.2	6.2	5.8	6.6	10.9	0.0	9.4	4.5	7.0	7.9	14.2	5.0	9.6	55.3	3.1	11.4	0.0	5.4	9.5	5.1	4.8	9.2	10.5	13.4	9.5	5.2	3.7	12.6	44.8	9.5	9.9	3.3	20.8	13.4	8.4	7.6	5.8	6.0	11.1	8.2	12.9	5.1	45.3	28.1	5.9	11.1	11.5	13.9	4.3
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 23.3"	"Group enriched"	"Detected in some"	4	"Leydig cells: 23.3;Peritubular cells: 29.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 19.6;NTERA-2: 11.9;U-2 OS: 20.3;WM-115: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"CAB008558: AB_2111910, HPA074275: AB_2686677"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	2.1	1.6	3.6	2.9	5.3	0.2	2.3	3.1	3.4	8.0	4.4	1.9	1.5	0.9	8.6	2.6	3.9	5.8	8.8	3.3	3.7	1.0	1.7	0.8	2.9	0.7	1.3	1.5	23.3	0.8	0.7	2.6	1.7	3.6	6.2	1.4	5.9	1.8	2.4	1.6	3.7	3.2	4.5	1.6	2.0	3.9	5.4	2.1	1.7	1.6	4.7	2.6	4.3	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	19.6	3.9	2.1	4.2	0.0	7.5	1.7	3.3	2.1	0.0	0.6	0.0	0.8	3.7	0.5	0.3	5.5	0.0	1.6	0.0	3.5	0.5	4.8	0.0	4.7	0.0	1.5	2.1	0.0	10.6	0.0	2.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	11.9	1.2	6.0	0.0	2.2	1.2	0.0	0.0	0.8	3.4	3.4	0.0	0.5	4.1	0.0	0.2	5.9	0.0	20.3	2.1	0.0	0.0	0.0	0.0	7.4	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.3	3.1	3.4	3.7	1.0	1.3	1.5	3.6	2.1	0.0	0.0	0.0	0.0	1.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	6.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	23.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	29.0	0.0	0.0	0.0	2.3	0.0	3.8	1.5	0.0	0.0	0.0	0.0
GMPR2		ENSG00000100938	"Guanosine monophosphate reductase 2"	Q9P2T1	14	24232422-24239242	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA067884, HPA068782"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No		160000	Nucleoplasm	Nucleoli	"HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032"	"unprognostic (1.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.86e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	18.9	44.2	19.6	14.6	24.2	11.5	26.2	13.6	31.7	22.5	21.1	25.1	20.3	21.3	18.8	26.3	17.8	28.7	23.4	15.0	20.1	21.9	39.1	26.3	19.0	18.1	23.0	21.2	26.1	26.9	49.1	22.4	22.7	26.0	20.3	21.6	21.9	22.6	23.7	16.1	14.4	21.7	18.2	20.3	25.5	21.2	10.6	19.1	21.6	43.0	11.2	21.0	21.8	17.6	7.5	14.4	32.3	14.0	7.6	14.9	11.0	9.2	10.6	14.3	9.3	16.6	23.5	13.1	10.9	19.4	15.3	19.6	12.4	7.3	12.3	9.9	15.9	9.8	12.8	15.8	23.6	21.9	11.6	11.6	9.7	6.6	45.2	15.6	15.8	15.2	22.0	16.9	8.1	16.8	21.4	24.8	17.7	5.6	11.6	15.4	17.2	15.7	14.2	11.1	13.6	13.8	11.9	9.7	10.1	21.1	15.2	10.1	14.4	7.8	17.2	14.6	15.2	14.9	12.7	12.7	7.3	5.8	9.5	7.9	25.9	24.8	8.1	6.0	12.1	7.0	9.0	14.0	7.2	10.1	11.2	10.7	7.5	10.2	11.2	14.4	7.1	9.1	10.2	32.3	7.6	11.3	6.5	14.9	11.0	19.6	24.2	13.6	31.7	20.1	21.9	23.0	21.2	26.0	19.1	23.8	16.0	23.8	32.5	9.7	16.4	10.5	40.8	33.5	25.0	50.6	3.9	53.9	86.2	34.2	9.9	19.0	34.2	0.0	29.0	39.0	17.4	19.6	31.1	22.4	45.3	17.5	9.9	11.6	32.6	7.7	26.7	30.1	20.3	23.4	20.4	34.1	30.5	30.6	23.7	96.9	13.6	25.8	25.8	15.2	9.6	9.4	41.2	23.0	27.6	21.0
GNL2	"HUMAUANTIG, Ngp-1, Nog2, Nug2"	ENSG00000134697	"G protein nucleolar 2"	Q13823	1	37566816-37595935	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027163, HPA060026"	Approved		Enhanced	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA027163: AB_10601655, HPA060026: AB_2684191"	"unprognostic (1.38e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.86e-9)"	"unprognostic (2.28e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (3.36e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.87e-1)"	24.1	17.4	13.8	24.1	15.0	30.7	21.9	11.2	14.2	15.9	15.7	11.7	16.8	12.4	20.2	18.3	21.8	16.4	14.8	17.9	12.5	11.3	18.0	26.9	18.7	19.6	21.2	11.5	19.6	17.4	15.2	21.6	24.5	15.8	16.4	18.7	10.1	19.4	18.9	40.3	22.2	16.3	17.4	15.0	21.8	17.8	21.4	15.2	24.3	17.1	27.5	22.2	20.5	19.8	18.4	25.2	14.4	22.7	20.7	17.4	12.2	19.3	10.0	19.4	20.3	15.6	18.0	31.6	29.5	20.5	27.3	27.9	27.3	22.9	31.8	19.3	21.7	15.4	18.3	31.7	24.0	37.7	18.0	24.8	31.9	20.1	21.9	20.9	41.8	22.9	11.3	22.1	37.2	44.6	13.0	19.6	13.9	42.3	22.9	26.4	17.1	22.5	25.3	50.9	14.0	19.6	24.1	35.3	36.1	22.8	21.2	23.8	21.9	22.3	22.5	21.9	30.2	16.1	24.4	15.7	18.5	26.1	39.1	40.9	21.5	19.3	55.3	21.3	33.7	23.5	10.3	17.1	14.4	15.3	22.7	17.4	18.4	14.3	16.5	25.2	13.5	15.1	14.5	1.8	20.7	20.7	18.5	16.9	12.2	13.8	15.0	11.2	14.2	12.5	11.3	21.2	11.5	15.8	15.2	14.9	47.4	26.7	52.5	56.2	7.6	18.2	5.1	73.6	79.6	7.0	9.8	32.5	23.2	37.6	45.3	20.2	13.4	0.0	54.2	43.6	26.3	29.5	46.2	16.2	28.9	6.4	16.6	11.6	17.1	7.8	22.2	29.8	8.5	36.1	16.0	19.1	39.6	17.8	18.0	12.9	8.6	0.0	33.0	50.5	54.9	46.2	38.6	26.7	19.7	42.6
GPATCH4	"DKFZP434F1735, FLJ20249, GPATC4"	ENSG00000160818	"G-patch domain containing 4"		1	156594487-156601496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028323, HPA054319"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA028323: AB_10601017, HPA054319: AB_2682447"	"unprognostic (2.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.60e-2)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.80e-2)"	18.2	13.3	14.7	16.9	27.7	9.4	15.1	6.9	22.5	10.0	12.1	8.3	3.9	9.7	13.8	10.0	14.0	11.6	7.2	11.9	12.6	12.1	18.0	23.1	10.0	15.7	15.3	12.4	15.3	12.9	19.6	16.2	10.0	24.2	12.6	14.6	5.7	11.5	11.9	47.1	10.9	10.0	15.1	10.2	16.6	12.5	8.8	13.2	8.0	10.3	19.0	19.1	12.5	10.1	16.6	10.1	0.3	11.2	10.7	15.9	7.6	17.1	23.7	10.0	14.4	9.2	7.1	13.0	21.3	8.5	16.7	9.8	24.2	13.0	41.4	17.7	14.9	10.8	12.0	22.7	18.8	18.5	12.3	22.5	24.7	23.2	18.5	8.3	55.1	16.0	8.0	15.9	31.6	28.0	4.7	11.7	13.5	40.4	10.4	13.5	32.0	22.6	13.3	43.8	29.9	25.0	22.6	17.1	28.7	11.5	20.4	15.8	23.8	20.4	44.9	13.1	11.4	14.7	26.8	17.8	15.9	21.7	16.5	38.1	19.1	21.0	53.4	14.4	28.6	24.0	0.0	5.4	0.1	13.3	10.5	13.4	16.6	13.5	14.7	10.1	16.6	15.4	15.9	0.3	10.7	11.2	6.4	8.5	7.6	14.7	27.7	6.9	22.5	12.6	12.1	15.3	12.4	24.2	13.2	29.8	34.7	41.0	38.8	65.5	7.1	24.8	28.1	16.0	40.9	15.7	7.9	31.9	21.6	38.5	7.6	30.2	8.5	23.3	48.9	40.5	22.6	43.6	56.6	37.8	33.7	7.9	35.5	14.7	10.7	7.4	24.7	22.6	21.9	19.8	19.7	4.3	44.1	14.0	25.1	25.9	5.9	32.3	59.0	37.1	39.9	54.7	12.9	29.7	28.3	36.6
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 27.1;smooth muscle: 21.0"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 149.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	2.4	0.9	2.1	3.6	1.7	0.0	1.9	1.2	4.0	7.3	4.9	3.1	8.5	0.8	27.1	8.2	7.4	7.7	5.6	2.4	2.8	1.5	1.1	0.4	2.8	0.4	3.0	1.2	7.6	11.0	4.9	1.3	1.3	3.0	8.2	2.3	3.4	2.3	9.4	0.8	1.5	2.1	21.0	3.0	1.2	2.2	3.0	0.8	1.4	1.2	1.7	0.7	2.8	6.8	0.3	1.2	1.5	0.5	0.2	0.3	0.2	6.1	3.8	15.5	9.9	3.7	6.6	0.0	5.9	6.5	5.1	5.4	24.0	1.0	0.0	3.3	8.9	9.6	18.4	3.7	5.8	3.0	2.3	4.8	2.2	3.0	0.1	1.6	0.6	1.5	2.3	3.8	4.4	7.1	11.9	10.2	1.9	2.0	0.1	7.7	0.5	0.7	0.1	6.3	10.3	6.0	1.8	6.7	0.0	2.7	1.7	3.1	13.7	6.5	0.2	17.8	6.1	3.4	0.7	13.7	10.5	5.5	14.1	6.7	0.0	0.0	0.0	2.8	0.0	2.7	1.5	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0.0	1.2	0.3	0.1	0.3	1.3	0.2	0.5	0.3	0.0	0.2	2.1	1.7	1.2	4.0	2.8	1.5	3.0	1.2	3.0	0.8	3.0	0.6	0.0	5.0	1.9	1.7	2.0	0.0	1.4	1.2	0.0	0.0	0.4	0.0	3.6	0.4	6.3	0.0	0.0	7.2	0.2	6.3	4.6	0.0	0.0	0.7	149.4	0.0	4.3	1.8	0.6	6.9	1.3	1.7	1.8	1.7	2.7	2.9	0.0	15.9	0.0	1.5	19.4	12.2	0.0	0.7	1.3	0.3	0.0	2.3	2.3
GPRIN3	"FLJ42625, GRIN3"	ENSG00000185477	"GPRIN family member 3"	Q6ZVF9	4	89236386-89308010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 75.7;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 41.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 47.1;RPMI-8226: 12.1;SCLC-21H: 12.6;U-266/70: 7.3;U-266/84: 5.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"basal ganglia: 53.1"	"HPA043148, HPA057666, HPA059092"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoli	Nucleoplasm	"HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902"	"unprognostic (9.05e-2)"	"unprognostic (4.92e-2)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.93e-1)"	"unprognostic (7.82e-4)"	7.0	1.8	4.0	11.5	9.1	8.9	3.2	41.0	5.0	3.5	7.2	2.8	0.0	8.4	2.3	1.7	1.8	2.1	5.6	5.4	3.6	4.1	5.5	2.8	11.2	12.7	4.1	3.1	4.8	7.0	1.1	12.4	1.4	6.5	2.1	9.8	6.4	2.9	1.0	2.1	1.6	7.0	2.0	6.0	12.9	4.7	1.1	6.2	5.3	2.9	1.4	10.5	4.5	2.4	0.3	1.5	0.1	2.2	2.9	6.6	1.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	12.1	0.1	0.0	12.6	0.2	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.3	5.7	0.0	0.2	0.0	0.0	0.1	0.5	0.0	4.8	1.7	6.6	0.3	4.7	3.7	1.5	0.1	1.9	1.9	0.1	2.9	2.2	0.0	5.3	1.4	4.0	9.1	41.0	5.0	3.6	4.1	4.1	3.1	6.5	6.2	0.0	19.9	3.7	0.7	1.0	9.4	14.6	5.1	1.4	9.1	3.5	0.0	0.1	1.7	1.1	0.1	3.6	9.6	0.0	8.2	0.0	2.3	0.2	7.0	0.0	18.9	25.4	75.7	2.5	26.9	0.0	0.3	31.5	1.7	5.4	25.1	0.8	1.7	5.8	1.1	1.8	10.3	77.6	8.2	0.1	0.1	0.9	0.2	34.6	21.8	0.3
GRB2	NCKAP2	ENSG00000177885	"Growth factor receptor bound protein 2"	P62993	17	75318076-75405709	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 288.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002589, HPA030749, HPA030750"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		1900000	Nucleoplasm	Nucleoli	"CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591"	"unprognostic (4.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.04e-7)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.58e-1)"	29.0	29.2	36.1	48.2	40.3	56.3	23.6	42.2	41.6	18.5	27.8	28.2	19.1	29.2	28.3	19.4	27.0	22.1	22.5	32.2	34.7	33.9	24.9	32.2	33.7	54.8	30.9	29.2	21.8	16.7	21.8	21.8	33.1	26.9	21.4	27.9	21.8	21.2	25.6	27.8	18.6	30.5	30.6	42.6	56.7	22.8	10.8	27.1	45.8	20.4	15.6	53.1	29.8	19.2	24.7	25.0	64.9	42.8	12.0	13.4	20.7	25.3	22.1	15.2	18.3	16.9	15.8	34.7	26.8	21.8	28.3	27.2	19.0	17.1	33.1	15.9	24.4	23.4	15.2	21.9	19.3	29.3	16.3	20.1	35.5	14.6	27.6	15.2	40.8	69.4	14.6	20.2	29.5	14.7	16.3	33.9	31.9	23.9	23.0	20.5	31.6	47.8	39.5	10.5	24.6	22.6	28.6	32.6	24.0	21.5	18.9	18.4	26.6	22.7	22.1	28.3	28.3	24.4	66.0	21.5	27.1	20.6	21.5	27.3	42.3	32.5	53.3	20.9	32.0	19.4	25.1	32.1	38.5	13.4	38.4	11.7	23.7	12.1	13.2	25.0	24.7	12.7	12.0	64.9	12.0	42.8	16.7	13.2	20.7	36.1	40.3	42.2	41.6	34.7	33.9	30.9	29.2	26.9	27.1	56.6	54.7	133.3	29.5	41.8	36.1	52.5	45.9	71.0	58.0	15.7	29.5	59.8	44.7	59.4	2.0	57.8	58.2	23.3	55.2	288.5	37.3	45.6	117.1	36.3	231.5	33.4	40.2	41.7	166.3	4.0	23.3	221.8	43.9	209.2	41.2	45.1	62.3	69.1	39.3	55.3	47.2	6.5	46.7	17.7	47.0	39.1	72.9	66.3	37.4	100.3
GTF3C1	TFIIIC220	ENSG00000077235	"General transcription factor IIIC subunit 1"	Q12789	16	27459555-27549913	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"gdT-cell: 20.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051617, HPA075900"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051617: AB_2681553, HPA075900: "	"unprognostic (6.46e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (8.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.32e-2)"	"prognostic favorable (9.56e-4)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.06e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.23e-3)"	13.6	18.4	19.4	12.1	25.9	17.3	10.6	25.3	31.2	17.3	12.8	21.0	18.8	11.0	19.0	12.0	39.3	19.9	16.5	23.7	15.8	16.2	16.9	13.2	14.1	13.5	14.3	19.1	20.7	24.0	33.8	33.2	13.5	15.8	35.4	12.4	22.3	15.3	16.9	29.5	41.5	11.7	19.3	12.8	14.2	15.7	24.4	17.1	25.2	35.8	18.8	21.0	12.3	20.7	1.9	4.2	2.1	2.1	7.8	20.6	3.6	12.9	28.5	21.0	24.5	18.9	15.3	11.9	14.1	15.9	19.6	16.8	21.3	12.2	14.2	20.8	17.2	15.0	14.5	26.6	17.9	16.2	6.4	25.5	11.8	24.1	30.4	10.6	13.4	15.7	18.7	13.7	24.0	10.7	13.2	19.4	16.5	14.5	11.7	15.4	31.8	14.9	16.2	28.2	7.0	13.6	27.9	26.0	14.6	12.3	13.6	26.6	17.8	14.2	12.1	8.7	17.6	21.7	10.2	20.5	19.8	12.0	12.4	14.4	12.5	11.3	14.5	8.2	15.0	14.5	1.0	2.1	2.1	20.6	1.9	15.2	1.9	2.4	10.3	2.7	1.6	2.5	6.7	1.6	7.8	2.0	4.2	2.5	3.6	19.4	25.9	25.3	31.2	15.8	16.2	14.3	19.1	15.8	17.1	17.9	22.9	5.6	6.3	16.4	42.3	23.4	10.2	25.4	15.9	12.2	88.4	6.4	5.0	10.2	2.0	12.8	10.9	0.0	9.9	3.8	13.3	16.1	18.5	12.5	9.2	25.4	28.8	15.4	12.3	4.0	17.8	6.4	3.3	8.2	15.9	13.3	13.1	8.6	14.9	7.9	30.3	12.9	7.2	19.1	14.9	18.1	3.5	27.7	11.1	6.2
GZF1	"dJ322G13.2, ZBTB23, ZNF336"	ENSG00000125812	"GDNF inducible zinc finger protein 1"	Q9H116	20	23362182-23373063	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024520	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA024520: AB_10963938"	"unprognostic (3.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.81e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-1)"	7.6	25.8	12.3	7.1	12.5	35.7	6.6	14.1	17.2	8.8	7.1	14.9	8.0	5.4	9.0	7.6	6.1	8.2	7.5	15.6	11.5	10.6	9.2	8.7	7.1	6.5	13.0	10.4	11.4	7.8	12.0	9.8	8.4	12.9	8.3	5.9	7.1	7.7	11.2	10.0	5.8	5.6	10.7	12.4	6.7	6.6	16.5	13.0	7.4	9.6	5.3	6.3	9.3	9.8	3.2	4.4	3.4	4.5	1.3	3.2	2.4	5.6	9.9	6.4	6.4	7.5	7.4	5.1	6.9	6.4	7.1	6.7	7.5	4.5	11.5	6.1	5.9	13.9	10.1	7.3	9.3	8.1	1.9	4.8	10.6	4.0	10.1	9.8	6.3	6.5	7.4	6.9	7.7	11.8	10.0	4.7	8.0	7.2	18.0	10.1	7.4	9.8	7.9	4.7	7.9	13.7	6.5	15.3	7.9	5.3	5.7	9.9	5.7	6.1	11.0	14.4	5.5	7.2	9.2	6.1	11.6	6.7	8.7	7.3	14.7	6.0	10.1	3.4	29.0	6.2	0.0	4.5	2.0	2.0	2.7	1.5	3.2	3.0	3.1	4.4	1.6	3.0	3.2	3.4	1.3	3.2	3.7	0.9	2.4	12.3	12.5	14.1	17.2	11.5	10.6	13.0	10.4	12.9	13.0	6.0	8.1	15.7	2.5	9.6	11.4	16.2	0.0	8.1	4.5	3.5	17.7	4.0	6.6	3.2	14.0	6.7	2.7	0.0	2.9	2.8	5.9	2.4	12.8	4.5	7.4	6.4	5.2	2.5	13.7	21.5	8.6	10.9	1.7	0.0	2.6	10.8	3.5	2.9	7.8	3.8	11.4	0.0	11.2	16.3	8.0	7.3	4.7	2.5	3.3	1.6
HAP1	"HAP2, hHLP1, HIP5, HLP"	ENSG00000173805	"Huntingtin associated protein 1"	P54257	17	41717742-41734644	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.5;stomach 1: 23.3"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 5.8;Syncytiotrophoblasts: 13.2"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"REH: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023394, HPA076992"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA023394: AB_1850492, HPA076992: AB_2686822"	"unprognostic (2.84e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.26e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.29e-2)"	0.7	3.2	11.7	1.1	16.2	0.8	2.0	5.6	13.1	4.8	1.3	3.8	2.2	5.2	4.6	3.5	0.9	2.8	3.1	0.6	10.1	30.5	1.1	1.2	1.4	0.9	6.6	6.6	1.0	2.2	0.5	6.8	3.1	15.5	1.6	1.4	0.4	3.4	3.0	1.0	1.6	2.5	1.7	8.3	3.3	23.3	3.4	2.2	0.0	7.2	0.0	1.0	0.9	1.2	1.2	0.8	2.6	0.6	1.5	1.0	0.1	0.1	1.5	0.7	1.5	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.9	0.1	0.1	0.5	0.1	0.2	6.3	3.3	0.2	0.0	0.0	1.6	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.8	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.8	9.0	0.4	45.8	0.0	1.7	0.3	0.5	0.2	0.0	0.3	0.2	0.0	0.8	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.6	0.6	0.5	0.6	0.3	0.4	0.5	0.5	0.6	0.2	1.2	0.8	1.0	2.6	1.5	0.6	0.8	0.8	0.1	11.7	16.2	5.6	9.3	10.1	30.5	6.6	6.6	15.5	2.2	0.0	1.7	0.0	5.8	2.7	1.4	2.0	0.0	2.7	2.3	0.0	2.0	1.2	0.0	0.3	0.2	2.5	0.2	0.0	0.8	0.6	2.3	3.9	0.0	0.8	0.4	0.0	0.0	0.6	0.8	0.0	0.3	1.9	0.0	0.0	0.2	0.8	0.8	0.0	0.7	0.0	1.2	0.0	1.0	0.0	4.5	2.8	13.2	0.7	1.0	3.1
HDDC2	"C6orf74, CGI-130, dJ167O5.2"	ENSG00000111906	"HD domain containing 2"	Q7Z4H3	6	125219962-125302078	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035677	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		19000	Nucleoli	Nucleoplasm	"HPA035677: AB_10603768"	"unprognostic (8.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.59e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.54e-2)"	17.5	29.8	50.5	12.0	36.1	11.3	21.1	26.4	31.7	14.8	15.2	11.1	31.6	12.4	12.9	25.2	19.6	17.2	12.4	34.7	41.1	37.0	31.3	8.9	13.4	18.8	45.0	18.9	18.3	22.9	16.3	15.6	11.5	23.4	15.7	16.9	19.3	54.8	42.0	42.8	13.5	16.1	19.0	25.8	12.2	14.4	25.7	16.8	12.9	24.3	35.4	18.2	17.7	11.2	27.3	15.4	4.4	14.2	23.6	33.9	17.7	8.6	24.1	15.0	61.5	12.2	16.8	20.9	11.6	17.7	12.6	13.1	37.9	10.4	40.0	25.2	22.1	29.1	8.6	21.0	17.0	16.1	15.7	49.3	18.5	13.4	37.2	27.8	23.9	13.7	23.5	26.2	17.9	41.3	19.8	9.0	22.2	69.9	17.3	27.2	48.0	18.5	25.2	17.6	25.8	19.6	27.9	11.9	8.4	29.4	11.0	29.4	14.3	14.2	27.7	25.4	14.7	16.2	40.6	5.5	12.7	14.0	19.5	23.4	20.6	14.2	33.1	18.3	43.3	25.9	4.4	14.2	2.5	22.9	12.2	18.7	27.3	25.3	31.0	14.7	22.0	31.4	33.9	3.2	23.6	11.1	15.4	21.5	17.7	50.5	36.1	26.4	31.7	41.1	37.0	45.0	18.9	23.4	16.8	23.8	38.7	42.4	51.6	39.6	51.4	109.7	33.1	34.8	30.7	59.3	13.7	75.6	286.8	71.8	43.7	26.4	42.4	23.3	86.1	127.4	62.7	54.8	36.9	18.1	98.5	65.2	61.9	11.6	46.6	33.2	84.3	41.0	75.9	12.6	64.1	45.8	55.3	45.6	107.8	202.1	18.2	38.8	76.2	115.5	66.8	37.6	38.2	62.3	78.2	45.1
HDHD3	"C9orf158, MGC12904"	ENSG00000119431	"Haloacid dehalogenase like hydrolase domain containing 3"	Q9BSH5	9	113373419-113376999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 54.7"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 204.4;Paneth cells: 171.9;Proximal tubular cells: 218.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020427, HPA024158, HPA024585"	Enhanced		Enhanced	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565"	"unprognostic (1.30e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.54e-7)"	"unprognostic (2.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.19e-3)"	4.9	54.7	5.1	10.1	8.4	3.3	12.7	6.2	8.5	6.0	29.8	5.6	10.6	38.2	6.4	15.5	13.8	5.8	18.1	9.1	4.6	5.3	17.7	36.6	4.4	6.3	4.5	9.4	7.2	23.7	20.5	9.1	6.5	7.3	10.6	16.8	8.3	24.4	12.5	2.8	11.4	47.1	8.0	4.8	6.0	17.7	4.5	4.0	8.0	18.2	6.1	6.8	7.0	6.9	12.1	10.6	5.9	2.9	5.6	12.3	5.8	3.4	9.7	2.1	5.8	5.2	2.3	17.7	2.5	4.8	4.1	4.5	17.8	17.0	7.5	3.2	1.4	8.2	13.3	3.3	3.9	1.4	10.4	7.6	10.3	5.3	11.0	6.1	0.6	8.0	3.6	8.3	3.3	9.5	4.8	2.1	7.0	8.1	1.9	1.9	22.1	4.7	3.0	4.7	34.0	7.6	3.9	0.0	6.0	5.2	7.1	5.3	3.4	4.3	18.8	6.3	4.8	11.8	2.1	2.1	0.8	0.0	0.7	0.8	4.6	9.0	3.1	1.0	0.0	0.6	0.1	2.9	5.9	9.9	1.6	11.2	11.3	11.5	9.0	4.5	12.1	12.0	8.9	1.9	5.6	0.2	10.6	12.3	5.8	5.1	8.4	6.2	8.5	4.6	5.3	4.5	9.4	7.3	4.0	8.9	8.5	18.1	18.5	8.9	9.4	12.0	73.9	22.7	11.4	22.7	9.8	23.7	72.9	66.3	0.1	8.9	204.4	23.3	138.2	16.2	7.5	24.3	7.0	74.9	17.6	1.6	38.8	8.6	5.1	0.9	13.3	6.7	10.1	19.8	61.9	10.8	96.2	171.9	8.5	218.3	12.1	6.5	7.5	0.2	6.1	12.8	26.4	17.3	72.5	40.4
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	22.0	22.3	14.2	21.0	16.8	22.0	18.5	22.3	18.9	19.4	17.9	15.2	20.2	11.5	17.6	15.7	30.4	16.1	15.2	26.2	13.5	14.3	18.0	35.2	15.0	14.1	14.5	14.5	18.2	15.1	34.8	20.5	27.0	18.8	16.8	15.5	16.8	18.9	16.4	88.5	24.3	16.3	15.6	13.7	16.4	18.8	18.9	14.4	16.7	24.8	23.0	18.6	18.6	22.3	10.6	9.3	12.6	8.6	8.9	8.1	3.3	28.8	18.1	15.9	9.9	50.4	26.4	15.2	17.7	17.9	15.8	13.7	13.5	15.7	22.7	18.8	32.3	11.3	19.6	21.2	16.0	24.1	13.9	8.7	23.2	14.9	54.0	23.5	24.1	17.0	23.2	22.1	17.8	28.0	22.0	29.1	13.5	16.6	10.5	24.6	23.7	9.3	10.3	12.1	25.3	16.5	17.3	18.4	9.9	24.7	30.0	11.8	13.9	25.9	18.0	15.7	20.2	18.9	15.6	29.1	18.4	14.4	13.2	15.0	11.5	16.4	25.6	8.7	12.2	15.5	12.6	8.6	11.3	7.1	7.1	8.1	7.2	8.0	6.3	9.3	10.6	6.7	6.6	4.4	8.9	5.3	7.8	8.0	3.3	14.2	16.8	22.3	18.9	13.5	14.3	14.5	14.5	18.8	14.4	44.7	63.3	37.1	68.0	76.9	78.2	103.0	22.9	155.2	84.2	68.0	92.3	53.4	10.0	37.6	2.9	56.2	38.8	23.3	31.4	36.2	49.1	82.9	31.3	79.7	25.8	62.0	46.8	39.9	39.7	6.7	63.9	34.4	32.1	29.7	30.4	36.8	41.9	28.1	70.0	20.0	175.8	45.3	41.2	53.4	107.2	100.5	117.1	37.4	37.3	267.3
HERPUD2	FLJ22313	ENSG00000122557	"HERPUD family member 2"	Q9BSE4	7	35632659-35695571	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 290.9;Late spermatids: 471.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015630, HPA076087"	Approved		Approved	"Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"		"HPA015630: AB_1850609, HPA076087: AB_2686774"	"unprognostic (1.85e-2)"	"unprognostic (5.31e-3)"	"unprognostic (2.76e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.42e-2)"	"unprognostic (6.54e-2)"	22.7	13.7	19.2	25.6	21.7	34.3	21.9	25.0	21.7	24.2	20.3	18.6	18.8	16.1	24.3	17.1	21.2	19.9	26.4	16.6	17.5	14.0	17.6	25.3	22.7	33.7	16.7	18.3	37.0	31.4	18.0	22.5	21.6	15.4	21.6	19.3	19.5	19.6	23.8	17.9	20.9	20.5	23.9	18.5	24.1	18.0	39.5	18.3	34.3	22.5	15.4	23.2	25.0	22.0	5.7	5.9	19.2	9.2	12.1	12.2	4.8	18.0	6.9	13.0	12.7	19.5	14.9	10.5	12.9	18.1	8.4	9.5	8.2	21.6	13.0	20.5	16.3	28.8	22.8	7.2	9.3	13.1	8.6	9.3	9.0	8.4	5.5	16.8	9.1	11.5	18.6	16.8	10.6	17.2	17.3	13.9	16.1	14.1	17.4	14.5	7.6	10.3	14.9	10.9	11.2	9.5	12.5	15.7	10.4	10.9	8.1	10.8	17.9	16.3	15.5	11.1	20.7	15.6	11.0	16.2	13.2	15.2	12.8	10.2	24.3	27.6	13.7	12.7	14.1	24.1	5.8	6.8	19.2	10.6	7.6	12.2	4.4	9.5	11.3	5.9	5.7	5.9	8.0	11.7	12.1	9.2	3.6	8.6	4.8	19.2	21.7	25.0	21.7	17.5	14.0	16.7	18.3	15.4	18.3	23.8	17.9	41.2	14.4	14.9	13.6	11.8	15.3	10.7	11.4	5.2	7.9	14.5	14.9	21.2	290.9	17.4	20.8	0.0	25.4	21.7	16.6	16.1	35.8	17.9	15.8	11.1	13.7	20.9	26.3	471.7	25.3	19.2	21.9	22.6	12.2	22.4	26.9	14.0	23.7	11.2	13.0	12.9	15.0	27.7	18.3	13.8	26.0	62.3	13.4	18.2
HES7	bHLHb37	ENSG00000179111	"Hes family bHLH transcription factor 7"	Q9BYE0	17	8120590-8124092	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.3;salivary gland: 10.5"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 2.4;Melanocytes: 3.3;Smooth muscle cells: 4.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.7;Daudi: 7.2;HAP1: 9.2;HDLM-2: 7.3;HeLa: 13.7"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	HPA072105	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoplasm	Nucleoli	"HPA072105: AB_2686488"	"unprognostic (1.98e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.99e-2)"		"unprognostic (2.84e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.55e-1)"	0.4	0.4	1.0	0.3	1.0	0.2	0.5	9.3	2.4	1.4	0.3	0.6	0.2	0.0	2.0	0.2	0.7	0.6	0.6	1.3	1.5	0.5	1.1	0.2	0.9	0.6	1.0	0.2	1.5	0.5	0.0	0.4	3.6	2.1	0.6	0.2	0.9	10.5	2.5	1.1	0.6	0.3	0.4	1.5	0.3	0.2	2.3	0.2	0.2	0.8	0.2	0.5	1.3	0.9	0.2	0.1	0.0	0.1	0.3	0.2	0.1	6.7	0.5	0.5	2.3	0.2	0.3	0.3	0.4	0.6	0.8	2.4	0.1	0.4	7.2	0.1	0.0	1.1	0.7	9.2	0.6	0.0	7.3	4.4	0.3	13.7	0.1	0.8	0.8	0.9	0.2	1.2	2.0	5.2	1.3	0.1	1.2	0.2	3.2	0.1	0.1	0.1	0.4	0.2	0.5	1.7	0.7	0.4	1.2	0.2	0.0	0.3	3.3	0.4	0.0	0.4	0.1	0.1	0.0	0.7	0.0	1.5	1.6	2.3	4.5	0.9	0.4	0.7	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	1.0	1.0	9.3	2.4	1.5	0.5	1.0	0.2	2.1	0.2	0.0	0.0	0.0	0.9	1.9	2.4	0.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.2	1.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.3	1.0	0.0	0.5	0.0	0.0	0.4	0.0	0.8	0.0	4.2	0.0	0.6	1.4	0.2	0.0	0.0	0.1
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 107.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 784.6;Pancreatic endocrine cells: 1097.2;Urothelial cells: 1250.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB032200, HPA065612, HPA068442"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA		18000	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	15.8	3.5	14.8	35.7	13.5	55.4	13.0	13.8	19.0	26.1	22.0	5.9	7.7	42.3	8.6	7.2	79.4	15.1	17.8	13.0	11.7	12.6	14.6	6.9	16.0	46.1	10.7	8.7	3.9	13.0	4.1	5.1	31.8	12.5	8.7	21.2	9.9	22.0	6.9	33.7	38.3	36.0	3.8	8.4	31.6	24.2	32.6	7.2	107.3	12.5	39.6	72.7	13.0	29.6	26.6	33.4	12.8	10.1	7.3	22.4	11.0	121.6	48.2	24.7	17.2	11.5	85.4	108.0	49.2	56.3	38.2	21.3	31.5	85.4	57.4	24.8	20.1	24.0	26.1	29.1	87.7	30.4	12.5	19.5	17.6	16.2	42.1	24.4	62.8	20.3	36.6	9.8	69.1	36.1	98.7	115.2	32.8	70.8	2.9	53.1	12.3	54.4	77.4	120.4	60.7	81.6	80.9	0.5	63.3	25.8	11.2	43.2	18.3	5.2	25.0	45.4	40.8	10.0	67.4	99.8	19.9	62.8	28.9	46.0	23.6	36.5	74.1	42.1	26.2	99.3	6.2	10.1	12.8	10.2	10.1	13.3	26.6	18.7	16.0	30.7	16.4	22.4	17.7	2.6	7.3	9.4	33.4	21.0	11.0	14.8	13.5	13.8	19.0	11.7	12.6	10.7	8.7	12.5	7.2	26.8	23.7	124.5	686.8	384.1	27.4	24.5	38.2	10.7	36.4	38.4	3.9	784.6	39.7	243.5	6.1	27.0	148.7	46.7	242.2	663.0	71.9	750.7	66.8	10.6	337.7	11.1	112.2	16.0	59.4	17.5	5.2	107.5	86.0	66.7	165.5	27.9	1097.2	162.4	2.5	9.0	27.8	0.0	34.9	38.5	398.0	315.9	688.1	51.7	282.8	1250.0
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331695-173335125	"Plasma proteins, Predicted intracellular proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1"	"Cell type enhanced"	"Detected in all"	15	"Erythroid cells: 2616.4;Extravillous trophoblasts: 751.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 166.6;MOLT-4: 171.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	Yes		380000	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109"	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	18.8	5.9	10.3	48.9	13.2	325.8	19.9	6.6	9.5	17.1	24.0	8.6	7.9	15.7	18.6	16.2	28.6	15.4	13.8	23.4	9.5	10.2	13.2	6.9	25.4	59.8	12.5	8.2	29.0	5.8	2.9	8.0	18.5	9.3	19.0	21.2	12.2	13.8	8.6	46.2	15.5	21.5	25.3	13.3	36.7	13.0	26.7	10.6	187.1	18.7	23.0	61.6	27.1	18.5	11.6	16.8	95.9	20.5	11.9	39.9	14.3	34.9	8.4	72.2	32.2	9.0	9.0	27.7	26.1	19.9	28.8	25.8	23.7	48.8	118.3	5.9	14.5	15.4	13.7	47.3	14.2	45.0	72.4	22.1	130.0	21.2	34.7	8.8	115.0	50.2	8.7	4.3	14.4	32.8	15.7	29.5	62.9	49.0	166.6	26.3	29.2	171.4	106.6	26.3	20.9	14.6	86.7	37.1	43.9	16.5	15.0	62.5	56.4	26.3	15.3	11.7	26.4	21.2	83.9	16.9	12.9	38.3	15.9	39.1	53.9	30.1	135.4	11.0	84.1	33.6	95.9	20.5	57.6	15.6	8.5	14.1	11.6	22.7	21.2	16.8	8.8	15.0	14.3	47.8	11.9	6.8	6.8	39.9	14.3	10.3	13.2	6.6	9.5	9.5	10.2	12.5	8.2	9.3	10.6	26.8	58.1	117.6	176.4	141.0	43.0	211.0	35.7	147.2	66.0	52.4	33.4	154.7	121.0	20.6	24.5	124.1	53.3	2616.4	14.4	751.8	109.8	81.7	104.4	22.2	176.6	42.9	71.7	149.1	275.5	29.5	97.5	149.6	64.1	109.2	104.0	79.8	10.0	83.9	54.1	36.3	129.5	77.6	96.6	461.9	435.2	117.1	107.7	264.5	185.0	64.8
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990775	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 54.3"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 337.0;Extravillous trophoblasts: 539.5;Syncytiotrophoblasts: 1171.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 108.8;U-698: 98.0"									HPA062583	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA062583: AB_2684800"	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	4.4	5.4	7.9	4.8	7.1	20.3	4.1	2.8	10.3	10.8	12.0	4.7	3.9	7.3	6.3	13.4	10.2	4.4	3.2	4.5	9.8	7.6	9.0	41.6	5.9	6.3	6.1	7.3	3.1	7.1	18.7	1.6	54.3	9.7	3.7	9.2	5.3	9.7	4.3	20.5	6.8	7.6	3.6	5.0	8.4	4.0	26.0	3.2	18.2	6.2	5.1	9.5	4.9	3.7	3.1	6.5	11.8	5.3	0.9	6.2	2.3	37.7	16.7	52.8	27.5	2.2	6.6	65.8	16.6	10.9	19.3	10.0	13.2	15.7	26.5	53.5	12.7	10.9	18.2	48.1	108.8	21.8	18.0	14.0	23.0	16.2	20.8	3.3	34.6	11.7	5.2	25.8	7.9	20.0	4.9	24.9	16.3	11.9	15.7	22.9	29.0	38.1	26.6	31.3	24.8	20.5	46.8	43.0	15.0	14.2	18.1	38.1	24.9	24.7	26.6	8.2	31.5	23.5	22.9	18.7	8.0	19.0	25.5	36.5	14.3	17.8	98.0	9.6	17.7	16.3	0.0	4.8	11.8	0.5	3.2	0.1	3.1	2.4	3.3	6.5	0.6	0.0	0.2	0.6	0.9	5.3	3.3	6.2	2.3	7.9	7.1	2.8	10.3	9.8	7.6	6.1	7.3	9.7	3.2	35.7	27.4	16.2	16.0	21.1	0.5	13.2	10.2	145.9	134.2	29.6	2.0	337.0	31.5	72.8	184.3	11.3	24.9	186.9	75.5	539.5	20.8	18.7	8.1	72.9	88.3	0.0	63.0	10.4	18.3	46.6	3.4	26.0	20.3	35.1	29.3	3.1	76.6	25.9	3.2	39.4	1.4	0.0	8.3	19.9	49.6	17.8	1171.0	14.0	52.8	17.0
HMGN2	HMG17	ENSG00000198830	"High mobility group nucleosomal binding domain 2"	P05204	1	26472450-26475972	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018371, HPA077364"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB018371: , HPA077364: AB_2686835"	"unprognostic (3.10e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.15e-1)"	30.6	34.9	36.0	52.4	32.3	169.1	37.6	30.8	39.1	51.3	43.4	30.3	53.6	30.0	46.1	60.6	44.1	50.1	51.6	37.6	30.5	32.0	35.9	37.1	62.9	100.2	32.7	30.5	64.7	59.4	16.7	52.7	49.6	26.0	48.0	49.9	42.5	58.9	51.9	41.1	33.9	41.3	68.1	40.4	50.0	33.2	29.9	31.1	104.6	48.6	52.5	83.2	43.7	38.7	60.4	81.4	157.4	73.6	38.6	83.4	103.5	83.3	28.9	83.9	35.2	7.8	18.1	32.8	41.3	23.8	80.9	62.5	29.8	78.2	93.9	39.5	33.6	23.6	48.2	105.8	41.0	68.9	57.8	74.9	100.8	34.3	29.1	14.7	213.4	58.9	19.0	21.6	44.2	26.2	16.9	37.6	62.7	79.7	45.1	42.4	61.6	152.1	97.0	70.3	96.0	53.8	105.9	131.8	57.5	25.4	22.9	83.7	51.9	124.1	34.9	45.7	21.8	57.2	101.2	27.9	40.4	75.5	77.3	68.8	55.2	74.8	104.6	25.9	224.6	80.0	30.3	59.9	157.4	34.2	69.0	32.0	60.4	46.8	41.4	60.9	59.1	51.5	41.7	53.1	38.6	73.6	81.4	83.4	103.5	36.0	32.3	30.8	39.1	30.5	32.0	32.7	30.5	26.0	31.1	318.6	348.4	323.5	270.1	256.3	146.9	79.2	191.1	714.7	343.5	247.7	133.5	686.4	315.0	197.4	143.3	140.8	163.3	537.3	235.1	491.1	459.0	285.8	361.7	123.4	660.0	89.0	554.4	172.5	336.2	26.8	172.0	473.8	215.9	762.9	372.7	230.4	94.5	305.1	142.8	214.8	300.1	122.9	297.7	273.8	419.4	186.6	772.2	318.1	517.4	227.4
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.23e-1)"	7.6	8.3	6.6	7.2	6.8	1.7	9.2	4.6	6.6	9.3	8.5	12.1	18.5	8.1	8.4	11.2	14.4	9.1	12.7	8.9	6.4	5.1	11.6	8.8	7.2	6.4	6.5	5.4	12.5	11.0	8.0	7.0	6.6	7.2	11.1	7.6	12.2	13.6	22.0	12.0	9.1	8.4	8.6	7.6	8.1	9.9	39.9	7.4	16.0	14.7	6.3	11.3	12.9	8.3	4.3	7.4	10.8	7.2	3.6	6.3	3.9	4.3	4.4	8.5	8.2	13.4	5.9	9.5	4.8	6.2	4.5	5.6	1.8	9.5	9.5	3.9	4.4	10.7	14.6	11.4	11.6	5.6	5.1	3.9	3.3	3.6	8.8	16.8	4.8	2.8	9.2	11.9	3.4	7.7	10.2	8.6	11.0	9.2	4.0	7.9	9.8	3.7	3.4	3.4	13.8	2.6	5.8	6.4	4.1	8.6	18.3	2.7	3.5	4.5	12.9	5.1	13.9	7.8	5.9	9.1	3.2	1.4	3.9	2.1	16.0	6.8	3.3	1.7	3.5	4.6	4.1	7.2	10.8	5.7	7.1	4.6	4.3	4.9	4.8	7.4	3.9	5.4	6.3	1.4	3.6	4.9	4.7	6.2	3.9	6.6	6.8	4.6	6.6	6.4	5.1	6.5	5.4	7.2	7.4	6.0	6.5	6.9	14.8	2.5	4.7	6.5	10.2	6.7	9.1	22.7	5.9	6.0	11.6	9.6	220.5	3.5	6.3	0.0	9.5	5.4	4.6	9.3	3.5	4.4	7.6	9.5	3.5	5.5	2.9	54.5	6.4	5.5	3.3	20.8	9.8	6.8	8.8	3.5	7.1	15.1	3.4	6.5	3.8	5.7	4.5	4.4	7.8	2.9	9.3	27.4
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720888	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 78.1"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 709.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.2;neutrophil: 4.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.4;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"A549: 5.7;HeLa: 4.5;hTCEpi: 19.4;SiHa: 5.9;SuSa: 6.8;THP-1: 11.2;U-2 OS: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA028346: AB_2672564, HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	1.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	3.2	0.1	0.1	0.1	0.4	0.0	78.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.6	4.4	1.2	0.0	0.2	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.1	6.8	0.0	11.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	1.2	0.3	0.2	0.4	0.0	0.2	0.1	0.0	0.6	0.1	0.0	0.0	4.4	0.0	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	54.2	0.1	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.6	22.1	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	32.3	0.1	709.1	118.4	8.2	1.8	0.0	0.0	0.0
HOXD9	"HOX4, HOX4C"	ENSG00000128709	"Homeobox D9"	P28356	2	176122720-176124937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 26.2"	"Cell type enhanced"	"Detected in some"	10	"Collecting duct cells: 22.7;Distal tubular cells: 31.5;Leydig cells: 31.7;Peritubular cells: 25.1;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.7;HEK 293: 12.2;RPTEC TERT1: 14.4;SH-SY5Y: 16.8;SK-MEL-30: 9.2;TIME: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068683			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA068683: AB_2686018"	"unprognostic (1.89e-1)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (9.58e-4)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.71e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.44e-2)"	4.1	2.7	0.2	1.7	0.4	0.0	11.4	0.2	0.2	13.1	10.8	0.2	10.4	0.0	26.2	12.0	1.6	5.1	2.6	0.5	0.2	0.0	19.7	0.2	0.7	2.4	0.2	0.2	8.9	0.2	0.0	0.2	1.6	0.4	13.0	2.2	0.2	0.4	16.0	3.8	3.9	1.1	12.6	0.6	3.7	0.1	9.8	0.2	0.3	2.2	2.2	1.3	2.4	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	1.2	0.8	1.0	0.8	0.0	0.0	0.0	8.7	1.1	0.6	5.7	0.0	0.0	0.7	0.0	12.2	0.0	0.7	0.0	0.1	0.0	0.0	2.8	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	14.4	5.3	3.3	16.8	4.1	0.0	9.2	0.8	0.0	0.0	12.7	0.0	2.8	4.1	4.4	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	1.5	2.2	0.0	0.6	0.0	0.0	0.0	22.7	0.0	0.0	31.5	0.0	0.2	11.7	0.0	0.0	0.0	0.2	1.0	0.9	0.0	0.0	0.2	0.0	7.5	0.0	0.0	0.5	31.7	0.0	1.7	0.0	2.1	0.0	0.0	0.0	25.1	2.2	0.0	38.8	0.8	0.7	1.2	1.6	0.0	0.0	4.1	0.5
HS1BP3	"FLJ14249, HS1-BP3"	ENSG00000118960	"HCLS1 binding protein 3"	Q53T59	2	20560448-20651089	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035050	Approved		Approved	Nucleoli,Cytosol		No	No		32000	Nucleoli	Cytosol	"HPA035050: AB_10601816"	"unprognostic (4.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (2.06e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (2.30e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-1)"	17.9	23.1	10.4	8.8	15.7	10.7	11.8	6.7	17.6	17.6	22.6	21.3	14.3	11.7	17.6	18.6	22.6	13.9	28.4	17.5	11.0	9.1	18.5	47.8	14.2	11.7	16.7	9.4	14.8	13.9	10.6	14.3	22.3	13.5	20.3	11.7	17.0	12.9	17.3	9.6	17.0	16.0	27.3	13.8	14.5	16.4	9.7	14.1	6.6	18.5	8.0	9.9	20.8	17.1	6.0	8.0	14.6	13.3	2.9	5.3	6.1	8.4	9.9	5.0	6.1	26.6	17.9	9.9	3.2	15.0	7.7	10.1	7.7	10.3	5.7	2.6	4.7	35.0	5.3	9.9	10.2	3.7	7.3	8.2	3.0	5.0	25.6	25.0	2.3	13.3	18.9	23.9	8.7	16.2	9.2	14.6	5.1	1.9	12.3	8.7	7.3	1.0	3.9	4.1	12.5	7.2	5.5	10.1	5.5	17.1	10.3	4.7	7.3	2.3	10.1	19.2	10.6	6.3	4.7	9.4	7.7	8.3	11.7	4.9	8.8	9.8	5.2	16.5	10.8	8.1	11.4	11.3	11.0	5.3	11.2	3.7	6.0	3.2	4.0	8.0	4.0	2.7	2.8	14.6	2.9	13.3	3.0	2.9	6.1	10.4	15.7	6.7	17.6	11.0	9.1	16.7	9.4	13.5	14.1	6.0	17.0	9.3	7.5	3.9	3.8	6.1	7.6	10.7	14.8	7.0	0.0	7.7	14.9	17.0	16.8	4.9	13.5	23.3	12.9	14.6	8.0	7.2	2.3	8.2	26.5	14.3	6.4	10.4	16.7	28.4	7.8	10.9	13.5	10.8	6.1	8.6	10.8	7.8	9.9	21.3	4.9	0.0	15.6	11.6	9.6	4.5	14.6	7.5	6.6	4.6
HTD2		ENSG00000255154	"Hydroxyacyl-thioester dehydratase type 2"	P86397	3	58306262-58318574	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Club cells: 2.3;granulocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA066812, HPA077228"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA066812: AB_2685727, HPA077228: "	"unprognostic (1.95e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	7.9	8.9	9.0	6.6	13.9	6.9	9.4	17.0	11.5	7.4	9.2	6.4	7.1	11.3	8.6	8.5	9.4	7.8	7.1	15.9	7.9	9.3	12.1	16.2	6.9	8.2	8.5	10.7	11.0	12.9	8.8	14.2	6.7	7.8	9.6	10.1	9.7	9.2	9.4	35.2	7.2	9.7	12.6	6.0	9.7	8.6	9.8	6.4	6.8	10.7	19.8	9.2	7.8	8.1	23.9	21.6	23.7	20.4	21.3	26.5	13.5	8.2	6.3	9.6	6.8	8.2	9.2	12.3	11.7	8.9	14.6	12.9	13.7	6.2	16.3	3.5	8.4	11.7	7.2	16.0	10.6	15.0	9.1	11.2	9.8	13.9	11.5	8.9	12.8	9.3	11.3	10.9	15.5	9.4	7.8	12.7	12.1	9.6	15.5	9.1	4.8	8.3	6.5	12.4	8.4	14.2	5.8	6.1	11.7	9.8	12.1	6.0	9.0	7.2	6.8	13.3	10.6	9.1	11.4	7.4	12.4	8.8	11.2	14.3	11.9	21.3	12.7	10.0	9.5	7.5	13.5	17.3	23.7	18.7	20.4	20.1	23.9	18.7	23.5	17.5	23.8	26.5	20.2	18.4	21.3	16.7	21.6	13.4	13.5	9.0	13.9	17.0	11.5	7.9	9.3	8.5	10.7	7.8	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase 3 (NAD(+)) gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria		Yes	No			"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	24.5	34.0	27.7	26.8	47.2	37.1	24.1	37.2	61.5	25.0	28.8	25.7	24.6	34.7	26.6	21.3	31.8	29.4	25.6	50.8	35.0	25.2	40.6	29.5	20.9	25.6	27.3	35.6	31.8	40.5	29.1	24.9	22.5	40.5	21.4	25.2	26.0	34.5	29.8	54.9	36.3	34.9	24.8	20.1	26.9	24.8	16.0	23.3	31.2	24.3	37.1	28.2	24.4	21.1	20.6	45.5	43.7	44.4	23.7	28.8	33.6	29.1	26.9	15.9	22.3	24.9	20.7	19.5	15.2	21.4	27.0	28.7	22.2	22.2	37.1	26.3	24.4	22.1	21.8	24.0	20.7	9.9	12.2	30.7	13.9	36.5	17.8	28.3	19.4	29.4	23.2	15.0	20.8	22.7	17.4	20.6	15.5	7.7	20.4	21.7	40.8	22.0	22.8	7.1	27.1	35.6	19.4	13.6	32.3	30.1	18.2	20.3	13.9	9.5	32.2	15.1	6.8	13.3	16.7	18.2	17.1	10.7	25.1	35.9	28.1	7.0	47.3	28.0	24.0	18.9	42.5	43.9	43.7	21.5	44.4	19.9	19.1	22.0	20.9	45.5	20.6	17.6	19.2	16.3	23.7	43.1	27.9	28.8	33.6	27.7	47.2	37.2	61.5	35.0	25.2	27.3	35.6	40.5	23.3	32.8	32.7	56.5	52.5	71.9	33.9	48.4	43.3	30.8	7.9	48.8	27.5	80.9	175.8	81.7	113.6	44.1	164.4	46.7	79.1	82.6	56.8	36.9	91.2	33.0	116.8	17.5	59.8	43.6	88.9	226.7	49.5	66.0	64.1	101.0	81.8	37.0	65.2	122.8	55.2	192.8	37.1	51.8	69.3	14.0	17.0	67.8	92.7	54.5	93.0	43.8
IER5		ENSG00000162783	"Immediate early response 5"	Q5VY09	1	181088712-181092899	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029894	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA029894: AB_10601433"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (2.42e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.81e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	9.4	7.2	4.7	16.2	5.4	45.7	13.8	6.2	12.6	7.8	7.8	5.1	5.9	6.6	12.8	5.3	20.9	14.3	10.3	22.9	6.0	4.9	3.7	6.7	22.6	9.6	10.1	5.7	4.4	4.3	1.8	4.6	34.5	6.9	6.7	6.9	3.7	5.7	4.9	42.3	16.6	10.8	9.6	7.2	27.3	6.8	5.1	5.0	11.2	4.3	22.9	19.8	8.4	16.3	5.4	1.6	5.4	7.8	1.5	2.1	0.9	12.1	10.7	5.9	5.1	8.2	11.4	15.8	21.6	23.0	12.3	10.9	2.9	6.9	4.0	9.6	8.3	8.6	22.5	1.9	14.7	8.0	23.0	9.3	3.6	5.5	2.0	12.9	4.1	11.7	8.1	15.0	14.2	9.5	9.3	8.3	3.4	14.8	18.3	21.6	5.5	4.1	6.6	6.1	4.6	5.4	4.7	10.3	15.1	4.4	6.7	8.6	9.3	10.9	10.7	23.9	7.5	8.5	3.6	12.5	8.8	15.5	10.0	13.0	12.1	4.2	3.1	6.9	4.4	2.4	5.4	2.1	3.8	1.6	7.8	1.9	5.4	1.4	2.1	1.6	3.6	0.3	0.9	1.8	1.5	7.3	0.2	1.8	0.9	4.7	5.4	6.2	12.6	6.0	4.9	10.1	5.7	6.9	5.0	20.8	75.0	63.8	120.3	62.0	22.9	92.8	17.8	14.7	19.4	8.7	35.3	8.9	0.0	9.0	3.6	66.0	73.5	0.0	6.0	36.7	51.2	79.2	34.7	4.9	43.9	7.9	54.2	36.2	111.7	8.2	11.2	133.8	43.9	41.5	70.2	18.9	15.6	54.7	8.9	1.1	19.9	0.0	68.4	3.6	5.0	52.1	28.6	25.4	34.5	130.7
IFI27L2	"FAM14A, TLH29"	ENSG00000119632	"Interferon alpha inducible protein 27 like 2"	Q9H2X8	14	94127779-94130253	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 57.7"					"Low region specificity"	"Detected in all"			HPA049588			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No			Cytosol	Nucleoli	"HPA049588: "	"unprognostic (9.70e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.76e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.52e-2)"	11.4	39.9	38.6	18.3	23.8	17.0	18.8	15.2	24.7	19.9	16.0	23.5	8.7	11.6	15.8	9.6	24.5	21.9	20.8	38.9	29.7	32.4	13.2	3.7	16.5	21.5	37.1	22.8	25.9	13.2	11.7	20.6	5.4	27.4	10.6	9.7	20.4	7.2	12.5	4.0	16.0	13.5	15.5	35.7	17.0	15.7	9.1	22.9	13.8	8.5	16.0	22.5	12.0	17.2	31.5	29.6	19.8	38.7	6.0	30.5	31.9	8.4	5.9	1.7	12.1	8.7	22.4	1.1	15.9	16.4	12.0	14.1	1.6	3.9	3.7	17.4	17.1	10.6	10.5	1.3	21.1	4.9	25.3	0.9	5.8	5.9	0.5	14.8	6.8	16.0	20.3	7.8	7.1	4.4	20.5	7.9	14.6	0.5	57.7	12.4	15.9	3.9	4.1	2.1	5.6	6.8	0.1	5.6	4.9	18.2	3.3	3.1	4.7	0.4	0.1	10.2	3.3	19.6	11.4	7.7	8.0	4.9	10.7	4.4	23.6	19.5	1.3	25.6	15.2	5.2	19.8	38.7	7.1	25.6	25.9	16.4	31.5	24.4	28.1	29.6	27.4	17.6	23.0	5.7	6.0	18.8	24.6	30.5	31.9	38.6	23.8	15.2	22.8	29.7	32.4	37.1	22.8	27.4	22.9	35.7	60.1	82.7	48.1	82.4	19.9	126.7	48.4	18.7	11.4	169.3	19.6	1.8	150.9	127.6	5.8	62.7	86.6	0.0	26.4	2.5	85.0	7.4	88.9	2.6	167.2	22.3	95.7	122.2	166.9	22.7	169.5	141.7	224.4	80.2	146.1	108.3	55.0	123.8	108.5	51.2	76.6	122.9	100.0	4.5	24.8	58.5	2.4	89.6	75.5	44.4
IMP3	"BRMS2, C15orf12, FLJ10968, MRPS4"	ENSG00000177971	"IMP3, U3 small nucleolar ribonucleoprotein"	Q9NV31	15	75639085-75648706	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060955, HPA061177"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA060955: AB_2684397, HPA061177: AB_2684445"	"unprognostic (6.01e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.04e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.44e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.22e-2)"	21.2	28.4	21.9	23.0	24.0	18.9	34.3	20.1	28.8	19.4	31.0	15.4	17.5	27.5	14.7	24.5	35.6	20.1	25.2	21.7	21.1	19.7	28.2	49.7	21.1	28.5	17.6	19.6	23.0	29.1	12.6	17.3	16.9	16.7	23.3	19.2	17.5	28.3	25.4	37.6	29.3	31.5	11.0	15.5	28.5	25.9	12.4	13.3	33.7	30.0	37.5	27.9	19.6	21.8	40.7	34.0	23.0	31.1	33.3	47.2	48.1	20.4	23.2	11.3	19.5	20.1	11.5	16.7	17.3	13.8	14.2	16.4	17.8	18.1	24.5	18.9	9.0	15.7	34.0	37.1	28.0	12.6	18.4	44.5	25.7	19.1	30.8	14.8	26.0	17.9	10.5	23.2	11.4	14.1	10.6	9.3	20.1	33.1	20.0	12.8	24.6	20.6	63.7	30.3	20.9	24.5	22.5	13.8	26.9	19.2	27.9	19.3	19.9	14.6	25.6	31.4	17.1	22.3	24.3	10.5	18.5	14.9	13.2	23.3	27.4	50.4	27.5	20.4	42.3	12.1	18.5	31.1	23.0	42.0	23.9	45.1	40.7	40.5	40.4	33.4	38.7	47.2	44.5	4.0	33.3	23.0	34.0	38.7	48.1	21.9	24.0	20.1	28.8	21.1	19.7	17.6	19.6	16.7	13.3	35.7	34.5	89.1	67.5	203.1	22.0	11.4	66.2	52.2	52.4	38.4	13.7	88.6	122.7	81.1	1.3	74.4	52.6	23.3	93.2	83.2	66.4	58.7	46.3	101.8	81.8	20.6	42.2	68.2	45.6	4.1	56.4	60.5	92.8	116.4	61.3	53.7	92.0	59.6	41.4	158.4	20.3	25.8	71.8	14.0	43.8	207.5	45.9	74.0	84.6	70.1
INO80B	"hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4"	ENSG00000115274	"INO80 complex subunit B"	Q9C086	2	74455023-74457960	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA070644			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA070644: AB_2732159"	"prognostic favorable (2.89e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.56e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.18e-3)"	18.7	22.4	31.0	20.5	33.4	21.4	22.6	31.3	48.6	23.3	16.2	15.6	24.8	24.0	28.5	23.4	22.6	26.8	21.5	19.7	39.3	20.0	20.3	22.5	18.7	22.5	19.6	32.6	39.8	31.8	36.6	32.3	14.0	38.2	25.6	16.7	15.5	32.1	37.6	28.1	39.7	18.0	20.0	49.6	19.3	22.1	28.3	25.0	21.3	30.0	15.9	24.7	20.6	23.8	4.9	6.5	6.8	5.4	4.4	3.8	1.3	12.8	14.3	3.9	5.7	8.2	13.3	11.9	12.2	9.8	8.4	7.4	9.2	14.2	22.1	15.0	8.0	8.0	13.6	3.7	8.3	8.0	20.8	14.2	16.6	6.7	8.9	8.4	16.1	7.4	12.0	14.7	12.0	14.7	22.8	10.9	11.5	9.3	7.2	7.2	15.4	18.3	21.3	2.8	8.0	19.7	10.7	15.8	20.1	10.2	9.0	7.3	15.3	6.3	16.2	5.4	5.3	5.4	5.1	9.7	6.9	12.5	14.0	8.7	28.5	22.1	8.0	15.3	9.6	7.0	3.9	5.4	2.0	2.7	3.7	3.2	4.8	2.9	1.5	3.1	4.9	2.7	2.3	6.8	4.4	2.8	6.5	3.8	1.3	31.0	33.4	31.3	48.6	39.3	20.0	19.6	32.6	38.2	25.0	0.0	2.1	4.8	2.3	24.8	13.2	0.8	2.5	9.4	4.5	3.5	11.8	3.7	0.0	13.2	1.7	3.1	6.9	0.0	23.3	3.6	3.3	1.2	5.7	8.9	4.9	12.7	4.6	4.3	7.8	5.1	2.8	5.6	5.0	16.2	7.5	4.9	15.7	3.5	2.8	6.8	15.3	0.0	8.0	4.9	2.3	27.7	4.5	6.4	5.5	1.4
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.2;thyroid gland: 71.2"	"Cell type enhanced"	"Detected in many"	11	"Collecting duct cells: 33.2;Enterocytes: 31.9;Muller glia cells: 20.3"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 12.3;SK-BR-3: 26.8;T-47d: 16.9;U-698: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034539			Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA034539: AB_10670974"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favorable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	0.9	4.6	0.8	6.3	0.5	3.7	27.4	13.4	1.5	6.4	0.8	16.7	7.9	1.3	0.8	1.0	1.0	1.0	9.5	7.4	2.0	9.5	0.5	1.5	0.7	2.3	4.6	0.8	5.3	65.2	3.7	0.5	5.5	3.5	2.2	5.6	15.5	19.2	1.6	1.7	21.7	1.2	0.9	0.6	3.8	1.6	1.1	0.0	71.2	0.0	0.7	1.1	0.9	0.3	2.4	0.0	0.4	0.0	0.0	0.2	1.3	1.3	0.8	1.5	0.2	0.2	0.7	0.5	0.5	2.7	2.6	0.8	0.8	0.0	0.6	0.2	0.3	1.6	1.6	0.7	1.1	0.0	4.3	0.0	5.6	0.2	0.5	12.3	0.1	0.1	0.8	2.2	0.2	1.8	0.1	0.0	1.1	1.9	0.0	4.1	0.1	0.0	1.5	1.7	0.2	0.0	0.3	2.9	1.1	1.6	6.5	4.9	1.0	26.8	0.3	0.7	16.9	1.0	0.0	0.1	4.9	0.5	0.3	0.0	2.1	11.6	0.4	0.0	2.0	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.2	4.6	6.3	27.4	13.4	7.4	2.0	2.3	4.6	5.5	1.1	0.0	2.6	0.0	2.3	0.8	7.9	4.8	0.0	0.0	1.2	33.2	0.0	0.0	10.0	1.2	0.3	0.0	31.9	0.0	1.9	0.1	0.2	3.7	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	5.0	20.3	1.0	10.5	0.0	0.6	2.3	0.0	0.3	1.7	0.9	1.1	0.1	0.0	6.8	0.9
INTS3	"C1orf60, FLJ21919, INT3, SOSS-A"	ENSG00000143624	"Integrator complex subunit 3"	Q68E01	1	153728067-153774808	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074391	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			Nucleoli	Nucleoplasm	"HPA074391: AB_2686685"	"unprognostic (2.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (6.97e-3)"	"unprognostic (3.26e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.29e-2)"	16.2	21.9	18.8	14.4	20.0	12.0	16.3	20.7	23.1	20.4	19.9	19.5	25.1	10.0	24.4	23.7	14.3	26.7	20.5	15.3	16.0	10.6	17.9	11.1	16.6	12.6	15.9	16.4	30.8	17.5	23.6	23.6	16.5	15.6	15.9	11.4	16.1	14.0	31.0	16.2	16.9	14.7	21.2	13.4	15.4	17.6	16.5	16.0	16.2	18.6	9.2	14.1	19.9	18.8	1.8	3.8	2.7	6.2	2.7	2.5	1.5	13.2	13.9	10.1	14.5	11.5	13.0	10.3	10.1	7.3	12.1	9.8	9.7	12.6	11.5	20.3	13.3	7.2	13.5	19.3	13.0	9.9	12.1	11.3	7.2	21.2	4.6	7.8	10.7	13.0	11.7	6.5	10.4	9.5	11.0	11.6	8.6	10.1	9.4	9.3	10.8	10.0	5.7	12.4	15.3	12.9	13.6	5.7	7.4	6.2	17.4	8.0	11.7	9.6	23.2	6.4	14.7	13.4	14.5	8.5	12.0	5.2	11.8	9.1	8.4	7.7	12.7	13.1	6.6	8.3	1.3	1.8	2.0	2.1	1.4	2.5	1.3	1.3	2.0	3.8	1.8	1.4	1.5	2.7	2.7	6.2	0.8	1.3	1.5	18.8	20.0	20.7	23.1	16.0	10.6	15.9	16.4	15.6	16.0	20.8	21.4	8.8	8.7	9.3	22.5	4.0	10.2	13.4	10.3	29.6	19.6	11.5	0.0	10.1	12.1	12.6	8.1	0.0	7.1	11.7	11.9	9.9	5.7	13.6	10.7	20.6	11.6	27.0	11.8	5.9	8.9	14.3	6.8	13.6	16.1	19.3	9.6	10.8	11.3	12.4	23.9	25.8	9.0	9.3	13.0	8.9	8.6	7.7	12.2	11.2
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751662	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 101.3;Alveolar cells type 2: 59.1;Basal keratinocytes: 179.6;Suprabasal keratinocytes: 114.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 40.5;BEWO: 24.3;HaCaT: 13.8;hTCEpi: 26.6;SK-BR-3: 16.3"	"Group enriched"	"Detected in many"	5	"midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3"	"Low region specificity"	"Detected in all"			"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	2.4	0.1	0.8	0.1	2.8	0.1	27.9	8.4	1.7	0.4	0.7	0.7	4.4	0.1	0.1	2.5	3.1	0.2	0.1	2.1	1.9	1.7	14.3	0.1	32.8	0.3	3.9	0.2	0.1	1.9	2.7	1.4	9.0	36.9	3.9	0.3	1.8	26.6	1.4	0.3	17.7	0.1	0.1	4.8	0.1	8.7	3.1	2.2	0.0	1.4	3.1	3.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	40.5	0.0	2.2	1.6	24.3	2.4	1.3	2.0	1.6	4.8	0.0	0.0	0.0	4.5	0.0	13.8	0.0	9.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	26.6	0.9	8.2	0.0	0.0	0.0	0.0	0.0	1.4	7.8	0.0	0.0	4.5	10.5	0.0	0.0	2.5	0.0	9.0	0.0	1.5	0.0	7.9	16.3	0.0	6.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	8.4	0.5	1.9	1.7	3.9	0.2	36.9	2.2	101.3	59.1	0.0	14.0	179.6	0.5	2.4	0.0	10.7	30.7	7.0	0.0	23.0	23.2	0.1	3.9	0.5	0.5	0.0	0.0	17.1	12.8	15.9	1.1	0.0	2.8	0.0	0.0	0.0	0.0	8.9	0.0	1.3	18.6	0.0	1.5	0.2	0.5	1.9	0.0	0.5	2.4	0.0	16.9	0.7	3.8	114.7	12.7	0.0	1.9	9.2
JADE3	"JADE-3, KIAA0215, PHF16"	ENSG00000102221	"Jade family PHD finger 3"	Q92613	X	46912276-47061242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatogonia: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 4.8;naive B-cell: 3.7;plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	9	"B-cells: 4.8;dendritic cells: 1.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 36.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006007, HPA064697"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA006007: AB_1079605, HPA064697: AB_2685326"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-3)"	"unprognostic (4.55e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.18e-2)"	"unprognostic (9.70e-2)"	4.9	12.6	3.5	2.7	5.1	1.5	6.2	3.3	4.9	5.7	4.5	7.1	14.0	1.9	9.5	16.3	4.7	4.3	3.2	5.2	3.9	3.3	3.7	7.7	4.3	4.1	9.2	1.4	7.2	8.7	3.0	2.1	15.9	4.7	5.4	3.2	2.1	4.3	12.2	3.3	3.8	3.5	6.0	8.5	9.8	4.7	14.5	8.4	8.4	4.2	1.4	7.5	7.6	13.1	4.8	1.7	0.0	0.3	0.2	0.2	0.4	6.4	5.8	9.5	6.5	3.5	2.6	36.4	3.8	3.2	4.3	4.9	6.6	5.6	0.0	2.7	2.8	6.4	2.5	11.5	3.1	6.3	17.1	7.5	5.1	6.5	6.4	5.7	3.8	2.7	2.0	4.3	3.0	9.9	2.6	8.1	9.8	3.5	3.0	3.3	6.6	13.8	4.6	7.4	4.1	4.9	14.2	10.7	8.9	3.6	5.9	8.2	7.3	11.0	10.2	6.0	16.4	6.8	4.0	5.0	4.6	8.0	6.4	2.5	2.3	2.0	12.2	1.2	3.3	4.4	0.0	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.1	3.7	0.0	0.0	0.0	0.2	0.3	1.7	0.0	0.4	3.5	5.1	3.3	4.9	3.9	3.3	9.2	1.4	4.7	8.4	0.0	8.5	0.5	2.3	3.8	1.5	3.3	2.5	0.0	1.2	5.2	0.0	7.9	0.0	2.1	0.3	4.5	0.9	0.0	3.2	8.1	2.2	3.8	0.0	11.1	1.5	0.0	8.1	3.7	1.2	2.0	4.4	0.8	3.3	4.6	1.9	1.2	2.9	0.0	3.5	2.1	1.6	6.5	1.9	9.2	26.6	7.0	11.9	0.5	2.3	3.3
KCNC4	"C1orf30, HKSHIIIC, Kv3.4"	ENSG00000116396	"Potassium voltage-gated channel subfamily C member 4"	Q03721	1	110211343-110283100	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 39.3;Ito cells: 63.3;Rod photoreceptor cells: 44.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.5;U-87 MG: 14.7;WM-115: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014740			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA014740: AB_1855580"	"unprognostic (9.16e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.25e-2)"	2.3	4.7	12.1	1.6	3.2	0.7	3.3	9.2	12.7	1.9	1.4	1.9	1.1	0.8	4.5	3.1	2.1	3.7	4.8	4.5	9.1	14.2	5.1	1.1	3.0	1.9	6.8	2.0	3.4	4.3	11.2	3.8	2.8	14.3	2.4	1.3	4.7	7.1	3.7	4.5	4.0	2.0	2.6	3.6	3.3	2.8	2.2	1.1	7.2	2.3	7.8	2.3	1.2	1.5	0.8	0.7	0.9	0.4	0.3	1.5	0.1	1.9	1.5	0.4	2.9	1.1	0.3	3.5	8.5	1.5	0.6	0.8	4.8	0.9	3.3	3.4	3.1	2.6	3.2	1.4	0.7	0.4	16.5	1.6	0.1	3.3	0.7	0.5	2.7	0.8	0.3	0.3	1.9	0.2	0.5	4.4	1.8	0.6	1.4	0.0	0.4	1.8	0.6	1.7	0.7	3.9	2.7	0.1	0.5	4.1	0.1	0.6	0.8	0.4	8.3	0.8	2.7	1.1	1.4	1.6	1.1	4.0	0.7	0.3	2.1	1.9	0.6	14.7	2.3	9.5	0.8	0.4	0.2	0.5	0.2	1.5	0.6	0.9	0.4	0.0	0.8	1.3	0.5	0.9	0.3	0.3	0.7	0.4	0.1	12.1	3.2	9.2	12.7	9.1	14.2	6.8	2.0	14.3	1.1	0.0	1.4	0.0	12.5	2.9	1.4	6.7	7.6	4.0	2.3	3.5	39.3	0.3	0.0	5.0	0.3	9.8	2.2	0.0	14.8	0.3	2.4	7.4	1.1	0.5	1.2	3.2	12.7	63.3	3.1	0.4	1.4	0.5	1.7	1.8	5.7	3.7	8.7	6.6	3.9	0.5	44.8	25.8	5.1	0.0	5.7	2.6	0.9	1.3	8.3	10.3
KCTD6	"KCASH3, MGC27385"	ENSG00000168301	"Potassium channel tetramerization domain containing 6"	Q8NC69	3	58492114-58502360	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036100, HPA036101"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA036100: AB_10673230, HPA036101: AB_2674941"	"unprognostic (8.63e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.00e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.67e-3)"	"unprognostic (9.36e-3)"	"unprognostic (7.48e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.44e-2)"	7.8	8.4	15.3	4.4	13.2	13.5	11.4	35.9	21.8	11.1	7.9	10.0	6.4	5.6	12.3	28.8	10.9	12.4	8.8	7.7	16.9	11.7	15.4	12.2	6.6	9.1	15.3	10.5	13.1	7.1	10.4	14.4	10.9	11.9	9.2	8.1	14.7	7.3	9.4	6.8	7.5	5.3	11.2	12.5	8.8	5.7	5.7	12.4	6.3	14.1	6.3	7.3	6.4	11.9	13.0	20.2	17.1	14.6	8.2	15.6	6.6	5.5	5.3	15.9	6.8	14.0	10.0	5.9	6.7	6.0	9.9	11.7	5.1	3.1	11.0	2.2	4.8	11.7	3.0	12.8	3.9	8.9	11.3	5.8	5.1	12.1	6.3	6.6	4.0	4.1	6.0	6.2	7.9	5.0	23.6	6.5	3.9	2.8	5.3	8.6	5.2	5.9	6.1	11.7	5.0	10.1	5.9	4.4	7.7	9.4	2.6	9.0	7.8	3.8	8.8	4.8	12.7	35.4	2.9	3.5	9.1	8.2	11.6	10.0	5.8	8.9	13.0	7.8	8.2	6.9	17.1	14.6	9.8	13.7	14.6	15.6	13.0	10.1	12.8	20.2	10.3	11.5	9.8	5.0	8.2	10.5	7.8	9.5	6.6	15.3	13.2	35.9	16.2	16.9	11.7	15.3	10.5	11.9	12.4	3.0	2.4	0.9	10.6	7.9	14.6	7.5	7.6	5.3	10.3	8.7	23.6	8.7	16.6	7.1	3.7	9.0	2.1	0.0	3.7	6.3	12.4	5.1	0.0	4.7	6.2	23.8	8.7	4.9	10.3	1.7	10.0	7.2	11.8	4.6	4.2	19.3	3.3	5.5	11.3	24.5	17.9	0.0	12.0	5.6	20.7	8.8	7.3	0.0	7.0	3.0
KDM7A	"JHDM1D, KIAA1718"	ENSG00000006459	"Lysine demethylase 7A"	Q6ZMT4	7	140084746-140177035	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012114	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA012114: AB_1852429"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.18e-1)"	20.1	3.2	6.6	15.2	4.7	18.7	10.4	8.7	6.1	13.2	12.0	4.7	4.6	10.3	8.9	5.8	13.0	5.8	6.0	8.0	5.7	3.5	4.9	8.5	9.7	10.1	4.8	2.8	5.0	6.4	7.0	6.7	15.5	6.7	6.9	12.2	3.7	11.4	4.5	24.6	15.0	16.3	9.3	6.0	6.7	11.9	9.4	5.9	10.8	6.4	10.3	15.2	13.1	9.1	2.8	3.0	6.1	2.3	1.8	1.6	0.8	0.9	0.4	2.9	3.1	2.7	2.3	5.9	1.3	1.9	0.5	0.6	0.3	0.4	2.0	2.0	1.3	1.6	1.1	4.1	2.5	0.9	11.3	2.5	0.1	0.4	5.3	2.7	1.9	2.1	2.7	5.6	1.6	8.8	1.4	2.8	5.4	6.4	8.9	0.5	0.8	3.5	3.1	4.7	6.5	1.6	4.0	0.2	4.0	1.0	1.2	5.2	6.3	3.0	7.0	3.0	4.9	9.6	0.7	4.9	0.6	1.1	1.9	0.8	3.1	0.4	6.6	1.6	5.2	1.1	1.6	2.3	0.9	1.1	1.3	0.9	1.5	1.6	1.5	3.0	2.8	1.5	1.0	6.1	1.8	0.5	1.2	1.3	0.8	6.6	4.7	8.7	6.1	5.7	3.5	4.8	2.8	6.7	5.9	14.9	27.5	13.2	37.9	44.3	12.4	12.1	10.2	26.8	25.0	15.7	25.5	7.1	1.7	6.4	4.1	20.3	28.2	23.3	8.2	2.5	15.4	28.1	8.1	16.9	9.7	6.4	50.6	24.5	36.3	3.4	7.2	33.7	3.3	3.6	38.6	3.7	10.2	26.8	3.9	2.6	9.5	6.5	17.6	24.7	10.0	40.7	31.7	13.1	21.9	43.9
KIAA0319L	"AAVR, KIAA1837"	ENSG00000142687	"KIAA0319 like"	Q8IZA0	1	35433490-35557950	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 27.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072692	Supported		Supported	"Nucleoli,Golgi apparatus"		NA	NA		870000	"Golgi apparatus"	Nucleoli	"HPA072692: AB_2686549"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-1)"	10.6	23.5	20.3	10.6	29.0	9.9	20.1	21.9	37.2	19.2	17.7	24.1	17.0	18.1	19.7	19.2	14.4	25.1	15.7	30.7	19.4	20.0	27.5	32.1	21.3	11.0	19.4	20.1	13.0	32.8	38.5	28.1	21.1	23.0	25.3	21.3	24.5	33.9	20.5	27.4	13.8	19.8	12.7	16.6	17.1	23.3	14.0	17.5	11.9	29.3	11.9	17.4	12.9	12.0	2.3	3.2	27.1	11.0	5.5	3.5	4.5	5.4	8.1	16.9	13.3	23.0	16.2	16.1	7.4	15.9	10.9	16.2	8.7	22.2	6.1	20.6	8.1	16.3	10.9	12.5	12.0	12.5	9.7	9.1	8.3	9.9	9.6	18.0	6.8	11.4	22.8	15.5	12.5	16.4	36.2	17.7	7.6	10.8	8.9	14.7	5.5	4.0	5.8	19.2	15.3	4.9	4.6	14.4	7.6	18.0	13.4	3.7	10.5	10.8	13.0	22.2	38.9	13.6	9.7	18.1	7.5	8.1	6.3	11.5	13.3	10.6	4.0	19.1	9.0	7.4	4.5	11.0	5.0	3.0	3.6	2.9	2.0	2.5	2.8	3.2	2.3	3.5	2.5	27.1	5.5	2.2	2.1	2.3	4.5	20.3	29.0	21.9	37.2	19.4	20.0	19.4	20.1	23.0	17.5	68.5	67.8	11.2	13.5	7.0	71.9	47.3	48.4	52.2	52.4	33.2	102.1	26.5	3.3	15.2	7.8	22.2	31.6	0.0	28.2	18.9	16.7	25.7	20.8	40.4	16.3	60.4	20.7	21.5	29.5	4.9	16.1	17.1	13.5	11.8	53.3	28.9	26.4	24.6	16.3	17.3	62.2	6.5	8.2	21.2	17.7	8.2	26.1	17.3	28.1	10.8
KIAA1841		ENSG00000162929	KIAA1841	Q6NSI8	2	61065871-61138034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 69.6;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051240	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051240: AB_2681401"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.71e-8)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.85e-6)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	5.1	3.6	9.8	3.9	8.9	2.3	4.3	13.3	12.4	10.0	7.1	7.0	1.0	5.5	4.4	6.8	3.8	7.5	3.6	5.2	9.6	11.6	2.6	2.3	8.0	3.2	8.8	12.1	2.4	3.6	3.9	8.2	3.5	20.6	9.6	8.3	3.6	3.6	3.1	3.7	8.5	5.9	5.4	10.1	3.3	5.6	7.5	6.2	3.3	4.0	2.7	3.5	4.3	3.7	1.5	1.2	4.8	2.5	1.4	3.7	0.6	4.6	9.0	11.8	5.1	6.8	7.7	3.7	8.9	2.2	4.6	4.3	2.7	3.0	1.9	2.4	6.8	9.5	5.9	7.5	3.0	6.5	8.1	1.8	1.7	6.2	7.5	3.7	2.1	1.7	3.6	4.9	8.3	2.9	5.3	6.4	2.7	1.7	1.5	12.8	0.4	1.8	1.4	3.7	5.4	1.8	6.0	9.7	0.4	5.8	9.5	7.0	4.4	10.7	2.4	3.2	9.2	1.8	2.5	8.4	7.5	2.8	6.0	6.0	0.8	2.4	2.8	5.4	1.5	5.1	0.8	1.4	4.8	1.3	1.5	1.2	1.5	1.2	0.6	1.2	0.6	0.2	1.0	3.0	1.4	2.5	0.8	3.7	0.6	9.8	8.9	13.3	12.4	9.6	11.6	8.8	12.1	20.6	6.2	6.0	4.3	0.0	2.9	2.3	12.4	6.5	2.5	69.6	15.9	3.5	53.0	0.9	0.0	3.1	2.4	3.8	5.1	0.0	5.4	2.2	6.6	4.4	1.1	1.0	5.0	7.9	7.5	5.5	4.0	1.7	3.4	4.2	3.3	9.0	4.3	4.8	7.6	7.0	1.8	0.5	45.8	0.0	3.6	10.4	19.2	2.9	0.3	2.2	4.5	2.6
KLLN	killin	ENSG00000227268	"Killin, p53 regulated DNA replication inhibitor"	B2CW77	10	87859161-87863437	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 6.3;skeletal muscle: 7.4"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 5.7;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 8.1;Karpas-707: 8.4"					"Low region specificity"	"Detected in many"			HPA074502			Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA074502: AB_2686695"	"unprognostic (4.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.79e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.02e-4)"	"unprognostic (1.60e-1)"	1.7	1.5	1.2	0.8	1.9	0.6	1.4	2.0	1.4	1.3	1.6			0.7	1.2	2.0	0.6	2.9	0.6	0.7	1.0	1.8	1.7	1.7	0.5	1.3	1.1		0.7	0.6	1.3	1.9	0.9		0.6	1.6		0.4	0.8	7.4	0.4	0.7	0.8	0.9	1.7	0.9	2.4			1.3		1.4	0.9	0.9	1.7	1.4	6.3	1.6	1.7	1.2	0.5	1.4	1.6	1.9	1.4	1.0	0.6	1.5	1.2	1.5	0.9	1.2	0.9	4.3	3.3	0.6	0.5	0.9	1.6	1.2	1.3	0.6	0.8	0.5	1.1	2.5	1.0	1.1	2.4	0.9	1.1	1.4	1.1	1.5	1.6	0.5	8.1	0.7	8.4	0.9	2.8	6.4	2.6	0.8	1.0	0.8	4.2	0.3	4.1	0.8	1.4	0.8	1.6	1.4	1.1	0.2	1.4	2.7	1.9	0.5	1.0	0.5	1.6	0.6	4.9	5.0	4.7	1.7	4.7	1.0	3.1	1.0	1.5	0.7	1.4	1.1	1.2	0.9	0.9	0.8	1.7	1.2	1.1	6.3	1.7	1.6	1.4	0.7	0.5											0.0	0.0	0.0	0.1	0.1	1.5	2.0	0.0	2.7	2.3	0.0	0.0	0.6	0.0	0.2	2.7	0.5	1.6	0.0	0.2	0.3	0.5	0.2	5.7	0.4	0.3	3.2	0.0	0.6	0.3	1.1	0.0	0.0	0.0	0.0	1.6	2.4	0.2	0.9	0.0	1.3	1.1	6.5	0.5	0.2	1.4	0.4	0.5	0.0	1.0	0.1
KRCC1	FLJ22333	ENSG00000172086	"Lysine rich coiled-coil 1"	Q9NPI7	2	88027205-88055729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA045618, HPA052666"	Approved		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA045618: AB_10960406, HPA052666: AB_2681907"	"unprognostic (7.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-3)"	22.5	15.0	23.1	30.6	27.3	5.7	25.9	23.5	20.4	23.3	29.9	15.8	19.9	20.7	17.8	29.1	26.4	18.4	16.5	21.4	27.0	15.7	21.5	28.1	23.4	22.3	30.3	15.2	20.3	19.4	24.8	23.8	17.3	23.8	24.0	29.7	12.1	20.8	37.9	23.0	16.7	28.9	24.7	28.2	22.0	17.5	10.0	29.9	20.2	26.9	14.5	20.5	22.1	20.2	18.3	12.7	37.2	11.6	14.8	16.5	8.0	11.5	7.1	11.2	8.2	27.1	32.1	8.3	18.3	20.5	9.8	9.7	0.6	15.6	16.4	6.6	11.6	15.0	6.0	2.5	3.8	11.1	17.2	3.5	3.1	1.9	1.1	19.8	4.7	2.2	16.0	19.1	6.5	14.1	25.7	11.0	13.3	4.4	8.2	21.1	9.8	5.4	6.6	8.5	16.8	4.8	11.1	2.0	1.7	14.8	6.3	8.7	8.8	7.0	9.7	21.3	8.7	6.8	19.6	15.3	11.7	0.8	19.1	5.7	18.7	13.0	13.1	12.5	12.7	27.4	24.7	11.0	37.2	10.1	11.6	11.7	18.3	12.4	12.3	12.7	16.9	14.2	11.2	17.9	14.8	10.0	11.2	16.5	8.0	23.1	27.3	23.5	20.4	27.0	15.7	30.3	15.2	23.8	29.9	32.8	32.4	29.1	30.1	29.3	9.3	36.0	35.7	69.6	47.8	33.2	2.0	40.4	51.4	41.9	2.6	25.4	58.0	0.0	62.9	15.7	37.7	49.3	41.6	47.4	42.5	9.5	40.0	35.6	34.9	3.1	44.3	35.7	27.0	47.7	57.8	33.8	42.5	69.1	40.7	60.7	5.4	19.4	29.2	38.7	19.0	37.3	35.0	34.6	65.3	23.8
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1, regulator of NFKB signaling"	O95751	X	141175745-141177125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 36.5;Peritubular cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 29.8;MCF7: 40.1;PC-3: 50.3;U-251 MG: 29.9"	"Region enriched"	"Detected in many"	5	"cerebellum: 21.5"	"Low region specificity"	"Detected in all"			"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051768: AB_2681599, HPA061842: AB_2684624"	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	21.1	24.2	24.4	5.9	31.8	2.0	9.9	18.3	51.2	24.2	5.5	21.0	11.0	5.1	17.3	12.1	10.0	30.3	10.4	6.7	27.3	25.6	15.6	3.1	9.7	5.5	23.2	23.3	31.8	18.3	13.0	54.9	1.8	30.2	23.1	3.5	13.5	47.9	36.4	3.8	17.9	5.2	12.5	19.5	9.3	7.8	6.6	16.6	1.8	22.6	3.7	5.7	11.2	9.9	8.2	4.8	8.2	0.0	19.2	8.9	3.0	0.0	29.8	4.6	12.8	8.0	9.8	0.0	7.1	8.8	9.7	13.6	0.0	11.7	0.0	5.6	11.6	9.6	14.0	5.0	10.4	6.9	0.0	9.2	0.0	16.1	0.0	3.1	0.0	2.8	17.3	5.4	8.4	4.5	7.8	8.2	0.0	0.2	0.0	8.7	40.1	0.0	0.0	4.8	0.0	50.3	0.0	4.1	0.0	11.9	7.0	0.0	4.0	0.0	6.2	0.0	2.6	7.9	0.0	14.8	0.0	9.6	0.0	29.9	0.0	0.0	0.0	5.0	0.0	0.0	8.2	0.0	0.1	4.3	0.0	3.1	3.3	8.9	3.3	0.8	8.2	7.9	5.1	0.2	19.2	0.0	4.8	8.1	3.0	24.4	31.8	18.3	47.4	27.3	25.6	23.2	23.3	30.2	16.6	0.0	4.0	0.0	15.7	5.4	25.2	1.6	22.9	5.3	10.3	22.7	7.9	1.9	36.5	12.0	0.5	11.3	0.0	0.0	12.3	1.6	11.7	14.6	2.3	0.0	0.8	19.1	5.2	11.1	0.8	0.9	20.4	1.6	3.3	0.0	0.2	20.6	11.6	0.0	36.4	26.8	9.6	12.9	19.4	0.9	7.7	5.9	1.3	5.7	0.0	14.0
LEKR1	FLJ16641	ENSG00000197980	"Leucine, glutamate and lysine rich 1"	Q6ZMV7	3	156825481-157046129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 29.8"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 34.8;Early spermatids: 63.2;Late spermatids: 32.2;Spermatocytes: 49.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 6.6;U-266/70: 6.2"	"Low region specificity"	"Detected in all"							"HPA044039, HPA047774"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA044039: AB_10794288, HPA047774: "	"unprognostic (5.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.80e-2)"	1.4	1.7	1.4	2.5	4.6	0.6	2.7	1.4	2.2	1.5	1.0	1.6	3.5	1.7	1.3	8.2	0.9	6.3	1.7	1.4	1.5	2.0	2.8	1.3	3.0	1.6	1.1	1.4	2.9	2.7	4.8	4.5	0.5	2.2	1.7	1.1	2.5	1.6	4.9	0.7	0.9	1.6	0.8	1.9	1.8	1.5	29.8	0.7	4.4	4.0	0.7	1.4	1.2	1.8	3.2	1.9	2.5	0.3	2.5	2.0	0.4	6.6	2.7	0.1	1.6	1.2	0.6	0.4	0.4	1.0	1.4	1.1	0.3	3.8	0.1	2.0	1.1	2.6	2.5	0.0	0.5	2.7	1.2	0.6	2.5	0.5	0.0	0.0	2.1	0.6	3.1	1.6	0.5	1.9	0.8	0.6	0.1	1.5	1.6	2.4	2.4	0.0	1.9	2.2	1.9	1.5	0.0	1.8	1.5	2.1	0.6	4.2	1.7	2.2	1.5	0.1	0.5	4.6	3.6	0.0	0.4	0.7	0.5	1.0	6.2	1.0	0.0	1.2	1.5	2.3	2.5	0.3	0.3	0.7	0.1	1.4	3.1	1.6	0.6	1.2	3.2	1.8	0.9	0.3	2.5	0.2	1.9	2.0	0.4	1.4	4.6	1.4	2.2	1.5	2.0	1.1	1.4	2.2	0.7	0.0	1.4	0.0	1.1	1.1	1.3	0.8	2.5	34.8	3.4	3.5	2.0	0.2	3.3	0.6	63.2	0.4	1.3	0.0	1.4	0.1	0.5	0.7	1.1	1.6	0.2	3.2	0.0	0.0	1.8	32.2	1.4	1.1	1.7	1.8	0.6	1.4	0.7	0.0	1.8	3.3	4.5	0.0	0.3	49.4	3.2	0.6	0.1	1.3	0.8	0.8
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205457091	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.1;testis: 34.8"	"Group enriched"	"Detected in some"	129	"Early spermatids: 869.0;Late spermatids: 3077.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in some"	13	"cerebellum: 2.6;pons and medulla: 5.3"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 29.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045425			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.26e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.2	0.2	0.2	0.0	0.3	0.0	0.3	2.6	0.2	0.4	1.4	0.0	3.8	0.6	1.0	13.1	1.0	1.5	0.7	0.2	0.2	0.3	0.9	0.2	0.4	0.0	0.3	0.0	0.6	0.6	0.0	0.6	4.7	5.3	0.3	0.0	0.3	3.2	0.4	0.2	0.3	1.4	0.1	0.2	0.2	0.3	34.8	0.0	0.0	4.8	2.2	2.6	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.7	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	29.9	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.9	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.3	2.6	0.2	0.2	0.3	0.3	0.0	5.3	0.0	0.0	1.6	0.0	1.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.4	869.0	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3077.5	11.8	0.0	0.0	0.0	0.0	0.9	4.0	0.0	13.1	1.5	0.7	6.5	0.0	15.3	7.2	0.0	0.3	0.0	0.0	2.2
LEUTX		ENSG00000213921	"Leucine twenty homeobox"	A8MZ59	19	39776595-39786167	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 1.0;HDLM-2: 2.3"									HPA041498	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041498: AB_10796346"															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.6		0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LLPH	"C12orf31, hLLP, MGC14817"	ENSG00000139233	"LLP homolog, long-term synaptic facilitation"	Q9BRT6	12	66116555-66130768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048920, HPA058786"			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Mitotic chromosome"	"HPA048920: AB_2680556, HPA058786: AB_2683820"	"unprognostic (3.60e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (6.44e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.94e-2)"	20.4	38.1	16.4	20.4	16.9	40.9	17.9	10.9	20.0	16.4	20.2	11.2	19.7	16.4	17.2	17.1	21.3	14.4	13.4	19.9	15.7	13.9	27.8	31.3	14.5	21.4	20.6	16.7	18.2	16.2	11.1	18.0	24.3	17.3	18.1	18.6	9.9	15.9	14.5	47.3	13.9	27.9	21.0	26.7	29.7	18.6	20.0	17.6	23.8	22.9	23.5	21.6	23.6	22.4	23.6	24.6	34.9	34.7	20.0	29.4	21.1	27.2	22.1	13.6	16.8	15.9	15.7	16.8	32.0	20.7	23.8	20.2	19.1	11.6	31.7	26.4	21.2	18.8	23.4	21.2	19.4	32.3	27.7	18.2	33.5	16.0	17.0	19.2	58.2	23.6	15.8	20.1	20.2	21.8	18.7	20.5	16.1	28.9	22.8	27.8	29.3	26.0	39.2	29.2	22.3	23.5	22.1	25.1	22.8	23.3	33.0	13.7	16.9	20.7	22.1	33.7	15.0	28.4	31.8	22.1	18.7	26.8	22.7	29.0	17.7	27.4	46.9	24.4	27.4	28.3	22.2	25.6	26.4	23.7	29.0	27.0	23.6	27.6	25.5	24.6	21.7	23.9	25.2	34.9	20.0	34.7	21.2	29.4	21.1	16.4	16.9	10.9	20.0	15.7	13.9	20.6	16.7	17.3	17.6	11.9	36.4	61.0	44.6	24.2	16.2	20.7	50.9	30.8	53.4	29.6	3.9	54.4	56.3	64.5	29.5	27.6	32.9	0.0	61.6	55.9	32.7	30.8	87.7	53.9	56.6	20.6	13.3	33.2	50.4	10.0	40.6	51.5	33.7	79.4	24.4	25.7	76.7	34.5	28.3	61.5	14.5	25.8	23.6	77.7	46.2	26.7	60.8	41.5	28.5	46.2
LRCH2	KIAA1495	ENSG00000130224	"Leucine rich repeats and calponin homology domain containing 2"	Q5VUJ6	X	115110616-115234072	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 10.5;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;hTERT-RPE1: 9.1;U-266/70: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003233	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA			Nucleoli	"Plasma membrane"	"HPA003233: AB_2265929"	"unprognostic (9.74e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.09e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.16e-2)"	5.1	8.7	11.6	3.4	10.2	0.7	3.3	11.2	10.6	11.2	11.6	5.5	4.0	1.6	9.9	4.5	3.6	4.6	5.3	4.7	7.9	8.9	2.6	1.0	5.7	1.8	5.7	4.6	13.8	1.6	1.3	20.9	13.7	7.6	16.4	4.2	2.5	1.3	14.5	1.2	1.1	3.2	13.7	6.4	3.7	3.6	4.3	7.9	0.0	4.8	0.4	1.1	11.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	3.9	5.5	4.6	0.0	3.5	7.6	3.4	7.9	0.0	0.0	0.1	0.0	4.6	2.7	0.3	17.8	0.0	5.2	0.0	4.8	0.0	0.0	0.0	4.4	0.0	0.1	2.7	0.0	1.4	0.2	9.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	5.2	0.0	3.8	0.0	4.3	0.5	0.0	6.8	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	2.1	0.0	4.9	11.8	2.0	0.0	1.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	10.2	11.2	8.4	7.9	8.9	5.7	4.6	7.6	7.9	3.0	10.5	0.0	0.0	0.6	6.7	5.5	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.0	5.7	4.5	0.0	0.0	0.0	0.1	5.4	1.2	0.0	0.0	0.5	1.6	0.0	1.8	0.0	1.5	8.1	0.0	1.7	0.0	0.0	6.6	0.0	0.0	6.0	0.0	2.4	25.8	7.1	3.6	3.0	0.1	0.2	0.0	0.0	0.0
LRP10	"DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087"	ENSG00000197324	"LDL receptor related protein 10"	Q7Z4F1	14	22871613-22881580	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 29.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000932			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA000932: AB_2281523"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (3.54e-7)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.55e-2)"	"prognostic favorable (6.31e-5)"	"unprognostic (3.06e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.14e-2)"	33.1	20.1	12.7	26.0	13.1	23.7	37.2	5.8	10.3	32.0	52.4	16.2	41.0	31.7	39.0	46.8	66.1	27.1	65.1	27.7	13.6	6.0	46.5	63.3	34.1	30.0	14.2	8.1	30.7	36.6	31.4	11.7	32.0	14.4	36.9	19.0	22.6	36.1	41.1	21.2	32.9	65.9	32.0	11.2	26.1	37.9	19.1	12.9	20.7	46.9	34.1	36.2	43.3	42.8	3.8	2.3	29.7	2.6	2.4	6.3	3.4	15.4	18.9	4.1	10.8	56.7	32.9	14.1	24.5	46.6	15.5	21.5	5.8	55.1	8.1	12.3	55.1	17.7	22.2	2.7	28.0	6.1	13.2	2.9	2.8	10.4	4.0	25.3	6.4	25.9	35.9	32.8	23.1	12.0	43.0	28.2	3.7	3.4	31.4	20.8	17.8	1.8	1.9	0.9	15.0	25.5	4.1	4.2	8.1	16.6	27.6	0.3	4.5	13.5	26.0	10.6	3.2	13.6	4.6	29.3	23.9	6.8	12.3	10.0	14.7	8.7	3.7	12.3	2.6	10.2	5.9	2.2	15.8	5.1	2.3	5.0	3.8	6.3	6.0	2.3	2.7	5.5	3.1	29.7	2.4	2.6	1.9	6.0	3.4	12.7	13.1	5.8	10.3	13.6	6.0	14.2	8.1	14.4	12.9	98.3	51.7	60.9	74.0	34.2	2.2	27.2	107.0	37.5	59.1	78.5	0.0	55.7	8.3	146.7	9.9	50.6	243.0	46.7	208.6	82.1	65.3	100.3	34.6	35.4	52.6	0.0	63.9	69.3	49.2	11.4	52.6	36.1	52.3	101.0	99.6	89.2	227.5	199.9	68.6	40.8	8.3	64.7	65.9	2.6	6.7	41.5	110.6	62.3	73.3	132.4
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508800-61511018	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	7	"brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 20.1;Muller glia cells: 7.8;Sertoli cells: 19.4;Smooth muscle cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 27.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 12.2;RH-30: 13.2;SCLC-21H: 6.8"	"Region enriched"	"Detected in many"	7	"basal ganglia: 202.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 39.3;hippocampal formation: 35.0"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoplasm	Nucleoli	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	2.4	1.6	4.8	0.9	27.8	0.5	1.9	0.2	5.8	3.4	1.6	1.2	1.0	0.9	2.2	3.7	1.1	36.2	0.8	1.2	5.2	1.9	0.9	0.6	3.7	0.5	1.1	4.3	3.0	1.5	2.1	14.8	1.2	1.2	0.9	1.0	0.0	1.1	1.2	0.7	0.5	0.9	2.5	0.2	0.6	1.0	2.4	8.3	0.9	0.8	0.2	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.0	0.0	13.2	0.0	0.0	0.0	6.8	0.6	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	27.8	0.2	5.8	5.2	1.9	1.1	4.3	1.2	8.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	20.1	4.5	1.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	7.8	0.1	0.0	0.0	0.0	0.0	19.4	11.8	0.5	0.9	0.3	0.1	0.0	0.0	0.0
LRRC23	"B7, LRPB7"	ENSG00000010626	"Leucine rich repeat containing 23"	Q53EV4	12	6873569-6914243	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"fallopian tube: 94.2"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 279.7;Rod photoreceptor cells: 113.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037766, HPA057533"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA037766: AB_10672609, HPA057533: AB_2683459"	"prognostic favorable (6.02e-4)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.25e-2)"	3.6	4.2	11.4	2.4	12.8	3.4	4.8	10.5	10.9	5.8	3.1	10.8	6.9	2.2	6.0	13.1	2.9	94.2	4.2	4.7	12.2	12.9	6.9	3.7	9.4	2.9	7.3	9.6	5.9	2.5	9.3	9.0	3.4	9.9	4.8	3.3	9.4	4.0	5.0	5.5	3.5	2.1	4.8	7.0	3.5	4.5	21.1	8.4	2.2	7.1	2.4	3.7	3.1	3.1	7.8	5.9	9.0	4.4	5.3	4.7	2.2	5.2	10.1	1.7	3.8	7.6	5.9	6.0	2.1	7.2	3.5	6.7	2.1	10.7	4.6	2.3	5.5	10.1	1.3	3.1	4.4	7.5	3.6	1.5	3.2	4.0	4.1	6.2	1.7	3.1	4.1	8.2	6.7	6.1	9.1	4.7	11.3	1.9	2.6	4.0	5.8	4.0	1.2	1.1	7.7	3.0	3.7	8.4	5.3	7.1	1.5	2.8	6.6	3.3	4.5	6.3	11.2	2.3	4.1	2.0	3.5	9.2	3.9	2.3	2.5	1.7	3.8	8.5	2.3	5.0	1.3	4.4	9.0	3.7	4.2	4.7	7.8	3.6	3.1	4.0	4.8	4.1	4.0	0.7	5.3	3.8	5.9	0.2	2.2	11.4	12.8	10.5	10.9	12.2	12.9	7.3	9.6	9.9	8.4	0.0	28.5	7.0	9.6	5.8	17.2	7.5	22.9	279.7	46.6	12.2	47.1	7.2	31.5	10.7	32.5	6.2	4.2	23.3	15.1	9.4	10.8	6.9	5.7	6.4	11.8	12.7	17.2	9.2	8.6	32.8	7.8	8.7	8.5	8.2	7.9	28.7	13.0	3.5	11.7	28.1	113.4	12.9	10.0	62.1	12.6	5.1	3.8	9.6	6.5	6.3
LSM3	"SMX4, USS2, YLR438C"	ENSG00000170860	"LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62310	3	14178358-14201119	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044966	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA044966: AB_2679159"	"unprognostic (3.84e-3)"	"unprognostic (7.00e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.94e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.07e-3)"	"unprognostic (4.93e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-3)"	14.1	13.6	18.2	12.5	17.1	18.9	15.5	13.2	17.3	11.5	15.6	11.8	7.6	15.0	11.6	13.4	19.1	10.3	11.3	20.1	15.1	12.5	27.6	26.7	10.1	14.2	14.2	13.5	12.4	15.6	7.3	12.4	16.5	14.4	14.2	13.9	12.3	13.3	11.0	31.9	12.1	17.6	15.8	15.0	16.3	12.5	21.5	13.9	24.4	19.7	21.4	13.9	12.9	11.1	21.3	23.1	27.2	18.3	17.1	17.7	18.7	14.6	11.9	12.8	13.2	6.0	7.0	32.7	12.2	8.1	15.6	15.0	13.4	11.6	16.2	10.1	8.4	11.0	6.9	14.4	11.8	15.4	15.3	17.9	17.1	17.2	12.8	3.1	19.1	12.5	5.2	8.6	15.6	6.7	7.0	8.0	14.2	18.4	13.0	11.5	16.8	20.2	26.1	22.2	16.5	16.2	11.2	15.9	17.8	14.5	15.2	7.2	11.7	13.9	19.5	11.3	15.4	22.5	24.4	7.2	10.0	16.0	12.1	20.7	9.2	26.9	30.5	12.7	18.8	14.2	27.2	15.9	23.3	12.8	18.3	15.0	21.3	15.0	14.9	14.6	17.1	16.5	17.3	15.2	17.1	15.3	23.1	17.7	18.7	18.2	17.1	13.2	17.3	15.1	12.5	14.2	13.5	14.4	13.9	62.5	87.7	130.3	102.5	86.8	44.5	230.9	170.7	87.0	91.0	120.4	17.7	322.3	411.1	178.6	266.0	108.5	137.9	70.0	230.7	336.7	102.8	94.5	135.1	199.8	207.0	52.4	100.7	114.8	112.2	107.8	129.8	142.9	92.8	201.0	161.2	94.1	180.4	182.4	131.5	513.1	53.0	103.5	91.2	226.0	285.5	88.3	266.3	100.1	174.8	132.7
LURAP1L	"bA3L8.2, C9orf150, FLJ38505, MGC46502"	ENSG00000153714	"Leucine rich adaptor protein 1 like"	Q8IV03	9	12775021-12822131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 48.7"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 80.1;Glandular cells: 116.6;Paneth cells: 77.2;Urothelial cells: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 45.3;hTERT-HME1: 36.3;T-47d: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024407	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA024407: AB_10603780"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.38e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-2)"	10.6	7.2	2.9	7.9	9.2	0.1	13.0	23.4	5.5	11.5	13.7	7.1	2.9	4.0	5.0	7.9	8.5	4.1	14.7	3.5	3.5	3.3	4.1	48.7	17.8	5.3	7.7	4.0	4.5	19.9	0.2	7.3	21.0	5.9	8.0	9.6	4.7	21.6	7.3	2.4	8.8	6.6	13.2	8.1	11.0	9.9	3.7	7.9	0.9	8.6	2.8	5.3	10.3	9.4	0.0	0.1	1.2	0.0	0.0	0.0	1.6	0.9	3.2	0.0	1.0	4.9	6.8	0.0	1.7	9.1	2.2	2.5	0.0	1.1	0.0	0.6	8.7	10.8	1.3	0.0	0.1	1.7	0.0	0.4	0.4	3.0	1.7	45.3	0.0	0.0	2.6	4.3	8.1	36.3	3.8	1.5	0.0	0.0	11.9	1.2	0.7	0.0	0.0	0.0	4.1	3.5	0.0	0.6	0.0	8.9	0.5	6.9	0.6	1.9	1.2	1.5	0.8	52.1	0.1	0.5	2.0	0.3	5.0	1.2	0.0	0.0	0.0	3.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.9	9.2	23.4	5.5	3.5	3.3	7.7	4.0	5.9	7.9	8.9	17.3	0.0	29.2	80.1	4.1	5.3	15.3	5.3	17.0	1.8	2.0	0.4	6.6	56.6	2.6	6.3	32.8	0.0	10.3	1.2	27.7	116.6	10.4	28.7	0.5	17.5	25.6	1.8	0.0	0.8	8.6	0.6	25.3	0.0	8.9	3.6	22.9	77.2	2.8	4.1	9.3	38.8	40.0	0.1	0.3	56.2	0.9	0.0	13.4	93.3
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 19.0;parathyroid gland: 64.9"	"Cell type enhanced"	"Detected in some"	21	"Horizontal cells: 19.1;Melanocytes: 18.6;Rod photoreceptor cells: 17.9;Sertoli cells: 64.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 36.7;U-698: 11.2;WM-115: 24.8"	"Group enriched"	"Detected in many"	5	"amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1"	"Group enriched"	"Detected in many"	9	"amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	2.4	2.1	13.3	1.8	19.0	0.8	1.9	0.6	19.0	1.6	1.1	2.2	0.4	1.1	2.2	1.5	3.5	1.4	3.5	2.3	8.9	2.6	1.9	1.1	4.0	1.5	2.5	8.8	1.7	1.6	64.9	1.4	5.8	1.9	1.7	1.1	10.3	1.3	1.7	1.6	4.2	1.2	2.7	0.8	1.1	1.3	6.6	1.5	0.3	2.0	0.9	1.1	1.9	1.0	0.2	0.1	0.7	0.1	0.1	2.2	0.5	0.0	0.0	4.8	4.0	0.0	0.0	0.6	2.4	0.0	2.1	1.8	0.1	0.0	5.3	1.7	1.5	0.8	0.1	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.8	0.0	0.3	0.0	5.7	0.0	0.0	7.0	0.0	9.2	0.0	6.0	0.0	0.0	0.0	7.7	0.0	1.3	0.2	7.4	6.4	0.0	0.0	36.7	4.2	0.0	0.2	0.0	2.5	1.7	0.0	0.7	0.0	0.0	11.2	0.0	0.5	24.8	0.2	0.1	0.0	2.2	0.0	0.8	0.0	0.7	0.4	0.0	0.2	0.2	0.3	0.7	0.1	0.0	0.1	0.0	0.5	13.3	19.0	0.6	19.0	8.9	2.6	2.5	8.8	1.9	1.5	0.0	0.0	0.0	0.6	1.1	1.5	1.0	0.0	0.0	0.0	0.0	3.9	6.1	1.7	0.0	0.4	0.7	0.0	0.0	0.0	1.6	1.0	0.1	0.0	0.0	0.8	19.1	0.0	0.0	0.0	0.4	1.1	0.0	18.6	0.0	0.0	0.9	0.0	0.0	0.4	0.2	17.9	64.7	10.5	0.2	1.1	0.1	0.7	0.0	0.0	0.0
M1AP	"C2orf65, D6Mm5e, SPATA37"	ENSG00000159374	"Meiosis 1 associated protein"	Q8TC57	2	74557883-74648338	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.8;testis: 13.2"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 8.7;Spermatogonia: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"NTERA-2: 6.1;RT4: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045420, HPA059302"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA045420: AB_10961177, HPA059302: AB_2683972"	"unprognostic (1.76e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-1)"	0.7	0.6	5.2	0.2	1.5	3.7	3.7	1.2	3.4	4.6	0.2	0.3	1.0	0.2	2.1	0.5	0.3	4.6	0.5	0.1	0.9	1.8	1.5	0.1	0.6	0.1	0.5	1.6	0.3	0.4	1.7	8.8	1.2	0.9	0.2	0.0	2.0	1.5	1.0	0.1	0.2	0.2	0.2	0.7	0.4	0.7	13.2	0.2	1.0	3.6	0.0	0.5	0.9	0.5	0.0	0.9	0.2	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.5	0.2	0.5	0.6	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	6.1	0.8	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	5.2	1.5	1.2	3.4	0.9	1.8	0.5	1.6	0.9	0.2	0.0	1.4	0.0	0.0	0.1	0.3	0.3	0.0	2.7	0.0	3.5	0.0	0.3	0.0	0.2	2.5	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	3.5	0.0	0.0	0.0	1.0	3.1	0.0	2.3	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	1.3	0.0	0.0	8.7	22.0	0.0	0.2	0.0	0.0	0.1
MACROD2	"C20orf133, dJ631M13.5"	ENSG00000172264	"MACRO domain containing 2"	A1Z1Q3	20	13995369-16053197	"Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.5"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 151.9;Bipolar cells: 89.0;Club cells: 67.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 7.4;naive B-cell: 14.1;neutrophil: 3.8"	"Group enriched"	"Detected in many"	5	"B-cells: 14.1;granulocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 14.7;Karpas-707: 18.2;RT4: 8.0;SCLC-21H: 10.0"	"Low region specificity"	"Detected in all"							HPA049076	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA049076: "	"unprognostic (1.70e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.15e-5)"	"unprognostic (9.80e-2)"	"unprognostic (9.91e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-2)"	2.8	5.1	15.2	3.0	47.5	2.0	4.2	20.8	13.6	6.4	2.7	3.7	2.0	1.4	12.1	3.9	2.3	10.3	4.1	1.9	10.5	8.2	5.6	2.7	15.7	5.5	7.6	8.9	4.5	4.2	5.4	12.0	1.8	10.5	7.1	2.1	4.0	2.4	14.9	3.1	3.9	1.8	5.8	6.9	6.9	3.4	7.9	9.9	0.0	4.1	0.1	7.2	10.6	3.1	14.1	0.5	3.8	1.8	0.3	0.6	0.5	1.0	0.6	2.8	0.9	0.9	0.8	0.5	0.5	2.0	1.1	0.6	1.0	0.7	1.9	14.7	1.4	2.6	1.4	0.4	0.7	1.9	1.0	0.9	1.1	1.1	1.9	3.6	0.3	0.3	1.6	1.1	0.0	0.8	1.0	1.1	0.3	1.3	18.2	3.1	0.4	0.5	0.7	1.0	6.3	0.4	1.1	0.5	3.5	2.1	8.0	10.0	4.3	1.5	0.1	0.7	1.3	1.0	1.6	0.8	1.5	3.1	0.2	0.1	1.5	0.5	1.8	0.9	1.0	1.8	0.3	0.6	0.6	0.4	1.3	0.4	7.4	0.3	0.4	0.5	14.1	0.4	0.6	3.8	0.3	1.8	0.2	0.2	0.5	15.2	47.5	20.8	12.8	10.5	8.2	7.6	8.9	10.5	9.9	47.6	151.9	14.5	37.6	3.9	89.0	4.0	12.7	12.0	67.1	12.2	37.3	4.4	8.3	9.1	28.4	2.1	1.1	0.0	1.4	0.2	2.6	4.4	1.1	3.9	0.8	7.9	1.2	2.5	0.3	46.6	3.1	1.0	3.3	0.0	3.7	9.3	4.6	1.1	16.6	5.1	18.6	6.5	4.1	17.9	16.4	5.8	1.7	0.0	2.4	3.8
MAD2L2	"FANCV, MAD2B, POLZ2, REV7"	ENSG00000116670	"Mitotic arrest deficient 2 like 2"	Q9UI95	1	11674480-11691650	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 383.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008110, HPA024176, HPA024612"	Approved		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB008110: AB_217976, HPA024176: AB_2671467, HPA024612: "	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.27e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.36e-1)"	12.4	10.1	15.4	15.7	15.6	37.9	13.7	15.5	13.5	10.0	10.5	14.5	11.9	8.6	10.4	11.8	9.8	9.9	10.3	17.3	13.2	11.2	13.2	34.4	12.9	18.3	19.6	9.7	14.6	23.0	5.8	11.1	8.2	12.4	11.8	6.1	8.4	21.0	9.2	23.0	12.0	7.4	11.5	15.0	11.9	12.4	37.0	15.8	42.1	12.0	10.4	19.0	11.9	13.4	19.5	46.9	13.8	31.7	13.2	29.8	27.7	11.7	10.8	18.2	20.5	5.6	11.0	7.3	10.9	12.3	21.5	19.2	14.0	11.4	16.6	13.4	11.4	12.6	5.2	22.5	11.3	12.5	25.0	25.0	7.4	16.7	17.1	9.9	15.0	12.3	7.1	11.6	15.7	13.6	8.4	9.7	22.4	30.5	26.6	10.6	17.4	69.0	70.9	46.8	4.8	17.6	46.9	20.0	20.4	7.8	2.5	33.8	23.7	18.2	7.0	31.6	13.1	10.2	32.6	5.1	17.9	22.7	16.6	15.4	21.4	14.9	43.0	13.2	52.7	13.7	11.9	29.4	13.8	29.8	31.7	23.9	19.5	20.1	23.1	34.0	15.9	13.7	20.3	12.5	13.2	27.2	46.9	22.9	27.7	15.4	15.6	15.5	13.4	13.2	11.2	19.6	9.7	12.4	15.8	0.0	5.3	24.6	22.8	34.3	5.5	13.9	12.7	4.0	5.7	14.0	3.9	14.0	43.1	34.8	122.4	28.4	2.1	70.0	66.1	41.4	31.5	29.1	13.9	52.9	36.0	11.1	32.6	23.9	40.3	383.8	28.7	45.0	45.5	100.0	10.5	7.5	37.7	3.5	15.9	23.1	3.9	38.8	30.9	46.4	40.3	30.4	7.0	38.7	7.5	12.9
MAGEH1	APR1	ENSG00000187601	"MAGE family member H1"	Q9H213	X	55452105-55453566	"Predicted membrane proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"epididymis: 207.1"	"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA011324, HPA011971"	Uncertain		Supported	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA011324: AB_1853499, HPA011971: "	"unprognostic (2.50e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.95e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.52e-1)"	8.3	13.2	21.5	7.6	21.6	3.0	8.1	19.9	29.7	13.5	7.5	14.4	13.8	5.2	13.3	207.1	5.2	19.2	8.3	10.2	22.8	32.1	11.4	8.7	10.2	9.0	19.8	20.6	16.1	11.9	9.0	22.5	9.2	17.9	20.8	5.9	11.4	8.9	19.6	5.7	5.6	6.3	11.8	17.2	8.1	9.3	18.2	15.3	10.8	12.4	5.2	7.5	8.5	10.0	9.4	14.0	9.5	8.5	8.3	26.0	9.4	0.0	2.6	15.0	0.0	24.3	14.7	0.2	16.2	15.0	4.5	12.1	0.0	3.4	0.0	22.3	16.3	8.5	2.2	5.6	6.1	7.1	18.7	0.9	5.0	0.0	2.0	8.0	0.2	6.5	12.2	0.5	2.6	1.9	4.2	6.8	5.4	2.8	20.1	4.9	9.6	13.3	4.3	4.2	0.0	3.1	8.4	1.9	10.5	8.2	0.0	0.1	11.4	0.0	4.4	6.7	11.8	2.1	3.8	7.9	6.2	7.2	3.7	0.8	12.0	15.1	2.1	11.5	7.0	7.8	5.0	4.4	9.5	11.3	6.8	10.1	9.4	18.7	12.9	6.7	8.8	26.0	16.1	0.6	8.3	8.5	14.0	24.7	9.4	21.5	21.6	19.9	28.4	22.8	32.1	19.8	20.6	17.9	15.3	6.0	11.8	20.4	7.1	7.1	37.4	7.9	22.9	9.4	18.2	12.2	9.8	2.2	11.6	27.6	0.8	20.5	1.0	0.0	9.3	1.3	39.5	9.9	12.7	13.6	12.7	35.0	15.2	30.7	2.5	2.1	43.7	7.1	20.3	10.8	6.4	51.7	5.9	7.0	60.1	14.4	15.4	25.8	37.6	1.2	1.7	5.5	1.4	10.7	4.5	3.0
MAK16	"MAK16L, RBM13"	ENSG00000198042	"MAK16 homolog"	Q9BXY0	8	33484750-33501260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044417, HPA050574"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA044417: AB_2678935, HPA050574: AB_2681181"	"unprognostic (2.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.47e-1)"	22.3	11.0	10.6	14.9	15.3	13.5	15.2	11.5	17.6	13.2	11.5	12.5	8.3	9.1	20.8	9.1	15.2	13.6	11.3	13.1	10.5	13.4	17.9	20.0	10.5	17.3	11.4	10.3	24.8	15.7	10.4	19.2	13.1	19.2	14.2	11.3	8.9	10.6	10.3	25.2	12.4	10.8	19.7	13.1	17.3	11.9	9.5	7.1	20.3	14.8	14.3	17.4	16.8	11.3	3.8	4.0	0.9	9.4	5.7	6.2	3.3	6.0	8.5	6.0	13.7	7.1	8.5	9.0	10.9	7.2	11.9	11.3	12.6	5.4	21.3	10.9	9.6	10.3	8.0	20.0	12.1	16.1	4.6	5.5	20.2	6.1	11.1	10.6	8.1	12.3	8.8	11.3	15.5	18.3	4.3	8.7	14.8	25.1	12.4	9.9	7.1	28.9	9.8	31.6	15.1	6.0	10.4	9.0	9.6	10.1	10.3	15.3	12.1	6.7	9.6	13.1	7.7	6.5	8.6	7.7	11.3	8.8	14.5	12.5	6.1	6.8	22.0	7.0	17.4	11.9	0.0	3.2	0.9	4.8	6.8	5.4	3.2	4.7	4.1	3.9	3.8	6.0	6.2	0.7	5.7	9.4	4.0	3.6	3.3	10.6	15.3	11.5	17.6	10.5	13.4	11.4	10.3	19.2	7.1	14.9	8.9	13.8	10.9	13.9	4.7	11.0	10.2	14.7	15.9	8.7	2.0	9.5	6.6	9.5	1.1	7.3	3.5	0.0	6.6	12.6	9.2	6.6	9.2	6.0	8.0	9.5	1.7	4.3	4.3	0.8	8.3	7.9	1.7	5.4	4.2	3.8	9.0	3.7	7.1	7.2	4.2	6.5	9.2	11.9	18.8	13.0	6.3	8.7	6.5	8.4
MAP2K5	"HsT17454, MAPKK5, MEK5, PRKMK5"	ENSG00000137764	"Mitogen-activated protein kinase kinase 5"	Q13163	15	67542709-67807123	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 115.1;Late spermatids: 149.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022094, HPA027347, HPA027755"	Supported		Approved	Nucleoli,Microtubules		NA	NA			"Nucleoli, Microtubules"		"CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883"	"unprognostic (4.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.41e-2)"	"prognostic favorable (8.03e-5)"	"unprognostic (1.68e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.73e-2)"	18.6	22.2	20.3	13.8	30.9	14.6	23.7	25.0	25.4	17.0	19.3	17.2	19.9	14.7	17.4	11.3	13.5	16.2	14.4	18.8	17.1	16.4	14.2	15.5	13.5	27.9	12.6	11.5	29.0	21.0	34.1	14.4	17.7	22.2	15.9	14.8	15.6	15.7	18.5	28.5	18.7	15.0	19.4	17.2	13.0	15.4	20.3	16.2	40.2	16.9	9.2	11.9	17.0	17.9	6.6	10.2	10.3	7.3	11.7	11.2	5.5	5.3	14.2	8.5	10.0	12.6	22.2	6.7	5.4	10.9	10.1	11.1	5.7	9.6	8.8	11.4	8.9	11.0	8.1	14.5	8.6	8.4	12.8	14.5	12.0	10.6	6.1	15.9	7.2	7.5	15.2	11.3	7.3	16.6	22.3	13.3	20.5	10.5	14.8	8.3	6.9	11.8	8.6	12.0	6.2	6.9	11.7	9.9	14.7	6.1	9.8	5.4	8.4	6.0	8.9	21.4	15.4	11.2	14.2	11.0	10.5	6.9	7.2	7.2	21.0	24.6	10.3	14.0	16.6	7.5	10.3	7.3	6.6	7.7	5.6	11.2	6.6	7.3	9.0	10.2	6.2	10.4	9.5	1.7	11.7	6.2	3.9	7.4	5.5	20.3	30.9	25.0	25.4	17.1	16.4	12.6	11.5	22.2	16.2	6.0	4.3	4.2	7.5	6.2	10.0	8.0	2.5	1.4	1.2	5.2	9.8	10.3	6.6	7.7	115.1	7.0	8.8	0.0	7.4	9.1	7.1	4.5	2.3	6.8	8.8	4.8	9.1	9.8	9.2	149.4	11.5	5.3	10.1	2.8	8.4	16.0	6.9	10.5	11.0	6.8	7.2	0.0	5.1	10.4	8.2	7.2	8.2	8.7	9.4	2.7
MAP3K9	"MEKK9, MLK1, PRKE1"	ENSG00000006432	"Mitogen-activated protein kinase kinase kinase 9"	P80192	14	70722526-70809534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 28.6;Urothelial cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000942	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA000942: AB_1079360"	"unprognostic (1.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.75e-5)"	"unprognostic (2.58e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.23e-6)"	"unprognostic (5.71e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-1)"	0.5	2.2	5.8	2.0	9.2	1.4	2.8	20.1	16.5	2.4	3.1	1.8	0.4	3.0	1.1	3.4	10.1	2.2	1.5	1.2	5.7	7.1	3.1	2.4	3.9	2.6	5.9	5.9	1.4	4.3	6.8	4.7	2.8	12.8	2.0	3.1	3.1	3.2	1.3	1.9	7.8	2.9	0.7	1.6	1.9	3.4	10.1	1.8	0.6	5.3	3.2	6.8	2.0	3.9	2.3	0.5	1.3	0.2	1.1	1.4	0.3	18.1	8.4	1.6	2.0	0.0	0.0	5.6	0.4	0.2	1.7	1.6	6.0	7.0	3.7	2.5	0.1	3.7	8.6	5.3	10.2	1.9	2.4	1.5	0.2	2.9	4.0	0.3	0.4	0.8	0.1	5.6	1.2	10.6	3.1	0.0	3.3	1.3	0.8	0.4	7.3	2.8	0.4	3.5	7.2	3.9	1.0	3.2	0.7	3.9	8.3	11.6	2.5	5.2	6.2	1.0	3.2	5.6	0.6	0.0	0.0	7.4	0.0	2.8	1.9	4.4	1.9	2.8	0.3	1.1	0.5	0.2	0.8	0.6	0.1	0.1	1.0	0.6	1.0	0.0	2.3	1.0	0.7	1.3	1.1	0.2	0.5	1.4	0.3	5.8	9.2	20.1	16.5	5.7	7.1	5.9	5.9	12.8	1.8	6.0	14.9	0.9	10.9	7.7	15.8	1.8	15.3	0.0	10.3	7.0	11.8	2.5	1.7	5.5	13.2	0.7	3.1	0.0	4.0	1.3	0.8	9.0	1.1	4.9	1.0	28.6	8.1	0.6	0.8	15.9	0.6	1.4	3.3	0.0	3.4	3.4	7.4	3.5	0.0	1.9	12.3	0.0	1.0	5.4	8.5	8.0	3.3	2.9	5.0	25.4
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161554-13211104	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 31.4"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 23.3;Extravillous trophoblasts: 17.2;Spermatogonia: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	3.0	0.5	0.3	5.6	0.3	10.8	2.1	0.3	0.5	1.4	2.6	0.4	0.3	1.8	1.1	0.6	5.9	0.2	0.7	0.7	0.3	0.3	0.6	0.9	1.4	6.0	0.3	0.6	0.7	0.3	0.3	0.4	3.6	0.5	0.6	2.9	0.4	1.1	0.3	1.5	1.3	1.8	0.9	0.7	2.9	1.1	4.3	0.3	31.4	0.9	3.3	6.9	0.9	1.8	0.5	1.0	1.5	0.4	0.8	3.4	1.5	13.7	15.5	18.4	13.9	0.6	1.1	8.0	14.4	2.2	16.2	16.9	15.1	9.8	20.7	6.5	3.6	6.0	16.1	25.8	8.5	15.0	10.8	12.3	25.8	6.9	10.0	0.0	13.2	11.7	0.2	0.3	16.4	1.5	1.3	5.2	16.8	30.4	14.2	8.8	12.3	31.3	5.7	10.9	13.2	3.8	24.8	16.3	12.8	3.7	5.0	3.7	14.0	11.6	8.3	2.2	10.0	10.4	9.1	3.2	10.3	19.4	15.5	15.5	4.4	17.1	27.2	6.6	14.6	8.0	0.2	0.3	0.2	1.1	0.1	0.2	0.5	1.6	3.4	1.0	0.4	0.4	2.8	1.5	0.8	0.4	0.2	1.6	1.5	0.3	0.3	0.3	0.5	0.3	0.3	0.3	0.6	0.5	0.3	0.0	0.0	1.5	0.2	1.4	0.0	1.2	0.0	0.0	1.2	0.0	0.0	4.1	0.0	0.4	1.1	0.1	0.0	23.3	0.2	17.2	1.0	0.2	0.0	0.0	4.3	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	1.9	5.9	14.0	0.4	2.9	1.0	1.8	0.0
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048499	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.2;pituitary gland: 38.3"	"Group enriched"	"Detected in many"	8	"Intestinal endocrine cells: 109.0;Melanocytes: 143.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 10.1;HAP1: 10.0;RH-30: 12.2;SK-MEL-30: 21.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 1.7"	"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA018106: AB_1853647, HPA062137: AB_2684695"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	4.7	29.2	1.5	0.8	0.8	0.0	3.0	0.2	0.4	6.1	2.8	0.9	2.1	3.2	5.4	15.6	0.8	1.1	0.6	5.1	3.4	0.3	4.5	0.2	4.1	0.0	0.5	0.0	2.2	6.5	17.9	38.3	1.8	2.7	0.5	0.5	4.5	8.1	0.4	1.9	2.5	1.9	1.1	0.3	0.9	1.6	0.4	0.3	2.6	1.5	0.9	0.4	0.7	2.8	0.0	0.0	0.0	0.0	0.0	2.9	0.7	6.5	1.5	0.0	0.0	5.3	4.8	1.7	0.1	10.1	2.5	7.0	0.5	1.2	0.0	0.7	0.1	2.3	0.0	10.0	3.2	1.6	2.6	5.9	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.2	2.1	1.2	2.6	0.0	0.0	0.0	0.0	4.9	0.6	0.0	0.0	0.7	0.0	0.6	0.0	12.2	0.0	0.3	0.0	0.4	0.0	0.3	0.0	21.6	0.8	4.1	5.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.8	0.2	0.4	3.4	0.3	0.5	0.0	2.7	0.3	14.9	1.7	0.0	3.6	7.7	0.0	6.9	10.2	0.0	1.2	3.5	0.0	6.4	0.0	1.9	0.3	0.5	1.3	0.0	8.4	0.1	5.1	1.1	0.0	0.0	3.4	0.0	109.0	0.0	0.0	0.0	1.7	0.8	143.4	2.8	0.6	0.0	4.9	7.8	0.0	2.2	0.0	6.5	1.2	0.9	1.6	3.0	2.2	0.0	0.6	0.3
MESP1	"bHLHc5, MGC10676"	ENSG00000166823	"Mesoderm posterior bHLH transcription factor 1"	Q9BRJ9	15	89748661-89751310	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.1;prostate: 10.9"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 37.0;Glandular cells: 36.0;Spermatocytes: 42.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 6.3;prostate cancer: 26.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HDLM-2: 5.0;HEK 293: 5.0;PC-3: 9.5;SCLC-21H: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069981			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA069981: AB_2686225"	"unprognostic (4.17e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.83e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-2)"	14.1	1.6	6.8	1.4	4.3	1.1	3.8	7.3	8.8	2.5	1.9	1.1	0.1	1.3	1.0	1.0	0.9	1.0	2.9	3.9	4.9	5.0	1.3	1.2	1.1	1.1	3.3	4.3	1.0	1.2	1.1	1.1	0.8	2.4	10.9	1.0	1.3	3.0	1.2	7.0	0.9	1.1	0.9	1.4	0.9	1.0	1.4	1.9	0.0	1.0	2.2	0.9	0.9	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	5.7	2.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.3	0.0	2.3	0.0	0.7	0.0	0.4	0.0	0.0	5.0	5.0	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.1	0.8	1.4	0.0	0.0	9.5	0.2	0.0	1.3	0.1	0.0	4.4	0.1	1.1	1.9	1.2	0.0	0.1	0.7	0.0	0.0	0.3	3.4	1.1	2.3	0.8	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.8	4.3	7.3	8.8	4.9	5.0	3.3	4.3	2.4	1.9	0.0	0.6	0.8	2.6	0.2	10.5	5.2	12.7	0.0	0.0	1.8	9.8	1.8	10.0	16.5	3.7	0.7	17.0	0.0	37.0	0.1	1.0	36.0	4.6	11.5	2.0	7.9	5.8	3.1	2.2	1.0	1.1	2.1	6.8	2.8	4.6	12.7	7.1	10.5	0.0	11.1	15.3	0.0	1.0	42.6	14.3	0.3	0.2	4.4	11.0	5.0
METTL5	HSPC133	ENSG00000138382	"Methyltransferase like 5"	Q9NRN9	2	169810081-169824931	"Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038223	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA038223: AB_10672509"	"unprognostic (2.55e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.73e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (3.06e-8)"	"unprognostic (8.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.87e-3)"	28.9	25.2	30.1	15.8	29.3	17.6	31.2	18.1	30.2	19.8	28.6	14.2	14.9	17.7	18.8	40.4	29.0	17.9	17.3	38.2	25.6	28.5	27.8	29.2	15.8	19.4	25.6	20.8	16.6	32.5	18.0	24.2	22.3	30.2	25.3	26.5	11.9	27.9	20.9	50.1	19.6	24.9	38.4	26.5	17.8	25.1	14.1	23.9	18.1	26.1	33.9	22.3	31.6	26.5	28.6	21.9	15.0	14.1	18.8	29.1	15.1	24.3	13.5	19.6	21.7	18.0	27.1	32.3	20.7	19.4	25.2	20.3	42.0	28.9	31.2	25.2	16.9	33.6	25.5	26.7	43.3	35.5	24.0	19.2	47.0	11.0	45.7	24.6	58.9	23.2	19.8	58.1	31.9	39.3	26.4	23.3	42.9	43.6	26.2	32.0	23.6	28.2	47.9	26.5	31.9	25.6	28.6	18.4	48.2	43.2	22.4	23.9	17.9	13.3	21.0	35.9	23.3	19.8	26.6	16.0	27.6	22.4	17.2	26.4	25.6	38.6	51.7	23.0	28.9	24.7	15.0	11.7	9.0	19.0	14.1	29.1	28.6	26.3	25.2	14.2	24.1	27.5	24.9	3.5	18.8	12.9	21.9	24.9	15.1	30.1	29.3	18.1	30.2	25.6	28.5	25.6	20.8	30.2	23.9	11.9	24.5	38.7	74.0	34.3	24.2	70.2	53.5	52.2	44.3	41.8	15.7	76.3	94.5	98.0	3.3	34.7	33.8	0.0	128.2	98.7	39.5	65.1	45.1	44.3	68.6	22.3	58.3	36.8	31.3	6.8	46.6	34.4	52.3	48.7	58.4	27.4	118.7	49.1	56.6	81.1	18.3	51.8	54.3	46.4	73.5	35.8	32.7	42.8	68.9	70.1
MFSD9	MGC11332	ENSG00000135953	"Major facilitator superfamily domain containing 9"	Q8NBP5	2	102715840-102736888	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055293, HPA061859"	Approved		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA055293: AB_2682775, HPA061859: AB_2684627"	"unprognostic (1.27e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.38e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.28e-2)"	4.3	4.1	3.0	3.5	3.1	6.2	6.2	12.9	5.2	4.6	8.4	2.4	11.0	11.6	2.8	3.8	7.2	2.7	4.1	3.8	2.3	2.8	7.2	16.2	3.0	4.5	2.3	1.5	3.3	16.8	6.3	10.7	3.4	4.8	3.4	7.9	5.1	9.0	6.8	2.2	4.4	16.0	4.0	2.7	4.8	6.7	2.7	1.7	10.0	5.0	3.9	6.3	5.5	3.5	3.0	4.4	6.4	3.2	4.1	4.3	3.0	3.9	3.3	3.6	6.3	4.2	1.8	8.7	2.6	2.4	3.9	3.9	10.0	6.0	3.2	4.2	1.8	6.4	6.2	4.9	2.6	2.7	13.0	5.0	5.8	3.6	13.1	3.6	4.5	7.7	2.1	6.5	2.7	1.4	3.4	2.6	9.2	3.5	2.0	1.8	3.8	4.3	7.0	3.4	7.8	3.7	3.5	5.6	3.3	6.7	13.5	6.9	5.1	2.6	7.8	7.7	3.9	3.3	6.5	1.9	3.1	5.7	4.2	3.4	4.7	3.7	2.4	2.8	9.7	3.6	3.7	1.2	6.4	4.3	3.2	3.3	3.0	3.4	3.1	2.6	2.7	3.7	3.8	5.0	4.1	1.9	4.4	2.2	3.0	3.0	3.1	12.9	5.2	2.3	2.8	2.3	1.5	4.8	1.7	0.0	1.0	4.4	2.9	3.0	1.5	2.2	2.5	2.7	4.5	7.0	3.9	7.3	0.0	5.3	13.0	1.2	8.4	0.0	7.4	7.2	2.1	3.9	3.5	7.8	4.1	0.0	2.9	0.6	1.2	3.0	0.9	2.1	0.0	4.6	7.9	1.7	8.5	8.6	1.1	2.9	2.6	6.5	1.2	0.9	4.9	3.9	9.6	5.2	6.3	8.0
MIS18BP1	"C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1"	ENSG00000129534	"MIS18 binding protein 1"	Q6P0N0	14	45203190-45253540	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA006504	Approved		Approved	Nucleoli,Cytosol		NA	Yes			Nucleoli	Cytosol	"HPA006504: AB_1078317"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.21e-1)"	10.3	5.2	5.1	22.5	5.7	26.3	14.1	1.8	5.7	9.0	11.8	2.3	7.6	6.0	9.8	9.5	10.2	8.6	5.7	5.3	5.1	2.8	5.0	4.3	14.3	23.9	4.5	4.1	12.5	7.1	1.8	5.2	9.5	6.7	7.9	7.6	1.9	12.5	10.2	3.0	8.4	10.7	7.3	10.2	22.5	6.9	9.5	3.1	38.4	7.1	8.2	15.5	8.2	7.7	13.1	14.7	23.6	22.6	4.5	4.8	4.0	21.0	7.9	16.5	7.2	5.1	7.3	12.2	14.6	7.7	12.2	15.2	4.2	20.4	29.1	6.4	7.2	5.2	14.8	9.7	7.4	23.0	15.3	6.1	17.4	9.8	5.4	3.4	40.1	16.3	5.2	3.0	7.2	6.8	7.9	14.8	5.6	7.6	6.9	11.8	7.7	16.7	17.7	12.5	10.4	9.9	20.0	6.7	11.2	6.2	8.8	11.6	5.1	5.9	10.0	5.3	10.3	11.9	23.0	8.1	6.5	19.8	7.9	6.4	6.2	8.2	13.6	3.6	16.8	9.1	23.6	14.2	16.2	3.9	13.2	4.1	13.1	3.6	3.2	9.6	12.9	2.4	2.5	8.5	4.5	22.6	14.7	4.8	4.0	5.1	5.7	1.8	5.7	5.1	2.8	4.5	4.1	6.7	3.1	23.8	23.8	43.1	9.7	17.9	7.9	11.8	10.2	20.1	35.2	8.7	15.7	30.2	5.0	11.5	2.9	28.7	11.1	23.3	9.7	38.0	14.2	17.4	41.7	6.7	32.5	0.0	26.5	30.1	69.4	3.6	51.2	58.2	5.0	70.3	23.5	4.8	11.1	34.8	57.0	3.6	8.2	0.0	14.2	67.2	107.7	23.1	16.2	47.3	24.4	11.0
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226654-35277000	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.5"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 38.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 91.3"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.6	1.3	4.0	0.4	7.8	0.6	0.4	38.5	8.9	0.7	0.3	1.3	0.2	2.8	1.6	0.9	0.2	2.8	0.6	1.0	2.7	3.2	8.6	0.9	6.1	0.3	1.8	1.5	0.9	8.0	0.0	3.8	0.6	1.7	2.2	0.1	0.5	0.4	6.0	0.2	1.5	1.7	2.5	0.9	0.6	0.7	0.4	1.4	0.2	0.8	0.2	0.2	0.5	0.2	0.8	0.4	2.2	0.8	0.6	1.2	0.3	0.3	20.1	0.0	0.1	0.1	0.0	0.6	1.1	1.3	2.1	1.1	30.6	5.4	0.0	9.0	1.4	0.7	0.3	4.7	0.0	0.9	0.1	0.2	1.1	0.6	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.1	7.7	0.0	1.4	0.0	0.1	0.0	13.8	0.1	8.0	5.5	1.4	0.5	0.2	1.8	0.3	0.1	0.3	4.3	10.4	1.0	0.4	0.1	0.1	0.0	0.9	0.1	0.6	1.0	0.6	0.1	1.0	0.7	1.2	0.6	0.7	0.8	0.4	0.8	0.6	0.6	2.2	0.6	0.8	0.2	0.0	0.3	4.0	7.8	38.5	5.3	2.7	3.2	1.8	1.5	1.7	1.4	14.9	1.0	0.0	0.1	0.1	3.6	0.6	12.7	0.0	2.3	1.8	0.0	0.0	5.0	7.5	0.6	0.7	0.3	0.0	0.8	0.1	0.2	0.4	0.0	0.2	0.0	14.3	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	0.2	2.1	0.0	0.0	7.3	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170226	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favorable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	13.7	15.5	32.0	17.5	25.1	12.3	54.1	37.1	32.6	18.5	16.0	9.3	7.0	9.9	18.9	17.1	26.5	11.9	12.3	9.4	25.4	22.2	12.0	11.5	13.6	16.1	17.5	21.9	10.4	7.2	13.6	43.5	17.4	24.0	11.3	18.7	10.8	18.1	10.3	15.4	28.4	11.0	16.8	31.7	12.7	11.2	9.9	17.9	10.8	8.7	12.9	18.2	19.6	18.5	18.6	24.6	19.4	25.2	17.1	28.3	15.6	19.6	10.7	24.1	11.7	11.7	16.6	13.3	21.2	25.5	18.5	9.0	17.3	11.5	16.2	12.9	11.6	13.7	20.7	22.9	22.0	24.9	12.0	15.0	13.0	9.0	31.1	11.7	32.3	20.2	10.4	19.8	11.0	31.7	9.4	21.2	22.7	30.5	4.6	28.1	15.9	24.8	38.2	22.0	24.5	14.9	30.8	11.1	10.7	16.7	20.7	16.5	7.1	35.7	15.9	15.2	10.3	27.9	20.1	16.6	17.4	17.3	15.3	15.0	6.8	16.4	64.4	15.7	26.6	22.0	13.0	22.0	19.4	22.3	25.2	28.3	18.6	23.1	23.2	24.6	14.6	24.8	23.6	2.7	17.1	17.4	14.7	23.0	15.6	32.0	25.1	37.1	32.6	25.4	22.2	17.5	21.9	24.0	17.9	17.9	37.6	25.3	34.6	34.5	13.8	29.0	12.7	34.8	35.2	19.2	9.8	52.1	43.1	41.7	4.8	14.3	15.1	46.7	24.5	35.8	39.3	21.5	17.4	13.0	43.1	19.1	8.6	19.0	33.6	7.6	10.3	56.9	30.4	71.3	17.4	31.2	42.3	28.1	9.6	33.9	22.5	19.4	25.8	30.3	54.8	47.2	27.5	22.9	28.6	40.1
MRPL40	"MRP-L22, NLVCF"	ENSG00000185608	"Mitochondrial ribosomal protein L40"	Q9NQ50	22	19431902-19436075	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 28.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006181	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA006181: AB_1079411"	"unprognostic (4.12e-2)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.14e-2)"	4.0	6.6	5.5	2.5	6.6	1.3	3.9	5.1	5.4	4.3	2.6			2.9	3.0	5.0	3.7	5.0	2.9	11.8	4.6	4.7	6.1	10.3	2.2	3.0	5.1		4.7	7.0	6.4	4.9	2.5		4.6	2.2		8.7	4.2	14.8	3.6	2.3	2.4	5.0	2.7	3.1	2.8			8.2		2.8	3.7	2.5	28.1	21.6	10.3	15.1	10.9	16.4	16.6	13.2	9.2	2.2	8.4	13.7	12.7	7.0	10.0	11.6	14.1	17.6	10.8	7.7	11.6	10.4	11.0	8.1	13.1	13.9	15.9	11.9	11.8	21.3	10.5	6.6	13.3	20.2	15.0	7.0	13.1	15.5	10.4	18.6	9.5	9.4	4.4	42.5	11.1	13.6	10.1	7.8	8.9	3.6	18.7	12.5	7.4	14.5	5.3	16.8	5.6	7.6	7.0	15.3	12.9	19.2	5.2	11.4	8.8	11.8	18.8	17.4	7.4	9.7	10.6	14.2	16.9	12.3	10.2	13.6	5.9	13.8	10.3	13.0	15.1	14.0	28.1	13.2	13.5	15.0	25.5	16.4	14.3	1.6	10.9	12.0	21.6	15.0	16.6											41.7	33.6	52.8	60.0	35.8	28.7	83.9	76.5	109.7	53.4	45.4	11.8	118.0	220.5	67.0	81.1	33.6	39.3	0.0	84.9	110.0	43.1	49.9	33.4	122.0	116.9	20.6	33.6	40.5	35.4	118.1	67.0	37.7	81.0	100.0	42.0	80.3	63.8	42.4	67.8	201.9	38.4	45.3	58.7	83.7	70.0	33.6	52.6	34.6	45.0	39.2
MRPS27	KIAA0264	ENSG00000113048	"Mitochondrial ribosomal protein S27"	Q92552	5	72219409-72320646	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA071751	Approved		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA071751: AB_2686442"	"unprognostic (3.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.07e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.95e-2)"	26.9	32.3	19.0	20.9	26.8	13.6	26.1	24.6	31.8	25.1	21.0	20.1	21.8	16.5	28.6	23.7	33.6	26.3	18.0	43.6	18.9	17.5	25.1	30.9	14.9	27.4	18.1	21.7	33.9	25.1	24.5	23.7	17.5	23.5	26.2	26.4	25.5	31.0	26.5	43.7	23.9	17.5	25.0	17.5	22.2	20.9	12.1	12.6	34.2	32.1	26.7	32.4	25.9	21.0	19.6	23.3	6.1	14.1	21.5	21.5	16.1	16.4	22.1	19.7	32.5	25.9	33.5	25.4	15.9	22.8	30.3	24.5	27.5	23.4	42.7	22.3	18.5	33.1	18.4	38.2	56.4	32.9	16.0	23.6	21.9	26.6	30.2	25.9	19.2	17.1	31.3	23.9	31.7	35.6	27.7	32.2	31.5	21.9	12.9	25.0	19.8	28.7	23.3	22.7	12.0	13.9	30.6	32.7	43.8	27.9	17.7	30.5	16.3	26.6	22.0	19.7	19.0	33.7	23.4	18.2	12.4	18.3	17.4	28.5	13.1	19.7	30.1	21.3	31.7	19.5	6.1	12.1	4.1	14.0	14.1	20.6	19.6	17.4	17.0	23.3	16.5	20.3	21.5	1.8	21.5	11.3	8.9	17.8	16.1	19.0	26.8	24.6	31.8	18.9	17.5	18.1	21.7	23.5	12.6	8.9	9.4	25.3	22.2	18.1	10.8	88.0	7.6	10.7	13.6	10.4	15.7	35.7	21.6	16.5	1.7	15.7	8.5	0.0	14.9	37.9	17.7	10.8	7.0	28.9	21.9	9.5	15.5	16.5	33.5	3.0	17.5	13.4	10.1	34.3	21.2	15.6	15.4	17.5	23.7	18.8	12.2	12.9	17.5	8.0	17.4	15.4	24.1	22.3	29.1	12.1
MRPS31	IMOGN38	ENSG00000102738	"Mitochondrial ribosomal protein S31"	Q92665	13	40729135-40771173	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Ciliated cells: 350.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039083, HPA046344"	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA039083: AB_2676340, HPA046344: AB_2679629"	"unprognostic (9.62e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.54e-2)"	14.2	20.1	19.3	17.9	21.2	13.2	18.2	27.7	22.9	14.4	16.4	16.9	10.7	15.4	18.0	15.4	18.9	16.6	10.9	24.3	18.4	16.9	26.7	29.9	12.1	22.5	17.9	17.1	21.5	15.0	10.7	35.3	13.1	22.1	12.6	17.0	12.4	14.7	12.5	32.5	14.2	16.3	16.3	16.0	16.0	15.3	17.9	23.3	22.9	21.1	17.2	25.1	18.0	15.9	22.2	11.8	17.2	10.4	15.9	25.7	10.9	8.0	7.7	13.1	8.6	9.0	10.6	13.1	10.3	7.2	13.7	9.2	19.8	12.0	47.3	10.1	5.9	18.4	21.3	16.4	12.9	16.3	12.4	12.4	19.6	5.8	12.6	7.5	20.0	9.5	8.5	9.5	11.2	9.5	9.1	10.4	13.6	13.1	5.0	8.7	9.1	15.5	19.6	12.7	27.5	9.2	14.9	10.8	8.8	17.9	9.3	5.7	8.4	7.1	11.9	16.2	16.4	10.4	17.7	6.3	4.3	7.2	9.9	10.7	3.9	7.2	23.8	8.7	14.3	8.1	17.2	9.6	14.4	19.1	9.7	18.6	22.2	21.4	19.2	11.8	18.9	25.7	22.6	7.0	15.9	10.4	11.6	21.4	10.9	19.3	21.2	27.7	22.9	18.4	16.9	17.9	17.1	22.1	23.3	44.7	16.3	16.4	28.7	8.7	32.3	61.3	30.6	350.7	67.1	21.0	17.7	53.8	92.9	37.0	42.6	34.6	21.2	23.3	29.4	40.9	23.6	14.3	22.0	64.5	22.6	39.7	22.4	35.6	18.6	4.9	32.8	19.5	18.6	45.9	31.0	30.1	28.6	21.0	28.7	51.9	47.6	45.3	25.8	51.0	45.1	11.7	56.9	27.4	31.5	26.5
MTUS1	"ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1"	ENSG00000129422	"Microtubule associated scaffold protein 1"	Q9ULD2	8	17643795-17800917	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 229.1;Endothelial cells: 164.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.2;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6"	"Lineage enriched"	"Detected in single"	21	"T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"A549: 29.7;AN3-CA: 26.1;HUVEC TERT2: 77.2;SK-MEL-30: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067903, HPA069795"			Enhanced	Nucleoli,Microtubules		No	No			"Nucleoli, Microtubules"		"HPA067903: AB_2685921, HPA069795: AB_2686198"	"unprognostic (3.20e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (2.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (3.33e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.43e-1)"	45.0	20.8	20.9	6.8	38.2	0.4	21.8	51.0	27.7	19.8	19.0	56.5	9.9	16.9	16.9	12.6	20.3	12.8	20.0	44.3	27.4	17.3	14.4	29.3	20.9	4.4	34.7	18.0	28.2	47.1	43.8	15.0	36.1	33.7	17.5	21.1	10.3	24.3	14.0	49.7	12.2	17.4	20.5	48.3	8.2	21.4	6.5	49.3	0.7	15.7	10.9	7.5	21.4	26.7	0.2	0.0	0.0	0.0	0.0	4.8	1.0	5.5	29.7	4.8	26.1	0.0	0.1	8.8	0.2	2.0	0.1	0.6	2.2	2.0	0.7	2.2	0.0	1.2	5.7	8.0	2.8	0.2	3.9	3.4	0.0	5.1	14.1	1.7	0.0	0.1	2.4	4.3	0.6	8.8	0.0	77.2	2.0	0.0	11.3	0.0	1.4	1.0	1.4	6.9	11.2	0.7	0.0	4.4	2.9	1.5	11.4	2.4	0.6	3.8	6.9	21.9	3.0	5.0	0.0	15.7	0.0	6.5	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.0	0.2	4.8	3.6	0.0	0.0	0.0	0.0	0.0	1.0	20.9	38.2	51.0	27.7	27.4	17.3	34.7	18.0	33.7	49.3	65.5	229.1	0.8	50.7	18.7	0.0	122.8	56.0	50.9	106.9	19.2	0.0	16.2	10.0	33.7	16.9	164.1	52.5	0.0	150.0	30.8	30.4	68.9	9.2	60.6	44.7	0.0	14.5	20.9	3.7	19.2	70.8	10.5	27.0	4.6	40.5	0.0	66.3	14.0	53.7	8.9	0.0	19.4	41.9	1.7	5.1	17.8	45.2	4.4	32.2	49.8
MTX2		ENSG00000128654	"Metaxin 2"	O75431	2	176269395-176338025	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 170.8;Spermatocytes: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031550, HPA031551, HPA031552"	Approved	Approved	Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoli	"HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616"	"unprognostic (2.61e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-2)"	13.2	26.4	21.3	12.0	22.3	5.5	18.8	15.0	44.9	13.0	20.7	18.5	16.6	15.4	15.5	27.9	22.2	20.0	12.0	33.6	23.6	26.3	31.5	20.2	10.6	8.9	21.5	16.5	13.2	16.4	23.7	25.7	17.3	21.8	18.9	24.6	16.3	24.7	16.5	45.0	12.5	14.8	17.6	25.7	9.4	14.6	40.6	14.0	10.2	14.7	19.8	13.6	14.4	13.6	16.2	12.1	4.7	12.6	15.1	13.4	7.9	17.5	10.4	21.2	13.0	14.3	16.5	20.4	18.9	17.7	17.4	20.3	17.9	19.2	22.5	32.1	16.7	28.1	11.8	23.1	23.3	24.0	22.3	16.6	21.4	13.1	31.5	22.6	33.1	7.2	18.4	29.1	18.2	31.4	21.3	24.7	22.0	28.4	17.5	20.4	16.0	11.6	33.7	20.2	34.4	16.5	0.0	15.4	20.0	49.2	31.9	30.3	26.0	15.8	21.1	39.0	42.7	11.7	21.6	21.7	17.4	15.4	18.2	19.7	19.6	20.4	26.9	21.6	16.7	21.0	4.7	7.7	3.2	8.5	12.6	11.5	16.2	10.9	9.6	12.1	11.4	13.2	13.4	0.0	15.1	10.9	9.8	13.4	7.9	21.3	22.3	15.0	44.9	23.6	26.3	21.5	16.5	21.8	14.0	17.9	16.9	20.4	33.1	27.6	0.0	60.5	28.1	33.5	20.5	54.1	0.0	65.7	170.8	45.6	18.6	25.5	29.0	0.0	34.6	53.9	27.4	37.9	42.7	32.0	41.3	0.0	39.9	12.3	17.8	12.3	32.8	24.8	33.7	34.3	41.6	0.0	41.1	17.5	30.8	83.3	0.0	38.8	36.0	167.0	118.7	36.6	54.3	16.2	51.9	46.0
MXD3	"bHLHc13, MAD3"	ENSG00000213347	"MAX dimerization protein 3"	Q9BW11	5	177301461-177312757	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.1;lymphoid tissue: 59.4"	"Cell type enriched"	"Detected in many"	7	"Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 14.1;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 59.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA070111			Approved	Nucleoplasm,Nucleoli		NA	Yes			"Nucleoplasm, Nucleoli"		"HPA070111: AB_2686228"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.26e-2)"	"unprognostic (6.18e-3)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.33e-16)"	"unprognostic (8.55e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-3)"	2.5	1.8	1.3	28.2	1.9	32.1	5.4	1.2	3.4	2.4	6.8	1.2	2.8	6.9	2.7	6.2	6.6	3.6	2.8	2.4	1.6	0.8	2.7	6.6	5.4	7.3	2.2	1.2	2.6	5.8	0.7	4.3	4.5	2.1	5.0	0.9	1.1	4.7	2.1	3.6	10.3	5.6	1.4	1.3	10.3	3.8	3.1	2.9	59.4	3.5	3.7	13.5	2.7	3.6	2.0	1.6	14.1	8.7	0.7	0.8	1.1	8.1	5.6	3.5	9.5	0.2	0.5	5.8	10.6	3.5	4.8	4.6	3.7	8.5	4.3	4.4	1.4	2.6	4.0	0.4	1.2	0.2	59.2	7.2	2.4	8.1	5.4	0.5	2.3	7.5	0.3	0.6	0.3	0.2	0.4	4.4	19.2	1.5	13.6	0.9	10.4	21.6	6.5	1.2	2.5	9.8	10.6	10.8	6.2	1.0	1.1	8.6	7.1	6.8	6.9	3.7	0.5	10.9	6.2	3.2	5.8	15.0	4.6	5.6	18.0	5.9	4.7	4.5	8.1	3.3	3.5	2.6	7.7	0.7	7.2	0.0	1.6	0.1	0.1	1.6	2.0	0.0	0.3	14.1	0.7	8.7	1.0	0.8	1.1	1.3	1.9	1.2	3.4	1.6	0.8	2.2	1.2	2.1	2.9	3.0	2.2	0.0	1.5	4.9	2.8	1.2	5.1	5.3	4.5	5.2	0.0	4.5	0.0	1.3	16.3	2.3	4.0	116.8	3.5	7.2	3.4	2.4	9.2	3.9	8.8	3.2	1.7	4.3	4.9	1.9	1.7	5.1	3.3	1.0	5.0	1.0	1.9	3.1	1.4	0.3	2.2	0.0	3.1	0.7	5.9	5.0	11.0	5.1	6.9	1.8
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555631	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles		No	No			Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (9.70e-2)"	14.1	11.6	13.8	16.5	14.6	13.2	16.2	15.0	21.5	11.3	10.2	14.9	11.1	12.9	15.4	11.7	17.1	15.8	12.4	11.5	11.7	9.2	8.7	21.5	11.6	16.0	15.2	11.1	15.3	23.7	10.5	13.1	7.2	13.0	17.0	7.2	12.7	24.5	15.3	30.8	25.0	12.8	10.9	7.3	15.0	12.9	9.3	12.6	14.6	11.7	18.2	17.6	15.4	13.2	5.3	4.9	0.4	4.9	4.3	5.9	3.8	19.5	31.3	4.1	18.8	5.3	6.2	14.0	13.6	6.0	13.7	10.6	23.0	8.0	26.7	15.8	8.0	6.8	24.7	17.0	20.4	6.4	13.3	45.9	12.8	19.3	20.4	8.6	15.0	11.7	9.0	11.7	20.1	10.0	3.7	9.1	15.4	20.9	12.3	5.8	16.9	17.5	5.9	18.8	6.1	16.4	22.7	6.9	17.7	3.2	15.7	8.7	16.7	13.9	9.7	9.2	2.7	9.3	6.1	11.7	11.9	10.7	11.1	38.8	11.1	7.5	10.9	11.3	17.6	15.3	0.0	2.8	0.4	5.1	2.7	5.9	5.3	4.2	5.5	4.9	3.3	4.5	4.6	0.1	4.3	4.9	3.5	1.8	3.8	13.8	14.6	15.0	21.5	11.7	9.2	15.2	11.1	13.0	12.6	8.9	16.4	12.7	5.2	11.4	7.6	3.6	15.3	10.7	19.4	3.5	11.8	2.6	0.0	8.1	0.4	10.8	5.9	0.0	10.7	4.1	5.9	5.4	4.7	6.6	5.7	9.5	10.9	8.6	3.4	0.4	5.2	5.0	3.3	3.6	8.1	3.5	7.2	3.5	11.3	2.2	5.7	6.5	10.3	2.6	12.0	10.5	0.9	6.9	10.3	5.1
MYCN	"bHLHe37, MYCNOT, N-myc, NMYC"	ENSG00000134323	"MYCN proto-oncogene, bHLH transcription factor"	P04198	2	15940564-15947007	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 16.8"	"Cell type enriched"	"Detected in some"	8	"Extravillous trophoblasts: 75.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 45.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.9;BEWO: 70.2;HMC-1: 16.9;NTERA-2: 26.6;RH-30: 18.6;SuSa: 12.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057420			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA057420: AB_2683434"	"unprognostic (8.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.23e-1)"	0.9	1.9	5.1	1.8	5.5	1.6	1.2	1.4	8.4	3.1	1.2	12.1	0.0	3.0	1.9	0.8	1.3	1.4	2.6	2.3	7.0	4.7	6.0	1.5	1.6	2.9	6.0	2.2	10.3	0.7	0.4	0.7	16.8	6.8	0.6	1.3	1.1	6.6	0.7	1.0	2.4	1.7	0.9	8.9	0.9	8.5	6.5	4.0	5.7	5.1	2.3	3.5	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	70.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	26.6	0.6	0.0	0.0	18.6	3.5	0.0	0.9	0.2	4.7	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.5	1.4	7.0	7.0	4.7	6.0	2.2	6.8	4.0	0.0	0.0	0.0	0.1	0.5	2.6	0.7	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	0.2	0.0	0.0	0.0	75.4	0.6	0.0	0.0	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.2	0.0	0.4	2.1	0.1	0.0	0.0	0.5	3.6	0.0	9.6	0.0	0.2	0.0
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46857872-46882169	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 398.1;skeletal muscle: 319.8"	"Cell type enriched"	"Detected in some"	65	"Cardiomyocytes: 3031.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA		15000000	"Nucleoli, Mitochondria"		"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	0.9	0.2	0.5	0.2	0.4	0.0	0.6	0.2	0.4	0.5	0.1	0.3	0.0	0.0	0.2	10.1	10.5	0.1	0.2	398.1	0.7	0.4	2.3	0.1	0.2	0.1	0.7	0.3	0.3	0.1	0.0	0.0	0.3	0.3	1.6	0.0	0.3	5.5	0.0	319.8	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.4	0.0	1.1	30.1	3.1	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	1.6	0.3	0.1	0.0	0.1	5.9	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.7	0.4	0.7	0.3	0.3	0.4	0.0	0.0	0.0	0.1	0.7	0.1	3031.1	0.0	0.0	0.0	1.8	0.0	0.4	46.4	0.0	2.0	0.3	0.0	0.0	0.0	5.0	7.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.5	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.7	46.2	0.4	6.5	1.3	0.0	0.4	0.4	0.7	0.0	0.0	0.0
MYL5		ENSG00000215375	"Myosin light chain 5"	Q02045	4	673580-682033	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 61.5"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 71.2;Rod photoreceptor cells: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.0;ASC TERT1: 23.4"					"Low region specificity"	"Detected in many"			"HPA037381, HPA039262"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037381: AB_10672484, HPA039262: AB_2676418"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-2)"	9.9	11.4	14.5	10.1	12.7	8.5	12.6	13.4	14.6	6.1	10.9	14.7	14.6	18.0	7.1	19.5	10.6	7.1	8.0	4.9	13.9	11.4	9.7	11.3	7.8	19.5	10.8	10.0	7.5	15.4	13.2	7.7	5.3	10.5	9.8	11.8	10.0	61.5	10.7	18.6	16.2	15.4	10.1	9.3	8.8	7.3	15.5	3.9	7.5	7.5	24.2	9.9	6.5	6.9	11.0	12.6	8.2	9.5	15.4	6.5	4.5	2.2	3.7	13.6	7.2	34.0	23.4	6.5	5.5	7.4	5.6	5.2	4.5	9.6	2.6	2.6	8.9	4.0	3.3	2.1	3.7	1.6	4.8	2.7	3.9	5.1	4.1	11.9	5.9	3.6	17.6	3.6	4.4	4.7	8.2	3.4	5.6	4.0	3.5	6.9	4.2	3.1	4.1	2.8	4.7	5.7	2.8	2.9	1.5	9.2	10.6	6.2	3.5	1.8	4.6	3.7	4.6	7.4	5.4	5.6	4.8	0.9	4.1	3.1	13.6	2.6	1.6	5.3	5.3	2.4	8.2	7.4	1.1	3.1	4.7	3.9	7.9	5.1	1.8	6.6	11.0	6.5	6.3	5.0	15.4	9.5	12.6	2.3	4.5	14.5	12.7	13.4	14.6	13.9	11.4	10.8	10.0	10.5	3.9	0.0	11.0	9.5	6.0	10.6	5.7	1.2	7.6	6.7	2.3	7.0	19.6	5.7	10.0	8.8	16.6	4.5	31.5	0.0	4.0	4.3	6.6	7.4	12.8	14.9	18.5	11.1	5.2	9.2	16.2	71.2	6.6	7.5	6.8	20.8	8.8	16.6	6.2	10.5	3.5	30.0	78.4	6.5	5.0	14.4	3.1	11.7	4.6	6.1	13.3	8.9
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58654739-58700092	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	13.2	12.3	14.1	14.4	15.7	24.4	17.3	16.9	24.3	14.3	13.7	11.4	11.9	12.5	17.5	14.3	13.5	13.0	9.9	14.1	11.7	8.1	11.0	11.0	12.9	14.3	14.0	13.3	18.1	14.0	16.5	19.2	11.3	18.0	14.4	11.6	9.3	15.5	15.2	23.2	20.4	14.6	13.7	15.2	14.2	11.5	8.3	14.7	11.9	15.5	10.6	12.9	13.3	14.7	1.1	0.7	2.2	2.1	0.2	2.3	0.5	8.3	2.4	6.2	6.6	5.7	7.3	8.9	5.0	5.6	5.0	4.3	4.2	3.7	8.7	1.5	3.8	5.9	6.4	6.8	2.9	9.6	5.8	4.6	10.5	1.1	4.6	6.9	15.8	8.0	5.2	5.0	6.4	3.3	6.6	1.2	5.6	11.1	5.6	5.7	2.8	7.7	13.2	9.8	3.4	4.5	6.6	14.9	5.3	4.1	3.2	5.1	5.0	4.2	8.3	11.7	11.7	2.5	9.0	4.0	8.9	4.0	6.8	9.5	10.2	4.8	11.6	5.2	11.5	9.7	0.8	0.7	0.5	2.0	1.0	1.4	0.9	1.4	1.6	0.6	1.1	2.3	1.1	2.2	0.2	2.1	0.7	1.4	0.5	14.1	15.7	16.9	24.3	11.7	8.1	14.0	13.3	18.0	14.7	20.8	28.9	12.6	19.3	16.9	20.3	24.6	10.2	22.7	48.9	10.4	23.6	7.0	13.3	7.0	3.2	17.3	18.0	0.0	8.1	4.8	11.6	20.1	54.4	12.4	9.7	17.5	15.5	31.3	13.2	4.0	11.8	14.6	8.5	15.4	16.2	12.0	10.3	14.4	16.3	6.3	26.3	25.8	14.1	13.0	20.4	16.2	9.5	25.5	13.6	22.6
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N(alpha)-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929242-153935223	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol		No	No			Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: AB_2673579"	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	18.9	21.2	17.7	20.3	14.0	12.5	31.8	15.5	20.8	12.4	15.3	8.1	19.2	16.7	17.2	17.6	19.7	16.5	17.6	26.4	15.0	14.2	16.3	18.6	20.7	30.0	15.0	18.0	14.1	33.3	12.3	12.0	13.7	17.5	13.6	11.7	9.3	19.0	17.9	57.8	14.1	14.7	21.7	14.7	14.9	17.7	7.1	11.8	11.4	12.2	25.3	16.3	17.1	22.1	33.7	34.8	35.0	31.9	27.6	44.8	29.0	32.1	33.9	6.4	20.8	9.1	9.6	18.1	11.3	6.6	15.5	13.6	22.0	10.2	24.5	37.7	9.3	20.1	15.4	13.4	13.6	6.0	10.2	62.5	8.8	23.7	22.1	12.5	17.1	19.5	7.3	15.3	14.4	15.0	7.8	17.5	9.6	17.6	10.4	10.2	42.2	27.3	25.5	10.7	30.4	47.1	21.7	16.5	26.8	11.3	14.8	13.7	16.5	4.4	17.9	26.7	6.3	9.6	14.2	10.1	6.5	22.3	22.5	34.3	22.0	24.5	46.0	8.8	22.1	18.9	12.0	24.2	35.0	29.0	28.0	38.0	33.7	31.2	31.7	31.6	32.6	18.7	28.0	22.6	27.6	31.9	34.8	44.8	29.0	17.7	14.0	15.5	20.8	15.0	14.2	15.0	18.0	17.5	11.8	8.9	27.5	83.3	53.7	62.3	28.9	38.0	53.5	29.4	26.1	36.6	11.8	113.1	81.2	114.3	2.1	90.5	71.7	46.7	129.7	161.7	59.9	66.0	66.9	63.8	109.5	35.0	55.8	64.4	62.9	8.3	43.1	71.4	113.1	75.7	61.8	26.2	121.2	58.3	43.9	155.0	22.4	64.7	78.5	5.8	39.4	79.2	91.0	68.3	80.9	64.7
NACC2	"BEND9, BTBD14A, BTBD31, MGC23427"	ENSG00000148411	"NACC family member 2"	Q96BF6	9	136006537-136095285	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 71.6;Late spermatids: 228.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047924, HPA052962"	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA047924: AB_2680212, HPA052962: AB_2681998"	"unprognostic (1.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (8.28e-5)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.12e-2)"	15.3	9.0	27.4	10.9	26.3	2.7	12.8	16.3	37.3	10.0	15.5	14.5	11.7	8.3	11.4	6.9	11.6	10.1	16.6	16.8	20.7	16.7	8.0	15.2	8.3	7.6	30.3	6.4	10.3	10.0	6.2	3.8	3.9	15.2	12.7	5.5	10.2	9.9	23.8	12.6	5.8	9.5	31.7	33.4	7.8	8.2	7.8	11.0	0.0	5.8	4.7	3.1	21.8	4.6	0.0	2.4	5.7	4.5	0.5	1.7	1.4	3.1	17.3	1.9	26.3	8.5	4.8	2.4	7.7	5.2	2.5	0.8	7.3	5.7	0.0	9.3	12.2	4.0	12.4	4.2	4.2	0.8	9.6	3.8	2.1	16.6	9.1	8.7	0.0	4.0	8.0	3.9	2.3	2.3	10.3	6.9	0.0	6.5	0.0	4.8	10.6	0.0	6.0	5.9	5.0	10.8	0.0	2.0	5.2	10.3	3.6	0.7	0.8	10.9	9.2	9.5	9.2	9.3	19.8	11.4	6.7	7.6	5.6	5.3	0.0	0.0	0.1	8.9	0.7	13.4	2.8	4.5	1.5	1.7	3.6	0.7	0.0	0.6	1.5	2.4	0.0	0.5	0.6	5.7	0.5	3.4	0.3	0.4	1.4	27.4	26.3	16.3	17.7	20.7	16.7	30.3	6.4	15.2	11.0	11.9	5.3	1.5	4.0	4.0	2.1	25.0	10.2	1.4	4.5	5.2	0.0	0.6	0.0	10.1	71.6	13.0	6.8	0.0	11.7	1.6	6.4	8.7	2.3	31.1	6.9	3.2	2.4	17.8	38.6	228.0	16.7	10.8	5.0	5.4	4.1	16.7	15.4	8.6	18.0	12.6	1.8	25.8	18.9	1.8	4.5	4.4	0.3	2.9	4.5	7.0
NARF	"DKFZp434G0420, FLJ10067, IOP2"	ENSG00000141562	"Nuclear prelamin A recognition factor"	Q9UHQ1	17	82458180-82490537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 375.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053006			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA053006: AB_2682013"	"unprognostic (1.84e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (1.48e-10)"	"unprognostic (3.57e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.83e-2)"	13.7	10.6	21.2	15.7	20.2	35.0	17.4	24.2	23.5	8.2	13.1	10.1	11.1	13.8	9.5	11.0	13.1	11.2	10.6	28.5	15.7	12.3	10.1	21.3	11.8	15.1	16.4	15.0	11.2	13.8	9.0	11.9	10.2	16.3	10.9	9.0	14.7	13.6	12.0	44.4	15.4	11.0	9.8	10.6	17.7	13.6	35.4	18.1	12.4	11.7	11.2	11.5	11.7	12.4	11.6	10.1	50.6	10.6	15.9	13.6	11.5	8.7	8.2	14.0	22.1	6.6	6.5	7.9	5.2	5.5	9.0	9.3	9.5	3.1	5.6	5.9	4.2	10.3	7.8	10.2	6.6	6.2	5.9	22.7	11.8	11.8	11.7	5.9	12.0	21.0	9.7	11.0	7.1	2.4	9.1	17.0	18.5	26.8	4.2	4.0	7.5	21.0	19.4	5.9	6.8	17.9	17.5	14.2	8.9	4.2	9.1	17.1	24.3	13.7	9.3	16.0	9.5	8.0	9.8	8.5	11.7	10.0	9.6	8.9	38.7	14.6	12.4	10.7	8.5	6.9	24.4	10.6	29.5	11.6	9.4	12.7	11.6	11.4	11.2	10.1	11.0	13.1	10.9	50.6	15.9	7.0	8.3	13.6	11.5	21.2	20.2	24.2	23.5	15.7	12.3	16.4	15.0	16.3	18.1	11.9	21.0	45.4	29.2	33.2	32.8	37.2	17.8	30.8	12.5	5.2	51.1	27.5	33.2	47.7	143.2	38.3	36.0	93.5	57.8	48.2	29.1	28.2	52.9	17.3	29.6	47.7	54.6	43.0	21.3	375.7	23.3	29.7	59.1	68.5	24.8	23.0	67.6	26.0	17.0	18.3	34.2	12.9	37.1	136.6	75.4	30.9	25.6	45.7	31.0	25.5
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105602-34147670	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	18.5	22.8	20.5	21.9	27.5	23.6	20.8	21.9	29.9	18.1	17.6	24.3	16.4	13.7	30.6	19.8	25.2	21.7	14.7	16.4	17.2	18.6	15.9	21.8	15.1	28.7	16.9	19.8	26.4	24.9	31.5	23.1	20.1	23.4	19.5	21.7	23.0	22.5	17.8	23.4	31.0	16.6	21.5	15.1	23.6	18.0	30.9	16.9	31.2	18.3	19.4	35.3	17.8	19.7	10.4	12.8	2.2	11.1	11.8	13.7	6.9	12.4	17.6	9.4	20.0	11.4	10.1	10.9	12.4	9.1	15.8	12.6	19.7	7.2	40.0	9.2	10.4	13.6	18.9	35.4	18.9	20.2	11.1	22.7	18.1	14.4	18.4	10.3	45.3	13.2	10.3	13.0	10.3	29.0	7.4	12.0	19.3	39.5	14.0	13.1	23.6	36.9	20.6	13.5	21.6	21.2	27.8	31.9	16.7	9.1	21.8	14.0	10.6	16.7	17.7	7.4	9.5	17.7	12.5	9.6	14.1	11.2	20.6	22.9	15.3	18.3	38.1	14.2	18.8	13.9	0.5	6.6	2.2	10.3	11.1	13.7	10.4	11.1	11.7	12.8	9.6	11.5	11.2	0.8	11.8	9.7	9.7	9.6	6.9	20.5	27.5	21.9	29.9	17.2	18.6	16.9	19.8	23.4	16.9	6.0	16.5	12.0	9.6	10.9	11.2	9.8	10.2	14.7	22.7	14.0	11.8	15.4	5.0	6.8	3.8	7.8	3.5	23.3	8.3	9.9	7.4	6.4	4.7	7.2	10.5	11.1	6.9	6.7	4.0	2.1	8.6	6.0	1.7	11.8	8.5	7.7	6.9	2.9	12.4	5.0	10.1	12.9	8.1	17.9	25.4	12.0	12.0	10.2	12.4	6.3
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002440-113019861	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Club cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA069654: AB_2686164"	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	15.1	12.3	12.6	12.9	19.8	15.9	15.5	22.8	21.3	14.4	12.8	15.3	11.6	12.3	15.4	19.0	12.7	12.8	13.0	14.0	13.2	12.5	12.4	10.3	11.3	19.3	14.2	13.7	14.8	16.5	13.4	18.2	12.4	15.6	12.4	9.8	11.5	13.5	15.1	28.1	18.2	13.6	16.0	17.5	17.5	14.2	19.1	12.8	21.9	20.0	16.4	15.5	17.5	10.9	3.8	3.4	2.9	3.0	7.9	6.4	2.7	10.0	8.4	13.4	10.0	4.4	8.0	7.2	9.7	6.1	5.4	3.6	7.6	6.6	13.3	5.3	3.1	7.6	10.6	9.8	4.3	7.5	2.6	6.2	20.4	7.4	5.6	8.0	12.9	7.5	12.6	7.8	4.4	11.2	14.7	4.7	13.2	6.9	10.7	3.9	6.4	11.1	7.6	13.9	8.9	10.8	9.1	10.6	6.9	6.1	8.9	9.3	13.6	5.5	7.0	15.9	10.4	8.0	11.1	9.4	7.5	7.5	2.7	6.8	10.6	8.2	15.7	12.0	10.3	5.3	2.9	2.3	2.7	4.4	3.0	4.5	3.8	5.1	3.7	3.4	3.1	6.4	6.3	1.5	7.9	1.2	2.4	2.2	2.7	12.6	19.8	22.8	21.3	13.2	12.5	14.2	13.7	15.6	12.8	8.9	10.9	0.0	0.0	0.0	0.0	0.0	0.0	16.0	19.4	17.4	0.0	15.4	14.9	12.5	0.0	0.0	0.0	0.0	11.1	12.4	0.0	0.0	16.3	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	16.2	0.0	0.0	12.4	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0
NIP7	"CGI-37, FLJ10296, HSPC031, KD93"	ENSG00000132603	"NIP7, nucleolar pre-rRNA processing protein"	Q9Y221	16	69339430-69343111	"Predicted intracellular proteins"	"Ribosome biogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040856, HPA059850"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA040856: AB_2677171, HPA059850: AB_2684142"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.37e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (6.99e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	17.8	15.5	8.1	16.4	8.7	20.4	14.0	7.0	12.4	10.2	13.7	9.5	11.1	11.8	15.6	13.1	24.0	13.0	11.3	9.1	9.0	7.8	18.0	18.0	10.7	17.6	12.6	9.6	11.6	18.4	9.6	10.2	14.3	10.9	10.1	14.2	8.8	13.1	13.2	12.1	14.7	14.2	11.7	8.3	15.4	12.3	14.8	9.5	27.1	19.2	23.8	21.0	10.6	11.8	16.6	14.2	8.4	11.7	15.3	19.0	9.5	15.1	10.8	9.2	12.2	12.1	11.0	13.7	13.7	11.1	24.1	17.7	17.4	16.4	27.7	15.4	12.7	10.1	15.2	17.3	21.8	30.7	7.3	13.9	14.4	7.7	22.8	11.9	31.6	9.5	11.8	17.4	22.1	24.5	7.5	13.2	15.0	28.5	5.0	16.6	18.6	19.0	23.2	26.8	14.0	12.6	27.6	9.5	25.3	14.8	11.3	11.7	16.7	27.5	8.8	16.9	10.9	12.0	19.4	11.5	17.6	15.5	13.1	25.3	15.3	11.6	67.8	10.2	18.9	17.5	8.4	8.1	5.7	16.8	9.2	18.1	16.6	15.6	19.0	14.2	12.1	15.1	18.3	4.0	15.3	11.7	12.5	14.8	9.5	8.1	8.7	7.0	12.4	9.0	7.8	12.6	9.6	10.9	9.5	3.0	10.1	24.6	46.2	47.7	8.2	4.8	17.8	29.4	18.2	19.2	15.7	27.5	18.3	30.3	29.3	22.4	13.8	0.0	22.6	28.1	22.2	16.9	17.3	9.6	21.6	11.1	2.9	18.4	10.8	29.4	15.8	15.5	18.6	16.2	11.7	8.8	30.2	17.5	16.3	21.4	6.9	12.9	19.8	31.2	39.4	45.9	21.4	27.7	16.6	36.0
NKIRAS2	"DKFZP434N1526, kappaB-Ras2, KBRAS2"	ENSG00000168256	"NFKB inhibitor interacting Ras like 2"	Q9NYR9	17	42011382-42025644	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062861			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA062861: AB_2684884"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (9.37e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.42e-3)"	15.3	10.9	6.7	11.5	8.4	12.5	12.9	9.2	10.3	12.0	14.6	11.0	10.3	8.7	15.4	12.5	22.0	10.5	14.1	27.5	6.1	5.6	14.0	16.1	11.7	10.4	8.5	3.6	14.9	10.7	8.4	9.0	30.8	7.2	12.5	9.9	14.6	12.3	11.1	31.5	16.1	15.6	15.7	8.3	12.4	11.3	17.1	6.0	17.7	9.5	15.4	19.1	14.5	12.7	8.2	23.0	21.0	25.5	12.0	7.4	10.4	9.2	15.9	24.5	12.7	17.2	11.6	14.6	15.7	11.9	24.7	18.5	17.3	13.0	15.3	24.8	15.9	16.4	19.5	19.8	11.8	12.6	12.7	21.6	13.7	14.8	12.7	27.0	18.2	11.3	17.2	21.0	16.3	12.6	16.4	29.9	19.5	19.3	15.5	14.0	9.1	35.1	11.3	14.4	11.9	12.2	27.7	28.2	14.3	15.9	9.5	29.4	38.5	11.5	34.8	15.5	25.0	22.1	22.1	21.6	15.6	16.7	16.7	17.5	20.4	33.0	12.6	10.4	10.9	21.8	21.0	25.5	20.5	7.0	20.5	6.9	7.8	7.1	7.0	20.5	8.2	7.4	7.1	14.4	12.0	21.5	23.0	6.0	10.4	6.7	8.4	9.2	10.3	6.1	5.6	8.5	3.6	7.2	6.0	14.9	9.3	12.9	16.9	15.0	20.3	22.4	2.5	8.1	17.0	15.7	19.6	45.4	18.3	25.5	5.4	22.4	18.3	0.0	24.7	32.7	21.6	17.9	13.9	13.4	33.2	22.3	18.4	12.3	22.5	4.0	18.1	26.6	10.1	33.3	17.6	22.0	22.8	14.0	17.3	15.0	25.1	6.5	19.6	28.1	33.2	22.5	52.1	10.0	14.0	18.0
NKRF	"ITBA4, NRF"	ENSG00000186416	"NFKB repressing factor"	O15226	X	119588337-119605895	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001476			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA001476: AB_1079488"	"unprognostic (6.12e-3)"	"unprognostic (7.58e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (4.92e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.08e-3)"	3.8	7.9	14.5	6.2	24.3	7.6	6.5	11.4	34.9	4.9	4.0	4.4	1.1	4.7	4.8	5.6	5.6	5.2	4.1	3.8	15.4	14.0	6.9	6.9	4.1	9.7	8.1	24.6	7.4	3.9	8.3	6.5	7.5	25.7	4.9	4.5	2.9	4.6	4.3	4.8	6.4	4.4	4.7	6.0	6.4	4.0	1.9	3.5	7.4	5.4	1.4	9.7	5.2	4.8	3.8	2.7	2.8	2.2	1.3	5.5	1.7	11.0	11.2	6.6	7.7	5.8	5.9	10.1	6.7	5.5	9.1	9.9	11.9	9.5	19.6	11.8	5.8	7.8	13.0	27.7	10.3	11.2	9.8	18.9	10.3	13.4	7.9	5.4	20.0	8.0	6.2	8.5	10.5	12.3	6.2	9.2	9.7	11.1	8.3	8.1	17.0	12.7	16.0	14.8	16.1	12.6	10.0	9.5	20.1	12.0	8.2	10.9	9.1	9.4	14.7	9.9	7.2	6.2	12.2	7.5	5.8	6.2	12.4	16.8	6.8	8.2	20.7	6.0	22.4	6.5	2.8	1.3	1.5	3.3	2.2	3.1	3.7	3.6	3.7	1.3	3.8	5.5	4.8	0.2	1.3	1.1	2.7	4.3	1.7	14.5	24.3	11.4	34.9	15.4	14.0	8.1	24.6	25.7	3.5	6.0	6.2	9.0	9.2	17.2	13.3	4.0	10.2	2.7	2.3	5.2	25.5	11.6	1.7	3.8	0.1	4.5	2.6	0.0	3.1	13.2	6.2	8.4	14.9	3.4	5.6	7.9	10.3	4.3	6.0	0.0	7.2	7.8	5.0	6.4	3.8	4.0	3.1	0.0	6.3	3.7	8.3	0.0	8.2	0.5	1.1	22.5	12.5	7.0	5.7	8.7
NKX2-3	"CSX3, NKX2.3, NKX2C, NKX4-3"	ENSG00000119919	"NK2 homeobox 3"	Q8TAU0	10	99532933-99536524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;NB-4: 4.8;REH: 6.2;THP-1: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047561	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA047561: AB_2680088"		"unprognostic (5.70e-2)"	"unprognostic (2.95e-1)"			"unprognostic (2.70e-4)"	"unprognostic (6.34e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	0.8	0.0	0.1	17.2	0.1	0.0	0.1	0.1	0.1	0.3	21.6	0.1	0.1	10.4	0.2	0.1	0.5	0.0	12.5	0.1	0.1	0.0	0.1	0.2	0.1	1.1	0.1	0.1	0.1	6.4	0.0	0.1	0.1	0.1	0.1	4.6	0.1	9.0	0.5	0.1	0.0	19.1	3.1	0.1	36.8	1.8	0.1	0.1	0.2	1.0	0.7	3.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	6.2	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.4	0.0	1.6	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NLE1	"FLJ10458, NLE"	ENSG00000073536	"Notchless homolog 1"	Q9NVX2	17	35128753-35142315	"Predicted intracellular proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 40.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018807	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA018807: AB_1848658"	"unprognostic (9.19e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (8.64e-8)"	"unprognostic (8.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (6.39e-4)"	6.3	6.9	7.0	8.2	7.6	6.4	11.4	7.6	9.1	5.6	5.8	5.4	3.3	5.1	10.0	5.5	7.9	10.0	8.3	4.8	6.0	6.4	4.8	6.9	4.5	9.1	5.6	7.7	16.3	40.3	5.1	4.2	6.1	5.4	9.2	5.3	6.2	9.1	7.5	8.8	7.6	5.1	10.2	5.1	8.3	6.8	7.2	6.4	10.0	10.0	6.6	8.3	6.3	5.4	6.4	4.5	0.4	3.2	2.4	9.1	3.0	8.2	20.0	6.7	12.0	4.2	6.3	10.8	7.4	7.0	13.3	11.0	13.8	8.0	18.2	10.2	6.2	9.7	11.0	15.3	19.0	9.1	2.9	23.8	8.2	9.6	17.2	5.7	15.7	6.6	7.1	10.2	13.7	21.0	5.9	8.5	17.9	22.0	6.7	7.8	11.3	24.1	12.8	12.7	6.9	8.9	19.5	11.8	20.1	7.8	8.0	13.9	8.4	7.0	7.2	8.8	6.5	17.6	11.4	7.6	7.2	10.1	6.9	24.8	5.2	4.0	15.3	5.0	13.0	13.7	0.1	3.0	0.0	5.7	3.2	9.1	4.8	5.4	6.0	4.5	6.4	7.4	5.1	0.4	2.4	1.6	1.0	3.0	3.0	7.0	7.6	7.6	9.1	6.0	6.4	5.6	7.7	5.4	6.4	3.0	0.6	12.4	6.2	7.7	4.1	2.0	12.7	4.0	3.4	3.5	2.0	9.0	0.0	8.7	0.6	4.2	1.6	0.0	12.9	16.0	8.2	4.0	3.5	5.5	6.7	1.6	4.7	4.3	2.8	4.7	3.7	2.2	1.7	3.6	7.8	1.4	9.4	2.9	4.6	5.6	2.9	0.0	4.1	3.6	5.3	8.8	4.1	4.4	12.0	5.1
NMD3	CGI-07	ENSG00000169251	"NMD3 ribosome export adaptor"	Q96D46	3	161104696-161253532	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035019			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035019: AB_10600922"	"unprognostic (1.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.97e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-3)"	26.8	15.7	16.2	10.7	16.5	34.7	20.3	26.6	21.8	23.1	14.4	13.2	10.9	10.8	23.4	17.7	22.9	14.3	14.2	24.1	15.5	13.6	25.7	46.7	19.4	12.5	16.7	18.2	27.9	29.0	13.4	27.5	20.1	21.6	21.7	13.5	14.1	19.7	13.3	31.8	15.5	16.3	22.1	16.3	17.1	25.3	12.1	13.1	19.6	21.7	21.3	15.0	32.1	16.0	12.1	13.2	15.9	11.8	22.8	18.7	13.6	21.9	12.8	12.7	12.9	15.9	21.9	17.5	25.2	19.1	18.8	22.0	21.7	18.2	28.0	32.2	17.6	13.2	14.5	20.2	18.5	29.5	29.0	12.4	28.8	11.3	13.5	17.5	34.6	17.5	18.3	13.8	13.3	44.0	20.2	20.4	9.8	21.1	15.5	22.2	50.2	15.6	13.2	15.9	26.6	20.5	19.3	18.3	28.3	17.9	49.9	20.2	12.6	14.3	35.2	20.8	14.4	26.2	15.9	17.8	15.1	10.8	17.2	30.3	25.6	17.2	28.7	18.8	22.6	20.5	15.9	10.8	5.7	11.8	11.8	18.3	12.1	13.9	14.5	13.2	10.4	18.7	14.5	2.5	22.8	7.3	7.4	17.1	13.6	16.2	16.5	26.6	21.8	15.5	13.6	16.7	18.2	21.6	13.1	17.9	13.4	25.1	43.8	57.7	23.4	39.6	20.4	16.0	17.0	10.4	13.7	29.3	29.9	22.3	12.2	23.2	13.4	0.0	33.9	37.0	34.9	39.0	25.3	38.5	21.3	28.6	13.2	20.9	32.4	4.7	23.6	22.5	23.6	25.2	17.7	12.3	30.1	10.5	25.8	26.9	18.0	25.8	91.0	30.3	26.0	65.0	47.4	25.9	18.8	62.7
NOC4L	"MGC3162, NET49, Noc4, UTP19"	ENSG00000184967	"Nucleolar complex associated 4 homolog"	Q9BVI4	12	132144448-132152473	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053424			Supported	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA053424: AB_2682147"	"unprognostic (9.44e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.79e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	11.9	10.3	9.0	14.2	11.6	18.8	11.1	11.5	17.2	9.9	9.2	14.1	7.8	14.8	11.5	6.4	12.0	10.7	10.4	8.6	8.0	7.5	11.2	15.6	9.2	13.7	14.7	8.5	13.6	16.8	7.1	10.4	9.7	12.1	9.8	6.9	10.3	16.2	8.8	22.5	15.7	11.9	8.2	9.2	15.5	12.5	28.4	10.6	15.7	10.5	13.2	12.3	9.5	9.5	13.9	18.8	5.9	16.1	7.4	11.4	8.1	12.4	23.1	5.1	8.0	2.6	2.7	26.2	8.6	4.4	10.6	5.8	18.8	5.9	19.1	9.5	4.4	6.3	11.2	9.1	9.4	2.3	7.5	25.0	12.8	7.6	12.3	6.8	14.9	15.0	4.0	6.5	8.3	6.7	4.0	7.4	14.7	21.7	4.4	4.3	14.6	14.2	35.1	15.0	7.3	18.4	18.5	5.7	16.7	5.5	9.2	12.6	10.0	7.3	10.0	6.3	3.1	14.0	9.3	9.8	6.3	16.1	10.1	14.3	11.2	6.9	16.7	9.7	12.9	13.3	2.5	11.8	5.9	11.4	16.1	11.0	13.8	10.6	11.3	15.8	13.9	9.3	8.9	1.7	7.4	12.1	18.8	8.7	8.1	9.0	11.6	11.5	17.2	8.0	7.5	14.7	8.5	12.1	10.6	8.9	7.8	13.0	13.7	19.8	7.9	6.0	25.5	0.0	3.4	3.5	0.0	28.1	6.6	25.9	57.6	11.1	15.2	0.0	28.5	27.4	15.4	9.4	16.1	9.5	22.0	7.9	7.0	11.6	11.0	60.3	13.6	14.1	13.5	13.6	11.1	6.7	23.0	8.6	7.4	16.5	5.0	19.4	14.4	37.9	50.3	18.9	25.5	14.9	16.2	11.9
NOL6	"bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22"	ENSG00000165271	"Nucleolar protein 6"	Q9H6R4	9	33461441-33473930	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055891, HPA061002"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA055891: AB_2682959, HPA061002: AB_2684410"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (7.37e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (4.09e-1)"	15.3	14.9	13.3	17.7	19.7	21.0	14.9	16.8	30.8	16.0	11.4	14.6	9.0	10.3	15.3	11.9	21.1	12.8	18.2	13.1	12.4	10.6	13.8	41.6	13.5	15.8	10.1	11.4	20.5	20.5	22.7	18.2	15.4	19.2	17.5	14.8	12.5	15.5	15.5	23.4	23.5	11.3	17.0	7.3	17.6	13.0	19.0	7.8	13.8	13.2	19.7	20.9	12.4	14.5	4.2	7.1	0.3	8.4	3.9	6.0	3.4	15.6	22.6	8.6	19.5	13.5	9.3	14.8	17.5	13.1	20.5	17.2	24.9	5.8	27.3	8.0	19.6	9.0	11.0	25.0	25.1	21.7	17.3	10.4	14.0	26.3	13.8	13.3	31.9	20.6	10.3	20.8	27.1	26.2	8.5	13.4	10.1	22.8	10.5	16.2	13.8	17.8	32.1	31.2	17.5	20.6	15.4	8.5	14.2	15.8	18.8	10.2	14.1	14.6	18.9	6.2	9.6	7.6	18.6	14.9	12.6	17.0	15.8	30.4	10.0	14.0	23.1	11.2	16.9	14.4	0.0	4.0	0.3	5.4	8.4	6.0	4.2	4.1	5.2	7.1	3.6	5.1	4.8	0.2	3.9	7.9	3.8	4.0	3.4	13.3	19.7	16.8	30.8	12.4	10.6	10.1	11.4	19.2	7.8	3.0	14.6	4.5	5.1	17.7	4.5	5.5	7.6	4.0	11.4	3.5	5.9	3.4	3.3	6.7	17.3	6.0	2.3	0.0	3.4	4.8	4.1	6.5	3.5	6.7	4.4	3.2	9.8	3.7	1.2	17.9	5.5	2.7	5.0	1.8	4.1	4.2	4.9	0.0	5.6	2.1	3.5	0.0	5.1	2.3	6.1	22.6	2.5	5.0	6.8	7.4
NOL8	"C9orf34, FLJ20736, Nop132"	ENSG00000198000	"Nucleolar protein 8"	Q76FK4	9	92297358-92325636	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044440, HPA062922"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Mitotic chromosome"	"HPA044440: AB_10963212, HPA062922: "	"unprognostic (3.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.69e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.53e-2)"	15.8	11.5	11.6	14.6	20.0	8.5	13.6	15.9	15.9	15.1	13.2	7.3	12.1	6.4	16.4	11.1	14.1	13.0	9.4	9.4	13.7	8.2	10.6	8.9	9.5	13.6	17.9	8.4	17.5	11.1	25.3	23.6	11.8	13.4	14.0	11.0	5.2	11.0	13.2	15.0	12.9	10.7	14.6	19.5	15.7	10.6	7.7	17.8	18.7	15.2	11.2	15.1	16.3	16.2	13.6	12.2	13.6	14.7	12.6	17.5	6.6	8.1	13.2	6.1	12.3	13.9	11.8	8.4	9.3	7.3	10.0	9.6	4.7	8.5	25.6	8.2	9.8	16.6	16.9	21.8	13.0	11.1	16.0	9.9	18.2	13.2	10.5	9.4	30.3	13.9	12.4	9.6	11.2	15.7	8.2	12.3	7.6	27.6	7.9	11.5	13.1	21.1	10.6	10.3	11.6	12.6	12.8	18.0	10.4	5.2	5.5	11.4	5.6	12.8	11.2	7.8	8.3	4.5	9.6	11.9	9.3	6.0	13.1	9.7	8.0	17.9	13.9	8.6	17.5	11.9	13.6	8.3	11.3	12.5	11.1	17.5	13.6	11.9	12.0	12.2	12.6	14.6	12.5	3.2	12.6	14.7	10.3	13.2	6.6	11.6	20.0	15.9	15.9	13.7	8.2	17.9	8.4	13.4	17.8	17.9	33.1	27.4	15.8	11.6	18.5	25.6	12.7	32.1	23.9	10.4	9.8	16.1	13.3	20.5	9.0	20.2	8.8	23.3	11.2	17.4	13.2	11.2	48.8	9.6	23.0	27.0	8.6	20.3	16.1	6.8	29.7	19.8	10.1	27.1	14.3	13.7	15.3	7.0	22.3	12.4	16.8	6.5	13.4	46.1	37.9	13.9	12.2	15.2	17.9	9.6
NOL9	"FLJ23323, Grc3, NET6"	ENSG00000162408	"Nucleolar protein 9"	Q5SY16	1	6521347-6554535	"Predicted intracellular proteins"	"rRNA processing"	"Kinase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036347			Supported	"Nucleoli,Intermediate filaments"		NA	NA			Nucleoli	"Intermediate filaments"	"HPA036347: AB_2675076"	"unprognostic (3.03e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.14e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.65e-2)"	12.7	11.3	10.4	10.3	15.1	19.3	11.0	16.4	19.3	14.7	11.2	14.1	6.8	7.7	13.3	11.6	12.1	11.4	8.8	8.3	10.8	9.7	9.6	15.2	9.4	14.4	8.6	9.6	16.8	14.7	15.5	10.5	9.8	12.0	13.0	10.0	9.4	9.1	10.3	17.9	18.0	11.4	12.4	7.2	22.0	11.0	9.4	9.2	20.9	9.4	8.9	14.9	11.0	9.3	6.9	5.8	5.0	4.8	2.8	8.4	1.9	5.1	7.4	4.2	12.6	5.6	3.4	4.5	5.1	3.3	5.3	5.6	10.1	7.0	14.3	6.1	5.7	4.6	6.8	8.4	6.9	9.2	5.8	4.5	9.7	11.4	7.9	5.6	8.2	5.4	4.9	2.1	11.3	9.9	3.1	6.2	6.4	11.4	6.0	5.4	8.9	8.0	7.4	5.7	4.0	7.2	10.2	9.8	6.7	4.2	4.8	8.1	3.7	7.9	10.0	6.2	4.5	6.5	3.8	8.1	8.5	6.9	6.0	8.5	5.1	4.8	26.1	7.9	9.2	4.0	5.0	3.5	2.6	5.7	3.2	5.7	5.1	8.1	5.2	2.3	6.9	8.4	7.0	2.2	2.8	4.8	5.8	5.1	1.9	10.4	15.1	16.4	19.3	10.8	9.7	8.6	9.6	12.0	9.2	17.9	17.9	11.5	5.7	13.7	15.8	12.1	10.2	9.4	7.9	7.0	13.7	13.0	13.3	8.4	4.6	11.3	5.8	0.0	7.4	11.0	11.7	4.8	4.7	11.6	7.8	9.5	6.4	17.2	11.4	13.3	8.9	6.5	1.7	10.0	11.7	7.2	7.8	7.0	12.0	7.8	17.0	0.0	11.1	10.8	19.7	12.9	10.6	15.7	11.8	5.3
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963385	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.3	16.8	9.8	22.4	13.2	19.0	16.2	21.1	15.2	12.0	12.6	9.0	12.6	12.0	14.3	11.7	19.0	12.1	14.7	14.8	8.9	7.1	13.6	34.0	12.9	20.8	10.0	8.7	20.7	26.8	13.9	15.5	12.8	10.6	12.3	12.8	11.1	14.7	14.6	38.6	21.4	13.1	12.4	9.8	18.0	15.1	9.8	11.4	17.9	15.4	16.3	20.9	18.1	18.9	5.2	4.9	1.3	3.8	4.4	8.4	3.0	16.3	13.9	8.3	17.1	11.2	12.7	14.5	15.1	10.8	15.8	13.0	18.1	17.3	46.3	10.7	12.2	11.5	11.3	22.8	19.6	17.0	8.8	21.8	36.8	13.2	16.4	14.8	39.9	16.1	12.8	17.7	17.8	16.3	7.8	13.2	14.3	33.3	16.5	11.8	11.7	42.1	30.1	21.6	15.1	22.8	27.3	12.6	15.4	7.9	26.4	17.2	10.1	12.5	9.3	11.8	7.9	17.8	15.8	16.4	13.2	7.7	16.1	27.7	12.4	19.9	40.0	13.8	29.6	13.7	1.3	3.2	0.6	4.8	3.8	8.4	3.4	5.8	7.0	4.0	5.2	7.0	5.2	0.5	4.4	2.5	4.9	3.8	3.0	9.8	13.2	21.1	15.2	8.9	7.1	10.0	8.7	10.6	11.4	17.9	22.5	10.4	13.9	23.0	9.0	18.2	15.3	17.4	35.2	1.8	13.7	12.7	10.0	12.9	1.7	14.3	3.6	0.0	20.6	13.2	7.6	9.5	19.7	23.1	9.9	19.1	8.6	9.2	3.2	2.1	11.5	11.3	0.0	15.4	9.7	6.0	16.8	8.6	9.2	10.1	7.1	12.9	13.3	9.2	20.6	28.4	9.6	12.5	13.4	14.8
NOVA1		ENSG00000139910	"NOVA alternative splicing regulator 1"	P51513	14	26443093-26597754	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 198.3;Horizontal cells: 128.7;Leydig cells: 139.2;Spermatocytes: 170.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 25.9;ASC diff: 14.1;HAP1: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004155	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA004155: AB_1079497"	"unprognostic (1.46e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.21e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.04e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.27e-4)"	"unprognostic (9.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-4)"	17.8	6.7	17.5	3.4	17.4	1.3	32.9	54.7	49.2	12.2	6.3	13.3	5.0	2.5	9.4	6.9	4.0	6.2	6.2	3.0	17.1	25.1	7.0	2.2	2.7	4.4	19.2	17.8	6.3	2.7	4.4	14.1	1.3	26.4	5.4	6.5	4.0	2.8	17.5	6.9	3.1	3.4	9.9	22.5	2.1	3.3	10.3	14.9	0.0	4.1	2.7	5.2	5.6	9.4	0.3	0.3	0.6	0.4	2.2	0.5	0.0	0.0	6.1	25.9	0.0	14.1	7.6	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.4	4.2	0.1	12.7	0.1	0.0	0.0	1.0	0.0	0.0	0.2	5.3	0.0	1.2	9.4	0.0	1.9	1.9	9.4	5.4	5.4	0.0	0.0	4.1	0.0	5.3	0.1	7.6	0.0	6.1	0.7	8.6	0.1	3.6	4.9	8.3	4.8	0.0	0.0	0.0	2.6	0.7	0.0	0.0	3.6	4.2	3.1	0.7	0.0	0.0	0.0	5.1	0.0	3.8	0.6	0.0	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.3	0.2	0.5	0.6	2.2	0.4	0.3	0.4	0.0	17.5	17.4	54.7	26.9	17.1	25.1	19.2	17.8	26.4	14.9	0.0	1.0	0.0	6.8	4.6	198.3	0.8	2.5	8.1	0.0	14.0	3.9	0.0	8.3	0.0	14.7	6.2	0.5	0.0	0.3	0.0	12.1	2.1	0.0	0.2	0.2	128.7	63.4	35.0	1.2	11.2	139.2	1.9	3.3	0.0	2.3	26.6	3.1	10.5	61.9	20.4	13.0	6.5	19.8	170.1	57.9	2.8	0.0	0.0	3.7	0.6
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 28.1;Cone photoreceptor cells: 19.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.1;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 13.3;HEL: 10.7;Hep G2: 23.7;JURKAT: 7.2;THP-1: 8.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.8	15.6	14.4	0.5	11.4	1.3	2.3	20.4	27.6	1.9	1.4	0.8	0.3	2.4	4.9	1.3	1.4	2.8	2.2	1.5	13.0	13.8	2.9	1.3	2.0	1.0	14.9	15.7	0.8	7.4	40.2	7.8	0.9	7.2	4.7	1.4	3.7	3.1	1.8	0.8	2.0	1.4	4.0	3.0	7.5	2.0	3.1	2.4	0.1	23.2	0.0	0.8	1.4	0.8	0.4	0.0	4.1	0.0	0.0	2.2	0.1	2.9	0.4	0.1	0.2	0.7	0.0	1.2	0.3	0.4	1.9	3.8	1.2	2.8	0.0	0.9	0.0	0.2	13.3	0.3	0.0	1.1	0.1	0.3	10.7	0.7	23.7	2.4	1.4	1.0	0.4	1.8	0.0	0.2	2.9	0.0	7.2	0.3	0.0	0.1	0.0	0.1	2.8	0.6	4.7	0.3	0.2	1.0	0.6	4.4	0.0	2.9	0.2	0.0	0.0	3.5	0.0	0.5	8.4	0.0	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.9	0.0	2.2	0.0	0.9	2.1	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	1.4	0.1	14.4	11.4	20.4	27.6	13.0	13.8	14.9	15.7	7.2	2.4	0.0	1.4	0.5	8.2	0.1	28.1	2.0	2.5	9.4	11.4	0.0	19.6	0.1	3.3	6.3	15.2	0.3	0.4	0.0	7.0	0.2	0.4	3.3	0.0	0.4	3.5	6.4	10.9	2.5	0.0	10.4	0.6	1.2	10.1	1.8	1.5	0.9	5.4	0.0	0.4	9.8	3.9	0.0	1.4	0.5	0.3	1.0	0.2	4.3	0.6	5.8
NRG2	"Don-1, HRG2, NTAK"	ENSG00000158458	"Neuregulin 2"	O14511	5	139846779-140043299	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 9.0;Bipolar cells: 15.1;Leydig cells: 8.9;Muller glia cells: 9.7;Peritubular cells: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.4;Karpas-707: 5.6;PC-3: 14.8;RPTEC TERT1: 7.5;SCLC-21H: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038935, HPA047973"	Approved		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA			Nucleoplasm	Nucleoli	"HPA038935: AB_10672833, HPA047973: AB_2680226"	"unprognostic (8.66e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.26e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.64e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.07e-2)"	4.5	4.5	4.0	1.4	7.0	0.6	4.4	27.3	5.1	13.1	2.3	3.8	2.6	1.0	3.0	2.9	3.7	7.6	7.6	1.5	4.2	3.5	1.3	0.6	1.2	2.1	5.2	3.4	15.9	3.2	15.8	7.7	1.1	4.1	4.5	0.9	2.9	13.6	4.7	6.0	5.0	1.0	5.1	3.6	3.3	1.1	2.7	4.9	0.0	0.8	1.0	1.5	4.8	3.7	0.4	0.1	0.0	0.1	0.0	2.1	0.1	0.0	2.0	0.2	8.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.0	0.4	0.0	4.0	2.4	0.4	0.2	0.1	4.8	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.5	0.9	0.2	0.2	0.0	5.6	0.0	0.4	0.0	0.0	0.1	0.0	14.8	0.1	0.0	0.0	7.5	1.8	5.6	3.4	0.0	3.2	3.3	0.0	0.0	0.0	0.2	2.6	0.4	0.0	1.6	1.1	0.0	0.0	3.7	0.0	0.7	0.0	0.0	0.0	2.1	0.1	0.5	0.1	0.2	0.4	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.1	0.0	0.1	4.0	7.0	27.3	5.1	4.2	3.5	5.2	3.4	4.1	4.9	0.0	0.0	0.0	9.0	2.5	15.1	1.4	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.3	0.5	0.9	0.0	0.0	1.9	0.0	1.8	1.3	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.6	8.9	0.0	3.3	0.0	0.0	9.7	0.8	0.0	9.6	1.5	0.7	6.5	1.1	3.0	4.3	0.3	0.0	0.8	0.0	5.9
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2, ribosome biogenesis homolog"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043487	Approved		Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA043487: AB_2678507"	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	25.4	32.6	17.4	26.8	29.3	28.3	24.0	14.0	29.4	31.8	25.8	8.0	18.0	26.2	26.5	22.6	27.9	22.9	13.5	27.7	20.8	13.6	27.4	35.4	27.0	42.5	16.7	19.1	54.2	31.2	13.5	35.4	25.4	20.3	27.8	20.6	10.4	33.8	17.9	51.1	17.3	22.2	23.1	28.5	28.5	24.3	44.5	15.7	26.4	27.2	21.7	26.1	36.7	26.1	17.0	11.1	4.4	11.9	13.1	19.3	6.1	20.6	11.3	14.0	18.8	8.7	16.1	21.4	14.8	7.7	9.5	7.5	18.7	20.3	16.7	31.6	8.2	23.3	12.8	11.0	16.3	13.4	11.4	17.0	8.7	22.0	21.4	8.1	15.2	20.5	10.6	15.4	12.7	9.4	15.5	7.9	15.2	8.6	14.1	10.1	15.7	25.5	38.2	9.3	8.8	9.9	18.3	16.4	31.5	11.9	22.8	15.0	19.6	8.9	17.3	39.9	11.0	16.3	43.3	9.1	7.3	22.1	13.7	42.5	14.1	18.8	27.3	18.3	27.0	10.8	4.4	7.2	4.2	10.5	11.9	15.1	17.0	16.0	15.8	11.1	12.4	19.3	19.1	1.3	13.1	8.8	10.4	15.8	6.1	17.4	29.3	14.0	29.4	20.8	13.6	16.7	19.1	20.3	15.7	74.5	77.0	155.5	140.9	83.6	31.6	79.5	137.6	66.9	104.6	59.3	13.7	119.1	127.6	113.6	331.3	86.4	114.1	116.8	204.5	170.1	84.0	110.5	116.6	184.7	121.5	47.7	134.0	113.5	170.4	102.0	257.7	109.4	79.2	149.7	219.3	47.0	172.0	119.3	161.2	158.4	31.4	135.8	91.0	120.5	95.0	75.2	113.3	107.1	207.0	165.4
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase family member 5"	Q96P11	7	73302517-73308867	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847"	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	9.0	7.7	11.2	13.1	12.8	40.9	8.7	12.9	14.4	8.5	10.3	15.0	4.8	12.6	12.3	6.9	10.8	12.0	8.1	9.4	10.8	9.3	9.4	9.8	8.0	16.1	19.4	11.9	10.6	19.6	9.5	8.3	8.3	13.6	9.7	6.2	7.7	13.6	9.7	27.1	11.8	12.1	10.9	11.6	15.8	9.6	14.6	13.6	23.5	10.6	11.2	12.1	10.6	8.9	33.5	21.2	18.7	14.4	16.8	22.3	15.3	12.2	17.0	4.8	10.5	2.0	2.5	18.2	5.9	3.4	9.1	9.8	22.9	9.1	20.2	4.0	2.9	13.4	10.6	9.0	5.9	3.0	13.3	20.9	7.6	12.4	13.1	7.8	16.8	10.4	3.4	9.9	7.8	6.6	2.1	1.2	15.2	24.9	4.8	4.3	29.5	14.2	34.6	19.3	9.0	13.1	17.4	3.6	28.9	3.9	6.1	12.4	20.7	10.3	27.6	13.3	5.4	17.7	13.4	1.9	0.1	13.3	13.2	3.9	19.3	24.9	28.8	0.2	23.6	0.9	14.2	14.4	15.0	14.0	12.5	11.0	21.5	15.9	14.3	16.5	33.5	22.3	18.8	18.7	16.8	9.3	21.2	17.3	15.3	11.2	12.8	12.9	14.4	10.8	9.3	19.4	11.9	13.6	13.6	6.0	6.1	51.6	17.1	15.0	25.1	17.1	25.5	10.7	12.5	34.9	11.8	33.4	31.5	36.0	12.8	7.3	18.6	0.0	28.6	37.8	16.9	12.9	26.5	20.3	30.9	30.2	3.5	6.7	17.4	16.3	27.0	19.4	20.3	46.9	16.4	13.8	24.0	17.5	19.4	19.5	21.4	6.5	14.1	60.6	58.5	18.6	18.2	25.4	19.9	15.5
NUB1	"BS4, NUB1L, NYREN18"	ENSG00000013374	"Negative regulator of ubiquitin like proteins 1"	Q9Y5A7	7	151341699-151378449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"monocytes: 930.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021220, HPA050722, HPA053648"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217"	"unprognostic (7.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (8.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.83e-3)"	20.1	17.3	17.1	22.1	15.5	13.2	20.5	20.5	20.0	22.2	25.0	17.6	17.3	30.9	24.4	17.6	18.1	19.8	17.0	16.5	14.8	12.9	17.1	18.9	21.2	28.7	14.3	15.4	25.4	21.7	28.0	26.4	23.7	18.5	21.6	15.3	16.2	19.8	15.7	30.3	16.9	38.3	20.8	19.8	26.5	17.7	56.0	16.0	32.3	26.5	15.9	19.8	25.3	22.3	21.1	18.9	28.9	24.0	24.5	24.7	17.1	27.0	12.3	16.6	9.8	17.3	21.2	13.8	21.8	20.1	16.6	19.2	12.0	24.0	29.2	28.9	13.6	21.3	13.7	9.9	14.2	10.7	25.8	16.7	10.6	11.7	7.6	24.3	24.6	13.8	13.5	16.7	11.9	11.3	20.6	10.9	14.9	27.7	0.8	13.3	14.5	43.5	18.7	26.0	27.7	16.2	24.2	17.2	4.4	12.3	13.4	15.6	26.0	40.9	17.6	20.8	12.1	12.0	14.2	22.0	14.1	5.0	18.7	20.6	28.5	21.7	25.7	28.5	21.2	23.0	10.4	15.7	20.7	20.9	20.3	24.7	21.1	18.3	21.1	13.6	19.9	20.4	19.0	28.9	24.5	24.0	18.9	14.3	17.1	17.1	15.5	20.5	20.0	14.8	12.9	14.3	15.4	18.5	16.0	68.5	57.3	44.2	28.5	22.0	35.4	51.7	30.6	72.3	71.7	24.4	11.8	39.1	51.4	43.6	181.4	36.0	42.1	0.0	60.6	37.7	28.4	41.4	69.4	33.4	27.3	46.1	28.2	30.7	34.8	15.4	40.9	42.6	15.1	930.6	41.4	52.7	51.5	17.5	38.5	30.5	40.1	25.8	38.7	96.0	12.7	25.3	41.9	48.0	21.9	30.6
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712819-205750276	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	25.6	25.3	46.9	17.3	55.5	12.1	31.3	45.0	49.2	33.0	24.2	38.3	18.8	12.5	36.5	27.8	25.3	32.1	22.5	40.6	43.8	35.6	30.9	43.9	20.6	29.4	43.6	47.6	49.1	17.4	50.3	21.0	20.8	32.8	31.9	21.1	21.9	19.0	32.7	43.1	21.7	14.6	42.9	49.1	22.6	17.9	14.2	38.9	35.3	42.5	20.6	24.8	32.0	22.6	7.8	7.4	4.5	4.9	10.7	11.8	4.0	40.6	25.0	67.5	26.6	18.7	25.9	31.8	29.4	30.3	41.3	33.3	13.7	47.0	45.2	17.1	28.6	13.1	30.1	51.2	24.6	47.4	21.6	25.6	29.4	22.1	14.9	13.8	46.1	10.5	20.5	22.3	24.5	42.8	22.2	32.2	29.3	47.1	14.5	32.2	47.0	41.8	23.3	68.9	16.3	18.7	43.7	83.2	25.9	23.1	25.1	28.1	52.0	43.3	34.7	23.5	54.6	53.1	34.8	32.1	31.7	28.2	36.1	51.9	13.4	15.7	36.5	21.8	26.0	42.6	4.5	3.4	3.7	9.9	4.9	9.6	5.8	9.2	8.6	4.7	7.8	11.5	11.8	0.6	10.7	4.0	7.4	5.5	4.0	46.9	55.5	45.0	36.6	43.8	35.6	43.6	47.6	32.8	38.9	199.5	245.2	149.9	252.8	229.2	349.8	365.7	310.8	239.6	291.2	287.9	68.7	230.3	326.6	177.1	41.7	224.6	54.9	233.6	148.6	321.5	312.0	255.4	201.9	550.1	225.1	298.8	172.0	219.1	173.7	32.2	474.1	194.8	165.4	192.0	193.2	516.1	113.3	94.7	456.1	297.2	177.2	310.4	243.6	46.5	115.0	213.3	148.2	154.5	216.0	173.7
NUDT14	UGPP	ENSG00000183828	"Nudix hydrolase 14"	O95848	14	105172938-105181323	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046755, HPA058759"	Approved		Approved	Nucleoli,Microtubules		NA	NA			Microtubules	Nucleoli	"HPA046755: AB_10963433, HPA058759: AB_2683809"	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.05e-3)"	"unprognostic (9.17e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.16e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.38e-1)"	18.2	12.6	22.4	5.0	16.0	3.1	14.3	2.5	23.4	6.5	11.0	7.9	5.9	16.7	4.7	11.7	7.1	12.6	9.8	20.9	15.4	13.5	16.7	11.2	12.6	9.4	16.1	14.8	4.0	26.0	4.7	27.6	4.8	11.2	10.5	4.6	14.7	16.7	9.9	28.7	6.2	13.8	3.1	13.2	6.3	12.7	8.9	7.8	3.1	17.9	9.2	5.7	4.9	4.7	5.8	15.1	1.7	27.3	6.1	5.8	8.9	8.2	11.3	1.0	4.4	1.3	1.6	18.1	2.3	3.1	3.8	5.5	8.0	8.8	0.6	11.6	1.2	8.5	10.4	0.5	6.3	0.3	4.3	8.3	1.8	4.9	5.5	9.7	2.2	22.3	2.3	8.0	0.9	0.7	1.6	7.5	4.1	2.8	1.4	1.3	24.0	0.2	0.0	5.9	19.5	15.8	4.3	10.4	4.8	4.1	23.8	15.7	2.3	4.1	0.1	9.6	1.9	8.9	10.7	17.6	6.3	2.8	4.5	2.3	0.7	0.4	1.0	9.3	2.5	2.3	1.7	18.5	0.5	5.8	17.4	3.6	5.8	4.6	3.8	15.1	4.0	4.5	5.2	0.6	6.1	27.3	7.3	2.5	8.9	22.4	16.0	2.5	23.4	15.4	13.5	16.1	14.8	11.2	7.8	11.9	22.0	13.7	80.0	34.6	11.8	47.7	35.7	34.8	5.7	33.2	17.7	39.7	149.2	84.7	2.5	43.4	95.9	0.0	26.5	19.7	19.5	39.7	39.1	21.8	112.1	33.4	35.8	22.7	24.1	8.2	10.6	28.5	43.9	36.9	61.8	28.1	58.1	126.7	3.5	138.7	12.3	0.0	9.5	10.0	28.9	16.7	31.9	15.2	80.1	65.1
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 18.2;eosinophil: 18.8;intermediate monocyte: 21.9;myeloid DC: 13.6;neutrophil: 14.6;non-classical monocyte: 24.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.6;granulocytes: 18.8;monocytes: 24.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA060452: AB_2684279, HPA062492: AB_2684781"	"unprognostic (4.85e-3)"	"prognostic favorable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	25.9	13.4	22.1	13.1	22.0	8.7	13.1	13.5	20.5	11.1	32.8	23.9	13.9	20.2	11.7	11.6	8.7	14.0	13.6	22.2	21.1	19.6	25.9	23.1	16.2	31.1	27.7	16.9	23.0	18.3	32.9	9.7	7.6	20.1	13.4	18.4	13.6	11.7	13.6	20.3	6.8	37.5	18.5	30.4	22.2	13.8	9.5	21.6	2.2	17.1	11.5	9.1	12.4	8.4	4.3	13.6	18.8	24.5	3.7	4.3	6.7	12.6	6.8	11.2	5.8	22.5	20.5	5.2	10.4	9.6	7.0	7.3	10.4	5.7	2.1	9.1	9.6	13.9	9.3	9.9	6.5	11.2	6.3	7.2	5.4	8.7	10.0	14.4	9.0	9.9	18.2	5.8	4.6	12.7	6.3	10.9	0.0	6.1	11.0	6.8	13.2	0.0	2.4	8.7	12.7	10.1	7.1	8.1	16.0	7.0	10.3	5.5	9.6	6.2	6.3	9.5	9.9	13.8	7.2	10.7	11.5	5.0	21.0	8.0	11.0	10.8	0.3	7.4	7.0	6.3	2.2	18.2	18.8	2.6	21.9	2.7	4.3	2.7	2.4	13.6	4.2	2.4	2.4	14.6	3.7	24.5	1.8	4.3	6.7	22.1	22.0	13.5	20.5	21.1	19.6	27.7	16.9	20.1	21.6	14.9	31.3	19.1	10.7	7.4	22.7	83.1	40.8	16.0	18.2	19.2	7.9	18.7	58.0	20.4	59.4	30.8	62.9	23.3	32.8	21.8	21.4	14.7	18.5	95.7	54.0	41.3	24.3	84.1	138.2	27.2	24.5	46.3	16.9	14.4	61.2	10.0	23.8	50.3	37.1	92.4	18.3	25.8	23.7	17.6	5.1	4.6	6.1	20.8	42.4	14.7
NUDT8	FLJ41567	ENSG00000167799	"Nudix hydrolase 8"	Q8WV74	11	67627938-67629930	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 96.8;Hepatocytes: 168.1;Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 68.5"					"Low region specificity"	"Detected in all"			"HPA041252, HPA041466"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA041252: AB_10794551, HPA041466: AB_10793967"	"unprognostic (8.31e-2)"	"unprognostic (7.26e-3)"	"unprognostic (7.31e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.69e-1)"	"unprognostic (4.12e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.70e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.19e-1)"	5.5	2.0	3.0	4.1	4.1	2.1	10.8	4.1	2.7	3.9	8.1	3.5	10.1	10.6	1.7	4.8	22.0	2.4	5.9	32.5	2.6	3.0	16.0	21.4	3.8	4.3	4.9	2.3	2.2	7.7	4.3	1.3	2.5	5.9	4.2	4.2	2.0	28.3	8.2	38.2	12.4	12.2	2.4	4.1	1.9	6.9	1.4	2.3	2.0	13.6	25.0	15.3	1.6	4.7	7.1	11.8	1.0	11.2	8.1	3.4	2.1	10.4	4.2	1.6	2.7	1.5	2.0	2.6	2.2	1.0	0.9	0.9	3.5	2.7	10.9	3.4	1.7	1.3	5.1	1.9	1.3	0.1	10.6	4.6	0.6	1.8	10.6	0.4	3.4	5.3	1.2	2.6	1.1	0.3	0.2	1.9	13.9	3.0	9.8	0.7	17.5	5.7	5.0	0.9	18.4	8.6	3.5	0.8	68.5	2.7	1.8	0.8	1.1	0.5	6.1	2.1	0.6	3.3	1.4	0.5	2.3	3.3	14.9	0.4	7.0	4.6	2.1	1.6	4.7	1.3	0.0	1.0	1.0	3.1	3.9	2.6	3.3	1.8	3.4	4.3	7.1	1.6	1.9	0.0	8.1	11.2	11.8	1.1	2.1	3.0	4.1	4.1	2.7	2.6	3.0	4.9	2.3	5.9	2.3	0.0	6.2	15.0	11.1	10.8	4.3	66.8	17.8	2.7	0.0	27.9	0.0	21.3	71.3	11.4	2.7	7.5	96.8	23.3	20.8	17.7	10.7	20.1	9.2	168.1	7.9	4.8	2.4	9.8	4.7	5.6	4.6	3.0	27.0	2.8	66.6	7.0	11.3	22.4	4.9	147.8	6.0	6.5	11.3	9.1	6.3	22.3	14.5	9.6	56.6	16.3
NUFIP1	NUFIP	ENSG00000083635	"NUFIP1, FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989483	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	8.9	9.8	10.4	10.7	16.4	17.4	11.6	11.0	17.2	9.8	7.8	10.8	4.8	7.1	11.7	14.4	9.2	9.2	6.3	6.4	12.7	9.6	10.2	13.7	11.2	8.5	8.9	12.6	13.7	11.5	9.3	9.6	7.7	7.9	9.1	7.9	6.3	8.6	8.8	17.0	10.1	6.4	10.3	10.0	8.4	8.6	14.1	8.8	11.4	10.1	6.8	9.3	8.9	8.3	6.6	6.3	1.1	3.7	8.3	6.9	2.5	5.4	4.3	7.3	6.1	5.0	5.3	8.8	6.5	5.6	12.1	7.8	11.6	8.8	16.0	5.5	6.0	7.3	8.6	13.6	9.2	15.8	4.9	10.7	12.2	2.9	10.4	8.4	15.7	5.0	5.5	8.6	8.1	12.4	4.7	6.0	8.3	9.7	2.7	8.5	6.2	12.9	9.9	17.3	14.6	7.1	12.8	7.0	9.8	7.3	4.7	4.0	9.0	5.6	7.6	7.0	7.2	5.8	8.8	4.5	6.2	5.3	7.9	8.9	3.7	5.7	20.2	7.0	11.1	8.7	0.0	3.7	1.1	3.9	3.7	6.9	5.9	4.3	4.1	4.7	6.6	6.8	5.1	0.2	8.3	2.3	6.3	2.4	2.5	10.4	16.4	11.0	17.2	12.7	9.6	8.9	12.6	7.9	8.8	6.0	9.8	6.7	10.1	13.7	7.2	4.0	5.1	5.3	18.2	5.2	11.8	13.3	14.9	11.0	34.3	7.7	2.4	23.3	14.4	12.0	9.3	4.8	17.3	8.1	9.3	7.9	5.2	8.0	4.3	47.9	10.0	7.9	8.5	6.4	4.7	8.2	8.9	0.0	10.6	12.2	6.6	6.5	8.5	26.7	28.3	14.4	7.3	6.2	8.1	7.1
NWD1		ENSG00000188039	"NACHT and WD repeat domain containing 1"	Q149M9	19	16719976-16817963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;fallopian tube: 14.1"	"Cell type enriched"	"Detected in some"	8	"Ciliated cells: 101.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 9.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"MCF7: 3.4;U-937: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075476			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA075476: "	"unprognostic (5.29e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.05e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (2.49e-1)"	"unprognostic (4.20e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.25e-1)"	0.6	0.7	6.9	0.6	8.1	0.8	1.0	0.9	5.9	1.7	0.9	11.3	0.5	0.7	1.1	6.5	0.6	14.1	0.8	0.7	10.9	4.2	1.0	0.7	1.8	0.7	3.9	7.8	0.7	4.3	0.6	1.3	0.7	27.8	10.6	0.9	10.3	2.7	3.9	0.8	0.6	0.7	0.8	2.2	0.6	1.0	1.4	4.6	0.0	1.6	0.0	0.6	0.8	0.5	0.5	0.1	1.3	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.5	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	1.3	0.5	0.0	0.1	0.0	0.1	6.9	8.1	0.9	5.9	10.9	4.2	3.9	7.8	27.8	4.6	0.0	1.0	0.0	1.6	0.2	0.1	0.6	0.0	101.7	5.7	0.0	0.0	0.1	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.1	0.0	6.7	0.0	0.0	0.1	0.0	1.2	0.0	0.0	2.7	0.6	0.2	0.0	0.0	0.6	9.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.0	0.4	1.4
OARD1	"C6orf130, dJ34B21.3, MGC19570, TARG1"	ENSG00000124596	"O-acyl-ADP-ribose deacylase 1"	Q9Y530	6	41033627-41097787	"Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 72.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029036	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA029036: AB_10602336"	"unprognostic (2.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (4.78e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	14.6	19.1	19.1	15.8	19.3	15.3	19.3	13.2	20.2	13.6	17.4	18.8	30.3	19.1	12.6	26.6	15.8	20.1	15.9	13.5	19.1	18.6	27.8	35.4	16.2	24.8	21.4	19.6	22.5	25.3	21.6	22.4	13.8	20.9	16.8	20.4	17.6	15.9	24.2	16.7	14.9	17.9	15.8	21.4	16.2	22.7	44.7	20.9	21.4	24.6	14.2	20.7	16.0	14.1	27.6	16.5	23.4	16.2	27.4	24.4	13.2	11.4	7.4	16.0	10.8	9.2	10.6	9.5	7.0	10.1	8.4	9.4	11.1	8.4	15.8	7.8	4.3	9.2	8.5	9.9	9.5	12.5	13.9	5.4	19.2	7.8	20.8	8.7	13.2	12.6	8.3	14.0	8.1	27.9	7.6	5.8	20.5	24.4	13.6	9.0	17.1	21.4	15.5	15.1	72.4	4.9	10.0	14.0	15.4	16.6	6.3	16.8	11.3	6.6	6.7	23.0	12.8	11.8	12.2	6.0	8.7	10.3	5.6	12.1	18.0	17.9	35.3	7.2	13.4	7.4	20.4	13.8	23.4	17.2	14.2	21.6	27.6	19.7	17.0	16.5	25.8	24.4	23.2	13.4	27.4	16.2	16.0	21.8	13.2	19.1	19.3	13.2	20.2	19.1	18.6	21.4	19.6	20.9	20.9	14.9	40.0	42.2	37.8	25.3	59.8	37.9	43.3	57.6	34.2	57.6	43.2	77.5	72.9	37.0	142.4	30.6	31.5	0.0	42.0	52.6	25.1	27.9	47.3	57.2	39.6	39.7	21.2	19.6	46.1	120.0	26.2	34.7	33.7	36.9	47.2	59.6	29.7	43.8	24.4	76.7	60.3	25.8	35.0	186.5	159.6	25.6	38.1	48.9	57.7	23.1
ORC4	"HsORC4, ORC4L, Orc4p"	ENSG00000115947	"Origin recognition complex subunit 4"	O43929	2	147930397-148021604	"Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015124, HPA064562"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB015124: AB_2157883, HPA064562: AB_2685287"	"unprognostic (5.04e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (4.98e-8)"	"unprognostic (5.55e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.10e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.95e-3)"	11.5	14.3	19.0	11.4	20.5	19.6	17.3	29.8	27.2	13.6	14.6	11.0	12.0	13.9	14.8	13.5	13.1	17.3	11.9	13.8	18.1	22.3	24.5	15.5	10.9	11.9	18.1	18.1	21.2	12.1	18.9	29.5	14.3	30.9	14.9	16.8	12.7	15.2	14.6	16.0	11.6	15.6	13.8	18.1	11.0	10.9	17.3	11.8	20.4	19.0	12.7	13.6	13.3	12.6	16.1	18.1	21.5	19.1	20.2	16.6	13.1	12.4	10.9	21.4	11.7	8.3	8.2	23.2	14.3	12.0	18.0	18.0	26.8	12.7	16.1	15.6	8.4	16.0	12.7	24.2	14.0	18.8	11.3	20.6	22.3	11.8	18.1	11.1	14.0	8.4	6.9	17.0	19.6	7.9	13.4	12.1	15.4	21.1	8.5	11.7	13.2	10.9	11.4	24.2	10.3	15.9	12.0	14.4	14.6	19.9	25.9	20.3	15.9	12.8	14.1	17.1	20.3	10.8	6.8	8.8	13.7	13.5	9.9	13.0	8.5	20.0	15.3	11.2	11.0	8.3	21.5	15.0	19.8	16.2	19.1	16.6	16.1	15.8	16.6	18.1	15.4	16.6	16.3	21.1	20.2	14.8	9.2	16.0	13.1	19.0	20.5	29.8	27.2	18.1	22.3	18.1	18.1	30.9	11.8	77.4	53.4	11.0	19.9	23.1	44.5	24.2	10.2	96.4	80.8	12.2	37.3	33.7	38.1	27.8	19.2	16.5	17.2	0.0	15.1	40.8	23.7	20.2	42.9	15.3	20.8	50.9	22.1	17.2	20.0	13.4	20.8	22.1	20.3	18.0	18.1	32.9	16.3	14.0	20.1	41.6	35.2	32.3	19.5	55.5	25.3	21.8	27.3	22.4	22.5	17.3
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796539-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 75.0;Club cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: AB_2680386"	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	3.7	2.2	3.9	18.2	9.5	3.8	6.6	1.2	16.0	12.1	6.1	6.2	0.7	9.8	3.8	3.7	10.2	6.2	10.4	5.3	4.3	4.3	14.4	1.9	9.0	10.9	4.2	7.4	8.4	3.9	23.1	4.2	6.3	3.1	4.3	6.7	3.7	6.9	2.9	6.7	12.8	10.4	4.0	6.7	10.2	8.7	3.5	4.1	13.9	16.8	7.2	14.7	12.4	9.6	3.7	3.5	6.3	2.1	8.1	9.8	2.4	14.7	4.0	3.0	5.5	6.8	13.7	6.7	16.7	18.7	7.9	12.5	10.0	19.7	8.2	2.4	17.9	10.4	13.0	9.0	12.6	12.2	4.9	3.7	1.9	5.9	7.5	9.7	5.6	44.0	6.7	10.5	10.2	12.4	10.1	11.7	7.2	10.3	11.5	13.3	0.0	3.4	6.8	5.8	14.1	5.2	2.7	8.3	3.3	7.9	10.5	0.6	6.2	11.4	8.2	2.5	9.3	4.2	0.5	13.9	3.5	7.0	18.9	12.5	8.0	11.5	20.7	7.6	9.2	38.7	6.3	2.1	1.5	9.8	1.8	8.4	3.7	6.2	6.3	3.5	1.7	2.1	4.2	0.4	8.1	1.2	2.5	9.8	2.4	3.9	9.5	1.2	16.0	4.3	4.3	4.2	7.4	3.1	4.1	0.0	25.0	4.5	6.6	10.8	0.0	4.7	0.0	75.0	30.7	24.4	0.0	7.1	3.3	3.3	0.3	2.9	2.9	0.0	3.4	1.3	2.6	2.1	0.0	0.2	9.4	0.0	1.7	4.3	12.0	0.0	0.6	9.2	15.1	7.2	0.5	5.8	14.9	3.5	0.0	0.5	0.1	0.0	2.2	0.5	4.1	6.9	3.3	13.1	3.4	12.9
OTUD7A	"C15orf16, CEZANNE2, OTUD7"	ENSG00000169918	"OTU deubiquitinase 7A"	Q8TE49	15	31475398-31870789	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 20.5;Horizontal cells: 23.8;Spermatogonia: 6.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044554	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA044554: AB_10794895"	"unprognostic (3.61e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-11)"	"unprognostic (6.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.79e-1)"	2.6	2.0	12.4	1.7	13.9	5.9	1.5	13.2	17.0	1.8	3.4	16.0	0.0	1.5	1.9	1.9	1.9	2.0	2.3	2.1	10.0	4.6	2.3	1.0	1.5	3.5	20.4	7.1	2.0	2.5	4.6	1.7	0.9	10.5	1.2	3.1	0.7	1.6	2.0	1.8	3.2	2.1	2.9	9.1	2.2	2.3	8.2	17.4	0.0	2.3	0.0	2.4	1.9	1.3	0.1	3.2	0.3	1.4	0.1	0.7	0.4	3.7	4.1	4.5	6.1	0.4	1.3	3.2	2.5	1.3	3.9	2.0	2.5	3.2	2.9	2.2	0.9	2.2	4.6	4.9	2.1	3.2	5.9	6.6	3.7	8.3	2.0	0.3	4.1	5.8	0.0	0.2	3.9	4.3	1.1	3.5	6.4	6.0	5.5	1.8	2.9	3.1	3.9	2.1	4.8	2.0	5.7	3.1	1.4	1.6	3.9	11.0	6.0	3.4	3.0	1.0	2.3	2.5	4.3	2.3	5.4	5.3	3.0	6.3	3.4	2.4	3.0	2.9	5.8	4.5	0.0	0.4	0.3	0.6	0.5	0.3	0.0	0.3	0.7	0.2	0.1	0.2	0.2	0.0	0.1	1.4	3.2	0.0	0.4	12.4	13.9	13.2	13.8	10.0	4.6	20.4	7.1	10.5	17.4	3.0	0.0	0.0	0.6	0.3	20.5	2.2	0.0	0.0	1.2	1.8	2.0	0.0	0.0	0.4	1.0	1.0	0.9	0.0	0.8	0.0	0.7	1.3	0.0	0.8	0.2	23.8	3.5	1.3	0.0	1.1	0.9	0.0	1.7	0.0	1.0	3.7	0.4	0.0	2.5	1.2	2.9	0.0	1.0	4.1	6.1	0.4	0.1	0.0	1.0	0.8
P2RX6	"MGC129625, P2RXL1, P2X6, P2XM"	ENSG00000099957	"Purinergic receptor P2X 6"	O15547	22	21009808-21028830	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 12.4"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 7.4;Ciliated cells: 4.0;Intestinal endocrine cells: 3.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 11.4;LHCN-M2: 7.7;RH-30: 4.8;U-87 MG: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028776, HPA028777"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA028776: AB_2672771, HPA028777: AB_2672772"	"unprognostic (1.81e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.79e-5)"	"unprognostic (1.70e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.88e-10)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.39e-3)"	0.2	1.6	0.0	0.2	0.2	0.0	0.0	0.9	3.2	0.0	0.0			0.0	0.1	0.0	0.1	0.3	1.1	1.9	0.2	0.8	0.1	0.0	0.2	0.0	0.6		0.3	0.0	0.0	1.6	1.1		0.2	0.0		0.1	1.1	12.4	0.0	0.0	0.0	0.8	2.3	0.1	1.2			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.8	0.3	0.1	0.0	1.0	0.1	1.9	0.8	1.4	0.0	0.0	0.0	1.3	0.5	3.4	1.6	0.0	0.1	0.1	0.3	0.0	2.1	0.8	0.0	3.3	0.0	2.8	0.4	0.0	1.4	0.1	11.4	0.0	0.0	2.3	0.7	7.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.8	0.2	0.0	0.0	0.2	3.6	1.4	0.1	0.6	0.2	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.2	0.0	0.0	13.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0											0.0	1.1	0.0	0.8	0.1	7.4	2.4	0.0	4.0	0.0	1.8	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	2.3	0.0	0.1	1.6	3.4	2.5	0.0	1.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.4	0.0	0.6	0.0	0.0	1.4	0.4	0.1	0.3	0.0	0.0	0.0
P3H1	"GROS1, LEPRE1, LEPRECAN, MGC117314"	ENSG00000117385	"Prolyl 3-hydroxylase 1"	Q32P28	1	42746335-42767084	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 37.3;Extravillous trophoblasts: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 50.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA012113, HPA016980"	Approved		Approved	Nucleoli,Vesicles	"Intracellular and membrane"	NA	NA		13000	Vesicles	Nucleoli	"HPA012113: AB_2668626, HPA016980: AB_2669498"	"unprognostic (3.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.95e-7)"	"unprognostic (5.41e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.60e-3)"	11.9	11.2	7.1	8.6	6.3	5.2	9.7	6.4	5.3	14.0	7.1	6.0	7.7	2.6	13.8	11.1	6.4	8.8	12.1	8.8	3.8	2.9	7.9	19.9	10.8	10.1	6.1	3.3	13.1	6.8	5.8	15.2	36.1	4.6	7.8	5.7	10.5	6.4	6.5	4.3	7.2	6.6	19.7	3.4	13.3	6.6	13.1	4.7	10.2	7.4	5.3	7.8	11.4	8.5	3.1	16.2	11.0	16.2	11.7	7.9	6.1	2.2	5.8	13.1	30.6	30.9	23.7	5.4	26.9	35.1	19.5	33.3	2.9	4.9	3.3	21.6	50.7	7.8	2.0	5.5	6.8	13.4	5.0	7.0	7.9	9.2	8.4	17.9	7.8	9.1	20.1	4.6	19.6	8.4	27.7	27.4	4.8	4.4	4.3	13.0	1.2	5.1	4.5	14.3	1.2	4.2	5.0	19.3	4.5	10.2	1.2	2.7	4.6	16.4	0.4	11.6	23.9	0.9	33.0	22.3	14.6	12.9	11.6	10.6	3.8	4.3	3.0	16.7	10.6	20.2	3.5	13.2	11.0	6.0	14.0	6.4	3.1	4.6	5.1	16.2	2.6	3.9	3.9	1.2	11.7	16.2	7.6	7.9	6.1	7.1	6.3	6.4	5.3	3.8	2.9	6.1	3.3	4.6	4.7	3.0	2.9	4.8	5.7	0.0	10.0	4.2	5.1	1.4	1.2	10.4	23.6	37.3	0.0	10.4	16.8	15.7	0.4	0.0	6.6	47.0	22.9	3.0	1.1	10.6	15.4	14.3	5.8	17.8	6.7	7.5	17.8	8.7	0.0	10.0	2.8	2.6	6.7	2.0	15.2	1.7	20.0	0.0	7.6	21.8	11.1	0.0	14.6	12.5	1.7	3.5
PARP1	"ADPRT, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360691-226408079	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 400.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		39000	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	17.3	16.6	31.2	35.7	31.2	14.3	15.3	21.1	29.2	14.3	21.8	37.4	10.3	15.0	18.2	13.0	18.1	15.0	10.8	24.2	27.8	21.9	13.4	24.8	14.1	56.3	40.7	21.8	14.6	28.1	62.6	22.9	28.7	30.4	22.0	19.2	16.3	17.0	24.7	47.3	11.7	19.6	25.5	49.1	32.7	15.9	22.5	34.8	29.5	14.5	16.5	70.2	19.9	13.7	53.0	16.5	9.0	17.5	11.1	21.8	11.5	28.9	15.5	43.2	30.6	11.3	9.4	24.6	19.2	17.1	26.1	21.5	24.7	14.2	84.4	28.7	11.6	11.5	21.8	59.4	18.8	23.1	35.4	82.9	32.6	20.7	16.1	6.8	54.2	15.8	9.2	7.5	21.0	14.9	7.3	20.3	19.6	51.9	43.1	13.5	13.8	17.3	19.6	79.5	40.9	30.8	52.5	74.0	78.0	12.2	20.7	43.5	38.1	25.0	28.0	15.7	31.8	23.5	34.0	15.4	13.9	23.0	18.7	35.9	17.6	29.4	72.5	11.6	18.3	31.1	9.0	6.7	6.9	18.3	11.3	21.6	46.8	19.4	18.0	14.3	53.0	15.2	16.4	1.0	11.1	17.5	16.5	21.8	11.5	31.2	31.2	21.1	28.4	27.8	21.9	40.7	21.8	30.4	34.8	50.6	68.3	130.2	75.6	64.2	94.4	106.4	43.3	75.0	97.8	54.1	133.5	400.4	61.3	77.0	28.3	54.0	16.8	23.3	91.9	75.6	55.5	70.8	116.9	65.7	117.1	85.8	72.1	31.9	42.2	16.3	37.2	45.7	59.1	93.8	46.5	78.6	54.3	24.6	32.9	36.1	102.8	45.3	47.4	92.8	211.4	42.0	115.1	74.0	57.9	42.9
PARP2	ADPRTL2	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343582-20357905	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052003	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052003: AB_2681689"	"unprognostic (3.93e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.89e-2)"	11.5	16.6	23.6	8.9	28.5	20.9	15.2	36.7	31.3	12.0	11.7	16.8	9.3	11.2	18.8	16.8	10.7	14.7	8.9	14.0	19.2	17.8	14.0	15.0	12.0	11.8	16.6	30.8	20.2	11.8	11.6	14.6	11.3	22.1	11.3	12.9	10.8	10.5	12.9	25.9	15.1	10.8	14.6	13.9	11.4	11.6	20.4	17.4	6.0	11.7	13.9	15.2	9.3	10.4	6.7	5.6	1.8	5.0	6.9	12.3	4.9	20.3	14.9	23.0	17.2	7.6	7.3	16.7	22.7	12.4	28.9	35.8	14.1	19.5	15.1	10.3	7.1	25.8	19.2	30.6	10.4	34.2	12.1	14.9	13.8	18.1	23.5	6.8	28.6	7.9	5.0	8.9	18.0	19.9	8.0	14.8	18.5	14.6	20.7	19.8	12.6	14.6	12.3	12.6	23.2	23.3	18.3	31.3	9.8	11.5	10.6	16.0	11.0	25.3	14.1	6.6	15.3	13.0	9.7	10.1	17.6	26.7	12.1	18.4	19.4	24.7	20.1	7.3	12.7	19.5	1.8	5.0	0.5	9.5	4.5	12.3	6.7	8.9	8.3	5.4	4.6	9.6	9.3	0.1	6.9	2.5	5.6	5.2	4.9	23.6	28.5	36.7	31.3	19.2	17.8	16.6	30.8	22.1	17.4	23.8	6.2	10.4	9.3	5.8	26.8	12.3	5.1	36.1	21.6	7.0	11.8	19.1	6.6	10.5	7.3	10.0	3.4	23.3	7.7	17.9	8.4	3.7	8.1	9.6	10.2	28.6	4.6	6.2	4.9	7.3	10.6	6.4	8.5	4.6	4.2	21.9	8.0	5.5	15.9	5.6	21.7	6.5	9.5	17.7	33.3	4.3	12.5	4.4	5.2	4.6
PCID2	FLJ11305	ENSG00000126226	"PCI domain containing 2"	Q5JVF3	13	113177539-113208715	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069107, HPA073074"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoli	Nucleoplasm	"HPA069107: AB_2686088, HPA073074: AB_2686568"	"unprognostic (2.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (1.73e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.24e-6)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	17.6	22.6	13.7	14.6	16.0	11.3	21.0	33.5	15.9	20.9	18.2	14.6	20.4	10.3	24.0	20.7	15.6	22.5	14.7	31.3	12.8	10.8	15.4	18.1	14.8	19.6	16.9	13.0	30.6	28.6	12.1	37.6	13.4	14.9	20.0	16.3	14.4	21.4	19.3	21.6	15.0	15.2	19.7	13.4	20.1	19.2	43.4	16.5	19.4	25.4	11.6	20.6	18.0	21.2	15.1	9.7	8.1	12.5	7.6	32.4	19.0	21.9	9.3	14.3	12.6	26.3	19.8	10.0	16.9	25.5	23.6	21.9	18.3	20.8	17.6	11.3	22.9	30.0	14.0	22.6	15.3	26.3	15.3	22.3	22.7	24.3	16.1	26.2	38.4	9.3	16.2	17.1	14.8	26.3	19.0	18.6	24.6	17.3	7.2	26.7	10.6	20.4	27.2	14.1	40.6	11.9	18.7	15.9	16.8	21.4	11.1	19.1	11.8	10.5	26.3	19.3	15.1	14.5	47.0	12.0	7.0	25.2	10.1	12.7	11.1	10.3	24.6	24.2	26.2	15.9	8.1	9.6	7.1	27.6	12.5	32.4	15.1	23.6	28.7	9.7	14.2	21.5	22.3	1.5	7.6	11.5	9.2	23.5	19.0	13.7	16.0	33.5	15.9	12.8	10.8	16.9	13.0	14.9	16.5	17.9	11.8	26.0	26.1	19.2	21.0	26.8	15.3	30.8	14.8	14.0	15.7	25.3	23.2	19.0	26.4	26.3	7.9	23.3	12.0	20.4	25.7	26.0	10.4	17.8	18.1	35.0	7.5	15.4	20.8	8.0	38.3	13.8	15.1	26.2	14.1	19.5	17.0	19.5	38.2	18.4	24.9	19.4	28.9	129.6	82.8	21.7	26.0	34.8	19.9	21.4
PCTP	STARD2	ENSG00000141179	"Phosphatidylcholine transfer protein"	Q9UKL6	17	55750979-55842830	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 56.4;liver: 53.2"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 61.2;Hepatocytes: 64.8;Syncytiotrophoblasts: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 56.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.8"	"Low region specificity"	"Detected in all"							HPA022979	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA022979: AB_2671018"	"unprognostic (1.14e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.27e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (9.35e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.93e-1)"	"unprognostic (6.89e-3)"	"unprognostic (3.04e-1)"	8.2	5.6	4.9	8.2	8.2	5.1	8.4	3.1	5.3	6.2	11.9	3.0	29.8	9.3	5.2	15.8	6.6	4.9	10.1	12.1	5.1	4.7	17.0	53.2	11.6	7.8	6.2	4.9	5.2	7.5	4.2	5.3	19.4	5.5	7.5	12.7	5.3	7.1	32.1	10.8	4.1	9.8	8.3	5.0	10.0	12.5	8.0	3.9	3.0	5.7	5.8	5.2	8.1	9.9	2.0	12.1	56.4	15.3	6.2	2.7	6.5	8.7	8.1	6.1	2.2	8.2	8.0	15.7	3.4	4.6	5.5	5.4	9.1	11.4	2.4	26.8	5.4	5.1	4.9	3.5	5.8	5.0	38.8	8.2	21.7	2.4	16.9	7.3	8.2	17.2	6.6	7.7	3.2	6.0	6.8	10.6	7.4	15.6	8.8	6.0	7.6	6.5	6.7	6.6	0.0	7.2	3.3	8.8	2.0	5.8	6.5	3.0	6.9	1.7	3.8	14.5	14.0	10.1	14.3	7.7	6.3	4.5	7.0	4.5	24.9	7.8	1.5	5.8	13.6	10.8	15.1	15.3	56.4	2.5	12.6	1.5	2.0	1.6	2.5	12.1	1.4	0.9	2.2	15.9	6.2	13.2	0.9	2.7	6.5	4.9	8.2	3.1	5.3	5.1	4.7	6.2	4.9	5.5	3.9	3.0	7.2	5.1	2.5	0.9	3.8	15.3	17.8	2.7	0.0	8.7	2.0	42.8	10.0	11.2	13.2	7.3	11.8	0.0	12.0	61.2	6.7	1.4	15.0	64.8	19.2	1.6	12.6	9.2	22.6	15.4	15.3	12.6	11.8	10.8	16.2	3.5	8.3	7.0	24.4	30.7	2.2	12.9	10.3	9.8	8.1	1.3	56.2	8.5	14.3	1.7
PDCD7	"ES18, HES18"	ENSG00000090470	"Programmed cell death 7"	Q8N8D1	15	65117379-65133836	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 165.8;Cone photoreceptor cells: 208.1;Rod photoreceptor cells: 177.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049388	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA049388: AB_2680741"	"unprognostic (7.71e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (8.18e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (5.29e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.62e-2)"	16.0	16.8	22.4	17.6	26.9	13.1	23.8	43.7	28.5	19.0	19.4	21.3	12.6	14.6	23.8	19.8	23.2	18.6	12.7	14.4	21.0	16.3	13.7	15.6	21.5	19.5	22.9	24.7	26.5	16.6	16.5	15.7	17.4	20.6	17.4	14.3	15.0	14.2	19.0	17.5	16.4	15.4	20.4	17.5	18.7	15.1	27.4	32.1	19.7	18.0	12.7	21.5	18.4	18.6	5.9	4.0	4.0	3.2	7.1	4.5	1.4	8.8	7.4	12.6	13.0	12.7	17.9	7.6	10.2	11.3	12.6	9.7	8.9	9.9	17.1	11.1	8.1	9.4	16.9	32.0	7.3	9.1	10.3	8.6	16.6	6.3	7.8	11.7	22.5	11.2	10.4	11.2	6.9	13.1	12.1	9.9	12.8	21.1	14.0	10.9	6.7	23.6	16.1	15.3	10.3	6.7	20.9	16.2	19.0	7.6	14.2	10.4	12.4	11.4	9.7	14.9	14.4	7.8	18.6	10.1	13.1	12.8	7.5	15.7	25.1	28.6	12.3	11.8	25.0	6.6	4.0	3.2	1.8	4.5	2.6	3.8	4.8	4.3	4.1	2.8	5.9	4.5	4.5	0.8	7.1	2.5	4.0	3.1	1.4	22.4	26.9	43.7	28.5	21.0	16.3	22.9	24.7	20.6	32.1	0.0	11.0	24.3	63.5	33.8	165.8	15.9	15.3	9.4	14.8	27.9	208.1	49.6	24.9	7.2	4.9	27.4	10.0	0.0	7.0	25.2	28.2	37.6	19.6	16.1	20.7	71.5	13.8	16.5	21.8	6.6	53.8	17.5	11.8	5.4	17.4	63.4	6.5	10.5	45.3	17.1	177.0	45.3	24.4	137.9	102.2	34.9	59.7	40.6	21.3	41.6
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465221-24539837	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA046583: AB_2679707, HPA072492: AB_2686526"	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	9.6	5.6	5.7	9.8	17.3	16.3	12.8	3.3	23.6	8.0	14.7	5.5	5.6	13.6	7.3	15.7	9.5	13.2	7.0	16.9	12.5	6.8	13.7	11.1	11.2	13.4	6.2	13.7	11.0	7.3	12.8	14.1	7.7	14.9	8.3	10.1	9.9	19.3	5.2	3.9	14.2	15.6	8.6	6.1	17.9	12.7	23.1	4.8	12.5	6.2	4.1	14.9	10.3	9.2	4.5	7.2	36.4	10.9	7.1	11.0	6.7	9.0	4.6	3.9	6.6	0.1	0.0	4.1	2.7	2.4	3.7	6.5	0.4	11.1	9.2	1.9	0.7	10.5	2.1	11.3	6.9	10.0	7.8	5.4	4.9	5.3	2.6	1.3	4.2	4.8	0.7	3.1	0.9	0.9	0.4	5.5	9.6	0.9	14.0	0.5	17.0	7.8	5.4	7.0	9.7	5.4	4.0	7.0	13.5	3.2	17.7	2.5	3.2	14.7	6.0	4.6	6.2	8.3	1.6	0.2	2.6	3.8	4.8	3.2	9.0	6.9	11.0	7.1	6.4	5.4	9.4	8.9	21.3	7.6	10.9	11.0	4.5	6.2	6.2	7.2	4.1	4.9	5.7	36.4	7.1	10.4	2.3	5.1	6.7	5.7	17.3	3.3	23.6	12.5	6.8	6.2	13.7	14.9	4.8	3.0	1.3	2.9	8.6	4.0	3.4	6.3	0.0	1.4	2.3	1.8	0.0	4.0	3.3	3.6	53.4	2.8	4.5	0.0	4.5	26.4	3.2	5.2	5.7	4.2	13.2	7.9	4.1	4.3	18.9	22.4	3.4	9.6	15.1	8.2	2.4	3.2	2.8	0.0	5.3	11.3	3.9	0.0	9.2	6.4	6.3	3.9	14.9	14.9	3.3	7.1
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355"	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.0	12.3	19.8	13.8	22.0	10.5	10.9	22.9	28.0	12.6	11.8	25.5	8.4	12.9	14.3	9.8	17.4	17.3	11.4	18.2	19.9	18.8	9.6	10.6	11.2	17.2	20.2	18.6	21.0	18.9	18.2	17.0	12.4	18.3	13.8	8.6	13.8	16.5	14.7	38.2	17.2	11.6	12.2	18.7	13.6	12.4	21.3	18.1	17.0	14.5	12.3	13.3	11.2	10.6	3.8	3.5	5.8	3.4	3.8	4.5	1.9	15.9	35.0	13.9	21.9	10.8	8.0	31.2	11.6	8.1	16.1	17.3	34.1	11.8	38.5	17.9	9.1	11.4	24.6	25.8	18.1	9.2	19.9	36.8	17.1	17.6	27.5	14.0	13.8	23.1	9.8	11.3	19.8	16.7	8.3	11.9	20.8	20.6	16.9	8.8	21.9	26.0	16.3	22.8	15.5	11.8	27.5	12.3	18.9	11.2	12.1	14.0	18.7	19.9	14.7	14.9	13.9	17.7	9.4	12.0	12.5	17.7	18.9	22.3	9.1	15.6	16.0	14.1	14.3	16.0	0.9	2.4	5.8	3.1	3.1	3.1	2.6	3.0	2.4	2.4	3.8	3.3	4.5	1.4	3.8	3.4	3.5	2.0	1.9	19.8	22.0	22.9	28.0	19.9	18.8	20.2	18.6	18.3	18.1	20.8	29.6	16.3	12.9	13.2	23.9	19.8	5.1	20.1	19.4	8.7	15.7	24.8	1.7	13.2	47.9	13.2	6.2	0.0	12.6	23.5	14.1	12.3	29.0	9.0	14.7	33.4	12.1	4.9	4.5	17.5	8.6	13.8	10.1	107.4	16.1	12.5	11.1	12.4	18.0	4.1	16.6	6.5	9.9	21.4	71.6	14.3	17.7	13.1	18.8	10.6
PFKL		ENSG00000141959	"Phosphofructokinase, liver type"	P17858	21	44300051-44327376	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030047	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA		1800000	"Nucleoli, Mitochondria"		"HPA030047: AB_10602815"	"unprognostic (6.21e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.98e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (5.69e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.01e-2)"	32.0	16.7	28.0	26.0	29.5	26.4	23.1	21.3	46.0	28.3	38.7	40.9	30.1	65.5	21.3	33.5	33.5	22.8	37.5	18.4	28.8	23.4	40.3	31.3	21.0	25.2	32.4	33.0	19.5	27.1	12.3	17.1	31.9	29.1	20.2	17.2	36.3	28.8	28.5	8.3	31.1	59.3	20.5	36.1	28.1	42.7	24.0	29.1	16.4	20.4	15.4	26.0	27.2	23.9	20.3	26.9	5.2	38.0	7.7	25.2	22.8	32.6	14.3	10.2	29.4	16.1	12.0	45.0	24.6	16.0	14.3	14.1	19.2	7.2	19.4	29.3	16.4	13.7	17.8	8.1	22.3	3.3	16.3	18.4	39.2	12.5	31.3	12.4	29.5	25.0	15.7	13.6	14.6	7.2	21.7	21.0	14.2	24.1	22.2	9.7	41.5	12.7	23.0	16.0	29.3	16.1	31.5	9.7	52.6	6.5	36.2	18.0	13.5	35.8	30.4	15.7	4.3	24.1	26.1	30.4	21.7	14.0	14.2	9.4	43.2	11.7	7.9	36.1	23.5	17.3	5.1	22.2	5.2	12.9	37.9	10.8	14.4	17.0	11.8	26.9	20.3	10.2	7.9	4.5	7.7	38.0	17.0	25.2	22.8	28.0	29.5	21.3	46.0	28.8	23.4	32.4	33.0	29.1	29.1	20.8	27.5	37.6	33.4	31.7	71.1	12.6	17.8	21.4	28.4	87.2	62.8	106.3	84.6	68.0	1.8	43.0	285.1	0.0	45.0	147.2	44.6	37.8	41.5	60.1	95.6	28.6	44.5	41.1	58.5	5.2	36.2	60.1	65.8	177.7	107.9	59.6	51.1	112.2	52.3	108.3	44.6	25.8	42.9	1.4	8.7	31.6	134.4	31.9	139.6	44.5
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 163.9"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 412.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		6000000	"Endoplasmic reticulum"	Nucleoli	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	25.0	46.0	37.7	11.9	36.9	5.6	60.2	21.8	37.8	36.2	30.5	30.9	42.9	27.0	39.9	71.4	15.0	38.9	20.1	10.0	38.6	50.4	58.7	163.9	15.6	8.8	38.1	29.6	24.7	10.9	23.8	15.5	12.3	35.3	33.5	22.5	22.1	17.5	53.7	5.7	12.5	42.9	22.0	46.9	10.0	18.9	14.2	27.1	6.9	24.7	12.2	7.7	21.3	17.3	3.6	9.9	11.4	11.8	4.8	8.0	28.7	27.3	17.3	34.0	39.1	73.6	35.3	22.1	41.3	48.2	22.0	27.4	20.9	33.6	7.9	45.3	42.8	25.7	21.9	37.1	17.3	29.7	8.4	42.6	8.9	16.6	23.4	12.3	14.5	4.8	36.3	9.8	26.7	13.9	16.3	14.1	9.5	9.3	4.9	25.7	29.2	10.9	10.7	89.1	30.0	29.2	13.0	21.3	11.4	29.0	20.9	31.8	14.2	30.2	50.3	16.2	34.3	11.6	9.3	10.9	15.3	22.6	54.1	38.9	5.2	9.5	8.5	41.9	23.2	29.2	9.2	11.8	11.4	5.5	11.3	7.3	3.6	7.5	8.0	9.9	3.1	7.7	6.3	5.7	4.8	10.0	7.1	7.6	28.7	37.7	36.9	21.8	37.2	38.6	50.4	38.1	29.6	35.3	27.1	116.1	75.0	12.3	114.6	83.6	185.1	15.3	109.5	124.5	78.5	69.8	64.8	71.9	58.0	77.8	2.7	78.8	222.6	23.3	64.6	112.3	104.2	108.1	39.3	412.3	46.0	62.0	55.4	54.6	35.5	4.9	159.3	45.1	97.8	14.4	77.2	101.7	56.7	112.1	170.8	277.5	72.5	103.5	130.8	27.1	70.9	76.7	51.9	21.5	125.9	110.4
PHF6	"BFLS, BORJ, CENP-31, KIAA1823, MGC14797"	ENSG00000156531	"PHD finger protein 6"	Q8IWS0	X	134373253-134428791	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Epilepsy, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001023	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA001023: AB_1079606"	"unprognostic (2.38e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-3)"	"unprognostic (5.20e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	7.4	19.3	10.2	14.1	12.2	6.5	9.7	18.2	13.5	8.7	8.0	11.6	20.3	7.8	9.0	30.1	11.5	7.3	6.1	7.2	11.0	11.1	9.9	7.5	8.4	20.4	12.5	9.3	30.7	10.4	24.1	18.1	8.2	13.3	8.6	9.5	5.4	11.3	16.8	6.2	7.4	10.2	8.1	17.1	17.8	8.1	8.3	14.4	30.2	11.8	6.0	25.0	8.9	9.8	18.4	11.0	5.3	7.4	9.6	9.9	5.0	11.5	9.6	42.3	17.3	7.9	10.1	8.0	11.6	9.3	12.5	15.5	5.7	12.0	18.6	26.7	7.0	12.2	10.4	29.5	13.1	21.1	15.1	13.7	18.0	16.5	6.6	8.4	17.9	10.0	6.7	10.0	13.6	17.0	12.6	17.4	18.2	13.2	9.2	15.3	7.6	28.9	8.9	12.9	15.8	13.0	28.5	15.4	14.1	13.3	14.0	14.7	17.2	8.9	8.2	12.2	13.1	7.7	9.9	13.2	11.7	8.4	14.6	17.8	4.7	10.9	25.1	7.6	21.4	14.5	5.3	6.1	3.7	7.9	6.0	8.5	18.4	8.2	7.1	8.8	12.8	9.9	8.2	2.5	9.6	7.4	11.0	8.3	5.0	10.2	12.2	18.2	13.5	11.0	11.1	12.5	9.3	13.3	14.4	20.8	17.3	24.1	12.5	11.6	21.9	13.7	7.6	16.0	13.6	15.7	17.7	9.9	19.9	12.5	2.6	14.3	7.9	0.0	11.8	6.8	11.3	10.2	23.2	12.7	13.2	17.5	10.9	19.6	12.6	2.1	19.2	15.3	6.8	19.0	13.4	25.6	12.4	15.0	14.5	16.5	18.2	25.8	9.2	4.6	17.9	10.0	3.9	22.0	16.6	11.0
PHTF1	PHTF	ENSG00000116793	"Putative homeodomain transcription factor 1"	Q9UMS5	1	113696831-113759489	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 138.9;Late spermatids: 106.5;Spermatocytes: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059486			Approved	"Nucleoli,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoli	"HPA059486: "	"unprognostic (1.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	6.5	10.4	11.5	7.9	8.6	19.5	11.8	31.6	15.1	7.1	5.4	4.0	7.6	4.5	6.6	9.6	3.4	13.1	8.8	8.2	10.1	12.4	8.9	10.1	10.8	11.9	8.2	12.9	4.0	8.2	15.3	20.9	8.5	10.4	5.8	6.5	8.2	5.2	6.9	5.5	2.4	4.9	8.4	6.4	10.5	8.0	33.8	6.6	3.4	6.1	2.4	7.7	8.1	6.3	3.0	4.5	6.0	2.6	4.3	5.7	1.7	12.8	6.7	19.1	10.1	9.5	8.6	5.0	11.8	15.7	10.6	17.4	7.3	10.4	3.7	16.8	8.2	7.8	7.1	7.2	4.7	12.2	15.2	7.2	8.9	14.1	8.4	7.9	10.9	12.6	7.2	1.3	14.2	3.1	15.4	19.5	0.0	5.3	17.1	12.8	19.0	0.1	11.0	15.1	4.8	10.9	11.5	28.7	7.4	17.0	5.6	13.5	12.4	13.2	6.5	7.0	10.4	2.6	8.9	20.6	8.4	11.6	15.4	11.4	23.9	24.2	6.9	20.6	9.5	22.7	3.0	2.6	4.9	3.0	1.3	2.3	3.0	3.7	3.7	4.5	1.6	0.1	2.6	6.0	4.3	1.7	3.0	5.7	1.7	11.5	8.6	31.6	15.1	10.1	12.4	8.2	12.9	10.4	6.6	6.0	10.9	21.0	6.3	2.2	28.1	7.4	15.3	49.5	10.3	5.2	51.1	17.2	8.3	9.9	138.9	17.6	2.7	23.3	18.2	7.7	11.1	7.1	20.8	7.6	10.9	27.0	18.4	9.2	13.2	106.5	7.5	9.8	5.0	10.8	2.7	5.3	15.5	0.0	8.5	5.4	45.4	0.0	11.4	106.3	31.1	1.5	22.1	18.7	2.9	6.5
PIGO	"DKFZp434M222, FLJ00135"	ENSG00000165282	"Phosphatidylinositol glycan anchor biosynthesis class O"	Q8TEQ8	9	35088688-35096601	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014905			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA014905: AB_1855369"	"unprognostic (1.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.81e-2)"	9.4	16.6	7.2	8.7	11.7	5.4	11.6	12.6	15.6	10.8	11.5	17.8	15.6	14.1	14.0	13.6	12.6	15.8	13.4	9.5	7.4	6.4	16.1	15.2	10.6	13.8	9.0	10.1	15.9	17.5	47.3	13.4	27.6	11.5	13.1	13.2	18.0	17.5	17.4	7.6	10.0	12.9	10.7	11.0	14.2	13.9	16.5	9.7	11.3	20.0	8.3	13.4	13.6	9.9	7.4	13.7	8.0	8.8	7.1	10.0	4.1	15.9	27.4	7.8	11.2	7.0	7.9	14.0	6.8	11.9	16.5	13.5	10.1	16.3	9.0	12.4	8.1	23.0	11.7	13.1	21.3	10.0	9.9	8.4	5.4	17.9	7.6	13.7	7.3	9.4	9.6	23.6	14.6	24.1	13.1	8.5	13.5	5.9	12.9	13.5	8.8	8.5	8.3	5.0	10.0	11.3	8.9	6.3	9.8	18.1	11.1	6.6	8.9	9.4	23.4	5.3	9.0	17.5	4.8	5.1	12.1	10.7	6.5	12.4	7.9	11.6	3.8	13.1	5.4	15.0	7.0	6.7	8.0	9.2	8.8	9.3	5.0	5.1	10.0	13.7	7.4	6.5	7.6	2.4	7.1	5.9	9.5	7.6	4.1	7.2	11.7	12.6	15.6	7.4	6.4	9.0	10.1	11.5	9.7	3.0	11.5	5.2	4.4	2.3	9.1	2.4	20.4	13.4	7.9	15.7	2.0	17.4	0.0	11.1	0.7	3.1	10.6	0.0	12.1	13.5	3.1	3.6	6.9	11.1	10.0	11.1	2.9	4.9	6.3	1.0	4.0	3.9	3.3	8.2	7.8	14.9	8.2	7.0	2.8	5.6	10.9	6.5	2.5	17.4	7.0	1.8	18.9	7.2	8.5	3.1
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170203-37175426	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Suprabasal keratinocytes: 199.7;Urothelial cells: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 64.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 64.6;T-cells: 19.0"	"Cell line enhanced"	"Detected in many"		"HEL: 35.7;HMC-1: 66.4;K-562: 30.6;U-698: 119.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	39.3	5.4	7.4	18.5	8.9	80.9	20.1	8.1	9.9	23.0	17.9	4.7	4.2	17.9	15.4	9.8	56.3	21.6	24.7	20.8	8.2	3.7	7.5	24.5	14.5	35.7	7.4	2.2	20.0	9.6	2.0	5.6	28.7	12.7	15.6	8.8	6.9	12.8	4.5	26.5	31.3	26.1	31.6	10.7	21.4	12.1	6.8	7.6	15.0	7.2	20.1	28.8	32.6	31.2	1.7	1.4	64.6	1.7	8.4	19.0	8.5	3.0	1.3	2.0	1.1	4.7	2.5	24.0	1.1	3.4	2.3	3.6	4.6	4.3	6.2	1.7	1.3	5.1	3.6	2.1	3.3	2.1	28.1	1.4	35.7	1.3	5.9	4.8	0.6	66.4	8.5	4.1	2.1	1.4	2.5	0.6	1.5	30.6	10.0	0.3	0.8	1.9	3.2	3.8	5.7	2.0	4.8	3.7	7.3	0.6	18.8	10.0	2.0	2.4	0.3	0.6	4.9	0.5	1.0	1.2	1.3	4.0	6.0	1.3	4.7	2.5	119.4	0.5	9.0	1.3	64.6	1.7	24.4	14.7	1.6	19.0	1.7	13.1	12.9	1.4	1.3	11.9	9.0	14.1	8.4	0.9	0.4	9.4	8.5	7.4	8.9	8.1	9.9	8.2	3.7	7.4	2.2	12.7	7.6	20.8	23.1	27.2	134.9	113.6	4.2	17.3	12.7	4.0	22.7	8.7	0.0	27.3	5.0	30.7	3.8	14.3	33.2	46.7	15.5	92.9	73.9	69.5	46.4	27.1	44.8	14.3	35.6	9.2	40.0	10.4	7.5	45.8	42.2	101.0	11.9	4.3	37.7	17.5	2.8	13.0	0.9	0.0	57.5	3.3	34.5	199.7	67.5	126.4	6.6	399.5
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 98.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	12.6	9.9	21.6	5.5	35.7	2.6	7.9	13.4	23.7	12.2	5.8	8.9	19.3	4.7	9.2	98.7	5.7	10.2	7.1	7.5	18.4	23.4	7.5	4.4	7.4	5.9	14.9	16.7	16.2	6.0	27.1	12.5	10.7	11.7	9.9	5.3	7.2	6.4	20.3	4.7	7.1	4.4	9.8	12.0	5.9	6.5	13.7	9.5	3.0	13.8	2.9	7.4	7.8	7.9	11.2	4.3	2.7	4.5	14.8	17.8	9.0	10.4	8.0	25.1	17.6	8.8	9.3	7.6	7.0	8.4	6.6	8.9	6.5	9.9	1.6	10.9	11.1	15.6	9.1	38.6	13.7	8.3	7.8	13.7	3.1	6.6	4.3	11.0	1.8	6.0	9.7	9.1	11.3	6.7	6.4	7.4	5.3	2.9	1.1	6.7	5.6	0.8	3.6	17.1	8.9	13.2	7.5	11.2	2.5	10.6	8.8	18.7	12.1	11.2	1.9	8.5	20.9	3.1	2.6	6.7	5.7	9.2	16.9	3.2	0.0	0.1	3.8	6.2	5.1	7.6	2.7	3.3	1.0	15.5	4.5	17.8	8.7	13.7	14.2	3.6	11.2	14.4	16.6	1.1	14.8	2.9	4.3	8.3	9.0	21.6	35.7	13.4	23.7	18.4	23.4	14.9	16.7	11.7	9.5	14.9	4.5	5.1	14.7	36.5	16.4	6.3	5.1	2.7	11.4	3.5	7.9	30.0	13.3	20.5	77.4	5.1	0.7	0.0	10.2	12.8	18.9	7.8	4.6	1.7	6.7	4.8	5.2	5.5	3.8	22.6	25.0	4.1	5.0	1.8	2.8	28.6	13.9	1.4	18.4	4.4	5.9	6.5	17.0	0.9	1.0	25.7	17.4	7.9	2.3	17.6
PLEKHM1	KIAA0356	ENSG00000225190	"Pleckstrin homology and RUN domain containing M1"	Q9Y4G2	17	45435900-45490749	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 9.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025018, HPA039473"	Approved		Supported	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA025018: AB_1855465, HPA039473: AB_2676526"	"unprognostic (1.52e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.28e-6)"	"unprognostic (8.71e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	8.0	3.6	2.5	3.6	4.5	10.9	5.3	7.6	5.6	6.1	4.1	2.6	0.9	2.2	2.9	2.0	17.2	3.7	3.8	3.9	4.2	1.7	1.7	3.1	4.5	7.3	10.5	2.9	2.5	4.2	3.5	3.6	2.8	4.7	2.6	3.0	3.4	7.6	2.7	6.3	5.8	3.4	2.5	5.3	4.5	3.0	2.4	3.4	6.7	3.8	6.5	10.4	5.2	6.7	2.4	1.3	9.8	1.4	1.3	1.4	0.9	5.2	7.6	1.3	2.5	5.4	2.6	4.7	1.5	3.5	2.7	2.8	2.4	2.8	2.7	4.6	5.0	13.2	1.4	3.1	1.9	0.8	10.6	3.7	0.0	2.8	3.1	5.7	0.0	4.0	10.2	6.0	4.3	7.1	2.3	8.0	2.1	2.6	3.1	4.3	3.3	5.2	1.0	0.8	15.5	5.4	2.3	2.8	2.4	3.9	8.1	2.3	2.1	2.6	2.0	2.9	2.5	4.7	2.3	9.2	6.5	2.5	4.9	2.7	3.2	3.4	1.1	3.7	1.3	2.7	3.8	1.4	1.3	1.4	1.0	0.8	2.4	1.0	1.1	1.3	1.0	0.7	0.6	9.8	1.3	1.3	1.0	1.2	0.9	2.5	4.5	7.6	5.6	4.2	1.7	10.5	2.9	4.7	3.4	11.9	21.5	8.3	16.6	16.0	9.3	7.2	12.7	8.1	12.5	12.2	15.7	3.8	5.0	7.1	4.0	8.7	14.8	23.3	7.0	4.0	7.3	22.8	1.1	6.8	7.8	15.9	13.2	9.2	24.5	1.4	6.6	12.6	6.8	4.6	11.8	6.3	12.8	14.4	7.4	6.3	8.0	0.0	7.1	5.9	3.4	14.3	7.2	13.8	10.1	35.7
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavorable (7.64e-10)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.99e-11)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	36.7	14.1	11.2	18.0	12.1	0.7	28.5	7.9	13.5	8.8	25.2	5.1	8.3	21.6	14.8	7.5	12.0	8.0	22.3	16.6	12.5	8.2	16.4	73.1	9.3	3.0	10.7	4.8	17.7	14.4	13.9	7.8	41.0	13.0	11.1	16.1	7.2	7.7	11.3	4.8	3.2	24.7	24.2	19.4	3.2	13.6	6.3	10.9	6.1	47.6	3.5	3.0	21.8	28.7	0.0	0.0	1.5	0.3	0.0	0.0	1.9	16.4	11.8	3.7	1.2	13.5	14.5	9.4	58.5	17.9	31.9	60.2	0.9	1.7	0.0	11.4	9.9	14.6	3.5	4.3	50.3	82.6	0.0	6.8	4.1	11.5	8.2	34.7	0.0	0.0	25.4	7.2	27.6	13.5	93.9	44.0	0.0	5.4	0.2	56.3	6.0	0.0	0.0	2.3	0.0	5.1	0.0	2.4	0.0	13.4	0.8	1.8	0.0	46.6	5.0	4.9	18.1	13.6	0.5	55.2	39.5	12.0	12.5	34.9	17.9	2.5	0.0	73.6	0.0	7.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	11.2	12.1	7.9	13.5	12.5	8.2	10.7	4.8	13.0	10.9	14.9	10.7	0.5	5.9	6.3	14.5	10.6	61.1	12.0	13.6	26.2	33.4	6.8	8.3	62.8	0.4	21.2	46.1	0.0	45.9	109.4	34.5	8.1	0.0	50.8	4.7	0.0	19.0	18.4	1.5	1.3	12.0	2.7	13.5	1.0	18.3	65.1	83.0	31.5	4.6	6.9	22.4	19.4	38.1	8.0	16.3	4.8	15.7	0.7	21.3	5.4
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favorable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	13.1	32.4	11.2	22.0	11.8	24.3	15.0	18.0	13.8	14.0	17.4	17.0	26.4	15.6	16.7	25.3	13.6	18.1	18.2	16.8	12.3	9.5	20.1	16.8	15.9	21.0	13.9	14.2	17.1	22.5	19.7	26.8	17.1	12.9	18.7	15.0	19.6	20.3	22.4	12.8	15.3	15.7	13.2	10.1	30.7	17.9	17.2	13.9	22.3	23.0	17.0	20.6	14.6	12.4	7.9	7.5	19.3	12.7	2.7	7.7	3.8	13.0	8.8	8.9	14.0	8.5	6.6	14.5	21.1	10.8	9.8	8.6	7.0	17.2	8.5	6.7	6.4	5.7	10.7	3.2	11.9	5.8	10.9	13.5	14.4	16.6	6.1	6.4	13.6	19.3	6.2	6.3	8.9	5.8	8.7	12.8	10.7	7.0	17.1	12.7	8.3	13.7	10.8	8.3	13.5	18.0	11.7	8.2	17.1	10.0	27.9	10.6	17.1	9.2	27.8	4.7	8.1	4.8	8.4	18.1	19.1	11.7	4.6	17.4	18.9	7.6	6.9	17.3	6.1	15.2	1.4	8.8	12.2	7.7	8.5	6.4	6.5	6.6	5.8	7.5	7.9	4.9	4.4	19.3	2.7	12.7	4.3	6.8	3.8	11.2	11.8	18.0	13.8	12.3	9.5	13.9	14.2	12.9	13.9	14.9	23.4	40.2	28.5	11.8	40.7	8.9	15.3	24.1	9.1	19.2	76.6	37.9	19.9	36.3	12.0	20.2	24.9	0.0	34.6	29.2	14.8	28.4	27.8	18.7	34.1	31.8	29.3	31.9	22.4	20.0	55.0	24.9	13.5	42.3	23.1	20.6	38.1	20.1	42.1	26.9	76.0	19.4	14.4	18.2	29.6	11.4	41.2	42.4	27.4	25.2
PNMA6A	"MGC15827, PNMA6C"	ENSG00000235961	"PNMA family member 6A"	P0CW24	X	153072482-153075018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 21.6;Distal tubular cells: 10.0;Horizontal cells: 22.3;Muller glia cells: 18.8;Proximal tubular cells: 20.3;Rod photoreceptor cells: 7.1"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	15	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 8.0;HMC-1: 6.9;SK-MEL-30: 6.6;U-2 OS: 15.2;U-698: 8.3"									"HPA045007, HPA052115"	Uncertain		Uncertain	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA045007: AB_2679181, HPA052115: AB_2681734"	"unprognostic (2.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.76e-4)"	"unprognostic (5.75e-3)"	"prognostic favorable (1.93e-5)"	"unprognostic (4.61e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.22e-2)"	1.3	2.0	7.2	0.1	6.2	0.2	0.3	7.0	16.3	3.7	0.2			0.5	1.8	7.0	0.1	1.5	0.9	2.1	6.5	11.0	6.2	7.9	0.1	0.2	5.5		3.1	0.7	0.4	3.9	0.1		0.1	0.1		0.9	0.7	0.0	0.3	0.3	0.6	1.6	0.5	0.5	0.8			1.8		0.2	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.0	5.3	0.1	1.6	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.0	0.5	0.0	1.9	0.4	0.9	0.0	2.9	0.0	0.0	0.0	0.6	0.0	0.3	0.2	8.0	3.2	6.9	1.2	0.0	0.1	0.0	0.2	0.2	5.7	1.3	0.0	0.1	0.4	1.1	0.0	3.4	5.8	0.0	0.0	0.0	0.0	0.3	0.0	3.3	1.9	0.4	0.0	6.6	0.3	0.0	4.1	0.0	0.0	15.2	0.0	0.0	5.8	4.3	8.3	0.0	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.4	0.0	21.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	2.5	3.2	22.3	0.0	0.6	0.0	0.4	2.6	0.0	0.0	0.0	0.0	18.8	0.4	0.0	2.8	20.3	7.1	0.0	0.2	1.0	2.2	0.0	0.0	0.0	0.0	0.1
PNO1	"KHRBP1, RRP20"	ENSG00000115946	"Partner of NOB1 homolog"	Q9NRX1	2	68157844-68176238	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056928			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA056928: "	"unprognostic (1.81e-3)"	"unprognostic (4.83e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (3.04e-8)"	"unprognostic (5.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.66e-2)"	18.5	19.2	13.0	17.2	19.0	21.8	15.4	10.0	12.8	10.8	13.1	9.1	10.2	9.9	15.3	15.4	14.9	13.8	13.2	24.5	19.1	9.6	16.6	27.4	12.9	15.0	15.0	11.9	20.0	27.0	13.2	15.7	16.3	13.1	14.4	12.2	8.9	12.7	15.0	48.8	12.4	9.5	15.1	11.7	13.6	13.2	11.4	13.9	9.7	16.6	15.1	15.2	15.8	21.4	14.7	12.6	2.0	13.2	10.6	15.5	14.4	15.1	16.6	7.7	12.6	9.5	7.9	19.3	14.4	9.4	16.3	11.6	31.7	9.0	20.7	12.1	9.5	22.6	13.0	24.7	17.0	25.6	14.4	17.3	20.1	7.9	23.2	14.8	16.0	9.3	10.2	12.6	16.4	18.8	4.7	11.9	13.4	27.7	11.3	14.5	11.1	15.6	15.2	21.6	27.5	18.1	13.3	18.9	22.0	12.4	12.8	13.8	10.2	10.7	13.4	23.1	12.9	9.4	9.0	8.9	18.7	20.2	16.6	39.9	9.1	13.0	32.0	15.4	24.1	25.5	0.4	9.4	1.9	10.1	13.2	15.5	14.7	11.4	11.5	12.6	11.1	13.3	12.2	2.0	10.6	9.4	9.0	11.7	14.4	13.0	19.0	10.0	12.8	19.1	9.6	15.0	11.9	13.1	13.9	14.9	10.4	31.0	31.3	73.8	22.7	10.4	12.7	33.5	46.6	7.0	11.8	34.1	16.6	26.1	20.1	20.3	4.2	0.0	25.8	33.6	22.6	19.3	30.1	14.3	23.5	17.5	16.6	13.5	10.6	4.2	11.5	23.3	11.8	20.8	9.7	13.7	24.7	7.0	15.6	27.9	40.1	6.5	48.7	23.9	42.8	49.1	39.8	20.4	13.6	22.3
PNRC1	"B4-2, PROL2, PRR2"	ENSG00000146278	"Proline rich nuclear receptor coactivator 1"	Q12796	6	89080751-89085160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 1093.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 54.1;hTCEpi: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029839, HPA066513"	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Nucleoplasm, Nucleoli"		"HPA029839: AB_10601247, HPA066513: AB_2685684"	"unprognostic (9.02e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (6.88e-6)"	"unprognostic (8.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.09e-2)"	70.5	58.1	21.3	46.1	28.3	105.4	48.1	30.8	31.8	55.9	51.5	30.3	27.0	23.6	60.3	30.9	45.4	73.6	45.0	48.5	20.8	17.9	32.9	97.9	59.5	87.1	23.1	22.3	83.4	41.3	31.3	29.5	38.8	20.4	56.6	26.0	46.5	35.5	40.8	154.1	49.0	32.4	63.6	31.1	46.9	38.2	35.5	20.8	91.2	38.4	30.8	45.4	113.2	41.0	9.6	7.3	37.5	7.1	6.9	10.4	3.8	2.9	2.8	6.1	10.3	24.8	41.8	4.2	3.8	26.8	7.2	16.9	2.4	8.2	6.4	18.7	4.6	29.6	10.1	3.2	5.8	11.0	8.0	10.0	1.1	16.5	7.7	54.1	5.9	14.8	30.0	57.5	4.8	22.2	27.2	11.8	7.6	0.9	19.7	7.9	2.9	1.5	31.3	1.7	3.3	6.1	7.0	7.4	5.1	16.9	5.2	3.9	11.0	9.9	13.6	10.0	19.0	6.7	29.9	11.2	5.7	3.4	4.0	1.4	31.0	15.1	2.1	11.5	5.1	3.5	10.3	6.6	36.7	7.5	7.1	7.8	8.3	8.9	7.8	4.2	9.6	10.4	10.4	37.5	6.9	6.3	7.3	7.1	3.8	21.3	28.3	30.8	31.8	20.8	17.9	23.1	22.3	20.4	20.8	131.0	125.0	333.4	716.3	860.7	129.0	174.7	124.9	45.5	52.4	85.5	47.1	189.8	198.9	158.1	59.9	195.6	165.4	23.3	206.9	57.7	278.7	681.2	165.7	181.5	204.0	68.3	237.9	148.0	328.8	20.9	446.1	557.5	416.7	926.1	131.7	222.1	145.2	115.8	354.7	216.2	99.3	413.9	840.5	47.0	44.3	1093.4	229.5	380.5	99.7	411.4
POLE3	"CHARAC17, CHRAC17, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410672	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047945	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047945: AB_2680218"	"unprognostic (9.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	16.9	23.9	18.2	22.0	18.5	56.3	19.3	36.0	25.0	17.0	17.6	15.8	12.5	15.1	18.2	16.5	27.8	17.6	17.0	17.9	16.1	14.8	14.3	29.5	15.8	29.0	15.1	18.5	15.4	20.8	13.1	8.4	21.2	20.0	15.9	20.3	12.4	17.9	16.3	48.3	24.7	17.3	16.9	16.9	26.8	17.2	29.9	15.9	35.0	16.3	27.3	32.4	18.8	16.7	34.9	33.5	34.3	34.4	28.0	44.0	47.7	15.9	19.9	14.0	21.0	8.0	7.2	12.3	21.3	10.9	24.2	19.1	18.4	14.5	58.1	13.3	12.4	14.7	27.4	27.3	23.4	22.4	11.0	16.5	30.1	20.7	18.8	8.6	62.4	18.2	8.1	16.2	21.0	27.0	8.8	16.7	29.6	41.9	32.5	16.7	40.6	42.8	33.6	18.1	34.3	36.1	43.9	58.5	32.6	10.5	15.3	30.5	17.6	31.0	19.6	16.7	8.9	29.3	28.1	13.7	17.9	24.3	22.7	36.4	17.0	55.5	78.3	16.4	36.9	21.4	25.4	34.0	34.3	35.5	34.4	44.0	34.9	34.0	33.7	33.2	33.5	36.9	34.3	7.2	28.0	26.6	33.5	39.0	47.7	18.2	18.5	36.0	25.0	16.1	14.8	15.1	18.5	20.0	15.9	35.7	27.5	46.8	23.7	83.3	13.9	39.7	22.9	46.8	44.3	29.6	5.9	49.3	36.5	26.8	4.0	34.3	14.2	0.0	39.2	47.2	34.7	19.7	54.5	37.2	44.5	12.7	23.6	23.4	27.8	11.5	33.1	54.6	38.8	53.3	31.4	30.3	28.9	10.5	40.0	22.0	17.1	12.9	47.2	27.9	98.5	82.9	29.2	63.4	39.3	18.2
POLR1B	"FLJ10816, FLJ21921, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112577150	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	8.8	11.0	6.4	10.6	6.8	4.9	15.7	8.0	8.2	7.6	7.0	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8.0	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10.0	8.3	14.7	9.2	8.0	7.9	4.8	11.4	8.1	15.7	5.0	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11.0	2.5	6.3	10.2	17.1	7.3	9.5	10.0	6.3	13.1	6.9	6.6	11.9	7.2	5.5	12.2	10.6	22.4	5.7	22.9	10.7	4.7	9.5	13.5	26.7	14.6	14.1	10.3	13.5	13.2	9.9	16.9	7.3	21.1	9.2	6.3	10.6	12.6	19.5	5.1	9.4	4.8	23.9	8.3	6.3	8.4	9.5	13.7	30.9	14.1	19.8	14.3	10.5	24.3	8.4	9.1	16.1	14.9	6.6	16.6	9.0	7.1	7.7	7.5	8.5	7.5	11.0	6.8	10.5	11.2	18.4	19.8	5.7	13.6	6.2	0.2	6.0	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11.0	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8.0	8.2	5.7	6.1	6.8	3.7	5.2	5.0	14.9	5.1	8.2	2.2	13.4	3.4	5.7	10.2	2.7	7.9	8.7	2.0	2.9	5.0	4.0	133.9	5.6	1.2	0.0	3.9	2.3	2.8	2.2	4.7	8.5	3.3	1.6	3.5	1.8	2.5	29.4	2.8	2.9	1.7	1.8	4.4	3.8	2.9	6.0	2.8	4.1	2.9	0.0	2.8	9.5	7.5	15.1	0.5	6.4	4.5	3.4
POP5		ENSG00000167272	"POP5 homolog, ribonuclease P/MRP subunit"	Q969H6	12	120578764-120581398	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047598, HPA069204"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA047598: AB_2680096, HPA069204: "	"unprognostic (1.50e-2)"	"prognostic favorable (2.68e-5)"	"unprognostic (1.55e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.68e-2)"	16.3	33.8	16.2	25.6	14.4	14.1	23.9	8.7	16.7	18.6	17.5	13.6	24.2	11.8	14.5	27.1	15.9	14.6	19.5	25.8	18.1	13.9	24.1	24.1	18.3	19.7	16.9	15.9	11.7	18.9	25.0	17.5	8.2	14.2	15.6	18.0	15.1	20.9	22.6	13.3	12.7	15.1	19.5	14.4	20.3	15.2	9.0	12.1	24.2	19.8	18.9	19.6	13.7	19.2	32.0	33.5	3.6	19.7	18.2	28.2	22.8	20.1	34.6	12.3	15.0	23.4	12.6	19.6	17.0	11.0	20.8	16.0	29.8	9.3	11.9	25.9	13.6	10.9	21.4	20.6	32.4	18.7	28.1	31.2	14.5	22.6	33.7	16.5	20.4	15.2	15.9	18.7	24.0	11.0	11.7	17.3	28.4	17.7	7.7	20.6	44.4	16.6	18.4	14.7	29.3	29.9	19.5	15.1	32.5	29.1	20.8	9.6	10.6	28.8	8.5	21.9	14.6	39.4	19.7	12.5	10.9	16.3	17.3	18.5	19.9	33.5	21.0	21.2	24.9	17.3	3.6	16.2	3.5	24.7	19.7	22.6	32.0	22.6	23.0	19.0	22.4	28.2	26.8	1.1	18.2	16.7	33.5	21.4	22.8	16.2	14.4	8.7	16.7	18.1	13.9	16.9	15.9	14.2	12.1	11.9	25.1	40.9	40.5	17.4	19.6	53.8	40.8	25.4	37.5	73.3	13.7	49.9	131.0	34.2	1.3	26.7	23.2	23.3	38.8	36.9	22.4	23.7	54.2	46.1	46.0	17.5	21.2	23.9	18.3	2.7	33.4	31.2	47.2	27.1	27.7	54.1	31.5	24.6	35.3	99.7	28.3	19.4	28.8	19.1	33.4	21.7	14.8	37.4	37.5	25.7
POP7	"RPP2, RPP20"	ENSG00000172336	"POP7 homolog, ribonuclease P/MRP subunit"	O75817	7	100706053-100707495	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021007	Uncertain		Supported	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA021007: AB_10963575"	"unprognostic (3.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.21e-2)"	"unprognostic (6.73e-2)"	12.3	16.6	20.5	15.1	21.0	25.3	16.1	25.1	33.2	11.3	14.7	8.7	14.0	17.5	13.9	12.5	20.4	13.4	13.9	19.6	18.3	18.1	13.1	31.4	11.7	18.2	16.8	22.0	13.2	21.2	6.6	11.5	18.1	13.3	16.0	8.1	10.0	24.2	15.8	46.4	22.6	17.6	12.3	12.9	12.3	15.5	7.0	9.4	11.0	11.6	20.5	11.8	11.5	12.5	32.1	30.4	46.4	35.6	42.1	37.0	32.0	24.6	24.6	9.9	17.5	5.3	5.1	19.5	14.0	6.6	15.6	15.5	35.9	16.0	20.0	23.6	6.1	17.2	15.7	14.5	16.5	7.7	18.2	43.9	9.0	16.0	34.4	9.0	13.8	11.1	5.9	6.2	15.9	15.7	4.4	8.6	14.3	31.9	17.9	8.1	70.0	34.6	47.3	30.5	15.7	34.0	26.2	10.5	34.0	9.3	13.6	20.0	20.3	11.3	34.9	16.6	9.3	11.5	14.0	8.4	21.6	26.0	42.4	27.5	7.6	20.6	35.9	13.6	23.9	23.4	46.4	35.6	38.2	32.4	34.1	29.4	32.1	32.5	31.6	30.4	26.4	29.9	31.1	21.9	42.1	35.3	27.9	37.0	32.0	20.5	21.0	25.1	33.2	18.3	18.1	16.8	22.0	13.3	9.4	17.9	14.2	18.6	25.5	93.3	23.7	23.0	33.1	25.4	10.3	33.2	5.9	127.6	79.6	64.3	1.9	39.5	51.5	70.0	76.1	144.7	43.7	49.5	17.3	88.3	57.5	30.2	38.6	28.8	23.7	5.6	38.9	27.4	54.0	41.5	44.2	33.8	71.6	45.0	35.0	66.2	18.4	45.3	39.1	7.5	43.1	104.3	116.5	27.4	49.7	41.7
POPDC3	"bA355M14.1, MGC22671, POP3"	ENSG00000132429	"Popeye domain containing 3"	Q9HBV1	6	105158280-105179995	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"heart muscle: 23.9;skeletal muscle: 68.9"	"Cell type enhanced"	"Detected in some"	27	"Cardiomyocytes: 40.0;Early spermatids: 75.0;Late spermatids: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 25.2;LHCN-M2: 11.9;RH-30: 13.4;U-87 MG: 12.0;WM-115: 11.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA012514			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA012514: "	"unprognostic (2.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.83e-9)"	"unprognostic (6.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.33e-2)"	0.9	0.8	2.2	1.4	4.5	0.6	2.5	0.4	6.8	0.8	1.4	2.1	0.8	0.7	1.3	2.2	2.1	0.7	1.1	23.9	3.7	2.3	0.6	0.6	0.7	0.7	6.1	3.5	0.7	0.6	0.6	3.2	1.2	4.0	1.2	0.6	1.9	1.0	0.8	68.9	0.6	0.6	0.6	3.6	0.6	1.6	3.6	4.0	0.0	0.8	8.8	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.4	0.1	2.4	6.3	0.5	2.4	2.6	4.3	5.2	0.0	1.4	0.0	1.0	4.9	25.2	0.0	1.2	1.1	3.6	0.0	2.6	0.0	0.9	0.0	0.1	0.0	0.0	2.5	0.2	6.9	0.9	1.2	0.3	0.0	2.6	7.3	11.9	0.0	0.0	0.9	2.8	0.0	4.1	0.4	13.4	0.0	0.0	0.0	6.1	11.0	0.0	0.0	8.6	1.5	0.0	4.7	5.4	2.6	0.0	1.7	9.0	0.0	0.0	0.0	12.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.5	0.4	6.8	3.7	2.3	6.1	3.5	4.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	75.0	0.0	0.0	0.0	0.0	1.1	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.6	0.6	0.0	0.0	3.6	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	1.6	1.4	0.0	0.1	0.0	0.0	0.0
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		35000	Nucleoplasm	Nucleoli	"HPA040765: AB_2677125, HPA062187: AB_2684706"	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	12.4	17.9	18.1	15.5	19.2	24.2	21.1	20.1	20.2	19.4	16.4	18.4	21.1	12.7	17.2	24.3	25.4	19.1	15.9	17.6	17.5	21.8	15.9	19.4	15.9	23.7	20.0	11.8	31.4	16.7	11.9	17.4	15.5	23.0	19.5	16.6	16.3	13.8	15.8	13.4	14.7	15.7	16.8	23.2	20.2	15.7	18.2	13.0	26.3	23.7	19.4	25.5	28.6	13.6	23.4	21.7	18.7	14.1	20.6	20.6	10.7	8.0	7.1	22.1	9.6	17.3	37.2	7.2	12.8	13.9	14.8	15.0	5.2	15.2	7.7	13.6	13.8	17.4	10.6	7.7	15.6	13.3	16.3	18.5	32.5	19.9	35.1	8.9	31.1	16.5	13.5	15.3	12.1	19.1	25.0	9.8	15.3	25.7	18.9	18.8	12.8	23.9	24.8	13.5	8.1	11.5	9.1	12.4	12.1	19.4	12.4	9.2	8.5	12.9	12.3	20.6	27.1	10.2	14.2	13.4	21.3	12.1	12.6	10.5	20.7	19.6	36.3	16.3	13.9	13.5	18.7	12.7	12.7	12.7	10.8	18.5	23.4	15.6	13.7	21.7	18.9	19.1	20.6	3.0	20.6	14.1	17.9	20.1	10.7	18.1	19.2	20.1	20.2	17.5	21.8	20.0	11.8	23.0	13.0	0.0	11.5	24.3	38.6	28.2	12.5	17.8	17.8	21.4	11.4	15.7	9.8	45.1	48.0	20.2	14.8	15.7	12.9	0.0	14.0	44.2	34.2	17.7	25.4	15.7	41.6	3.2	9.1	16.0	41.1	2.7	33.9	45.8	27.0	23.4	25.0	17.1	18.9	24.6	26.5	45.3	10.5	19.4	29.4	36.5	22.3	40.5	25.7	32.6	29.2	23.7
PPM1B	"PP2CB, PP2CBETA, PPC2BETAX"	ENSG00000138032	"Protein phosphatase, Mg2+/Mn2+ dependent 1B"	O75688	2	44167969-44244384	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016745	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA016745: AB_1855622"	"unprognostic (5.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	23.7	13.8	31.2	12.2	33.8	24.7	15.2	32.6	25.2	16.3	18.2	26.0	13.6	13.2	15.7	20.4	14.9	12.7	14.3	21.1	29.6	24.6	19.4	27.7	13.4	16.6	34.6	22.4	15.8	20.9	34.6	17.9	12.1	22.9	20.7	19.0	24.3	16.4	16.4	72.0	12.5	14.3	21.1	27.3	16.1	14.8	13.3	34.1	19.1	15.0	13.1	16.8	18.2	15.9	6.5	5.5	11.1	5.0	4.7	9.5	1.6	17.0	15.3	20.4	14.8	25.4	11.9	23.1	13.2	15.3	13.8	12.2	20.5	11.1	18.8	20.8	15.3	11.2	9.3	22.7	8.7	20.4	18.9	8.8	19.8	9.1	14.1	20.6	17.7	16.6	11.4	15.2	10.9	18.6	10.8	11.2	8.8	14.4	20.0	12.3	14.2	17.5	28.5	25.1	15.8	5.2	18.6	22.7	12.6	32.1	17.3	16.4	20.7	11.9	17.9	15.3	31.7	9.7	12.4	10.2	12.1	17.4	10.0	12.7	17.5	11.4	17.6	6.4	29.5	8.7	8.3	3.3	11.1	7.2	4.5	6.2	5.8	6.9	6.1	5.5	6.5	9.5	6.4	9.2	4.7	5.0	5.3	6.2	1.6	31.2	33.8	32.6	24.9	29.6	24.6	34.6	22.4	22.9	34.1	17.9	17.3	29.6	37.1	53.8	47.2	45.6	28.1	5.3	20.5	38.4	60.9	27.6	39.7	35.0	59.2	17.3	39.4	0.0	41.1	24.4	27.3	58.6	26.5	49.9	23.3	101.7	38.6	16.5	48.5	32.9	33.1	41.2	54.0	37.9	27.4	54.4	35.2	40.3	31.8	30.8	128.5	25.8	38.7	33.8	26.0	54.5	54.0	54.2	32.8	45.7
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	12.2	7.0	6.1	5.7	9.2	13.6	11.9	30.8	6.6	11.1	10.0	10.6	7.8	7.6	12.0	8.3	8.6	11.1	8.3	5.8	7.7	4.4	7.4	7.4	9.2	7.9	10.3	4.6	17.3	12.3	8.1	8.9	18.5	8.8	9.3	9.4	8.2	8.1	6.8	9.7	8.1	8.1	8.2	7.3	9.2	7.3	16.2	12.5	15.5	8.7	6.9	7.0	7.8	11.3	7.3	13.1	20.5	13.2	6.8	8.3	6.8	2.7	5.5	6.2	5.3	4.2	2.6	8.0	4.3	2.9	2.8	4.0	5.6	1.6	7.9	3.6	3.0	1.1	3.0	4.0	1.8	3.8	1.4	8.8	5.7	5.4	6.5	3.5	2.3	4.4	2.3	2.9	4.2	2.5	2.3	6.4	3.4	4.1	3.3	3.0	26.9	6.2	3.4	2.7	2.6	4.3	7.6	7.9	4.7	2.5	3.4	8.5	6.2	5.7	1.9	1.3	6.9	2.3	3.1	4.7	3.7	10.1	2.8	2.3	5.4	5.7	6.0	1.5	2.3	2.8	8.2	13.2	14.1	6.7	10.2	5.9	7.3	5.6	6.1	13.1	5.9	6.1	6.2	20.5	6.8	6.1	5.8	8.3	6.8	6.1	9.2	30.8	6.6	7.7	4.4	10.3	4.6	8.8	12.5	29.8	7.7	13.7	4.0	18.7	12.0	5.6	5.1	2.7	4.5	5.2	3.9	13.6	3.3	6.0	51.4	15.8	10.1	0.0	6.0	5.1	11.2	6.9	1.1	2.8	7.5	3.2	13.8	20.3	23.0	8.1	12.7	9.8	3.3	6.4	9.0	6.4	5.1	8.6	7.1	4.2	10.1	0.0	12.0	24.5	13.9	15.7	32.3	7.5	10.5	5.5
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755869-58985176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 10.7;brain: 36.5;testis: 13.1"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 16.0;Cone photoreceptor cells: 29.5;Early spermatids: 22.1;Horizontal cells: 73.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 2.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"AF22: 10.2;HAP1: 16.5;MOLT-4: 7.8;SCLC-21H: 7.6;SH-SY5Y: 15.8;THP-1: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.7	10.7	15.0	0.8	7.5	0.7	0.7	11.9	23.3	1.0	0.7	3.6	0.0	0.8	1.1	2.2	0.7	3.3	0.8	2.3	36.5	5.4	1.9	2.4	1.0	0.9	3.2	9.2	1.0	1.7	0.8	3.4	0.6	10.5	3.2	0.7	3.5	0.8	0.7	0.6	0.7	1.0	1.3	2.7	0.8	1.4	13.1	2.0	0.0	0.8	0.0	1.0	0.6	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.5	0.0	0.0	0.8	0.0	0.0	0.8	1.2	0.0	0.0	6.5	0.1	0.1	2.3	0.0	16.5	0.0	0.4	0.1	4.9	0.0	0.1	0.0	1.2	0.5	2.1	0.3	1.3	0.1	0.0	0.5	0.0	4.1	1.6	0.0	0.0	2.9	7.8	0.0	2.9	0.0	0.8	0.0	1.3	0.0	0.0	0.0	7.6	15.8	0.2	0.0	1.0	0.1	0.0	7.0	0.0	0.0	1.9	0.0	2.4	0.0	0.1	4.4	0.3	0.0	2.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	7.5	11.9	14.0	36.5	5.4	3.2	9.2	10.5	2.0	0.0	0.0	0.0	0.0	0.0	16.0	1.6	0.0	0.0	3.4	0.0	29.5	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.1	73.1	2.9	0.0	0.3	14.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.4	0.0	11.7	0.0	0.0	9.3	2.5	0.0	0.0	0.0	0.0	0.0
PRAG1	"DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223"	ENSG00000275342	"PEAK1 related, kinase-activating pseudokinase 1"	Q86YV5	8	8317736-8386498	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.2;Cytotrophoblasts: 6.4;Ductal cells: 6.6;Extravillous trophoblasts: 5.5;Hofbauer cells: 14.8;Pancreatic endocrine cells: 5.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 27.5;NTERA-2: 17.8;SuSa: 19.0"	"Low region specificity"	"Detected in all"							"HPA011776, HPA012066"	Uncertain		Uncertain	"Nucleoli,Focal adhesion sites"		NA	NA			Nucleoli	"Focal adhesion sites"	"HPA011776: , HPA012066: AB_1847706"	"unprognostic (7.04e-3)"	"unprognostic (7.90e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.22e-3)"	7.6	0.2	6.4	8.8	4.9	0.1	5.4	30.4	7.0	2.4	5.7	1.8	3.2	9.8	0.8	1.7	2.6	5.0	4.0	1.8	2.1		1.3	0.9	4.3	9.1	0.0	1.4	1.7	1.0	2.2	0.0	5.4	1.2	1.5	3.4	0.0	1.7	5.7	5.6	2.8	9.4	0.9	1.4	5.7	3.9	0.7	1.2	1.8	15.4	4.7	6.2	1.5	0.2	3.1	4.6	2.2	1.6	1.3	3.9	0.4	3.3	27.5	3.1	0.4	0.0	0.2	7.8	7.0	1.5	2.8	1.1	13.6	8.0	5.5	4.8	3.3	7.6	12.0	0.5	8.4	0.6	0.2	0.8	0.0	3.3	7.6	3.0	0.8	8.7	0.7	5.5	0.4	1.2	1.6	5.7	0.8	0.0	0.0	2.1	4.6	0.7	2.6	17.8	10.5	7.1	3.5	3.3	1.3	4.1	9.5	1.5	1.0	2.7	7.7	2.7	19.0	6.0	3.4	7.5	0.2	7.4	0.0	1.7	0.4	0.6	7.5	1.7	1.8	4.1	0.0	0.5	2.2	1.2	0.1	0.9	3.1	1.5	0.4	0.7	2.6	3.9	3.2	0.0	1.3	1.6	4.6	0.2	0.4											8.9	6.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	6.4	0.0	6.6	0.0	0.0	0.0	0.0	2.7	5.5	0.0	0.0	2.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.8	0.0	0.0	5.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	106086320-106109939	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 49.1;T-cells: 100.2;Urothelial cells: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;T-cells: 19.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 68.5;RPMI-8226: 12.8;U-266/70: 25.7;U-266/84: 16.6"	"Region enriched"	"Detected in single"	6	"olfactory region: 4.4"	"Low region specificity"	"Detected in all"			"HPA030033, HPA075427"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA030033: AB_10601050, HPA075427: "	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	11.6	1.5	1.6	26.3	3.2	10.4	7.0	5.3	1.6	14.0	16.5	1.9	1.4	5.4	11.6	2.2	33.4	3.8	8.1	2.3	1.9	2.0	3.1	2.4	18.8	33.3	2.1	0.5	4.2	1.8	1.2	2.1	9.0	4.9	3.6	11.0	4.3	10.6	3.0	2.0	8.9	18.2	3.4	7.4	24.2	8.6	3.0	1.5	3.1	7.7	35.7	49.9	12.8	18.0	1.5	0.2	6.8	0.6	2.5	19.3	1.3	0.4	0.1	0.3	0.0	0.5	0.7	0.0	2.3	7.2	0.7	1.3	0.4	2.8	0.6	0.1	4.6	0.1	0.1	0.0	1.1	0.8	6.4	0.0	0.1	1.4	0.0	1.1	0.2	0.5	0.7	3.6	1.0	3.0	0.2	0.9	0.3	0.4	68.5	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.0	12.8	0.6	0.1	0.0	0.0	0.3	0.3	0.0	0.5	0.3	0.7	0.4	1.1	0.6	0.6	2.1	25.7	16.6	1.5	1.6	0.4	0.6	1.2	0.4	5.6	12.6	0.6	19.3	1.5	12.0	11.6	0.2	0.5	1.1	6.8	6.8	2.5	0.1	0.2	15.4	1.3	1.6	3.2	5.3	1.6	1.9	2.0	2.1	0.5	4.9	1.5	0.0	9.0	19.7	8.0	17.3	0.8	1.4	0.0	2.7	7.9	3.5	49.1	0.4	0.0	0.3	0.8	20.4	7.3	23.3	0.2	0.5	5.1	3.1	3.5	1.5	19.3	0.0	1.7	8.0	24.7	0.0	0.0	38.5	35.4	47.7	3.1	0.5	4.8	4.3	1.1	0.1	0.4	0.0	16.4	0.3	1.3	36.3	0.6	100.2	2.5	77.0
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056679-107059294	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 83.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059424: AB_2684012"	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	6.6	16.1	14.4	10.5	13.4	4.6	10.8	12.6	13.9	8.9	10.3	11.5	10.4	8.1	9.7	11.3	10.9	12.2	9.8	5.0	11.8	16.2	16.7	16.3	5.9	11.5	12.2	14.1	12.3	16.8	15.0	13.8	9.6	13.2	11.8	9.7	12.6	8.3	11.4	2.1	7.6	9.3	8.0	13.6	11.5	9.5	9.4	10.6	18.2	9.5	3.4	11.1	10.1	7.3	9.7	14.7	1.8	10.1	14.6	10.9	7.6	3.6	0.0	7.3	3.2	4.8	5.4	2.0	4.9	3.7	4.8	4.9	4.7	2.5	9.0	6.8	4.5	2.6	5.2	6.6	7.2	3.8	0.0	7.1	5.4	10.2	6.7	4.8	11.2	3.4	5.0	4.0	4.3	4.4	3.2	4.1	5.2	7.2	1.4	4.3	83.6	6.5	3.9	3.1	2.9	6.9	8.3	15.9	3.4	11.5	7.4	13.6	16.6	6.7	9.7	3.2	4.6	6.7	8.4	4.7	3.5	7.3	7.4	7.3	1.5	1.0	1.5	5.3	5.3	2.8	1.8	8.9	1.6	7.5	10.1	8.4	6.9	7.6	6.8	11.9	9.7	10.9	10.9	0.5	14.6	9.2	14.7	7.8	7.6	14.4	13.4	12.6	13.9	11.8	16.2	12.2	14.1	13.2	10.6	0.0	4.1	8.2	6.2	3.9	12.5	2.2	0.0	8.1	2.3	14.0	0.0	16.1	23.2	9.0	0.9	4.2	3.5	0.0	6.5	11.9	3.9	3.6	1.1	0.0	8.5	14.3	16.8	4.9	7.0	2.3	8.1	3.6	1.7	1.8	8.7	6.9	4.9	7.0	8.5	15.2	4.3	12.9	8.4	8.4	8.8	5.4	5.9	5.4	9.5	5.8
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase, non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.1;lymphoid tissue: 69.0"	"Group enriched"	"Detected in many"	5	"B-cells: 106.2;Early spermatids: 45.6;granulocytes: 130.8;Hofbauer cells: 168.2;Kupffer cells: 145.1;Macrophages: 118.2;T-cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 28.7;HL-60: 25.5;HMC-1: 112.6;THP-1: 43.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		7400000	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	6.6	8.8	2.4	42.9	4.4	27.7	4.6	1.2	2.7	2.8	7.0	5.1	4.7	7.5	3.7	8.8	7.0	5.0	9.8	2.9	3.1	2.3	7.0	6.8	25.4	58.1	5.2	1.8	2.3	6.7	2.7	5.6	7.7	3.9	5.6	5.2	3.6	10.6	7.0	1.3	6.1	21.0	2.6	4.9	69.0	6.6	1.5	3.3	31.4	6.3	4.1	50.7	8.5	4.2	63.9	38.0	107.1	103.2	22.2	28.2	63.2	2.9	5.6	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	3.0	6.6	2.0	1.5	0.0	0.0	3.4	0.0	3.9	0.0	1.2	1.2	28.7	0.6	2.4	0.0	25.5	112.6	0.0	2.8	0.0	1.2	0.0	0.0	10.3	0.0	0.2	0.0	6.1	9.2	14.9	1.5	6.8	0.9	8.4	0.0	14.5	3.1	5.5	0.5	0.0	0.9	4.6	0.0	4.1	1.4	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	11.2	0.1	54.4	35.9	107.1	28.2	71.3	18.2	62.3	13.7	21.0	38.0	63.9	15.8	19.9	66.7	22.2	103.2	10.0	14.4	63.2	2.4	4.4	1.2	2.7	3.1	2.3	5.2	1.8	3.9	3.3	6.0	18.1	106.2	8.1	8.0	0.0	1.6	12.7	12.0	11.4	5.2	0.0	21.7	13.3	12.3	45.6	4.1	15.8	23.3	13.5	15.5	3.5	4.1	130.8	10.2	168.2	0.0	23.7	9.8	145.1	8.7	0.9	118.2	13.5	6.4	12.0	0.4	11.8	17.3	0.0	10.5	0.6	6.5	2.3	0.3	1.1	7.5	15.4	105.5	15.6	5.6
PTTG1	"EAP1, HPTTG, PTTG, securin, TUTR1"	ENSG00000164611	"Pituitary tumor-transforming 1"	O95997	5	160421822-160428744	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.5;testis: 100.1"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 470.4;Erythroid cells: 654.1;Spermatocytes: 278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 54.5"	"Lineage enriched"	"Detected in all"	7	"T-cells: 54.5"	"Low cell line specificity"	"Detected in all"											"CAB008373, HPA008890, HPA045034"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			Cytosol	Nucleoli	"CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (6.48e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.46e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (7.50e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.35e-2)"	1.5	1.7	2.1	16.2	5.5	34.1	2.9	1.4	4.6	3.8	8.2	1.0	0.7	5.8	1.3	2.6	24.1	1.0	1.9	2.3	5.1	2.7	1.7	1.4	3.8	19.2	1.5	2.2	1.1	1.2	0.2	2.0	5.0	2.2	1.6	11.3	1.5	4.5	1.1	1.2	8.7	5.8	4.5	1.4	7.5	3.4	100.1	1.0	29.8	23.9	23.2	35.1	3.3	7.2	8.1	6.1	2.4	2.1	3.3	54.5	4.7	45.7	23.8	53.8	38.5	9.1	9.0	16.8	24.3	55.7	64.6	70.8	46.0	40.3	50.0	21.7	27.6	74.3	24.0	33.4	67.6	92.7	57.1	30.3	26.4	32.2	27.7	1.8	23.9	23.2	4.2	11.3	43.8	26.6	19.8	45.5	33.5	21.1	39.0	66.3	21.5	28.6	58.8	27.1	37.7	34.6	26.7	63.3	42.9	32.9	9.3	33.5	21.3	35.1	21.4	72.2	45.5	43.7	26.2	19.4	29.2	39.1	22.8	70.9	33.6	29.9	57.2	31.5	41.4	51.7	1.9	0.7	2.4	7.0	2.1	2.5	8.1	14.4	16.2	6.1	5.5	3.6	8.9	0.8	3.3	1.4	5.8	54.5	4.7	2.1	5.5	1.4	4.6	5.1	2.7	1.5	2.2	2.2	1.0	6.0	15.5	20.5	54.1	220.3	1.3	4.9	7.6	1.4	11.4	5.2	0.0	50.4	3.3	4.0	470.4	10.3	6.3	654.1	4.5	163.8	37.7	15.3	38.0	2.9	72.7	0.0	5.8	17.8	20.0	39.3	10.3	35.9	82.7	39.7	15.4	2.7	3.5	9.1	7.4	1.2	0.7	6.5	35.3	278.1	72.8	136.5	26.7	44.5	34.5	30.7
PTTG2		ENSG00000250254	"Pituitary tumor-transforming 2"	Q9NZH5	4	37960435-37961125	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.8"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 4.1;Early spermatids: 3.1;Spermatocytes: 1.9;Suprabasal keratinocytes: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4;T-reg: 1.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;MOLT-4: 3.1;U-698: 2.1"									"HPA008890, HPA045034"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (3.29e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.74e-1)"		"unprognostic (7.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.60e-5)"	1.0	0.4	0.9	5.2	1.2	5.0	0.5	2.2	2.4	1.1	3.9	0.2	0.0	0.0	1.6	2.2	3.3	1.8	1.5	2.5	1.0	0.4	0.7	0.5	0.9	1.0	0.7	0.4	1.2	1.0	1.4	0.4	1.8	0.3	0.8	0.7	0.0	0.2	1.4	1.9	0.6	3.1	2.0	0.9	2.3	1.0	5.3	0.0	15.8	1.3	7.5	7.3	1.8	0.7	0.4	0.0	1.4	0.4	0.0	1.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	3.1	0.5	0.0	0.0	0.0	0.7	0.5	0.9	0.0	0.5	0.3	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	2.1	0.0	1.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.0	1.4	0.0	0.0	0.0	1.0	0.1	0.9	1.2	2.2	2.4	1.0	0.4	0.7	0.4	0.3	0.0	0.0	0.0	1.4	0.5	4.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.7	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.2	2.5	0.0	0.0	0.0	0.3
PUS7L	DKFZP434G1415	ENSG00000129317	"Pseudouridylate synthase 7 like"	Q9H0K6	12	43718993-43758817	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056203, HPA058750"	Uncertain		Approved	"Nucleoli,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoli	"HPA056203: AB_2683064, HPA058750: AB_2683807"	"unprognostic (3.41e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	8.0	7.0	14.9	9.1	18.5	6.1	10.6	20.3	16.6	9.2	7.3	3.7	8.3	7.3	7.3	7.9	9.7	6.1	7.7	6.9	14.2	9.0	9.3	7.9	5.4	10.4	8.3	12.6	10.2	9.5	12.7	21.7	7.7	11.5	8.3	9.1	2.7	8.4	9.4	6.1	7.2	7.6	6.3	12.1	9.2	7.6	5.6	11.3	13.0	11.6	6.1	11.3	8.6	8.3	6.6	5.2	8.6	4.3	5.1	6.9	3.4	6.4	4.9	4.3	2.5	3.0	10.8	7.7	5.6	4.8	7.6	5.9	17.4	4.7	14.9	7.2	6.9	4.4	5.9	6.2	5.7	13.1	4.6	3.9	10.9	5.5	6.5	3.7	17.4	7.1	4.5	4.3	7.9	8.3	7.1	5.5	8.8	18.9	6.6	17.7	2.6	8.9	4.5	7.9	0.0	5.2	8.5	10.2	8.9	3.3	5.0	7.3	2.4	7.0	7.6	3.0	5.4	9.0	4.9	4.0	7.8	5.1	9.0	8.9	5.8	9.9	15.1	7.2	28.8	2.6	8.6	4.3	4.8	5.0	3.8	6.2	4.4	5.4	5.3	4.4	6.6	4.8	6.9	3.1	5.1	3.1	5.2	2.1	3.4	14.9	18.5	20.3	16.6	14.2	9.0	8.3	12.6	11.5	11.3	8.9	12.1	29.0	16.6	10.3	66.3	11.7	12.7	5.3	14.8	24.4	64.8	29.4	34.9	17.4	1.7	17.6	11.0	0.0	20.2	20.3	20.3	16.9	16.2	18.3	17.8	41.3	18.6	17.2	23.4	2.1	18.7	16.6	11.8	12.6	22.4	37.1	15.1	14.0	25.1	17.7	103.5	19.4	16.6	23.6	34.3	9.7	20.3	25.4	28.5	8.7
PVRIG	"C7orf15, CD112R, MGC2463"	ENSG00000213413	"PVR related immunoglobulin domain containing"	Q6DKI7	7	100218241-100221490	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 51.7;lymphoid tissue: 21.0"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 1.1;granulocytes: 2.3;Horizontal cells: 3.2;T-cells: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	32	"gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8"	"Group enriched"	"Detected in many"	37	"B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7"	"Group enriched"	"Detected in some"	26	"Daudi: 36.9;JURKAT: 21.8;MOLT-4: 40.2;U-698: 11.9"					"Low region specificity"	"Detected in all"			HPA047497	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Nucleoli, Endoplasmic reticulum"		"HPA047497: AB_2680069"	"unprognostic (1.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.13e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.71e-3)"	0.5	0.1	0.4	5.6	0.7	1.2	0.4	0.4	1.1	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.0	0.5	0.9	0.9	15.9	0.4	0.4	0.6	0.5	0.0	0.4	0.4	0.8	0.4	0.0	0.4	0.7	0.4	2.0	0.0	8.9	0.4	0.4	21.0	1.4	0.6	0.4	18.0	0.5	0.4	4.2	1.0	0.4	24.8	0.2	1.0	0.1	42.9	51.7	17.5	0.1	0.8	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	21.8	0.0	0.1	0.0	0.1	40.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.1	0.1	0.0	43.5	0.1	51.7	24.8	28.9	42.9	0.1	19.3	32.6	32.2	1.0	42.9	0.1	0.2	22.8	17.5	0.4	0.7	0.4	0.4	0.4	0.0	0.4	0.4	0.8	0.4	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2, small subunit processome component"	Q15269	21	44107290-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 9.5;Smooth muscle cells: 13.4;Suprabasal keratinocytes: 7.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 31.0;Daudi: 26.8"									HPA024573	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	6.1	6.1	11.3	7.7	14.6	3.6	6.3	9.7	12.8	4.0	9.0	9.6	2.4	4.4	7.8	9.2	8.2	5.9	4.8	4.6	6.8	4.8	6.9	8.7	5.0	7.9	15.4	5.7	5.0	12.8	1.4	4.0	7.6	8.9	8.1	1.8	4.9	8.2	5.2	8.0	14.7	5.6	2.2	6.4	8.8	10.6	5.3	17.2	3.6	4.8	8.6	16.8	5.0	5.7	6.8	2.6	2.9	4.3	3.4	6.9	5.0	1.2	0.4	0.3	1.2	3.6	3.6	9.3	12.0	6.3	16.0	10.8	31.0	0.5	26.8	0.4	0.0	0.9	1.4	0.5	9.1	9.2	6.6	19.4	3.2	5.6	7.2	2.3	2.4	0.9	0.3	0.0	11.1	0.0	2.8	0.5	11.4	10.2	10.8	5.3	0.4	0.1	0.7	0.3	0.7	1.2	1.5	0.1	13.9	0.0	0.4	9.4	1.6	0.6	1.0	7.5	4.6	0.0	1.0	6.1	6.5	1.1	14.4	1.4	14.5	17.3	1.2	0.4	2.9	9.2	0.2	2.2	2.9	6.0	3.1	6.6	6.8	4.9	6.9	1.6	4.1	4.9	6.1	1.2	3.4	4.3	2.6	3.5	5.0	11.3	14.6	9.7	12.8	6.8	4.8	15.4	5.7	8.9	17.2	0.0	1.3	0.5	0.1	9.5	0.1	3.4	0.0	1.4	2.3	0.0	0.0	0.1	1.7	0.0	0.1	1.4	2.6	0.0	0.0	1.2	1.0	0.7	0.0	0.0	1.7	0.0	2.4	3.1	5.4	0.0	1.1	0.0	1.7	0.0	4.7	0.2	0.0	3.2	0.0	0.0	0.2	0.0	13.4	0.6	1.7	7.4	0.6	2.9	4.7	0.0
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977054	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.4;lymphoid tissue: 23.3"	"Cell type enriched"	"Detected in some"	11	"T-cells: 126.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 33.4;MAIT T-cell: 19.1;memory CD4 T-cell: 14.2;memory CD8 T-cell: 25.2;naive CD8 T-cell: 16.0;NK-cell: 11.4;T-reg: 21.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.4;T-cells: 33.4"	"Cell line enriched"	"Detected in some"	6	"U-698: 33.1"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"	4.0	0.6	0.5	20.1	0.5	3.9	2.1	0.4	0.4	2.0	2.7	0.2	0.3	1.2	2.2	1.4	1.7	1.6	3.2	1.2	0.6	0.5	1.8	2.6	11.7	18.8	0.7	0.0	1.6	0.8	0.0	0.8	1.7	0.4	2.6	1.8	1.2	3.4	1.2	0.7	0.9	7.8	0.4	1.3	20.7	2.0	1.0	0.0	6.6	2.5	1.9	23.3	5.7	1.6	4.9	0.1	1.2	0.1	11.4	33.4	6.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	33.1	0.0	5.1	0.0	0.4	0.1	0.1	33.4	0.1	19.1	4.9	14.2	25.2	0.1	2.4	4.8	16.0	1.2	11.4	0.1	0.1	21.0	6.0	0.5	0.5	0.4	0.4	0.6	0.5	0.7	0.0	0.4	0.0	11.9	3.2	9.5	0.7	0.3	0.2	0.3	0.0	9.4	3.4	3.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.1	0.4	2.3	1.3	2.1	0.0	0.0	3.1	4.3	0.0	0.0	1.4	1.7	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.2	0.0	0.1	0.5	0.1	126.8	0.0	0.3
RABGEF1	"rabex-5, RABEX5"	ENSG00000154710	"RAB guanine nucleotide exchange factor 1"	Q9UJ41	7	66682164-66811464	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001407			Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA001407: AB_1856024"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (3.77e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.64e-4)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.55e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	18.4	15.2	13.0	14.7	14.4	59.2	12.0	22.4	16.8	16.9	14.1	12.6	9.4	9.1	16.4	9.5	20.6	12.0	13.5	10.8	13.5	15.6	14.9	17.2	10.5	10.6	12.8	12.1	14.7	13.2	13.3	10.2	18.8	13.5	13.1	11.0	13.8	10.6	16.1	12.1	21.9	15.5	15.3	11.9	15.3	11.9	21.5	9.8	13.1	22.3	20.7	18.2	19.1	16.3	15.7	10.4	18.1	13.5	15.4	10.9	7.6	20.6	6.2	5.4	9.1	14.7	20.6	5.4	18.2	23.3	19.2	18.3	5.8	13.4	10.1	7.1	26.3	14.1	8.7	7.4	9.8	26.8	6.9	5.9	5.4	7.3	5.7	11.7	9.2	7.7	10.2	12.7	24.7	27.4	15.9	5.0	6.9	9.9	7.4	19.0	10.4	6.2	12.9	7.1	9.6	9.0	5.5	9.4	7.6	16.8	9.5	6.2	9.7	8.4	18.6	9.8	9.4	10.7	5.8	6.5	31.2	6.5	19.1	14.2	9.6	12.5	12.0	14.4	10.3	9.9	18.1	7.8	9.4	8.6	6.9	9.3	11.2	8.1	10.9	7.3	15.7	8.8	8.2	15.1	15.4	13.5	10.4	6.7	7.6	13.0	14.4	22.4	16.8	13.5	15.6	12.8	12.1	13.5	9.8	11.9	13.8	5.2	6.5	3.7	9.7	4.2	0.0	20.1	18.2	5.2	15.7	3.2	10.0	4.5	4.1	5.8	5.9	0.0	4.8	3.0	5.1	10.1	13.9	5.9	4.2	7.9	17.2	4.9	12.3	1.8	5.5	9.3	1.7	5.4	5.1	4.8	12.5	14.0	8.9	4.0	16.7	0.0	7.3	6.6	6.4	5.8	11.3	2.5	4.7	11.1
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA049042: AB_2680610, HPA058085: AB_2683600"	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	12.9	17.0	13.7	10.9	23.1	13.5	13.0	20.9	23.3	13.7	11.2	16.4	6.7	11.3	16.4	12.8	11.9	12.6	9.9	10.4	13.2	12.9	20.6	17.3	10.5	16.5	13.5	12.5	16.2	16.8	15.9	21.5	10.3	15.0	11.8	13.2	12.7	14.6	12.0	18.8	14.9	12.7	11.6	10.5	14.0	10.7	9.5	13.7	22.5	17.4	8.9	19.8	11.7	16.7	8.6	6.1	19.1	7.7	7.7	9.6	3.3	10.7	11.4	11.0	13.0	15.4	8.9	12.0	10.2	8.8	13.1	13.1	12.0	13.0	16.8	7.9	7.5	10.7	12.4	18.3	6.8	15.6	14.2	9.8	14.0	11.6	9.7	10.0	17.5	11.5	7.1	8.9	12.2	10.4	8.8	10.5	12.1	27.0	17.2	10.9	9.9	16.8	7.5	17.9	9.4	19.0	15.1	23.5	20.9	9.1	7.9	17.3	14.0	14.4	15.3	13.0	13.8	16.5	9.9	7.9	10.9	11.7	15.9	13.4	8.5	11.7	20.6	9.7	11.0	16.7	19.1	5.2	7.5	8.6	6.3	9.2	8.6	8.1	8.8	5.4	7.1	8.0	9.6	11.9	7.7	7.7	6.1	8.1	3.3	13.7	23.1	20.9	23.3	13.2	12.9	13.5	12.5	15.0	13.7	17.9	13.5	16.3	9.4	23.9	13.8	6.5	7.6	14.7	17.0	21.0	27.5	8.0	8.3	10.8	6.4	13.8	14.0	0.0	10.0	8.2	9.8	10.8	12.8	20.2	9.7	15.9	11.6	17.8	14.1	1.7	11.8	15.2	18.6	10.0	12.4	15.8	11.6	10.5	15.2	23.1	18.8	19.4	9.8	8.8	18.1	29.5	9.0	21.7	13.3	12.2
RBM43	"C2orf38, FLJ45645"	ENSG00000184898	"RNA binding motif protein 43"	Q6ZSC3	2	151247940-151261879	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.2;HSkMC: 16.4"	"Low region specificity"	"Detected in all"							HPA038204	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA038204: AB_10669520"	"unprognostic (3.50e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.94e-2)"	10.7	14.8	5.2	7.6	6.4	6.0	7.9	1.6	4.9	14.4	8.1	5.4	7.4	3.1	14.6	14.6	8.4	13.6	7.2	4.4	6.0	4.8	7.8	7.0	14.3	13.6	4.5	5.3	17.6	6.8	8.7	7.8	6.0	4.3	14.4	4.7	14.3	6.2	8.9	4.5	6.2	6.3	11.5	5.6	8.4	5.9	6.5	4.1	11.0	13.4	3.6	6.9	20.5	6.6	3.2	1.1	5.9	4.6	5.3	4.9	1.2	2.9	1.9	3.1	4.1	8.3	18.2	2.0	3.4	7.8	4.3	6.3	0.1	4.9	2.3	1.3	6.1	2.3	1.5	0.9	3.9	2.2	3.4	2.1	5.5	0.7	0.2	8.1	6.7	1.9	16.4	4.4	3.4	2.6	6.5	9.1	2.5	2.2	2.6	5.8	2.9	3.8	3.2	1.1	0.0	3.6	2.6	3.5	1.3	7.3	2.5	1.1	3.6	3.3	2.4	6.4	0.5	3.5	4.4	5.1	3.2	2.9	2.8	1.4	0.9	0.6	0.0	8.5	2.7	1.9	1.9	1.7	5.9	2.8	2.1	4.6	2.8	3.9	3.5	1.1	3.2	4.9	3.4	2.0	5.3	4.6	0.5	1.9	1.2	5.2	6.4	1.6	4.9	6.0	4.8	4.5	5.3	4.3	4.1	3.0	6.2	4.7	2.3	3.0	7.5	2.1	15.3	32.1	6.8	17.4	0.0	5.6	23.2	4.9	2.3	9.0	2.9	0.0	5.1	3.3	8.7	3.3	3.5	8.6	4.7	6.4	5.8	15.4	11.3	1.1	25.9	4.8	3.3	8.2	6.9	21.7	3.8	5.3	27.3	8.8	0.9	0.0	5.7	0.7	3.2	2.8	1.1	5.9	4.3	2.0
RBMX2	"CGI-79, Snu17"	ENSG00000134597	"RNA binding motif protein, X-linked 2"	Q9Y388	X	130401969-130413343	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026609	Approved		Approved	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane"	Nucleoli	"HPA026609: AB_1846601"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.04e-4)"	"prognostic favorable (9.15e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (8.44e-9)"	"unprognostic (1.06e-1)"	"unprognostic (4.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.63e-3)"	19.4	16.7	22.3	16.7	20.0	17.1	25.0	22.7	22.9	25.1	19.9	18.9	19.1	17.0	29.4	29.5	18.7	19.8	18.8	17.8	21.0	18.7	17.7	21.1	16.9	21.2	18.6	22.1	28.2	21.9	17.9	24.4	17.3	21.0	23.0	20.0	16.3	20.5	23.7	21.0	21.4	15.9	23.0	18.9	21.1	18.4	10.8	19.0	26.4	23.0	17.9	26.7	27.2	20.2	12.6	10.5	11.0	9.5	9.4	19.3	5.4	14.0	14.7	14.7	15.2	14.7	27.6	15.0	13.2	13.5	15.0	16.4	10.9	17.2	13.5	31.7	10.0	19.8	15.2	23.5	12.2	21.9	12.3	20.9	12.1	13.5	11.4	13.3	18.7	14.4	20.0	17.4	16.8	23.4	21.8	16.8	16.8	10.5	11.8	16.7	24.4	21.4	23.3	11.1	24.6	23.9	16.6	14.6	18.2	15.2	11.2	17.2	20.6	8.3	17.7	23.2	12.5	11.5	13.8	10.9	12.1	9.9	28.2	27.4	15.7	17.0	19.2	14.8	30.5	15.3	11.0	9.4	10.8	11.1	9.5	11.1	12.4	13.8	14.0	7.8	12.6	15.1	14.2	8.0	9.4	9.4	10.5	19.3	5.4	22.3	20.0	22.7	22.9	21.0	18.7	18.6	22.1	21.0	19.0	17.9	14.7	30.6	27.8	28.5	21.4	20.3	25.5	29.4	45.5	10.4	9.8	28.5	13.3	28.8	2.9	30.2	14.2	0.0	30.8	34.2	26.7	22.1	34.6	23.6	30.5	15.9	39.0	35.0	46.7	3.5	30.0	32.5	27.0	31.5	21.9	19.8	26.5	17.5	41.4	32.3	10.4	32.3	30.7	16.5	47.3	26.0	21.6	32.0	27.7	20.3
RDM1	"MGC33977, RAD52B"	ENSG00000278023	"RAD52 motif containing 1"	Q8NG50	17	35918066-35930773	"Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.7;lymphoid tissue: 6.2;testis: 24.0"	"Group enriched"	"Detected in some"	16	"Early spermatids: 50.7;Late spermatids: 58.2;Spermatocytes: 19.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 5.7"	"Group enriched"	"Detected in many"	14	"NK-cells: 1.5;T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.2;JURKAT: 14.1;T-47d: 16.7"	"Low region specificity"	"Detected in all"							"HPA024794, HPA067546"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA024794: AB_1856039, HPA067546: AB_2732769"	"unprognostic (9.36e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-8)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.53e-1)"	0.0	0.0	0.9	0.9	1.2	0.6	0.0	0.0	1.8	0.0	0.9	0.1	0.0	1.3	0.2	0.7	0.3	0.1	0.3	0.0	1.0		0.1	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.2	0.2	1.7	0.0	0.0	0.0	0.0	1.1	1.5	0.1	0.2	0.1	1.1	24.0	0.0	6.2	0.3	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	1.5	5.7	0.3	5.7	6.8	1.3	2.4	0.1	0.0	2.1	1.4	0.1	0.8	1.3	10.2	5.7	6.3	2.8	0.4	3.8	0.9	3.9	1.7	3.9	1.5	8.0	4.1	1.8	0.0	0.0	0.2	2.9	0.0	0.7	0.5	0.4	1.0	0.1	14.1	1.8	0.0	0.5	2.3	2.2	2.2	0.9	5.0	2.5	0.7	0.0	0.0	1.5	3.3	4.6	0.8	1.8	1.7	2.5	3.7	16.7	0.3	0.0	0.1	2.0	0.0	0.4	5.3	1.9	2.2	3.3	2.3	1.0	0.0	0.0	0.0	1.4	0.0	2.3	0.1	1.6	5.7	0.2	0.0	0.0	0.7	0.0	1.5	0.0	0.0	1.5	0.3											0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	50.7	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.4	1.4	0.0	1.2	0.6	0.0	58.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	19.7	2.6	0.0	0.6	0.0	0.6	0.3
REXO4	"hPMC2, XPMC2H"	ENSG00000148300	"REX4 homolog, 3'-5' exonuclease"	Q9GZR2	9	133406059-133418096	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047006	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047006: AB_2679900"	"unprognostic (2.69e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (2.15e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.20e-1)"	9.9	13.7	16.9	15.1	18.4	10.9	14.5	21.6	18.3	12.7	11.9	11.9	13.2	13.8	14.5	10.7	15.5	13.5	11.2	14.6	13.8	11.8	12.0	19.3	9.7	18.3	18.0	13.2	22.2	21.4	13.3	14.6	14.1	15.4	13.7	10.1	8.8	14.9	13.1	36.4	15.1	13.5	11.9	16.1	16.9	13.0	18.7	18.4	15.0	15.2	9.1	16.3	12.5	21.3	5.5	3.6	3.3	2.5	7.2	5.2	1.8	5.7	13.5	6.3	9.3	6.6	6.9	11.3	10.0	5.7	10.6	7.0	16.0	7.5	18.9	6.8	5.4	8.6	15.8	13.2	10.5	6.1	12.2	12.3	10.2	14.3	12.5	8.3	23.3	10.0	6.4	8.9	11.1	15.3	8.1	7.7	10.2	22.4	8.3	6.7	16.6	16.3	14.0	12.8	20.9	19.4	11.6	10.4	18.7	6.7	5.5	18.2	9.9	10.6	12.4	11.4	6.6	15.2	9.4	6.7	19.4	10.1	9.2	12.1	5.5	6.7	12.9	7.2	13.5	11.5	0.7	2.5	3.3	3.9	2.5	4.3	4.7	4.0	4.0	2.0	5.5	5.1	5.2	0.1	7.2	2.0	3.6	3.4	1.8	16.9	18.4	21.6	18.3	13.8	11.8	18.0	13.2	15.4	18.4	20.8	16.7	29.8	15.4	22.1	25.1	8.3	20.4	10.7	5.7	24.4	21.6	30.4	16.6	26.8	36.5	13.7	23.1	0.0	24.7	31.4	12.1	12.4	17.3	25.5	18.7	15.9	12.7	14.1	16.4	56.5	26.7	12.6	6.8	50.5	19.2	14.2	26.4	17.5	22.6	14.7	29.5	19.4	11.7	39.0	65.9	24.1	26.3	27.7	26.9	11.2
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457559-41470882	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.9;lung: 120.1"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 621.5;Erythroid cells: 303.7;Glandular cells: 288.4;Hofbauer cells: 320.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 46.2"	"Lineage enriched"	"Detected in many"	26	"T-cells: 46.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.4;BJ hTERT+: 80.7;Daudi: 26.2;U-698: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		390000	Nucleoplasm	Nucleoli	"HPA035638: AB_10670152, HPA063701: AB_2685096"	"unprognostic (1.39e-3)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-3)"	58.6	6.7	26.7	8.8	33.1	109.9	27.7	21.6	22.7	12.8	5.6	36.1	4.2	5.7	8.7	3.1	5.4	7.6	14.3	15.1	32.1	16.8	11.0	8.3	120.1	10.8	41.7	15.2	1.8	13.4	8.7	7.1	70.6	21.1	10.7	3.6	16.1	33.2	6.8	12.7	10.8	4.9	11.3	22.2	7.3	8.0	7.1	34.8	15.2	26.9	5.8	6.9	9.5	8.7	1.7	1.7	0.2	0.2	0.1	46.2	2.8	0.2	0.1	9.0	0.0	1.7	15.4	0.3	0.2	80.7	0.0	0.3	11.2	0.1	26.2	0.2	1.0	0.0	0.2	0.3	0.5	0.1	2.7	1.3	0.0	1.9	0.8	0.9	0.9	0.3	1.2	1.7	0.3	11.2	0.1	9.2	6.1	2.0	0.0	0.2	0.0	5.8	0.5	0.1	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.8	0.2	5.0	6.2	0.0	1.0	0.5	0.1	0.0	0.0	27.6	0.0	0.6	0.2	0.0	0.2	0.0	1.6	0.1	1.6	1.2	13.8	4.4	1.7	1.7	46.2	10.5	0.2	0.1	0.0	0.5	23.1	2.8	26.7	33.1	21.6	21.7	32.1	16.8	41.7	15.2	21.1	34.8	229.3	54.7	23.2	621.5	76.8	0.8	12.0	0.0	38.8	47.8	3.5	2.0	3.9	29.9	0.6	7.3	237.2	0.3	303.7	0.0	5.3	88.9	288.4	49.5	0.8	320.9	0.0	81.3	31.9	23.8	7.0	7.5	180.3	183.9	0.0	7.4	1.4	0.3	3.4	2.1	0.5	1.4	122.9	80.2	14.1	4.1	57.0	9.3	44.5	6.6	105.6
RIOX2	"FLJ14393, JMJD10, mdig, MINA, MINA53, NO52"	ENSG00000170854	"Ribosomal oxygenase 2"	Q8IUF8	3	97941818-97972457	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 25.4;Cytotrophoblasts: 30.5;Distal tubular cells: 41.4;Extravillous trophoblasts: 36.7;Syncytiotrophoblasts: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007603, HPA008080, CAB013458"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960"	"prognostic unfavorable (4.41e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.68e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.56e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.76e-1)"	13.9	9.6	12.7	13.6	16.7	2.2	14.1	8.1	11.1	9.8	11.0	12.2	14.5	8.1	10.7	11.3	20.4	11.3	12.1	8.2	10.9	12.6	13.1	14.2	9.1	13.1	13.9	11.9	14.2	22.5	13.8	15.0	27.1	14.1	11.2	13.9	10.2	20.3	11.3	27.1	14.9	8.3	11.2	14.7	12.1	10.5	6.6	11.2	6.3	48.4	12.8	15.6	14.7	12.5	13.1	21.8	1.6	11.1	8.2	13.6	9.1	20.3	12.3	4.4	9.5	10.3	15.9	11.6	10.0	7.6	11.8	9.7	8.3	10.8	27.3	11.5	11.3	16.0	11.9	13.9	14.2	18.5	51.7	6.4	8.6	5.4	9.9	16.8	17.6	4.1	12.1	19.2	9.0	22.1	5.8	11.9	12.3	11.9	12.2	11.9	6.0	13.9	5.7	9.5	22.4	16.4	0.0	14.8	27.3	11.9	12.0	23.5	8.5	10.7	14.8	16.6	5.1	13.1	7.3	9.6	11.8	13.0	6.4	20.6	18.0	9.3	27.5	13.9	17.6	12.7	1.6	10.9	0.6	8.7	9.4	13.3	13.1	13.6	10.6	13.4	10.3	13.2	10.8	0.7	8.2	11.1	21.8	12.0	9.1	12.7	16.7	8.1	11.1	10.9	12.6	13.9	11.9	14.1	11.2	8.9	10.2	0.0	0.0	0.0	0.0	0.0	0.0	25.4	19.4	7.0	0.0	30.5	41.4	14.2	0.0	0.0	0.0	0.0	11.5	36.7	0.0	0.0	2.3	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	12.6	0.0	0.0	10.2	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"Rearranged L-myc fusion"	Q13129	1	40161373-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA054653: AB_2682557, HPA057300: AB_2683404"	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	14.8	8.1	12.6	11.3	12.6	44.5	13.9	20.8	17.1	12.4	11.1	11.6	7.1	8.6	14.1	8.6	12.4	9.9	11.2	12.3	11.0	8.3	8.7	12.7	12.8	11.8	12.8	11.8	14.6	9.4	12.5	15.1	11.9	15.4	13.2	9.2	10.2	9.4	9.9	13.4	17.7	9.9	14.3	14.1	10.1	9.3	15.9	11.8	14.9	10.0	8.4	13.5	18.1	14.8	4.1	3.5	10.1	4.1	4.1	4.9	2.4	12.4	4.8	9.5	9.9	8.5	6.9	11.3	4.7	7.0	8.1	10.8	9.7	6.6	12.4	6.2	6.0	6.1	11.8	11.9	8.2	14.8	5.8	8.1	10.2	5.9	5.9	6.7	8.4	6.2	6.8	8.7	8.6	9.8	9.7	5.5	6.9	15.5	7.7	7.4	3.9	7.1	5.1	12.6	4.6	5.6	5.6	15.6	7.2	5.2	12.6	6.8	9.5	8.7	11.7	8.3	15.4	5.5	30.8	4.7	9.6	10.2	7.8	8.7	7.0	6.6	11.7	8.3	7.9	5.9	10.1	2.8	5.5	3.7	3.9	4.9	4.1	3.7	3.8	3.5	4.1	4.8	4.0	6.3	4.1	4.1	1.6	3.3	2.4	12.6	12.6	20.8	17.1	11.0	8.3	12.8	11.8	15.4	11.8	29.8	10.8	22.4	42.2	58.3	17.2	13.4	5.1	30.8	30.7	3.5	15.7	6.9	5.0	10.9	32.9	23.3	8.4	0.0	5.9	8.0	34.2	25.7	26.5	8.3	8.5	25.4	19.4	16.0	13.9	4.9	8.3	16.8	16.9	10.0	7.8	17.0	9.3	14.0	7.4	5.7	15.8	12.9	27.8	26.5	20.0	53.3	14.4	14.1	6.7	27.2
RNF115	"CL469780, ZNF364"	ENSG00000265491	"Ring finger protein 115"	Q9Y4L5	1	145738868-145824077	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019130	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA019130: AB_1859220"	"unprognostic (3.44e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	7.2	5.2	6.8	4.8	6.8	6.4	7.7	16.2	7.0	6.3	3.4	4.6	5.7	3.5	8.9	5.0	5.8	4.3	4.8	23.5	5.8		5.6	5.1	3.9	5.6	4.7	6.2	4.7	4.5	5.8	5.9	3.5	5.2	6.5	3.8	7.3	3.6	5.6	27.6	3.8	3.1	10.9	4.5	4.2	3.8	3.4	4.5	6.0	5.0	5.4	4.5	4.1	6.3	2.7	2.4	9.0	2.2	3.2	3.2	1.4	11.3	4.7	5.8	4.3	10.7	14.0	4.7	8.6	16.0	6.4	7.8	5.1	4.1	8.0	9.8	12.2	6.3	8.0	6.4	5.9	6.9	8.0	4.2	6.4	6.1	4.7	6.7	9.9	14.8	8.1	5.2	6.4	7.8	7.3	8.1	6.3	6.3	13.1	11.5	8.6	7.2	6.3	7.3	7.2	10.0	7.0	5.8	6.6	12.4	3.8	5.9	8.1	7.0	8.6	6.4	7.5	9.5	9.5	10.0	9.3	7.3	5.6	9.1	11.0	10.4	8.4	4.7	6.7	5.9	9.0	2.2	3.2	3.2	1.5	2.7	2.7	2.2	3.2	1.8	2.4	2.3	3.1	1.7	3.2	1.6	2.4	2.0	1.4											14.9	29.8	29.4	28.9	18.3	96.0	134.9	25.5	24.1	26.1	17.4	108.0	23.1	28.2	34.8	52.4	66.1	14.0	23.3	69.3	24.5	48.2	51.0	31.1	28.7	32.3	77.9	26.0	66.3	32.6	18.4	36.5	29.9	37.1	88.4	19.7	66.7	49.7	20.9	76.0	37.2	104.3	58.2	49.2	78.7	54.1	15.7	16.6	66.0	23.8	32.8
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018372-32073213	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 67.5;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	21.9	2.3	4.1	9.1	5.7	18.2	20.4	1.2	6.6	5.0	8.9	12.2	3.3	12.3	7.2	5.5	3.9	4.3	6.0	5.4	6.1	4.1	2.1	14.1	10.3	13.5	7.7	3.1	2.4	4.2	2.5	1.3	4.4	7.0	3.1	7.8	1.6	5.0	1.9	4.4	6.0	26.0	4.1	12.0	7.4	4.2	3.3	8.3	14.8	3.2	2.9	7.2	4.5	6.2	2.1	3.4	9.0	3.8	11.7	12.5	5.1	0.7	0.1	0.1	0.2	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.2	0.5	0.9	0.8	0.1	4.0	1.6	0.2	0.2	0.2	0.1	5.2	32.5	1.0	1.5	0.0	1.8	0.2	0.3	1.6	0.1	1.2	0.0	1.2	1.3	4.9	2.6	5.3	0.9	5.5	0.4	0.1	0.3	0.3	0.5	0.2	0.1	0.1	8.0	1.1	0.8	2.5	0.1	0.1	0.5	0.1	0.0	3.8	0.1	0.1	0.4	7.0	4.2	9.0	3.8	3.3	12.5	2.0	8.2	2.0	10.1	10.5	3.4	2.1	8.2	10.6	1.5	11.7	1.9	3.4	10.0	5.1	4.1	5.7	1.2	6.6	6.1	4.1	7.7	3.1	7.0	8.3	3.0	8.0	9.9	2.9	8.8	0.4	1.4	2.5	2.7	5.7	12.2	0.0	0.3	1.7	0.8	67.5	23.2	25.5	0.0	1.6	0.1	1.9	2.4	17.4	15.5	8.9	0.0	1.2	6.7	14.8	11.5	2.6	13.9	1.7	1.0	8.2	1.2	1.3	0.0	0.0	1.1	0.6	0.0	1.9	0.5	0.7	5.9	0.7	66.0	13.6	2.1
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468874	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Basal keratinocytes: 563.5;Suprabasal keratinocytes: 1312.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 28.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 55.9;EFO-21: 15.4;hTCEpi: 17.8;HUVEC TERT2: 16.5;TIME: 16.5;U-698: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	16.3	2.0	4.6	11.1	6.8	15.7	21.1	5.1	7.5	8.0	4.2	2.8	4.6	1.5	6.8	7.5	9.4	9.0	6.8	8.7	5.3	4.3	13.8	11.4	39.0	11.1	8.3	2.3	4.2	3.7	3.0	2.3	11.1	8.8	12.8	2.3	8.3	16.9	6.2	36.8	19.2	3.7	4.9	9.2	37.1	4.3	3.3	6.9	5.8	32.9	11.4	12.2	7.3	6.6	2.0	7.9	15.6	28.8	0.2	0.7	2.6	1.3	0.2	0.1	0.0	0.0	0.6	2.9	1.5	1.7	3.3	3.6	0.0	0.1	55.9	15.4	0.6	0.2	4.8	0.0	4.7	4.7	0.2	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.8	17.8	1.3	4.0	1.5	16.5	1.2	0.0	0.0	0.8	0.5	0.4	0.0	0.5	0.1	0.3	0.2	0.5	3.3	10.0	3.1	0.5	0.0	0.3	7.1	5.3	0.4	8.4	0.1	16.5	2.6	0.5	0.2	0.3	0.0	0.0	47.0	0.3	0.1	0.2	0.1	9.1	5.1	0.2	16.4	0.7	2.0	0.3	0.3	5.6	1.6	0.7	0.4	15.6	0.2	28.8	7.9	0.2	2.6	4.6	6.8	5.1	7.5	5.3	4.3	8.3	2.3	8.8	6.9	41.7	12.9	4.2	36.0	563.5	0.9	10.4	10.2	21.4	36.4	36.6	2.0	9.7	16.6	8.2	1.6	32.1	1.0	0.0	7.7	2.9	12.4	85.1	3.5	17.4	13.8	0.0	1.2	28.8	98.2	1.6	1.1	68.0	57.3	44.1	1.3	16.0	6.0	2.9	2.8	16.3	1.0	0.0	10.1	1.7	2.6	1312.2	1.3	3.2	2.4	20.3
RNF215		ENSG00000099999	"Ring finger protein 215"	Q9Y6U7	22	30368811-30421771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 12.9;Cone photoreceptor cells: 11.8;Muller glia cells: 10.3;Rod photoreceptor cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029427, HPA056498"	Approved		Approved	Nucleoli,Microtubules		NA	NA			Microtubules	Nucleoli	"HPA029427: AB_2732447, HPA056498: AB_2683154"	"unprognostic (1.24e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.67e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (6.37e-10)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	9.8	7.1	17.5	7.3	12.6	8.0	8.0	20.7	24.5	10.1	7.8	7.3	11.9	10.4	14.0	13.0	6.4	10.6	13.3	7.7	11.3	14.4	8.5	8.0	6.9	6.5	10.4	15.2	10.8	15.4	12.6	7.9	9.0	10.7	12.3	5.2	11.2	8.8	11.8	7.4	7.9	5.5	10.9	8.1	8.8	6.9	10.0	5.5	2.2	10.3	1.6	5.0	7.9	8.0	4.8	3.5	3.5	2.1	6.1	4.8	0.9	4.3	9.0	9.5	15.4	9.3	9.8	9.4	7.4	6.7	7.4	4.6	2.5	4.8	1.7	13.4	6.0	14.1	5.4	5.8	8.5	6.0	10.0	7.0	3.0	9.8	3.2	12.9	2.2	12.2	13.3	10.5	12.8	6.9	24.5	8.7	4.6	2.5	8.3	8.8	6.9	1.6	5.4	3.0	6.2	10.1	7.8	5.5	6.8	9.7	6.6	4.2	10.7	7.4	5.5	5.5	9.1	5.0	2.5	12.0	20.2	9.0	5.8	4.3	8.8	2.2	2.3	11.8	1.7	7.8	1.9	2.1	3.5	2.5	1.9	2.5	2.7	2.6	2.0	1.1	4.8	4.8	4.3	1.6	6.1	1.7	3.5	1.3	0.9	17.5	12.6	20.7	24.5	11.3	14.4	10.4	15.2	10.7	5.5	3.0	3.8	0.0	1.2	0.2	12.9	1.7	0.0	0.0	3.4	0.0	11.8	1.4	0.0	1.3	0.6	1.4	0.5	0.0	1.2	1.2	1.6	1.1	0.0	1.7	1.5	7.9	0.0	4.3	1.9	0.2	0.9	0.6	1.7	2.8	0.6	10.3	1.5	0.0	1.1	0.8	12.8	6.5	1.0	1.9	0.9	0.1	1.4	0.0	0.6	1.0
RPAP2	"C1orf82, FLJ13150, Rtr1"	ENSG00000122484	"RNA polymerase II associated protein 2"	Q8IXW5	1	92298965-92402056	"Enzymes, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 104.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046443	Approved		Supported	Nucleoli,Cytosol		No	No			"Nucleoli, Cytosol"		"HPA046443: AB_2679669"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.29e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.10e-2)"	6.8	7.0	7.8	7.3	10.5	12.0	7.6	27.2	11.6	8.4	6.3	7.1	7.2	6.6	11.1	11.5	5.6	6.3	5.5	5.9	8.1	8.6	8.1	10.6	5.2	8.2	7.7	6.7	8.2	8.6	9.4	16.1	6.7	11.7	7.6	5.8	6.4	7.2	7.1	10.5	10.7	6.3	7.4	9.9	7.6	6.4	6.7	8.7	12.8	9.4	6.5	6.3	6.6	7.6	4.4	3.5	4.9	2.4	4.0	4.8	1.2	6.3	3.9	6.8	6.3	5.6	7.2	5.8	5.0	3.5	3.3	2.7	2.8	2.9	9.5	8.7	3.7	4.5	4.4	5.6	3.2	5.1	6.5	4.0	5.8	7.0	3.7	3.3	10.0	5.8	3.7	4.0	4.2	4.1	4.9	3.5	5.9	5.9	6.4	5.0	3.3	8.4	6.3	5.3	3.6	4.4	6.3	9.0	4.1	4.3	5.7	6.4	4.7	8.1	7.5	4.0	5.3	3.9	7.7	6.1	5.0	6.4	5.7	7.1	6.2	7.1	5.0	3.5	6.3	3.4	4.8	2.4	1.9	4.1	1.7	4.8	3.4	3.2	3.5	1.8	4.4	3.5	3.8	4.9	4.0	1.9	3.5	2.8	1.2	7.8	10.5	27.2	11.6	8.1	8.6	7.7	6.7	11.7	8.7	59.6	66.2	8.2	15.1	8.1	55.5	21.2	5.1	75.0	68.2	7.0	104.1	17.6	10.0	16.4	39.3	17.1	7.7	23.3	11.9	12.3	13.6	12.8	59.1	7.4	8.5	33.4	12.1	8.0	10.8	4.7	17.5	8.8	1.7	15.4	11.9	39.3	12.8	10.7	20.1	13.0	87.8	25.8	12.0	18.9	18.8	8.5	19.8	24.2	11.1	9.8
RPL13A	"L13A, TSTA1"	ENSG00000142541	"Ribosomal protein L13a"	P40429	19	49487554-49492308	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038751	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA038751: AB_10962004"	"unprognostic (2.35e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.81e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.87e-1)"	85.4	87.0	45.7	114.3	46.9	132.5	106.4	38.9	41.2	103.8	145.5	38.8	89.2	84.1	129.4	80.7	117.7	83.5	119.9	112.5	37.2	31.2	65.4	113.9	71.8	265.3	41.5	37.0	203.8	334.9	21.8	54.2	76.7	44.1	114.3	46.8	65.4	169.0	95.4	216.0	122.9	77.0	121.1	44.2	121.4	87.8	54.5	27.8	124.0	119.8	147.0	115.0	112.7	196.5	284.6	144.9	40.5	81.3	148.0	268.3	354.3	120.1	147.8	70.3	205.2	134.2	212.6	83.8	105.2	130.3	75.9	82.4	125.3	92.4	304.9	84.7	78.6	31.8	79.7	87.6	152.2	45.0	85.4	206.5	153.9	96.2	178.5	163.5	231.1	122.4	245.8	254.2	53.8	182.8	168.6	122.3	107.9	132.5	115.1	87.3	104.5	161.5	234.8	135.9	114.9	133.0	157.1	160.5	132.9	103.1	204.3	120.6	158.6	54.9	244.9	232.4	58.8	108.0	266.7	150.6	95.8	103.4	59.4	138.5	116.5	157.9	137.6	59.9	158.5	87.8	40.5	81.3	20.7	132.2	70.3	194.3	284.6	226.2	180.3	126.7	264.8	268.3	212.3	13.6	148.0	60.4	144.9	165.3	354.3	45.7	46.9	38.9	41.2	37.2	31.2	41.5	37.0	44.1	27.8	1503.7	1729.8	9229.7	10612.9	10289.3	512.1	472.1	3870.0	2000.9	3534.0	1509.2	202.2	6720.7	4604.1	3662.2	243.1	4976.1	2426.8	1868.9	11119.9	8860.9	5735.6	8516.9	2404.2	3758.5	5124.9	208.2	3836.4	4121.8	6096.6	467.8	8451.2	6154.9	5402.0	6444.6	6340.8	679.2	7721.8	5811.0	4166.9	5142.4	507.0	2612.9	6508.5	432.4	584.7	12485.0	7026.2	7155.4	9081.3	10590.2
RPL18A	L18A	ENSG00000105640	"Ribosomal protein L18a"	Q02543	19	17859876-17864153	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 430.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055259	Approved		Approved	Nucleoli,Cytosol		No	No			"Nucleoli, Cytosol"		"HPA055259: AB_2682764"	"unprognostic (3.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.36e-1)"	48.8	33.8	24.9	42.2	43.0	85.7	53.6	27.8	61.1	49.9	46.0	26.5	28.1	40.4	47.8	36.4	65.5	56.5	38.9	31.5	22.6	16.2	50.0	85.9	34.8	83.7	22.3	26.1	109.2	106.6	9.3	30.5	46.9	30.9	41.8	26.8	30.4	99.8	31.6	157.7	90.1	43.3	36.6	21.9	57.6	50.1	67.3	17.6	59.5	65.3	107.9	54.0	45.0	57.1	395.8	193.6	24.8	110.7	126.0	278.4	430.5	126.2	98.3	65.7	92.6	98.7	162.7	166.5	77.5	98.5	102.6	97.9	135.7	127.1	191.0	179.7	66.7	41.0	95.2	77.4	165.0	35.9	97.6	208.7	89.2	94.6	154.5	171.0	128.3	97.8	203.0	217.6	56.7	122.3	106.8	112.2	157.6	113.3	123.9	64.7	196.8	173.5	169.5	154.6	142.0	151.7	156.2	69.7	226.4	93.6	120.2	95.2	142.9	27.5	192.0	239.8	33.9	91.2	249.4	85.9	63.6	74.1	126.9	129.9	166.2	151.1	123.3	83.5	205.4	78.8	24.8	110.4	16.5	134.8	110.7	234.6	368.3	232.2	167.1	166.6	395.8	278.4	212.5	11.3	126.0	85.6	193.6	195.9	430.5	24.9	43.0	27.8	61.1	22.6	16.2	22.3	26.1	30.9	17.6	482.4	926.8	6413.8	4901.3	7713.4	240.4	390.4	1829.3	614.3	1162.5	875.9	119.8	4308.9	2022.7	2828.9	39.6	2919.7	1766.7	1097.9	7783.8	7254.8	3471.5	4168.2	1383.3	2046.3	2960.9	123.9	1772.7	2331.9	4202.4	100.2	3856.5	5199.5	4502.8	5216.5	3612.2	346.7	5814.1	2767.0	1530.2	2592.2	347.7	1235.3	4175.6	138.6	661.5	9733.7	3896.6	4323.4	4712.9	6201.7
RPL19	"DKFZp779D216, FLJ27452, L19, MGC71997"	ENSG00000108298	"Ribosomal protein L19"	P84098	17	39200283-39204727	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"SK-BR-3: 959.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043014, HPA051987"	Approved		Enhanced	Nucleoli,Cytosol		NA	NA		100000	"Nucleoli, Cytosol"		"HPA043014: AB_10965840, HPA051987: AB_2681682"	"unprognostic (4.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.60e-2)"	72.3	57.7	51.3	56.7	56.9	122.5	94.7	41.8	88.6	72.2	64.5	42.2	62.7	48.7	67.0	56.7	77.7	78.1	65.9	87.3	49.2	37.0	62.3	124.4	70.7	229.5	50.5	53.0	156.4	124.4	33.1	51.7	57.3	58.7	60.0	52.5	48.1	113.8	67.6	91.4	95.8	58.8	57.5	57.1	74.4	66.1	45.2	34.1	53.0	63.3	94.9	103.4	63.1	75.9	208.2	143.4	40.4	108.7	116.2	236.3	325.8	48.1	65.5	47.5	57.6	87.0	110.0	49.2	45.3	92.6	93.9	75.5	71.4	45.6	117.8	79.8	64.7	54.9	81.9	71.4	93.7	48.4	47.8	125.4	42.0	48.9	92.8	135.7	102.9	58.2	122.5	103.0	72.3	130.9	88.2	80.9	101.1	73.1	69.0	64.8	47.4	136.4	143.9	48.6	56.3	48.8	80.9	67.6	117.8	84.6	60.3	57.8	64.3	27.2	959.6	141.5	53.6	92.9	131.0	47.6	36.7	49.7	55.9	83.3	91.1	90.1	86.7	49.8	78.6	47.2	36.7	108.7	40.4	116.1	90.3	180.1	208.2	187.2	146.8	143.4	193.1	236.3	190.8	17.1	116.2	72.6	132.4	146.2	325.8	51.3	56.9	41.8	88.6	49.2	37.0	50.5	53.0	58.7	34.1	821.9	1155.8	5178.5	5153.7	4931.6	221.1	502.6	2265.0	995.7	1437.7	1080.0	88.4	3138.3	3070.4	2271.3	1107.8	2991.3	1604.9	1214.8	5434.8	4726.5	2858.0	4250.3	1510.1	1935.0	3620.1	125.5	1883.0	2240.5	3562.4	3346.4	3629.9	4014.1	3104.2	3202.1	2957.8	586.7	3801.6	2980.9	1917.8	3691.6	289.1	1506.9	3219.7	1098.4	764.8	5786.0	3261.3	3671.2	4220.8	5947.6
RPL22	"EAP, L22"	ENSG00000116251	"Ribosomal protein L22"	P35268	1	6181269-6209389	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068294			Approved	Nucleoplasm,Nucleoli		NA	NA		320000	Nucleoli	Nucleoplasm	"HPA068294: AB_2732781"	"unprognostic (3.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.98e-1)"	75.5	71.5	54.3	79.7	42.8	124.7	75.0	46.7	39.5	95.8	73.9	39.2	53.9	66.5	133.6	63.9	103.9	59.1	61.8	50.8	47.4	38.6	58.8	90.2	55.3	142.6	50.6	39.7	163.1	154.8	30.4	57.0	49.8	37.4	90.8	46.4	57.0	140.3	66.8	114.0	79.7	62.6	106.6	58.3	79.1	62.0	38.2	35.0	95.3	91.0	112.8	81.1	101.5	91.9	75.6	62.3	11.0	38.9	42.2	98.8	73.9	89.4	25.5	54.4	55.5	38.3	60.3	43.0	78.2	31.5	28.8	24.6	50.6	77.8	138.9	64.4	28.9	19.9	51.8	40.8	40.6	38.0	68.0	66.5	135.0	58.1	62.8	38.0	178.6	54.2	53.1	33.7	25.6	53.1	59.6	35.9	39.0	111.2	84.2	33.0	39.5	78.0	145.7	33.8	59.9	56.7	75.3	112.8	107.6	42.1	31.1	75.2	69.0	63.6	184.4	143.1	49.3	59.3	141.6	87.7	41.1	45.3	54.2	73.4	67.7	92.9	210.2	27.2	184.7	25.4	11.0	38.9	8.8	38.0	34.3	66.9	75.6	71.1	52.3	59.8	72.4	98.8	78.1	2.9	42.2	27.8	62.3	54.0	73.9	54.3	42.8	46.7	39.5	47.4	38.6	50.6	39.7	37.4	35.0	413.9	647.4	2117.2	1742.6	1617.7	195.0	241.8	1080.3	472.4	833.7	554.8	123.7	1561.4	1614.8	1042.5	368.7	1236.7	707.2	537.3	1569.0	2352.9	1052.3	1320.4	878.8	1234.2	1317.3	133.5	877.3	1218.4	1697.8	247.8	1877.2	1676.9	1020.7	1556.4	1647.3	322.2	1580.5	1090.7	1160.1	1724.2	283.7	763.2	1114.2	317.0	420.5	1692.2	1548.7	1448.0	2302.5	1714.3
RPL27	L27	ENSG00000131469	"Ribosomal protein L27"	P61353	17	42998273-43002959	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes, Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002649	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		30000	Nucleoli	Nucleoplasm	"HPA002649: AB_1079840"	"unprognostic (8.53e-3)"	"unprognostic (7.15e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.91e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (7.80e-8)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	78.4	66.9	61.7	82.2	45.7	150.0	148.7	63.1	82.7	75.1	76.8	27.2	65.4	48.8	74.8	80.1	91.9	64.9	80.8	120.6	46.2	38.5	76.2	121.7	109.5	222.2	49.2	49.0	123.7	185.0	17.2	44.1	81.0	48.3	65.3	55.0	43.8	119.1	78.5	127.5	113.8	61.9	82.4	43.6	84.4	69.7	40.3	28.8	72.6	70.5	153.8	78.5	86.1	80.9	178.5	152.7	44.2	99.0	111.4	184.7	216.0	114.1	144.8	88.7	128.4	157.1	233.0	143.3	133.0	109.3	143.0	102.6	205.0	89.9	216.5	113.2	104.6	77.6	100.2	101.6	169.8	137.6	100.2	241.7	85.0	121.4	216.7	193.9	244.1	89.5	219.6	145.5	96.5	123.8	146.7	118.5	114.9	158.0	134.0	132.0	111.6	203.2	206.9	134.3	132.4	92.7	142.6	249.8	244.5	120.8	154.3	99.8	110.2	52.2	103.0	211.8	125.8	173.2	258.0	133.7	106.6	105.6	130.2	195.6	117.1	188.5	211.9	95.8	151.7	108.6	44.2	99.0	29.5	106.6	87.9	150.2	178.5	159.0	124.5	118.6	168.3	184.7	159.1	20.4	111.4	67.3	152.7	112.5	216.0	61.7	45.7	63.1	82.7	46.2	38.5	49.2	49.0	48.3	28.8	681.9	960.2	2744.7	1731.4	2247.5	123.8	670.7	1245.8	627.7	1104.4	492.0	84.4	1811.7	1268.3	1382.3	339.9	1526.1	906.3	700.8	2626.7	2977.9	1476.5	1638.9	947.9	1517.2	1848.2	62.0	876.6	1298.9	2145.4	659.2	2254.1	2398.0	1353.0	2460.8	1687.2	280.7	2397.9	1157.3	1202.8	1660.9	156.7	853.7	1593.4	457.6	394.4	2946.9	1827.2	1797.0	2037.9	2132.8
RPL3	L3	ENSG00000100316	"Ribosomal protein L3"	P39023	22	39312882-39320389	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003365, HPA055361"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA		120000	"Nucleoli, Cytosol"		"HPA003365: AB_1079841, HPA055361: AB_2732594"	"unprognostic (9.79e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.32e-2)"	71.7	71.8	51.3	72.3	50.3	107.0	134.5	50.8	49.3	102.2	94.4	42.7	78.1	63.1	207.5	79.6	126.9	101.6	96.2	54.5	41.4	38.8	66.6	102.5	74.5	205.9	47.4	57.7	217.8	453.1	50.9	75.0	74.5	58.0	138.7	57.0	74.8	216.3	68.5	48.9	118.1	62.6	115.6	50.7	84.3	74.4	76.4	23.3	105.5	158.5	82.3	109.8	119.9	105.7	198.9	114.8	18.9	56.4	150.3	249.0	326.4	87.2	80.8	92.5	102.2	118.4	256.8	124.7	67.7	128.8	67.7	60.9	101.6	66.7	361.2	93.8	81.4	40.8	58.2	98.7	144.7	45.1	61.4	97.2	90.9	96.7	151.9	174.9	129.1	76.7	248.1	196.1	58.5	208.7	177.2	131.6	96.4	102.3	125.6	97.9	112.4	131.1	188.1	96.8	92.9	56.4	105.3	89.8	181.3	125.1	129.4	84.7	100.1	42.5	139.0	221.5	61.4	104.7	210.6	130.4	45.5	72.0	47.7	77.0	96.5	72.9	159.9	102.6	114.2	51.4	18.9	56.4	11.9	132.5	51.7	205.6	198.9	192.1	153.7	101.2	175.8	249.0	195.2	8.1	150.3	44.5	114.8	126.1	326.4	51.3	50.3	50.8	49.3	41.4	38.8	47.4	57.7	58.0	23.3	914.2	2163.5	5410.7	7867.8	9248.8	998.0	126.1	2876.4	1092.1	2307.8	1367.8	400.5	4667.0	4993.6	2515.3	1583.9	3488.3	1382.2	934.5	5706.5	6677.9	4026.4	5687.6	1692.6	1824.7	2890.1	338.5	2624.6	2557.1	2528.9	3527.0	5167.6	3086.7	4841.9	3599.8	3269.3	905.4	3905.0	2588.2	3289.3	3749.1	924.0	1552.2	5807.1	1006.7	702.5	10743.1	4590.8	4458.7	5068.7	8140.4
RPL7A	"L7A, SURF3, TRUP"	ENSG00000148303	"Ribosomal protein L7a"	P62424	9	133348214-133351426	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA046794			Approved	Nucleoli,Vesicles		NA	NA		160000	Nucleoli	Vesicles	"HPA046794: AB_2732534"	"unprognostic (5.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.07e-3)"	"unprognostic (4.17e-3)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (1.98e-1)"	"unprognostic (8.88e-2)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (4.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.89e-2)"	58.8	72.8	34.9	64.0	39.6	78.6	96.3	33.1	43.2	70.1	66.6	27.6	66.9	38.9	137.4	81.5	96.0	94.8	74.4	48.2	29.5	25.7	51.0	59.3	48.1	159.6	32.7	45.2	164.9	193.1	29.1	50.6	42.4	34.1	90.1	67.6	47.3	204.8	70.0	85.2	91.9	48.6	91.0	35.5	68.1	61.4	78.2	24.0	80.5	77.9	70.1	93.2	75.1	109.7	79.7	56.4	12.1	35.8	50.2	80.4	94.0	44.6	68.0	77.7	77.3	136.7	227.0	74.2	56.3	115.3	101.6	56.7	103.3	58.9	140.1	34.8	98.1	54.9	109.5	114.8	135.3	82.0	59.4	65.0	49.3	101.1	100.4	90.7	116.6	58.4	228.3	202.5	73.4	127.5	165.7	128.9	98.9	94.2	73.9	116.6	151.6	90.4	122.1	84.4	200.3	67.1	79.6	97.5	178.2	130.8	57.2	73.0	64.5	46.1	118.7	71.9	67.4	129.4	123.6	70.3	67.1	48.3	60.3	66.7	28.9	57.5	86.1	52.4	81.5	52.1	12.1	35.8	7.7	52.2	33.6	77.3	79.7	71.2	64.3	56.4	71.8	80.4	73.5	5.5	50.2	29.3	56.1	54.6	94.0	34.9	39.6	33.1	43.2	29.5	25.7	32.7	45.2	34.1	24.0	482.4	687.0	2813.3	3757.7	2882.1	278.7	355.9	1538.8	477.8	915.6	567.0	135.5	3181.9	1798.9	1584.8	1644.9	1944.8	1276.3	864.3	3823.0	4356.2	1751.6	3047.6	827.3	1030.7	2186.7	123.9	1445.6	1391.5	1793.3	3226.4	3459.6	1682.6	1434.0	2247.1	2534.7	429.4	2742.5	1749.9	1813.9	2011.8	362.0	950.7	1790.0	984.2	735.4	3479.5	2766.0	1939.0	3532.0	4275.0
RPL7L1	dJ475N16.4	ENSG00000146223	"Ribosomal protein L7 like 1"	Q6DKI1	6	42879618-42889925	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046049, HPA050478"			Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA046049: AB_10964167, HPA050478: AB_2681138"	"unprognostic (1.03e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.31e-3)"	"unprognostic (4.58e-2)"	17.5	22.1	19.9	14.4	27.5	9.0	19.9	20.5	35.9	14.8	14.2	16.9	16.4	11.9	15.7	17.4	18.9	17.2	10.2	14.4	17.6	16.5	18.8	23.5	11.9	16.5	14.9	20.4	17.4	16.9	22.9	22.4	15.1	17.9	17.0	17.0	13.2	17.4	14.4	19.9	16.3	12.8	16.5	13.9	15.4	13.7	33.0	14.5	25.1	17.8	15.6	20.3	13.7	13.3	15.4	12.5	10.2	13.6	16.4	18.6	10.6	31.3	10.0	17.8	28.5	16.8	21.7	12.1	25.1	18.3	24.4	20.2	24.8	12.0	47.2	22.8	21.1	19.9	15.1	40.4	30.6	40.6	24.7	30.4	25.1	14.1	22.4	18.5	38.7	19.5	22.2	23.5	32.0	31.0	16.6	23.9	20.9	48.5	16.3	22.2	23.1	22.0	25.2	17.9	96.5	14.8	25.3	20.0	29.9	19.0	19.9	34.1	20.8	21.5	16.5	26.4	14.7	22.1	37.5	22.8	23.7	19.8	18.7	43.3	20.6	32.1	71.8	13.2	36.8	24.6	5.6	11.4	10.2	14.9	13.6	18.6	13.3	14.6	15.5	10.8	15.4	15.5	14.9	2.6	16.4	11.9	12.5	12.0	10.6	19.9	27.5	20.5	35.9	17.6	16.5	14.9	20.4	17.9	14.5	71.5	90.2	79.6	70.6	50.7	62.2	36.8	43.3	96.4	85.3	40.1	31.4	75.2	72.9	77.0	9.5	60.8	22.6	93.5	57.9	63.9	52.5	52.0	48.7	57.8	46.3	68.3	90.5	48.5	37.5	8.6	73.4	44.1	28.7	74.9	39.6	69.6	70.8	31.6	67.1	57.2	58.0	51.8	56.9	40.4	84.8	52.7	66.9	64.5	43.4	52.0
RRNAD1	"C1orf66, CGI-41, METTL25B"	ENSG00000143303	"Ribosomal RNA adenine dimethylase domain containing 1"	Q96FB5	1	156728442-156736960	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047426	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA047426: AB_2680041"	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.03e-3)"	14.1	19.4	12.4	22.6	19.0	8.7	19.1	15.3	18.8	17.6	25.7	20.8	31.2	22.5	20.3	22.9	18.4	24.4	20.2	12.5	13.3	10.9	15.9	25.8	14.5	14.4	19.9	14.5	24.5	29.2	24.3	18.8	20.5	16.1	21.8	14.8	20.2	22.5	24.5	21.9	23.9	26.6	12.9	14.7	18.5	19.3	25.9	17.7	11.9	30.3	13.5	15.9	21.7	27.9	4.9	5.9	7.0	4.0	6.5	8.6	2.9	5.9	11.8	8.8	8.6	23.7	10.9	13.4	4.5	13.9	7.8	5.9	6.4	27.6	10.2	13.6	7.1	11.0	25.6	12.2	10.6	3.2	20.2	10.3	6.1	11.2	4.7	14.9	9.1	16.8	16.8	20.4	7.8	14.9	9.3	6.5	9.2	14.6	23.1	4.1	14.4	4.6	10.7	10.1	26.0	3.7	7.6	5.8	23.6	9.3	6.5	11.4	16.5	8.0	16.5	9.8	14.0	21.8	19.6	6.3	4.9	6.0	7.5	6.0	26.9	26.3	12.6	5.4	10.3	5.8	6.7	3.3	4.7	6.8	2.5	6.9	3.4	6.6	4.8	5.9	4.9	5.3	6.0	7.0	6.5	4.0	2.2	8.6	2.9	12.4	19.0	15.3	18.8	13.3	10.9	19.9	14.5	16.1	17.7	6.0	10.8	9.7	21.1	9.0	9.9	6.1	20.4	6.7	10.3	3.5	11.8	21.2	8.3	10.3	44.1	11.3	18.0	0.0	11.6	14.3	9.4	17.5	4.7	18.5	9.6	7.9	9.2	9.2	10.2	10.3	10.3	6.6	8.5	9.0	16.6	20.3	9.4	17.5	8.9	11.6	11.6	12.9	6.2	15.8	22.8	10.0	27.1	8.3	16.5	15.9
RRP1	"D21S2056E, NNP-1, Nop52, RRP1A"	ENSG00000160214	"Ribosomal RNA processing 1"	P56182	21	43789513-43805293	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016818, HPA018166"	Approved		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoli, Mitotic chromosome"		"HPA016818: AB_1854561, HPA018166: AB_1854562"	"unprognostic (5.38e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (6.29e-5)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.88e-1)"	12.0	10.6	12.1	12.8	15.6	9.7	9.4	11.4	20.0	8.6	8.9	18.0	6.0	10.6	10.0	9.1	19.8	10.9	9.3	8.5	14.3	11.3	8.3	16.6	7.3	15.1	16.3	14.4	14.8	16.6	9.4	7.6	10.3	14.9	9.4	6.7	9.9	14.7	9.8	15.6	20.1	9.7	7.4	11.5	11.1	11.9	13.8	15.6	10.5	9.6	11.4	14.7	8.9	9.8	10.9	8.8	1.5	4.3	10.4	12.3	6.0	16.3	8.8	6.0	10.1	3.3	3.8	11.7	8.4	4.9	11.7	8.3	23.1	9.7	15.8	7.0	4.5	10.8	8.4	11.2	8.1	5.3	7.8	22.0	22.5	8.1	14.0	6.9	14.2	8.1	5.0	7.7	11.7	9.2	3.0	6.2	14.9	29.4	11.9	5.4	19.3	12.3	19.5	20.3	11.3	13.2	22.8	4.9	29.1	6.0	9.1	14.4	8.6	8.7	9.4	11.0	1.7	9.8	9.8	7.0	7.8	8.9	8.2	14.4	14.9	12.8	16.4	11.9	23.8	10.1	0.1	4.3	1.5	9.7	4.0	12.3	9.6	10.1	9.9	8.8	10.9	11.2	7.4	0.9	10.4	1.9	7.5	5.8	6.0	12.1	15.6	11.4	20.0	14.3	11.3	16.3	14.4	14.9	15.6	14.9	20.8	16.0	24.4	64.2	17.6	4.5	7.6	20.1	39.8	7.0	19.6	27.0	6.6	26.5	3.5	19.1	9.1	23.3	28.6	31.6	22.6	15.8	20.7	13.5	29.5	7.9	20.1	12.9	6.7	2.4	17.8	19.7	40.5	19.8	15.3	9.9	31.9	5.8	19.4	17.0	17.4	32.3	24.7	22.6	29.6	61.4	25.4	13.1	25.2	35.2
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021645-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	25.0	29.7	21.0	24.9	27.2	23.3	57.7	18.0	42.1	21.3	22.4	16.0	24.9	19.4	23.8	24.7	31.9	20.6	20.1	31.3	22.7	21.4	25.2	32.7	24.1	46.5	21.1	28.0	17.3	37.4	37.0	28.8	23.4	27.3	24.6	23.8	19.5	23.5	36.4	61.9	28.4	21.4	28.3	28.5	29.4	25.7	23.9	15.8	25.0	22.6	30.9	31.8	23.7	28.2	6.5	9.7	4.0	4.6	3.1	7.7	1.2	39.4	22.3	22.2	32.4	24.0	22.5	18.7	31.3	28.4	40.2	39.5	40.5	17.3	18.3	25.6	32.6	29.5	21.2	37.1	38.0	44.5	23.1	37.8	29.4	24.8	43.2	27.9	24.4	22.9	22.7	23.3	48.0	20.6	14.4	32.6	16.6	35.5	20.0	37.2	41.6	29.3	26.7	24.6	70.7	23.2	27.7	21.9	21.1	24.6	37.4	28.5	25.0	23.1	21.2	35.8	21.8	29.2	30.1	26.2	37.2	28.3	24.4	49.1	18.8	28.2	48.9	16.2	30.9	34.5	3.9	3.6	3.1	5.9	4.6	4.7	6.5	4.2	7.0	3.7	2.6	3.9	7.7	4.0	3.1	3.6	9.7	2.1	1.2	21.0	27.2	18.0	42.1	22.7	21.4	21.1	28.0	27.3	15.8	0.0	14.1	20.6	9.5	11.8	15.3	13.7	28.1	8.1	12.5	19.2	15.7	25.9	11.6	31.6	8.6	11.3	10.5	0.0	38.9	36.9	13.2	13.1	5.8	34.3	25.3	17.5	13.4	22.1	14.3	18.5	10.9	13.4	13.5	28.9	11.3	25.1	32.5	7.0	17.7	16.1	17.2	6.5	12.0	7.6	10.2	16.3	28.1	10.0	12.8	12.1
RTF2	"C20orf43, CDAO5, HSPC164, RTFDC1"	ENSG00000022277	"Replication termination factor 2"	Q9BY42	20	56468585-56519449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 133.3;Distal tubular cells: 132.6;monocytes: 160.5;Syncytiotrophoblasts: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053986	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053986: AB_2682333"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (8.90e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.48e-3)"	33.4	34.2	43.5	29.1	43.9	52.6	28.9	27.4	48.7	28.8	29.4	53.0	20.1	28.0	31.4	24.1	30.5	31.6	23.2	38.7	40.6	35.6	31.8	30.3	24.2	29.7	49.6	35.7	35.2	27.5	26.0	29.3	30.5	46.6	28.5	26.0	26.0	25.8	31.7	74.6	27.9	29.8	34.1	59.7	30.2	25.3	29.1	45.2	31.4	29.1	28.9	34.4	29.0	23.9	20.0	35.1	91.6	31.8	29.4	23.0	33.2	28.9	20.8	21.1	20.6	26.4	23.6	19.6	45.2	34.2	65.3	37.5	42.4	28.1	24.8	53.7	36.6	32.1	32.5	21.1	34.8	45.2	11.6	16.4	31.0	22.8	32.8	30.3	44.1	42.9	20.9	36.2	29.1	25.3	27.8	28.0	26.6	24.0	26.0	32.0	55.3	36.9	37.6	15.6	41.1	39.7	25.4	57.5	32.7	27.2	19.1	21.8	23.7	47.5	80.6	42.5	16.3	37.3	42.1	30.0	55.9	36.2	30.4	36.5	21.7	24.9	35.3	44.0	30.1	30.4	39.2	31.8	84.1	20.9	29.6	17.6	18.6	18.0	20.3	35.1	20.0	20.5	18.8	91.6	29.4	28.8	29.9	23.0	33.2	43.5	43.9	27.4	48.7	40.6	35.6	49.6	35.7	46.6	45.2	47.6	50.4	0.0	0.0	0.0	0.0	0.0	0.0	62.9	62.6	62.8	0.0	133.3	132.6	81.8	0.0	0.0	0.0	0.0	83.7	92.1	0.0	0.0	83.7	0.0	98.1	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.0	160.5	0.0	0.0	80.1	0.0	0.0	106.9	0.0	0.0	0.0	0.0	0.0	0.0	153.0	0.0	0.0	0.0
SCML2		ENSG00000102098	"Scm polycomb group protein like 2"	Q9UQR0	X	18239314-18354727	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Spermatocytes: 22.8;Spermatogonia: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 7.0"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 20.0;REH: 17.8"					"Low region specificity"	"Detected in all"			"HPA001662, HPA064713"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA001662: AB_1079879, HPA064713: AB_2685333"	"unprognostic (5.15e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.26e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.95e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.15e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.35e-4)"	"unprognostic (3.30e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.31e-3)"	2.4	7.7	3.1	2.1	4.1	8.6	3.1	3.4	3.8	3.7	3.7	3.7	2.0	2.1	4.9	2.5	2.3	2.9	2.8	2.0	2.3	2.0	1.5	2.6	1.3	2.0	3.6	0.5	9.5	3.9	3.2	8.0	7.1	2.3	2.9	2.3	3.6	10.0	2.2	2.0	3.4	2.0	6.5	2.2	2.3	1.7	19.0	4.2	12.5	4.3	2.3	2.1	2.7	4.2	0.8	7.0	0.2	0.2	0.9	0.7	0.2	0.9	3.3	11.8	3.0	0.9	1.5	3.5	2.0	1.4	4.0	4.5	4.8	0.7	0.0	0.4	0.9	2.9	0.0	16.5	0.2	4.9	0.0	13.5	0.0	3.0	2.1	0.5	10.3	2.7	0.6	0.6	2.9	3.4	1.0	0.2	10.5	7.7	0.0	2.8	1.5	16.5	5.5	20.0	0.3	4.2	17.8	5.9	2.4	0.0	0.2	7.2	8.4	3.5	3.3	0.0	13.6	4.2	4.6	0.3	3.6	2.6	8.0	1.8	0.0	9.4	16.6	1.2	7.1	2.7	0.0	0.2	0.2	0.7	0.2	0.7	0.2	0.3	0.2	0.9	0.8	0.2	0.1	0.2	0.9	0.1	7.0	0.0	0.2	3.1	4.1	3.4	3.8	2.3	2.0	3.6	0.5	2.3	4.2	0.0	0.3	0.8	1.0	3.2	2.2	1.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.3	1.3	0.7	0.0	0.9	1.5	6.4	1.2	0.0	0.0	1.1	1.7	0.0	0.0	0.0	0.5	2.1	0.3	0.0	1.1	0.6	3.6	0.0	0.4	22.8	28.0	3.6	0.3	0.0	1.2	0.3
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	17.0	17.9	19.6	16.5	30.2	7.3	21.5	17.6	26.7	19.9	17.9	9.6	14.0	14.0	26.2	23.2	19.5	18.9	10.6	16.4	18.2	15.4	21.9	23.9	14.6	22.8	16.4	19.1	22.7	26.9	20.4	30.6	17.5	22.6	18.5	18.6	9.4	18.3	20.8	32.3	19.6	16.1	24.9	16.2	23.5	18.1	24.1	19.9	21.5	25.8	17.1	22.9	21.3	17.5	13.2	10.3	5.6	16.8	15.4	17.8	10.5	14.6	5.9	14.6	19.5	17.4	15.7	15.3	20.8	18.1	17.4	15.2	18.2	21.0	23.0	15.7	19.0	16.7	15.1	22.2	20.1	21.9	20.2	11.7	19.6	13.1	15.0	16.4	33.3	22.4	13.7	22.8	18.4	20.3	10.8	15.2	15.7	35.1	19.0	17.8	16.2	33.7	11.8	23.7	23.7	9.0	20.5	27.5	19.3	16.6	16.4	22.1	18.4	14.2	29.0	23.5	16.6	13.3	19.6	14.3	18.8	19.0	22.4	17.3	17.5	18.2	31.4	21.1	15.1	23.2	5.6	9.9	2.7	14.2	12.7	17.7	12.1	17.4	16.1	10.3	13.2	17.8	14.9	1.6	15.4	16.8	9.0	14.7	10.5	19.6	30.2	17.6	26.7	18.2	15.4	16.4	19.1	22.6	19.9	17.9	26.7	35.6	21.5	24.5	19.7	10.6	15.3	33.5	50.0	21.0	5.9	26.9	29.9	34.3	86.0	21.1	13.9	0.0	21.5	26.1	23.2	22.2	48.5	20.5	32.6	12.7	21.9	16.0	23.5	81.4	23.6	29.5	23.6	39.7	22.8	22.4	28.9	22.9	31.1	37.2	19.7	19.4	24.5	58.5	94.3	29.0	20.9	32.0	26.0	19.7
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-256700	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.1;skeletal muscle: 114.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		780000	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	17.6	31.4	15.3	11.5	20.3	10.6	12.8	18.8	29.0	10.2	29.4	17.3	10.0	44.3	11.3	12.1	15.3	12.6	14.8	100.1	15.8	14.5	36.5	55.4	10.7	11.7	19.6	19.3	14.5	14.7	23.2	9.5	9.2	29.7	10.7	24.6	14.5	17.3	12.0	114.0	11.5	39.9	16.5	13.2	13.9	21.2	14.6	14.8	15.7	12.5	39.6	12.5	13.2	11.1	28.3	31.9	29.1	29.2	27.1	48.9	32.4	18.7	30.4	12.5	20.4	21.6	16.2	34.0	14.5	18.4	25.0	25.5	32.9	25.6	23.2	45.8	16.5	18.9	24.3	22.1	29.6	14.8	49.4	20.2	11.8	84.1	42.8	13.4	14.7	15.4	16.1	19.0	18.6	9.9	19.9	27.0	16.6	19.0	19.3	11.7	28.7	19.4	39.7	4.3	20.5	38.6	25.1	18.2	45.0	53.1	24.9	13.8	7.9	68.2	44.1	17.9	8.1	26.7	18.6	19.5	18.5	18.2	11.0	11.9	20.6	8.8	17.1	17.9	21.2	11.7	17.8	24.4	29.1	36.4	29.2	32.1	28.3	34.8	35.1	31.9	24.5	34.5	31.7	5.9	27.1	24.1	20.5	48.9	32.4	15.3	20.3	18.8	29.0	15.8	14.5	19.6	19.3	29.7	14.8	32.8	63.8	52.9	58.0	54.4	45.7	238.2	76.5	58.9	40.9	71.5	96.2	94.1	121.0	78.8	32.8	37.6	207.8	0.0	39.4	87.2	53.2	29.4	42.7	135.6	60.4	95.3	45.6	43.0	39.1	20.2	63.3	43.9	86.0	78.5	75.8	40.3	44.9	92.8	52.3	129.8	77.8	77.6	45.0	66.5	55.1	31.5	129.4	59.9	128.8	78.3
SELENOF	SEP15	ENSG00000183291	"Selenoprotein F"		1	86862445-86914424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 217.7;Extravillous trophoblasts: 290.7;Hofbauer cells: 216.8;Syncytiotrophoblasts: 263.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054937			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No			Nucleoli	Cytosol	"HPA054937: AB_2682642"	"unprognostic (6.15e-2)"	"unprognostic (6.98e-3)"	"prognostic favorable (6.53e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.65e-1)"	"unprognostic (6.51e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.34e-2)"	41.5	48.9	34.7	32.4	33.2	27.1	41.4	20.4	33.9	44.3	37.0	28.9	42.7	32.9	34.9	62.0	36.9	36.8	36.1	31.4	33.4	35.8	68.4	85.3	47.8	45.4	36.0	25.1	47.6	38.5	20.6	46.9	65.6	34.3	41.5	37.4	30.8	35.8	33.7	22.0	21.7	51.1	30.2	45.0	58.7	32.3	36.4	29.0	57.0	100.7	22.8	33.7	40.0	29.7	68.9	57.5	44.3	41.8	26.8	41.3	51.1	39.1	26.9	22.5	24.8	73.7	87.7	36.8	49.4	56.6	46.5	47.4	38.0	47.7	48.4	63.4	43.8	40.3	24.7	25.4	27.5	54.9	45.1	35.9	49.2	25.7	35.9	46.6	64.3	33.6	56.3	43.6	30.9	46.7	37.9	39.1	40.2	45.5	50.6	45.1	17.6	46.7	43.3	33.0	40.7	37.2	39.1	41.6	47.2	64.5	40.5	29.2	24.2	49.2	44.9	65.1	21.5	19.6	56.1	40.8	34.1	25.4	65.6	53.9	30.5	30.9	49.5	19.9	53.2	39.9	44.3	40.0	36.8	32.8	38.4	41.3	56.7	35.8	34.7	39.0	68.9	37.1	37.5	36.7	26.8	41.8	57.5	38.3	51.1	34.7	33.2	20.4	33.9	33.4	35.8	36.0	25.1	34.3	29.0	110.2	143.1	0.0	0.0	0.0	0.0	0.0	0.0	128.5	137.6	102.9	0.0	217.7	63.0	187.2	0.0	0.0	0.0	0.0	170.1	290.7	0.0	0.0	59.3	0.0	216.8	0.0	0.0	0.0	0.0	0.0	0.0	83.2	0.0	111.8	0.0	0.0	167.0	0.0	0.0	129.7	0.0	0.0	0.0	0.0	0.0	0.0	263.6	0.0	0.0	0.0
SELENOH	"C11orf31, SELH"	ENSG00000211450	"Selenoprotein H"	Q8IZQ5	11	57741250-57743554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 376.4;Hofbauer cells: 352.0;Proximal tubular cells: 359.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048362	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA048362: AB_2680370"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.60e-1)"	27.5	49.3	34.8	35.6	49.9	36.2	30.4	17.0	52.5	23.6	30.6	14.8	23.3	38.5	22.1	38.1	36.3	26.9	28.7	32.7	29.7	31.9	33.8	49.5	26.4	40.1	29.3	40.0	28.4	41.5	9.7	30.7	28.9	22.2	32.8	16.2	22.8	48.2	26.0	52.7	21.1	37.8	15.5	19.5	49.3	36.8	30.8	18.7	44.4	43.2	25.4	35.5	21.6	23.3	61.7	83.7	39.6	71.7	29.9	53.1	71.6	32.3	23.7	25.6	14.7	3.9	12.5	4.7	13.1	11.1	11.2	6.6	6.4	16.4	15.6	36.6	7.2	10.4	14.4	11.9	15.9	7.5	22.7	25.7	20.7	15.1	15.6	23.0	30.5	40.6	13.2	13.5	13.2	12.4	16.8	19.5	22.5	19.7	14.8	13.3	31.1	26.3	46.9	45.4	10.5	31.1	33.6	24.7	29.7	10.7	15.1	13.8	28.1	11.5	10.8	33.6	15.8	29.7	22.9	19.4	12.7	28.0	25.0	18.9	74.4	53.4	10.3	27.4	24.3	30.1	39.6	71.7	34.5	29.9	71.0	28.2	59.7	39.7	31.3	71.2	61.7	53.1	37.6	5.4	29.9	65.4	83.7	29.4	71.6	34.8	49.9	17.0	52.5	29.7	31.9	29.3	40.0	22.2	18.7	154.9	129.2	0.0	0.0	0.0	0.0	0.0	0.0	262.3	136.5	143.1	0.0	264.9	376.4	215.3	0.0	0.0	0.0	0.0	273.6	236.1	0.0	0.0	123.2	0.0	352.0	0.0	0.0	0.0	0.0	0.0	0.0	84.9	0.0	178.5	0.0	0.0	265.5	0.0	0.0	359.8	0.0	0.0	0.0	0.0	0.0	0.0	123.1	0.0	0.0	0.0
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO1/sentrin/SMT3 specific peptidase 3"	Q9H4L4	17	7561875-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	16.3	16.0	22.3	20.9	23.4	16.6	18.0	29.2	38.4	15.9	22.5	18.4	16.8	16.2	18.6	22.7	18.6	19.9	17.0	26.1	21.0	19.2	17.5	15.1	18.7	18.8	20.0	23.3	19.6	17.8	29.5	17.3	23.6	17.2	16.0	20.5	17.3	18.6	21.9	22.0	20.8	17.6	23.1	15.3	18.9	17.2	28.8	16.4	18.9	19.0	14.2	23.4	16.8	32.8	0.8	0.7	1.1	0.7	1.1	1.7	0.3	26.5	32.2	19.1	29.6	21.7	15.9	20.0	19.5	20.0	34.0	32.0	19.2	11.6	31.8	19.4	25.6	23.5	25.6	41.1	30.5	28.6	22.4	37.5	16.5	27.3	19.7	29.3	15.1	21.0	20.3	31.2	38.8	38.1	19.6	27.3	36.3	21.1	9.0	26.2	17.8	36.8	11.5	23.7	24.8	19.6	33.7	17.9	18.3	22.7	15.6	19.1	24.7	19.5	18.9	20.7	25.5	15.9	9.9	14.3	19.6	17.0	18.6	41.8	13.2	13.7	20.2	19.7	16.1	28.9	0.1	0.7	0.2	0.4	0.4	0.1	0.4	0.2	1.3	0.1	0.8	1.7	0.5	1.1	1.1	0.1	0.7	0.3	0.3	22.3	23.4	29.2	38.4	21.0	19.2	20.0	23.3	17.2	16.4	3.0	4.8	2.7	5.7	7.6	5.8	5.9	7.6	1.4	4.5	1.8	21.6	2.6	0.0	1.9	1.1	4.5	2.3	0.0	2.1	1.9	3.9	4.1	1.1	2.6	1.3	6.4	6.3	9.8	6.9	0.4	3.7	4.1	3.3	1.8	2.5	5.0	1.9	0.0	2.1	0.7	8.0	0.0	3.6	2.8	3.5	10.2	3.4	4.9	3.4	5.6
SERF2	"4F5REL, FAM2C, H4F5rel, HsT17089"	ENSG00000140264	"Small EDRK-rich factor 2"	P84101	15	43777087-43802589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056613			Uncertain	Nucleoplasm,Nucleoli		NA	Yes			Nucleoplasm	Nucleoli	"HPA056613: "	"unprognostic (3.29e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (5.33e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.42e-2)"	78.4	109.1	61.4	103.2	58.1	110.6	115.0	33.0	45.9	71.2	107.6	45.1	99.7	59.2	65.1	121.7	109.6	60.0	128.9	166.4	56.1	48.2	97.5	153.1	79.7	81.4	72.9	42.6	51.8	125.4	23.5	62.5	102.9	89.4	84.7	87.6	63.0	134.3	106.7	98.7	59.9	86.4	68.5	66.7	79.5	79.5	65.5	45.8	77.0	122.5	116.7	82.9	84.8	116.3	146.1	259.3	225.7	218.7	91.4	142.8	413.5	34.8	58.0	43.3	59.0	150.7	111.1	33.4	62.2	78.0	40.5	51.9	74.4	35.1	18.1	51.6	106.7	53.7	46.4	33.8	46.7	20.3	49.5	40.1	43.7	84.4	142.7	73.9	40.7	94.4	104.9	60.6	32.8	35.2	63.3	59.0	51.4	45.0	119.6	79.4	106.8	52.0	96.5	36.9	136.5	67.6	53.4	28.7	83.0	110.5	127.6	32.5	35.0	33.3	140.1	31.8	39.2	117.3	174.4	49.9	69.4	35.4	104.1	45.4	44.2	59.2	125.6	74.8	74.1	71.8	127.3	218.7	225.7	113.6	194.5	103.1	142.2	125.7	116.0	185.9	146.1	116.7	118.3	129.1	91.4	166.0	259.3	142.8	413.5	61.4	58.1	33.0	45.9	56.1	48.2	72.9	42.6	89.4	45.8	470.5	717.5	1171.8	1145.4	1022.8	54.4	1942.2	1490.4	1019.8	757.5	1647.0	51.1	2342.3	3302.5	1581.0	331.8	1228.3	2242.3	817.7	1967.3	2747.0	1831.7	2360.8	754.3	2534.0	3171.2	44.5	1122.7	1502.0	1926.7	193.3	1134.5	1999.7	1724.2	2939.6	2776.8	318.1	1792.5	2080.9	932.7	3520.7	108.9	595.0	1152.9	641.0	342.8	1360.5	2739.6	1068.3	1696.1	2044.0
SFRP1	"FRP, FRP-1, SARP2"	ENSG00000104332	"Secreted frizzled related protein 1"	Q8N474	8	41261958-41309497	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Cardiomyocytes: 175.8;Leydig cells: 535.6;Peritubular cells: 122.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 270.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB008116, HPA064870"	Approved		Approved	Nucleoli,Cytosol	"Secreted in other tissues"	Yes	No		1600000	Nucleoli	Cytosol	"CAB008116: AB_2187070, HPA064870: AB_2685376"	"unprognostic (1.23e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.13e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (3.12e-4)"	20.1	3.4	4.6	2.4	7.5	0.3	73.2	10.8	5.6	58.4	6.1	15.2	8.0	3.0	35.6	19.3	9.7	25.9	15.5	43.9	7.8	2.5	30.6	1.5	1.8	0.9	4.5	6.7	12.5	1.5	0.6	0.7	9.9	24.1	12.8	7.8	19.3	73.2	27.1	1.9	20.8	5.4	21.4	2.8	5.0	11.0	11.1	13.7	0.0	3.3	18.4	5.1	10.9	41.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	6.3	0.1	5.7	0.3	1.2	10.9	57.4	16.6	15.8	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.8	4.4	23.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	1.0	21.4	1.6	1.6	270.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	17.1	0.0	0.0	0.0	1.3	0.0	35.3	0.0	0.3	1.5	0.4	0.0	3.3	23.2	0.0	0.1	0.1	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	7.5	10.8	5.6	7.8	2.5	4.5	6.7	24.1	13.7	0.0	0.0	0.0	104.7	10.0	1.5	175.8	0.0	0.0	1.2	59.3	2.0	0.7	68.0	3.1	4.8	6.7	0.0	0.0	0.0	55.3	47.0	19.9	0.0	0.0	1.7	1.6	0.0	15.4	0.0	13.0	535.6	1.4	94.5	0.0	0.0	51.5	0.1	0.0	122.4	3.5	1.5	0.0	4.1	1.6	20.6	4.8	0.7	0.0	0.0	8.5
SGF29	"CCDC101, FLJ32446, TDRD29"	ENSG00000176476	"SAGA complex associated factor 29"	Q96ES7	16	28553915-28591790	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 187.5;Late spermatids: 270.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA052590, HPA053608"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoli	Nucleoplasm	"HPA052590: AB_2681875, HPA053608: AB_2682205"	"unprognostic (1.38e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.42e-3)"	11.1	11.4	7.9	11.8	12.5	9.9	15.5	20.9	11.0	19.5	17.1	10.6	16.9	11.6	21.4	10.2	9.0	17.6	11.1	10.7	7.9	6.8	9.8	12.9	11.1	17.2	16.5	7.1	31.5	17.7	8.6	9.4	8.4	10.8	13.1	6.9	12.1	14.8	20.0	36.1	12.2	13.4	21.4	13.4	11.6	13.5	35.6	14.4	17.6	19.5	9.0	10.4	17.1	25.1	25.4	27.6	18.8	18.2	19.5	36.1	20.4	7.0	12.0	9.2	6.0	6.4	6.3	16.8	4.8	5.4	12.6	11.9	13.8	6.4	21.3	12.0	3.7	7.6	8.3	7.0	8.4	3.6	6.8	13.3	13.2	7.4	18.3	15.6	11.8	14.9	6.7	11.5	7.5	7.6	6.8	4.7	13.6	11.1	10.9	4.4	23.6	13.4	23.2	12.7	5.2	11.7	21.0	6.0	18.5	6.3	10.7	14.9	6.9	7.4	14.2	7.9	3.7	11.7	9.8	3.3	8.7	7.4	5.0	8.3	12.7	18.4	12.4	6.2	20.1	7.0	5.0	18.2	18.8	22.3	15.6	26.9	22.2	31.2	27.2	18.3	25.4	36.1	27.8	5.6	19.5	12.5	27.6	29.6	20.4	7.9	12.5	20.9	11.0	7.9	6.8	16.5	7.1	10.8	14.4	14.9	11.8	6.7	16.2	0.0	6.1	0.0	5.1	12.0	13.6	17.4	13.7	15.2	8.3	9.9	187.5	3.6	9.3	0.0	11.3	10.4	9.5	6.7	5.8	14.3	12.7	0.0	3.5	6.2	12.9	270.5	28.4	12.1	0.0	11.8	9.2	11.2	11.3	12.2	20.5	18.8	13.9	19.4	0.0	8.4	19.2	0.0	17.6	13.1	14.0	11.1
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643415-60658259	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0"	"Cell type enhanced"	"Detected in some"	19	"Basal glandular cells: 23.3;Ciliated cells: 65.6;Club cells: 33.0;Glandular cells: 24.0;Urothelial cells: 14.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 1.2;pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 14.3;LHCN-M2: 53.4;RH-30: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	7.1	0.4	0.3	0.1	0.5	0.1	4.7	0.3	0.6	7.4	0.2	0.2	0.0	0.1	0.2	2.1	1.3	0.5	0.4	0.4	0.3	0.3	0.3	0.2	1.8	0.3	0.4	1.2	0.3	0.3	16.8	39.1	0.1	4.5	8.7	0.1	2.0	55.1	0.2	59.0	0.4	0.2	0.7	0.5	0.2	0.5	1.6	0.0	6.5	2.4	22.5	3.0	1.4	9.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.9	0.2	11.9	6.9	8.1	0.1	2.0	4.5	2.3	2.0	0.0	3.8	0.0	1.1	0.4	1.1	2.7	3.9	3.6	0.8	0.0	9.5	0.9	0.8	2.7	0.0	0.0	0.1	6.0	1.8	1.6	0.3	14.3	0.1	0.7	2.6	0.0	53.4	1.3	0.0	0.2	0.0	0.0	4.8	0.0	29.2	0.0	2.3	6.5	1.1	0.1	2.3	0.1	2.4	0.2	1.4	0.2	6.8	3.2	3.2	3.7	3.0	0.2	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.3	0.3	0.4	1.2	4.5	0.0	3.0	1.0	0.0	23.3	0.1	0.0	0.8	0.0	65.6	33.0	1.8	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.8	24.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	1.1	0.0	0.3	0.0	0.2	0.0	2.5	0.1	0.2	0.0	0.0	14.9
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.6;lymphoid tissue: 23.8"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"HEL: 3.8;HMC-1: 3.7;NB-4: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA029590, HPA050378, HPA068540"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA029590: AB_10794613, HPA050378: , HPA068540: "	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	13.5	4.7	4.3	14.9	13.3	11.6	2.6	0.6	9.3	1.7	1.8	4.6	0.0	1.3	1.3	2.1	1.4	4.1	3.0	6.5	15.0	2.6	2.1	3.2	37.6	19.9	17.1	0.7	2.4	3.3	1.2	1.9	6.2	11.3	1.7	1.0	1.7	2.0	1.2	2.0	1.0	1.2	4.6	18.1	23.8	1.7	2.4	10.3	0.0	1.8	0.2	1.0	7.1	1.3	0.4	2.4	6.0	7.9	0.2	0.4	2.6	0.3	0.7	0.0	0.4	0.1	0.1	0.9	0.0	0.0	0.1	0.2	1.0	2.1	0.2	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.7	0.1	3.8	0.6	0.7	0.1	0.0	3.7	0.3	0.1	0.0	0.2	0.3	0.0	1.2	1.0	0.7	0.1	1.3	0.2	3.1	0.0	0.6	0.2	0.2	0.6	0.4	0.1	0.3	0.8	0.2	0.5	0.4	0.4	0.2	0.3	1.1	0.3	0.7	0.4	0.2	0.0	0.3	0.3	0.7	0.2	0.4	0.4	0.3	7.9	0.6	0.4	5.8	0.3	0.1	0.2	0.2	2.4	0.4	0.4	0.3	6.0	0.2	7.0	0.2	0.2	2.6	4.3	13.3	0.6	9.3	15.0	2.6	17.1	0.7	11.3	10.3	20.8	52.4	3.0	3.9	0.8	3.6	6.3	5.1	17.4	22.7	8.7	0.0	1.6	8.3	0.8	1.2	4.7	1.2	0.0	1.8	7.2	2.4	5.7	24.3	4.7	110.2	1.6	1.2	8.6	163.4	0.4	2.0	201.4	1.7	1.0	4.0	7.6	0.6	0.9	0.7	6.8	3.0	19.4	5.0	0.5	1.7	0.9	6.8	1.7	2.2	2.7
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36606355-36688334	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 188.6"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 579.8"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	39	"dendritic cells: 3.4;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	17.3	10.3	76.1	5.9	70.6	3.1	6.3	45.8	188.6	6.9	3.2	26.3	0.0	2.1	2.8	2.3	7.2	5.4	5.9	12.0	57.9	27.3	3.1	3.6	4.7	8.6	32.7	39.6	8.6	4.0	2.6	3.7	12.7	28.5	3.3	2.6	1.9	3.0	4.4	7.6	5.5	2.3	4.1	29.4	5.8	2.9	2.7	33.6	0.0	2.6	0.7	4.5	4.8	1.2	0.0	3.4	0.0	4.3	0.0	0.0	0.8	0.4	0.1	21.5	1.9	2.2	6.0	13.8	0.0	0.0	0.8	1.9	34.7	1.7	0.0	10.5	0.3	0.3	26.3	6.3	2.8	0.9	0.3	12.9	0.0	0.1	0.0	0.4	0.4	0.1	11.1	13.0	5.3	2.2	0.4	0.0	0.4	0.0	0.1	3.6	0.0	0.0	0.1	2.5	0.0	2.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	2.1	6.3	0.3	10.5	0.0	1.0	0.0	1.9	3.2	0.0	7.6	0.0	0.0	0.0	8.8	14.5	4.9	0.0	4.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	76.1	70.6	45.8	57.8	57.9	27.3	32.7	39.6	28.5	33.6	3.0	0.3	0.5	10.4	9.5	7.7	33.9	0.0	5.3	1.2	0.0	2.0	25.3	0.0	0.4	0.6	1.1	0.0	0.0	0.0	13.5	11.8	3.2	0.0	0.2	38.2	3.2	0.0	1.3	63.4	1.9	4.0	11.0	6.8	3.6	0.0	579.8	0.3	0.0	0.0	0.0	11.3	6.5	4.7	0.2	0.1	6.1	7.7	0.0	0.0	3.3
SLC35E2	KIAA0447	ENSG00000215790	"Solute carrier family 35 member E2"	P0CK97	1	1724838-1745999	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 26.8;Alveolar cells type 2: 22.1;Ciliated cells: 10.7;Club cells: 11.4;Horizontal cells: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA006118, HPA062711"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA006118: , HPA062711: AB_2684844"	"unprognostic (3.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-4)"	"unprognostic (9.52e-4)"	"unprognostic (6.57e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.87e-4)"	3.0	4.1	8.0	5.2	5.1	0.6	3.0	9.8	6.2	4.0	3.0	2.9	1.6	4.9	6.0	10.5	4.5	5.8	7.6	3.0	5.0	3.5	2.5	2.4	4.8	11.6	4.4	4.7	5.5	3.5	6.9	5.9	3.5	4.0	3.6	5.4	3.6	9.1	1.6	4.7	6.4	4.8	3.7	3.7	6.8	6.2	6.2	5.5	5.5	3.5	3.8	4.3	4.3	7.7	5.0	5.2	6.4	3.4	3.1	6.5	3.2	1.6	1.6	5.4	11.5	11.2	11.0	3.6	7.4	15.3	7.0	9.0	4.6	15.1	4.9	1.3	1.7	1.7	7.5	1.4	2.9	7.6	6.8	1.7	6.4	7.5	1.2	2.3	1.3	7.2	8.8	3.7	1.2	6.3	5.8	2.1	9.2	2.1	2.2	1.3	1.2	1.9	3.2	1.0	0.9	1.9	3.7	5.0	1.0	7.4	5.3	15.2	3.1	2.2	9.2	8.8	1.3	17.9	3.6	9.6	7.3	1.5	2.2	0.4	3.0	0.4	1.6	5.2	3.9	1.2	6.4	3.4	2.1	5.5	2.6	6.5	4.5	4.8	5.3	1.5	5.0	5.5	4.8	4.0	3.1	1.6	5.2	4.5	3.2	8.0	5.1	9.8	6.2	5.0	3.5	4.4	4.7	4.0	5.5	26.8	22.1	0.0	0.5	0.5	5.1	0.0	2.5	10.7	11.4	0.0	2.0	0.8	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.4	1.0	0.4	2.3	0.8	0.6	12.7	0.0	1.8	0.6	0.0	2.8	0.3	0.0	0.0	0.7	1.2	0.0	0.0	3.2	0.0	3.9	0.0	0.0	0.7	1.3	1.5	0.2	4.9	1.2	0.4
SLC35F3	FLJ37712	ENSG00000183780	"Solute carrier family 35 member F3"	Q8IY50	1	233904933-234324516	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell type enhanced"	"Detected in some"	9	"Basal glandular cells: 2.4;Distal tubular cells: 3.3;Exocrine glandular cells: 3.0;Glandular cells: 1.7;Intestinal endocrine cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	49	"plasmacytoid DC: 7.1"	"Lineage enriched"	"Detected in single"	69	"dendritic cells: 7.1"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051327, HPA061582"	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA051327: AB_2681443, HPA061582: AB_2684563"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.69e-5)"	"unprognostic (3.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.58e-1)"	0.8	3.5	4.6	1.3	26.0	0.7	6.8	25.1	16.7	1.4	0.8	0.5	0.0	0.8	1.0	2.5	1.6	1.7	0.8	0.6	5.4	4.6	1.6	0.6	1.2	2.4	4.8	6.6	0.6	3.6	4.6	2.8	0.7	4.1	2.0	0.8	0.0	6.6	1.1	1.1	0.8	0.9	1.1	4.8	1.0	2.5	1.1	4.3	0.5	1.9	0.3	1.9	0.8	0.6	0.0	7.1	0.0	0.1	0.0	0.0	0.0	1.4	3.9	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.1	0.3	0.0	3.6	0.0	49.4	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.4	0.0	0.0	0.0	3.6	0.0	2.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	4.6	26.0	25.1	11.6	5.4	4.6	4.8	6.6	4.1	4.3	0.0	0.0	0.0	2.4	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.6	0.0	0.0	0.0	3.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.7	1.3	0.1	0.0	0.0	0.0	0.0
SLC6A15	"FLJ10316, hv7-3, NTT73, SBAT1, V7-3"	ENSG00000072041	"Solute carrier family 6 member 15"	Q9H2J7	12	84859488-84913615	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 18.0;Horizontal cells: 11.1;Melanocytes: 30.4;Rod photoreceptor cells: 10.2"	"Cancer enhanced"	"Detected in some"		"melanoma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 31.1;ASC TERT1: 19.2;hTERT-HME1: 43.9;SCLC-21H: 30.0;SK-MEL-30: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008609	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA008609: AB_1857190"	"unprognostic (1.01e-4)"	"unprognostic (9.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.65e-6)"	"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"unprognostic (7.65e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.69e-4)"	"unprognostic (2.57e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-3)"	1.4	4.5	18.0	2.2	16.2	1.0	2.3	17.8	31.0	1.7	2.2	5.4	0.0	1.4	2.8	1.1	6.7	1.2	1.3	1.0	10.9	18.2	1.5	1.0	1.3	1.1	10.3	16.9	2.1	1.0	1.0	5.6	8.9	14.7	1.8	1.8	9.2	1.4	1.5	1.0	4.9	2.1	1.6	4.9	1.1	1.3	3.6	12.8	0.0	2.0	1.8	1.8	1.1	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	3.6	0.0	31.1	19.2	0.0	0.0	6.5	0.5	0.3	0.0	0.0	0.0	0.0	0.2	4.1	0.4	0.0	8.3	0.0	0.0	9.5	0.0	1.5	0.0	11.5	0.0	0.2	10.7	16.0	4.2	43.9	8.5	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	7.8	0.0	9.9	22.1	0.1	0.0	0.0	0.0	4.7	2.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.0	16.2	17.8	18.6	10.9	18.2	10.3	16.9	14.7	12.8	0.0	0.0	0.0	0.0	2.4	18.0	0.4	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.1	11.1	0.0	0.0	0.0	0.2	0.0	0.0	30.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.2	0.0	0.2	0.1	0.4	0.5	0.2	0.0	0.0	0.0
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.9;brain: 13.6;breast: 15.6"	"Group enriched"	"Detected in some"	5	"Muller glia cells: 1.8;Spermatogonia: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 4.3;HHSteC: 2.6;HSkMC: 3.7;THP-1: 8.4;U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	40.9	1.0	9.8	1.9	13.6	1.0	15.6	2.4	12.1	1.0	2.2	0.8	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.1	4.7	6.2	1.3	1.0	1.0	1.2	7.6	5.0	1.0	1.2	1.0	0.0	1.2	9.0	1.0	1.0	8.4	2.3	1.0	1.0	1.1	1.0	1.1	0.8	1.0	1.0	1.4	1.8	0.0	1.4	0.0	1.4	1.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	8.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.8	13.6	2.4	12.1	4.7	6.2	7.6	5.0	9.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.0	0.0
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141417	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 96.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA071309: AB_2686385"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	7.4	6.1	6.6	10.1	10.5	15.2	6.1	8.1	9.1	7.9	7.5	4.0	5.1	7.0	6.1	5.2	11.4	5.1	3.6	7.1	6.5	6.8	8.6	5.7	5.5	14.2	8.2	5.2	6.0	4.1	5.2	6.5	7.5	10.7	5.2	8.5	3.0	5.9	4.7	4.2	6.8	6.9	5.4	8.6	13.7	5.9	12.3	8.7	56.1	7.2	12.9	14.7	6.1	6.3	8.9	5.1	12.0	8.3	8.0	7.4	2.8	18.3	14.2	16.0	14.8	3.4	5.0	15.0	17.0	8.1	15.3	12.9	12.3	14.3	35.2	8.3	8.7	13.2	31.2	23.1	11.0	20.7	22.3	9.7	21.2	22.7	7.9	0.9	12.8	21.4	3.2	2.3	20.7	8.4	5.2	10.8	22.7	17.0	29.0	13.8	8.9	33.3	6.6	13.8	14.9	11.2	22.3	45.9	13.2	6.5	6.7	15.1	11.7	20.3	9.5	5.0	7.0	19.1	8.7	8.6	18.6	19.6	25.7	21.2	10.6	35.7	20.6	12.1	18.8	22.5	12.0	2.8	2.8	6.2	7.1	7.0	8.5	5.7	6.2	3.0	8.9	6.7	7.4	0.4	8.0	8.3	5.1	6.9	2.8	6.6	10.5	8.1	9.1	6.5	6.8	8.2	5.2	10.7	8.7	23.8	11.0	20.1	9.5	24.3	34.1	38.9	7.6	10.7	14.8	15.7	7.9	30.9	29.9	16.5	27.3	15.5	6.5	0.0	17.9	78.9	14.2	5.9	21.9	6.8	37.8	27.0	4.7	19.6	12.1	20.4	17.3	20.0	6.8	27.1	11.4	14.5	14.2	7.0	11.7	13.3	18.4	12.9	17.5	56.4	96.0	20.3	21.6	14.9	24.7	6.7
SMG6	"C17orf31, EST1A, KIAA0732, SMG-6"	ENSG00000070366	"SMG6, nonsense mediated mRNA decay factor"	Q86US8	17	2059839-2303771	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042932	Approved		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA042932: AB_10964261"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.30e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.08e-2)"	12.7	16.6	18.1	18.9	17.6	11.9	10.9	19.1	18.4	15.0	10.6	15.1	13.2	9.0	26.2	11.9	16.1	22.2	16.7	16.4	12.8	15.9	11.5	7.3	11.5	10.7	13.4	16.1	38.7	9.3	16.2	17.2	10.1	14.5	14.5	9.5	18.6	10.4	13.3	14.0	15.3	10.3	18.9	12.8	9.0	9.7	39.2	11.5	22.3	11.6	8.4	16.8	12.7	12.4	2.0	3.3	4.8	3.6	4.6	4.3	1.5	8.2	12.7	18.4	11.9	19.9	16.1	9.5	13.4	14.8	15.3	13.0	15.4	4.2	8.7	4.8	19.6	7.0	12.1	13.4	11.4	16.0	8.7	8.4	8.5	6.8	7.5	11.4	4.5	6.1	22.8	8.5	12.3	10.9	24.9	13.9	8.7	7.0	10.7	11.4	6.5	11.4	3.7	5.9	5.0	6.6	11.8	11.7	3.4	8.8	7.6	3.1	9.4	14.0	4.1	5.8	13.5	6.4	3.3	18.2	14.1	7.8	14.8	14.0	9.3	5.5	4.1	11.2	5.1	8.2	4.8	1.8	2.0	3.7	0.8	3.7	1.2	3.1	3.5	1.0	2.0	4.3	2.9	1.4	4.6	3.6	3.3	1.8	1.5	18.1	17.6	19.1	18.4	12.8	15.9	13.4	16.1	14.5	11.5	20.8	17.3	9.3	12.4	7.0	32.9	5.6	12.7	14.7	9.1	14.0	70.7	13.6	5.0	12.0	17.3	13.2	10.7	0.0	11.1	9.3	13.6	11.7	10.4	6.6	8.9	44.5	4.1	12.9	6.3	25.4	15.5	9.2	8.5	19.8	8.0	26.2	13.2	14.4	18.7	6.3	49.0	25.8	13.3	51.6	47.3	7.5	14.5	14.9	8.8	11.2
SNAPC1	"PTFgamma, SNAP43"	ENSG00000023608	"Small nuclear RNA activating complex polypeptide 1"	Q16533	14	61762357-61796428	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 120.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 41.4;hTERT-HME1: 41.6;U-2 OS: 55.1;U-251 MG: 38.0"					"Low region specificity"	"Detected in all"			"HPA067076, HPA072276"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA067076: AB_2732757, HPA072276: AB_2732199"	"unprognostic (7.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.26e-1)"	9.9	12.3	7.5	8.6	10.3	7.0	8.4	12.1	8.0	14.4	6.8	5.6	11.6	4.9	10.3	15.8	9.2	8.7	10.4	11.2	7.8	7.6	8.7	7.0	10.5	9.7	11.8	5.4	12.1	5.0	8.8	27.2	11.3	14.2	10.3	4.2	5.7	7.2	19.8	5.6	8.7	5.2	6.9	14.5	9.5	5.4	24.9	9.4	9.1	9.8	8.2	8.9	17.4	14.3	12.0	9.3	7.5	7.0	9.6	13.1	5.1	14.6	2.8	2.8	6.0	3.2	3.7	3.4	12.4	8.3	14.3	8.5	1.0	3.0	3.0	16.6	5.2	41.4	4.6	2.8	3.7	23.6	3.3	2.0	1.8	1.5	2.0	8.4	1.9	4.0	3.5	2.5	12.0	41.6	5.6	5.4	4.2	2.0	2.8	13.6	1.8	4.6	3.0	2.7	1.6	9.5	3.5	7.5	1.1	11.7	2.3	2.0	4.9	8.2	1.4	9.8	3.7	2.9	3.0	8.3	15.8	55.1	10.2	38.0	1.8	1.9	2.7	10.7	2.4	9.3	7.5	7.0	5.8	6.4	5.9	8.3	12.0	8.1	5.5	7.0	12.0	13.1	8.5	7.1	9.6	4.9	9.3	8.7	5.1	7.5	10.3	12.1	8.0	7.8	7.6	11.8	5.4	14.2	9.4	32.8	16.5	17.9	48.3	84.6	10.6	18.8	5.1	57.6	28.4	27.9	2.0	14.9	6.6	20.7	35.6	28.5	4.0	0.0	14.0	21.4	31.0	23.1	40.5	5.8	15.6	7.9	4.1	27.6	12.6	8.2	20.4	19.5	16.9	13.6	4.5	42.6	16.7	0.0	19.1	8.2	11.7	19.4	30.3	120.2	67.0	56.3	4.7	15.2	6.4	22.2
SNAPIN	"BLOC1S7, BORCS3, SNAPAP"	ENSG00000143553	"SNAP associated protein"	O95295	1	153658654-153661830	"Predicted intracellular proteins, Transporters"	"Exocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046974	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA		15000	"Golgi apparatus"	Nucleoli	"HPA046974: AB_10962506"	"unprognostic (3.65e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.31e-3)"	"unprognostic (4.89e-2)"	21.8	32.5	20.2	14.5	25.9	8.4	30.2	12.1	26.3	17.5	19.2	18.5	17.2	9.1	19.7	25.0	20.7	20.4	21.4	38.1	17.4	17.7	21.8	22.1	15.7	26.1	21.6	17.8	17.9	22.9	18.0	10.8	14.5	20.5	17.9	14.7	15.6	14.1	22.6	56.9	16.1	13.2	24.9	22.1	19.4	16.0	16.5	20.8	18.1	19.9	29.8	21.7	19.6	13.9	42.4	50.8	44.6	49.9	35.4	42.8	42.8	20.1	24.8	21.1	12.7	27.0	18.1	13.6	17.1	19.0	24.3	18.5	17.6	16.2	14.5	34.6	17.4	11.9	27.0	17.3	22.3	17.0	19.3	23.9	16.0	19.1	8.4	27.9	15.7	10.2	21.7	16.7	18.1	20.7	24.5	22.7	17.0	13.6	11.2	24.3	32.6	17.9	9.2	11.4	31.7	26.7	17.1	18.4	38.3	26.8	19.4	16.1	28.2	19.7	22.9	22.4	20.7	34.8	16.8	20.0	11.3	17.3	22.4	16.0	27.3	29.8	22.1	21.6	9.9	14.7	27.6	49.9	44.6	30.9	49.1	35.0	42.4	31.4	31.0	50.8	36.9	34.8	31.8	10.4	35.4	39.0	38.1	42.8	42.8	20.2	25.9	12.1	26.3	17.4	17.7	21.6	17.8	20.5	20.8	17.9	17.6	24.3	31.9	18.3	13.6	35.0	22.9	36.1	22.7	27.9	7.9	54.7	63.0	60.4	5.7	30.1	18.8	0.0	57.1	40.8	26.9	29.4	30.0	25.5	77.8	20.6	13.3	31.9	48.5	18.5	28.4	40.8	25.3	91.0	20.8	57.6	41.2	25.7	46.7	60.8	17.2	45.3	38.2	29.6	39.2	20.6	61.7	26.6	25.6	33.4
SNORC	"ASCL830, C2orf82, UNQ830"	ENSG00000182600	"Secondary ossification center associated regulator of chondrocyte maturation"	Q6UX34	2	232857270-232878708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.9;breast: 19.6"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 5.0;Pancreatic endocrine cells: 9.1;Proximal tubular cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 6.3"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 36.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA052824	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA052824: AB_2681964"	"unprognostic (4.58e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.30e-7)"	"unprognostic (1.83e-3)"	"unprognostic (8.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-2)"	1.4	1.5	4.8	0.8	6.4	1.5	19.6	2.8	9.0	0.3	2.4	9.3	0.0	2.7	0.7	2.0	0.3	0.4	0.3	0.4	8.8	7.8	1.2	2.1	1.3	1.7	11.9	7.0	0.5	4.2	0.7	0.3	0.9	9.1	3.0	1.1	0.0	3.2	0.6	2.8	10.8	2.0	0.6	27.9	1.4	1.3	6.2	7.4	0.0	0.9	0.0	0.5	0.5	0.0	0.0	0.0	6.3	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.9	0.6	1.0	1.5	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.4	0.1	0.3	0.3	0.0	0.0	0.0	0.4	1.3	0.3	0.2	36.4	0.5	0.0	1.1	0.0	0.9	0.2	0.5	0.4	1.0	0.4	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	1.4	0.2	0.3	0.2	0.0	0.5	0.1	0.5	0.2	0.0	1.3	0.6	0.0	1.6	0.5	0.1	0.5	0.5	0.4	2.4	2.5	0.1	0.0	0.8	0.2	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.4	2.8	9.0	8.8	7.8	11.9	7.0	9.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.5	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
SOGA1	"C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA"	ENSG00000149639	"Suppressor of glucose, autophagy associated 1"	O94964	20	36777442-36863686	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.5"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043992	Approved		Approved	Nucleoli,Cytosol	"Secreted to blood"	NA	Yes			"Nucleoli, Cytosol"		"HPA043992: AB_2678762"	"unprognostic (2.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (8.28e-5)"	"unprognostic (1.09e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.45e-3)"	6.2	11.4	10.8	4.5	10.6	1.4	6.0	55.5	12.5	11.3	8.3	20.5	7.2	2.5	8.8	5.3	7.2	9.4	9.9	6.7	9.9	7.5	4.7	1.3	6.1	3.0	12.7	8.9	12.6	3.7	11.5	4.4	7.9	8.7	10.7	3.9	6.7	4.4	12.3	2.9	11.0	4.6	14.1	7.9	5.3	5.3	14.8	14.7	0.9	16.0	4.7	4.1	8.0	10.5	1.0	2.1	1.4	0.7	0.7	0.2	0.2	7.5	10.3	12.5	13.5	7.3	6.7	3.3	6.6	7.2	9.5	5.6	4.1	1.2	3.3	2.5	11.6	8.2	10.2	10.0	6.2	10.0	0.5	2.0	5.4	9.6	5.4	3.8	1.2	5.3	3.8	7.6	9.0	6.4	4.1	6.1	3.7	3.8	0.7	10.3	7.3	3.8	2.8	3.2	0.8	8.0	9.0	11.7	1.3	5.5	2.3	15.0	9.4	13.8	15.2	4.4	5.8	19.3	8.1	9.3	23.8	4.6	11.6	14.4	1.4	0.3	3.4	10.1	1.6	15.0	1.4	0.7	0.2	0.1	0.4	0.2	1.0	0.1	0.1	0.4	1.0	0.2	0.2	1.4	0.7	0.3	2.1	0.1	0.2	10.8	10.6	55.5	12.0	9.9	7.5	12.7	8.9	8.7	14.7	0.0	2.6	1.4	4.8	11.2	18.8	12.1	0.0	2.7	7.9	19.2	35.3	12.5	1.7	3.4	0.4	10.5	1.7	0.0	1.3	8.6	11.0	5.2	10.4	0.2	8.5	22.3	5.8	9.8	5.3	1.5	11.2	6.0	5.0	1.0	1.3	19.4	1.8	0.0	17.7	1.2	3.7	12.9	11.3	0.7	1.0	14.1	2.7	1.0	2.5	2.5
SP5		ENSG00000204335	"Sp5 transcription factor"	Q6BEB4	2	170715351-170718078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Cardiomyocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 3.3;Fibroblasts: 2.3;Mucus-secreting cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 51.7"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Group enriched"	"Detected in many"	4	"cerebellum: 5.3;hippocampal formation: 1.2;olfactory region: 5.8;thalamus: 3.6"	HPA074123			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA074123: AB_2686664"	"unprognostic (1.16e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.77e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-8)"	"unprognostic (8.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.17e-1)"	8.7	1.8	0.5	2.5	0.6	0.1	7.4	1.6	1.0	11.4	3.9	1.4	3.2	3.1	7.2	3.0	1.9	3.0	5.1	0.8	0.6	1.4	0.8	5.9	4.6	3.1	0.2	0.8	1.5	0.5	0.1	0.1	2.1	0.4	7.2	1.0	3.8	2.1	0.9	0.7	6.6	3.1	3.1	0.1	0.2	7.3	2.4	0.0	0.2	0.1	0.8	6.5	3.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.9	0.0	0.0	0.2	0.0	0.2	0.6	0.1	0.0	0.0	1.5	0.1	0.2	0.0	51.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.6	1.0	0.6	1.4	0.2	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.7	0.0	2.8	0.0	0.0	0.0	1.8	0.0	0.9	3.3	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.3	0.1	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.9	0.0
SPATA17	IQCH	ENSG00000162814	"Spermatogenesis associated 17"	Q96L03	1	217631324-217871696	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 48.0"	"Cell type enhanced"	"Detected in many"	21	"Ciliated cells: 161.9;Early spermatids: 584.1;Late spermatids: 424.1;Spermatocytes: 138.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030099	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA030099: AB_2270988"	"unprognostic (4.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.24e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.82e-1)"	0.5	0.6	1.4	0.3	5.2	2.4	0.9	0.5	1.2	1.0	0.5	2.7	2.9	0.6	0.7	9.7	0.5	6.8	0.8	1.1	2.3	2.2	2.8	0.4	3.0	0.3	0.8	1.6	3.3	0.6	3.0	10.8	0.4	11.1	0.7	0.3	1.2	0.6	1.2	2.9	1.0	0.7	0.2	0.7	0.4	0.6	48.0	1.4	0.0	3.1	0.3	0.2	0.5	0.5	1.3	0.6	2.3	0.6	0.6	1.0	0.1	0.6	1.2	1.2	1.2	0.3	2.0	0.9	0.5	0.7	0.6	0.3	0.8	3.2	0.6	1.0	0.4	0.4	2.2	0.8	1.1	0.7	0.6	1.2	0.5	1.5	0.8	0.6	0.3	0.5	0.7	2.3	1.2	1.2	1.4	0.1	0.7	0.7	1.3	0.6	2.5	0.4	1.0	2.3	1.6	1.2	0.4	0.4	0.4	2.3	0.9	4.8	1.9	0.7	0.8	0.6	2.0	1.5	0.6	0.6	0.8	0.6	0.9	0.5	1.3	0.8	0.3	1.9	0.5	1.1	2.3	0.5	0.5	0.9	0.5	0.8	0.7	0.7	0.7	0.3	1.3	0.9	1.0	1.5	0.6	0.6	0.6	0.3	0.1	1.4	5.2	0.5	1.2	2.3	2.2	0.8	1.6	11.1	1.4	3.0	0.0	0.0	0.8	0.6	0.4	1.4	0.0	161.9	25.0	3.5	19.6	0.7	5.0	1.7	584.1	0.5	0.0	0.0	0.6	0.5	0.7	1.6	0.0	0.0	0.2	0.0	1.7	0.0	0.0	424.1	8.1	0.7	1.7	0.0	1.0	5.1	0.2	0.0	6.3	8.4	18.5	0.0	0.1	138.2	8.1	0.9	0.2	0.0	0.6	0.4
SPATA5L1	"FLJ12286, MGC5347"	ENSG00000171763	"Spermatogenesis associated 5 like 1"	Q9BVQ7	15	45402331-45421419	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA043679	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA043679: AB_10964179"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.57e-2)"	"unprognostic (9.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.40e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.80e-2)"	9.0	8.7	10.7	12.3	10.7	11.1	9.5	21.3	8.2	10.3	9.9	10.0	10.2	12.1	9.8	8.4	17.5	8.8	8.3	9.6	9.6	5.9	10.8	14.8	11.2	14.1	13.5	5.8	12.9	12.0	7.6	7.6	10.6	8.9	9.9	10.2	7.2	9.4	12.8	15.9	16.1	13.2	9.4	7.1	8.6	8.2	12.1	12.0	9.9	11.2	12.3	10.9	10.2	11.9	3.6	3.3	4.8	6.4	3.3	4.7	0.7	7.1	5.5	7.4	5.4	6.1	6.0	9.0	6.4	5.8	7.0	6.9	12.6	4.7	5.2	7.1	4.2	12.8	16.5	11.0	8.0	7.9	7.1	6.1	6.8	8.8	9.8	7.0	9.1	2.9	4.9	9.2	5.7	7.7	8.0	5.5	6.9	11.0	8.5	7.8	4.8	6.3	17.5	5.3	18.0	7.1	7.0	10.4	4.9	8.7	7.1	10.2	5.2	5.3	11.6	5.7	9.2	10.2	16.7	3.4	3.4	5.2	20.8	13.6	7.2	14.4	8.1	8.8	15.1	6.1	0.1	2.8	4.8	4.1	2.6	1.5	1.9	2.8	4.7	3.3	3.6	2.9	3.0	4.2	3.3	6.4	2.5	2.6	0.7	10.7	10.7	21.3	8.2	9.6	5.9	13.5	5.8	8.9	12.0	0.0	1.4	5.4	5.2	4.4	5.7	5.6	10.2	0.0	4.5	3.5	15.7	10.2	3.3	5.6	17.3	6.0	5.5	0.0	6.4	8.8	4.6	3.8	4.6	5.0	6.8	6.4	3.5	0.6	4.3	5.3	7.2	4.1	3.3	6.4	7.2	4.4	4.8	0.0	3.5	4.9	6.5	0.0	4.7	5.4	5.7	5.9	5.6	4.9	7.5	7.0
SPATS2L	"DNAPTP6, SGNP"	ENSG00000196141	"Spermatogenesis associated serine rich 2 like"	Q9NUQ6	2	200305881-200482263	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055427, HPA066310"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA055427: AB_2682813, HPA066310: AB_2685655"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (3.95e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.99e-1)"	25.0	13.5	22.4	14.3	20.1	4.2	46.1	15.7	25.7	33.1	34.5	14.5	27.2	34.3	20.4	20.7	28.0	34.8	46.9	46.4	18.4	18.8	37.7	44.9	22.4	14.7	21.9	20.9	30.0	24.3	17.1	24.7	26.9	20.3	27.3	34.6	14.9	63.4	28.8	26.5	15.6	44.6	20.6	23.4	22.1	42.2	11.5	16.7	14.3	21.6	17.5	12.3	25.4	46.5	2.2	9.8	22.9	3.3	4.2	17.0	1.6	27.3	15.8	18.6	2.3	12.5	16.0	6.9	49.0	16.4	31.9	23.9	42.6	30.1	0.1	11.3	31.1	17.4	27.1	5.6	28.6	21.0	16.4	7.8	0.2	14.4	51.1	22.5	4.7	2.1	19.6	28.5	21.3	20.4	22.7	12.4	3.4	6.3	19.7	42.4	8.4	0.7	1.3	4.5	48.8	36.4	0.1	66.3	1.9	76.9	22.4	0.5	5.3	12.7	7.1	19.9	27.6	3.8	6.5	20.5	21.2	21.4	6.6	27.9	5.8	5.6	0.3	18.1	2.2	29.8	22.9	3.1	4.2	3.6	3.3	8.3	1.6	3.9	3.6	9.8	2.2	1.7	2.0	3.1	4.2	2.5	7.6	17.0	1.6	22.4	20.1	15.7	25.7	18.4	18.8	21.9	20.9	20.3	16.7	80.4	19.2	18.1	208.3	80.9	13.9	110.0	359.2	145.9	56.9	164.0	11.8	13.7	94.5	137.6	58.2	54.0	166.5	0.0	128.0	30.2	94.6	270.0	56.4	183.0	67.0	57.2	52.9	86.5	88.0	14.5	153.4	70.0	121.4	18.0	201.8	6.1	152.6	164.9	133.7	331.2	48.9	77.6	97.1	16.5	78.7	68.1	8.2	19.2	64.2	162.6
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24, NDC80 kinetochore complex component"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.0"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			Nucleoplasm	Nucleoli	"HPA051234: AB_2681397"	"unprognostic (1.57e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	2.8	3.2	1.1	9.0	1.0	19.4	3.8	0.4	1.9	2.8	4.0	0.8	0.9	3.5	2.2	2.8	8.4	1.4	2.4	8.2	1.0	0.4	1.8	2.6	4.2	4.9	0.6	1.0	1.1	1.0	0.1	1.0	5.9	0.6	1.4	3.5	0.8	2.4	1.5	2.7	3.2	4.4	6.7	0.7	5.5	4.0	13.3	0.7	58.0	0.9	12.8	12.2	2.3	3.2	1.9	1.3	7.2	1.4	4.2	3.7	0.7	26.2	9.9	13.7	11.1	1.9	3.6	6.2	15.4	5.7	14.6	16.6	10.4	9.0	20.8	17.6	6.8	8.5	14.3	10.6	11.0	10.8	11.0	9.1	28.0	23.0	15.4	0.4	19.6	12.5	0.7	0.4	10.4	4.8	3.8	12.8	23.0	14.9	43.9	10.1	17.3	26.7	11.9	9.6	7.3	16.0	21.4	21.0	6.7	4.3	8.7	14.3	10.3	13.5	8.4	3.6	6.8	8.3	7.1	12.1	13.8	14.7	18.5	18.4	26.8	13.8	20.0	10.2	19.4	11.2	4.1	1.4	1.5	1.4	1.2	1.2	1.9	2.3	3.4	0.5	1.9	2.7	1.7	7.2	4.2	1.3	1.3	3.7	0.7	1.1	1.0	0.4	1.9	1.0	0.4	0.6	1.0	0.6	0.7	0.0	0.3	0.0	0.8	1.0	0.0	7.0	2.5	0.0	1.2	5.2	5.9	3.0	0.0	0.2	0.1	0.1	0.7	70.0	0.0	13.5	4.0	0.3	5.7	0.0	11.2	0.0	2.4	2.5	2.8	1.7	0.6	1.3	0.0	0.0	1.1	0.9	0.2	0.0	0.4	0.4	0.3	0.0	0.3	6.5	10.1	0.3	1.7	2.2	2.9	0.4
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 55.8;salivary gland: 98.0"	"Group enriched"	"Detected in many"	6	"Glandular cells: 80.8;Mucus-secreting cells: 228.3"	"Group enriched"	"Detected in many"	10	"breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 68.7;OE19: 28.3;SK-BR-3: 47.5;T-47d: 38.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055707			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA055707: AB_2682894"	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.4	2.4	0.2	0.0	28.5	0.3	0.7	12.0	6.5	0.2	0.3	4.4	4.0	0.3	0.9	2.4	16.1	0.1	0.4	0.3	0.1	0.1	5.5	0.1	0.3	0.1	0.6	1.3	0.0	0.1	0.2	0.1	55.8	4.0	0.2	98.0	4.5	0.1	3.0	7.8	0.1	0.1	0.1	10.8	0.1	0.1	0.2	0.1	7.8	22.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.7	0.0	0.1	0.0	28.3	9.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	47.5	0.0	0.0	38.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.7	0.4	0.3	0.3	0.1	0.1	0.1	0.0	2.1	0.0	12.1	0.1	0.0	0.1	2.5	0.0	3.4	0.0	0.0	0.0	0.0	3.2	1.1	0.0	8.1	0.0	1.1	0.0	0.0	80.8	0.0	0.0	0.0	0.0	5.2	0.6	0.0	2.9	0.0	0.0	3.3	0.0	228.3	0.0	12.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	26.3	9.7
SPIN4	"FLJ44984, TDRD28"	ENSG00000186767	"Spindlin family member 4"	Q56A73	X	63347228-63351344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 27.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA044559	Uncertain		Approved	Nucleoli,Cytosol		NA	Yes			Cytosol	Nucleoli	"HPA044559: AB_10794171"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.22e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.44e-3)"	"unprognostic (8.62e-2)"	"unprognostic (3.65e-3)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (1.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.09e-2)"	3.9	3.2	4.2	5.1	4.4	13.8	13.7	2.3	5.4	5.1	5.9	6.7	2.0	3.5	6.7	4.7	16.8	3.9	3.5	3.2	4.7	6.1	3.3	2.4	16.8	7.6	4.5	2.3	6.6	4.2	4.8	4.7	12.3	5.2	7.2	6.9	4.8	27.4	2.9	1.2	3.5	4.9	5.8	5.2	5.9	3.9	3.4	3.5	11.2	5.6	6.4	11.8	4.3	8.2	1.2	1.4	3.7	2.1	6.0	1.5	0.8	16.0	4.1	9.6	7.8	2.1	3.0	6.9	8.0	3.4	4.7	5.7	2.7	16.0	0.0	3.5	3.7	5.4	5.4	12.3	5.8	8.6	6.9	3.9	20.6	5.5	2.5	0.9	17.8	16.1	1.4	2.0	7.8	4.2	2.3	5.1	3.6	6.2	20.1	10.7	5.4	5.9	9.6	9.9	2.6	6.0	8.3	20.7	4.4	3.4	4.3	0.0	5.3	14.4	4.2	1.5	20.8	9.1	8.5	2.2	9.5	10.7	15.7	5.0	4.4	5.1	10.6	5.0	14.7	5.6	1.7	1.8	3.7	1.5	2.1	0.7	1.2	0.8	0.9	1.4	1.1	0.5	1.0	0.0	6.0	1.7	0.0	0.5	0.8	4.2	4.4	2.3	5.4	4.7	6.1	4.5	2.3	5.2	3.5	0.0	1.3	0.5	1.3	3.0	5.2	1.2	0.0	4.0	2.3	3.5	2.0	5.5	1.7	0.6	0.0	2.7	1.7	0.0	1.2	5.8	3.1	2.6	9.2	0.8	2.2	1.6	6.4	8.6	1.3	0.0	2.8	1.7	5.0	0.0	7.2	1.2	1.3	7.0	3.2	1.0	2.4	0.0	1.6	0.0	0.2	5.5	2.7	3.2	6.0	4.7
SPRY3	HSPRY3	ENSG00000168939	"Sprouty RTK signaling antagonist 3"	O43610	X	155767812-155782459	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.5"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 3.5;Cone photoreceptor cells: 3.9"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.6;EFO-21: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013505	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB013505: "	"unprognostic (3.70e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.52e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.49e-2)"	1.6	2.1	1.3	0.4	1.8	2.8	1.2	7.5	1.5	1.3	0.8			1.2	1.5	5.8	0.8	1.1	0.8	0.9	1.3	1.5	0.9	0.7	0.9	0.3	1.1		2.8	0.4	1.3	1.1	1.9		0.9	1.4		1.1	1.2	1.2	0.4	1.1	1.2	1.2	1.4	0.7	0.1			1.0		0.5	0.8	0.7	0.0	0.5	0.4	0.5	0.2	0.2	0.0	0.5	0.2	2.4	8.6	1.7	0.8	0.0	2.0	1.3	0.6	1.0	0.2	1.4	0.0	4.2	1.1	1.6	0.3	0.9	0.6	0.6	0.2	0.4	1.0	2.2	0.1	0.7	0.4	0.4	2.1	1.1	0.8	0.5	0.8	1.3	0.5	0.1	0.6	1.6	0.3	0.2	0.3	0.8	0.2	0.0	0.5	0.2	2.1	0.9	0.8	0.6	0.6	1.0	0.0	0.5	1.2	0.5	0.6	2.2	0.6	0.9	0.3	0.6	0.7	0.1	1.9	2.1	1.0	1.2	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.5	0.0	0.0											0.0	0.0	0.0	0.1	0.1	3.5	0.8	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.9	1.1	0.0	0.6	0.1	0.4	0.1	0.0	0.8	0.3	0.0	0.0	1.3	0.6	0.0	0.9	0.1	1.7	0.0	1.0	0.8	0.5	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.1
SPTBN4	"KIAA1642, SPTBN3"	ENSG00000160460	"Spectrin beta, non-erythrocytic 4"	Q9H254	19	40466241-40576464	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 36.3"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 55.4;Cone photoreceptor cells: 53.0;Horizontal cells: 69.9;Rod photoreceptor cells: 67.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 3.5;Karpas-707: 5.1;SCLC-21H: 8.0;SH-SY5Y: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054481	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA054481: AB_2682502"	"unprognostic (1.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.65e-4)"	"unprognostic (3.72e-4)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.02e-1)"	3.1	5.9	13.4	1.2	15.3	1.2	1.2	36.3	27.1	1.4	1.3	1.8	0.0	1.7	2.3	1.3	1.6	2.0	1.8	3.3	9.8	10.8	1.9	1.3	1.2	1.0	7.5	13.0	4.1	3.0	3.3	8.0	1.0	10.4	2.8	1.1	2.6	2.2	2.0	5.1	1.3	1.5	1.8	2.8	1.3	2.5	3.5	3.7	0.0	1.6	0.0	1.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	2.3	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	2.4	0.5	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.3	3.5	5.1	0.0	1.3	0.0	0.0	0.2	0.3	0.9	0.5	0.0	1.1	0.0	0.0	8.0	4.9	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	1.5	0.8	0.0	0.2	0.3	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.3	36.3	22.7	9.8	10.8	7.5	13.0	10.4	3.7	0.0	0.0	0.0	0.1	0.1	55.4	4.4	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.2	69.9	15.6	0.6	0.3	0.9	7.5	0.0	1.7	1.0	0.3	4.7	0.2	0.0	6.7	1.4	67.0	0.0	0.9	3.2	4.6	0.4	0.0	0.0	0.2	0.1
SPTY2D1	"DKFZp686I068, FLJ39441, Spt2"	ENSG00000179119	"SPT2 chromatin protein domain containing 1"	Q68D10	11	18606401-18634791	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039372, HPA040177, HPA047957"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-1)"	14.0	12.7	6.2	9.7	9.2	33.6	11.9	10.9	10.9	13.7	10.9	6.9	9.9	8.3	11.9	8.6	15.5	12.5	12.2	9.9	5.8	6.5	14.9	25.1	9.7	8.7	6.0	6.8	16.7	16.9	13.6	14.0	15.3	8.5	12.5	9.7	7.9	13.3	13.9	16.3	12.5	13.7	9.3	7.6	15.0	11.0	7.1	5.5	17.7	12.8	8.0	13.3	12.5	11.8	2.7	3.4	7.8	5.7	7.3	8.7	3.3	8.2	8.1	6.5	9.1	10.9	11.4	10.0	12.2	13.4	10.2	12.3	7.2	3.6	18.5	6.9	11.5	8.0	8.6	10.8	9.6	14.7	9.7	10.1	7.4	4.9	6.6	10.5	15.6	14.8	9.4	10.0	6.5	13.3	7.4	11.2	11.1	10.3	29.5	11.3	8.9	10.4	6.2	5.9	16.2	9.1	9.6	18.1	7.9	10.7	11.9	6.3	8.9	10.9	12.7	8.5	8.9	7.9	6.7	9.8	10.0	8.5	19.4	7.4	10.3	12.7	14.5	11.9	8.7	8.4	7.8	4.1	5.8	5.7	5.7	8.7	2.6	5.6	5.7	3.4	2.7	5.2	5.6	6.0	7.3	5.4	2.9	6.0	3.3	6.2	9.2	10.9	10.9	5.8	6.5	6.0	6.8	8.5	5.5	23.8	45.0	23.8	18.6	49.6	12.8	23.6	12.7	61.6	34.2	26.2	9.8	12.3	14.9	21.5	1.6	21.9	22.7	0.0	21.7	19.7	31.0	20.1	56.6	25.6	14.3	11.1	42.5	21.5	27.0	1.7	17.5	31.7	15.1	13.6	24.2	13.8	21.6	22.1	13.1	12.6	11.2	32.3	23.0	10.7	14.2	58.1	23.0	35.5	18.6	29.3
SREK1IP1	"FLJ36754, P18SRP, SFRS12IP1"	ENSG00000153006	"SREK1 interacting protein 1"	Q8N9Q2	5	64718144-64768685	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 266.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045677, HPA062853"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045677: AB_10964635, HPA062853: AB_2684881"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.60e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.99e-1)"	16.3	12.1	12.2	10.9	16.5	8.3	13.8	13.9	12.8	17.0	16.1	4.1	10.8	8.6	12.5	12.4	25.3	10.8	11.6	13.1	12.3	10.7	18.0	13.1	13.2	12.1	10.6	9.5	14.6	11.7	10.8	20.5	20.2	11.9	15.5	10.4	4.7	10.3	15.0	15.7	18.7	15.2	12.6	15.5	19.0	10.9	11.7	11.5	19.2	13.9	17.9	12.3	24.1	14.6	4.0	8.2	3.8	4.1	4.1	4.7	2.1	7.0	3.6	9.2	7.0	8.3	13.7	5.5	10.7	8.6	7.3	9.8	6.7	7.7	7.3	11.0	8.5	7.0	4.6	8.3	16.1	12.9	8.7	10.1	8.0	6.7	5.9	8.5	8.5	8.1	9.0	15.3	10.2	13.3	7.8	10.8	9.2	7.0	4.5	8.6	2.5	15.1	8.6	4.7	1.9	4.9	7.3	7.5	11.6	12.5	5.6	4.0	5.9	6.7	4.8	10.2	6.7	6.1	16.5	10.9	5.4	3.2	6.4	11.0	6.7	11.3	6.5	10.2	13.4	7.2	3.8	4.1	1.7	4.5	3.0	4.7	3.9	4.6	4.2	3.4	4.0	4.5	4.7	1.6	4.1	1.9	8.2	4.0	2.1	12.2	16.5	13.9	12.8	12.3	10.7	10.6	9.5	11.9	11.5	44.7	36.1	35.8	47.3	72.7	50.8	26.2	76.5	41.5	43.3	82.0	29.5	62.3	76.3	67.8	266.8	54.7	61.7	46.7	64.6	64.7	50.4	43.7	52.0	85.5	55.9	92.2	58.6	78.5	70.9	129.9	88.6	70.4	37.1	46.9	60.5	43.1	140.5	64.5	68.2	63.3	36.0	64.7	57.4	32.7	40.7	90.8	40.7	54.9	45.7	82.3
SRP14	"ALURBP, MGC14326"	ENSG00000140319	"Signal recognition particle 14"	P37108	15	40035739-40039188	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053738, HPA065118"			Approved	Nucleoplasm,Nucleoli		NA	NA		400000	Nucleoli	Nucleoplasm	"HPA053738: , HPA065118: "	"unprognostic (2.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (2.20e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.41e-3)"	"unprognostic (4.94e-2)"	63.0	81.2	100.0	46.0	102.8	85.9	75.4	65.4	91.3	87.8	62.6	67.9	54.7	50.7	83.0	115.7	75.6	87.8	64.2	114.2	80.7	95.4	107.2	79.6	52.2	60.8	103.5	86.3	99.1	59.1	69.6	82.3	68.8	84.3	84.1	65.0	61.0	71.3	66.4	107.5	44.4	65.7	67.2	86.5	67.5	56.0	43.4	68.9	58.7	98.9	56.6	65.0	80.9	72.7	78.7	151.5	111.2	69.3	63.6	96.4	135.1	24.2	30.4	73.8	55.1	55.3	50.1	36.0	44.7	47.4	38.8	39.9	54.7	20.8	20.4	46.6	54.2	62.1	39.3	58.6	46.5	36.8	48.6	41.9	48.6	97.1	64.0	42.4	43.2	39.7	52.1	53.3	32.1	39.4	73.9	65.2	55.9	50.8	37.4	62.0	36.8	63.8	51.0	40.2	94.1	55.2	43.9	33.7	34.3	83.7	72.4	53.8	48.0	45.1	44.8	29.3	47.6	61.6	80.2	56.1	45.2	30.7	42.6	32.6	30.5	85.1	50.5	43.9	47.2	41.8	76.2	69.3	111.2	68.5	62.5	66.4	78.7	77.7	76.3	74.5	66.1	75.4	72.8	60.7	63.6	56.5	151.5	96.4	135.1	100.0	102.8	65.4	91.3	80.7	95.4	103.5	86.3	84.3	68.9	428.8	342.1	635.3	745.6	592.5	436.3	765.2	639.5	717.4	483.4	943.9	117.8	766.6	2161.9	1141.2	204.6	898.5	667.3	467.2	948.8	912.5	754.8	783.4	543.5	639.1	894.6	328.9	532.2	609.5	565.3	236.1	962.8	751.5	749.0	1439.1	546.1	918.4	1056.2	782.0	927.8	1642.5	369.6	614.4	716.0	645.9	602.6	620.9	634.6	518.4	577.5	829.8
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029567	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Hydrolase, Ribonucleoprotein, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 276.0;Late spermatids: 646.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA048977: AB_2680583, HPA062044: AB_2684668"	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	18.4	27.5	18.6	21.3	21.0	13.6	22.5	18.2	26.0	24.6	19.2	23.2	31.2	19.3	24.1	25.5	22.6	18.0	17.1	21.8	18.7	22.5	34.4	67.8	19.4	24.0	23.7	17.1	21.1	43.2	30.1	47.1	26.4	29.4	23.2	21.7	19.2	48.1	31.2	28.4	19.6	24.4	20.0	22.3	23.5	22.3	30.8	19.4	32.3	23.6	22.5	27.9	23.9	17.6	20.5	23.4	26.3	30.1	29.5	33.4	19.7	20.7	22.5	21.6	20.2	22.3	23.0	25.9	29.8	27.1	30.8	39.5	27.0	23.3	30.3	30.4	28.4	28.5	21.9	29.5	23.4	44.8	30.1	14.8	24.5	21.4	63.3	34.6	26.2	24.8	19.2	23.1	22.7	40.4	24.0	31.0	24.4	21.7	33.2	32.0	34.5	27.9	14.7	16.5	34.4	21.8	22.3	26.4	24.2	36.7	31.8	20.5	22.0	21.4	27.7	27.1	27.5	36.8	18.2	23.5	18.8	20.2	22.3	20.5	28.8	38.6	37.9	13.4	16.9	22.4	15.9	19.8	26.3	23.6	24.0	29.3	20.5	23.6	26.0	23.4	18.6	22.3	21.7	19.3	29.5	30.1	16.0	33.4	19.7	18.6	21.0	18.2	26.0	18.7	22.5	23.7	17.1	29.4	19.4	11.9	36.4	40.4	46.3	35.5	36.9	37.2	33.1	69.6	51.2	38.4	55.0	59.6	54.7	58.2	276.0	33.1	35.1	0.0	69.6	58.9	47.2	64.3	46.2	104.3	43.9	25.4	43.1	39.9	42.5	646.5	35.6	43.2	27.0	55.1	39.6	44.1	49.6	29.4	35.3	59.6	42.9	25.8	33.7	79.0	57.0	44.0	78.6	47.1	27.0	51.8
SRSF9	"SFRS9, SRp30c"	ENSG00000111786	"Serine and arginine rich splicing factor 9"	Q13242	12	120461668-120469793	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049849	Supported		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA049849: AB_2680911"	"unprognostic (3.80e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.50e-3)"	"prognostic unfavorable (9.85e-7)"	"unprognostic (9.65e-3)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	25.8	50.7	29.5	37.9	28.5	33.8	31.2	24.9	30.6	31.5	36.4	21.7	35.5	29.8	26.7	37.4	53.6	32.6	42.3	20.7	26.7	27.9	37.2	42.5	27.2	41.4	31.6	25.3	37.1	68.5	34.9	36.5	49.3	27.9	33.1	35.8	29.3	33.9	30.4	17.0	32.4	31.0	25.1	23.8	39.6	33.0	52.5	25.0	53.1	43.7	36.8	51.0	26.5	35.7	22.1	18.7	28.8	15.4	15.7	14.8	5.1	55.7	39.0	59.9	38.5	27.4	27.6	64.1	38.3	34.5	49.3	42.4	46.8	26.3	54.4	44.9	32.1	26.8	33.4	53.9	54.5	54.4	40.7	55.4	46.4	26.2	45.6	35.4	57.1	42.4	29.1	35.2	42.8	37.3	52.9	44.8	35.6	58.2	16.5	42.3	78.0	56.3	111.5	75.0	37.9	34.1	62.9	25.1	52.5	42.6	71.2	53.2	38.0	44.9	23.9	44.3	40.8	72.1	50.4	39.0	36.7	43.5	27.5	41.4	50.7	38.0	68.0	38.6	43.1	38.2	12.3	10.7	28.8	14.8	11.7	11.2	22.1	11.7	13.0	13.9	17.7	11.5	12.8	12.2	15.7	15.4	18.7	11.9	5.1	29.5	28.5	24.9	30.6	26.7	27.9	31.6	25.3	27.9	25.0	23.8	30.4	155.5	203.9	235.3	77.2	1.3	147.7	20.1	26.1	153.5	27.5	301.6	414.4	172.1	51.9	119.1	86.4	23.3	135.5	354.8	182.5	290.8	33.4	118.4	178.0	68.3	138.9	108.1	103.3	17.4	115.3	184.7	190.6	190.2	126.0	96.8	139.8	80.7	145.6	272.7	44.3	51.8	162.7	260.2	249.1	273.9	397.6	97.9	129.8	332.4
SSX1	CT5.1	ENSG00000126752	"SSX family member 1"	Q16384	X	48255317-48267444	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 12.6"	"Group enriched"	"Detected in some"	12	"Sertoli cells: 6.5;Spermatocytes: 9.8;Spermatogonia: 22.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;Karpas-707: 41.8;U-2197: 9.7"									HPA045683	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"					"unprognostic (2.25e-1)"		"unprognostic (3.51e-3)"		"unprognostic (2.36e-1)"	"unprognostic (4.32e-3)"				"unprognostic (3.38e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.94e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.7	0.0	0.0	2.0	0.0	2.4	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	9.8	22.6	0.0	0.0	0.0	0.0	0.0
SSX2	"CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX"	ENSG00000241476	"SSX family member 2"	Q16385	X	52696896-52707189	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	57	"testis: 24.1"	"Cell type enriched"	"Detected in single"	28	"Spermatogonia: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 3.2;U-2197: 1.9"									"HPA045683, CAB046020"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB046020: AB_2194010, HPA045683: AB_2679418"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1			0.4		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.6	0.1	0.6	1.9	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0
SSX2B	CT5.2b	ENSG00000268447	"SSX family member 2B"	Q16385	X	52751132-52790305	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 13.5"	"Cell type enriched"	"Detected in single"	10	"Spermatogonia: 4.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;HMC-1: 5.4;PC-3: 5.2;T-47d: 2.3;U-2197: 3.3"									HPA045683	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.9	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.6	0.5	0.1	0.0	0.0	0.2	0.0	5.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	2.3	0.0	1.0	0.0	0.5	3.3	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.4	0.0	0.0	0.0	0.0	0.0
SSX3	CT5.3	ENSG00000165584	"SSX family member 3"	Q99909	X	48346428-48356707	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 18.0"	"Cell type enriched"	"Detected in some"	9	"Spermatogonia: 144.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"Karpas-707: 6.9"									HPA045683	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"															"unprognostic (1.86e-1)"	"unprognostic (2.13e-2)"		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.2	0.4	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.0	1.6	0.5	0.2	0.2	0.0	0.0	1.6	0.2	0.8	0.3	0.1	0.2	0.8	0.3	0.4	0.0	0.9	0.4	0.4	0.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.7	144.8	0.0	0.0	0.0	0.0	0.0
SSX4	CT5.4	ENSG00000268009	"SSX family member 4"	O60224	X	48383516-48393347	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5"									HPA045683	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.8	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.2	9.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX4B	OTTHUMT00000056510	ENSG00000269791	"SSX family member 4B"	O60224	X	48402078-48411910	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5"									HPA045683	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.4	0.0	0.3			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	6.7			0.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.8	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.2	9.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX5		ENSG00000165583	"SSX family member 5"	O60225	X	48186220-48196763	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 4.3;thyroid gland: 2.9"	"Cell type enriched"	"Detected in single"	14	"Spermatogonia: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BEWO: 10.8"									HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"									"unprognostic (1.20e-1)"						"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"		0.4	0.0	0.1	0.1	0.4	1.0	0.1	0.1	0.1	0.1	1.2	0.1	0.1	0.0	0.5	0.2	0.1	0.8	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.3	0.1	1.6	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.6	0.2	0.1	0.1	0.8	0.0	4.3	0.1	0.1	2.9	0.1	0.1	0.1	0.1	0.5	0.2	0.9	0.2	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.7	1.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.4	0.3	0.4	0.1	0.5	0.1	0.4	0.9	0.6	0.0	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0
SSX7		ENSG00000187754	"SSX family member 7"	Q7RTT5	X	52644090-52654900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 1.7;HMC-1: 8.1;RT4: 4.3"									HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																"unprognostic (1.29e-1)"		0.1	0.2	0.2	0.4	0.1	0.7	0.1	0.1	1.0	0.1	0.2			0.6	0.2	0.0	1.5	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.5	0.3	0.1		0.8	0.1	0.0	0.1	0.0		0.1	0.0		1.8	0.0	0.1	1.5	0.1	0.0	0.1	0.6	0.4	1.0			0.4		0.0	0.2	0.1	0.0	0.2	1.0	0.7	0.3	0.4	0.0	0.4	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.1	0.6	0.3	1.7	0.7	0.3	0.0	0.0	8.1	0.0	0.2	0.2	0.0	0.3	0.1	0.4	0.2	1.4	0.1	1.0	0.7	0.2	0.0	0.2	0.0	0.4	0.5	0.0	0.0	4.3	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.3	0.1	0.0	0.0	0.3	0.4	0.6	0.1	0.0	0.1	0.1	0.1	0.5	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.0	0.3	0.7	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
STAG3		ENSG00000066923	"Stromal antigen 3"	Q9UJ98	7	100177563-100221488	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Chromosome partition, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 85.4"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 79.6;Spermatocytes: 87.4;Spermatogonia: 38.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"memory B-cell: 4.8;naive B-cell: 7.6"	"Lineage enriched"	"Detected in single"	10	"B-cells: 7.6"	"Group enriched"	"Detected in some"	6	"BEWO: 27.0;HMC-1: 34.2;U-698: 9.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA049106, HPA058330"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA049106: AB_2680634, HPA058330: AB_2683681"	"unprognostic (6.56e-4)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.31e-4)"	"unprognostic (4.26e-4)"	"unprognostic (7.48e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.07e-4)"	0.4	0.7	0.4	0.9	1.0	0.3	0.2	0.6	3.8	0.3	0.3	1.1	0.5	0.1	0.5	0.4	0.3	7.8	0.4	0.5	0.6	0.2	0.2	3.9	0.3	1.2	0.5	0.6	0.4	1.4	0.0	0.2	0.4	0.5	0.3	0.2	0.5	0.2	0.5	4.1	0.5	2.2	0.4	0.7	5.1	0.1	85.4	0.8	0.7	0.3	0.2	1.6	0.3	0.2	7.6	0.5	0.2	0.7	0.2	0.5	0.3	0.0	2.0	0.8	0.1	0.1	0.0	27.0	1.4	0.0	0.1	0.1	0.0	0.0	0.9	0.2	0.3	0.0	0.0	0.0	0.1	0.0	3.8	0.4	0.0	0.0	0.6	0.0	0.0	34.2	0.0	0.0	0.6	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.5	1.6	0.1	0.8	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.5	1.5	0.6	0.4	0.0	0.4	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	9.8	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.1	4.8	0.2	0.5	0.5	7.6	0.4	0.3	0.2	0.2	0.3	0.1	0.0	0.3	0.4	1.0	0.6	0.7	0.6	0.2	0.5	0.6	0.5	0.8	0.0	2.4	79.6	8.0	6.1	7.0	1.8	2.5	14.7	1.2	7.0	2.0	1.7	11.6	0.1	19.3	2.9	1.1	0.0	0.2	2.7	3.3	7.0	1.1	22.9	2.1	19.1	1.2	3.7	2.1	18.4	4.4	4.8	5.0	4.6	4.1	3.2	0.2	0.0	1.8	3.4	7.3	0.0	7.5	87.4	38.7	7.4	2.4	10.4	1.6	9.6
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Predicted membrane proteins"	"Apoptosis, Cell cycle, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 82.3;parathyroid gland: 47.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 30.8;Exocrine glandular cells: 31.3;Hepatocytes: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.1;U-87 MG: 46.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol		NA	NA		28000	Cytosol	Nucleoli	"HPA050510: AB_2681151"	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"	8.1	2.8	2.5	1.2	4.2	5.1	9.2	3.0	2.2	6.4	6.1	3.0	3.7	7.9	1.3	3.1	5.1	4.0	2.8	6.6	2.9	1.4	3.4	82.3	3.9	4.9	3.9	0.4	5.2	9.0	47.4	5.1	4.3	6.1	4.8	2.4	2.1	12.6	9.1	10.9	3.0	9.8	0.9	6.4	1.0	6.7	1.5	3.2	0.2	3.3	6.9	4.0	4.2	3.7	0.8	7.0	0.7	4.3	2.1	0.2	1.5	6.4	7.7	0.0	2.6	3.8	36.1	6.8	2.0	2.2	4.1	3.7	5.8	8.8	0.0	15.6	11.6	29.3	10.9	3.4	6.8	4.6	0.0	11.0	12.5	7.0	11.5	9.5	3.1	2.4	21.4	12.0	24.2	8.7	28.1	3.5	0.0	6.1	1.3	11.5	6.1	0.0	1.8	10.6	9.9	16.1	0.0	4.5	5.5	5.0	16.3	13.0	2.4	5.7	19.8	1.5	1.6	3.9	4.1	15.0	25.5	14.9	5.4	11.1	0.0	0.0	0.0	46.7	7.9	5.2	0.0	4.0	0.7	0.2	4.3	0.0	0.8	0.0	0.0	7.0	0.2	0.0	0.0	0.1	2.1	0.6	0.3	0.0	1.5	2.5	4.2	3.0	2.2	2.9	1.4	3.9	0.4	6.1	3.2	0.0	6.4	0.5	6.8	1.8	0.1	5.5	5.1	30.8	10.3	0.0	0.0	25.8	0.0	7.9	0.2	2.9	10.9	0.0	31.3	3.0	4.3	4.8	3.5	86.3	11.1	0.0	1.7	0.6	3.8	0.0	1.7	6.4	0.0	0.0	4.6	0.0	17.9	7.8	7.1	0.5	0.0	6.5	2.1	0.2	0.0	1.3	19.8	0.0	9.1	8.1
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol		No	No		2800000	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavorable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favorable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	28.6	14.2	15.0	29.7	16.9	19.1	34.8	12.2	21.0	36.3	37.4	12.1	23.0	31.9	24.6	26.5	68.4	20.4	41.3	30.0	14.7	12.8	30.5	14.2	23.9	31.2	10.6	10.1	20.0	20.6	12.4	13.9	38.4	14.7	28.3	28.8	36.8	30.8	21.6	18.8	60.6	67.9	34.8	9.2	31.7	30.2	22.1	7.6	38.2	28.2	41.6	48.5	39.2	45.4	8.1	11.2	11.4	13.4	1.5	13.7	6.7	36.0	11.3	20.0	18.5	30.8	18.5	28.5	16.9	23.8	23.7	23.2	33.0	49.1	25.7	8.6	21.1	14.9	32.7	18.5	37.3	22.7	64.1	9.5	27.5	14.4	18.9	43.6	27.6	19.5	11.9	59.6	18.6	54.9	25.1	20.4	20.3	9.9	17.8	15.5	15.7	20.6	11.4	17.9	49.1	8.5	26.1	12.3	13.9	22.9	32.6	11.7	16.8	10.7	17.3	22.8	31.9	20.8	26.9	27.4	15.1	11.0	12.3	19.4	17.4	9.1	9.6	23.5	16.7	24.8	5.8	13.4	6.1	6.1	10.6	7.2	6.6	11.4	8.7	11.2	8.1	7.8	6.1	11.4	1.5	12.7	7.5	13.7	6.7	15.0	16.9	12.2	21.0	14.7	12.8	10.6	10.1	14.7	7.6	11.9	24.3	29.0	62.3	63.0	20.3	2.8	68.8	34.8	44.3	64.6	53.0	35.6	21.6	29.9	2.5	26.3	110.9	0.0	47.8	36.3	36.7	53.4	18.4	22.9	24.7	9.5	40.9	27.0	68.7	3.4	24.7	40.1	54.0	16.2	70.9	22.1	67.8	59.4	28.7	31.9	11.4	38.8	29.0	1.8	3.6	71.8	16.7	21.8	51.8	117.9
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 23.2;Proximal tubular cells: 20.1;Urothelial cells: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;intermediate monocyte: 3.6"	"Lineage enriched"	"Detected in single"	4	"monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"HEL: 43.7;HMC-1: 24.8;Karpas-707: 22.5;RT4: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003086	Enhanced		Approved	Nucleoli,Cytosol		NA	NA		9800	"Nucleoli, Cytosol"		"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	6.1	1.2	26.8	1.5	23.5	5.6	11.5	2.0	22.4	4.3	5.3	18.1	1.6	4.7	1.8	6.7	11.3	13.6	7.1	4.0	26.1	11.6	17.5	3.7	5.0	1.3	10.3	11.5	3.7	1.3	0.6	7.9	4.3	9.6	2.6	6.1	7.9	4.6	3.8	9.5	9.2	4.9	2.2	4.5	18.7	6.8	4.0	15.9	0.3	13.1	4.9	3.4	6.8	6.6	0.0	0.5	0.8	3.6	0.0	0.1	3.2	1.8	1.3	4.8	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.1	4.3	1.5	0.0	2.2	0.0	1.3	12.0	6.7	15.1	0.0	0.2	2.3	43.7	8.0	1.6	0.0	0.0	24.8	0.6	13.3	0.0	4.6	0.0	0.0	2.5	16.0	22.5	0.4	2.7	2.1	0.0	4.8	4.3	1.1	0.0	7.1	1.4	3.2	18.1	11.8	0.7	5.3	0.2	0.0	4.0	0.6	0.1	0.2	0.9	3.7	4.0	1.0	2.6	4.6	0.0	3.3	0.1	1.1	0.0	2.4	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	3.2	26.8	23.5	2.0	17.5	26.1	11.6	10.3	11.5	9.6	15.9	3.0	0.3	0.0	9.7	12.0	0.4	1.2	2.5	2.7	1.2	17.4	11.8	0.8	6.6	0.6	0.2	2.2	4.1	0.0	0.4	0.3	5.3	4.6	0.0	0.8	2.6	3.2	0.0	4.9	10.2	1.1	9.5	2.5	1.7	0.0	2.5	23.2	2.1	1.5	8.1	20.1	6.7	0.0	1.2	0.9	6.6	7.8	12.9	0.5	3.3	26.4
STX17	FLJ20651	ENSG00000136874	"Syntaxin 17"	P56962	9	99906633-99970341	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001204	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA001204: AB_1080118"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.62e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	15.1	15.8	13.5	16.4	16.3	13.6	16.1	10.8	17.8	19.4	18.5	14.2	29.3	13.4	21.7	25.2	19.9	12.0	14.9	14.5	13.8	13.2	14.3	26.0	13.2	11.9	15.4	14.2	18.2	17.8	25.5	37.1	17.6	14.1	18.2	14.6	16.3	20.6	28.7	28.5	20.6	18.9	20.4	19.1	13.3	15.0	12.0	10.4	17.0	21.8	18.3	15.9	18.8	17.8	7.4	4.9	15.5	8.1	14.3	10.4	4.5	10.7	9.8	10.0	12.0	11.4	11.6	19.9	8.2	12.2	9.3	8.0	12.2	14.4	21.0	8.2	8.7	15.0	12.3	8.3	11.5	7.5	18.3	6.8	13.5	12.9	7.4	13.3	19.8	4.9	11.4	13.4	10.0	15.2	9.8	10.8	18.2	18.7	11.7	7.0	13.1	11.8	5.4	8.8	14.0	7.9	10.1	17.7	9.6	12.3	12.5	5.8	10.3	16.6	12.7	8.1	6.7	12.6	5.5	8.5	6.2	8.8	10.0	6.6	16.6	20.2	4.2	8.7	8.3	6.7	15.5	4.2	7.3	7.4	4.5	10.3	7.4	9.1	8.2	4.9	5.9	10.4	9.8	4.3	14.3	8.1	3.1	4.9	4.5	13.5	16.3	10.8	17.8	13.8	13.2	15.4	14.2	14.1	10.4	14.9	21.7	14.5	18.1	9.4	14.0	16.9	10.2	24.1	22.7	22.7	19.6	20.4	24.9	15.8	40.4	13.7	9.7	0.0	17.1	15.8	11.1	23.3	25.4	23.1	9.2	9.5	24.2	20.9	8.3	24.8	23.9	15.1	8.5	27.1	15.7	20.3	14.1	15.9	17.0	15.7	12.9	38.8	13.9	25.9	16.6	10.7	22.9	16.6	13.1	12.9
SUB1	"p14, p15, PC4"	ENSG00000113387	"SUB1 homolog, transcriptional regulator"	P53999	5	32531633-32604079	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 165.5"	"Low region specificity"	"Detected in all"							"HPA001311, CAB015351"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB015351: AB_2197157, HPA001311: AB_1080123"	"unprognostic (5.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.25e-6)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.46e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.45e-1)"	54.4	40.8	64.1	50.9	69.8	87.6	52.3	28.2	82.4	48.9	44.4	21.5	23.2	36.2	36.8	36.3	52.7	27.4	31.3	46.9	79.3	53.5	54.7	60.7	36.3	58.4	45.8	57.5	30.7	26.9	26.5	49.0	47.0	51.6	34.5	46.0	17.4	32.3	29.1	39.6	26.8	47.5	33.2	39.6	67.2	38.7	28.1	29.8	72.4	42.2	54.2	54.6	39.8	29.7	61.1	69.4	92.0	24.6	25.9	59.5	49.2	22.1	18.3	36.4	34.1	22.2	39.5	22.9	38.7	28.2	35.1	32.4	26.5	35.0	11.2	27.0	26.7	35.9	15.1	30.5	31.7	47.3	46.8	28.1	37.7	44.7	50.2	31.5	65.6	51.6	27.6	27.5	37.2	26.7	19.4	26.2	43.1	43.7	165.5	30.9	19.7	61.9	104.8	24.0	26.3	37.6	27.5	47.6	71.7	34.8	20.1	19.8	16.4	60.0	28.3	27.5	24.0	31.3	61.0	27.1	38.0	41.3	32.0	29.1	64.8	111.6	19.6	35.0	71.3	23.1	92.0	23.9	54.9	31.5	24.6	28.4	61.1	41.4	41.2	46.8	35.1	32.9	37.6	29.2	25.9	21.9	69.4	59.5	49.2	64.1	69.8	28.2	82.4	79.3	53.5	45.8	57.5	51.6	29.8	134.0	164.3	396.8	516.1	519.5	114.4	178.2	247.1	151.3	121.7	294.8	41.2	431.0	855.4	544.4	65.7	278.7	291.1	256.9	284.6	652.5	391.4	435.3	302.3	359.4	432.3	81.0	269.9	203.1	322.6	51.2	222.1	419.5	501.0	571.7	258.1	146.4	357.5	396.3	323.9	714.8	66.1	200.5	303.1	377.2	414.8	494.2	699.8	467.7	329.5	537.0
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076002	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	23.5	13.4	24.6	14.3	23.4	27.7	14.7	14.0	33.7	18.0	16.6	19.5	15.3	10.0	13.9	14.7	22.1	9.9	18.0	19.2	25.3	26.9	22.3	21.0	11.5	8.6	32.2	22.6	6.6	15.9	14.6	21.2	21.0	35.8	16.9	18.2	7.7	14.5	11.7	40.9	13.0	12.8	22.2	36.1	7.7	14.0	10.3	20.7	4.1	18.2	16.6	14.8	16.4	11.0	1.3	3.0	7.9	4.6	0.5	2.3	0.8	20.6	5.4	8.3	12.1	24.0	22.5	13.8	49.1	20.8	20.0	20.3	8.6	4.7	7.9	18.8	32.6	11.9	8.7	14.6	17.7	30.2	13.5	3.3	7.9	13.2	8.9	19.0	13.9	12.1	20.0	21.3	33.5	18.3	10.8	17.1	7.3	15.1	7.7	27.0	11.9	7.3	3.8	16.6	9.6	11.3	5.7	15.0	3.1	23.6	18.0	8.7	10.8	24.1	15.6	17.7	15.5	5.3	9.9	22.3	33.1	12.6	23.3	26.8	9.4	23.7	10.6	35.2	7.4	49.1	2.6	4.6	3.7	1.7	3.3	1.5	1.2	1.1	1.7	1.5	1.3	1.1	1.6	7.9	0.5	2.8	3.0	2.3	0.8	24.6	23.4	14.0	33.7	25.3	26.9	32.2	22.6	35.8	20.7	17.9	21.1	8.2	9.3	62.4	4.5	57.2	10.2	16.0	26.1	7.0	0.0	15.5	11.6	14.4	29.0	19.7	31.6	23.3	18.1	26.6	20.6	18.8	13.9	35.8	16.4	6.4	30.6	24.5	29.7	2.9	8.6	18.4	13.5	12.6	26.1	10.8	24.9	20.1	12.0	26.2	7.5	6.5	26.2	9.8	15.7	72.0	45.9	7.7	10.5	25.9
TAF1B	"RAF1B, RAFI63, SL1, TAFI63"	ENSG00000115750	"TATA-box binding protein associated factor, RNA polymerase I subunit B"	Q53T94	2	9843354-9934416	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071254			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA071254: "	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (8.58e-5)"	"unprognostic (1.44e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (9.17e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-2)"	13.4	11.7	10.2	10.7	11.1	7.8	12.1	14.0	12.7	12.3	7.4	8.4	15.9	7.1	19.2	14.5	16.5	13.6	9.7	8.5	9.3	11.7	17.9	9.9	11.5	13.9	9.2	9.5	12.7	8.9	22.6	19.5	20.2	10.7	12.6	8.1	11.6	10.1	20.1	7.2	11.3	7.5	11.1	8.5	13.9	8.4	17.1	9.2	23.3	14.9	10.9	15.8	9.9	14.4	9.8	11.3	4.9	13.1	8.5	12.9	4.6	12.2	12.2	16.9	5.2	8.5	13.1	27.3	13.4	13.4	14.7	12.7	11.3	9.9	14.4	7.1	10.9	14.3	7.0	14.7	16.6	16.3	14.0	16.0	15.5	5.2	15.1	11.0	12.2	17.4	10.3	9.7	10.8	15.9	11.6	22.0	7.9	10.3	15.4	14.7	8.1	9.1	10.4	20.4	7.9	9.0	5.5	14.3	4.5	14.9	11.0	7.2	18.4	11.5	15.6	11.8	11.7	5.4	9.7	10.2	17.7	20.9	17.3	18.5	7.5	9.0	20.5	10.7	14.1	15.1	2.6	8.4	4.9	11.5	13.1	10.9	9.5	9.5	12.9	11.3	9.8	6.3	9.4	0.4	8.5	10.0	9.4	9.4	4.6	10.2	11.1	14.0	12.7	9.3	11.7	9.2	9.5	10.7	9.2	17.9	19.5	12.3	24.6	14.3	21.2	3.7	2.5	40.2	38.7	12.2	25.5	22.4	11.6	17.0	4.7	12.8	1.6	0.0	16.3	29.6	12.8	9.4	8.1	4.9	11.3	14.3	1.7	8.6	12.9	1.5	17.5	12.3	0.0	14.4	2.9	23.3	13.4	3.5	12.4	19.9	20.2	19.4	13.4	35.8	32.4	11.5	19.8	13.1	4.0	20.2
TANK	"I-TRAF, TRAF2"	ENSG00000136560	"TRAF family member associated NFKB activator"	Q92844	2	161136908-161236221	"Predicted intracellular proteins"	"DNA damage, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"monocytes: 219.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010345, HPA037675, HPA037676"	Approved		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB010345: AB_2199871, HPA037675: AB_2675600, HPA037676: AB_2675601"	"unprognostic (1.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.78e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.30e-2)"	35.9	23.6	17.2	32.0	21.1	43.0	34.2	17.7	16.8	19.6	22.3	11.7	18.0	15.8	20.6	21.8	23.2	20.9	25.1	18.4	16.2	17.2	22.7	37.2	35.4	28.8	20.1	12.7	19.7	15.4	17.0	33.3	41.7	18.2	26.0	21.5	15.7	21.9	15.5	49.5	21.4	22.6	32.2	21.3	42.1	18.2	13.5	19.1	29.2	29.0	25.1	29.0	37.3	38.6	22.4	20.7	54.0	27.9	13.3	28.1	14.7	12.1	7.7	10.2	11.6	29.9	39.5	14.7	17.4	27.5	12.7	19.3	9.5	15.9	17.3	12.7	20.7	8.7	8.7	6.3	13.6	19.3	39.9	6.6	9.3	7.5	24.2	24.4	15.4	10.4	31.6	21.9	19.3	15.1	22.4	32.6	9.9	9.3	22.7	24.4	9.2	9.2	15.5	5.9	13.0	7.0	5.4	15.1	11.2	28.8	19.8	8.7	10.2	11.3	13.4	18.8	15.1	5.6	18.9	34.3	16.1	9.8	8.1	10.4	15.4	14.2	26.2	21.3	12.2	12.2	28.1	21.6	26.4	12.1	25.1	18.5	22.1	19.5	17.5	20.7	22.4	12.9	13.2	54.0	13.3	27.9	12.1	28.1	14.7	17.2	21.1	17.7	16.8	16.2	17.2	20.1	12.7	18.2	19.1	53.6	61.0	77.0	96.8	53.1	31.6	23.2	20.4	58.9	56.9	43.6	11.8	35.7	51.4	53.0	11.7	37.9	37.3	23.3	35.6	75.1	64.1	65.4	57.8	52.3	41.5	20.6	45.5	25.8	73.5	7.0	48.9	97.6	69.2	219.2	26.2	31.1	45.1	43.2	24.8	37.4	33.3	25.8	47.6	43.1	31.7	53.2	112.8	82.3	27.5	129.1
TBCA		ENSG00000171530	"Tubulin folding cofactor A"	O75347	5	77691166-77868780	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 1097.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036487	Approved		Supported	Nucleoli,Microtubules		NA	NA		1000000	Microtubules	Nucleoli	"HPA036487: AB_10669794"	"unprognostic (2.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	40.5	77.3	50.0	32.5	66.7	41.2	108.9	46.8	86.9	33.0	35.7	22.1	34.1	31.8	37.5	78.5	44.4	43.0	27.1	76.7	69.2	56.5	57.7	85.1	59.8	69.6	51.0	50.8	62.3	80.7	24.0	57.9	36.7	77.9	39.1	33.2	30.6	37.3	36.8	43.4	24.6	31.0	62.4	117.9	30.3	38.9	31.2	29.0	26.7	39.8	35.2	40.7	33.3	35.4	53.6	63.1	20.9	39.2	30.9	57.8	34.8	60.2	42.0	77.2	76.1	34.4	49.0	42.2	51.3	44.1	55.9	64.4	57.5	66.6	93.3	94.1	28.8	81.9	37.5	47.7	65.5	55.4	43.4	76.4	44.3	45.2	63.2	50.4	38.3	37.0	49.1	51.7	39.8	61.6	55.3	47.8	77.4	46.1	58.5	50.3	53.5	80.5	92.0	47.4	17.0	38.6	54.5	64.5	99.7	54.1	54.0	74.5	48.5	49.3	34.9	92.2	69.7	49.5	97.1	44.5	28.8	32.0	50.6	80.4	48.4	46.6	81.4	65.6	66.2	57.1	13.9	34.9	18.2	35.9	36.7	40.4	53.6	43.0	42.4	42.4	49.0	41.3	52.0	20.9	30.9	39.2	63.1	57.8	34.8	50.0	66.7	46.8	86.9	69.2	56.5	51.0	50.8	77.9	29.0	142.9	126.0	317.1	216.5	187.4	175.0	82.6	310.8	251.6	117.2	287.9	55.0	354.5	608.5	336.6	34.6	194.4	208.5	233.6	337.0	312.3	228.2	275.0	154.8	1097.6	351.6	139.8	243.5	299.6	467.9	22.5	283.9	268.6	214.2	303.0	234.6	152.1	407.1	224.7	243.3	722.7	101.8	232.8	249.2	165.4	125.2	197.6	471.5	186.9	246.2	247.1
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Congenital hypothyroidism, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 65.3;Hepatocytes: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.3"	"Low cell line specificity"	"Detected in many"											"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: AB_2685892"	"prognostic unfavorable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	6.5	7.1	10.1	6.0	12.3	4.5	8.1	3.3	8.1	21.4	7.9	13.2	18.0	2.1	33.0	26.4	8.3	12.4	6.7	5.2	8.6	9.0	12.5	11.0	5.2	9.5	7.6	6.0	13.8	11.3	21.0	24.3	14.5	7.5	24.7	4.1	9.8	5.5	33.0	4.9	5.8	4.2	22.4	9.0	5.7	7.0	9.9	8.5	14.7	9.4	3.4	7.1	15.3	24.5	3.2	3.1	17.3	4.2	0.3	3.1	1.7	0.0	13.5	8.6	22.9	8.0	8.4	8.5	5.2	11.6	10.0	10.5	10.1	9.3	14.3	0.3	10.3	4.3	3.1	18.8	4.0	14.6	5.9	9.2	9.0	16.5	11.8	11.3	3.2	32.3	7.4	4.7	10.4	5.5	5.4	9.2	7.9	15.7	25.0	5.7	11.4	7.8	12.1	17.1	6.4	14.5	17.6	6.8	17.6	13.5	7.6	11.0	5.0	12.5	3.1	7.4	23.6	6.1	7.0	13.3	3.5	8.7	0.3	2.0	15.3	11.8	11.4	12.9	7.8	3.3	4.4	4.2	4.9	2.1	2.6	1.7	2.0	1.6	1.9	3.1	3.2	3.1	2.8	17.3	0.3	1.7	0.3	2.5	1.7	10.1	12.3	3.3	8.1	8.6	9.0	7.6	6.0	7.5	8.5	0.0	5.0	15.2	9.4	5.8	11.5	9.5	22.9	12.0	6.8	29.6	21.6	65.3	11.6	9.9	0.8	9.4	2.6	0.0	6.7	2.4	10.0	18.9	10.5	59.7	10.0	6.4	21.9	11.6	32.3	1.7	13.3	19.9	5.0	10.8	4.8	38.8	8.5	3.5	26.9	17.0	22.7	0.0	25.9	1.4	17.9	10.8	37.6	10.7	4.7	22.3
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 221.6;Spermatocytes: 178.1;Syncytiotrophoblasts: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA071810: AB_2686451, HPA071813: AB_2686452"	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favorable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	7.1	7.7	10.8	8.9	11.7	19.3	12.2	16.4	16.6	7.3	7.3	5.2	7.8	8.1	7.9	5.6	7.1	8.5	7.4	7.9	15.9	14.2	5.7	8.5	6.6	12.0	10.0	11.8	8.3	6.0	4.7	8.2	9.2	11.1	8.0	9.3	4.6	5.7	9.2	4.4	5.9	7.7	7.2	8.5	7.6	7.2	71.2	8.0	11.7	10.7	5.0	10.2	9.2	12.0	27.8	14.7	43.1	14.9	21.1	30.8	25.3	6.3	7.8	17.9	11.6	13.7	14.2	10.1	12.1	12.8	16.2	21.3	9.1	5.1	19.8	8.3	9.6	18.0	8.4	11.4	13.0	19.6	15.1	14.2	34.8	4.7	10.0	13.9	18.2	13.6	8.7	13.3	18.1	19.6	12.3	15.3	17.5	50.2	13.6	11.5	14.5	15.2	10.9	20.0	9.3	10.2	10.6	10.8	7.6	9.5	5.7	23.3	23.2	7.1	9.4	14.9	15.6	4.3	7.3	13.8	9.3	13.5	20.5	13.2	11.0	11.9	12.9	15.6	11.9	11.1	43.1	13.7	32.7	28.5	13.8	30.8	27.8	24.1	29.9	12.4	25.0	23.4	27.3	31.4	21.1	14.9	14.7	24.6	25.3	10.8	11.7	16.4	16.6	15.9	14.2	10.0	11.8	11.1	8.0	6.0	12.6	23.3	25.8	62.8	20.7	9.2	20.4	12.0	7.9	7.0	17.7	36.2	24.9	25.0	221.6	33.3	12.0	0.0	22.1	57.3	32.7	32.8	40.3	8.9	21.4	14.3	68.1	17.2	16.7	29.8	19.5	20.0	30.4	19.0	22.4	12.3	24.3	21.0	17.3	18.9	9.4	19.4	34.0	178.1	63.9	57.5	204.8	47.3	23.6	36.7
TCEA1	"GTF2S, SII, TCEA, TF2S, TFIIS"	ENSG00000187735	"Transcription elongation factor A1"	P23193	8	53966552-54022529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043786	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA043786: AB_10959468"	"unprognostic (5.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.80e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	26.7	25.3	30.7	40.5	31.5	29.6	31.1	26.1	27.4	26.0	28.3	21.9	26.6	20.3	27.3	20.9	27.5	23.6	24.7	21.4	27.8	24.2	26.5	56.8	22.3	39.2	29.7	17.6	28.5	38.4	32.2	28.7	21.1	27.1	31.3	22.5	20.6	25.4	25.4	21.8	22.8	22.4	38.9	36.8	30.0	26.1	17.3	31.3	39.9	54.6	18.6	46.9	39.6	37.3	60.0	31.9	20.5	17.8	25.2	40.1	17.8	27.3	27.7	24.8	25.5	17.6	21.9	17.8	21.7	25.5	25.7	28.7	15.8	22.9	67.2	24.7	24.9	27.4	21.1	31.3	19.9	37.5	38.4	15.7	50.8	13.5	23.3	55.3	19.9	21.9	15.7	53.8	24.2	106.8	21.3	21.9	23.2	32.2	58.4	23.3	13.0	41.1	13.9	40.3	44.5	8.3	31.9	8.7	12.0	35.4	18.7	23.3	16.9	17.9	15.8	58.3	24.2	22.8	22.3	19.4	18.9	17.4	21.2	19.5	36.1	22.6	45.5	33.3	22.8	26.6	18.1	17.8	20.5	30.1	16.8	28.6	60.0	31.4	27.7	22.1	44.4	28.0	29.1	6.4	25.2	15.6	31.9	40.1	17.8	30.7	31.5	26.1	27.4	27.8	24.2	29.7	17.6	27.1	31.3	83.4	82.6	150.6	116.2	120.3	70.8	20.7	79.0	139.2	124.0	94.2	84.4	99.1	142.6	96.9	85.2	85.7	52.6	93.5	95.8	104.8	89.7	121.1	94.9	140.5	76.9	54.0	83.7	48.5	68.2	129.1	124.8	89.2	111.3	118.2	83.8	139.0	101.0	71.9	124.8	130.8	97.6	77.6	122.7	77.9	84.3	131.6	93.7	107.1	78.7	109.8
TCF19	SC1	ENSG00000137310	"Transcription factor 19"	Q9Y242	6	31158542-31167159	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.3"	"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 33.2;GAMG: 19.8;HEK 293: 18.7;JURKAT: 17.0;Karpas-707: 16.2;SCLC-21H: 20.6;U-138 MG: 20.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA065994			Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoplasm	Nucleoli	"HPA065994: "	"unprognostic (1.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (3.54e-10)"	"unprognostic (3.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.21e-1)"	4.3	1.5	1.3	12.4	4.1	2.3	5.2	8.2	3.9	7.0	5.6	2.3	3.7	9.2	4.2	6.2	11.2	3.2	3.8	3.4	1.7	1.1	4.3	1.6	4.8	18.0	3.0	1.0	4.6	3.6	0.4	0.9	1.5	2.0	5.5	4.0	2.3	4.1	6.7	2.5	11.5	6.0	3.9	1.8	8.6	5.9	3.1	1.8	31.3	2.8	14.4	13.8	4.8	6.7	2.0	0.9	0.2	0.3	1.2	3.8	1.2	33.2	0.3	0.3	0.0	2.3	3.0	0.3	0.2	0.0	0.0	0.0	2.1	0.0	0.0	7.5	8.2	19.8	0.0	0.0	12.4	0.0	0.2	18.7	2.9	1.9	0.8	0.0	0.1	8.8	1.2	0.0	0.9	0.0	1.8	7.4	17.0	0.0	16.2	3.2	0.1	0.4	5.3	0.0	0.0	0.0	0.4	2.0	0.2	2.9	0.1	20.6	0.2	0.2	0.0	0.2	2.7	0.0	2.4	0.0	20.6	0.1	0.1	0.1	5.3	6.0	10.2	0.0	0.1	0.1	0.0	0.3	0.0	0.7	0.0	3.8	1.6	1.9	3.4	0.9	2.0	2.4	0.9	0.2	1.2	0.1	0.0	2.6	1.2	1.3	4.1	8.2	3.9	1.7	1.1	3.0	1.0	2.0	1.8	3.0	1.1	6.0	2.1	4.5	2.6	1.2	0.0	0.0	3.4	3.5	0.0	0.6	6.6	1.6	0.3	3.3	1.1	0.0	1.6	7.2	2.7	1.0	1.1	0.2	7.5	1.6	1.2	1.3	1.9	0.4	4.6	4.3	11.8	10.0	3.3	3.3	0.8	0.0	6.0	0.3	0.5	0.0	6.8	0.5	12.8	3.3	0.3	5.1	7.7	0.9
TCHHL1	"S100A17, THHL1"	ENSG00000182898	"Trichohyalin like 1"	Q5QJ38	1	152084144-152089064	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 1.7;skin 1: 3.8;tongue: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	59	"SK-BR-3: 10.7"					"Not detected"	"Not detected"			"HPA042579, HPA063483"	Enhanced		Approved	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane, Nucleoli"		"HPA042579: AB_10794283, HPA063483: AB_2685021"						"unprognostic (8.21e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TERB2	"C15orf43, MGC33951"	ENSG00000167014	"Telomere repeat binding bouquet formation protein 2"	Q8NHR7	15	44956702-44979229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 51.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041780			Uncertain	Nucleoplasm,Nucleoli		No	NA			Nucleoli	Nucleoplasm	"HPA041780: AB_10796460"							"unprognostic (1.42e-3)"					"unprognostic (4.19e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 310.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	15.7	34.6	15.1	15.3	18.7	9.0	20.0	8.6	22.8	17.5	21.3	15.0	36.0	18.7	20.1	25.5	17.7	21.9	24.8	19.0	14.6	15.6	35.9	30.7	17.0	22.6	15.7	17.9	15.8	29.0	29.9	12.3	24.5	12.2	20.3	16.7	22.6	43.6	44.3	16.3	29.5	20.8	16.6	15.8	18.6	19.0	90.8	11.5	16.6	33.9	18.5	15.9	16.7	16.3	33.1	34.5	24.7	36.7	22.8	50.7	41.1	11.8	21.8	3.9	20.1	40.7	19.8	8.0	10.2	24.2	17.0	17.2	11.6	28.2	17.1	7.5	14.6	28.8	11.6	11.0	20.6	8.3	13.7	17.6	16.3	13.6	15.4	36.3	10.2	18.3	26.1	32.9	19.2	19.7	15.5	12.4	13.0	8.5	29.9	17.5	13.7	16.3	23.8	4.3	19.6	24.5	7.9	5.2	32.2	26.8	16.5	5.6	9.2	12.5	34.5	15.7	5.6	16.8	21.7	9.1	17.2	7.2	18.0	13.5	20.9	22.5	8.4	21.0	21.6	17.1	24.7	36.7	21.7	41.9	36.7	41.9	32.2	43.5	39.7	34.5	33.1	36.5	37.0	7.7	22.8	34.7	30.5	50.7	41.1	15.1	18.7	8.6	22.8	14.6	15.6	15.7	17.9	12.2	11.5	32.8	15.0	27.5	46.0	30.9	30.1	22.8	53.5	25.4	28.4	94.2	55.0	125.5	53.0	63.6	30.2	49.7	69.9	0.0	67.2	73.8	45.6	36.2	16.1	51.7	92.2	39.7	31.6	28.3	36.7	48.4	47.2	49.0	62.4	55.9	51.0	59.8	56.9	65.4	46.0	101.0	46.9	25.8	20.0	310.0	58.8	30.9	63.8	52.4	81.7	32.5
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"		21	42311667-42315651	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"gallbladder: 230.9;thyroid gland: 258.3"	"Cell type enriched"	"Detected in many"	21	"Mucus-secreting cells: 36697.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	30	"eosinophil: 9.5"	"Lineage enriched"	"Detected in single"	63	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 28.4;OE19: 44.4;SCLC-21H: 8.7;T-47d: 13.3;TIME: 36.9"	"Region enriched"	"Detected in single"	20	"cerebellum: 1.7"	"Not detected"	"Not detected"			"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000		Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	2.2	1.2	0.2	16.8	0.2	0.0	4.3	0.2	0.2	45.1	66.3	0.2	0.5	40.8	2.8	1.2	5.1	8.0	230.9	0.7	0.2	0.3	1.0	0.6	12.6	0.6	0.4	0.2	2.0	4.8	0.0	0.5	0.5	0.2	3.6	63.3	0.3	54.8	0.7	0.6	1.6	70.6	1.5	0.5	5.0	1.1	0.4	0.2	0.3	258.3	14.4	72.6	1.1	1.6	0.0	0.0	9.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	28.4	0.0	0.5	0.1	44.4	4.3	0.0	3.2	0.3	0.0	0.0	8.7	0.1	0.0	0.8	0.0	0.0	13.3	0.0	36.9	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	14.9	22.3	0.9	17.0	37.0	0.0	13.4	1110.8	464.4	316.2	21.0	0.0	0.3	0.0	9.0	0.0	51.4	1768.3	0.0	62.1	0.6	20.3	103.0	60.8	0.9	1.9	4.8	740.8	82.9	2.6	0.8	2.3	2.5	91.1	0.0	36697.4	0.0	28.0	1779.2	7.4	0.0	0.0	0.0	6.1	0.3	0.3	33.8	0.7	1.0	1243.2	29.6
THTPA	THTPASE	ENSG00000259431	"Thiamine triphosphatase"	Q9BU02	14	23555988-23560271	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028876	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA028876: AB_10600731"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.70e-9)"	"unprognostic (3.47e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.40e-2)"	14.9	19.5	27.7	12.2	23.3	7.6	12.9	16.4	24.3	12.3	14.0	20.7	15.9	15.7	13.3	18.4	10.1	17.7	16.8	16.3	23.3	17.4	16.3	12.1	10.7	10.7	21.9	13.3	15.4	12.7	25.0	12.4	7.6	16.1	18.8	12.3	17.1	18.0	23.5	21.9	7.4	11.7	13.7	19.5	11.3	11.6	18.8	14.3	14.1	15.9	12.3	11.2	9.9	7.9	14.3	17.0	11.1	14.4	6.9	11.6	8.7	2.7	17.1	8.4	9.1	19.3	10.9	4.6	8.0	7.1	7.9	7.9	3.5	11.3	5.2	7.0	9.6	9.0	8.5	8.8	10.0	5.9	10.9	9.6	7.0	12.1	9.3	9.8	6.4	6.4	14.8	7.4	12.1	8.9	16.7	9.5	8.4	5.3	11.4	11.5	8.2	10.1	2.6	3.0	14.6	14.6	6.9	5.7	9.4	13.9	5.4	16.2	7.7	7.9	16.2	4.6	5.2	10.8	3.1	7.4	5.2	5.5	10.7	4.7	13.5	8.2	2.9	5.4	2.9	8.0	11.1	14.4	7.3	9.6	10.6	9.5	9.6	6.9	7.5	13.2	14.3	11.6	9.9	1.5	6.9	13.4	17.0	5.4	8.7	27.7	23.3	16.4	24.3	23.3	17.4	21.9	13.3	16.1	14.3	6.0	6.9	15.9	5.8	0.0	27.6	0.0	10.2	5.3	6.8	7.0	7.9	9.0	46.4	13.0	16.7	2.9	8.4	0.0	10.7	4.4	7.2	8.5	23.1	7.6	15.9	7.9	5.8	8.0	10.0	16.8	10.6	8.2	0.0	11.8	6.4	18.8	8.1	8.6	7.1	24.6	9.4	12.9	0.1	19.6	8.7	0.0	5.6	6.4	8.5	5.4
THUMPD3	DKFZP434F091	ENSG00000134077	"THUMP domain containing 3"	Q9BV44	3	9362842-9386791	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 224.3;Spermatocytes: 126.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036170, HPA036171"	Approved		Enhanced	Nucleoli,Cytosol		No	No			Cytosol	Nucleoli	"HPA036170: AB_10671836, HPA036171: AB_2674985"	"unprognostic (2.13e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.25e-7)"	"unprognostic (6.54e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-2)"	17.4	17.2	13.3	12.9	14.8	22.2	14.2	13.4	19.6	15.2	14.4	13.8	12.5	12.8	14.0	15.8	16.5	12.3	10.9	19.3	12.3	13.9	20.7	23.9	11.1	13.5	18.3	11.0	14.3	14.8	22.2	27.8	14.4	23.2	15.9	15.1	14.0	16.1	14.9	29.4	13.4	14.9	12.3	15.8	14.5	12.5	42.8	14.8	22.3	18.2	17.5	13.2	16.2	11.7	13.9	15.4	12.5	19.3	11.7	22.3	10.1	12.8	17.5	12.2	6.4	16.1	15.6	49.2	15.7	12.9	16.0	12.2	13.1	13.6	13.2	12.3	14.2	25.6	8.5	22.3	16.0	16.3	14.7	13.0	16.5	17.7	11.4	15.8	21.0	12.0	12.5	18.2	18.9	19.7	13.0	10.5	21.5	25.9	19.2	21.1	18.2	24.8	9.0	23.5	14.4	17.0	15.8	21.0	18.8	10.5	19.5	5.1	16.5	13.0	9.4	13.9	13.2	15.1	13.6	7.4	15.4	13.3	18.5	17.2	24.6	57.2	42.5	18.7	19.7	22.0	10.6	13.2	12.5	16.2	17.4	21.1	12.3	14.1	16.8	15.0	13.9	22.3	16.8	2.7	11.7	19.3	15.4	13.2	10.1	13.3	14.8	13.4	19.6	12.3	13.9	18.3	11.0	23.2	14.8	23.8	17.9	6.7	21.7	9.5	20.8	43.1	20.4	16.0	29.6	21.0	15.7	29.0	44.7	33.1	224.3	13.1	8.7	0.0	25.5	25.1	18.7	25.5	26.7	23.1	24.1	36.5	2.9	11.6	15.1	105.0	19.0	17.7	11.8	17.2	15.2	28.6	27.1	3.5	24.4	25.2	34.6	6.5	13.4	126.9	51.4	11.3	23.0	15.2	18.8	18.0
TLCD2		ENSG00000185561	"TLC domain containing 2"	A6NGC4	17	1702790-1710438	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 59.3;Cone photoreceptor cells: 121.7;Enterocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 4.1;neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 6.6;ASC TERT1: 7.7;HaCaT: 6.3;SiHa: 8.3;T-47d: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046063	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA046063: AB_2679520"	"unprognostic (1.78e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.94e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (3.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.44e-2)"	11.3	9.2	0.5	4.7	1.4	1.7	18.4	0.1	1.5	2.7	9.6	0.3	1.7	7.9	1.8	3.1	6.8	2.7	5.6	4.0	0.6	0.4	2.3	14.8	4.6	0.5	1.2	0.4	4.6	1.2	1.5	0.9	1.6	1.9	4.1	5.4	3.0	2.9	3.6	2.2	2.2	18.4	4.3	1.3	1.1	4.5	0.8	0.5	0.3	2.6	1.2	2.7	4.8	6.3	0.7	0.4	4.1	0.4	0.6	0.5	0.1	0.7	1.5	0.8	2.5	6.6	7.7	0.5	1.3	1.3	0.7	0.5	4.7	2.2	0.1	1.4	2.1	0.7	6.3	1.0	0.6	0.5	0.2	1.1	0.6	2.1	0.4	3.8	0.0	1.7	6.2	2.3	0.8	1.5	2.1	0.5	0.1	0.5	0.3	0.6	1.3	0.0	0.3	0.1	2.3	0.4	0.1	3.7	0.1	0.4	2.2	0.1	0.3	8.3	0.7	1.2	1.1	6.7	0.6	1.8	0.4	2.0	1.4	0.3	0.1	0.0	0.1	0.4	0.2	1.0	4.1	0.4	0.6	0.4	0.2	0.2	0.4	0.5	0.2	0.1	0.7	0.4	0.4	2.7	0.6	0.2	0.4	0.2	0.1	0.5	1.4	0.1	1.5	0.6	0.4	1.2	0.4	1.9	0.5	47.6	59.3	1.4	7.6	0.0	8.1	2.8	15.3	36.1	33.0	10.4	121.7	4.1	0.0	5.8	0.6	8.5	77.5	0.0	8.5	2.5	7.7	6.0	15.1	14.9	4.7	0.0	8.6	17.8	3.9	0.9	12.4	4.3	0.0	1.8	22.4	8.8	11.1	38.7	5.3	0.8	50.0	6.5	2.7	0.2	0.9	0.3	3.3	0.7	26.4	11.7
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: AB_2681916"	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.70e-5)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.1	13.1	7.1	25.3	9.6	10.2	16.0	8.9	11.5	17.5	11.5	8.9	11.8	9.4	18.5	17.7	16.1	12.8	13.5	12.0	8.7	7.4	13.5	16.8	10.2	22.1	7.6	8.8	16.0	19.3	7.2	12.4	12.6	9.9	11.6	11.0	8.8	16.9	12.2	17.2	15.1	9.8	13.1	11.1	21.1	13.0	30.0	8.5	28.2	10.6	15.0	18.3	15.6	13.5	21.4	28.2	3.3	21.9	13.5	14.0	7.4	15.7	8.3	13.4	12.2	5.6	9.6	13.8	18.5	9.3	10.1	8.6	8.0	21.6	35.0	7.7	9.8	8.3	8.0	15.6	13.2	12.8	18.0	13.4	48.8	7.9	12.7	12.4	38.5	15.2	6.2	12.0	8.5	10.7	8.4	11.0	11.3	17.1	25.7	11.0	14.2	23.1	20.0	14.9	8.6	12.2	22.1	12.7	22.1	8.0	7.8	7.8	11.5	11.7	15.7	13.8	8.9	9.4	15.0	19.3	8.1	15.3	7.7	19.5	18.7	24.0	40.7	16.0	20.5	24.2	3.3	14.5	1.3	7.7	21.9	11.4	21.4	14.0	9.9	16.5	19.9	13.2	11.1	0.5	13.5	17.7	28.2	11.5	7.4	7.1	9.6	8.9	11.5	8.7	7.4	7.6	8.8	9.9	8.5	20.8	28.2	49.6	29.7	29.2	13.2	32.7	50.9	14.7	27.3	31.4	3.9	47.8	54.7	39.8	141.5	25.9	10.6	23.3	60.9	76.4	30.6	17.5	27.8	47.0	32.6	14.3	29.3	38.6	33.4	132.5	51.5	37.8	25.3	35.1	34.4	14.7	45.8	28.1	30.1	37.2	13.4	38.8	30.6	59.7	38.5	34.6	25.5	21.7	37.6	23.0
TMEM151A	"MGC33486, TMEM151"	ENSG00000179292	"Transmembrane protein 151A"	Q8N4L1	11	66291870-66296664	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 48.5"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 8.1;Cholangiocytes: 5.1;Horizontal cells: 14.3;Intestinal endocrine cells: 7.5"	"Cancer enhanced"	"Detected in some"		"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041035	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA041035: AB_10794404"	"unprognostic (1.20e-1)"	"unprognostic (8.24e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.48e-3)"	"unprognostic (8.57e-2)"	"unprognostic (8.73e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.67e-2)"	1.4	3.8	12.4	1.5	16.8	1.4	1.4	5.9	48.5	1.4	1.5	41.8	0.0	1.5	1.4	1.4	1.4	1.4	2.8	1.6	22.7	14.3	1.4	1.4	1.4	1.4	21.2	13.1	1.5	2.4	1.8	3.3	1.4	22.2	1.4	1.4	1.0	1.5	1.4	1.4	1.4	1.5	1.4	43.2	1.4	3.9	1.6	13.6	0.0	1.4	0.0	1.4	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.0	1.3	0.0	3.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	18.4	4.2	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.4	16.8	5.9	31.1	22.7	14.3	21.2	13.1	22.2	13.6	0.0	0.0	0.0	0.1	0.0	8.1	0.6	5.1	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	14.3	7.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0
TMEM178B	DKFZp547G036	ENSG00000261115	"Transmembrane protein 178B"	H3BS89	7	141074232-141480380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 23.0;Cardiomyocytes: 39.1;Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 7.1;HDLM-2: 6.4;NTERA-2: 6.0;RPTEC TERT1: 9.8;SCLC-21H: 7.7;WM-115: 10.4"									HPA048771	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA048771: AB_2680517"	"unprognostic (7.33e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.79e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.10e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.35e-3)"	"unprognostic (8.98e-2)"	0.9	1.7	5.2	0.7	7.4	0.1	0.7	3.2	13.4	0.5	0.8	1.0	2.3	0.1	1.1	0.6	1.8	0.3	0.7	11.6	4.8	5.8	2.9	0.6	0.4	1.5	4.9	1.0	0.2	2.6	20.6	18.5	0.1	1.8	2.8	0.4	0.5	4.4	0.8	4.5	0.2	1.2	1.3	2.4	0.8	0.5	0.8	0.4	1.0	9.5	0.1	3.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.6	0.3	1.8	0.1	2.8	0.8	1.0	0.0	0.0	2.2	2.4	0.2	0.5	0.0	7.1	0.0	2.3	6.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.0	6.0	0.0	0.0	0.4	1.1	3.0	9.8	2.8	7.7	4.7	0.1	0.3	1.0	1.5	1.0	0.0	0.0	0.1	1.2	3.2	0.0	0.1	0.0	0.0	0.5	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	7.4	3.2	9.6	4.8	5.8	4.9	1.0	1.8	0.4	0.0	0.0	0.0	0.4	0.5	23.0	39.1	0.0	0.0	0.0	1.8	2.0	0.0	1.7	0.0	0.8	0.1	0.0	0.0	0.3	0.0	0.2	3.1	0.0	0.0	0.1	28.6	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.0	3.8	1.2	0.0	0.7	2.8	1.6	0.0	0.8	0.5	0.7	0.1	0.2	0.0	0.0	1.6
TMEM187	"CXorf12, DXS9878E, ITBA1"	ENSG00000177854	"Transmembrane protein 187"	Q14656	X	153972327-153983195	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA038134	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA038134: AB_10669517"	"unprognostic (1.51e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (9.14e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.04e-2)"	8.8	13.0	9.2	6.8	10.2	3.4	10.5	13.2	9.0	7.6	9.0	10.5	13.9	6.8	8.8	9.3	9.5	12.0	6.8	8.1	9.6	6.0	7.6	10.2	7.7	10.2	10.4	9.0	10.9	24.4	7.5	13.0	7.3	11.0	10.3	4.5	6.7	14.1	10.1	8.5	10.7	10.9	6.8	8.0	10.0	8.0	5.9	8.7	8.4	10.8	2.9	9.9	7.9	7.4	13.4	19.6	17.8	9.8	10.1	22.5	10.9	8.4	9.7	2.1	7.7	8.4	7.5	1.2	3.5	1.7	1.0	3.4	1.9	14.6	1.3	20.0	2.8	5.3	7.7	2.9	5.1	0.8	10.9	4.0	2.3	5.1	3.1	7.1	1.1	2.6	8.4	7.7	3.0	4.3	4.8	2.6	5.1	2.1	11.0	4.4	9.1	4.5	1.5	1.6	9.5	10.7	4.2	1.2	14.1	5.3	2.7	2.9	2.8	5.1	4.3	3.6	2.1	8.1	2.8	4.8	1.7	1.8	7.0	1.9	7.8	5.2	1.7	5.2	5.1	0.9	17.8	9.8	11.9	14.7	7.3	14.7	9.7	18.1	15.9	7.4	13.4	22.5	13.9	9.5	10.1	6.9	19.6	17.6	10.9	9.2	10.2	13.2	9.0	9.6	6.0	10.4	9.0	11.0	8.7	0.0	4.6	4.1	5.2	2.5	3.5	3.6	17.8	2.7	1.2	7.0	5.9	11.8	1.7	9.2	0.3	3.8	6.5	23.3	7.7	9.1	9.6	5.3	3.5	13.5	10.8	1.6	2.4	4.9	6.0	0.0	13.6	4.8	10.1	9.0	6.7	12.4	8.0	3.5	13.4	6.8	4.3	6.5	5.5	0.2	8.8	4.1	8.2	5.1	7.6	3.3
TMEM217	"C6orf128, dJ355M6.2"	ENSG00000172738	"Transmembrane protein 217"	Q8N7C4	6	37212180-37258155	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 20.1"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 13.1;Exocrine glandular cells: 13.9;Pancreatic endocrine cells: 14.4;Spermatocytes: 19.2;Urothelial cells: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HEL: 4.8;hTEC/SVTERT24-B: 3.4;HUVEC TERT2: 5.0;TIME: 13.1"					"Not detected"	"Not detected"			"HPA045432, HPA071187"			Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA045432: AB_2732519, HPA071187: AB_2732174"	"unprognostic (7.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-4)"	"unprognostic (8.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.59e-1)"	0.3	2.7	0.4	0.4	1.4	1.3	0.3	0.4	1.1	0.3	0.3	1.6	0.0	0.4	0.2	1.1	1.4	0.4	0.7	0.4	0.3	0.4	0.9	0.5	0.5	0.1	0.9	1.0	1.1	3.1	0.6	2.3	0.2	1.0	0.4	0.3	1.1	1.5	0.1	1.0	0.5	0.4	0.5	1.6	0.2	0.2	20.1	0.9	0.0	0.5	0.0	0.3	0.4	0.3	0.1	0.4	0.2	0.0	0.0	0.6	0.1	0.1	0.0	0.3	0.0	0.2	1.3	0.0	0.4	2.8	1.0	3.7	0.7	0.5	0.1	0.2	0.0	1.5	0.5	0.3	0.3	1.1	0.1	0.2	4.8	0.0	0.1	0.3	0.0	2.8	0.5	0.7	3.4	0.2	1.2	5.0	0.4	1.3	0.0	0.5	0.0	0.1	0.4	0.2	0.0	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.5	0.0	0.2	0.6	0.0	0.1	13.1	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.0	1.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.1	0.4	1.4	0.4	1.1	0.3	0.4	0.9	1.0	1.0	0.9	0.0	1.1	0.0	8.5	2.3	0.4	0.2	0.0	2.7	2.3	1.8	0.0	0.7	3.3	13.1	12.1	2.1	1.2	0.0	13.9	0.4	2.4	6.4	5.7	0.0	0.8	3.2	1.7	0.0	0.0	11.8	0.6	1.4	1.7	0.0	0.2	6.0	14.4	0.0	0.0	1.0	0.5	0.0	0.8	19.2	0.8	2.6	0.9	0.0	0.4	14.2
TMEM35B	ZMYM6NB	ENSG00000243749	"Transmembrane protein 35B"	Q8NCS4	1	34981535-34985353	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 8.3;Ciliated cells: 28.1;Club cells: 11.4;granulocytes: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 43.0;CAPAN-2: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051024	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051024: AB_2681316"	"unprognostic (3.34e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.07e-1)"	23.1	20.6	6.4	10.7	8.0	5.3	24.4	5.7	7.9	23.7	13.8	9.3	12.6	7.4	22.3	19.0	15.2	19.7	26.1	17.6	6.4	5.8	27.5	24.4	25.3	28.0	9.9	7.6	20.0	20.5	9.2	14.6	29.5	9.6	29.6	12.6	26.6	14.2	17.4	10.5	7.2	16.0	18.3	10.2	19.0	12.9	21.4	7.8	17.9	48.7	9.8	18.4	22.0	19.1	24.9	37.3	29.4	26.8	36.4	53.1	38.4	9.1	7.0	1.7	2.8	43.0	25.5	3.5	10.0	16.8	7.2	9.8	6.9	40.6	4.7	15.6	10.3	11.1	9.9	3.1	8.5	5.8	17.3	4.7	9.8	3.7	8.2	23.6	6.5	10.3	25.3	8.0	6.4	13.6	14.5	14.0	9.7	6.3	13.4	12.5	5.6	4.7	6.5	7.6	0.0	4.9	6.4	13.8	1.5	19.2	9.1	4.2	1.4	15.2	0.2	13.4	8.3	3.8	9.9	14.2	9.6	9.0	8.4	5.7	7.8	4.4	3.2	9.7	10.6	8.0	29.4	24.5	25.4	47.3	26.8	50.7	24.9	52.3	51.9	16.8	21.0	46.1	46.3	7.6	36.4	21.9	37.3	53.1	38.4	6.4	8.0	5.7	7.9	6.4	5.8	9.9	7.6	9.6	7.8	20.8	8.3	0.0	0.0	0.0	0.0	0.0	0.0	28.1	11.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	8.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TMEM42	MGC29956	ENSG00000169964	"Transmembrane protein 42"	Q69YG0	3	44861869-44865670	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052569	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052569: AB_2681871"	"prognostic favorable (5.23e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.16e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	11.1	14.6	18.6	5.7	26.1	4.6	13.4	7.8	17.3	12.7	8.5	17.7	8.5	6.1	10.4	25.9	7.2	16.8	8.9	10.2	18.4	19.7	12.9	19.1	9.7	9.3	19.1	14.1	17.1	17.5	12.7	16.5	8.9	16.4	12.7	8.5	8.5	10.9	12.7	16.6	8.6	6.2	9.2	19.8	8.7	9.9	20.0	15.5	11.6	17.1	6.5	9.1	7.5	8.7	13.9	11.8	4.2	10.2	9.1	15.9	9.2	4.1	4.2	1.2	2.4	16.1	12.7	0.1	3.4	4.8	4.2	4.2	0.9	8.2	2.8	6.7	6.6	1.9	2.8	0.3	5.2	4.2	4.4	0.0	1.7	5.4	4.4	17.1	2.0	0.1	13.1	13.4	4.3	9.7	9.0	7.1	7.2	0.1	5.8	6.3	3.2	1.7	3.4	2.3	5.0	1.9	1.5	0.7	0.6	9.1	1.6	1.3	1.7	4.1	1.4	1.6	4.2	3.0	3.5	4.6	3.7	0.4	5.4	3.7	2.0	1.5	0.8	7.4	2.4	1.6	3.7	8.6	4.2	7.8	7.7	8.2	13.9	11.6	7.2	10.6	11.9	15.9	12.6	1.6	9.1	10.2	11.8	9.2	9.2	18.6	26.1	7.8	17.3	18.4	19.7	19.1	14.1	16.4	15.5	20.8	4.8	10.7	14.4	5.5	8.0	10.1	15.3	16.0	4.5	31.4	2.0	17.6	11.6	15.3	56.7	9.3	5.2	0.0	8.9	11.3	14.2	14.8	3.5	15.3	19.8	17.5	11.5	11.6	13.3	73.6	25.3	10.3	6.8	9.0	9.1	20.9	11.7	8.4	18.4	17.0	15.9	6.5	6.9	36.1	19.3	7.9	8.1	13.1	11.8	6.2
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	67	"intestine: 154.6"	"Cell type enriched"	"Detected in single"	11	"Early spermatids: 4.2"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	20	"U-138 MG: 20.3;U-87 MG: 56.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 9.3"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	80.5	0.0	0.0	154.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	42.4	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.5	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.1	0.0	0.3	0.0	0.1	56.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
TMX1	"PDIA11, TMX, TXNDC, TXNDC1"	ENSG00000139921	"Thioredoxin related transmembrane protein 1"	Q9H3N1	14	51240162-51257546	"Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003085	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		740000	"Endoplasmic reticulum"	Nucleoli	"HPA003085: AB_1080424"	"unprognostic (1.83e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (3.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.44e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.21e-3)"	21.8	24.2	13.6	18.5	18.3	15.5	19.7	14.1	12.3	14.4	20.7	17.2	27.0	17.7	17.5	19.2	25.0	13.3	15.0	11.3	13.5	11.9	24.9	29.2	20.0	25.3	22.6	9.2	15.5	23.9	18.4	19.0	21.9	16.3	14.2	21.2	13.3	21.0	27.9	12.5	16.7	23.4	17.0	24.9	29.1	18.1	12.9	17.9	37.5	23.5	17.6	17.4	20.2	19.9	9.4	17.0	9.6	17.5	12.6	12.5	13.3	13.7	12.7	17.7	9.5	14.1	11.1	19.0	17.4	14.1	17.6	22.6	12.9	25.4	19.7	16.3	11.6	8.3	13.6	31.2	11.4	32.1	19.8	10.7	14.4	11.1	12.6	12.3	33.0	14.6	13.3	10.5	11.8	8.7	12.7	15.5	16.3	11.8	13.6	16.7	17.0	14.7	17.8	20.1	21.5	16.0	15.6	32.0	11.9	17.0	18.0	11.2	8.3	13.9	9.3	12.4	12.2	13.6	14.7	10.0	18.6	17.3	13.1	15.8	12.0	12.0	16.2	8.2	18.8	17.4	9.6	15.4	7.2	10.2	17.5	12.5	9.4	10.9	10.5	16.2	7.4	10.8	12.0	5.7	12.6	12.6	17.0	12.1	13.3	13.6	18.3	14.1	12.3	13.5	11.9	22.6	9.2	16.3	17.9	35.7	23.2	35.8	51.8	96.5	10.8	6.7	48.4	37.5	36.4	33.2	11.8	67.4	8.3	51.3	2.1	45.4	23.8	0.0	59.1	119.6	52.3	42.1	41.7	33.6	66.6	9.5	16.7	39.3	52.2	3.1	23.0	71.7	52.3	61.3	31.4	24.3	42.4	52.6	26.9	27.4	31.6	58.2	50.9	43.2	74.1	85.1	48.3	58.6	44.9	56.5
TNFRSF9	"4-1BB, CD137, ILA"	ENSG00000049249	"TNF receptor superfamily member 9"	Q07011	1	7915894-7943165	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 13.5;lymphoid tissue: 18.3"	"Group enriched"	"Detected in some"	4	"granulocytes: 62.3;monocytes: 53.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 47.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA071425			Approved	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA071425: AB_2686394"	"unprognostic (7.23e-2)"	"unprognostic (1.72e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-4)"	"unprognostic (9.47e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (2.69e-8)"	"unprognostic (1.64e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.55e-2)"	0.8	1.0	0.3	11.0	0.3	1.9	0.5	0.2	0.3	0.4	0.5	0.1	0.1	0.6	0.3	0.1	0.6	0.8	1.6	1.8	0.3	1.0	0.7	0.7	2.1	10.8	0.3	0.1	0.3	0.6	0.0	0.5	0.2	0.5	0.4	0.7	0.3	2.1	0.1	0.3	0.5	2.3	0.1	0.3	7.9	0.7	0.5	0.1	18.3	0.7	0.9	17.5	1.4	0.4	0.5	1.1	6.6	1.5	4.1	13.5	1.1	1.2	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	1.0	0.4	0.1	0.4	0.0	0.8	0.2	0.0	0.2	0.5	47.0	0.1	0.2	0.2	0.0	0.9	0.0	0.5	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.7	0.0	0.2	0.2	0.2	1.6	0.1	0.2	0.1	0.1	0.1	5.8	0.2	0.0	1.1	1.5	0.2	1.5	0.4	0.2	0.2	1.0	8.0	1.1	0.5	0.3	1.6	6.6	4.1	0.1	0.3	13.5	1.1	0.3	0.3	0.2	0.3	0.3	1.0	0.3	0.1	0.5	0.1	0.0	1.7	0.0	0.4	0.2	0.0	0.3	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	1.0	0.0	0.4	0.3	62.3	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	1.8	5.0	53.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.4	0.0	12.9	0.0	0.3
TNNI1		ENSG00000159173	"Troponin I1, slow skeletal type"	P19237	1	201403768-201429866	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 559.6"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 50.9"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.6;prostate cancer: 3.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	9	"RH-30: 106.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA028190	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA		25000	Nucleoplasm	Nucleoli	"HPA028190: AB_10600831"	"unprognostic (2.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	22.9	9.5	0.0	0.1	6.6	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	6.8	0.0	559.6	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.7	83.8	10.7	0.0	0.1	0.2	0.6	1.7	0.4	0.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	106.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.3	0.3	0.1	0.2	0.2	0.2	0.6	0.2	0.3	0.5	1.7	0.4	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	50.9	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	2.7	0.0	0.8	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0
TNPO2	"FLJ12155, IPO3, KPNB2B, TRN2"	ENSG00000105576	"Transportin 2"	O14787	19	12699194-12724011	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046446, HPA071498"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"CAB046446: AB_10603392, HPA071498: AB_2686405"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (2.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.76e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-3)"	"unprognostic (7.63e-2)"	21.7	19.8	37.1	16.0	35.7	17.8	13.5	33.1	44.7	17.9	13.9	23.2	12.7	13.4	20.7	20.9	22.9	22.4	15.9	20.0	31.1	24.9	14.3	10.1	13.7	16.6	24.8	36.6	32.9	16.0	26.6	19.1	16.1	22.2	16.8	15.9	18.2	15.1	20.0	15.2	36.6	12.5	23.3	25.2	15.3	12.9	24.1	20.9	14.9	17.8	9.9	17.8	18.9	14.7	1.6	4.3	2.6	1.2	0.4	3.3	0.7	17.6	13.5	20.8	26.5	12.7	16.8	13.5	20.4	13.5	29.6	20.9	18.4	9.6	12.0	16.0	17.2	8.3	23.6	36.8	20.2	16.5	14.8	29.5	18.5	21.2	22.3	14.3	32.6	17.8	14.9	16.0	19.6	20.9	19.2	13.8	24.4	28.7	11.5	16.3	30.6	27.3	22.5	24.1	13.1	40.8	26.3	16.2	22.0	17.5	12.9	51.0	25.3	16.6	21.1	10.1	14.7	14.7	11.6	13.8	45.5	12.0	24.3	29.9	22.9	22.0	20.5	13.5	29.7	16.1	0.6	0.9	0.3	2.1	0.8	3.0	1.5	1.5	1.7	1.2	1.6	2.7	3.3	2.6	0.4	1.2	4.3	0.5	0.7	37.1	35.7	33.1	42.1	31.1	24.9	24.8	36.6	22.2	20.9	6.0	19.9	11.8	8.5	27.5	38.9	15.9	17.8	6.7	9.1	21.0	94.2	9.1	5.0	8.3	9.5	17.5	10.5	0.0	7.3	5.6	14.7	12.6	3.5	15.3	8.9	54.0	22.0	18.4	11.3	15.4	28.7	9.5	8.5	10.8	17.0	24.7	13.1	5.8	30.4	14.6	32.2	6.5	17.8	24.7	10.0	36.3	12.1	11.5	15.0	8.0
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388516-40417950	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 146.3;testis: 36.8"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 280.4;Spermatocytes: 527.8;Spermatogonia: 241.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.7	2.0	0.4	20.0	0.5	14.6	4.1	0.4	0.5	3.0	6.9	0.5	0.5	7.0	2.0	3.4	18.2	0.7	2.4	2.3	0.6	0.5	1.4	1.9	5.5	15.4	0.6	0.4	1.2	1.1	0.0	0.4	10.7	0.6	1.2	8.0	0.6	3.2	0.3	0.6	5.9	9.2	2.6	1.8	7.3	4.5	36.8	0.3	146.3	0.9	11.8	16.7	3.2	5.7	1.3	0.3	0.3	0.3	3.2	5.7	1.1	34.3	45.6	58.1	26.6	2.9	5.9	12.9	47.1	25.4	43.4	38.5	21.4	26.3	55.4	24.0	15.9	26.0	54.7	44.6	18.8	58.3	29.5	29.8	36.6	29.2	35.6	0.2	51.2	39.0	1.3	1.5	30.5	31.1	9.4	22.8	36.1	39.5	38.0	46.8	11.9	59.3	34.4	24.1	24.9	18.2	50.4	90.2	23.0	10.4	22.0	34.3	24.7	38.0	47.5	15.0	35.3	39.8	23.6	14.9	28.6	40.4	33.0	45.2	21.8	24.6	48.3	16.1	35.3	47.7	0.3	0.0	0.0	0.6	0.0	0.0	1.3	0.9	0.9	0.3	0.4	0.2	0.1	0.3	3.2	0.3	0.0	5.7	1.1	0.4	0.5	0.4	0.5	0.6	0.5	0.6	0.4	0.6	0.3	0.0	1.3	28.7	1.4	10.4	0.0	1.1	2.5	0.0	6.8	0.0	0.0	8.4	0.0	0.9	12.5	0.7	2.1	280.4	0.0	81.4	9.7	1.2	0.0	3.9	64.5	0.0	0.0	27.6	30.0	15.2	4.4	13.1	1.7	2.8	5.9	0.0	0.2	3.6	1.8	0.0	0.0	71.1	1.4	527.8	241.9	5.4	7.4	7.7	24.2	2.6
TRAF6	RNF85	ENSG00000175104	"TNF receptor associated factor 6"	Q9Y4K3	11	36487027-36510272	"Enzymes, Predicted intracellular proteins"	"DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004605, HPA019805, HPA020599"	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.07e-1)"	13.0	11.0	12.9	8.5	17.0	31.8	11.9	18.1	15.0	10.6	10.7	13.6	8.2	9.5	12.9	9.8	12.4	11.5	9.4	13.9	9.8	7.1	11.2	12.3	15.2	9.2	14.8	10.6	14.6	11.3	11.0	11.9	10.3	12.7	9.6	10.5	10.5	11.0	9.3	13.9	12.7	12.5	12.1	10.1	13.0	10.3	15.0	12.8	18.5	15.6	6.7	10.8	11.3	13.0	10.6	7.7	27.7	11.4	9.6	13.1	8.5	5.2	6.6	12.9	7.2	12.2	8.9	5.6	7.9	8.6	7.4	9.6	5.8	3.5	6.9	4.9	8.4	8.5	9.9	10.2	8.0	12.2	11.3	11.9	6.6	5.2	5.2	7.8	7.3	8.2	8.2	11.3	3.9	12.1	7.2	10.3	9.3	9.9	7.6	9.2	6.4	11.7	4.0	7.0	6.0	6.1	7.8	17.5	3.9	8.9	10.9	2.1	11.3	7.9	7.7	5.6	9.0	8.9	7.2	8.1	10.5	9.3	9.6	9.6	8.8	7.4	7.5	5.9	5.3	7.8	27.7	8.0	20.9	11.9	11.4	11.7	10.6	10.3	11.6	7.7	8.1	10.0	13.1	11.1	9.6	8.2	4.5	8.0	8.5	12.9	17.0	18.1	15.0	9.8	7.1	14.8	10.6	12.7	12.8	8.9	6.1	5.0	10.6	11.3	2.6	6.9	10.2	1.4	1.2	3.5	5.9	5.6	5.0	7.6	3.2	9.2	7.2	0.0	6.4	5.2	6.0	9.7	18.5	5.6	6.2	7.9	4.1	20.3	8.1	2.7	2.3	6.6	6.8	11.8	5.5	3.9	5.9	5.7	3.9	4.3	2.6	12.9	10.5	9.1	8.3	10.9	5.4	8.5	3.2	10.6
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923989	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA048684: AB_2680493, HPA053408: AB_2682139"	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (2.71e-4)"	11.5	10.6	8.8	25.5	9.7	7.9	9.3	10.1	12.2	11.2	10.2	8.7	20.2	23.8	12.1	13.2	7.8	12.1	11.4	8.1	8.2	9.6	10.1	22.5	10.4	17.4	12.6	8.3	14.7	31.0	7.4	13.9	13.7	10.6	13.7	4.6	7.7	17.0	25.2	12.2	9.7	19.4	9.2	8.4	18.6	18.5	9.2	9.2	16.7	12.5	7.9	12.1	9.9	11.8	12.5	12.5	13.8	13.9	11.2	15.9	13.8	3.3	2.3	1.0	6.1	0.8	1.7	0.7	4.6	1.1	1.4	1.7	1.7	1.4	7.7	8.0	1.3	3.0	7.4	1.1	2.7	0.1	3.0	13.1	11.0	0.5	2.3	1.3	4.6	1.7	1.3	1.7	1.2	0.5	0.1	1.2	8.0	10.6	3.3	0.4	1.3	6.4	2.4	0.0	2.1	7.4	9.1	7.0	14.3	1.1	1.1	3.3	13.1	5.6	3.4	7.4	0.3	3.3	3.6	4.0	3.5	7.1	6.3	2.7	12.2	14.6	12.2	1.8	11.7	5.2	12.6	13.8	8.8	12.7	13.9	15.9	12.5	12.6	14.4	12.5	10.5	11.8	12.1	13.8	11.2	12.1	9.8	10.4	13.8	8.8	9.7	10.1	12.2	8.2	9.6	12.6	8.3	10.6	9.2	14.9	21.9	30.9	26.1	25.2	11.0	14.9	30.6	24.1	19.4	27.9	15.7	41.3	18.3	35.7	9.4	29.1	15.7	23.3	37.7	49.1	24.4	31.4	20.8	36.5	36.4	7.9	26.5	25.2	23.8	4.4	22.2	24.5	8.5	25.2	24.4	9.8	42.8	19.5	17.3	24.1	13.1	19.4	21.1	5.1	11.2	17.1	38.1	26.2	24.4	24.0
TRIM34	RNF21	ENSG00000258659	"Tripartite motif containing 34"	Q9BYJ4	11	5619764-5644398	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"	24	"Ciliated cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.5;SK-BR-3: 17.6"									HPA077996			Approved	Nucleoli,Centrosome		NA	NA			Centrosome	Nucleoli	"HPA077996: AB_2686873"	"unprognostic (8.66e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.16e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-1)"	"unprognostic (6.76e-2)"	15.9	14.6	2.7	12.2	2.9	1.4	7.3	0.9	3.4	9.3	7.9	6.0	8.5	6.6	15.7	10.6	8.7	7.8	5.6	4.1	3.6	2.2	7.1	4.4	7.9	11.7	2.6	3.9	11.4	5.5	4.5	5.5	8.7	4.7	9.5	6.8	7.8	10.2	6.3	2.0	6.2	14.2	5.8	6.2	16.6	6.1	4.6	4.3	12.5	7.0	5.0	14.3	10.0	7.8	12.8	15.9	15.2	15.9	5.9	9.5	7.8	2.3	1.3	0.5	0.2	5.3	8.3	16.5	3.5	10.2	9.1	8.9	1.0	8.1	8.1	1.6	4.7	6.8	3.7	0.3	7.5	4.6	10.6	0.3	4.3	0.4	0.4	2.4	4.7	3.0	8.7	6.5	4.6	1.5	7.1	11.6	7.2	0.2	0.6	4.3	1.0	4.2	2.7	0.0	3.2	0.7	6.3	0.3	0.5	5.4	6.2	0.0	0.0	0.1	17.6	2.6	1.6	3.1	2.3	9.3	2.4	0.5	0.9	1.3	0.9	1.1	3.1	6.8	0.6	1.2	8.7	14.3	3.6	5.6	15.9	6.1	12.6	5.4	6.9	15.9	12.8	6.8	5.7	15.2	5.9	13.5	8.1	9.5	7.8	2.7	2.9	0.9	3.4	3.6	2.2	2.6	3.9	4.7	4.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TRIM41	"MGC1127, RINCK"	ENSG00000146063	"Tripartite motif containing 41"	Q8WV44	5	181222499-181235809	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024204	Approved		Supported	"Nucleoli,Nuclear bodies"		NA	NA			"Nucleoli, Nuclear bodies"		"HPA024204: AB_1858299"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.56e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (2.68e-2)"	10.0	8.3	25.5	9.4	24.3	9.3	5.4	7.3	17.0	6.9	6.5	19.8	8.8	11.2	6.1	8.3	7.3	8.4	7.0	9.8	26.9	20.4	10.7	7.6	6.9	6.0	37.3	12.5	5.9	12.3	18.8	7.6	7.3	17.0	7.0	4.0	7.8	8.3	8.4	30.0	9.0	9.0	5.3	43.7	7.5	9.5	19.1	18.3	10.6	11.3	7.2	7.2	5.8	5.2	2.2	2.4	3.9	2.3	1.9	4.3	1.4	4.6	12.3	4.6	7.6	5.4	5.4	10.8	6.9	3.7	5.1	4.8	10.3	7.1	7.9	11.3	4.7	9.5	8.9	4.7	16.5	2.8	39.0	15.1	9.0	12.1	5.8	5.2	6.6	6.2	4.7	8.5	6.3	2.3	4.9	2.9	12.3	11.2	9.9	2.8	16.8	9.9	7.4	4.3	3.5	5.9	9.4	7.0	10.3	2.9	7.5	7.1	6.7	6.3	7.5	9.6	2.1	15.0	7.5	6.0	7.0	4.7	4.1	5.2	21.7	13.7	11.2	7.3	7.8	5.8	0.9	1.4	2.2	2.4	1.1	3.6	1.9	2.5	4.3	1.6	2.2	2.6	3.1	3.9	1.9	2.3	2.4	3.2	1.4	25.5	24.3	7.3	17.0	26.9	20.4	37.3	12.5	17.0	18.3	3.0	14.3	11.3	9.2	7.1	18.9	11.3	7.6	20.1	10.3	10.4	17.7	12.2	10.0	7.4	5.5	9.2	10.7	0.0	10.6	7.8	6.2	7.5	2.3	19.5	7.7	27.0	12.2	11.6	12.3	2.6	4.9	6.7	8.5	8.2	12.0	14.5	8.9	10.1	11.0	6.7	27.6	0.0	7.5	32.2	19.0	9.8	10.9	12.7	10.6	5.8
TRIM51	"SPRYD5, TRIM51A"	ENSG00000124900	"Tripartite motif-containing 51"	Q9BSJ1	11	55883297-55891810	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"blood: 11.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	50	"melanoma: 4.3"					"Cell type enriched"	"Detected in single"	111	"basophil: 11.0"	"Lineage enriched"	"Detected in single"	111	"granulocytes: 11.0"	"Group enriched"	"Detected in some"	124	"SK-MEL-30: 36.0;WM-115: 9.2"									"HPA044988, HPA077883"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA044988: AB_2679171, HPA077883: AB_2732362"									"unprognostic (9.60e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.8	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.1	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM52	RNF102	ENSG00000183718	"Tripartite motif containing 52"	Q96A61	5	181254417-181261139	"Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA054565, HPA056819"	Approved		Approved	"Nucleoli,Intermediate filaments"		NA	NA			Nucleoli	"Intermediate filaments"	"HPA054565: AB_2682525, HPA056819: AB_2683245"	"unprognostic (1.21e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.23e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.24e-3)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (2.96e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (4.07e-4)"	9.2	13.0	17.8	15.3	19.7	10.9	11.5	42.3	24.2	10.9	10.9	9.8	15.4	11.8	12.1	14.3	6.6	10.3	8.2	9.1	15.0	10.5	11.2	9.7	11.0	18.8	18.0	12.0	17.7	14.6	15.3	19.4	8.6	16.2	13.8	10.2	8.1	14.0	15.6	9.8	14.5	12.6	8.3	14.0	16.9	11.3	11.7	20.8	15.3	16.8	5.0	13.9	10.3	15.1	5.4	2.7	5.6	2.5	5.5	11.2	3.7	3.6	4.2	6.8	8.8	12.4	7.9	6.1	4.0	3.5	3.9	3.4	6.0	6.7	7.9	4.4	4.3	10.6	6.7	3.7	5.3	4.6	13.4	7.8	3.0	15.9	5.1	3.0	9.2	7.0	7.9	4.5	4.2	2.4	6.4	4.6	11.7	3.2	18.6	4.0	6.9	5.0	8.4	2.4	4.1	5.5	6.0	3.7	5.4	3.2	4.8	7.8	6.3	5.7	4.1	3.6	6.3	7.7	6.3	5.6	7.9	4.1	3.7	3.7	13.7	6.7	5.4	8.9	8.1	3.0	5.0	2.5	5.6	8.4	2.2	9.3	5.4	9.0	9.2	2.0	4.2	11.2	8.9	2.6	5.5	2.0	2.7	5.9	3.7	17.8	19.7	42.3	24.2	15.0	10.5	18.0	12.0	16.2	20.8	17.9	20.5	8.3	5.9	7.8	26.6	6.6	7.6	16.0	23.9	7.0	37.3	3.1	3.3	3.0	24.4	10.1	6.7	0.0	2.2	1.0	9.3	5.3	17.3	2.6	3.6	27.0	8.6	8.6	6.2	3.6	11.8	8.7	5.0	3.6	6.8	19.8	2.1	5.9	8.9	2.8	42.6	0.0	14.8	14.9	6.4	5.4	3.5	10.2	7.5	3.4
TRIM6-TRIM34		ENSG00000258588	"TRIM6-TRIM34 readthrough"		11	5596725-5644398	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"kidney: 30.3;salivary gland: 9.5;testis: 8.0"	"Cell type enriched"	"Detected in single"	9	"Ciliated cells: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"A549: 10.1"									HPA077996			Uncertain	Nucleoli,Centrosome		NA	NA			Centrosome	Nucleoli	"HPA077996: AB_2686873"																		0.9	0.7	0.4	0.6	0.4	0.1	0.9	0.4	0.4	1.4	0.4	0.0	0.7	0.8	1.5	1.6	1.9	0.7	0.2	1.4	0.4	0.3	30.3	0.4	0.7	0.1	0.3	0.0	1.7	2.7	1.1	0.4	1.4	0.3	1.5	0.2	2.2	9.5	1.9	0.4	0.4	0.6	1.9	0.4	1.1	0.4	8.0	0.0	0.0	1.7	0.0	1.5	1.1	0.5	0.5	1.5	1.3	0.8	0.9	0.2	0.2	0.0	10.1	0.0	0.0	0.2	0.8	1.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	1.1	0.0	0.0	0.7	0.6	0.6	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	0.2	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.2	0.2	0.1	0.4	0.0	0.1	1.5	0.5	0.1	0.1	1.3	0.9	0.4	0.3	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRMT1L	C1orf25	ENSG00000121486	"TRNA methyltransferase 1 like"	Q7Z2T5	1	185118098-185157072	"Predicted intracellular proteins"	"Behavior, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026728	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA026728: AB_1845641"	"unprognostic (1.07e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.26e-1)"	7.6	12.9	9.4	10.1	12.8	5.9	8.9	14.2	11.3	10.5	10.0	9.6	9.6	9.6	9.3	11.3	10.5	12.6	8.2	13.2	10.3	10.6	15.3	16.0	10.3	11.1	11.2	9.1	13.7	8.3	18.0	26.9	9.7	11.9	11.7	8.5	5.2	7.6	10.0	27.4	5.5	8.7	8.5	12.4	12.8	8.4	29.4	12.8	16.5	12.4	7.6	13.0	11.8	12.2	16.2	12.1	19.0	15.8	11.0	12.7	8.1	7.8	14.5	10.0	7.5	14.8	13.6	14.2	7.6	6.9	10.4	11.0	13.1	15.2	8.6	19.1	5.2	16.0	10.2	16.8	10.0	10.3	10.2	7.3	8.2	11.0	13.3	10.3	12.1	13.7	6.5	13.6	10.6	10.8	11.1	11.4	11.7	21.6	11.9	12.4	6.6	9.2	7.1	16.5	16.2	3.0	10.9	14.4	13.7	10.0	8.8	8.9	7.9	14.8	14.5	10.3	23.9	14.8	6.8	11.0	9.6	7.7	6.6	10.2	19.1	25.6	13.7	6.3	10.8	9.2	16.8	9.8	19.0	7.4	13.4	7.9	11.7	9.7	8.9	12.1	16.2	12.2	9.5	11.1	11.0	15.8	5.1	12.7	8.1	9.4	12.8	14.2	11.3	10.3	10.6	11.2	9.1	11.9	12.8	11.9	10.4	9.8	7.8	2.4	8.7	25.8	10.2	45.5	15.9	15.7	7.9	13.5	23.2	9.3	32.0	7.0	7.9	0.0	5.3	9.1	7.4	5.4	8.1	20.2	11.2	3.2	5.8	8.6	13.7	15.5	11.5	12.8	1.7	18.0	7.9	9.5	6.6	10.5	11.3	18.8	8.2	0.0	5.2	83.9	26.0	2.0	9.5	7.5	7.1	4.7
TRMT5	"KIAA1393, TRM5"	ENSG00000126814	"TRNA methyltransferase 5"	Q32P41	14	60971451-60981358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000943	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA000943: AB_1080388"	"unprognostic (1.58e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.82e-3)"	"unprognostic (4.50e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	15.8	10.1	7.9	13.8	12.1	5.4	12.9	9.3	11.8	10.9	8.6	5.7	11.9	7.5	12.0	10.9	11.1	10.0	6.7	6.8	7.7	7.1	12.5	13.9	6.6	7.3	6.7	8.3	17.1	11.1	15.9	13.1	10.8	9.0	10.6	8.1	4.8	11.5	9.9	14.8	9.7	7.4	9.2	6.3	8.6	8.1	24.9	5.9	12.4	10.4	12.1	7.2	13.3	9.0	7.2	7.4	0.9	7.5	2.0	6.0	3.7	28.9	7.4	10.9	15.2	9.7	14.5	11.9	10.9	8.4	11.7	9.4	5.4	17.4	14.9	12.2	7.9	8.8	13.4	13.7	15.8	15.4	14.7	6.9	10.9	5.0	6.0	15.8	19.3	6.1	11.4	15.3	10.6	15.8	10.4	10.2	13.0	14.2	5.4	17.1	10.9	9.9	9.7	10.0	11.3	12.3	3.2	25.3	12.6	9.9	9.9	13.4	13.3	12.1	12.2	9.7	9.9	20.4	11.6	9.6	13.6	16.5	9.6	10.4	3.3	6.1	7.0	9.5	4.2	12.6	0.1	4.6	0.9	3.5	7.5	5.0	7.2	5.2	5.2	4.2	4.9	5.6	5.1	0.4	2.0	7.5	7.4	6.0	3.7	7.9	12.1	9.3	11.8	7.7	7.1	6.7	8.3	9.0	5.9	6.0	7.5	8.3	16.7	5.7	5.0	7.1	0.0	18.7	25.0	10.4	3.9	11.0	1.7	7.1	162.4	8.6	2.9	0.0	6.5	11.6	7.7	5.7	5.8	5.9	9.5	3.2	5.2	11.6	6.1	35.3	10.3	8.2	6.8	4.6	7.3	10.4	7.2	3.5	7.1	8.8	4.5	12.9	6.2	10.9	10.9	3.8	16.0	4.6	7.1	10.7
TSEN15	C1orf19	ENSG00000198860	"TRNA splicing endonuclease subunit 15"	Q8WW01	1	184051651-184123978	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029237	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA029237: AB_10671361"	"unprognostic (4.54e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.72e-3)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.82e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.82e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.66e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-1)"	14.2	17.5	20.6	13.2	22.1	16.2	17.3	14.0	34.0	16.4	16.8	25.4	7.8	11.2	16.7	24.5	12.7	13.9	12.3	17.2	22.1	19.0	12.8	14.2	15.9	16.3	27.6	16.6	15.0	19.2	13.0	13.4	16.0	20.7	16.3	11.8	13.2	13.9	14.5	31.8	13.7	10.3	15.0	34.5	13.4	13.9	12.4	24.2	20.8	19.4	15.4	15.2	13.7	12.5	14.0	20.2	15.9	14.2	28.2	21.9	17.6	22.7	7.6	9.9	12.2	8.3	7.9	28.2	10.9	19.6	16.5	16.3	7.1	9.9	14.8	12.0	12.2	10.1	10.5	10.7	9.2	16.9	21.7	6.8	6.7	5.7	9.4	15.3	26.4	9.4	5.4	17.9	7.2	15.1	6.7	9.2	25.6	14.9	41.5	14.6	11.0	26.3	13.4	21.2	27.1	8.6	16.7	16.5	31.3	10.5	7.6	10.3	15.2	14.3	11.4	27.6	10.9	14.4	16.6	4.7	11.0	24.8	7.5	17.4	56.5	38.6	22.6	10.5	14.8	23.9	15.9	9.8	13.5	20.4	14.2	17.6	14.0	19.3	20.9	20.2	10.4	15.0	20.4	1.8	28.2	13.0	18.1	21.9	17.6	20.6	22.1	14.0	34.0	22.1	19.0	27.6	16.6	20.7	24.2	44.7	7.2	17.1	10.6	9.8	8.6	28.6	10.2	6.7	14.8	12.2	3.9	38.5	46.4	27.7	1.2	12.0	3.3	0.0	36.4	40.6	19.8	10.9	31.2	33.9	27.3	3.2	6.4	17.8	13.1	1.7	20.1	20.1	32.1	24.4	7.9	13.0	30.5	3.5	18.4	51.8	12.1	12.9	20.6	40.8	50.7	11.5	18.9	35.9	10.2	9.5
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116276578-116279903	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031970	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favorable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	14.0	34.1	38.3	9.8	67.2	18.5	14.4	49.1	64.5	15.2	12.8	9.8	20.1	14.7	13.9	21.4	15.4	20.3	12.9	21.4	34.6	36.6	31.5	23.5	12.9	11.8	21.8	49.8	22.9	17.6	41.3	17.2	9.7	31.1	27.1	11.3	13.3	17.2	22.6	61.6	11.2	12.9	17.1	11.5	15.6	15.3	12.9	12.2	9.8	25.0	15.5	15.2	14.6	12.9	30.7	24.6	52.9	29.4	17.4	36.2	17.0	13.2	13.0	16.8	30.6	29.8	19.7	14.1	21.3	21.3	19.6	22.5	16.8	9.7	28.4	26.8	24.6	17.6	23.5	13.2	36.4	21.0	11.5	34.4	11.4	19.3	30.4	18.9	18.7	6.9	23.0	28.5	20.1	19.6	20.4	18.6	12.6	20.1	22.1	27.2	29.1	12.4	11.0	8.3	12.7	12.2	11.5	14.5	15.5	33.8	25.9	14.8	14.6	17.7	23.8	10.2	19.9	31.3	23.3	22.4	13.2	11.8	10.6	23.0	12.1	13.1	15.6	21.8	12.2	8.5	52.9	17.8	27.2	24.2	27.7	36.2	25.9	31.7	26.7	14.3	30.7	31.3	30.4	13.5	17.4	29.4	24.6	23.7	17.0	38.3	67.2	49.1	64.5	34.6	36.6	21.8	49.8	31.1	12.2	32.8	41.6	47.2	90.2	147.6	76.3	93.6	53.5	20.1	39.8	99.5	25.5	48.1	131.0	34.9	24.0	35.6	43.4	0.0	38.5	23.1	50.3	71.7	31.1	71.3	35.6	36.5	71.6	63.3	55.3	16.8	69.9	47.1	82.7	28.9	56.9	82.6	40.7	56.1	89.8	169.2	50.8	129.4	74.1	48.1	24.5	141.5	49.9	52.4	55.2	61.6
TTC27	FLJ20272	ENSG00000018699	"Tetratricopeptide repeat domain 27"	Q6P3X3	2	32628032-32821051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031246	Approved		Approved	Nucleoli,Mitochondria		No	No		11000	Mitochondria	Nucleoli	"HPA031246: AB_10603139"	"unprognostic (3.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (6.28e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	18.4	18.2	7.0	18.8	11.5	9.9	17.8	8.6	10.7	16.4	11.9	16.1	12.0	8.2	25.1	13.6	17.5	14.7	8.5	14.3	8.2	6.9	11.0	15.7	10.8	13.6	12.5	8.1	18.6	17.7	15.7	19.4	11.9	8.9	14.7	13.1	13.2	17.2	14.7	18.7	16.8	11.0	15.3	11.0	19.3	13.4	17.4	10.3	16.4	14.9	15.5	20.4	14.6	14.6	9.6	9.6	0.3	9.0	8.4	12.5	5.7	22.0	10.7	7.4	5.8	6.2	12.7	3.8	9.2	7.6	14.2	12.5	16.5	13.4	19.3	8.3	13.8	14.8	11.1	11.9	14.3	20.9	9.2	14.6	21.9	5.9	22.4	12.1	20.9	11.6	8.4	13.2	17.2	18.7	7.1	12.9	4.9	30.1	5.7	12.7	8.8	16.5	7.3	13.6	10.0	11.2	11.1	16.2	16.9	11.0	12.9	6.2	8.9	7.6	7.2	8.5	9.0	8.8	5.0	10.7	9.1	10.0	10.7	15.7	8.3	2.1	21.9	9.8	16.3	9.7	0.0	4.5	0.0	9.1	9.0	10.0	9.3	10.0	8.9	9.6	9.6	12.5	9.8	0.3	8.4	6.1	4.7	8.7	5.7	7.0	11.5	8.6	10.7	8.2	6.9	12.5	8.1	8.9	10.3	8.9	7.2	4.5	8.0	4.9	5.4	6.7	0.0	16.0	9.1	0.0	3.9	10.8	6.6	7.7	14.7	6.3	1.7	0.0	8.3	10.2	6.2	5.0	11.5	3.9	7.0	3.2	7.0	4.3	7.2	0.9	7.8	4.6	5.0	7.2	4.6	4.6	5.3	5.9	6.7	3.8	5.6	6.5	7.1	18.4	10.4	5.0	5.4	6.1	7.6	5.4
TTC28	KIAA1043	ENSG00000100154	"Tetratricopeptide repeat domain 28"	Q96AY4	22	27978014-28679865	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 42.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003099			Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA003099: AB_1079195"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (4.30e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (4.36e-1)"	4.6	3.0	1.4	1.1	2.0	0.0	4.2	0.6	1.3	6.0	4.1			1.4	7.6	6.5	3.0	5.7	3.7	2.8	1.2	1.0	2.8	2.1	4.7	0.5	0.9		11.8	2.7	3.2	2.4	5.4		3.3	1.3		3.7	4.4	2.6	1.6	2.1	5.3	1.0	1.6	3.1	5.0			4.3		0.2	4.3	3.4	1.0	2.5	0.4	0.2	0.9	0.6	0.5	0.0	5.3	13.8	5.9	8.3	12.4	0.3	4.0	7.5	5.7	5.0	0.4	0.0	0.0	5.6	11.7	1.9	0.8	8.9	0.2	3.1	0.5	5.9	0.8	6.7	5.0	3.8	0.1	5.5	12.3	0.3	3.7	2.6	3.9	10.4	3.6	3.4	0.5	1.3	1.9	0.1	0.4	2.5	0.0	3.4	5.4	3.5	0.1	2.7	0.2	3.9	8.6	5.6	0.2	3.7	4.0	2.8	0.5	9.6	6.8	3.4	4.4	3.0	1.8	0.2	0.1	2.4	0.1	2.9	0.4	0.2	0.1	0.5	0.1	0.3	0.3	0.4	0.3	0.3	1.0	0.6	0.5	0.4	0.9	0.2	2.5	0.1	0.5											3.0	12.2	2.0	4.6	5.4	32.1	8.9	7.6	2.7	2.3	12.2	17.7	4.5	0.0	4.3	7.2	28.6	2.6	0.0	5.2	1.2	19.2	5.3	1.1	12.4	3.2	27.0	8.6	29.4	5.9	5.6	29.1	4.8	10.1	1.0	4.9	12.1	5.1	5.1	42.8	14.1	22.1	12.9	18.6	22.9	11.4	3.3	2.1	4.9	6.7	3.0
TTF1		ENSG00000125482	"Transcription termination factor 1"	Q15361	9	132375548-132406851	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"DNA replication inhibitor, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA054837	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA054837: AB_2682621"	"unprognostic (7.07e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.71e-2)"	10.3	6.6	9.9	12.6	14.6	18.0	12.5	15.0	13.4	10.3	12.1	8.5	13.8	6.2	11.9	12.1	8.5	9.6	6.8	16.6	9.8	8.5	8.3	6.2	8.9	12.2	10.4	11.3	11.8	8.7	8.7	15.4	8.3	14.1	13.4	8.8	6.8	9.0	10.1	18.0	9.3	8.6	9.5	13.5	9.7	8.7	11.6	12.7	15.1	16.9	7.0	12.3	13.4	11.5	12.3	10.2	19.4	6.3	7.3	9.1	3.0	7.4	7.1	10.1	9.2	5.7	7.3	9.2	8.4	6.5	9.8	7.2	7.3	8.3	12.3	7.1	6.2	11.2	18.0	11.2	6.5	10.6	7.9	7.8	5.6	10.7	5.5	5.6	15.0	9.2	4.4	7.7	8.5	6.3	7.8	8.4	20.4	11.2	10.8	7.6	11.2	34.6	9.1	18.6	13.3	11.0	22.1	14.0	14.6	7.8	6.1	9.0	15.4	11.8	9.0	6.0	10.1	11.0	8.0	8.0	16.1	9.9	13.5	9.8	5.1	14.4	15.0	9.1	12.3	15.3	11.3	5.4	10.3	6.5	5.2	8.3	11.2	8.2	7.4	3.3	12.3	9.1	6.9	19.4	7.3	6.3	10.2	8.4	3.0	9.9	14.6	15.0	13.4	9.8	8.5	10.4	11.3	14.1	12.7	23.8	16.3	52.5	19.7	8.8	26.4	37.0	20.4	24.1	13.6	17.4	56.9	21.3	16.6	23.7	13.3	29.0	11.8	46.7	18.3	18.6	14.6	18.1	22.0	7.3	16.3	28.6	11.6	25.8	18.6	5.6	21.9	22.5	1.7	22.6	13.5	19.1	21.2	20.3	24.4	12.9	53.5	25.8	18.4	48.9	61.5	7.4	21.1	34.9	16.6	19.5
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.3;testis: 31.7"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 19.9;Erythroid cells: 23.3;Spermatocytes: 63.4;Spermatogonia: 28.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	1.1	1.4	0.3	3.2	0.4	13.9	1.0	0.3	0.4	1.0	2.7	0.2	0.2	2.2	0.5	1.0	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0.0	0.3	3.0	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2.0	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0.0	1.1	0.0	1.1	4.0	0.8	13.3	8.0	24.0	19.6	1.1	3.5	13.6	15.5	9.5	22.7	27.8	10.9	10.2	19.8	12.1	6.6	23.8	17.3	21.1	9.5	31.6	18.0	17.0	18.3	10.6	8.9	0.0	21.5	11.9	0.4	1.0	15.8	10.1	3.3	12.8	27.9	19.9	20.4	19.2	9.9	12.2	15.5	14.1	12.0	9.7	11.0	43.8	8.2	5.7	8.6	16.5	9.7	9.1	9.9	5.6	13.5	9.3	16.3	5.3	10.2	10.2	6.6	24.7	4.6	15.5	11.0	3.6	20.0	8.7	0.0	0.0	1.1	0.6	0.0	0.6	0.9	1.0	1.6	0.0	1.7	0.3	0.5	0.3	1.1	0.0	0.0	4.0	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2	3.0	0.6	0.0	0.5	1.1	0.0	0.7	0.0	4.0	3.4	0.0	2.0	4.1	3.3	0.4	19.9	0.1	0.2	23.3	0.2	13.1	0.8	0.2	1.1	0.0	5.2	0.0	1.7	0.0	2.4	12.8	0.9	1.2	0.0	9.0	1.0	0.3	0.4	0.0	0.7	0.0	1.2	6.5	0.2	63.4	28.5	0.3	3.1	0.0	1.2	0.7
TTLL1	C22orf7	ENSG00000100271	"Tubulin tyrosine ligase like 1"	O95922	22	43039644-43089428	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 24.1;Early spermatids: 30.7;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048392	Approved		Approved	Nucleoli,Mitochondria		No	No			Nucleoli	Mitochondria	"HPA048392: AB_2680384"	"unprognostic (1.02e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.18e-3)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (8.22e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	4.0	7.3	16.5	3.6	12.0	2.9	6.8	12.8	16.6	7.6	4.6	8.8	0.9	2.5	7.1	12.5	5.7	14.6	5.7	12.5	13.9	12.6	6.1	2.1	5.3	4.9	9.2	14.1	8.3	4.2	8.5	9.8	3.9	13.2	7.7	4.6	6.8	4.7	6.0	4.4	5.8	2.9	5.9	10.0	4.5	5.4	14.0	8.4	4.7	10.3	1.8	4.8	5.4	4.6	4.7	10.4	7.0	6.5	9.9	14.1	6.2	0.8	1.5	12.8	9.7	14.5	12.9	0.6	4.3	4.8	2.5	4.2	0.1	1.9	0.9	3.1	7.9	1.5	0.6	1.1	1.1	2.5	1.1	2.1	1.3	0.7	1.2	10.4	3.2	1.7	10.6	16.6	1.6	4.1	10.7	8.2	10.9	0.3	8.3	9.2	4.2	3.0	5.2	1.7	3.4	0.9	7.4	7.2	0.7	4.6	1.1	3.2	6.1	3.4	1.7	11.8	6.9	5.1	5.4	7.8	2.7	1.8	6.2	0.6	2.9	0.8	0.3	6.8	5.9	4.8	5.2	5.9	7.0	13.0	6.5	12.2	3.1	11.4	14.1	10.4	4.7	9.7	12.2	1.7	9.9	4.9	6.7	6.9	6.2	16.5	12.0	12.8	16.6	13.9	12.6	9.2	14.1	13.2	8.4	0.0	2.4	0.5	2.5	2.1	5.3	4.0	2.5	24.1	4.5	1.8	5.9	2.5	13.3	5.5	30.7	3.3	0.5	0.0	4.2	1.2	5.1	3.2	1.1	0.4	4.3	4.8	0.0	6.7	2.1	14.5	3.7	2.3	8.5	4.6	2.6	5.5	4.4	7.0	5.6	5.7	10.1	6.5	1.4	8.6	37.7	2.4	0.6	2.9	1.5	1.3
TTLL2	"C6orf104, dJ366N23.3, NYD-TSPG"	ENSG00000120440	"Tubulin tyrosine ligase like 2"	Q9BWV7	6	167325086-167359503	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"testis: 54.1"	"Group enriched"	"Detected in some"	167	"Early spermatids: 407.9;Late spermatids: 161.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 6.3"	"Not detected"	"Not detected"							HPA027985			Approved	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane, Nucleoli"		"HPA027985: AB_2211832"	"unprognostic (5.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.47e-4)"		"unprognostic (7.57e-2)"	"unprognostic (2.63e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.02e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	54.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.8	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	407.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0
TUB	rd5	ENSG00000166402	"Tubby bipartite transcription factor"	P50607	11	8019244-8106112	"Disease related genes, Predicted intracellular proteins"	"Phagocytosis, Sensory transduction"		Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 39.3;Horizontal cells: 28.6;Rod photoreceptor cells: 51.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 13.3;HEK 293: 18.2;HeLa: 24.3;SCLC-21H: 27.6;SH-SY5Y: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017997, HPA049019"	Enhanced		Approved	"Nucleoli,Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Centriolar satellite"	Nucleoli	"HPA017997: AB_1858449, HPA049019: AB_2680601"	"unprognostic (2.53e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.06e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.71e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (2.85e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.35e-5)"	"unprognostic (8.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-2)"	5.0	18.3	18.9	2.8	16.1	0.7	4.5	12.4	36.4	18.2	4.2	6.3	2.8	2.5	24.3	10.7	3.6	20.8	5.5	10.2	20.5	17.9	11.7	1.0	3.4	2.2	25.1	22.6	17.9	5.1	11.0	18.4	4.6	17.7	8.7	2.9	11.3	5.6	9.0	3.1	6.5	2.4	12.0	9.2	2.1	2.4	5.1	9.1	0.5	10.5	2.9	1.3	5.2	8.7	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.9	7.1	8.8	6.7	2.3	0.0	4.8	1.2	5.2	6.8	0.0	0.0	0.0	0.4	6.4	2.4	0.0	13.3	1.0	4.5	0.0	18.2	0.0	24.3	2.9	1.1	0.0	0.2	3.5	1.2	2.3	0.0	0.4	0.4	8.2	0.0	0.0	2.4	0.6	0.0	0.0	4.9	0.0	0.0	6.6	0.1	0.0	0.0	0.2	27.6	20.6	3.4	0.0	1.3	3.2	0.8	0.1	0.0	2.9	6.9	0.4	2.0	0.0	0.0	0.0	2.5	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.2	1.2	0.0	0.7	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.9	16.1	12.4	36.4	20.5	17.9	25.1	22.6	17.7	9.1	0.0	0.0	0.0	1.7	0.7	14.6	2.2	0.0	6.7	1.2	0.0	39.3	0.1	5.0	0.1	3.3	0.5	0.0	0.0	0.0	0.3	6.2	0.7	1.1	0.0	0.2	28.6	1.7	1.8	0.0	3.7	13.6	0.0	1.7	0.0	0.0	11.7	0.0	0.0	13.8	6.3	51.9	0.0	1.3	1.5	1.1	0.6	0.0	0.0	0.0	0.1
TWF1	"A6, PTK9"	ENSG00000151239	"Twinfilin actin binding protein 1"	Q12792	12	43793723-43806375	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018116	Approved		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA018116: AB_1855899"	"unprognostic (3.06e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (8.29e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.51e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.62e-1)"	14.2	15.8	15.1	11.0	15.8	11.8	20.4	7.8	13.5	17.9	19.7	8.5	33.1	20.5	13.3	15.4	39.5	13.8	14.8	6.7	14.9	11.9	17.6	31.3	12.6	13.7	16.1	9.6	15.7	21.0	8.8	23.5	14.0	14.6	14.6	20.5	4.6	14.8	32.1	3.5	10.7	24.1	16.0	15.7	10.0	16.9	9.7	12.7	7.1	25.0	19.1	9.6	18.3	19.4	7.8	5.4	10.1	5.2	14.7	8.7	4.1	26.4	19.8	10.3	12.5	27.0	31.3	25.2	37.4	30.7	30.3	23.0	31.7	37.3	7.2	34.8	35.6	17.7	18.1	14.1	26.5	43.2	2.4	16.5	6.6	16.8	15.0	22.1	7.6	8.6	21.3	21.7	31.4	35.2	38.6	26.4	3.6	7.2	8.1	47.0	14.1	3.6	5.2	6.2	0.0	32.6	3.1	11.6	8.1	40.1	33.3	7.7	11.5	31.0	28.3	26.8	15.1	26.4	7.6	25.3	37.5	24.9	29.9	30.9	7.1	7.0	9.8	34.4	19.7	14.1	10.1	3.3	6.7	6.7	4.9	7.6	7.8	8.1	8.3	5.4	3.9	8.1	8.7	5.4	14.7	5.2	3.4	8.0	4.1	15.1	15.8	7.8	13.5	14.9	11.9	16.1	9.6	14.6	12.7	11.9	26.0	17.9	26.8	37.1	20.9	5.7	38.2	29.4	34.2	33.2	19.6	35.6	34.9	42.9	10.5	29.2	58.0	0.0	69.1	48.1	27.0	50.2	4.7	27.9	23.2	19.1	43.1	22.1	27.4	8.5	24.7	18.4	33.7	17.2	45.0	29.0	57.9	63.2	30.1	49.4	29.6	25.8	45.3	10.2	22.2	44.7	71.1	15.4	50.2	53.7
TWIST2	"bHLHa39, Dermo-1, DERMO1"	ENSG00000233608	"Twist family bHLH transcription factor 2"	Q8WVJ9	2	238848032-238910543	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 34.6"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 14.2;Fibroblasts: 25.5;Leydig cells: 44.5;Peritubular cells: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	21	"eosinophil: 11.2"	"Lineage enriched"	"Detected in single"	52	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 33.5;ASC TERT1: 21.3;BJ: 27.2;BJ hTERT+: 85.8;fHDF/TERT166: 38.9;U-2197: 33.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062870			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA062870: AB_2684888"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.83e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-9)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.48e-2)"	25.8	1.3	0.2	4.7	0.6	0.6	21.7	0.1	0.4	34.6	8.4	0.4	4.3	0.6	14.3	6.2	9.1	7.4	5.8	4.3	0.6	0.2	0.7	0.3	4.2	0.9	1.1	0.0	15.6	0.7	0.0	2.1	9.1	0.4	13.1	1.9	3.9	2.2	7.1	4.3	9.7	2.3	12.4	1.7	1.2	3.3	4.6	0.5	0.0	4.0	6.4	3.4	15.9	18.6	0.2	0.0	11.2	0.1	0.0	0.0	0.0	0.0	1.8	0.1	0.0	33.5	21.3	0.0	27.2	85.8	12.7	19.2	0.0	0.0	0.0	0.8	38.9	1.0	0.2	0.3	2.2	9.3	0.0	2.9	0.0	1.6	0.1	5.7	0.0	0.6	4.9	1.2	6.1	5.1	1.5	1.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.3	4.7	0.5	0.9	33.2	0.3	0.0	0.0	0.0	0.1	0.8	1.7	0.0	0.1	11.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.3	0.6	0.2	1.1	0.0	0.4	0.5	0.0	1.6	0.0	14.2	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.7	25.5	2.5	1.1	0.0	2.0	0.0	0.0	4.3	0.0	0.2	44.5	0.0	1.7	0.0	0.0	0.0	0.1	0.0	36.7	0.0	0.0	0.0	5.1	0.5	1.7	1.5	1.4	0.0	0.0	3.0
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.8"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 186.9;Extravillous trophoblasts: 82.9;Spermatocytes: 115.5;Spermatogonia: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	1.9	4.2	9.6	8.5	12.2	20.8	3.9	4.4	13.5	3.5	11.2	0.7	17.2	7.5	4.3	4.1	10.3	2.9	3.0	8.8	8.8	11.2	4.5	2.8	3.1	15.2	8.7	8.2	1.3	0.9	2.4	3.1	8.7	8.2	2.2	13.9	1.9	2.8	7.0	13.1	4.5	6.9	8.1	3.4	6.7	4.0	16.0	1.8	46.8	2.6	12.8	15.3	6.3	4.5	9.0	3.6	1.7	8.6	1.1	11.1	2.9	30.4	29.1	43.3	20.4	4.0	7.4	24.8	33.3	18.6	38.1	26.9	20.7	37.4	35.5	13.2	12.1	28.4	24.9	40.0	19.5	34.4	32.2	22.9	21.7	15.8	23.6	1.8	25.9	26.4	2.6	4.7	29.9	12.5	9.1	22.1	40.1	27.3	29.3	29.8	28.3	46.4	33.1	16.8	31.7	14.8	36.0	46.1	30.8	14.6	14.6	34.1	34.8	23.3	28.7	11.1	13.5	30.2	16.4	10.8	17.2	27.5	30.0	39.5	14.9	29.1	45.2	17.0	27.0	35.6	0.0	0.8	1.7	3.7	2.4	2.8	9.0	5.0	3.9	1.7	6.3	7.3	8.0	0.0	1.1	8.6	3.6	11.1	2.9	9.6	12.2	4.4	13.5	8.8	11.2	8.7	8.2	8.2	1.8	0.0	2.1	10.4	11.0	12.7	5.2	12.2	0.0	6.7	7.9	5.2	0.0	33.9	5.0	11.2	13.0	1.9	2.7	186.9	6.6	82.9	4.8	2.2	8.1	1.7	23.5	9.5	1.2	4.3	1.8	6.6	2.8	5.2	3.3	3.6	9.0	1.3	7.8	0.0	3.9	7.9	0.9	6.5	1.9	115.5	96.9	9.5	18.8	9.5	19.6	4.1
UBFD1	"FLJ38870, FLJ42145, UBPH"	ENSG00000103353	"Ubiquitin family domain containing 1"	O14562	16	23557362-23574389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051746			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA051746: AB_2681587"	"unprognostic (2.70e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.45e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.06e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.46e-1)"	10.2	16.2	11.9	8.9	13.0	7.1	10.0	23.1	19.5	11.7	9.2	9.4	15.2	6.1	16.4	14.9	9.6	13.9	11.8	21.2	11.3	17.6	12.3	15.4	7.6	8.7	13.0	11.8	14.5	17.5	28.5	17.2	16.5	13.6	12.5	9.4	12.3	12.3	12.6	52.8	7.6	7.0	14.6	7.4	9.1	8.1	27.6	7.0	16.2	16.4	11.1	11.7	10.9	12.9	2.8	4.1	1.0	1.9	3.0	4.0	1.1	6.5	14.8	21.1	15.2	24.2	30.2	19.8	20.2	16.6	16.1	15.2	11.2	11.2	14.5	31.6	24.7	10.9	9.0	33.2	13.4	20.8	24.0	19.6	7.5	13.4	24.4	12.9	7.9	14.6	21.5	10.1	15.7	14.8	24.9	15.5	11.8	19.1	8.0	17.7	13.6	11.2	14.3	50.3	10.7	6.6	20.5	13.0	11.9	15.1	5.5	21.0	19.2	6.7	13.1	11.8	21.1	17.9	11.7	16.4	9.1	10.5	9.8	10.5	12.0	12.0	8.8	16.6	9.5	13.7	0.0	1.3	1.0	4.0	1.9	2.3	1.6	2.8	3.9	3.0	2.8	1.7	2.3	0.0	3.0	1.0	4.1	2.3	1.1	11.9	13.0	23.1	19.5	11.3	17.6	13.0	11.8	13.6	7.0	6.0	1.6	3.0	8.4	7.8	11.4	31.3	10.2	5.3	3.4	19.2	21.6	16.4	13.3	11.9	38.7	10.5	5.5	0.0	9.9	21.4	13.5	12.6	0.0	16.6	11.5	6.4	6.9	4.3	7.5	54.1	17.3	4.3	10.1	10.8	9.3	10.8	9.0	7.6	9.2	13.6	14.1	25.8	8.2	20.4	22.5	12.4	30.1	5.3	8.6	10.7
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3 (putative)"	Q6ZT12	2	169827458-170084131	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.3"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 97.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	11.9	15.5	10.9	6.1	18.3	5.4	9.6	15.5	18.9	9.9	10.0	9.8	9.1	6.7	11.5	7.1	10.7	8.1	7.8	23.1	10.3	7.2	12.9	16.9	9.2	5.6	11.9	14.0	8.9	9.8	20.9	14.9	7.2	14.7	11.2	7.3	8.0	11.1	9.2	76.3	11.5	8.4	9.6	10.2	6.9	9.2	7.9	11.4	6.3	14.9	10.9	6.0	12.8	8.7	2.0	2.8	1.9	2.1	2.4	4.3	1.2	8.9	7.6	8.1	10.7	16.2	12.9	6.8	16.2	9.4	9.4	7.6	11.7	5.7	10.2	14.1	12.6	7.6	11.9	9.7	8.2	11.7	10.5	8.3	37.1	8.1	12.3	8.1	12.2	12.0	7.7	7.7	12.3	8.2	7.5	9.2	5.1	19.3	11.1	16.0	8.4	7.9	6.0	6.3	9.1	6.4	7.6	13.3	10.8	6.8	12.7	16.0	8.7	11.4	10.5	6.5	6.8	6.9	6.9	11.7	14.2	5.7	11.1	10.2	9.0	7.0	9.4	11.7	7.2	7.8	0.0	2.1	1.7	3.2	1.8	4.2	2.0	1.9	2.7	2.8	1.2	3.3	4.3	1.9	2.4	1.6	2.4	3.1	1.2	10.9	18.3	15.5	18.6	10.3	7.2	11.9	14.0	14.7	11.4	41.7	21.1	7.5	11.4	23.0	40.4	97.6	15.3	9.4	19.4	12.2	76.6	14.8	3.3	8.0	6.6	23.7	13.4	23.3	9.5	6.8	18.3	22.3	16.1	32.7	8.9	60.4	16.0	31.9	21.5	7.4	23.9	16.8	15.1	4.6	12.5	63.3	9.4	14.0	18.0	10.2	53.7	25.8	26.4	13.0	7.6	25.3	19.2	13.1	9.9	12.3
UBXN11	"SOC, SOCI, UBXD5"	ENSG00000158062	"UBX domain protein 11"	Q5T124	1	26281328-26318363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 103.4;Late spermatids: 252.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 32.4;intermediate monocyte: 28.1;myeloid DC: 16.6;non-classical monocyte: 22.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 16.6;monocytes: 32.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028600, HPA031357"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA028600: AB_10604001, HPA031357: AB_2673840"	"unprognostic (1.78e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (8.18e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.53e-1)"	"prognostic favorable (4.90e-4)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (8.41e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.59e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-2)"	5.4	7.6	16.6	10.2	25.7	18.9	5.6	7.0	21.5	8.6	4.6	7.9	9.0	4.2	6.7	23.8	4.3	35.4	8.4	5.9	17.0	15.0	9.3	3.7	12.0	8.2	9.8	12.3	9.7	8.2	8.4	18.3	5.2	12.7	5.4	3.5	13.6	8.3	8.3	6.2	6.0	4.4	5.0	5.6	11.7	4.8	27.4	8.5	6.2	15.7	2.7	5.7	6.1	3.9	5.3	16.6	2.4	32.4	1.9	5.7	13.2	17.4	7.9	3.9	7.9	2.9	2.2	13.7	3.9	6.1	10.8	7.9	3.1	15.5	10.2	5.9	2.4	7.2	9.5	2.4	6.3	2.8	5.1	9.3	1.7	11.2	7.5	5.1	7.4	3.5	3.3	6.8	18.2	4.6	3.4	3.0	7.5	6.6	7.1	3.6	7.8	4.2	3.6	7.9	4.9	6.1	8.7	2.9	9.2	6.0	2.6	18.7	4.4	9.6	9.1	6.7	2.1	7.0	7.2	2.8	6.3	9.5	9.3	5.7	6.7	19.0	11.6	7.7	10.3	5.1	0.7	32.4	1.5	3.4	28.1	4.1	4.4	5.0	3.9	16.6	5.3	5.7	3.6	2.4	1.9	22.5	2.5	4.1	13.2	16.6	25.7	7.0	21.5	17.0	15.0	9.8	12.3	12.7	8.5	0.0	1.4	9.1	13.3	19.1	9.8	1.1	7.6	17.4	7.9	22.7	21.6	7.5	11.6	11.5	103.4	4.4	1.7	0.0	7.5	17.4	10.8	8.6	10.3	2.4	19.7	22.3	8.6	7.4	69.6	252.6	11.8	30.3	10.1	3.6	4.3	12.1	6.8	2.9	9.6	21.2	50.8	19.4	7.8	13.9	22.6	11.7	6.1	13.1	5.6	11.0
UCK1	"FLJ12255, URK1"	ENSG00000130717	"Uridine-cytidine kinase 1"	Q9HA47	9	131523801-131531268	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050969, HPA070526"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA050969: AB_2681294, HPA070526: "	"unprognostic (2.20e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (5.11e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-1)"	13.2	15.9	21.7	13.7	22.5	13.7	15.6	29.9	23.2	15.0	15.6	17.3	20.8	11.4	12.2	19.3	14.5	17.6	16.5	21.0	19.6	18.4	18.3	26.7	12.7	12.9	20.4	19.1	21.3	24.0	17.6	14.4	16.4	14.8	14.9	9.2	17.6	24.1	18.3	30.0	12.0	12.2	14.8	19.9	12.1	13.4	15.7	15.6	12.5	18.5	10.8	11.5	13.6	9.4	7.9	6.6	9.4	7.8	6.8	13.5	6.1	7.0	15.7	18.2	23.3	12.9	9.2	15.5	11.5	17.0	20.0	15.2	15.6	6.5	7.7	7.0	13.8	15.6	13.8	16.9	14.7	8.6	14.1	15.7	7.2	23.6	9.8	18.5	11.8	10.7	10.3	13.9	16.1	11.7	12.1	12.2	19.2	9.0	5.9	14.6	28.2	16.0	6.0	21.5	13.9	15.7	15.4	28.1	12.9	12.8	6.7	24.6	15.5	16.6	12.7	17.9	8.7	24.8	7.0	8.9	22.2	11.3	13.7	11.2	12.2	15.6	9.8	11.0	8.3	15.4	2.3	6.2	9.4	8.5	7.8	11.3	7.9	10.1	7.6	5.7	7.9	13.5	6.8	4.1	6.8	2.7	6.6	12.3	6.1	21.7	22.5	29.9	23.2	19.6	18.4	20.4	19.1	14.8	15.6	14.9	5.3	14.9	10.3	12.7	17.5	12.9	7.6	0.0	3.4	14.0	7.9	26.0	24.9	19.6	15.1	13.4	17.0	0.0	22.9	12.0	15.5	11.2	2.3	19.4	22.3	25.4	11.6	11.1	11.1	20.2	16.4	8.2	15.1	27.1	11.8	17.7	15.6	11.6	18.7	23.7	10.2	19.4	18.9	29.3	29.4	10.9	21.5	9.6	11.8	7.1
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568361	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 117.3;Late spermatids: 116.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	10.4	8.4	9.2	9.7	10.5	19.2	9.0	16.2	10.0	8.3	6.6	10.4	8.0	5.8	9.6	15.8	8.2	7.8	7.0	6.9	7.4	5.5	6.1	7.4	8.1	10.5	8.7	7.8	15.3	6.9	10.7	17.1	8.5	8.7	7.3	7.0	7.4	9.7	9.6	11.1	9.9	7.2	8.1	10.2	7.0	6.6	22.2	10.5	13.4	9.8	5.4	9.4	10.5	9.1	7.4	6.1	7.4	4.8	5.9	9.0	2.5	7.4	5.4	11.5	8.8	3.0	3.7	9.8	5.7	4.1	9.9	11.2	10.2	5.9	6.8	6.2	4.4	7.6	7.1	12.5	6.3	10.9	9.2	6.6	18.3	11.0	6.7	3.4	11.9	9.2	2.0	3.8	10.4	7.5	3.6	4.2	11.9	13.2	13.1	6.2	5.5	15.3	8.2	9.8	4.8	4.7	12.4	17.2	6.2	3.4	8.8	12.6	6.8	9.1	4.5	5.7	11.5	5.2	8.4	5.4	11.2	9.8	6.2	7.4	8.9	7.9	13.9	6.0	8.8	7.6	6.5	4.2	7.4	7.0	4.8	7.3	5.4	5.8	5.9	4.4	7.4	9.0	5.7	3.5	5.9	4.4	6.1	7.3	2.5	9.2	10.5	16.2	10.0	7.4	5.5	8.7	7.8	8.7	10.5	0.0	8.3	11.5	5.5	17.3	16.4	3.3	2.5	10.7	10.3	7.0	25.5	6.1	0.0	4.6	117.3	9.0	5.1	0.0	2.0	5.4	9.3	10.2	4.7	10.2	6.5	14.3	9.9	11.6	8.1	116.2	9.2	13.7	20.3	5.4	8.1	9.9	4.6	6.8	9.2	3.6	21.1	6.5	10.3	40.0	12.8	18.1	6.1	17.9	7.0	5.8
USP46	FLJ12552	ENSG00000109189	"Ubiquitin specific peptidase 46"	P62068	4	52590972-52659335	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Behavior, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 123.5;Early spermatids: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA007288, CAB076369, CAB076370"	Uncertain		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	4.7	9.5	26.0	3.5	20.9	2.8	7.0	23.7	29.4	8.9	4.2	12.8	5.2	4.8	7.2	6.2	12.4	7.8	5.8	28.9	21.9	19.0	10.8	3.1	4.4	3.7	19.1	13.9	12.3	5.6	12.2	5.3	10.6	12.7	7.7	4.6	5.3	8.0	7.8	13.7	8.0	4.5	5.5	18.9	3.5	6.3	12.2	15.0	1.0	10.0	4.3	5.8	7.3	5.7	1.4	4.4	2.0	1.4	1.2	3.9	1.0	5.4	3.8	12.5	9.2	13.6	17.1	13.8	8.9	7.2	6.6	5.6	7.7	4.2	3.6	10.5	8.8	9.3	3.2	21.7	10.3	12.1	3.1	7.6	5.6	3.7	8.6	13.6	7.3	6.5	14.5	9.7	6.8	6.4	12.9	9.8	5.1	5.5	5.1	13.9	4.9	3.1	3.9	9.2	6.0	4.7	8.0	9.1	0.7	14.2	10.0	7.5	9.0	4.3	14.9	8.5	12.5	5.4	5.5	9.0	6.5	14.2	7.6	13.3	5.2	2.4	2.9	10.0	4.5	8.0	2.0	1.4	0.3	2.3	1.2	1.7	1.4	3.9	2.0	2.8	1.2	0.9	0.8	0.3	1.2	0.9	4.4	1.2	1.0	26.0	20.9	23.7	24.3	21.9	19.0	19.1	13.9	12.7	15.0	6.0	4.5	1.9	9.8	4.7	123.5	42.3	12.7	24.1	11.4	14.0	3.9	10.5	18.3	10.3	151.7	8.4	3.8	0.0	10.5	10.9	10.3	17.3	0.0	5.7	5.0	33.4	4.1	7.4	7.6	24.3	26.7	4.4	8.5	14.4	5.6	21.3	9.7	7.6	33.9	12.6	7.9	6.5	8.3	3.0	11.5	7.2	6.4	4.4	6.0	15.9
UTP14A	"NY-CO-16, SDCCAG16, Utp14"	ENSG00000156697	"UTP14A, small subunit processome component"	Q9BVJ6	X	129906121-129929761	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA047217: AB_2679987, HPA054023: AB_2682346"	"unprognostic (6.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.00e-3)"	"unprognostic (8.24e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.99e-3)"	"prognostic unfavorable (8.12e-8)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"unprognostic (9.99e-2)"	15.1	11.4	8.2	13.3	11.2	10.2	15.8	12.7	13.8	13.3	13.4	8.4	8.5	8.5	17.6	13.9	16.9	13.9	9.0	10.0	7.1	7.2	13.2	14.9	10.7	14.8	7.6	9.8	17.4	22.7	13.1	13.8	12.5	10.6	13.5	14.7	8.6	13.2	10.6	19.6	11.8	11.0	15.3	7.7	16.1	13.3	4.3	7.7	20.7	12.4	16.3	19.5	16.0	13.5	11.1	11.8	16.2	14.3	15.5	14.6	7.7	14.3	16.0	8.6	22.6	14.5	14.8	14.5	15.9	12.2	16.0	12.8	16.3	14.2	34.0	32.1	11.5	17.5	18.4	34.4	17.3	19.7	11.3	17.1	19.4	13.7	12.3	16.4	27.4	14.9	18.1	15.3	21.7	23.0	10.4	12.6	12.7	19.3	10.7	13.8	23.6	19.7	20.9	17.9	27.4	18.0	15.5	13.0	23.3	11.1	11.0	9.0	23.8	9.0	16.7	18.8	11.9	9.0	16.0	10.9	7.1	9.2	19.7	30.5	13.4	15.5	30.3	10.7	34.1	15.9	16.2	8.0	4.0	12.7	14.3	14.6	11.1	10.7	11.8	11.8	10.9	13.5	12.4	1.0	15.5	12.0	9.4	14.4	7.7	8.2	11.2	12.7	13.8	7.1	7.2	7.6	9.8	10.6	7.7	11.9	10.4	11.5	13.1	7.4	5.4	8.1	15.3	12.0	29.6	0.0	3.9	19.7	11.6	16.5	0.3	7.4	2.9	0.0	10.9	16.6	8.7	7.6	13.9	4.0	12.0	1.6	7.5	6.2	7.8	0.2	5.8	9.4	5.0	17.2	7.3	6.0	12.1	10.2	6.7	6.7	4.4	12.9	10.8	1.4	2.4	6.9	34.0	10.2	10.1	9.5
UTP14C	"2700066J21Rik, KIAA0266"	ENSG00000253797	"UTP14C, small subunit processome component"	Q5TAP6	13	52024691-52033600	"Predicted intracellular proteins"	"Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA047217: AB_2679987, HPA054023: AB_2682346"	"unprognostic (7.89e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.47e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (7.35e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.46e-5)"	"unprognostic (2.44e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.04e-2)"	4.8	4.8	5.3	3.4	5.9	0.5	6.2	6.6	5.9	6.8	5.3			4.6	6.7	4.6	3.6	5.2	3.9	5.5	5.1	5.2	8.0	7.9	4.5	3.5	5.5		6.1	5.8	8.9	4.8	6.6		7.1	5.9		5.7	5.5	5.3	2.9	4.5	5.3	6.2	4.4	5.7	2.3			9.1		3.8	4.6	4.2	4.1	5.8	6.7	4.8	3.5	6.8	3.1	4.2	6.8	14.1	11.1	14.5	10.5	10.9	12.3	9.6	8.3	7.7	6.7	9.0	10.5	3.3	11.6	10.5	10.0	12.4	6.8	11.0	10.7	8.8	20.2	4.8	6.5	9.9	17.9	14.0	9.2	13.0	6.4	12.4	10.9	6.8	12.5	11.6	5.3	12.4	3.1	10.9	10.0	12.8	19.5	4.9	10.7	9.9	4.5	14.1	6.9	4.6	9.5	7.3	11.0	8.4	13.5	9.8	14.2	10.3	7.7	8.0	8.6	8.4	5.4	7.8	12.7	4.1	6.7	14.4	6.7	3.7	5.4	4.6	4.8	3.9	3.0	4.9	3.7	4.4	4.1	6.8	6.7	2.4	3.5	3.9	5.8	5.2	3.1											6.0	17.4	11.2	5.0	5.3	13.0	18.5	20.4	12.0	13.6	15.7	3.9	8.5	0.0	6.0	0.3	10.6	10.8	0.0	6.6	8.1	10.8	11.1	11.5	28.1	7.9	23.8	17.9	12.3	14.8	0.0	9.8	6.7	8.5	2.8	15.1	13.6	6.8	14.0	13.4	5.0	10.6	6.5	7.6	6.6	12.2	7.3	5.8	6.9	12.7	5.4
UTP15	"FLJ12787, FLJ23637, NET21"	ENSG00000164338	"UTP15, small subunit processome component"	Q8TED0	5	73565443-73583377	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044697			Approved	"Nucleoli,Endoplasmic reticulum"		No	No			"Nucleoli, Endoplasmic reticulum"		"HPA044697: AB_2679050"	"unprognostic (8.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.22e-1)"	17.1	11.8	6.5	9.4	11.7	38.6	13.2	8.7	12.5	7.5	8.6	10.4	9.3	7.0	11.3	8.7	13.6	10.4	6.7	8.8	12.9	5.6	9.3	12.9	10.2	12.1	11.0	8.0	11.0	9.7	11.8	16.4	8.8	12.5	10.1	10.9	7.5	10.9	6.6	14.5	18.3	10.7	9.9	10.3	11.4	11.9	10.1	10.0	11.4	10.3	13.2	12.8	9.5	9.4	8.3	9.0	4.6	8.0	8.8	10.8	5.4	10.7	11.6	7.9	23.7	6.9	8.2	15.0	12.8	7.4	14.5	16.1	13.0	14.4	24.2	13.0	8.6	16.8	9.0	13.5	23.8	22.5	11.8	9.8	11.1	12.3	10.6	8.5	10.1	9.1	8.3	10.8	16.4	18.5	4.3	10.0	10.5	17.0	13.4	12.3	13.5	15.3	7.2	10.7	3.8	6.7	12.3	12.1	23.4	8.7	14.7	8.1	8.7	11.5	9.5	13.4	7.0	12.1	7.5	8.1	8.6	11.9	10.1	24.9	9.8	13.0	31.2	13.6	17.4	12.5	2.5	7.0	4.6	9.7	8.0	9.7	8.3	9.8	10.6	9.0	7.2	10.5	10.8	3.8	8.8	7.3	6.5	7.9	5.4	6.5	11.7	8.7	12.5	12.9	5.6	11.0	8.0	12.5	10.0	0.0	5.3	2.9	10.8	13.1	3.9	6.4	2.5	0.0	4.5	5.2	5.9	6.8	3.3	8.1	3.5	4.9	2.3	0.0	6.8	7.3	4.9	5.6	6.9	6.7	6.0	1.6	2.4	3.1	7.3	2.2	2.8	4.3	6.8	1.8	3.6	3.5	5.7	3.5	4.9	4.9	4.4	6.5	8.5	6.3	13.6	14.9	5.5	4.4	6.0	9.0
UTP20	"1A6/DRIM, DRIM"	ENSG00000120800	"UTP20, small subunit processome component"	O75691	12	101280109-101386616	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049341			Supported	"Nucleoli,Plasma membrane"		No	No			Nucleoli	"Plasma membrane"	"HPA049341: AB_2680720"	"unprognostic (3.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (8.34e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (8.87e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.92e-3)"	14.7	11.9	8.4	10.7	9.7	8.3	15.3	8.4	9.6	14.1	8.0	11.8	7.0	5.0	12.5	8.4	10.9	10.3	5.8	8.3	6.7	5.8	8.0	12.0	12.0	17.8	9.0	6.3	16.3	14.2	17.9	9.5	9.7	8.2	8.8	10.1	9.9	13.8	8.5	13.1	10.8	8.0	9.4	7.1	11.3	8.6	12.6	9.7	11.9	9.8	11.0	12.9	9.4	13.8	3.1	2.8	0.1	1.1	2.0	2.8	0.6	4.5	11.3	8.6	4.0	7.7	9.1	10.6	7.9	6.2	12.6	7.0	13.0	3.3	12.1	4.2	8.7	9.5	9.5	19.0	8.1	16.4	5.4	7.7	12.8	6.1	9.7	4.3	21.2	5.9	5.9	4.2	17.4	6.0	4.8	8.6	6.2	20.1	2.5	9.1	5.9	9.2	6.0	22.6	6.3	11.9	10.5	14.1	9.4	5.3	13.8	9.9	6.7	14.7	9.3	8.9	7.4	9.8	4.7	9.7	14.9	7.3	10.3	15.2	4.6	6.8	20.3	8.1	9.7	22.8	0.1	0.8	0.1	1.9	1.1	1.9	3.1	2.1	2.4	1.4	2.4	2.3	2.8	0.1	2.0	0.7	2.8	1.8	0.6	8.4	9.7	8.4	9.6	6.7	5.8	9.0	6.3	8.2	9.7	8.9	6.9	6.5	7.6	9.0	9.5	9.8	7.6	8.1	14.8	3.5	9.8	6.7	5.0	5.6	1.3	9.0	1.3	0.0	9.7	7.0	7.8	8.4	12.7	6.7	5.1	20.6	6.3	7.4	6.3	0.9	8.9	3.8	3.3	1.0	4.4	3.4	6.1	0.0	7.8	2.3	8.0	6.5	6.2	15.6	22.4	9.7	2.4	5.7	8.0	7.5
UTP3	"CRLZ1, DKFZp761F222, FLJ23256, SAS10"	ENSG00000132467	"UTP3, small subunit processome component"	Q9NQZ2	4	70688479-70690551	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035655, HPA041453"	Approved		Supported	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA035655: AB_10601832, HPA041453: AB_2677488"	"unprognostic (2.44e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.79e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.44e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.24e-2)"	19.9	23.4	17.6	21.3	17.9	14.5	17.1	20.1	20.3	15.7	16.1	12.1	12.1	14.3	19.4	14.2	23.5	19.4	13.3	18.9	17.0	12.1	24.5	27.5	16.4	26.7	15.5	16.2	17.2	17.0	16.4	21.2	22.9	18.4	14.5	15.2	9.9	16.0	16.7	18.1	20.1	22.8	18.2	14.7	38.7	19.5	11.5	20.3	33.3	16.5	21.6	27.2	15.5	17.6	7.3	13.6	6.3	12.7	6.5	8.6	5.2	12.3	12.1	16.2	13.5	23.1	17.5	13.9	25.7	16.6	14.7	14.4	15.7	16.5	54.4	16.2	21.9	16.9	10.4	23.7	35.2	21.5	16.8	13.6	20.7	16.2	16.8	25.1	31.2	18.4	23.7	21.2	18.0	17.8	16.4	19.7	16.0	23.6	18.4	23.8	25.5	28.9	17.5	11.3	25.5	17.7	12.4	22.4	22.2	26.6	20.0	13.7	18.7	10.9	25.0	15.9	18.6	13.7	12.6	21.9	15.1	25.6	14.3	16.4	26.9	19.8	39.6	18.4	15.4	13.1	6.3	11.1	5.5	7.0	12.7	7.3	7.3	5.8	7.8	13.5	6.8	8.6	7.2	0.9	6.5	10.8	13.6	7.0	5.2	17.6	17.9	20.1	20.3	17.0	12.1	15.5	16.2	18.4	20.3	53.6	50.4	14.5	40.4	20.4	18.4	17.9	10.2	60.2	61.4	12.2	5.9	22.5	16.6	25.7	0.7	22.8	13.4	23.3	25.9	12.8	18.2	14.0	28.8	23.7	19.4	15.9	14.5	19.6	29.5	1.5	16.1	25.1	11.8	14.4	12.3	26.4	20.3	8.6	23.7	25.4	21.9	12.9	25.5	11.6	9.3	22.3	18.1	21.8	12.7	31.6
UTP6	"C17orf40, HCA66"	ENSG00000108651	"UTP6, small subunit processome component"	Q9NYH9	17	31860899-31901765	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025936, HPA055806"	Supported		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Mitotic chromosome"	"HPA025936: AB_1845588, HPA055806: AB_2682930"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (5.68e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-2)"	"unprognostic (4.76e-2)"	19.3	17.9	18.7	16.9	19.3	19.0	26.4	28.7	19.3	17.7	19.5	18.0	12.5	10.8	23.4	30.4	15.7	13.3	10.7	13.0	19.5	17.0	16.7	20.7	15.4	23.3	16.2	16.1	19.5	17.0	14.1	26.0	21.4	16.2	19.9	15.9	15.0	15.9	15.0	17.0	25.3	15.2	17.0	18.8	23.1	16.4	18.5	19.1	23.2	17.1	18.5	28.1	16.0	15.5	15.4	19.7	13.1	10.9	5.7	8.0	7.0	8.5	5.6	7.9	4.5	8.2	5.4	9.6	7.4	4.2	11.3	8.7	20.1	4.5	12.9	9.3	6.8	10.9	11.2	11.1	9.2	10.4	3.3	16.8	8.0	12.6	18.2	9.0	12.3	8.3	8.3	9.2	11.0	8.1	10.2	7.2	8.5	14.1	7.4	9.0	7.0	11.4	32.8	10.4	10.6	8.8	12.0	11.3	12.6	11.6	7.9	5.2	7.9	7.8	5.6	12.4	12.8	13.6	23.0	7.5	17.0	12.8	8.9	14.8	8.3	14.8	18.7	11.6	8.5	9.1	10.6	10.8	6.7	7.6	10.9	7.3	12.7	8.0	8.0	13.6	15.4	7.1	8.0	13.1	5.7	9.7	19.7	7.7	7.0	18.7	19.3	28.7	19.3	19.5	17.0	16.2	16.1	16.2	19.1	17.9	22.4	27.9	22.9	22.9	16.2	12.5	7.6	30.8	30.7	5.2	7.9	36.3	8.3	22.3	20.6	18.0	9.1	0.0	20.7	41.1	23.1	22.0	35.7	14.4	32.5	11.1	5.2	12.9	20.5	3.6	17.3	29.1	8.5	44.1	14.6	17.8	22.2	7.0	15.9	15.0	16.0	6.5	23.1	62.6	62.6	22.7	32.0	13.3	15.3	27.6
VGLL3	VGL-3	ENSG00000206538	"Vestigial like family member 3"	A8MV65	3	86876388-86991119	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 195.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 105.6;Extravillous trophoblasts: 167.0;Late spermatids: 52.5;Leydig cells: 122.6;Peritubular cells: 140.4;Syncytiotrophoblasts: 67.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.9"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"U-2197: 106.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054983	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA054983: AB_2682663"	"unprognostic (9.08e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.73e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.05e-1)"	22.5	1.0	0.5	3.4	0.5	0.2	8.6	0.2	0.3	6.3	6.2	0.4	3.3	0.6	8.2	7.8	6.1	5.2	6.8	4.3	1.0	0.7	1.8	0.6	16.1	3.6	0.6	0.3	10.6	2.7	0.7	0.4	195.7	0.8	8.0	1.6	2.8	1.9	3.1	7.5	4.0	2.1	11.9	0.8	2.4	2.9	8.0	0.3	0.1	3.4	1.9	1.0	12.2	9.2	1.1	0.6	2.3	0.5	0.8	0.7	0.1	1.5	2.6	14.2	0.0	19.0	23.8	0.2	9.8	6.9	8.4	10.5	3.0	0.6	0.0	0.0	15.3	0.9	1.3	0.9	0.9	11.6	5.5	0.0	0.7	0.9	0.0	8.7	0.1	0.0	18.1	1.5	12.3	5.5	4.5	1.2	0.0	0.0	0.0	10.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	18.9	0.1	0.0	1.6	0.0	0.0	4.2	0.1	0.0	0.5	0.0	0.0	0.5	18.7	2.7	106.2	0.3	0.0	0.0	0.0	3.4	0.0	0.7	2.3	0.5	0.7	0.4	0.3	0.4	0.5	0.5	0.3	0.2	1.1	0.6	0.7	2.0	0.8	0.4	0.6	0.5	0.1	0.5	0.5	0.2	0.3	1.0	0.7	0.6	0.3	0.8	0.3	3.0	2.1	0.0	7.4	7.1	0.0	0.7	0.0	5.3	4.5	10.4	0.0	20.7	0.0	10.3	105.6	1.5	0.0	0.0	2.1	167.0	26.2	18.3	0.0	0.0	6.7	0.0	0.0	4.3	0.0	52.5	122.6	2.4	3.3	0.0	0.0	15.8	8.4	0.0	140.4	0.0	0.3	12.9	17.8	1.4	1.0	4.5	67.5	0.0	0.0	3.7
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 193.2"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 872.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 193.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 193.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: AB_2685348"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	22.0	37.8	20.4	21.9	24.9	13.0	18.6	20.0	28.7	18.2	32.0	27.8	16.7	40.5	18.3	15.4	22.9	14.4	25.2	19.6	21.7	22.3	22.9	43.0	22.4	20.1	23.1	15.6	16.5	22.9	19.0	20.1	27.9	29.8	17.3	29.3	20.0	17.8	13.9	19.8	19.2	39.7	14.3	26.4	36.6	19.0	17.6	16.2	14.4	18.1	12.5	16.8	19.5	17.6	3.3	10.9	193.2	39.9	3.8	4.1	24.7	20.3	41.0	13.3	20.5	28.5	17.5	21.4	32.4	23.1	20.2	27.2	26.8	29.3	11.7	48.4	21.9	22.1	25.3	15.4	18.6	25.2	30.0	19.3	15.0	23.5	28.2	27.8	17.0	18.4	26.8	15.9	26.0	22.1	16.2	21.4	10.0	19.6	20.7	20.9	56.0	15.8	8.9	15.0	42.3	21.1	8.7	23.4	24.1	25.0	23.8	9.6	21.7	18.5	15.7	21.5	19.1	32.5	14.6	30.2	27.2	26.0	21.6	26.7	32.2	36.9	16.3	30.0	10.4	27.4	7.0	35.1	4.4	3.8	24.4	4.0	3.3	3.7	4.0	10.9	2.8	3.5	3.8	193.2	3.8	39.9	3.6	4.1	24.7	20.4	24.9	20.0	28.7	21.7	22.3	23.1	15.6	29.8	16.2	83.4	125.2	71.3	872.7	143.1	32.8	26.9	112.1	278.4	247.9	261.7	55.0	83.1	19.9	167.6	5.2	128.4	394.9	0.0	118.5	105.1	178.7	606.4	129.6	93.2	107.6	27.0	298.1	52.2	269.6	8.8	33.1	306.0	123.2	55.9	173.1	46.7	132.9	326.1	33.2	57.2	44.2	90.5	178.6	63.8	38.3	113.3	147.0	90.6	149.1	526.3
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115362-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	15	"granulocytes: 538.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 25.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.2;HEL: 20.3;HHSteC: 15.8;HUVEC TERT2: 18.7;RPTEC TERT1: 20.6"					"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	14.8	20.2	13.8	7.5	13.4	1.6	16.0	2.3	9.3	15.5	23.9	7.5	10.0	16.7	16.6	17.0	12.6	9.9	19.9	6.5	14.1	24.6	16.0	4.3	19.4	6.8	12.5	6.6	9.6	15.3	5.5	34.2	25.9	15.2	22.5	28.4	10.3	31.2	13.2	3.0	17.9	24.0	13.6	15.0	6.0	17.8	6.3	7.6	3.9	13.7	7.1	9.8	14.9	11.8	4.5	4.8	25.6	5.3	4.3	7.5	3.6	0.0	0.2	3.6	0.2	3.9	3.6	1.3	0.5	0.2	0.3	0.1	0.2	28.2	0.0	3.5	0.6	4.9	0.1	0.7	6.4	0.0	9.6	0.0	20.3	5.1	0.6	15.8	0.2	9.5	10.7	0.7	0.6	2.1	1.4	18.7	2.7	1.1	3.5	1.1	0.1	0.4	0.3	5.7	0.0	0.7	0.0	12.6	0.1	20.6	0.2	3.2	0.3	0.5	0.2	1.0	8.7	2.5	0.9	0.5	0.1	2.7	0.1	0.0	1.3	1.1	0.0	11.7	0.4	0.2	25.6	4.8	0.5	2.9	3.3	0.7	4.5	3.2	1.7	4.8	2.3	4.1	2.6	0.3	4.3	5.3	2.6	7.5	3.6	13.8	13.4	2.3	9.3	14.1	24.6	12.5	6.6	15.2	7.6	8.9	36.5	0.8	11.6	15.2	2.9	2.4	7.6	25.4	14.8	31.4	2.0	7.8	8.3	19.7	32.8	3.6	25.8	0.0	25.0	2.1	7.8	8.4	538.2	2.4	29.2	30.2	14.5	1.8	5.6	3.6	2.6	6.0	5.0	2.8	22.5	12.0	20.8	17.3	0.4	11.5	1.1	0.0	3.8	0.2	2.3	10.9	1.6	4.9	22.5	14.0
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"Wiskott-Aldrich syndrome like"	O00401	7	123681935-123749067	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 212.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 45.1;U-2197: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favorable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	17.9	19.3	25.6	11.6	29.5	3.8	20.7	21.0	39.3	23.7	31.2	17.0	8.9	27.4	21.0	14.6	22.5	14.8	21.7	15.4	35.2	22.5	33.3	34.5	15.3	5.5	18.8	23.0	27.8	21.9	36.7	16.9	25.4	28.6	19.9	28.8	18.0	16.9	19.5	21.6	14.4	30.2	18.2	16.6	12.1	22.0	17.3	15.0	10.0	26.7	12.0	9.7	23.7	21.1	4.6	4.5	4.9	6.2	6.2	4.3	1.5	10.9	8.1	8.9	7.6	14.1	14.6	11.6	7.6	12.8	5.6	7.3	6.6	13.9	1.1	6.1	11.5	12.1	8.3	16.5	8.4	8.8	1.9	6.6	0.9	6.7	7.1	15.3	1.4	0.9	11.7	15.8	8.3	14.3	12.8	9.7	1.1	4.8	2.1	13.4	6.6	1.8	1.9	16.7	11.7	7.4	1.1	7.2	2.4	11.9	45.1	11.0	16.2	10.5	31.6	20.5	14.5	6.1	1.4	11.0	15.2	4.3	42.8	7.4	2.4	0.8	2.4	13.1	1.2	12.1	4.9	4.1	1.8	4.3	4.1	3.6	4.6	2.8	2.6	3.5	3.2	3.6	3.8	1.8	6.2	6.2	4.5	1.4	1.5	25.6	29.5	21.0	39.3	35.2	22.5	18.8	23.0	28.6	15.0	80.4	46.6	7.8	37.8	53.7	27.6	63.7	61.1	45.5	51.2	50.6	19.6	36.7	44.7	43.5	16.7	34.6	105.1	0.0	46.9	46.1	45.8	67.4	3.5	49.7	11.1	25.4	65.3	56.4	14.8	6.2	44.5	13.4	28.7	14.4	96.1	57.1	59.0	118.1	60.8	80.1	28.9	19.4	43.2	15.5	19.8	59.7	68.0	7.5	56.6	212.0
WDCP	"C2orf44, FLJ21945"	ENSG00000163026	"WD repeat and coiled coil containing"	Q9H6R7	2	24029340-24049575	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	12	"Collecting duct cells: 8.7;Distal tubular cells: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041054	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA041054: AB_10796566"	"unprognostic (1.07e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (5.14e-8)"	"unprognostic (7.69e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.00e-1)"	11.7	9.6	8.3	7.6	9.4	2.4	9.2	14.6	9.8	9.6	9.3	11.5	8.4	5.3	10.7	8.0	7.4	7.2	5.6	6.8	7.1	6.9	7.5	8.9	5.4	12.4	8.3	4.8	11.6	7.7	11.2	9.4	8.5	8.7	8.7	6.2	7.8	7.1	12.9	13.8	5.9	7.5	7.4	8.0	9.4	7.0	12.5	9.2	17.9	8.9	5.5	13.7	9.4	6.4	4.9	4.3	1.5	3.8	5.0	7.8	4.2	7.3	11.4	12.6	8.7	8.6	6.9	4.5	9.0	4.8	9.4	9.0	10.3	3.4	19.4	3.9	4.6	7.9	5.4	17.8	6.1	9.8	11.6	10.2	11.8	5.7	10.7	5.9	10.7	8.2	4.1	4.8	9.6	4.8	4.9	8.8	11.3	16.3	5.4	9.8	3.3	13.9	6.4	15.1	7.4	8.9	15.4	21.2	7.8	4.4	3.6	9.7	13.4	4.4	4.3	5.5	9.2	3.3	4.8	8.4	7.6	8.4	4.5	8.1	8.9	11.2	27.4	4.8	11.5	5.9	0.0	2.4	1.5	7.5	3.8	7.8	4.9	5.0	5.5	4.3	4.7	6.8	7.5	0.7	5.0	2.6	1.6	7.1	4.2	8.3	9.4	14.6	9.8	7.1	6.9	8.3	4.8	8.7	9.2	3.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	8.7	0.0	2.6	6.6	2.1	0.0	0.0	0.0	0.0	1.7	2.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	12.5	13.5	7.7	10.6	10.7	3.3	12.2	8.4	9.7	10.5	7.7	6.8	9.7	7.3	12.6	6.5	13.3	10.5	4.6	8.7	7.1	6.4	8.5	14.8	7.3	15.5	6.9	6.2	12.1	21.4	16.3	14.8	8.4	8.3	8.4	10.8	6.6	9.8	8.1	25.4	10.5	6.8	11.7	6.2	8.5	9.3	14.9	6.9	15.2	11.1	9.5	15.2	10.2	9.1	8.7	11.9	0.5	6.6	7.9	12.4	6.3	15.2	9.7	9.7	14.8	10.6	8.7	11.2	10.7	7.0	12.5	11.0	10.2	5.1	18.1	14.7	7.9	8.0	10.3	24.1	12.3	19.9	14.9	12.5	17.0	10.4	8.2	8.7	31.8	9.0	8.5	8.9	15.8	24.0	7.4	11.9	12.8	20.7	8.9	10.9	8.8	15.1	7.3	35.0	13.4	15.6	14.5	33.7	13.8	6.2	10.2	15.0	13.7	12.2	15.1	17.3	14.1	6.0	13.3	10.5	9.4	15.0	17.1	23.9	13.1	15.3	28.4	13.8	20.6	24.2	0.1	6.0	0.5	8.8	6.1	11.4	8.7	8.0	10.3	11.9	7.9	12.4	11.3	0.5	7.9	6.6	6.6	10.7	6.3	7.7	10.7	8.4	9.7	7.1	6.4	6.9	6.2	8.3	6.9	8.9	11.0	9.2	10.8	18.5	9.6	14.0	5.1	25.4	33.0	7.0	5.9	9.2	8.3	8.4	28.6	11.7	2.7	0.0	11.8	7.5	9.5	8.9	15.1	25.5	7.2	14.3	3.5	11.6	6.3	34.2	11.5	7.4	10.1	2.8	5.1	6.5	10.6	3.5	11.0	6.0	6.4	12.9	14.6	25.9	60.1	19.6	4.2	5.7	9.4	7.7
WDR55	"FLJ20195, FLJ21702"	ENSG00000120314	"WD repeat domain 55"	Q9H6Y2	5	140664676-140674124	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043470, HPA048143, HPA075133"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: "	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.88e-6)"	"unprognostic (9.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.51e-2)"	17.9	12.4	7.6	17.8	8.8	18.1	12.9	13.0	12.7	9.5	16.6	11.4	16.9	14.9	12.0	11.0	18.8	10.9	20.2	9.6	7.7	9.1	15.3	29.9	12.7	15.0	12.6	8.5	12.0	16.2	11.4	13.2	13.9	10.6	12.8	17.5	8.9	16.7	14.8	18.2	15.8	20.8	11.1	8.9	18.8	14.9	8.0	8.5	12.5	12.0	14.0	21.4	13.5	11.0	10.4	11.3	10.4	18.9	11.3	14.3	10.2	7.9	10.9	5.3	21.3	8.3	6.7	14.9	7.9	9.8	8.5	9.7	18.7	10.9	7.5	10.7	10.3	15.3	9.9	7.2	13.9	6.6	6.9	5.9	8.5	9.0	7.6	8.0	8.9	16.1	7.9	8.1	11.6	6.2	5.8	9.0	8.4	5.9	5.9	9.3	11.3	8.2	8.0	5.6	11.4	9.6	7.0	7.7	7.0	10.1	12.0	5.2	7.0	10.9	31.9	12.1	6.8	22.6	9.6	8.0	11.1	5.8	12.7	10.7	9.8	7.6	5.9	14.3	11.9	6.5	6.9	11.7	8.6	13.9	18.9	14.3	10.4	12.9	11.8	11.3	8.8	10.5	10.7	10.4	11.3	15.4	8.4	14.1	10.2	7.6	8.8	13.0	12.7	7.7	9.1	12.6	8.5	10.6	8.5	8.9	18.4	22.6	8.8	12.9	12.9	4.5	5.1	17.4	18.2	17.4	11.8	19.4	18.3	17.5	20.3	9.5	24.1	0.0	24.4	36.3	12.9	11.7	19.6	13.5	18.9	22.3	14.3	8.6	12.4	6.8	8.9	18.9	8.5	26.2	17.8	5.6	23.0	28.1	7.1	15.6	7.8	12.9	12.3	7.1	9.6	11.7	19.5	20.0	19.8	12.9
WDR74	FLJ10439	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.4"	"Group enriched"	"Detected in many"	4	"Club cells: 168.4;Early spermatids: 612.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	14.2	13.2	12.6	19.7	13.8	77.4	14.2	14.6	21.5	12.5	12.5	10.9	8.7	10.8	14.1	10.2	16.1	15.1	12.8	12.6	12.2	11.9	15.5	19.7	10.0	18.1	15.4	16.5	17.4	20.6	9.4	8.0	11.9	13.6	12.5	11.2	8.0	16.5	9.8	42.1	19.8	10.6	11.5	9.5	18.0	13.4	23.5	16.6	16.0	20.0	19.1	16.0	12.4	14.0	39.1	44.8	15.9	34.8	26.8	16.7	11.9	16.4	19.8	7.7	12.8	6.4	8.8	24.0	9.2	10.0	20.1	13.4	28.9	20.2	28.9	26.3	7.6	16.2	22.0	23.7	18.4	15.8	18.4	17.5	14.6	21.8	25.0	18.8	28.9	9.6	8.5	20.7	12.8	42.6	6.6	9.8	21.1	31.8	8.6	9.1	31.6	27.6	46.0	31.5	18.9	26.3	28.2	13.3	50.4	14.2	9.4	17.2	19.4	10.7	22.0	29.7	7.8	15.5	22.4	7.0	11.8	14.2	26.3	23.1	21.4	29.7	35.1	13.0	17.7	15.3	8.7	34.8	3.2	11.7	16.9	14.7	18.6	12.1	11.0	29.2	39.1	16.7	14.8	15.9	26.8	11.3	44.8	13.7	11.9	12.6	13.8	14.6	21.5	12.2	11.9	15.4	16.5	13.6	16.6	35.7	64.8	46.3	33.6	92.8	13.9	1.4	33.1	44.2	168.4	15.7	15.7	47.5	36.5	39.1	612.8	32.3	22.2	0.0	34.8	40.2	35.6	20.1	41.7	28.4	34.0	3.2	39.4	17.8	30.3	74.1	30.5	38.9	28.7	18.0	28.7	13.4	36.2	26.6	20.1	37.0	11.0	19.4	37.3	14.7	27.4	95.5	29.1	57.9	38.1	31.5
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414715	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;liver: 32.5"	"Group enriched"	"Detected in many"	5	"Enterocytes: 95.3;Hepatocytes: 35.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 6.2;HBEC3-KT: 15.3;hTERT-HME1: 24.5;U-251 MG: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No			Nucleoplasm	Nucleoli	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (8.73e-6)"	0.2	0.2	0.2	2.4	0.2	0.0	17.8	0.2	0.2	2.6	17.9	0.1	0.0	20.1	0.3	6.3	9.3	0.2	1.8	0.2	0.1	0.2	0.4	32.5	0.2	0.0	0.2	0.0	0.2	0.4	0.0	1.5	3.7	0.1	1.2	4.2	0.1	20.9	0.0	0.7	1.0	78.6	0.1	0.2	0.2	1.3	0.2	0.0	0.2	0.3	2.4	6.1	1.8	1.1	0.7	0.3	1.0	0.6	0.7	0.5	0.0	1.5	0.3	0.0	0.0	0.0	0.1	0.1	6.2	3.6	0.7	1.1	0.2	1.7	0.0	1.2	0.2	0.6	3.2	0.0	15.3	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.9	24.5	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.9	0.1	0.0	1.1	3.3	4.5	3.9	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	3.0	1.9	0.1	6.7	2.0	0.1	0.0	0.2	0.0	0.0	0.5	0.6	0.2	0.2	0.2	0.4	0.1	0.3	0.3	0.0	0.7	0.2	0.5	1.0	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.0	0.0	3.7	0.0	2.6	0.5	0.3	0.3	2.5	0.0	2.3	0.0	0.0	0.1	0.0	2.4	0.2	0.0	95.3	0.0	7.2	0.5	0.0	0.5	0.0	35.8	0.0	0.0	11.3	1.8	1.6	0.0	0.0	0.0	0.0	0.0	5.2	0.1	8.8	7.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.3	0.0	12.8	14.2
XRN2		ENSG00000088930	"5'-3' exoribonuclease 2"	Q9H0D6	20	21303304-21389827	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047118, HPA050485"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA047118: AB_2679941, HPA050485: AB_2681141"	"unprognostic (9.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.54e-5)"	"unprognostic (7.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.31e-1)"	42.9	35.1	12.5	24.5	17.7	38.3	30.4	18.0	16.4	26.8	22.8	18.6	23.3	14.4	38.6	25.2	22.1	30.6	21.8	19.3	13.7	10.3	31.4	35.3	27.5	33.4	17.4	12.1	32.1	26.4	30.0	35.3	26.5	15.9	25.7	20.1	19.1	27.6	25.0	36.8	23.0	21.6	24.1	18.6	40.9	23.2	27.4	18.3	41.1	31.3	20.4	30.6	33.1	21.7	16.0	30.6	35.0	33.9	21.7	24.6	23.8	27.4	32.7	36.1	27.6	27.0	33.3	35.8	25.3	33.1	33.8	39.5	21.8	31.6	27.1	15.1	26.5	46.1	32.7	40.6	42.6	43.5	12.2	20.5	35.0	12.3	41.1	23.8	31.4	30.5	31.5	21.6	37.2	32.7	30.2	29.0	26.1	28.0	23.3	31.3	21.5	46.2	20.8	28.1	26.8	22.1	34.0	61.4	23.1	28.8	29.2	28.0	36.4	29.5	36.4	27.1	29.2	20.4	37.5	26.7	34.0	25.5	7.7	31.9	20.6	26.4	29.1	13.1	14.7	25.6	15.1	33.9	23.8	18.6	27.2	24.6	16.0	20.4	20.2	30.6	15.1	21.8	21.0	35.0	21.7	32.7	13.2	24.0	23.8	12.5	17.7	18.0	16.4	13.7	10.3	17.4	12.1	15.9	18.3	56.6	105.5	63.6	78.1	56.4	39.0	48.7	53.5	108.4	109.2	38.4	39.3	93.9	23.2	104.4	113.2	77.5	32.5	0.0	104.1	85.7	61.2	59.6	79.9	61.8	93.6	47.7	57.1	43.0	136.4	16.3	53.5	87.6	57.3	76.7	45.4	69.3	88.3	45.9	52.3	62.6	44.7	58.2	72.1	99.1	113.5	58.7	88.0	62.3	54.7	73.2
YAP1	YAP65	ENSG00000137693	"Yes associated protein 1"	P46937	11	102110461-102233423	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009370, HPA038885, CAB069915, HPA070359"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB009370: AB_2273277, CAB069915: AB_922796, HPA038885: AB_2676255, HPA070359: AB_2732154"	"unprognostic (9.56e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (9.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-2)"	27.1	15.8	11.6	12.1	10.0	0.0	34.9	7.0	9.5	37.5	21.3	7.0	40.1	9.8	51.7	33.3	36.9	25.5	34.6	18.8	12.5	6.0	17.3	32.1	26.2	7.6	9.3	6.1	41.1	8.9	18.9	6.4	34.0	15.0	34.8	11.4	21.7	22.2	35.2	27.8	23.4	15.1	58.2	17.2	7.6	18.2	15.6	9.7	2.6	34.0	25.7	12.6	42.3	41.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	11.7	11.0	30.7	15.0	33.6	32.1	25.7	27.7	31.7	27.0	22.3	27.4	28.6	0.0	22.9	36.2	20.1	20.8	15.2	39.5	28.7	3.4	5.4	0.0	15.0	18.6	25.7	0.0	0.5	25.6	26.0	29.6	48.3	30.2	8.4	1.4	0.0	0.0	30.5	5.6	0.5	0.0	14.5	28.3	10.5	0.0	17.3	0.0	19.9	21.0	0.1	1.0	32.6	12.3	9.2	29.4	22.2	0.1	9.2	38.5	15.1	19.3	11.6	0.0	0.0	0.1	11.2	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	11.6	10.0	7.0	9.5	12.5	6.0	9.3	6.1	15.0	9.7	32.8	51.8	1.7	40.6	101.0	0.3	34.4	76.5	24.1	35.2	87.2	0.0	79.0	10.0	28.8	3.9	26.3	16.2	0.0	15.8	14.7	61.4	50.8	0.0	36.0	9.2	0.0	7.0	24.5	1.3	2.7	35.1	2.3	42.2	1.8	13.7	26.2	23.1	20.9	38.2	20.0	1.0	38.8	48.4	2.7	0.9	107.6	51.5	0.0	24.7	55.2
ZBTB43	"FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B"	ENSG00000169155	"Zinc finger and BTB domain containing 43"	O43298	9	126805006-126838210	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016825	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA016825: AB_1858959"	"unprognostic (1.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.14e-1)"	"unprognostic (5.41e-3)"	"prognostic favorable (8.73e-4)"	"unprognostic (6.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.13e-2)"	6.6	6.2	7.8	4.9	12.1	51.7	6.6	10.6	13.6	5.8	5.6	9.5	3.0	5.6	6.6	5.2	10.3	5.3	5.9	9.5	7.9	5.7	5.1	9.0	9.3	6.0	8.6	7.1	7.1	5.9	9.6	9.3	8.2	8.1	5.1	6.6	7.5	7.4	4.4	34.7	14.6	6.7	6.0	8.5	5.7	7.4	15.7	9.3	5.3	6.2	7.1	10.1	5.5	7.0	6.1	5.2	10.6	6.3	9.0	10.7	4.3	4.6	3.6	6.5	6.0	5.6	7.9	6.8	6.6	6.1	4.9	4.4	8.7	3.2	6.5	3.1	6.2	9.9	13.5	5.8	6.1	6.1	6.1	3.8	4.5	10.6	3.7	7.5	6.2	8.5	9.6	15.5	7.9	19.9	4.7	3.7	5.4	7.7	15.1	7.2	5.0	5.4	4.0	5.9	5.0	6.2	4.7	21.1	5.2	5.4	5.4	5.8	5.4	6.7	6.4	5.8	6.2	5.9	4.0	3.5	5.9	5.7	6.6	5.3	16.2	11.5	2.5	7.4	5.3	4.8	10.6	6.3	5.3	10.7	6.3	10.2	6.1	5.8	6.2	5.2	5.1	6.4	7.3	3.5	9.0	4.8	2.8	8.2	4.3	7.8	12.1	10.6	13.6	7.9	5.7	8.6	7.1	8.1	9.3	32.8	40.1	29.9	62.2	75.4	37.7	33.5	22.9	20.1	46.6	26.2	102.1	15.5	1.7	27.3	73.1	17.3	40.0	0.0	16.1	10.4	25.7	47.1	30.1	22.9	13.6	25.4	10.9	17.2	14.6	30.4	16.4	26.4	23.6	11.8	16.6	33.0	31.3	14.2	13.4	5.8	56.4	12.9	25.9	42.1	61.8	102.6	43.5	20.1	18.1	123.4
ZCCHC11	"KIAA0191, PAPD3, TUT4"	ENSG00000134744	"Zinc finger CCHC-type containing 11"	Q5TAX3	1	52408282-52553487	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 229.7;Horizontal cells: 198.6;Rod photoreceptor cells: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	13.8	19.1	18.4	25.6	19.0	20.5	18.7	50.9	21.3	22.4	13.3	11.8	16.1	7.7	22.1	22.0	11.5	16.8	14.0	13.5	17.8	16.5	14.2	17.7	13.3	27.4	15.4	14.6	28.3	17.6	34.4	56.0	18.8	16.3	16.1	10.5	12.1	12.6	20.6	44.6	28.1	17.1	20.3	26.6	20.9	12.3	24.9	21.1	31.9	23.9	14.6	25.1	18.3	17.0	23.2	26.0	26.7	4.3	10.3	15.0	2.2	10.3	9.8	24.2	16.3	9.5	12.2	16.8	9.2	13.5	13.4	15.6	10.1	5.4	22.1	10.9	12.8	21.8	8.6	18.1	9.8	17.2	18.0	16.5	23.3	12.7	21.0	15.8	25.2	13.3	14.4	21.7	14.4	17.9	17.1	9.3	15.5	18.9	11.1	11.2	0.1	25.1	18.0	17.5	5.3	12.5	22.3	24.6	17.3	14.5	8.6	13.0	12.9	14.2	6.1	13.8	28.7	8.4	13.2	7.8	10.5	14.2	9.6	11.2	24.3	31.9	31.8	6.9	13.8	7.6	26.7	4.3	13.8	11.8	1.7	8.8	19.1	12.4	9.5	2.1	23.2	15.0	9.9	16.2	10.3	1.4	26.0	9.3	2.2	18.4	19.0	50.9	21.3	17.8	16.5	15.4	14.6	16.3	21.1	56.6	47.0	71.8	47.7	40.9	133.4	0.0	45.9	66.9	56.9	0.0	229.7	39.6	0.0	0.0	48.0	31.6	5.9	0.0	0.0	15.9	34.0	45.0	55.6	29.2	14.9	198.6	35.3	38.1	14.9	22.9	59.2	16.4	16.9	0.0	15.8	50.0	0.0	12.2	57.3	0.0	193.4	19.4	28.8	108.0	77.6	44.5	30.9	55.4	16.1	36.0
ZCCHC7	"AIR1, FLJ22611"	ENSG00000147905	"Zinc finger CCHC-type containing 7"	Q8N3Z6	9	37120539-37358149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020600, HPA021088, HPA029522"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.29e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.49e-2)"	15.2	12.7	9.9	28.4	11.3	16.2	16.8	16.5	12.1	16.1	13.4	10.2	20.0	11.3	19.2	14.9	11.5	13.1	12.4	10.2	10.1	10.3	10.0	11.1	10.9	27.5	11.8	8.4	21.9	19.8	8.6	30.7	10.2	11.2	13.5	14.2	9.8	14.3	19.2	9.9	12.7	13.9	14.0	11.8	18.4	11.8	14.3	12.4	19.9	16.1	12.3	29.3	19.2	12.9	29.7	7.5	10.9	8.5	10.1	11.4	5.2	7.4	5.0	7.0	7.5	7.3	11.4	6.5	7.3	8.5	5.7	7.8	5.0	3.6	26.4	4.0	5.7	6.7	3.1	6.7	6.9	8.2	12.1	4.7	7.5	8.2	4.3	11.4	12.9	7.5	7.8	10.8	5.9	23.3	10.9	6.5	9.8	20.6	9.2	5.1	3.5	9.9	7.2	7.4	8.1	7.5	48.0	4.7	6.7	7.1	2.9	7.9	5.7	5.2	6.3	6.7	7.2	4.5	8.4	5.8	4.2	5.3	6.0	4.4	3.1	5.8	31.5	6.8	8.4	7.7	4.7	4.4	10.9	7.8	5.0	7.7	18.1	8.9	8.8	4.0	29.7	11.4	10.4	8.8	10.1	8.5	7.5	7.4	5.2	9.9	11.3	16.5	12.1	10.1	10.3	11.8	8.4	11.2	12.4	32.8	14.4	78.3	25.6	25.1	15.3	9.3	5.1	24.1	20.5	5.2	9.8	13.5	23.2	14.0	40.8	19.1	9.7	0.0	13.7	21.8	25.2	22.7	23.1	10.6	14.4	11.1	18.3	15.4	13.0	15.6	25.0	16.4	15.1	9.0	19.9	18.5	12.5	14.4	18.4	15.4	23.6	6.5	21.7	45.1	42.1	28.5	15.6	27.7	19.5	19.2
ZCCHC9	"DKFZp761J139, PPP1R41"	ENSG00000131732	"Zinc finger CCHC-type containing 9"	Q8N567	5	81301590-81313297	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038404	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA038404: AB_10672744"	"unprognostic (1.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-1)"	14.4	12.9	11.7	16.1	10.5	8.9	15.2	14.3	11.5	21.1	19.7	7.4	14.5	13.9	18.4	16.4	21.4	13.9	14.3	11.9	10.0	10.7	23.0	36.3	10.7	16.2	11.1	10.1	19.6	13.8	10.9	22.6	23.0	10.4	23.1	14.6	13.6	12.2	18.1	14.4	15.2	27.7	22.5	12.2	18.0	14.5	14.8	10.0	17.9	19.6	19.1	16.4	26.8	23.5	14.9	17.5	12.8	16.2	11.6	19.1	7.3	10.3	7.3	18.1	9.5	15.7	14.9	24.4	15.6	18.6	12.1	16.9	16.1	14.3	9.6	6.5	7.8	20.9	7.7	14.3	14.3	19.3	21.5	13.5	9.9	8.2	18.9	18.5	12.5	8.2	11.5	12.5	10.3	25.8	9.4	10.1	10.6	16.5	9.4	12.4	14.1	20.7	18.9	13.1	5.8	9.4	12.4	23.3	14.1	9.4	10.4	8.8	8.4	12.4	7.5	55.7	13.7	9.3	20.3	6.9	7.6	9.3	13.5	17.0	13.5	13.9	14.7	13.4	18.3	16.2	12.8	12.3	11.9	12.8	16.2	16.3	14.9	17.2	15.5	14.8	13.2	16.7	17.1	12.0	11.6	14.0	17.5	19.1	7.3	11.7	10.5	14.3	11.5	10.0	10.7	11.1	10.1	10.4	10.0	8.9	15.2	18.2	10.8	8.0	16.3	10.0	38.2	34.8	18.2	29.6	13.7	24.6	26.6	18.8	41.9	12.3	15.4	0.0	17.9	44.7	16.4	11.3	12.7	47.4	31.3	25.4	7.5	32.5	16.7	12.8	30.2	22.3	3.3	32.5	18.1	18.2	22.3	18.7	27.3	37.0	28.3	19.4	24.8	64.6	31.5	8.2	19.2	17.5	18.1	11.4
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type containing 14"	Q8IZN3	6	157381133-157678146	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063754	Approved		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"HPA063754: AB_2685113"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	6.4	3.9	9.0	4.4	10.8	4.8	3.6	15.6	16.2	7.4	5.3	22.1	2.9	6.2	22.6	2.6	4.2	4.8	5.3	11.1	10.6	8.8	6.9	8.7	6.4	4.8	15.8	7.1	3.3	5.7	12.7	3.7	5.1	15.3	7.9	4.0	9.1	4.6	3.8	4.7	3.3	8.6	13.7	22.0	6.4	8.1	6.3	11.8	0.7	3.8	1.5	5.7	5.3	5.0	1.5	4.2	0.0	0.1	0.4	0.9	0.4	1.7	1.8	0.6	2.6	1.4	1.1	5.9	2.7	2.5	1.9	1.7	2.2	1.3	4.3	0.9	2.2	3.7	0.9	1.5	1.5	1.8	33.4	2.1	8.4	0.7	1.0	1.9	1.1	1.9	0.7	1.6	2.0	0.8	1.7	2.9	1.9	6.7	3.2	1.1	1.1	0.7	2.8	1.1	3.4	2.2	0.1	0.3	2.5	4.0	0.7	4.3	1.3	3.2	2.1	2.3	1.2	0.3	1.3	4.0	2.9	2.1	5.7	3.5	0.7	0.8	0.6	1.0	3.0	3.2	0.0	0.1	0.0	0.5	0.0	0.9	1.5	0.4	0.4	0.0	0.8	0.0	0.3	0.0	0.4	0.0	4.2	0.0	0.4	9.0	10.8	15.6	16.2	10.6	8.8	15.8	7.1	15.3	11.8	3.0	0.0	2.7	2.3	11.4	14.5	14.4	15.3	0.0	1.2	7.0	5.9	8.9	10.0	5.2	7.8	10.5	6.6	0.0	2.8	1.8	7.9	14.3	0.0	21.2	9.2	116.0	2.4	24.5	12.1	4.0	7.5	3.6	10.1	1.8	12.2	4.8	2.5	9.9	9.6	3.3	5.7	0.0	7.2	2.4	4.1	7.3	17.6	5.0	9.7	2.4
ZEB1	"AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a"	ENSG00000148516	"Zinc finger E-box binding homeobox 1"	P37275	10	31318495-31529814	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 99.5;Early spermatids: 98.1;Endothelial cells: 105.0;Late spermatids: 111.0;Peritubular cells: 95.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 47.1;RH-30: 27.8;TIME: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027524, CAB058686, CAB079943"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.66e-2)"	18.8	7.4	14.4	13.9	14.4	6.1	11.4	15.5	24.1	31.3	31.2	7.1	8.0	4.9	32.9	14.1	17.3	12.0	16.0	27.9	12.9	14.7	5.9	8.1	12.5	7.0	13.7	11.9	11.5	3.4	2.7	9.3	13.3	13.1	20.4	11.0	4.8	5.9	24.2	36.2	5.1	8.3	40.4	20.4	6.6	14.8	7.3	14.9	22.6	8.3	18.7	8.0	53.1	20.7	5.4	3.8	11.5	0.0	7.2	10.2	2.2	0.0	6.1	15.4	15.0	21.6	47.1	0.0	13.4	18.7	2.5	4.9	0.0	0.0	4.3	6.4	16.2	3.6	0.0	6.5	0.0	4.6	8.2	3.2	0.0	3.6	2.7	18.0	3.4	0.1	21.8	0.0	8.0	8.1	8.2	23.7	3.6	3.0	5.7	16.7	0.0	11.9	1.8	0.9	0.0	3.1	4.3	27.8	1.7	4.4	0.0	0.4	5.7	4.6	0.0	0.0	3.0	0.0	2.3	36.2	15.2	3.6	3.4	6.4	2.8	2.3	5.1	4.3	0.0	1.7	5.1	0.0	6.6	3.6	0.0	4.8	5.4	4.5	2.3	1.5	4.7	10.2	4.5	11.5	7.2	0.0	3.8	5.8	2.2	14.4	14.4	15.5	11.9	12.9	14.7	13.7	11.9	13.1	14.9	0.0	11.4	18.0	2.5	10.0	38.8	99.5	2.5	1.4	5.7	1.8	43.2	0.2	0.0	1.8	98.1	105.0	0.0	0.0	2.2	0.4	37.0	2.6	1.1	11.3	1.2	9.5	0.0	44.8	5.3	111.0	28.4	5.0	25.3	17.2	0.0	3.1	1.9	0.0	95.8	1.4	39.7	77.6	47.8	16.3	15.3	7.5	0.6	14.9	0.0	3.7
ZFP91	"PZF, ZNF757"	ENSG00000186660	"ZFP91 zinc finger protein"	Q96JP5	11	58579111-58621042	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 181.7;Late spermatids: 146.8;Spermatocytes: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024037, CAB025417, HPA065325"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468"	"unprognostic (6.10e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-3)"	17.1	14.7	20.1	13.6	25.6	32.0	14.9	24.4	21.7	15.3	18.1	23.2	15.8	16.2	16.3	11.8	16.3	13.6	13.8	26.5	20.3	15.4	16.3	19.4	15.0	14.4	20.8	18.1	14.9	14.3	26.7	17.0	14.2	19.7	13.1	21.9	11.2	14.5	15.5	33.8	17.5	19.6	16.9	21.6	15.0	13.9	71.0	19.4	15.7	16.8	14.6	15.9	17.8	21.4	4.6	7.0	5.4	5.0	3.7	5.4	2.8	24.8	14.3	16.8	17.0	16.1	19.5	9.2	20.6	38.7	23.8	20.4	7.8	26.3	29.8	20.4	25.9	23.8	22.2	17.0	21.8	31.4	15.8	9.6	19.6	14.5	8.4	18.3	24.7	32.4	17.0	21.5	33.5	39.3	19.8	23.6	20.2	19.4	28.3	30.6	8.3	21.3	13.7	8.8	14.4	13.9	16.6	28.4	19.7	17.5	24.0	18.0	14.4	26.2	24.1	33.5	9.5	26.9	18.6	26.4	30.2	20.8	45.3	22.8	16.4	12.1	24.7	26.6	13.9	30.7	3.9	5.0	3.5	5.4	4.5	3.0	4.5	3.3	3.3	4.9	4.6	3.6	4.6	5.4	3.7	4.2	7.0	2.6	2.8	20.1	25.6	24.4	21.7	20.3	15.4	20.8	18.1	19.7	19.4	23.8	34.8	33.2	21.5	53.3	28.8	39.5	48.4	25.4	21.6	17.4	15.7	10.3	11.6	19.8	181.7	27.0	27.7	46.7	27.1	10.5	32.9	25.9	48.6	41.4	14.5	33.4	24.2	25.8	36.8	146.8	28.4	27.0	21.9	20.8	30.4	19.8	24.5	11.5	25.5	19.1	19.0	19.4	20.6	142.7	40.2	58.2	11.6	21.8	37.2	34.3
ZFX	ZNF926	ENSG00000005889	"Zinc finger protein, X-linked"	P17010	X	24149173-24216255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001748, HPA003877, HPA071863"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.22e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.95e-2)"	20.3	8.8	10.8	8.2	11.7	25.9	23.5	22.1	12.6	18.5	12.2	7.2	8.4	6.6	18.5	11.0	10.6	15.8	7.2	17.8	10.1	6.6	16.6	11.3	9.7	12.7	13.1	9.6	20.2	11.8	20.2	17.9	23.2	10.4	16.4	6.5	7.0	9.4	13.1	24.1	8.9	11.8	15.7	11.3	12.4	10.1	5.4	14.7	16.4	13.9	8.9	10.6	12.5	25.3	11.9	9.6	16.6	10.3	9.9	10.7	7.0	8.0	10.9	11.3	13.1	15.3	10.7	5.9	7.6	7.2	8.8	9.2	6.7	6.0	9.3	10.3	11.7	19.3	10.3	12.9	14.1	11.8	9.0	16.0	8.2	33.8	3.9	6.4	10.8	14.5	9.3	4.5	17.1	22.3	9.5	11.0	5.6	9.7	10.1	6.3	4.4	7.7	8.0	6.5	3.5	8.4	10.6	9.0	8.1	5.2	13.0	6.0	9.0	23.0	9.2	7.4	7.8	5.8	5.7	10.8	7.8	4.6	10.8	5.3	5.7	7.5	9.3	6.1	4.6	9.0	11.2	8.7	13.5	10.6	10.3	10.7	8.4	9.9	10.6	9.6	11.9	9.9	9.4	16.6	9.9	9.4	6.9	5.7	7.0	10.8	11.7	22.1	12.6	10.1	6.6	13.1	9.6	10.4	14.7	17.9	11.8	18.4	16.0	19.6	19.3	13.7	22.9	16.0	22.7	7.0	19.6	46.1	5.0	13.6	1.5	25.5	11.9	23.3	13.8	10.2	28.3	17.9	27.6	20.7	15.1	14.3	19.7	27.6	25.3	3.1	33.1	20.1	28.7	19.8	15.1	15.6	11.6	14.2	33.6	9.4	19.1	32.3	26.9	9.3	25.2	18.2	17.3	22.5	15.1	15.4
ZFY	ZNF911	ENSG00000067646	"Zinc finger protein, Y-linked"	P08048	Y	2935281-2982506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA001748, HPA071863"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA071863: AB_2686463"			"unprognostic (1.07e-1)"		"unprognostic (7.43e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"		"unprognostic (2.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.91e-1)"		"unprognostic (2.54e-2)"	4.1	2.9	2.8	6.8	4.3	9.6	3.4	6.8	5.3	0.0	5.4	2.8	14.1	3.2	0.0	9.1	7.2	0.0	7.0	6.1	3.0	3.0	2.7	13.1	10.1	10.9	2.6	0.0	0.0	10.0	0.1	3.3	5.8	4.5	10.6	8.0	3.5	15.8	10.2	7.0	2.9	6.3	5.8	3.3	9.1	4.7	10.5	0.0	12.6	7.2	5.7	5.8	6.1	0.0	5.8	5.9	4.7	4.7	6.2	7.0	2.7	0.0	3.6	0.0	0.0	0.0	0.0	6.5	9.1	8.8	7.8	7.6	0.0	0.0	7.0	0.0	9.5	0.0	0.0	0.0	0.0	10.5	10.5	0.0	12.9	0.1	4.6	6.9	0.0	0.0	7.6	6.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	8.8	0.0	5.3	0.0	2.9	0.0	0.0	0.0	5.7	2.7	5.3	11.9	6.2	0.0	0.0	0.0	9.1	4.3	0.0	4.2	7.9	7.6	0.0	0.0	4.6	4.9	0.0	11.8	1.0	0.0	0.0	0.0	4.7	4.7	5.0	3.9	7.0	4.3	5.5	2.8	5.9	5.8	6.3	3.0	3.2	6.2	3.3	4.3	3.1	2.7	2.8	4.3	6.8	5.3	3.0	3.0	2.6	0.0	4.5	0.0	8.9	8.0	16.9	9.6	9.8	11.8	5.9	5.1	8.1	13.6	1.8	7.9	4.4	0.0	2.7	28.3	7.3	0.0	0.0	0.0	1.2	7.8	7.9	6.9	0.5	2.6	12.7	1.7	8.0	5.0	59.3	9.2	8.5	3.3	3.6	0.0	11.2	2.1	0.0	10.3	2.9	7.8	12.9	7.6	19.0	3.8	8.3	3.1	11.4	0.0	10.5
ZMAT4	FLJ13842	ENSG00000165061	"Zinc finger matrin-type 4"	Q9H898	8	40530590-40897833	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.5;brain: 21.6;thyroid gland: 29.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 18.2;Late spermatids: 39.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"NK-cell: 11.5"	"Lineage enriched"	"Detected in single"	115	"NK-cells: 11.5"	"Group enriched"	"Detected in some"	5	"AF22: 21.1;U-2197: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA069813, HPA071585"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Nucleoplasm, Nucleoli"		"HPA069813: AB_2686206, HPA071585: AB_2686423"	"unprognostic (1.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.07e-1)"		"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.46e-4)"	"unprognostic (5.44e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.79e-3)"	0.8	2.0	4.4	0.9	15.3	0.8	0.9	0.6	20.4	3.3	1.0	0.9	0.0	0.7	1.4	1.0	0.7	0.9	1.0	1.5	6.1	4.0	1.2	0.7	0.8	0.9	3.3	7.8	1.6	0.7	0.7	5.3	1.0	21.6	1.6	1.2	1.4	0.8	1.5	0.7	0.7	0.8	0.8	1.0	1.3	1.0	2.9	3.9	0.0	29.1	0.0	0.9	0.8	0.2	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	1.2	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.0	0.2	0.0	0.0	1.2	0.3	0.0	0.0	0.0	1.8	3.4	0.0	0.0	0.0	0.6	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.1	4.4	15.3	0.6	20.4	6.1	4.0	3.3	7.8	21.6	3.9	0.0	0.0	0.0	0.2	0.0	6.0	0.4	2.5	0.0	0.0	0.0	5.9	0.0	1.7	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	39.7	2.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0
ZNF16	KOX9	ENSG00000170631	"Zinc finger protein 16"	P17020	8	144930358-144950888	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035782, HPA061835"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA035782: AB_10603243, HPA061835: AB_2684621"	"unprognostic (4.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (2.39e-4)"	"unprognostic (7.53e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.17e-3)"	8.1	6.0	8.9	7.1	9.0	3.4	9.7	8.1	10.1	9.7	10.1	7.8	7.1	7.2	13.8	11.1	9.4	11.2	13.3	6.5	7.5	4.9	8.5	5.9	5.7	5.0	6.4	7.5	17.4	12.1	15.9	7.0	6.0	6.5	8.9	7.3	7.7	7.4	9.2	12.4	14.0	10.8	10.3	4.9	6.4	7.7	10.9	5.3	6.7	10.8	5.3	6.8	9.1	10.1	5.6	6.4	3.5	4.0	12.2	7.8	4.1	4.9	4.4	8.7	4.8	7.5	10.5	6.3	4.5	10.0	9.1	8.3	3.3	5.1	7.9	6.0	5.8	4.9	4.0	6.1	10.0	8.3	3.3	5.1	9.0	4.9	4.9	12.5	3.3	5.3	12.8	10.1	5.8	15.3	9.1	5.0	6.0	6.1	5.3	7.2	6.7	6.5	3.3	5.4	7.6	10.0	8.2	5.1	5.0	7.7	7.5	7.3	5.4	9.5	5.8	7.7	7.0	10.8	6.1	5.3	4.1	8.8	4.8	5.0	3.9	3.2	7.2	4.8	4.5	6.5	3.5	4.0	2.7	6.9	3.7	7.8	4.1	5.5	6.3	6.4	5.6	5.6	5.1	0.5	12.2	3.7	3.5	7.2	4.1	8.9	9.0	8.1	10.1	7.5	4.9	6.4	7.5	6.5	5.3	3.0	4.1	0.0	5.7	2.4	10.8	3.6	7.6	2.7	0.0	8.7	11.8	4.6	1.7	5.6	8.1	3.1	4.5	0.0	3.8	2.9	3.8	3.2	6.9	3.4	3.1	6.4	4.1	6.2	3.2	1.9	5.8	2.6	1.7	4.6	4.7	6.0	3.5	3.5	6.0	3.6	23.7	0.0	2.0	14.0	12.4	4.0	4.6	5.3	4.9	4.7
ZNF324B	FLJ45850	ENSG00000249471	"Zinc finger protein 324B"	Q6AW86	19	58451604-58457833	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"NK-cell: 8.3"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 29.4"									HPA023400	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA023400: AB_1859195"	"unprognostic (2.75e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (5.58e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.94e-2)"	7.4	6.2	6.9	8.3	12.4	5.0	9.0	11.4	12.6	8.7	5.9	7.6	9.8	5.9	8.5	5.0	8.4	9.0	6.8	4.7	6.6	5.5	6.2	6.6	7.3	6.8	9.1	7.0	10.2	10.1	8.0	8.4	4.8	8.8	7.5	6.1	8.4	8.9	8.5	8.2	11.2	6.0	7.4	5.3	10.3	8.0	11.3	9.3	9.4	8.0	6.0	6.4	9.3	6.9	1.1	0.6	1.3	1.0	8.3	1.3	0.7	4.3	7.2	4.0	6.6	2.8	2.5	2.9	3.9	2.9	3.2	2.3	2.5	1.9	5.9	2.5	2.3	3.3	3.6	5.2	3.6	2.5	6.0	29.4	5.1	5.4	1.0	2.9	8.3	7.6	2.5	3.6	3.6	3.1	2.1	2.3	5.3	7.3	3.6	3.3	2.8	6.1	2.0	2.2	5.1	4.1	5.8	5.2	3.5	2.1	8.7	9.5	5.4	3.7	6.0	0.9	2.9	2.2	2.4	2.6	7.7	2.0	4.1	6.3	7.8	7.0	4.4	3.0	3.6	2.9	0.0	1.0	0.1	1.3	0.6	0.9	0.5	0.6	0.9	0.6	1.1	1.3	0.9	1.3	8.3	0.4	0.6	0.4	0.7	6.9	12.4	11.4	12.6	6.6	5.5	9.1	7.0	8.8	9.3	0.0	0.3	0.5	0.9	0.7	3.0	0.8	0.0	2.7	3.4	1.8	21.6	0.8	0.0	2.0	0.7	0.7	1.1	0.0	1.4	0.7	1.1	0.6	0.0	1.0	0.8	4.8	0.0	1.3	1.9	1.3	2.8	0.4	0.0	1.8	0.8	1.5	1.5	0.0	2.5	0.8	5.8	6.5	1.1	3.1	1.9	0.9	0.6	1.5	1.1	0.9
ZNF362	"FLJ25476, lin-29, RN"	ENSG00000160094	"Zinc finger protein 362"	Q5T0B9	1	33256545-33300719	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059239	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA059239: AB_2683955"	"unprognostic (8.31e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.66e-1)"	21.6	14.0	18.1	12.0	17.2	8.9	21.7	24.5	30.5	18.6	17.3	13.8	9.6	11.0	23.7	23.8	14.2	20.1	20.7	28.0	15.4	13.8	16.8	8.8	18.7	26.3	12.8	15.6	23.3	19.9	16.4	19.1	17.9	12.3	20.4	8.8	27.4	22.8	21.7	26.1	23.5	11.6	28.1	13.1	22.6	14.0	8.5	10.3	17.9	17.4	14.1	15.3	20.1	15.4	6.0	8.3	6.0	4.6	4.2	4.7	2.5	3.3	5.4	23.7	9.4	6.3	4.4	15.6	4.7	5.5	5.8	6.2	5.6	11.4	1.7	10.3	5.9	1.8	11.3	5.5	2.6	2.4	10.0	5.0	8.5	3.3	6.8	5.6	4.0	6.9	9.4	6.6	2.5	2.2	5.9	7.9	11.3	0.9	2.9	4.4	8.1	13.0	6.7	14.1	2.0	5.1	21.3	5.6	0.7	4.6	5.4	8.4	25.4	13.3	4.2	20.9	10.6	4.1	10.4	11.4	3.5	4.8	8.3	3.1	8.9	8.2	1.8	2.8	3.6	10.4	3.8	4.6	6.0	4.7	4.1	3.4	3.0	3.5	4.1	3.3	6.0	3.1	2.9	3.5	4.2	4.5	8.3	2.6	2.5	18.1	17.2	24.5	30.5	15.4	13.8	12.8	15.6	12.3	10.3	8.9	11.3	1.9	4.0	9.0	12.3	19.4	7.6	1.4	9.1	10.4	0.0	9.4	1.7	5.5	0.9	10.5	3.1	0.0	6.5	5.7	9.7	2.2	9.3	6.6	8.7	7.9	1.7	19.6	14.5	5.4	12.7	6.1	8.5	1.0	4.0	7.7	3.7	8.5	20.1	9.9	4.5	6.5	11.3	0.9	2.5	8.3	3.0	4.9	6.9	1.3
ZNF428	"C19orf37, MGC51082, Zfp428"	ENSG00000131116	"Zinc finger protein 428"	Q96B54	19	43607219-43619874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042596, HPA048072"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA042596: AB_2678070, HPA048072: AB_2680249"	"unprognostic (2.45e-3)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (3.60e-5)"	"unprognostic (3.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.74e-2)"	18.8	31.2	36.8	15.8	37.6	18.9	9.2	25.9	48.8	13.7	14.2	14.4	8.8	17.0	18.8	14.9	8.8	13.0	18.4	19.9	31.3	28.7	17.4	15.5	13.1	15.5	27.0	31.1	19.2	19.4	9.8	19.2	12.7	18.0	20.1	6.3	14.8	21.7	13.2	37.7	6.6	13.7	17.2	22.2	16.8	16.6	19.7	17.0	17.8	16.6	8.7	8.9	10.0	11.4	7.8	7.1	9.4	3.2	3.1	8.5	1.0	11.2	9.0	14.1	23.3	5.4	4.0	6.6	8.5	3.9	6.0	6.3	5.5	7.5	19.0	19.5	6.5	3.8	2.8	5.6	1.6	2.0	15.9	23.9	20.7	9.4	9.3	10.6	16.2	17.2	7.3	3.6	5.3	2.8	6.2	8.4	13.6	21.6	12.0	6.2	11.9	40.0	29.1	9.4	5.0	6.3	39.9	6.5	13.9	7.2	6.8	27.1	31.6	12.3	7.6	19.0	3.9	4.6	23.3	16.5	7.2	20.5	6.8	13.0	13.4	16.1	33.2	10.4	16.6	15.8	2.5	2.5	9.4	7.8	1.4	4.4	5.2	7.1	7.4	2.7	7.8	8.5	3.7	1.3	3.1	3.2	7.1	4.1	1.0	36.8	37.6	25.9	48.8	31.3	28.7	27.0	31.1	18.0	17.0	0.0	3.8	39.5	61.1	28.5	98.9	17.9	63.7	4.0	3.4	62.8	13.7	115.0	126.0	77.7	112.3	58.4	31.5	0.0	69.0	37.8	99.2	49.9	36.8	47.0	89.6	54.0	155.7	74.9	36.5	48.8	82.3	46.8	108.0	43.3	49.3	108.0	64.6	46.0	85.2	176.5	53.3	71.1	93.7	20.4	56.9	22.6	46.1	73.0	46.0	41.6
ZNF444	"EZF2, FLJ11137, ZSCAN17"	ENSG00000167685	"Zinc finger protein 444"	Q8N0Y2	19	56132599-56160893	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056895, HPA065203"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA056895: AB_2683267, HPA065203: AB_2685431"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.87e-4)"	9.4	13.4	15.0	7.1	21.0	3.7	8.3	14.9	20.1	9.0	14.8	12.8	14.3	13.6	10.5	9.9	6.6	11.9	11.2	10.5	13.5	13.3	9.9	37.4	10.9	6.1	12.3	11.0	12.5	25.3	8.5	12.2	12.5	8.0	14.3	5.3	10.4	14.1	25.6	17.2	11.5	11.3	7.5	10.3	8.6	17.2	9.2	10.4	28.1	16.6	2.8	8.2	10.4	6.8	4.3	3.5	3.5	1.7	3.7	7.1	1.8	4.7	9.1	8.4	7.3	3.6	3.7	5.5	6.1	4.0	5.2	5.7	10.0	5.4	8.4	5.4	3.5	2.6	4.4	5.2	4.1	2.2	7.3	51.5	8.2	6.1	18.0	5.9	3.6	7.7	4.3	3.8	4.2	3.3	7.9	4.6	10.5	10.6	3.7	3.6	6.2	11.8	10.3	9.1	9.5	16.7	13.8	5.4	4.4	5.7	4.4	9.0	12.4	3.1	10.3	4.5	4.8	10.2	6.7	6.0	9.4	8.1	2.0	6.6	9.1	7.7	6.3	5.9	5.0	6.1	3.1	1.7	3.5	4.1	1.4	4.5	2.0	6.9	6.9	2.1	4.3	7.1	4.6	0.2	3.7	1.0	3.5	4.2	1.8	15.0	21.0	14.9	20.1	13.5	13.3	12.3	11.0	8.0	10.4	3.0	14.9	10.2	14.2	2.7	16.7	11.4	33.1	13.4	9.1	10.4	7.9	16.2	8.3	23.1	26.9	15.8	12.8	0.0	19.3	7.9	9.2	13.8	10.3	34.7	9.4	19.1	28.2	19.6	5.3	28.6	11.2	3.9	15.1	19.8	24.4	16.6	21.0	10.5	11.3	18.8	13.6	25.8	13.2	10.4	19.8	4.5	10.4	13.1	19.3	8.9
ZNF507	KIAA1084	ENSG00000168813	"Zinc finger protein 507"	Q8TCN5	19	32345594-32387667	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030964, HPA049728"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA030964: AB_10670562, HPA049728: AB_2680864"	"unprognostic (3.39e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.28e-3)"	"unprognostic (7.24e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.46e-2)"	10.9	8.7	11.3	16.0	13.1	13.5	12.0	18.4	16.4	12.0	11.4	9.0	10.2	10.0	12.4	9.8	9.6	12.2	10.3	10.1	9.4	8.1	9.0	11.1	8.2	10.5	12.3	10.3	18.6	10.9	13.6	15.7	16.9	11.1	10.7	9.9	6.8	11.0	9.6	21.0	8.6	14.7	11.9	12.9	9.6	9.7	28.3	13.0	17.1	18.7	10.0	10.5	11.0	20.1	4.0	0.4	2.3	1.4	2.0	4.7	1.4	9.3	18.6	13.8	8.6	9.1	14.3	11.2	8.4	8.2	7.7	8.7	10.7	7.3	13.8	10.4	8.0	8.4	5.4	20.1	10.4	14.9	10.7	18.3	14.2	8.9	7.2	10.9	11.8	7.8	9.0	8.0	9.9	16.1	8.0	10.3	11.6	20.8	11.2	8.1	5.8	12.7	3.9	14.8	13.8	5.9	13.2	16.1	5.6	4.7	10.4	11.4	9.9	11.1	7.5	9.1	11.5	5.9	8.5	11.0	12.4	13.3	7.2	10.8	10.9	12.6	14.3	8.7	8.7	11.1	0.4	0.1	2.3	4.1	0.0	4.7	2.5	3.1	2.8	0.0	4.0	4.2	3.4	2.0	2.0	1.4	0.4	2.4	1.4	11.3	13.1	18.4	16.4	9.4	8.1	12.3	10.3	11.1	13.0	8.9	15.3	7.3	5.9	2.5	19.9	12.6	2.5	22.7	11.4	0.0	13.7	8.0	1.7	5.1	13.1	6.3	8.1	0.0	4.8	4.4	5.7	9.3	3.5	9.6	2.9	55.6	8.6	12.9	0.3	8.2	8.6	1.1	1.7	0.0	14.3	19.5	4.9	10.5	6.7	3.5	25.0	0.0	7.2	20.4	16.2	2.4	7.3	8.7	11.2	6.8
ZNF554	FLJ34817	ENSG00000172006	"Zinc finger protein 554"	Q86TJ5	19	2819874-2835773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060247, HPA063358"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA060247: AB_2684230, HPA063358: AB_2684995"	"unprognostic (3.81e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.58e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.36e-5)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.99e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.79e-2)"	"prognostic favorable (5.00e-4)"	4.1	4.4	7.9	2.0	9.1	1.9	5.1	12.2	14.1	6.0	4.6	7.7	5.6	6.1	6.8	4.5	4.0	6.4	5.6	7.3	8.2	8.4	6.6	8.6	5.0	3.9	6.2	6.9	8.2	5.0	9.8	8.4	25.9	6.0	5.7	4.3	7.7	7.6	5.4	8.9	7.4	4.7	5.6	4.2	3.7	4.2	4.0	6.5	5.1	7.9	4.7	6.0	4.5	4.1	2.3	3.6	0.6	0.6	1.8	1.8	0.7	3.7	0.1	3.3	3.6	2.3	3.0	4.2	2.4	2.6	5.0	2.3	0.3	1.0	3.5	2.3	1.9	3.8	1.8	0.3	1.9	0.7	0.0	1.7	1.0	1.2	1.5	1.8	0.5	0.8	2.4	4.4	1.4	2.0	3.0	0.4	4.4	3.6	2.0	1.6	0.7	1.7	0.4	1.6	1.2	1.1	1.9	2.2	0.9	3.2	3.0	3.0	5.4	2.7	0.5	4.0	4.2	1.4	1.8	0.0	0.4	1.0	1.4	0.9	6.6	7.3	0.7	1.9	1.7	1.0	0.2	0.3	0.6	0.4	0.1	1.5	0.8	0.7	0.9	0.0	2.3	1.8	0.3	0.2	1.8	0.6	3.6	0.3	0.7	7.9	9.1	12.2	11.2	8.2	8.4	6.2	6.9	6.0	6.5	11.9	15.1	0.9	2.6	1.1	4.1	2.8	2.5	8.1	6.8	0.0	7.9	1.9	3.3	2.0	0.4	2.5	3.8	0.0	1.2	1.0	2.0	2.5	0.0	1.9	1.3	3.2	3.5	2.5	1.0	0.2	2.8	2.0	0.0	1.0	1.7	4.6	1.7	0.0	2.5	2.1	4.7	0.0	1.5	4.4	10.4	1.3	7.3	4.5	2.2	1.5
ZNF577	MGC4400	ENSG00000161551	"Zinc finger protein 577"	Q9BSK1	19	51804816-51890950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 33.2;Early spermatids: 47.8;Late spermatids: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041499, HPA046761"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041499: AB_2677516, HPA046761: AB_2679791"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.17e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (2.03e-4)"	7.9	6.8	13.4	5.8	15.5	4.2	13.9	14.6	12.1	10.2	10.9	9.9	15.5	5.1	12.3	11.1	6.3	10.0	8.9	8.0	14.8	5.6	11.0	5.5	6.8	5.6	7.6	8.7	27.2	7.1	17.4	7.5	10.1	9.9	17.4	7.6	17.2	12.9	16.1	9.4	22.3	8.1	14.4	11.0	10.1	7.1	22.5	14.9	3.8	16.3	5.2	6.3	8.8	10.2	9.4	3.2	7.1	4.0	4.6	4.6	1.8	1.2	0.1	6.6	8.1	11.4	12.4	0.0	7.7	2.9	3.0	6.1	0.8	1.0	1.3	0.8	3.5	4.4	2.1	2.6	1.6	1.6	0.0	7.6	12.7	0.1	1.1	8.8	2.8	4.3	9.6	5.0	4.4	1.3	9.5	1.5	0.0	2.7	0.0	3.8	0.0	7.8	3.6	7.6	0.0	0.2	3.4	3.3	2.3	4.9	2.9	2.7	1.4	1.9	0.9	6.5	7.0	1.3	3.1	1.0	5.5	7.7	1.6	2.7	5.4	0.0	1.7	1.5	0.5	8.9	7.1	2.6	5.7	1.7	4.0	4.6	9.4	3.0	3.6	2.8	5.1	3.8	2.4	1.2	4.6	3.0	3.2	1.4	1.8	13.4	15.5	14.6	12.1	14.8	5.6	7.6	8.7	9.9	14.9	0.0	1.6	6.7	3.0	3.9	11.1	7.8	5.1	1.4	1.2	17.4	9.8	6.0	33.2	3.1	47.8	6.0	2.7	0.0	1.0	4.5	5.5	6.1	4.7	1.5	4.7	6.4	2.9	4.3	2.4	35.6	7.5	5.1	0.0	5.4	5.0	14.0	1.2	0.0	12.0	4.2	9.3	0.0	6.6	10.7	14.4	4.5	3.8	2.5	4.2	2.1
ZNF583	FLJ31030	ENSG00000198440	"Zinc finger protein 583"	Q96ND8	19	56397966-56436035	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 53.6;Late spermatids: 29.3;Spermatocytes: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 14.0"	"Low region specificity"	"Detected in all"							"HPA023805, HPA023957"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA023805: AB_2671318, HPA023957: AB_2671383"	"unprognostic (9.89e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	7.2	5.9	7.9	3.9	9.3	2.3	4.7	11.6	12.4	5.6	4.6	5.6	3.7	3.2	6.1	5.5	3.6	5.8	5.4	5.0	7.7	7.3	6.6	5.9	6.6	4.5	7.5	6.3	11.2	5.9	7.3	8.4	4.7	8.3	6.0	3.5	3.3	2.6	4.7	4.8	2.1	3.1	6.2	7.6	5.4	3.9	15.8	7.6	5.0	7.9	2.1	4.1	4.4	5.7	6.3	3.5	9.4	4.7	9.2	7.4	2.8	0.0	2.0	4.7	0.0	3.3	2.7	0.0	5.8	5.9	2.7	2.2	0.2	0.6	4.3	2.9	5.3	5.0	0.3	1.9	1.8	2.9	2.0	10.2	5.7	0.0	1.0	3.8	4.7	5.2	3.7	2.9	3.9	1.9	4.0	2.6	4.5	2.1	1.6	8.8	0.0	5.8	1.6	1.2	0.0	1.9	2.9	8.9	3.2	2.1	4.2	2.7	4.1	0.0	0.5	1.5	2.5	2.9	6.1	1.8	14.0	3.8	2.7	11.4	6.0	11.0	6.8	0.3	1.3	4.9	9.4	2.2	4.7	4.9	3.2	7.2	6.3	4.0	4.5	2.5	5.5	7.4	4.4	1.0	9.2	4.7	3.5	4.9	2.8	7.9	9.3	11.6	12.4	7.7	7.3	7.5	6.3	8.3	7.6	3.0	1.0	3.2	3.1	1.5	16.1	4.4	0.0	1.4	0.0	1.8	5.9	1.4	8.3	5.1	53.6	5.5	0.4	0.0	2.4	0.4	5.0	2.5	10.4	1.6	3.4	9.5	0.0	6.2	4.0	29.3	6.4	3.5	3.3	1.8	1.5	10.2	2.3	1.5	12.7	4.8	14.3	6.5	5.3	25.1	12.8	1.5	0.9	8.5	1.7	1.4
ZNF593	ZT86	ENSG00000142684	"Zinc finger protein 593"	O00488	1	26169871-26170873	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054363, HPA059387"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA054363: AB_2682462, HPA059387: AB_2684001"	"unprognostic (1.23e-2)"	"unprognostic (8.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (7.42e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-2)"	11.7	11.5	9.4	10.7	9.4	15.7	18.3	7.2	12.1	9.0	11.7	7.0	12.1	11.4	8.7	9.0	10.9	8.4	11.3	14.5	8.9	10.0	13.5	30.8	7.7	16.8	10.0	7.0	11.6	36.2	9.7	9.3	12.7	10.9	10.4	5.8	5.9	15.9	12.0	59.3	9.8	11.0	6.5	7.3	13.0	15.2	9.3	8.3	5.4	15.1	17.2	9.2	10.6	10.1	23.5	26.8	0.7	25.0	16.1	21.7	14.1	20.1	11.1	3.8	13.4	3.7	4.9	20.2	9.0	4.6	10.5	10.1	17.0	12.2	23.6	16.6	5.6	8.4	13.2	12.9	11.7	3.8	14.1	41.4	16.0	9.1	25.7	16.1	22.1	14.1	8.8	11.5	11.6	12.2	4.4	8.8	5.8	24.0	9.1	6.2	15.4	9.0	41.1	15.1	19.5	39.5	11.3	6.7	23.8	7.5	8.9	10.1	11.0	10.9	27.4	34.2	3.3	11.3	12.5	9.1	10.1	11.9	21.1	16.8	18.0	18.2	25.5	11.8	45.9	12.9	0.1	15.7	0.2	14.2	25.0	13.3	23.5	20.1	14.0	21.7	22.7	15.0	14.3	0.7	16.1	25.0	26.8	21.7	14.1	9.4	9.4	7.2	12.1	8.9	10.0	10.0	7.0	10.9	8.3	11.9	63.0	48.3	137.4	152.1	16.6	5.9	58.6	21.4	40.9	57.6	2.0	93.3	87.9	89.4	5.0	36.0	55.3	23.3	126.2	135.2	54.6	99.4	51.7	184.5	69.6	3.2	105.3	38.6	55.7	10.0	30.0	42.5	47.2	47.7	71.1	18.5	122.6	60.4	21.9	148.8	11.7	12.9	55.6	33.0	56.3	147.0	186.2	28.8	68.1	152.9
ZNF596		ENSG00000172748	"Zinc finger protein 596"	Q8TC21	8	232137-264703	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 35.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.0"					"Low region specificity"	"Detected in all"			HPA055463	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA055463: AB_2682821"	"unprognostic (3.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.07e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-1)"	"unprognostic (1.70e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.53e-1)"	4.9	6.2	6.3	9.9	7.4	2.6	8.5	18.2	10.1	6.7	4.4	8.3	8.3	4.3	10.4	11.9	4.7	6.7	6.3	5.1	7.5	7.0	6.1	5.3	4.8	5.3	6.8	7.3	7.8	7.1	13.5	10.9	5.5	6.2	6.1	5.3	6.6	4.2	9.4	10.2	6.7	4.1	7.7	7.8	6.8	5.4	22.4	7.8	7.4	9.2	4.2	4.4	4.5	4.8	6.8	4.4	6.4	5.0	2.9	7.3	2.6	1.8	1.1	5.5	14.0	2.9	2.7	4.6	4.2	1.9	1.7	2.9	1.4	2.3	1.8	1.4	3.4	2.3	3.6	1.5	3.3	2.1	1.4	2.1	3.9	3.4	1.3	3.2	1.7	1.9	6.2	0.5	1.9	3.0	2.7	1.3	6.1	2.4	6.0	9.8	5.9	4.3	1.6	2.9	3.6	1.3	2.0	1.2	3.3	5.5	3.3	3.1	8.3	2.8	1.4	2.0	2.9	4.2	5.1	3.3	4.1	1.2	0.3	1.8	2.1	5.3	2.2	4.9	1.5	2.6	6.4	2.8	4.5	4.8	2.3	6.7	6.4	5.2	4.2	3.6	6.8	6.2	7.3	3.1	2.9	5.0	4.4	5.6	2.6	6.3	7.4	18.2	10.1	7.5	7.0	6.8	7.3	6.2	7.8	3.0	2.4	0.0	0.7	0.3	8.1	2.8	0.0	5.3	2.3	1.8	2.0	1.8	3.3	1.5	35.2	2.2	1.0	0.0	1.5	1.2	1.1	0.6	4.7	0.9	0.9	11.1	0.0	3.1	0.6	11.0	3.7	0.5	0.0	0.0	1.5	4.0	1.1	0.0	1.1	1.6	8.5	0.0	0.9	10.2	3.9	0.4	1.3	0.8	1.2	0.1
ZNF597	"FLJ33071, HIT-4"	ENSG00000167981	"Zinc finger protein 597"	Q96LX8	16	3432422-3443542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA001556	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA001556: AB_1080740"	"unprognostic (1.98e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.75e-3)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.99e-3)"	6.7	6.7	4.5	4.6	8.5	5.0	5.9	5.2	8.7	4.7	4.2	7.3	2.4	3.8	5.6	6.8	4.0	5.9	6.0	5.4	4.8	4.4	5.2	5.4	7.4	6.1	4.5	4.5	7.2	5.2	4.5	7.7	7.9	8.9	4.8	3.2	5.8	4.6	4.9	3.6	4.4	5.1	4.1	4.6	5.4	4.8	13.2	5.4	5.4	6.4	2.6	5.6	5.7	4.6	1.4	1.1	11.3	2.2	0.9	2.2	0.8	0.0	1.8	2.3	5.4	1.7	2.6	8.7	2.6	3.2	2.5	3.2	0.0	3.3	4.4	2.5	2.9	1.9	1.4	5.1	2.3	3.3	2.6	2.0	7.5	4.8	3.1	2.5	4.4	4.5	3.3	3.7	2.8	3.2	2.5	6.8	2.4	1.6	2.9	2.9	1.4	3.1	4.7	7.3	1.9	0.0	2.0	6.7	3.0	2.1	7.1	2.9	4.1	5.1	2.7	1.9	6.4	2.3	6.7	4.4	4.2	2.2	0.0	2.5	3.8	4.0	0.5	0.0	2.6	2.5	3.8	1.1	11.3	1.3	2.2	2.2	1.4	1.0	1.1	1.1	1.1	1.9	1.4	0.3	0.9	1.0	0.5	1.6	0.8	4.5	8.5	5.2	8.7	4.8	4.4	4.5	4.5	8.9	5.4	23.8	1.6	2.7	1.6	0.1	1.9	1.4	0.0	1.4	9.1	1.8	0.0	1.0	0.0	0.9	3.8	2.2	0.7	0.0	0.9	1.6	1.0	2.1	3.5	1.0	1.0	0.0	2.4	3.1	1.5	3.3	1.1	0.9	0.0	2.8	1.6	1.5	1.6	0.0	2.1	1.2	3.2	6.5	1.0	4.2	6.9	0.4	1.3	0.7	2.3	1.8
ZNF615	FLJ33710	ENSG00000197619	"Zinc finger protein 615"	Q8N8J6	19	51991332-52008230	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA052422	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA052422: AB_2681825"	"unprognostic (2.20e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.08e-3)"	"unprognostic (7.28e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.98e-4)"	10.2	7.4	11.9	6.0	16.4	7.5	10.1	20.7	12.2	8.2	8.8	7.3	6.9	5.2	12.0	7.8	6.5	9.8	7.6	8.5	8.5	7.1	9.5	6.1	7.6	6.2	11.7	9.8	15.7	7.5	16.6	17.8	8.3	9.9	26.9	5.8	8.0	7.7	11.0	7.2	7.2	6.0	9.6	12.8	7.9	6.7	5.5	13.6	7.3	11.7	3.8	6.1	11.1	8.8	4.7	4.8	6.9	4.4	12.0	7.8	3.8	1.3	5.2	5.8	11.8	10.6	7.7	4.4	3.9	6.6	5.4	5.6	1.1	1.4	2.1	2.2	4.7	3.4	1.4	4.0	2.5	5.0	0.3	8.9	6.7	5.2	3.9	8.3	0.0	4.0	6.5	2.8	8.5	9.1	10.0	2.9	2.1	0.0	0.0	4.1	0.4	0.0	3.5	6.0	0.2	8.8	4.2	9.1	3.7	3.7	9.1	5.2	4.5	4.8	4.5	3.2	6.4	6.5	3.3	5.2	5.1	5.9	3.3	2.8	4.0	10.4	2.6	3.0	0.0	8.2	6.9	3.0	5.8	3.7	4.4	7.8	3.9	6.6	5.3	4.8	4.7	6.6	4.3	4.1	12.0	2.7	2.9	5.7	3.8	11.9	16.4	20.7	12.2	8.5	7.1	11.7	9.8	9.9	13.6	6.0	4.5	3.2	1.9	2.5	7.1	5.9	2.5	4.0	1.2	3.5	5.9	3.2	3.3	1.6	0.9	2.9	1.1	0.0	1.0	2.2	3.8	5.2	0.0	1.9	2.6	3.2	8.6	3.7	3.3	0.9	2.3	3.2	6.8	1.8	2.6	3.0	1.3	3.7	3.9	2.4	6.2	6.5	5.7	2.6	2.1	3.4	4.2	4.4	2.1	1.8
ZNF627	FLJ90365	ENSG00000198551	"Zinc finger protein 627"	Q7L945	19	11559374-11619135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA049770, HPA073463"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA049770: AB_2680871, HPA073463: AB_2686606"	"unprognostic (1.81e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.89e-3)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-1)"	"unprognostic (6.39e-3)"	10.3	8.4	9.9	10.1	11.1	10.5	17.5	15.6	12.8	13.8	9.2	11.1	15.4	8.1	16.7	14.6	7.9	19.4	10.1	8.4	9.2	10.0	15.4	11.0	9.6	10.3	12.3	10.0	20.9	19.7	9.3	17.8	9.8	10.3	13.4	11.0	12.5	11.6	14.8	7.7	10.1	8.5	14.1	9.6	9.9	9.2	12.1	11.8	17.4	19.9	7.8	11.3	11.9	13.8	10.2	8.0	13.4	5.6	7.9	8.9	4.8	4.7	3.9	12.8	15.7	5.8	6.1	7.2	7.0	8.3	8.0	8.2	3.2	3.3	3.5	7.1	5.5	4.1	4.3	5.1	6.9	9.1	6.3	2.3	9.9	2.5	6.2	10.9	5.6	5.7	7.3	9.9	5.5	12.2	12.5	8.8	9.0	9.3	5.1	10.6	9.8	9.0	5.6	9.4	3.2	8.6	10.0	9.6	4.8	9.1	7.5	17.7	12.8	9.2	5.2	9.8	11.4	9.1	15.9	7.8	8.7	4.0	4.9	4.9	7.2	7.0	3.9	4.0	9.3	7.1	13.4	4.9	7.8	5.4	5.6	6.4	10.2	6.6	6.6	8.0	6.9	8.9	7.9	2.6	7.9	5.3	3.1	3.6	4.8	9.9	11.1	15.6	12.8	9.2	10.0	12.3	10.0	10.3	11.8	11.9	5.1	11.9	3.2	1.1	4.7	11.5	10.2	9.4	1.2	8.7	3.9	4.3	14.9	4.7	6.0	3.2	3.2	0.0	2.1	3.5	3.3	4.2	1.1	5.3	2.8	6.4	5.1	4.3	5.7	2.4	4.9	2.1	0.0	3.6	3.8	5.5	4.0	3.5	4.9	6.0	5.6	0.0	4.1	14.4	3.9	2.4	3.9	3.2	3.7	2.6
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	5.6	8.7	15.3	7.9	25.0	11.1	10.7	27.7	22.3	11.6	8.1	16.5	17.8	8.3	13.6	15.1	9.7	13.1	9.4	7.4	20.1	11.6	9.7	8.6	6.9	9.8	30.4	14.3	17.2	12.2	18.4	13.8	8.1	21.2	14.9	7.0	7.7	21.9	11.1	11.5	19.6	8.9	9.2	18.3	10.0	8.7	22.9	25.7	6.6	11.3	9.2	7.8	9.1	8.8	4.6	4.4	4.8	2.1	10.6	6.4	2.8	4.8	5.1	4.3	10.7	3.7	1.9	18.7	4.1	1.4	4.7	3.0	5.8	7.0	6.0	8.5	2.0	1.9	7.0	6.5	6.2	3.4	8.9	4.4	7.1	10.9	1.6	2.8	7.9	5.7	2.4	8.0	4.8	12.8	4.7	4.3	8.0	14.6	4.4	2.1	3.4	4.0	16.3	8.8	12.4	11.1	13.7	2.8	12.0	9.0	3.6	8.5	6.3	4.5	7.8	8.4	1.7	9.5	13.0	3.0	2.1	3.5	2.3	5.6	12.4	7.8	3.8	4.6	10.5	3.5	0.0	2.1	1.9	5.7	1.6	4.9	4.6	4.5	6.0	4.4	3.8	6.4	4.6	4.8	10.6	1.4	3.5	4.7	2.8	15.3	25.0	27.7	22.3	20.1	11.6	30.4	14.3	21.2	25.7	8.9	7.5	8.0	10.6	8.5	14.0	3.0	10.2	8.1	2.3	10.4	21.6	10.2	5.0	6.3	8.0	6.3	8.8	23.3	3.4	9.1	6.6	13.7	5.7	5.9	5.7	11.1	7.9	1.8	6.9	5.8	9.5	5.4	15.1	6.4	9.4	8.4	6.1	5.8	6.7	3.1	13.8	0.0	4.9	31.1	15.6	6.9	5.1	10.2	11.7	8.5
ZNF696	FLJ14129	ENSG00000185730	"Zinc finger protein 696"	Q9H7X3	8	143289676-143298061	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA057855, HPA072473"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA057855: AB_2683545, HPA072473: AB_2686524"	"unprognostic (3.23e-2)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (3.52e-5)"	"unprognostic (2.58e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.76e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (6.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.09e-3)"	8.5	6.9	10.3	8.1	10.6	6.3	6.9	13.9	13.7	5.6	5.4	9.8	5.4	13.5	8.8	4.8	5.0	6.6	7.1	5.2	10.4	10.3	7.2	8.1	7.6	8.6	12.6	7.2	9.8	13.7	8.6	6.7	5.5	10.6	7.5	4.1	7.2	11.9	5.1	7.7	13.3	8.0	10.7	8.9	8.3	6.5	6.9	12.8	6.5	7.5	3.0	6.6	7.2	5.2	6.4	6.4	2.3	3.3	5.3	7.5	3.3	6.3	5.9	5.7	6.8	2.5	1.7	12.4	5.0	1.6	3.6	2.1	3.4	5.0	0.4	7.0	1.7	2.0	4.5	6.6	2.7	3.2	7.1	14.4	8.5	5.6	5.1	2.5	3.4	10.9	1.5	4.5	2.4	5.0	2.3	1.7	5.1	17.6	3.9	2.1	12.7	3.7	7.0	8.1	6.9	15.1	7.8	3.6	6.2	1.9	4.6	9.7	13.6	7.6	4.9	6.2	3.9	8.0	6.2	3.6	4.9	11.2	4.3	8.8	8.1	5.4	7.9	3.3	7.0	5.7	1.1	3.3	2.3	5.3	1.9	5.8	4.2	4.0	5.9	3.7	6.4	7.5	6.2	1.4	5.3	2.9	6.4	1.3	3.3	10.3	10.6	13.9	13.5	10.4	10.3	12.6	7.2	10.6	12.8	0.0	0.0	0.0	2.1	2.6	4.3	2.4	0.0	0.0	0.0	3.5	5.9	1.2	3.3	2.3	0.6	2.1	2.0	0.0	1.8	2.1	1.5	1.2	0.0	2.1	1.1	3.2	0.0	1.8	0.0	1.6	3.7	0.0	1.7	1.0	0.9	2.5	1.6	0.0	1.1	1.9	3.4	6.5	1.6	2.1	5.9	1.8	0.3	1.5	1.9	0.7
ZNF71	"Cos26, EZFIT"	ENSG00000197951	"Zinc finger protein 71"	Q9NQZ8	19	56595264-56626481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.3"					"Low region specificity"	"Detected in all"			HPA018124	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA018124: AB_1848339"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.03e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.97e-3)"	11.8	6.4	12.9	6.9	8.7	3.5	11.7	12.0	12.5	7.9	9.9	10.2	6.5	6.7	12.3	6.6	8.6	8.7	7.0	10.5	9.3	8.0	6.4	3.4	9.6	10.6	7.7	10.2	12.3	8.8	7.6	8.5	8.0	9.3	8.7	5.0	6.4	8.9	10.5	10.6	7.4	6.0	16.6	8.5	10.2	7.0	8.7	8.2	9.8	7.5	5.9	6.2	10.0	10.7	7.0	4.9	6.8	4.2	9.0	8.3	4.2	3.4	6.6	9.8	8.1	4.1	3.6	6.3	4.0	3.8	2.8	4.0	1.2	1.0	2.9	3.7	3.4	3.3	1.2	2.2	3.1	2.4	0.0	20.3	4.4	0.9	2.6	3.4	5.5	4.3	4.1	3.3	2.8	1.8	4.3	4.5	7.3	2.6	0.0	3.0	0.0	11.3	2.1	7.6	0.0	6.5	4.2	6.1	2.4	2.0	3.9	8.7	10.6	2.8	3.7	4.0	4.0	2.1	5.7	5.9	9.4	5.3	2.2	6.4	2.8	3.5	4.5	3.1	3.3	2.5	2.9	3.2	6.8	7.7	2.0	8.3	6.5	6.4	7.3	4.9	7.0	7.2	7.4	1.3	9.0	4.2	3.7	6.6	4.2	12.9	8.7	12.0	12.5	9.3	8.0	7.7	10.2	9.3	8.2	3.0	1.7	2.2	2.5	2.6	7.8	3.2	2.5	0.0	1.2	7.0	3.9	4.5	3.3	8.7	2.2	6.0	0.7	0.0	4.3	5.2	5.3	1.9	0.0	0.6	5.1	11.1	2.4	3.1	1.6	3.1	5.8	3.9	3.3	5.4	1.7	3.2	5.5	2.3	5.3	4.6	7.7	0.0	4.1	2.1	8.0	3.8	1.3	5.4	2.4	1.0
ZNF77	pT1	ENSG00000175691	"Zinc finger protein 77"	Q15935	19	2933218-2944971	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023397	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA023397: AB_1859447"	"unprognostic (1.17e-2)"	"prognostic favorable (8.49e-4)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.65e-5)"	"unprognostic (2.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-6)"	"unprognostic (2.06e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.93e-3)"	"unprognostic (2.65e-3)"	"unprognostic (3.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.79e-3)"	6.3	6.6	6.6	5.4	8.9	5.6	13.2	18.2	9.8	8.4	6.1	8.4	9.9	4.1	8.5	8.5	7.5	7.3	4.2	7.4	5.9	5.8	6.4	6.3	12.7	6.6	7.0	7.8	9.7	8.2	8.2	8.2	8.2	6.5	6.9	6.4	8.9	11.4	6.7	6.1	8.3	6.1	8.7	5.5	6.8	8.1	8.3	4.3	9.6	8.8	4.0	9.3	6.4	6.7	5.5	3.7	1.3	3.1	3.9	6.2	3.3	4.7	2.2	10.8	6.3	2.3	3.0	4.9	2.9	4.3	5.8	6.9	7.3	1.9	5.3	2.4	3.2	3.2	3.8	7.0	4.7	9.8	0.4	5.1	6.4	3.4	8.1	5.7	0.2	5.3	4.6	6.5	4.5	6.7	7.2	8.0	10.5	8.4	0.0	3.9	5.2	7.8	4.6	2.4	4.1	3.1	8.9	8.3	3.7	4.6	7.4	4.4	8.3	4.4	4.2	5.0	5.5	4.0	11.1	3.8	2.4	3.1	6.8	5.2	5.5	5.3	2.5	6.2	0.1	4.4	0.0	2.7	1.3	5.5	2.6	6.2	5.5	5.8	5.9	3.7	5.3	4.5	6.2	0.2	3.9	3.1	3.0	2.8	3.3	6.6	8.9	18.2	9.8	5.9	5.8	7.0	7.8	6.5	4.3	3.0	3.8	0.0	4.2	10.3	2.8	2.0	0.0	2.7	4.5	1.8	2.0	2.9	0.0	1.8	1.6	2.1	1.3	0.0	1.5	2.6	2.2	2.0	2.3	1.5	1.5	0.0	6.9	3.1	0.6	0.0	2.6	1.6	1.7	0.0	2.2	3.0	2.0	1.9	1.4	1.0	5.5	0.0	2.1	10.0	7.3	9.5	5.1	1.9	3.1	1.8
ZNF771	DSC43	ENSG00000179965	"Zinc finger protein 771"	Q7L3S4	16	30407297-30431108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 27.0;REH: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030730, HPA046672, HPA059398"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002"	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-5)"	"unprognostic (3.53e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.99e-3)"	6.6	6.7	15.3	5.0	14.5	4.0	5.3	10.7	18.3	6.6	6.1	4.9	6.6	4.5	10.4	7.2	4.6	7.5	6.1	4.6	13.4	10.6	9.2	8.6	4.1	3.3	8.8	16.9	10.8	7.3	8.1	6.2	2.4	8.8	10.1	5.4	4.0	4.9	12.3	18.2	6.1	4.3	9.6	5.1	3.6	4.8	3.7	8.1	1.9	5.4	3.5	4.2	6.8	5.6	6.6	3.7	1.9	2.5	1.8	6.2	2.7	3.1	3.6	5.0	4.1	7.2	3.0	3.8	4.7	2.3	3.0	3.1	1.6	1.6	3.8	8.0	2.3	3.7	2.4	5.2	2.1	3.1	1.3	27.0	3.2	2.4	4.8	3.7	1.6	3.8	4.6	1.6	3.7	2.3	3.1	3.0	4.0	7.7	2.3	2.5	5.7	3.8	5.2	4.0	1.9	2.9	17.3	3.7	2.4	1.7	1.3	7.9	5.0	2.5	2.2	3.0	2.7	2.9	1.8	2.7	5.0	6.0	2.9	3.3	3.5	3.7	1.9	3.3	3.5	3.2	1.0	1.1	0.7	3.6	2.5	4.9	2.7	4.3	4.2	2.8	6.6	6.2	3.7	1.9	1.8	0.5	3.7	4.4	2.7	15.3	14.5	10.7	18.3	13.4	10.6	8.8	16.9	8.8	8.1	3.0	0.3	2.2	10.4	4.5	11.2	6.3	15.3	0.0	1.2	5.2	9.8	4.8	28.2	6.4	1.3	5.8	5.3	0.0	3.7	2.6	9.4	8.8	1.1	16.3	2.9	11.1	4.1	14.7	0.6	1.5	23.3	2.8	5.0	1.0	8.1	15.1	3.6	4.2	28.0	23.6	7.1	12.9	8.9	1.1	1.6	5.8	3.0	3.9	9.8	3.4
ZNF865		ENSG00000261221	"Zinc finger protein 865"	P0CJ78	19	55605405-55617269	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.2"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068079	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA068079: AB_2685947"	"unprognostic (3.98e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.72e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.41e-3)"	12.1	7.5	8.3	11.0	10.5	11.1	8.2	12.3	15.1	8.0	10.0	9.7	6.6	11.0	11.5	6.8	6.2	8.7	7.0	12.2	7.3	5.8	8.3	6.7	8.7	13.3	7.4	8.5	10.3	11.2	9.9	9.5	6.1	7.4	9.9	4.8	8.1	12.1	7.7	56.2	11.1	10.4	7.4	7.3	16.0	12.2	4.7	7.9	14.0	9.5	8.0	9.1	9.3	9.9	1.2	0.5	1.4	0.1	0.1	0.6	0.1	6.4	5.3	2.3	3.7	2.5	1.9	6.3	4.6	2.6	2.5	2.4	1.7	4.2	7.5	5.4	3.4	1.3	5.4	1.4	2.8	1.0	7.4	17.6	4.3	3.2	2.2	4.0	4.9	8.4	2.9	4.5	3.1	1.9	2.3	1.7	4.7	8.2	5.1	1.6	3.0	7.7	5.3	5.2	3.7	9.2	12.0	3.6	4.7	2.9	4.4	5.5	8.9	6.4	3.9	3.9	1.2	3.1	7.7	5.0	3.9	9.3	3.5	5.8	10.8	9.3	3.9	4.8	3.8	6.2	0.0	0.0	1.4	0.3	0.1	0.2	1.2	0.2	0.1	0.1	0.2	0.1	0.6	0.8	0.1	0.1	0.5	0.0	0.1	8.3	10.5	12.3	15.1	7.3	5.8	7.4	8.5	7.4	7.9	0.0	0.0	1.9	1.0	3.7	3.7	18.6	2.5	0.0	0.0	14.0	0.0	2.1	5.0	3.1	1.9	5.2	5.2	0.0	3.8	2.7	3.8	1.2	0.0	5.4	4.0	9.5	5.8	6.7	5.4	3.2	4.9	4.2	5.0	1.8	6.3	3.9	4.7	0.0	9.6	3.6	3.2	6.5	4.1	1.2	1.4	3.8	2.2	4.8	5.7	0.9
ZNF878		ENSG00000257446	"Zinc finger protein 878"	C9JN71	19	12043805-12052939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Cytotrophoblasts: 1.1;Spermatogonia: 1.5;Syncytiotrophoblasts: 1.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.4"									HPA052735	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052735: AB_2681932"	"unprognostic (3.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.62e-2)"	1.1	1.4	0.4	1.5	3.1	5.8	0.8	2.5	2.4	1.5	1.2	0.4	0.0	0.6	1.8	1.2	1.4	1.2	1.4	0.7	1.9	0.5	7.7	2.5	1.5	1.4	4.4	0.3	2.4	5.0	0.8	2.4	5.1	7.4	1.4	1.2	0.4	3.2	0.3	0.5	1.0	1.3	1.4	1.9	1.3	1.2	4.6	2.2	1.7	1.4	0.0	1.3	1.2	1.7	0.3	0.1	0.5	0.0	1.5	0.5	0.1	3.0	0.0	1.7	6.4	0.1	0.0	3.8	1.0	0.5	1.3	1.7	2.5	0.4	1.4	1.5	0.4	1.8	0.8	0.6	0.9	1.2	0.0	0.9	1.8	0.0	3.5	0.0	1.2	3.3	0.2	0.0	0.7	0.0	0.1	0.0	3.9	0.0	0.0	1.3	0.0	2.9	1.7	3.6	0.0	0.5	2.4	3.3	0.0	2.2	2.2	1.7	0.3	0.0	0.1	0.3	3.5	3.3	3.9	0.0	1.9	1.4	1.5	1.8	1.2	3.8	0.3	0.0	0.6	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.5	0.1	0.0	1.5	0.0	0.0	0.0	0.1	0.4	3.1	2.5	2.4	1.9	0.5	4.4	0.3	7.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.0	0.0	0.0	0.0
ZSCAN26	"SRE-ZBP, ZNF187"	ENSG00000197062	"Zinc finger and SCAN domain containing 26"	Q16670	6	28267010-28278224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027521			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA027521: AB_2672314"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (6.79e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (1.68e-4)"	4.4	5.4	7.4	4.8	10.5	2.5	8.3	17.7	11.4	8.4	4.3	10.5	7.3	4.2	10.5	7.4	4.9	7.9	6.7	6.3	8.1		5.1	3.6	5.2	4.9	7.3	11.5	18.7	4.0	8.9	7.8	4.6	9.6	7.7	5.0	5.7	4.5	10.7	6.4	4.9	4.4	8.9	6.6	7.6	4.9	2.9	9.6	4.0	7.6	2.0	6.1	5.8	4.6	15.2	9.6	10.7	6.2	16.1	16.3	9.6	5.6	4.8	13.7	11.7	14.9	14.3	3.1	11.2	11.2	14.8	15.3	3.5	4.1	3.2	17.4	7.1	11.1	4.3	6.3	8.2	16.3	6.8	6.8	8.5	6.7	7.5	10.3	7.0	5.5	11.9	7.8	11.3	10.3	19.1	14.9	5.0	7.0	6.8	11.6	4.7	7.4	9.6	4.0	3.0	7.3	7.5	11.9	5.4	12.5	5.8	9.9	7.7	6.9	2.9	9.3	11.6	4.8	4.8	9.7	11.9	8.7	4.2	13.6	7.2	9.6	6.2	4.3	7.9	10.3	10.5	6.2	10.7	13.4	4.8	15.8	13.4	13.1	14.4	9.6	15.2	16.3	13.5	4.4	16.1	4.0	4.5	11.8	9.6											0.0	3.5	10.4	2.8	0.0	8.6	8.7	0.0	2.7	11.4	0.0	3.9	3.8	3.3	4.2	3.2	6.8	2.6	0.0	4.4	2.7	3.5	3.0	5.8	1.5	5.0	1.6	6.4	4.3	5.0	1.7	8.3	1.9	0.0	1.0	2.3	11.7	3.0	4.0	12.4	4.9	9.7	19.4	2.7	5.5	8.1	0.0	1.1	7.5	2.7	0.9